data_1p8a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1p8a _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.691 0.758 . . . . 4.21 110.46 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -119.4 143.19 47.59 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.092 -0.707 . . . . 4.3899999999999997 109.092 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' A' ' 33' ' ' LEU . 15.3 mttt -115.19 -131.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.138 -0.976 . . . . 3.02 110.708 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.805 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . -176.79 103.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.438 -0.789 . . . . 1.6699999999999999 109.672 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.517 ' CG1' ' HB2' ' A' ' 84' ' ' ALA . 41.4 t -90.32 138.65 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 1.8500000000000001 110.495 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 5.7 tp -87.0 94.56 9.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 1.72 110.019 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.575 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 2.4 m-85 -78.44 104.33 8.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 3.21 110.063 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' CG2' ' CB ' ' A' ' 38' ' ' ALA . 30.5 t -123.46 163.11 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 1.97 110.296 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 1.5 p -149.99 -53.53 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 2.54 110.39 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 173.88 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.139 -0.975 . . . . 2.5299999999999998 110.237 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . 136.21 -4.9 3.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.724 -1.35 . . . . 1.99 109.724 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.52 ' N ' ' HB3' ' A' ' 39' ' ' ALA . 5.0 t30 69.43 38.13 1.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -1.148 . . . . 2.6299999999999999 110.262 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 15' ' ' ILE . 12.5 mt -136.49 -39.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 1.9199999999999999 110.235 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 88.3 m -90.39 107.79 19.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 3.6699999999999999 110.178 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.551 ' CB ' ' O ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER 73.55 -4.19 2.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 3.8599999999999999 110.392 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -84.42 -51.53 0.57 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 4.7699999999999996 110.66 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 18' ' ' SER . 47.3 Cg_endo -75.22 3.48 5.69 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.817 1.43 . . . . 2.9399999999999999 110.619 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.526 ' HB1' ' CE ' ' A' ' 128' ' ' MET . . . -98.85 -19.01 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 1.74 110.209 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . 22.0 m -71.55 -36.98 71.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 2.1400000000000001 109.991 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -63.04 -38.38 90.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 2.2799999999999998 110.015 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -76.72 -56.01 4.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.636 -1.386 . . . . 0.87 109.636 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 129' ' ' PHE . 5.7 tp -50.11 -44.78 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -1.198 . . . . 1.71 110.129 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.579 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 69.4 m -72.22 -53.31 12.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 1.79 110.042 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -43.53 -41.03 4.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 2.7999999999999998 109.99 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -33.66 26.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 2.0600000000000001 110.243 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -59.12 -44.37 92.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 2.9300000000000002 110.468 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.466 HG12 ' HD2' ' A' ' 32' ' ' LYS . 5.6 t -108.3 -32.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.96 . . . . 2.6000000000000001 110.517 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 123.55 -54.1 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.546 -1.422 . . . . 2.52 109.546 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.6 t70 179.61 90.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 3.5899999999999999 110.254 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HD2' HG12 ' A' ' 29' ' ' VAL . 15.0 mttt -141.61 -137.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 3.8300000000000001 110.173 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.793 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.9 mt -116.39 -123.07 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 4.1399999999999997 110.07 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.805 ' CA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 50.45 5.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.53 -0.731 . . . . 2.4300000000000002 111.305 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 25' ' ' CYS . 3.5 mt -121.2 109.27 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.95 -1.094 . . . . 2.7400000000000002 110.724 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.593 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 6.7 m-20 -143.1 91.75 2.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.8799999999999999 109.986 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 2.8 m -69.4 137.97 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.9399999999999999 110.221 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' CB ' ' CG2' ' A' ' 10' ' ' VAL . . . -151.61 177.18 10.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 1.51 110.315 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB3' ' N ' ' A' ' 14' ' ' ASN . . . -162.71 144.99 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 1.53 110.176 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -109.0 38.93 2.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 2.2799999999999998 110.193 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -160.72 87.04 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 2.25 110.214 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.26 68.7 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.517 -1.433 . . . . 2.1600000000000001 109.517 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' SER . 2.1 m-85 -108.39 -61.05 1.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -1.164 . . . . 3.7000000000000002 110.172 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -92.05 91.22 7.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 3.0099999999999998 110.191 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 64.5 t -136.06 162.77 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 2.4700000000000002 110.229 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.61 37.12 55.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 1.8500000000000001 109.561 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.487 ' HG3' ' N ' ' A' ' 48' ' ' SER . 11.1 pt20 -172.11 -144.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -1.127 . . . . 1.9399999999999999 110.196 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.6 OUTLIER 57.27 110.7 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 2.29 110.167 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.46 92.37 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.012 1.533 . . . . 2.0899999999999999 110.45 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 1.2 m-20 -86.48 19.02 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 2.8399999999999999 110.207 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -75.43 -27.93 59.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.247 -0.908 . . . . 1.8100000000000001 109.077 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 45.0 mtt180 -72.6 -51.65 18.8 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.822 -0.751 . . . . 3.7000000000000002 109.369 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 t -63.55 -49.83 71.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -0.794 . . . . 1.9099999999999999 109.615 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -60.42 -39.92 89.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.274 -0.891 . . . . 2.8100000000000001 109.305 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -59.42 -67.68 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 3.6000000000000001 109.542 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.576 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 22.0 t -48.41 -34.21 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 2.5299999999999998 109.239 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.509 ' SG ' ' CG1' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.22 -54.93 41.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 1.6000000000000001 109.605 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -68.54 -20.36 64.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 3.0600000000000001 109.706 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.464 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 2.4 t -87.65 -13.58 42.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.357 -0.839 . . . . 1.8600000000000001 110.103 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -114.77 -30.7 6.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 2.1000000000000001 109.326 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 136.22 79.73 0.1 OUTLIER Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.922 -1.271 . . . . 1.29 109.922 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 40.6 t -159.61 123.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -1.079 . . . . 2.2799999999999998 110.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.14 105.05 14.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 2.46 110.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.493 HG13 ' N ' ' A' ' 65' ' ' SER . 35.6 pt -120.73 -145.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 2.46 110.237 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.493 ' N ' HG13 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -170.03 -64.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 4.1200000000000001 110.229 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 65' ' ' SER . 15.7 mmtt -142.25 145.93 34.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 6.1799999999999997 110.126 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.463 ' HA ' ' OE1' ' A' ' 67' ' ' GLN . 32.3 mm-40 -122.11 56.65 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 2.77 110.258 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ALA . 1.5 ttp85 -69.18 71.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 4.71 110.182 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 13' ' ' GLY . . . -42.51 136.28 2.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 1.8 110.236 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 ptt-85 -140.34 158.44 44.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 2.73 110.203 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.55 145.32 55.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 2.2400000000000002 110.197 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 72' ' ' ILE . 6.6 tt -89.96 128.76 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 1.9099999999999999 110.213 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.2 p -86.22 -142.75 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 2.6000000000000001 110.213 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -109.43 -5.98 15.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 3.8900000000000001 110.222 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -75.19 -21.34 58.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.8100000000000001 110.247 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 4.2 p-10 -44.68 -28.81 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 2.46 110.194 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 25.1 m-85 -79.63 -46.49 17.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 2.3500000000000001 110.248 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -95.06 8.42 43.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 2.21 110.209 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.59 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 14.0 tptt -102.62 -2.76 27.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 3.2000000000000002 110.228 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.593 ' CD2' ' CG ' ' A' ' 36' ' ' ASP . 91.8 m-85 -151.62 -157.56 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 2.5499999999999998 110.298 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.3 -26.28 2.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 2.3300000000000001 110.551 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.556 HG12 ' CD2' ' A' ' 143' ' ' HIS . 97.0 t -136.94 150.88 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.052 . . . . 1.77 110.576 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.52 HG21 ' CD1' ' A' ' 94' ' ' ILE . 1.7 mp -123.24 116.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.824 . . . . 1.3899999999999999 109.902 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -103.12 118.82 37.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 1.4399999999999999 110.483 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.61 112.72 24.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 1.3400000000000001 110.065 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 5.0 mp -59.48 -84.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 1.75 110.356 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.515 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -62.77 159.81 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 2.02 110.273 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 2.48 110.184 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -52.81 -40.16 63.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 2.0899999999999999 110.165 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.527 ' CG2' HG11 ' A' ' 10' ' ' VAL . 2.8 mt -65.2 -51.73 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 2.3100000000000001 110.189 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -61.29 -43.55 98.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 1.49 110.378 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 t -64.81 -48.62 73.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.917 . . . . 1.5700000000000001 110.264 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -64.65 -63.67 1.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 1.73 110.265 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.52 ' CD1' HG21 ' A' ' 83' ' ' ILE . 6.1 tt -42.76 -38.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 2.0699999999999998 110.248 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.498 ' N ' HG22 ' A' ' 94' ' ' ILE . 28.6 t-20 -71.9 -24.9 61.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 2.27 110.214 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 93' ' ' ASP . 42.7 t -76.88 -2.02 31.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 1.6399999999999999 110.225 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.516 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.0 ptt? -123.97 -25.33 4.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 1.53 110.219 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 1.4 mtpt -49.04 143.02 9.16 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 1.6499999999999999 110.26 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.09 -159.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.991 1.522 . . . . 1.6000000000000001 110.438 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.84 2.62 15.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.86 . . . . 2.29 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -149.16 108.11 3.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 3.8799999999999999 110.263 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.4 p -149.48 -173.79 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.887 . . . . 2.3700000000000001 110.222 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 17.08 7.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 3.25 110.218 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.46 157.93 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 1.25 110.208 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -115.43 157.23 24.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.281 -0.887 . . . . 3.1400000000000001 110.177 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.451 HG11 HG23 ' A' ' 83' ' ' ILE . 39.6 t -118.61 114.51 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 1.98 110.185 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' CE1' ' A' ' 143' ' ' HIS . 27.6 m -121.58 148.19 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 2.0499999999999998 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 109' ' ' PHE . 1.3 tp -85.68 152.8 22.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 1.95 110.181 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.515 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 4.4 t80 -115.82 109.3 17.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 2.9900000000000002 110.268 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.479 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER 57.79 156.25 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 3.6200000000000001 110.28 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.479 ' HD2' ' ND2' ' A' ' 110' ' ' ASN . 47.0 Cg_endo -74.83 174.26 13.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.039 1.547 . . . . 3.1899999999999999 110.28 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.85 52.33 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 4.71 110.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -145.9 -47.03 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 3.1299999999999999 110.251 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.39 -102.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 2.8300000000000001 109.552 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.503 ' CG2' HD21 ' A' ' 86' ' ' LEU . 30.8 m -54.55 105.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 2.25 110.225 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -148.22 29.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 4.1500000000000004 110.247 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.512 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 6.9 t0 -48.95 112.41 2.43 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 4.1399999999999997 110.199 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 46.8 Cg_endo -72.73 -93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.939 1.494 . . . . 4.2699999999999996 110.427 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 168.12 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 4.1699999999999999 110.178 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.19 -46.99 0.34 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 6.4299999999999997 110.254 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.59 167.07 10.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 2.5899999999999999 110.227 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.566 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -88.24 32.68 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 2.9300000000000002 110.185 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.91 16.61 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 2.1600000000000001 110.221 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -118.91 -44.12 0.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.497 -1.441 . . . . 1.6299999999999999 109.497 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.626 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 5.2 m-85 -44.17 -48.15 23.76 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.169 . . . . 2.79 110.396 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.7 Cg_endo -72.59 -54.53 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.625 1.329 . . . . 1.1899999999999999 110.349 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 128' ' ' MET . 23.1 m -62.13 -53.88 49.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 2.1099999999999999 110.142 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.533 ' HG3' ' CG ' ' A' ' 17' ' ' ARG . 10.7 ttp -41.85 -65.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 1.3700000000000001 110.108 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 50.2 t80 -56.25 -44.78 80.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 2.3100000000000001 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -44.06 -59.73 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 1.6699999999999999 109.99 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 25.7 m -70.75 -42.31 70.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.9199999999999999 109.867 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.572 ' CG2' ' CG1' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -41.58 -43.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 2.04 109.904 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.532 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.2 -40.49 7.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 1.8500000000000001 110.241 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 33.5 tttt -55.47 -16.64 3.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 3.9500000000000002 110.227 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.468 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 4.2 tp10 -117.9 16.13 14.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 3.0899999999999999 109.809 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.55 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -102.97 -21.2 13.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 3.3399999999999999 110.162 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 19.4 mttt -81.93 -47.04 1.01 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 3.6299999999999999 110.148 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -77.79 -2.52 12.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.982 1.517 . . . . 1.2 110.271 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 143' ' ' HIS . 48.8 t80 -111.03 -72.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 2.5600000000000001 110.116 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.528 ' CD1' HD12 ' A' ' 34' ' ' ILE . 1.8 tp -47.83 -49.34 29.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 2.1400000000000001 110.052 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.514 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 6.7 m -58.3 -29.19 65.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.72 110.349 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -106.84 5.93 28.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 2.2999999999999998 110.397 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.69 ' CE1' ' CE2' ' A' ' 139' ' ' PHE . 0.5 OUTLIER -96.33 -6.16 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.129 -0.982 . . . . 2.9300000000000002 110.348 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 124.77 28.47 1.15 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 2.6800000000000002 109.726 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.47 HD13 HG22 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -144.36 -103.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -1.182 . . . . 2.8399999999999999 110.191 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.527 ' CD1' ' OXT' ' A' ' 146' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.0 -1.0 . . . . 3.4300000000000002 110.148 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.558 0.694 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -119.42 145.07 46.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.456 ' O ' HG21 ' A' ' 34' ' ' ILE . 16.0 mtmt -125.7 -156.21 0.72 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.058 -1.026 . . . . 0.0 110.975 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.655 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -124.88 157.13 36.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.678 -0.639 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.621 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 13.6 t -138.75 121.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.554 HD13 ' CD2' ' A' ' 80' ' ' PHE . 7.7 tp -76.91 103.39 6.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.568 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 18.3 m-85 -83.16 86.28 7.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 38' ' ' ALA . 6.7 t -93.86 154.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 16' ' ' CYS . 59.2 m -146.72 -71.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.136 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 175.96 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.262 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 80.47 -2.3 78.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.514 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 67.86 8.42 6.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mt -118.61 -22.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.151 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 119' ' ' TYR . 14.5 m -86.09 111.64 20.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.267 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.584 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 1.1 mpt_? 60.9 12.28 3.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.522 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -78.85 -55.18 1.0 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.465 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 18' ' ' SER . 47.4 Cg_endo -74.23 1.34 7.39 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.844 1.444 . . . . 0.0 110.576 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -97.54 -28.34 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.347 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.559 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 63.8 m -74.1 -33.95 63.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -63.78 -45.66 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.462 -0.773 . . . . 0.0 110.304 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.77 -51.58 6.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.613 ' CD1' ' CB ' ' A' ' 133' ' ' SER . 1.1 tt -52.01 -45.22 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 0.0 110.357 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.596 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 88.4 m -75.76 -51.85 11.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.179 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 3.6 mtp85 -44.12 -40.95 5.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.904 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -80.48 -43.01 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -58.38 -52.6 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 0.0 110.437 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.8 -34.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.369 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.38 -82.84 0.33 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 16.4 t0 -156.39 85.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -1.09 . . . . 0.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 31' ' ' ASP . 18.0 mmtm -129.8 -139.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.125 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.5 mt -119.15 -33.02 4.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.987 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.4 pp -32.17 -31.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.647 -0.658 . . . . 0.0 111.145 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.6 ' N ' ' O ' ' A' ' 33' ' ' LEU . 1.7 mt -73.96 88.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.483 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.579 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 49.0 m-20 -127.33 68.75 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.117 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -54.77 139.41 39.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.479 ' HB2' ' HG ' ' A' ' 8' ' ' LEU . . . -153.73 -179.09 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' CB ' ' A' ' 14' ' ' ASN . . . -150.07 -173.7 4.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.416 ' HA ' HG23 ' A' ' 72' ' ' ILE . 5.3 t -162.04 67.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.908 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 -68.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 110.206 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -22.6 39.63 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 45' ' ' VAL . 9.8 m-85 -62.69 -63.44 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.44 70.88 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 43' ' ' PHE . 44.5 t -144.75 142.27 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.95 18.98 58.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -168.11 -142.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 110.255 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.1 108.36 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.208 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 103.06 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.072 1.564 . . . . 0.0 110.486 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 61.5 m-20 -95.99 20.51 9.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -74.39 -27.76 60.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.949 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.586 ' HB3' ' CG ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -74.01 -52.07 13.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.296 179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.486 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 1.0 OUTLIER -61.37 -51.67 67.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.486 ' NE2' HG12 ' A' ' 64' ' ' ILE . 0.6 OUTLIER -61.37 -41.01 96.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 109.263 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -54.2 -66.16 0.45 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.416 -0.803 . . . . 0.0 109.467 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.582 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 10.0 p -53.41 -32.01 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.911 . . . . 0.0 109.216 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.519 ' SG ' ' CG1' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -56.3 -52.12 65.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.534 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -24.34 60.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.302 -0.874 . . . . 0.0 109.651 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.74 -12.42 58.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.3 m120 -114.59 -29.07 6.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 131.71 81.02 0.2 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 26.0 t -160.36 133.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -1.131 . . . . 0.0 110.14 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -122.15 93.15 3.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 0.0 110.2 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.486 HG12 ' NE2' ' A' ' 54' ' ' GLN . 26.0 pt -97.54 165.5 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.83 37.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.48 85.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 0.0 110.183 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.521 ' NE2' ' HB3' ' A' ' 19' ' ' PRO . 5.0 mp0 -105.18 -79.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.148 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' ALA . 7.3 ttp180 43.61 75.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 110.242 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 68' ' ' ARG . . . -42.43 149.22 0.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.87 -170.44 3.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -107.66 155.43 20.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.416 HG23 ' HA ' ' A' ' 40' ' ' THR . 18.5 tt -98.68 155.78 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.02 168.99 9.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -16.31 23.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -22.57 62.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.182 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 28.4 p-10 -48.38 -37.88 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.241 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CE2' ' HD3' ' A' ' 99' ' ' PRO . 20.8 m-85 -65.85 -10.87 42.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 110.21 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.414 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 27.7 t -144.52 30.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.585 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 15.7 tptt -111.17 -5.33 14.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.585 ' CD2' ' HB3' ' A' ' 79' ' ' LYS . 87.0 m-85 -151.7 -139.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.235 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 -53.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.918 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 74.6 t -119.13 111.04 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.467 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.454 ' HB ' HG21 ' A' ' 106' ' ' VAL . 3.9 mt -84.29 110.39 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.053 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.73 135.78 38.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 110.386 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.43 121.75 41.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.584 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 2.2 mp -66.09 -80.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.439 ' CB ' ' CD1' ' A' ' 90' ' ' ILE . 1.3 t0 -67.4 178.72 1.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.254 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -85.88 -35.07 20.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -51.46 -33.51 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 110.229 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 11' ' ' CYS . 1.9 mt -71.02 -52.53 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.5 OUTLIER -64.12 -34.4 77.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.23 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 t -77.86 -46.97 19.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 89' ' ' SER . 5.4 m-20 -67.09 -57.41 6.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 95' ' ' ASN . 3.9 tt -46.37 -40.82 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.514 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 8.3 t-20 -68.23 -24.93 64.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 93' ' ' ASP . 8.5 t -73.19 -17.08 61.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.458 ' CE ' HG13 ' A' ' 94' ' ' ILE . 9.3 ptt? -109.68 -27.14 9.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 2.3 mtpt -42.73 138.65 2.21 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.557 ' HD3' ' CE2' ' A' ' 77' ' ' PHE . 46.0 Cg_endo -73.26 -160.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.094 1.576 . . . . 0.0 110.422 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.497 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 26.3 t -113.36 15.78 19.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 110.153 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 100' ' ' SER . 4.8 m-80 -155.02 104.95 2.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.2 p -137.33 -179.91 6.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.89 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.414 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -127.05 -5.54 6.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.52 -168.06 1.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.253 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.64 150.45 41.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.454 HG21 ' HB ' ' A' ' 83' ' ' ILE . 45.1 t -116.37 142.6 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.209 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.1 m -151.64 155.36 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.523 ' CG ' ' OD1' ' A' ' 110' ' ' ASN . 1.6 tp -89.28 142.2 27.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.545 ' CE1' ' HE2' ' A' ' 136' ' ' MET . 36.1 t80 -129.11 76.14 1.7 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.523 ' OD1' ' CG ' ' A' ' 108' ' ' LEU . 6.8 p-10 -176.9 166.24 1.42 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.7 Cg_endo -75.53 175.89 10.69 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.043 1.549 . . . . 0.0 110.296 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.509 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.0 Cg_endo -73.72 4.72 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.932 1.491 . . . . 0.0 110.489 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -122.36 -14.86 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.217 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.04 141.56 8.91 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 4.0 m -80.06 4.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -1.138 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 14.5 t70 178.01 169.4 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.237 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.563 ' CB ' ' CD ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -179.8 -59.35 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 117' ' ' ASP . 46.9 Cg_endo -73.13 88.76 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.94 1.494 . . . . 0.0 110.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.567 ' CE1' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -65.78 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.942 . . . . 0.0 110.17 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.474 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 1.7 t80 66.66 -62.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 119' ' ' TYR . 52.4 p -70.47 144.73 51.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.46 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 5.5 p -80.89 48.59 1.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.72 42.45 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -159.65 -37.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.627 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 47.5 m-85 -52.15 -44.98 93.94 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -1.163 . . . . 0.0 110.572 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 46.8 Cg_endo -74.13 -59.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.685 1.36 . . . . 0.0 110.286 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -55.3 -43.12 74.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.58 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 27.1 ttp -48.6 -80.55 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.605 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 6.1 t80 -49.01 -55.51 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.088 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -44.21 -28.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 110.513 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.8 m -88.85 -60.32 1.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.558 HG12 ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -50.46 -19.48 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.268 179.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.613 ' CB ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -98.15 -48.68 5.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.894 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 1.9 mmmm -71.02 -2.71 16.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 110.131 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.15 5.22 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.839 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.545 ' HE2' ' CE1' ' A' ' 109' ' ' PHE . 1.5 tpt -82.97 11.77 5.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.394 -0.816 . . . . 0.0 110.193 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.524 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 2.3 mmtt -90.51 -55.16 0.28 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.213 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 48.2 Cg_endo -76.26 -2.87 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.539 ' CD1' ' HE1' ' A' ' 136' ' ' MET . 25.1 t80 -108.16 -51.92 2.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.259 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.508 ' HA ' ' HA3' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -71.67 -55.95 6.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.545 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 56.3 m -41.93 -36.71 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 110.468 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.22 -63.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.724 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -100.96 63.72 1.03 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.752 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 145' ' ' LEU . . . -179.8 -32.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.533 ' HG ' ' CG2' ' A' ' 146' ' ' ILE . 0.6 OUTLIER 172.56 -91.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.472 -1.016 . . . . 0.0 109.864 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.545 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 1.1 tp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.129 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.241 0.543 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.558 ' HG2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -76.58 -175.31 3.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.293 -0.879 . . . . 0.0 109.05 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.558 ' N ' ' HG2' ' A' ' 4' ' ' LYS . 33.0 mtpt -145.9 177.37 8.98 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.901 -1.124 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.723 ' HA ' HG13 ' A' ' 34' ' ' ILE . . . -145.77 124.4 12.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.066 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 18.7 t -114.43 125.37 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.53 HD11 ' CE2' ' A' ' 80' ' ' PHE . 50.2 tp -79.24 98.94 6.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.64 ' CZ ' ' CG1' ' A' ' 7' ' ' VAL . 96.7 m-85 -85.98 104.63 15.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 38' ' ' ALA . 3.8 t -103.11 149.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.446 ' SG ' HD21 ' A' ' 86' ' ' LEU . 24.2 m -127.08 -151.33 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.92 . . . . 0.0 110.021 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.12 -30.46 21.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -144.18 9.99 2.0 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 43.5 t-20 59.26 49.68 8.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 0.0 110.29 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 13' ' ' GLY . 15.3 mt -136.75 -57.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.2 t -124.37 -138.42 0.29 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.288 -0.883 . . . . 0.0 110.133 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.38 -55.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.392 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.52 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 1.3 m -161.08 53.65 0.49 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.477 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.0 Cg_endo -75.31 -23.78 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.031 1.542 . . . . 0.0 110.308 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' CB ' ' SG ' ' A' ' 57' ' ' CYS . . . -78.49 6.82 7.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' CE2' ' A' ' 9' ' ' PHE . 6.0 t -61.24 -32.04 71.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.447 ' HA ' ' HB ' ' A' ' 35' ' ' ILE . 2.1 tt0 -56.03 -54.05 49.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -76.48 -39.31 30.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.672 ' CD1' ' CD2' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -53.87 -47.21 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.243 . . . . 0.0 110.037 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.591 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -79.28 -49.97 11.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 9.0 mtt180 -54.23 -31.0 52.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.68 -40.83 12.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.496 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.515 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.55 -30.95 70.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.701 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.533 ' CG2' HD22 ' A' ' 33' ' ' LEU . 83.1 t -124.72 -22.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.92 -82.4 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.462 ' C ' ' CG ' ' A' ' 32' ' ' LYS . 2.7 m-20 -149.76 68.14 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.261 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.546 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 2.0 mtpm? -148.9 37.86 0.81 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER 166.6 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.437 -0.789 . . . . 0.0 109.591 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.723 HG13 ' HA ' ' A' ' 6' ' ' ALA . 2.7 pp -42.59 168.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.634 ' CG2' ' CD1' ' A' ' 9' ' ' PHE . 4.7 mp -121.06 102.32 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 80' ' ' PHE . 9.4 m-20 -88.31 114.21 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.062 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.7 m -75.17 116.3 15.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.032 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.477 ' HB3' HG23 ' A' ' 10' ' ' VAL . . . -120.85 175.18 6.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.511 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . . . -161.16 149.3 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.454 HG22 HG23 ' A' ' 90' ' ' ILE . 5.2 t -116.75 -2.45 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.09 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.28 170.81 13.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 110.145 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.52 50.15 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -17.36 32.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -1.165 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.401 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -141.97 80.47 1.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.5 t -134.44 146.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.07 58.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 48' ' ' SER . 1.3 pt20 -158.94 -146.79 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -1.147 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 65.12 99.68 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 100.89 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.083 1.57 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 1.6 t0 -89.72 26.83 1.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -76.32 -31.92 58.42 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.225 -0.922 . . . . 0.0 109.051 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -70.31 -49.7 46.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.262 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.581 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.3 t -63.35 -53.49 51.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.573 -0.704 . . . . 0.0 109.683 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.555 ' NE2' ' N ' ' A' ' 55' ' ' LYS . 4.1 pp0? -61.04 -31.2 70.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.257 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.4 -66.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.383 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.571 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 35.7 m -52.79 -33.36 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.203 -0.935 . . . . 0.0 109.115 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.516 ' SG ' ' CB ' ' A' ' 20' ' ' ALA . 32.0 m -57.47 -53.07 62.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 109.508 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -23.17 63.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.99 -11.9 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 110.061 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.6 m-80 -112.44 -23.77 10.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.212 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 124.17 75.79 0.29 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 55.0 t -158.09 102.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -1.145 . . . . 0.0 110.205 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -78.34 74.26 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.988 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.452 HG22 ' CG1' ' A' ' 62' ' ' VAL . 3.4 pt -60.1 -173.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -160.22 70.07 0.41 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.22 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 90.3 mm-40 -56.52 -60.0 4.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.218 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.38 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.269 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.453 ' HB2' ' CG1' ' A' ' 15' ' ' ILE . . . -60.59 131.4 50.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -140.44 152.23 45.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.245 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.06 144.18 38.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.195 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.7 tt -75.8 145.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.1 t -89.72 -146.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.13 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -118.6 -5.29 10.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.31 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.67 -8.43 31.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.1 -47.63 12.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.231 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 53.5 m-85 -48.61 -36.71 16.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.9 t -102.07 -16.04 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.16 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -66.25 -25.56 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.194 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.564 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 7.4 m-85 -132.28 169.6 16.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.1 -33.78 20.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.377 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.551 HG12 ' CD2' ' A' ' 143' ' ' HIS . 47.6 t -134.23 153.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.31 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 4.8 mt -129.75 128.3 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -126.12 143.37 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.67 156.49 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.58 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 1.2 tp -85.3 -52.88 5.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.479 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 3.7 m-20 -99.56 -174.87 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.905 . . . . 0.0 110.244 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.58 -35.74 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -46.13 -41.27 12.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 87' ' ' ASP . 1.4 mp -71.02 -54.15 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.152 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -15.81 30.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 t -93.26 -41.26 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.18 -16.88 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.182 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.52 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.3 tt -74.14 -40.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.168 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.501 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 29.6 p30 -68.12 -9.76 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.65 -38.71 23.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.883 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.52 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.1 ptt? -84.1 -34.3 24.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.239 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -52.62 126.55 40.09 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 100' ' ' SER . 45.2 Cg_endo -73.39 -87.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.053 1.554 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 169.74 -23.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.4 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.84 43.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.128 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.8 p -99.47 -145.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.267 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 27.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.03 32.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.45 146.05 45.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 9.8 m -108.41 132.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 m -131.27 156.51 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.256 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.4 tp -92.46 102.4 14.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.123 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -81.09 82.61 6.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.134 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 7.7 t30 -170.09 142.16 1.84 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.495 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 47.5 Cg_endo -74.35 175.01 11.56 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.94 1.495 . . . . 0.0 110.35 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.02 52.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.977 1.514 . . . . 0.0 110.434 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.59 -37.18 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.206 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 101.54 2.51 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.66 98.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -1.209 . . . . 0.0 110.118 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.23 148.03 26.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 110.197 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 87.73 6.52 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.89 173.47 13.48 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.005 1.529 . . . . 0.0 110.406 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -115.75 161.92 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.23 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 50.38 41.65 25.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.155 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -150.89 -174.76 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.3 p -143.79 40.17 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.892 . . . . 0.0 110.174 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.32 54.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.556 ' HA2' ' CG2' ' A' ' 127' ' ' THR . . . -179.08 -32.84 0.06 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.606 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 8.1 m-85 -41.76 -50.29 10.05 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 110.731 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 43.4 Cg_endo -71.38 -74.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.81 1.426 . . . . 0.0 110.975 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.556 ' CG2' ' HA2' ' A' ' 124' ' ' GLY . 15.1 t -39.95 -40.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.168 -0.958 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.59 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 9.6 ttp -55.17 -78.95 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.188 -0.945 . . . . 0.0 109.823 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.672 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 2.7 t80 -42.6 -51.29 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.167 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' N ' ' HD1' ' A' ' 129' ' ' PHE . . . -58.81 -22.41 58.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.5 t -90.32 -51.28 5.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.04 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.547 HD13 ' CA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -61.8 -16.96 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.578 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 2.3 t -96.0 -51.05 4.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.557 -0.714 . . . . 0.0 109.849 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.22 -20.84 65.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.974 . . . . 0.0 110.111 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 131' ' ' SER . 0.2 OUTLIER -76.93 -30.17 55.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.552 ' CE ' ' HA ' ' A' ' 133' ' ' SER . 0.6 OUTLIER -77.57 5.23 9.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.209 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.525 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 3.0 mmtt -89.24 -54.65 0.31 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.35 -10.73 17.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.041 1.548 . . . . 0.0 110.426 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 32.9 t80 -102.17 -77.23 0.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 136' ' ' MET . 14.6 tp -40.81 -62.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.382 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.525 HG22 ' CD1' ' A' ' 146' ' ' ILE . 30.6 m -41.66 -29.13 0.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LEU . 3.3 mm-40 -101.59 -25.82 13.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.551 ' CD2' HG12 ' A' ' 82' ' ' VAL . 1.5 t60 -66.32 -21.66 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.02 36.42 0.18 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.515 ' CD2' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -173.38 93.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 110.14 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.525 ' CD1' HG22 ' A' ' 141' ' ' THR . 4.2 tp . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.246 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.51 ' O ' ' CD2' ' A' ' 145' ' ' LEU . 2.2 mm-40 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.249 0.547 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -80.47 171.2 15.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.309 -0.869 . . . . 0.0 108.762 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.452 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 9.4 mtpp -151.8 164.12 37.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.86 -1.15 . . . . 0.0 111.26 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.839 ' HA ' ' CG1' ' A' ' 34' ' ' ILE . . . -105.91 99.93 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.75 -0.593 . . . . 0.0 109.773 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.569 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 12.6 t -104.01 108.35 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 38' ' ' ALA . 29.7 tp -92.56 111.04 22.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.616 ' CD1' ' CG2' ' A' ' 35' ' ' ILE . 12.5 m-85 -85.97 128.48 34.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.814 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 39' ' ' ALA . 10.9 p -143.37 172.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -0.981 . . . . 0.0 110.633 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.617 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 16.8 t -153.6 -69.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 110.126 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER 172.99 84.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.919 . . . . 0.0 110.285 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 134.06 -31.67 2.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 6.4 t30 72.15 -0.15 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -1.183 . . . . 0.0 110.352 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.458 HG23 ' OH ' ' A' ' 119' ' ' TYR . 23.4 mt -96.71 -85.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -85.27 44.17 1.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 9.7 mmt180 -115.73 69.14 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.451 ' OG ' HD23 ' A' ' 86' ' ' LEU . 16.5 m 44.18 57.29 13.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.9 . . . . 0.0 110.323 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.473 ' HD2' ' SD ' ' A' ' 128' ' ' MET . 43.7 Cg_endo -71.2 -13.18 30.88 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.971 1.511 . . . . 0.0 110.067 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -82.16 6.71 15.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.778 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.572 ' CB ' HG22 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -63.76 -38.78 92.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.647 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.57 -44.93 80.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.805 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.9 -54.65 13.44 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.634 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 4.8 tp -50.86 -44.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -1.174 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.597 ' CB ' ' HB ' ' A' ' 35' ' ' ILE . 5.8 t -71.31 -32.12 68.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -62.56 -55.42 27.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -34.11 66.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 110.492 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.532 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 6.1 ttm -73.05 -59.33 2.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 31' ' ' ASP . 11.5 m -141.53 46.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 0.0 110.396 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . -59.59 78.14 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER 165.55 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -1.102 . . . . 0.0 110.123 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.574 ' O ' ' CB ' ' A' ' 33' ' ' LEU . 11.6 mttp -139.42 112.93 8.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.737 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.574 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 77.54 65.02 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.043 0.925 . . . . 0.0 109.167 -179.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.839 ' CG1' ' HA ' ' A' ' 6' ' ' ALA . 2.6 pp -59.57 145.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.82 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.616 ' CG2' ' CD1' ' A' ' 9' ' ' PHE . 8.5 mt -119.31 89.87 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 69.1 m-20 -85.19 178.27 7.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 111.006 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 5.7 p -130.55 123.22 29.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -133.06 -160.45 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.125 -0.985 . . . . 0.0 110.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . . . -171.55 144.43 1.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.455 ' OG1' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -81.3 -49.16 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.158 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.6 t -128.28 141.29 51.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.0 97.56 0.24 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.97 23.53 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.326 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.88 26.79 5.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 69' ' ' ALA . 16.0 m -64.96 125.27 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.258 -0.901 . . . . 0.0 110.304 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.68 34.0 0.62 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -101.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -1.114 . . . . 0.0 110.172 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.9 t 61.26 71.69 0.76 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.206 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.51 66.42 1.62 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.0 1.526 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 21.5 m-20 -92.22 35.84 0.99 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 110.367 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -31.62 58.48 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mpt_? -73.94 -48.77 28.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.299 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -62.25 -48.21 80.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.459 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 0.0 OUTLIER -64.65 -36.37 84.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 109.262 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.3 ttpt -58.75 -64.74 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.258 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.583 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 9.0 p -54.81 -35.53 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.581 ' CA ' ' CG2' ' A' ' 62' ' ' VAL . 4.3 m -53.51 -54.11 41.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.777 . . . . 0.0 109.411 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 54' ' ' GLN . 15.6 mtmt -69.03 -27.42 65.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 t -77.57 -14.08 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.89 -32.36 6.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.533 ' O ' ' CG1' ' A' ' 62' ' ' VAL . . . 114.1 85.68 1.37 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.581 ' CG2' ' CA ' ' A' ' 57' ' ' CYS . 2.5 m -162.65 87.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -1.084 . . . . 0.0 110.111 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -52.85 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.452 ' CG2' ' O ' ' A' ' 62' ' ' VAL . 1.2 pt -103.71 -158.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -144.75 -170.94 3.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.155 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 68' ' ' ARG . 21.2 mmtt -80.42 4.16 19.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 76.6 mm-40 59.75 -75.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 65.91 104.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' O ' HG12 ' A' ' 45' ' ' VAL . . . -61.43 113.13 2.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.433 ' CD ' ' O ' ' A' ' 71' ' ' GLN . 8.0 tmm_? -135.98 143.45 44.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.203 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.433 ' O ' ' CD ' ' A' ' 70' ' ' ARG . 1.6 tt0 -72.53 139.47 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.248 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.0 tt -95.46 136.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 178.79 6.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.47 4.05 33.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.88 -12.33 55.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 7.6 p-10 -49.97 -24.42 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.141 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.2 m-85 -75.83 -10.11 59.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 110.142 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.55 -45.48 4.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 80' ' ' PHE . 7.9 tptp -57.81 -51.2 70.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.488 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 11.8 m-85 -115.57 144.23 44.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.349 -0.845 . . . . 0.0 110.13 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 56.0 m-20 -91.32 -24.04 19.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 7' ' ' VAL . 9.9 t -113.71 138.71 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.239 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.54 115.38 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.066 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.472 ' HB1' ' CD2' ' A' ' 9' ' ' PHE . . . -91.5 141.63 28.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB1' HD11 ' A' ' 91' ' ' LEU . . . -117.27 141.25 48.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.516 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.4 OUTLIER -73.33 -52.55 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -107.97 -178.92 3.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.03 -28.39 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.253 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.52 -59.8 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.182 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 11' ' ' CYS . 4.3 tt -51.39 -38.59 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.486 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -74.03 -27.52 60.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.479 ' O ' ' ND2' ' A' ' 95' ' ' ASN . 40.0 t -78.64 -29.38 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 0.0 110.2 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.98 -45.22 8.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.53 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.4 tt -48.45 -36.03 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 92' ' ' SER . 20.8 p30 -71.71 -8.99 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -77.72 -20.07 54.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.181 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.53 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.0 ptt? -102.78 -25.28 13.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -53.38 139.59 47.2 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.185 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.16 169.72 21.56 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.996 1.524 . . . . 0.0 110.415 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -71.58 -6.5 41.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.06 68.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.238 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 30.7 p -83.95 164.0 19.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.19 38.66 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 81' ' ' ASP . . . -157.61 161.42 38.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -122.73 132.41 54.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.9 . . . . 0.0 110.158 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.517 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 10.3 m -96.84 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.357 -0.839 . . . . 0.0 110.187 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 t -96.74 161.66 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.45 113.13 26.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 42.7 t80 -83.73 122.96 29.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.49 170.09 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.504 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.6 Cg_endo -75.8 175.62 11.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.026 1.54 . . . . 0.0 110.227 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.57 4.44 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.02 1.537 . . . . 0.0 110.514 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -54.3 -64.43 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 110.145 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.96 130.99 2.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.3 t -124.3 26.52 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 117' ' ' ASP . 1.0 OUTLIER -148.83 -40.91 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.243 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER 66.79 145.3 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.149 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 119' ' ' TYR . 45.9 Cg_endo -73.39 73.29 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.458 ' OH ' HG23 ' A' ' 15' ' ' ILE . 26.0 m-85 51.22 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.271 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 121' ' ' SER . 1.7 t80 -152.13 94.53 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' TYR . 6.2 t 43.23 -145.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 15.1 m -70.25 -19.68 63.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.239 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 128' ' ' MET . . . 142.17 -71.5 0.4 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 3.2 m-85 -42.66 -48.6 13.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.149 . . . . 0.0 110.325 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.638 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -72.97 -55.0 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.671 1.353 . . . . 0.0 110.396 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 128' ' ' MET . 67.2 m -63.23 -53.26 55.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.186 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 124' ' ' GLY . 10.7 ttp -40.85 -70.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 66.7 t80 -58.31 -45.47 87.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -43.22 -67.32 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.869 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -65.12 -39.95 93.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.2 -0.938 . . . . 0.0 109.754 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.548 ' CG2' HD11 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -42.26 -42.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.819 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.532 ' CB ' HD13 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -98.26 -42.92 7.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.335 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 3.4 mmtt -47.5 -30.19 3.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.2 OUTLIER -105.65 -2.98 22.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.544 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.8 OUTLIER -84.98 20.21 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.59 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -105.17 -65.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.153 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 48.3 Cg_endo -73.09 -1.54 10.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.753 1.396 . . . . 0.0 110.492 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.488 ' CD2' ' CE ' ' A' ' 136' ' ' MET . 92.9 t80 -77.02 -76.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 110.339 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.536 ' CD1' HD11 ' A' ' 146' ' ' ILE . 3.1 pp -71.46 -33.51 69.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.297 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 146' ' ' ILE . 85.8 m -57.13 -30.11 64.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 144' ' ' GLY . 5.0 mm-40 -104.81 -44.99 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.424 ' CD2' ' O ' ' A' ' 139' ' ' PHE . 14.9 m-70 -43.51 -25.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.068 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 126.96 66.8 0.15 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.545 ' CD1' ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -153.17 -45.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -1.106 . . . . 0.0 110.226 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.536 HD11 ' CD1' ' A' ' 140' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.436 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.354 0.597 . . . . 0.0 110.363 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.572 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -160.68 -42.86 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 110.446 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 2.0 ptpt 37.43 -155.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.699 -0.626 . . . . 0.0 110.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.788 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . -159.91 138.43 10.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.497 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 2.8 m -103.16 112.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.403 -0.811 . . . . 0.0 109.56 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -59.44 95.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.98 . . . . 0.0 110.328 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.578 ' CD2' HG21 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -85.79 108.97 18.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.301 -0.874 . . . . 0.0 109.303 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.547 ' HB ' ' CB ' ' A' ' 38' ' ' ALA . 6.8 p -137.86 171.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 111.088 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 23.9 t -162.74 55.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.895 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.61 ' O ' ' N ' ' A' ' 14' ' ' ASN . 3.8 mm? 59.54 -158.55 0.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.888 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.74 86.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.61 ' N ' ' O ' ' A' ' 12' ' ' LEU . 1.7 p-10 -134.46 5.8 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -1.209 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.615 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 2.9 mt 57.47 31.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 110.747 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.555 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 50.4 m 53.55 117.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.123 -0.986 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -83.21 66.66 8.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.633 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -68.24 -44.94 38.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.789 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 18' ' ' SER . 47.0 Cg_endo -74.51 -2.9 13.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.712 1.375 . . . . 0.0 110.781 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . . . -102.77 -62.27 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.183 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.565 ' SG ' ' CG ' ' A' ' 9' ' ' PHE . 95.4 m -76.52 -48.29 19.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -65.79 -34.19 77.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.801 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' A' ' 26' ' ' ARG . . . -73.73 -57.16 5.07 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.6 ' CB ' ' CG2' ' A' ' 132' ' ' ILE . 8.7 tp -54.22 -40.43 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -1.174 . . . . 0.0 110.075 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 8.5 t -75.43 -67.08 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.531 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 ptm180 -41.82 -33.53 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' CG ' ' A' ' 26' ' ' ARG . 5.8 t70 -85.18 -36.32 21.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.452 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 4.9 ttt -84.29 -0.23 51.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.445 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.498 ' CG1' ' HG3' ' A' ' 32' ' ' LYS . 21.2 t -130.13 -43.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.321 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.16 65.54 0.16 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 72.7 m-20 47.81 77.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -1.196 . . . . 0.0 110.282 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' HG3' ' CG1' ' A' ' 29' ' ' VAL . 23.6 mmtm -128.54 -137.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.148 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.747 ' O ' HG13 ' A' ' 34' ' ' ILE . 96.4 mt -140.93 -95.12 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.788 ' CA ' ' HA ' ' A' ' 6' ' ' ALA . 0.7 OUTLIER 41.79 18.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.597 -0.69 . . . . 0.0 111.234 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.539 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -157.95 144.08 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.761 -1.212 . . . . 0.0 110.798 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.572 ' OD2' ' CD1' ' A' ' 80' ' ' PHE . 6.7 m-20 -146.54 105.0 3.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.4 p -68.63 125.74 27.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 110.52 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.547 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . . . -127.2 -169.4 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 110.192 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 10' ' ' VAL . . . -174.79 88.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.499 ' OG1' ' CD1' ' A' ' 72' ' ' ILE . 18.4 m -71.3 87.96 0.84 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.4 p -159.6 -50.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.1 48.49 25.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.54 -47.06 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -1.132 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.402 ' O ' HG13 ' A' ' 15' ' ' ILE . 49.5 m-70 -94.01 44.0 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 46' ' ' GLY . 88.2 t -111.79 156.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 64.59 28.09 72.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 48' ' ' SER . 4.3 pt20 -170.34 -147.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -1.124 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.444 ' OG ' HD11 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 61.06 108.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.59 99.62 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.513 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -90.5 27.76 1.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.153 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.4 m -74.95 -27.87 60.36 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.268 -0.895 . . . . 0.0 109.043 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HB3' ' CD2' ' A' ' 125' ' ' PHE . 11.0 mmt180 -73.48 -51.41 17.23 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.361 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.478 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 9.6 p -62.7 -50.85 69.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.781 . . . . 0.0 109.608 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.472 ' HA ' ' CD1' ' A' ' 64' ' ' ILE . 1.1 tt0 -61.43 -39.39 90.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.256 -0.903 . . . . 0.0 109.31 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -59.23 -70.12 0.17 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 109.59 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.557 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 35.8 m -48.82 -32.7 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.955 . . . . 0.0 109.19 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.466 ' C ' ' HB ' ' A' ' 62' ' ' VAL . 1.2 m -58.41 -52.48 65.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.845 . . . . 0.0 109.491 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -24.41 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.5 t -86.01 -10.78 54.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 8.8 m120 -114.93 -32.32 5.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.549 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 140.88 86.08 0.1 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 20.8 t -161.5 138.37 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -1.102 . . . . 0.0 110.058 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.493 ' CB ' ' HD3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -103.11 95.94 6.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.284 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.508 HG22 ' CG1' ' A' ' 62' ' ' VAL . 6.3 pt -137.52 -171.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 p -176.91 -40.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.273 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 140.88 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.56 133.58 0.62 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -89.43 -141.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.106 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.23 153.2 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -141.18 -148.37 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.501 ' N ' ' HG3' ' A' ' 70' ' ' ARG . 7.6 tt0 -136.09 162.25 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.952 . . . . 0.0 110.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.499 ' CD1' ' OG1' ' A' ' 40' ' ' THR . 14.9 mt -77.1 -72.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.156 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER 65.78 -145.59 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -100.39 -14.44 18.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.42 74.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.883 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -53.53 -46.71 70.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.188 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.606 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 26.2 m-85 -67.23 60.57 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.032 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER 169.71 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.933 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 2.8 tptt -73.48 -1.31 17.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.65 ' CD1' ' HB1' ' A' ' 6' ' ' ALA . 79.8 m-85 -154.97 -153.1 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.473 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -130.25 -13.69 3.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 0.0 110.79 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 83' ' ' ILE . 58.8 t -133.72 157.62 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.675 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 8' ' ' LEU . 1.7 mp -145.54 115.93 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.476 -0.765 . . . . 0.0 109.511 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 9' ' ' PHE . . . -106.14 132.01 52.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 111.134 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.522 ' CB ' HG23 ' A' ' 90' ' ' ILE . . . -108.35 124.87 51.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.497 -0.752 . . . . 0.0 109.687 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 5.4 mp -58.14 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 90' ' ' ILE . 67.8 m-20 -67.8 -175.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.438 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' SER . 16.2 mt-30 -84.28 -43.36 14.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -43.12 -56.48 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.075 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.534 ' CD1' HG11 ' A' ' 10' ' ' VAL . 4.8 tt -49.81 -41.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -71.15 -41.13 70.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 t -62.75 -37.89 88.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -0.92 . . . . 0.0 110.216 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.4 OUTLIER -85.57 -55.72 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.542 ' CG2' ' N ' ' A' ' 95' ' ' ASN . 12.9 tt -44.83 -42.79 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 110.184 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.542 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 20.1 t-20 -75.55 -11.78 60.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' ASP . 11.0 t -95.69 6.54 48.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.558 ' HE3' ' CZ ' ' A' ' 77' ' ' PHE . 2.4 ptt? -128.83 -32.31 2.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.243 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.606 ' CE ' ' CD1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -42.63 150.78 0.41 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.291 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.03 1.542 . . . . 0.0 110.411 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.07 29.05 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 80.22 1.43 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.9 p -155.4 -174.28 4.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 110.196 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.458 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -139.65 48.91 1.81 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.46 178.61 4.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.87 137.56 48.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.69 130.39 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 108' ' ' LEU . 1.2 p -129.79 171.35 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.92 . . . . 0.0 110.279 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.561 ' N ' ' CG2' ' A' ' 107' ' ' VAL . 22.4 tp -105.69 156.1 18.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 110.167 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.435 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 43.0 t80 -149.4 106.81 3.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.962 . . . . 0.0 110.219 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' PHE . 0.7 OUTLIER -171.16 106.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 115' ' ' VAL . 47.6 Cg_endo -74.49 175.82 10.52 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.119 1.589 . . . . 0.0 110.266 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.8 Cg_endo -71.53 54.24 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.926 1.487 . . . . 0.0 110.484 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.62 -40.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.147 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.3 133.0 6.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.527 ' CG2' ' HD2' ' A' ' 111' ' ' PRO . 5.5 t -121.34 -9.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -1.118 . . . . 0.0 110.177 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 1.5 p30 -55.93 133.12 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.92 109.98 31.7 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 116' ' ' ASP . 47.0 Cg_endo -73.68 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.978 1.515 . . . . 0.0 110.496 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.581 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 50.2 t80 -154.39 36.92 0.42 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -119.8 -11.47 9.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 123' ' ' ASP . 0.4 OUTLIER 174.95 166.55 0.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 74.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.241 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 121' ' ' SER . 1.0 OUTLIER -125.57 0.22 7.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 110.232 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -115.85 -44.09 0.65 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.654 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 8.6 m-85 -44.58 -47.96 27.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.186 -1.185 . . . . 0.0 110.358 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.7 Cg_endo -72.91 -51.72 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.72 1.379 . . . . 0.0 110.201 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 128' ' ' MET . 3.7 m -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.493 ' N ' ' O ' ' A' ' 124' ' ' GLY . 9.3 ttp -42.1 -65.9 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.106 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.503 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 44.9 t80 -56.12 -45.31 79.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -44.64 -62.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 0.5 OUTLIER -59.14 -47.61 84.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.6 ' CG2' ' CB ' ' A' ' 24' ' ' ILE . 4.3 mm -42.14 -65.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.868 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.53 ' O ' ' CE ' ' A' ' 136' ' ' MET . 1.7 p -71.35 -21.73 62.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -0.828 . . . . 0.0 110.43 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 2.7 tttp -63.5 -34.7 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.025 . . . . 0.0 110.109 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -132.22 66.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.328 -0.857 . . . . 0.0 110.442 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.53 ' CE ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -118.22 -5.29 10.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 110.08 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.0 mttt -87.48 -49.67 0.45 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 110.382 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -77.45 -8.08 17.11 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.888 1.467 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.698 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 10.7 t80 -88.08 -50.17 6.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 145' ' ' LEU . 28.2 tp -82.12 -30.09 31.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.531 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 54.9 m -71.01 -24.06 62.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.966 . . . . 0.0 110.328 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -104.06 -44.16 5.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.913 . . . . 0.0 110.208 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.698 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -45.68 -39.11 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.273 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 148.06 53.43 0.02 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.6 OUTLIER -160.6 -98.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.168 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.531 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 1.5 tp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.193 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.331 0.586 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.04 -159.47 0.06 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 108.725 178.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 22.7 mttp -158.13 -164.29 1.47 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 110.62 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.037 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.93 119.43 8.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 110.803 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.533 ' CG2' HD12 ' A' ' 34' ' ' ILE . 5.8 t -114.14 121.55 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.543 -0.723 . . . . 0.0 109.79 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 3.6 tp -97.52 86.75 3.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.247 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 18' ' ' SER . 7.5 p90 -72.92 143.58 47.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.977 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 38' ' ' ALA . 46.9 t -142.83 155.68 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 110.28 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.487 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 8.1 t -139.56 -60.68 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 110.128 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 -55.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.176 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -131.79 21.44 4.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER 64.8 21.46 12.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -1.13 . . . . 0.0 110.265 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 45' ' ' VAL . 10.2 mt -121.47 -27.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.179 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -106.1 123.8 48.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.127 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.584 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 40.4 mtt180 66.91 -53.97 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.603 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -42.1 -51.56 10.27 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.027 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.2 Cg_endo -72.35 -7.08 20.3 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.816 1.429 . . . . 0.0 110.563 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' ARG . . . -93.39 -21.17 19.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.584 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 16.8 t -70.05 -55.53 9.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.48 ' HG3' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -44.28 -37.04 3.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.437 -0.789 . . . . 0.0 109.43 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.94 -52.57 8.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.632 ' CD1' ' CE2' ' A' ' 129' ' ' PHE . 2.8 tp -55.06 -34.29 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -1.23 . . . . 0.0 109.941 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.4 m -73.14 -52.79 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 110.04 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -31.02 63.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' OD2' HG22 ' A' ' 62' ' ' VAL . 19.1 m-20 -87.95 -58.61 2.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.087 -1.008 . . . . 0.0 110.088 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.7 OUTLIER -50.74 -27.05 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 32' ' ' LYS . 6.7 t -105.82 -33.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 110.223 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.45 -68.39 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -174.65 38.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -1.157 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 32' ' ' LYS . 4.1 mptp? -75.07 -113.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.579 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 80.2 mt -152.92 -107.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.932 -1.105 . . . . 0.0 110.26 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.037 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 33.46 31.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 111.653 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.579 ' CD1' ' O ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -102.24 102.43 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 110.112 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.58 ' OD2' ' CD1' ' A' ' 80' ' ' PHE . 50.5 m-20 -135.84 140.67 44.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 110.02 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.578 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 10.2 t -124.17 143.4 50.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.482 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.533 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . -146.21 167.53 23.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -154.98 154.53 32.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -134.76 80.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 t -170.02 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.17 32.57 4.28 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -114.72 -36.38 4.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.128 . . . . 0.0 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.489 ' NE2' ' OG ' ' A' ' 48' ' ' SER . 2.0 t60 -122.61 84.3 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.231 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.483 HG11 ' CB ' ' A' ' 69' ' ' ALA . 46.1 t -146.15 135.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.86 76.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.37 51.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.382 -1.069 . . . . 0.0 110.192 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.489 ' OG ' ' NE2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -154.79 129.53 4.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.53 106.67 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.971 1.511 . . . . 0.0 110.4 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.3 p-10 -90.82 22.49 3.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.8 m -71.98 -28.16 63.23 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.22 -0.925 . . . . 0.0 108.794 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.605 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 5.0 mmt180 -74.5 -45.23 47.26 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -63.57 -53.64 48.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 19.8 mt-30 -61.95 -41.44 97.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.323 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.7 ttpp -55.2 -69.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 109.485 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.565 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 37.4 t -48.28 -36.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.591 ' CB ' ' CG1' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.547 -0.721 . . . . 0.0 109.513 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -24.55 61.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.383 -0.823 . . . . 0.0 109.481 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -81.27 -13.06 58.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.481 ' ND2' HG11 ' A' ' 56' ' ' VAL . 16.9 m-80 -111.91 -31.04 7.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.291 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 119.5 94.56 1.54 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.591 ' CG1' ' CB ' ' A' ' 57' ' ' CYS . 9.8 p -178.71 151.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -1.114 . . . . 0.0 110.065 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -127.3 140.78 51.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.247 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 54' ' ' GLN . 7.4 pt -124.73 163.58 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.139 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -112.27 -34.14 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 110.223 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' C ' ' CD ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -166.88 150.33 6.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.261 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.411 ' OE1' ' HB2' ' A' ' 50' ' ' ASP . 1.6 mt-30 -132.16 74.85 1.6 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 110.28 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.424 ' NH1' ' HG2' ' A' ' 68' ' ' ARG . 33.5 ttp85 -126.29 111.14 14.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.483 ' CB ' HG11 ' A' ' 45' ' ' VAL . . . -53.8 144.44 18.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.187 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.99 39.38 0.84 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' CA ' ' OE1' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 54.46 -164.15 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.267 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 73' ' ' THR . 15.4 tt -121.93 -39.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.508 ' N ' HG23 ' A' ' 72' ' ' ILE . 1.0 OUTLIER 63.72 157.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -67.37 -23.6 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.214 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -58.77 -26.69 64.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.269 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 24.6 p-10 -48.31 -34.75 11.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.46 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 44.7 m-85 -73.14 -39.09 65.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.242 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.52 -52.85 4.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -44.85 -26.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.214 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.58 ' CD1' ' OD2' ' A' ' 36' ' ' ASP . 9.3 m-85 -134.2 172.58 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.68 -20.26 9.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 58.4 t -125.56 139.15 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.9 . . . . 0.0 110.361 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 105' ' ' LYS . 1.4 mp -123.67 144.23 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 110.082 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . . . -123.05 118.8 28.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.88 116.97 32.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.091 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.584 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 4.2 mp -62.86 -85.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.426 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.45 ' HB2' HD13 ' A' ' 90' ' ' ILE . 79.2 m-20 -73.53 -177.63 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 89' ' ' SER . 14.1 mt-30 -79.05 -40.85 30.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 110.183 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 4.3 m -42.02 -40.37 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.298 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 10' ' ' VAL . 3.8 mt -69.36 -48.14 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -61.56 -41.63 97.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 t -73.47 -40.41 64.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 96' ' ' SER . 82.9 m-20 -65.52 -61.97 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 95' ' ' ASN . 3.7 tt -42.71 -43.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.525 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 3.0 t-20 -61.88 -33.03 73.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.973 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -67.47 -13.59 62.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 4.4 ptt? -122.34 -24.79 4.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 110.143 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 94' ' ' ILE . 0.3 OUTLIER -43.09 140.48 1.99 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -159.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.06 1.558 . . . . 0.0 110.397 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 m -129.37 3.99 5.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -152.38 88.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.4 p -144.32 -169.46 3.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.04 48.4 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.61 164.77 25.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.246 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.444 ' O ' HD13 ' A' ' 83' ' ' ILE . 33.8 tttt -123.58 160.51 26.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.163 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.84 106.94 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 83' ' ' ILE . 26.7 m -109.69 143.71 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.8 114.8 21.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -50.13 -69.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.953 . . . . 0.0 110.172 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.466 ' HB3' ' HD2' ' A' ' 111' ' ' PRO . 13.3 m-80 -147.19 166.91 14.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.48 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.6 Cg_endo -74.49 174.94 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.966 1.508 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.3 Cg_endo -72.86 52.81 2.23 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.921 1.485 . . . . 0.0 110.481 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -149.1 -36.86 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.07 -96.99 0.04 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.517 HG13 ' CB ' ' A' ' 131' ' ' SER . 4.7 m -62.67 136.65 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -1.139 . . . . 0.0 110.309 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.77 149.46 14.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -168.29 108.04 0.55 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 46.5 Cg_endo -73.15 -1.0 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' PRO . 1.2 m-85 61.31 24.83 14.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -126.88 -38.23 2.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.28 -176.01 3.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 122' ' ' SER . 1.8 t -87.6 22.67 2.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 0.0 110.166 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.32 62.34 5.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.73 -31.31 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.605 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 8.9 m-85 -56.4 -54.02 57.73 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.326 -1.103 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.6 Cg_endo -71.88 -43.39 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.867 1.456 . . . . 0.0 110.375 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 130' ' ' ALA . 2.7 m -62.81 -35.73 80.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.577 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 25.6 ttp -52.51 -69.97 0.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.9 . . . . 0.0 109.92 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.632 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 30.7 t80 -62.93 -30.9 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.702 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -56.98 -35.91 69.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.977 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.517 ' CB ' HG13 ' A' ' 115' ' ' VAL . 5.6 m -87.29 -42.76 12.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.572 HG22 ' CB ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -56.47 -27.25 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.805 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.466 ' HB3' HD12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -102.06 -40.58 6.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.407 -0.808 . . . . 0.0 110.201 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -76.35 -4.91 44.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 131' ' ' SER . 6.0 mm-40 -126.19 18.82 7.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.504 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 1.8 tpt -96.17 7.97 45.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.349 -0.845 . . . . 0.0 110.245 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.543 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -86.59 -49.09 0.5 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.298 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.95 7.4 4.35 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.874 1.46 . . . . 0.0 110.591 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.603 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 5.6 t80 -107.96 -51.19 2.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.355 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.454 ' HG ' HD11 ' A' ' 145' ' ' LEU . 4.2 tt -83.51 -15.04 50.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.339 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.518 ' CG2' ' OXT' ' A' ' 146' ' ' ILE . 24.7 m -82.8 -28.05 30.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -105.14 -25.48 12.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.286 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.603 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -52.74 -18.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.481 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 115.75 51.81 0.41 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 144' ' ' GLY . 11.9 mt -143.41 -52.78 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.518 ' OXT' ' CG2' ' A' ' 141' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.415 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.287 0.565 . . . . 0.0 110.113 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.582 ' C ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -80.9 -55.42 4.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.545 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' CG ' ' C ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER 35.21 -155.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.729 . . . . 0.0 110.541 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.767 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . -166.12 156.53 12.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 0.0 109.958 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 84' ' ' ALA . 89.0 t -120.92 103.51 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.908 . . . . 0.0 109.903 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 36' ' ' ASP . 16.6 tp -59.48 94.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 110.026 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.491 ' CE2' ' SD ' ' A' ' 136' ' ' MET . 0.4 OUTLIER -78.31 103.89 8.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.93 . . . . 0.0 109.818 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 39' ' ' ALA . 61.3 t -124.67 161.75 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.445 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB2' HD12 ' A' ' 86' ' ' LEU . 39.3 t -165.14 64.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 6.9 mt 57.09 33.59 23.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 147.0 -32.34 1.42 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 65.3 7.62 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -1.138 . . . . 0.0 110.102 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.486 HG21 HD12 ' A' ' 15' ' ' ILE . 44.6 mt -96.51 -5.51 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 110.353 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 35.6 m -144.43 -173.25 3.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.456 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.582 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 1.9 mmt85 64.49 -78.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.556 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.515 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 9.1 m -129.83 55.66 19.87 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 110.699 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.6 Cg_endo -79.79 0.57 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.987 1.519 . . . . 0.0 110.004 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.523 ' CB ' HG13 ' A' ' 132' ' ' ILE . . . -96.0 6.8 48.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.425 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 9.1 p -58.78 -35.54 72.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 64' ' ' ILE . 1.4 tp10 -65.43 -48.54 72.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.67 -0.644 . . . . 0.0 109.866 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.583 ' CA ' ' CG1' ' A' ' 62' ' ' VAL . . . -69.83 -57.8 6.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.612 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 5.3 tp -47.44 -43.47 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -1.163 . . . . 0.0 109.922 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.541 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 7.3 t -65.33 -51.53 59.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.412 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 15.3 mmt-85 -52.62 -40.62 62.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.145 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -76.0 -30.51 58.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.48 -57.96 3.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.485 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 32' ' ' LYS . 61.9 t -87.09 -18.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.552 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 104.4 -66.91 0.29 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 53.8 t0 -176.25 57.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -1.13 . . . . 0.0 110.111 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.534 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -120.79 -100.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.815 ' O ' HG13 ' A' ' 34' ' ' ILE . 21.3 mt -143.95 -125.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.815 HG13 ' O ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER 70.81 -17.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.987 -0.446 . . . . 0.0 111.102 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.513 ' N ' HG13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -136.83 144.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.808 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.585 ' OD2' ' CZ ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -155.35 94.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.461 ' HB2' ' OE1' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -63.82 125.92 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 110.116 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' A' ' 10' ' ' VAL . . . -149.76 170.43 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.552 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.521 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -138.72 145.37 40.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.053 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 t -118.67 -9.65 10.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.31 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 t -112.36 109.48 19.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -55.97 101.58 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 2.5 m-85 -162.12 160.43 27.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -1.169 . . . . 0.0 110.264 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 63.19 25.21 14.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.6 t -85.25 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 37.68 6.37 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 48' ' ' SER . 4.3 pt20 179.59 -108.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -1.118 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.3 OUTLIER 65.6 93.62 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.074 -1.016 . . . . 0.0 110.184 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 45.1 Cg_endo -69.11 -62.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.672 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 2.8 m-20 71.46 -5.95 1.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.241 -0.912 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -74.32 -27.54 60.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.177 -0.952 . . . . 0.0 108.975 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -52.85 12.52 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.336 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HA ' ' HE3' ' A' ' 128' ' ' MET . 1.7 t -61.57 -53.69 52.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -57.98 -42.46 85.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.584 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -51.85 -65.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.653 ' CG2' ' CG ' ' A' ' 125' ' ' PHE . 53.0 t -49.46 -35.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 109.113 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.526 ' SG ' ' CG1' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -57.27 -46.71 82.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.57 -0.706 . . . . 0.0 109.642 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -79.63 -17.86 52.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.479 ' HB2' ' CE ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -88.95 -12.25 42.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -116.37 -24.17 8.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.586 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.5 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 117.21 62.34 0.31 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.583 ' CG1' ' CA ' ' A' ' 23' ' ' GLY . 46.0 t -155.63 170.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.457 ' N ' HG11 ' A' ' 62' ' ' VAL . 58.6 t0 -157.02 121.21 4.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 110.267 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.497 ' HB ' ' NE2' ' A' ' 54' ' ' GLN . 18.1 mt -108.82 170.62 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.147 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.39 -68.69 0.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -145.08 128.02 16.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 10.7 pt20 -142.26 98.43 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.217 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.453 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -140.05 -162.69 1.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.174 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.87 123.65 50.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.229 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.78 33.02 1.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 60.02 158.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 76' ' ' ASP . 21.0 tt -138.87 152.5 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -112.57 -163.92 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HA ' ' CE2' ' A' ' 77' ' ' PHE . 4.1 mttp -69.7 -5.21 23.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.16 81.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.0 110.124 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 77' ' ' PHE . 38.4 p-10 -47.84 -31.46 5.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.58 ' CE1' ' HD2' ' A' ' 98' ' ' LYS . 13.1 m-85 -72.45 -25.74 61.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.0 p -127.29 41.86 3.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.202 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.545 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 37.8 tptt -123.19 -13.52 7.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.585 ' CZ ' ' OD2' ' A' ' 36' ' ' ASP . 97.5 m-85 -151.74 -122.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 65.4 t0 -151.59 -40.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.045 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 83' ' ' ILE . 81.7 t -127.04 152.84 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.169 -0.957 . . . . 0.0 110.47 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.49 ' N ' HG11 ' A' ' 82' ' ' VAL . 1.7 mp -131.71 134.06 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 110.022 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.492 ' HB3' ' CE1' ' A' ' 109' ' ' PHE . . . -104.49 127.87 52.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.551 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' HB1' HD12 ' A' ' 91' ' ' LEU . . . -109.68 105.74 15.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.582 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 2.2 mp -50.36 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.505 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.534 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -81.5 -177.4 6.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.37 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -85.44 -40.8 16.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.37 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -41.67 -38.43 1.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' A' ' 87' ' ' ASP . 1.5 mp -69.62 -55.63 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.185 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -58.1 -28.74 64.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 t -78.39 -41.91 31.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 5.6 m-20 -80.92 -60.15 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.29 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 90' ' ' ILE . 4.7 tt -49.87 -25.3 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.301 -0.875 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 58.4 t-20 -90.37 -22.87 21.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.208 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -6.59 28.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.471 ' HE2' ' HA ' ' A' ' 94' ' ' ILE . 6.2 mtm -108.81 -51.67 2.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -40.47 132.6 1.67 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.412 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 100' ' ' SER . 46.4 Cg_endo -73.51 0.66 7.79 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.06 1.558 . . . . 0.0 110.502 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER 68.02 19.22 9.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.131 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.12 67.76 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 95.4 m -132.21 -159.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.41 25.83 10.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.27 -175.46 3.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.89 . . . . 0.0 110.192 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.37 158.2 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 19.3 t -127.13 124.58 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.139 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -122.17 144.0 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -77.11 133.81 38.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 110.173 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 1.9 m-85 -106.44 127.44 53.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.315 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 109' ' ' PHE . 0.9 OUTLIER 64.54 176.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -74.83 175.3 11.36 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 110.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.9 Cg_endo -72.26 53.86 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.051 1.553 . . . . 0.0 110.433 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.88 -38.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.03 145.12 11.19 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 17' ' ' ARG . 18.5 m -70.34 153.84 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -1.105 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.44 ' CB ' HG23 ' A' ' 127' ' ' THR . 42.9 t0 -42.09 134.58 2.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.369 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.8 p-10 -94.94 113.1 60.53 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.544 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 46.3 Cg_endo -73.7 58.31 3.91 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.936 1.492 . . . . 0.0 110.616 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 121' ' ' SER . 3.7 t80 -117.03 142.61 46.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.095 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 49.1 t80 61.0 -73.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.196 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 119' ' ' TYR . 2.2 m -89.89 118.33 29.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.84 89.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.77 9.64 1.55 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.258 -0.901 . . . . 0.0 110.183 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.544 ' CA ' ' HB3' ' A' ' 118' ' ' PRO . . . -118.88 -22.24 3.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.653 ' CG ' ' CG2' ' A' ' 56' ' ' VAL . 2.8 m-85 -34.1 -59.34 0.54 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.521 -0.988 . . . . 0.0 110.49 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.0 Cg_endo -72.12 -52.48 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.869 1.457 . . . . 0.0 110.318 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 128' ' ' MET . 8.8 m -58.18 -57.66 11.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.375 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.538 ' N ' ' O ' ' A' ' 124' ' ' GLY . 8.1 ttp -40.31 -48.85 2.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.612 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 48.7 t80 -70.17 -62.1 1.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 129' ' ' PHE . . . -43.05 -56.39 3.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.53 ' HB3' ' CG1' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -60.88 -45.07 96.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.926 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.538 HG21 ' CG1' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -46.76 -47.52 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.592 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 134' ' ' LYS . 0.4 OUTLIER -78.85 -59.26 2.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.297 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.498 ' N ' ' OG ' ' A' ' 133' ' ' SER . 3.2 mmtt -45.19 -29.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 131' ' ' SER . 27.0 mt-10 -74.97 -31.55 61.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.203 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.533 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 18.0 mtm -103.48 9.32 37.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 6.5 mtpt -82.28 -48.74 0.88 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 51.5 Cg_endo -81.11 -9.07 12.94 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.148 1.604 . . . . 0.0 110.402 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.68 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 47.4 t80 -107.97 -77.96 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.583 ' CD1' ' CD2' ' A' ' 145' ' ' LEU . 13.8 tp -44.03 -24.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 11.8 m -87.07 -29.13 22.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 110.353 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 139' ' ' PHE . 4.7 mm-40 -105.2 -13.9 15.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.405 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.68 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 4.6 t60 -84.94 40.27 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.64 38.08 90.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.583 ' CD2' ' CD1' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.8 -31.08 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.106 . . . . 0.0 110.305 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 140' ' ' LEU . 18.2 mm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.228 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.26 0.553 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.68 -162.54 0.43 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.534 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 18.5 mttt -148.44 -164.5 2.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.729 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -130.74 148.92 52.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.183 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.593 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 5.5 m -147.06 136.87 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.945 -1.097 . . . . 0.0 110.226 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.9 OUTLIER -89.65 118.31 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 0.0 110.945 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.487 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m-85 -93.85 96.06 9.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.555 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 16.0 t -100.65 156.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.444 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.491 ' CB ' ' OG ' ' A' ' 18' ' ' SER . 47.8 t -150.0 -65.9 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.015 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 177.05 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.174 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 85.92 -4.75 85.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 8.7 t30 59.7 29.87 19.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -1.158 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 48' ' ' SER . 26.9 mt -113.0 -20.4 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 110.376 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 18' ' ' SER . 9.6 p -131.59 132.77 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.546 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 3.7 mtm180 65.46 -59.56 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.196 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.615 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -44.83 -50.7 24.6 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.428 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.6 Cg_endo -72.13 -19.97 25.57 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.848 1.446 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' HB3' ' CE ' ' A' ' 128' ' ' MET . . . -69.78 -23.56 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.98 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.54 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 21.4 m -67.39 -32.88 74.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.863 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HA ' ' CG1' ' A' ' 35' ' ' ILE . 1.6 tt0 -57.77 -54.89 41.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.912 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.09 -45.95 77.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.618 ' CD1' ' CD2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -54.66 -54.36 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -1.202 . . . . 0.0 110.191 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.597 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 79.4 m -60.29 -50.8 72.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.036 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.493 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 25.5 mtt-85 -45.82 -52.63 10.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -20.0 60.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.558 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.07 -45.82 32.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.831 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 32' ' ' LYS . 63.1 t -137.05 -12.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.034 . . . . 0.0 111.258 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 29' ' ' VAL . . . 59.31 122.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' GLY . 11.8 t0 40.42 77.36 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.187 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.574 ' CG ' ' CG1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -131.05 11.19 5.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.547 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.8 mt 65.01 -63.05 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.285 -0.884 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.5 pp -27.39 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.454 -0.779 . . . . 0.0 111.047 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' LEU . 7.8 tt -64.03 87.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 121.368 -0.832 . . . . 0.0 111.079 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.616 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 18.6 m-20 -126.83 66.82 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 109.692 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.28 150.07 18.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 110.397 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.471 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . . . -163.9 -171.62 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -150.17 120.9 7.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.485 HG21 ' N ' ' A' ' 41' ' ' SER . 10.8 t -67.06 -39.45 86.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.485 ' N ' HG21 ' A' ' 40' ' ' THR . 3.3 t -127.87 133.02 49.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . -67.76 -79.9 0.23 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 66.05 -73.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER -90.15 91.06 8.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.4 t -130.29 173.28 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 110.137 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 57.97 18.35 33.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.632 ' O ' ' CB ' ' A' ' 48' ' ' SER . 3.1 pt20 -177.68 152.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -1.124 . . . . 0.0 110.168 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.632 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 2.2 t 159.12 105.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.263 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 47.4 Cg_endo -69.78 70.78 1.57 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.104 1.581 . . . . 0.0 110.28 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.5 p30 -83.92 16.32 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.9 m -75.53 -32.58 60.52 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.185 -0.947 . . . . 0.0 109.007 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -74.1 -55.74 5.74 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.294 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.558 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -58.67 -53.43 58.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.454 -0.778 . . . . 0.0 109.501 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.502 ' HG3' ' CD1' ' A' ' 64' ' ' ILE . 12.1 tt0 -57.51 -45.56 84.82 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.25 -0.906 . . . . 0.0 109.508 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.569 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.2 ttpp -50.83 -65.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.422 -0.799 . . . . 0.0 109.793 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.569 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 11.3 p -56.55 -34.0 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.633 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.518 ' N ' HG12 ' A' ' 56' ' ' VAL . 1.3 m -56.66 -47.47 79.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.696 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -73.8 -30.46 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.361 -0.837 . . . . 0.0 109.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 m -77.96 -12.05 59.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.003 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -116.08 -27.01 7.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.855 . . . . 0.0 109.38 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 139.25 98.78 0.42 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 13.0 t -162.63 168.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -1.065 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.509 ' N ' ' CG1' ' A' ' 62' ' ' VAL . 12.5 t0 -153.37 67.17 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.502 ' CD1' ' HG3' ' A' ' 54' ' ' GLN . 11.8 pt -116.55 -173.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.187 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -153.68 88.74 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.19 153.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.359 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -171.93 126.99 0.59 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.358 -0.839 . . . . 0.0 110.194 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 mtm105 -99.87 -89.15 0.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . 176.94 79.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 ttp-105 -76.6 141.2 41.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.62 151.88 44.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.162 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 39' ' ' ALA . 19.4 tt -90.8 172.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t -124.4 172.2 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -78.33 2.85 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.112 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.02 -13.28 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' CG ' ' CG1' ' A' ' 72' ' ' ILE . 2.9 m-20 -52.92 -42.11 65.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -45.13 -55.77 5.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 26.82 3.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.622 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -104.64 -11.14 17.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 110.237 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.622 ' CE1' ' CG ' ' A' ' 79' ' ' LYS . 77.9 m-85 -143.07 -137.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -128.2 -53.42 1.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.471 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.56 HG12 ' CE1' ' A' ' 143' ' ' HIS . 48.9 t -133.26 123.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.195 -0.941 . . . . 0.0 110.451 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.514 HG23 ' CD1' ' A' ' 94' ' ' ILE . 5.7 mt -90.63 105.74 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.9 143.58 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.429 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -103.49 147.91 26.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.546 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 2.8 tp -98.64 31.77 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.519 ' CB ' HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER 174.31 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 110.178 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -59.93 -43.57 94.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.243 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 87' ' ' ASP . 1.9 mp -57.67 -63.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.153 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.4 OUTLIER -53.09 -37.14 61.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.151 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -70.83 -26.89 63.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.236 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -92.06 -61.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.255 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.514 ' CD1' HG23 ' A' ' 83' ' ' ILE . 5.6 tt -45.63 -39.89 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.501 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 4.6 t-20 -71.89 -15.18 62.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -76.37 -12.36 60.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.226 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.444 ' HE1' ' HA ' ' A' ' 94' ' ' ILE . 8.2 mtm -109.64 -52.04 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 5.6 mtpt -40.85 134.85 1.67 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 110.443 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.14 -169.59 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.069 1.562 . . . . 0.0 110.424 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.7 t -91.35 23.91 3.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 6.5 p-10 -176.79 123.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.4 p -143.59 -151.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -116.37 -18.63 10.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.104 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 -149.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -157.66 169.31 24.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.19 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 106' ' ' VAL . 29.0 m -128.07 146.43 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 108' ' ' LEU . 78.6 t -144.01 170.19 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.94 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.492 ' CD2' ' O ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -109.52 121.91 46.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.181 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 132' ' ' ILE . 11.6 t80 -48.49 -51.52 26.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.536 ' CB ' ' HD2' ' A' ' 111' ' ' PRO . 1.1 m-20 -176.52 -178.26 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 110' ' ' ASN . 46.7 Cg_endo -74.67 175.03 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.012 1.533 . . . . 0.0 110.302 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.2 52.94 2.41 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.959 1.505 . . . . 0.0 110.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -124.69 -27.3 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.75 -89.98 1.25 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 115' ' ' VAL . 19.5 m -75.9 103.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -1.156 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 15.6 p-10 -137.08 -156.63 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER 55.78 72.74 0.96 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 112.03 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.995 1.524 . . . . 0.0 110.508 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.499 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 12.4 m-85 50.48 -138.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 119' ' ' TYR . 27.5 p -168.79 -151.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 82.7 p -90.32 -138.56 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 122' ' ' SER . 2.3 t70 67.06 17.09 10.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' A' ' 126' ' ' PRO . . . -144.29 -42.08 0.05 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.611 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 11.8 m-85 -42.08 -50.47 10.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.11 . . . . 0.0 110.473 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 44.6 Cg_endo -72.0 -56.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.619 1.326 . . . . 0.0 110.247 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -55.75 -43.66 76.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 110.006 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.589 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 14.0 ttp -50.69 -75.71 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.618 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 4.6 t80 -46.67 -55.6 7.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.236 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -52.7 -22.56 5.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.4 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 128' ' ' MET . 3.2 m -90.12 -55.82 3.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.412 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.556 ' CG2' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -60.09 -15.33 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 0.0 109.028 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.504 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 2.0 t -101.93 -49.96 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 110.139 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -59.23 -30.85 68.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.108 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' OE2' ' ND2' ' A' ' 110' ' ' ASN . 6.1 mt-10 -102.75 22.37 13.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.562 ' HE3' ' CD2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -89.61 1.36 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.25 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 77.0 mttt -91.88 -42.13 0.37 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 111.353 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.2 Cg_endo -76.41 4.79 5.16 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.403 1.212 . . . . 0.0 110.733 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.562 ' CD2' ' HE3' ' A' ' 136' ' ' MET . 39.2 t80 -108.08 -71.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -58.98 -55.0 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.116 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.47 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 16.2 m -61.04 -12.87 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 144' ' ' GLY . 27.8 mt-10 -105.06 -55.33 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.56 ' CE1' HG12 ' A' ' 82' ' ' VAL . 3.1 t-80 -42.34 -26.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 130.84 46.62 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 140' ' ' LEU . 15.0 mt -144.66 -98.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -1.186 . . . . 0.0 110.27 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.47 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 2.9 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 3' ' ' GLU . 4.8 mm-40 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.272 0.558 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.514 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -82.38 156.02 24.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 178.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' A' ' 144' ' ' GLY . 26.7 mttt -139.37 -165.79 1.93 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.989 -1.07 . . . . 0.0 110.867 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.19 156.79 29.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 110.516 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.733 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 40.0 t -141.95 113.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.668 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 80' ' ' PHE . 26.2 tp -82.64 81.45 8.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 111.02 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.519 ' HA ' ' CB ' ' A' ' 84' ' ' ALA . 16.6 m-85 -55.84 126.39 25.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.086 -1.009 . . . . 0.0 109.367 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 38' ' ' ALA . 73.8 t -142.03 161.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 110.767 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 86' ' ' LEU . 1.1 t -153.36 -58.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.413 -0.805 . . . . 0.0 110.191 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.584 ' CB ' ' NH1' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 169.84 150.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.463 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 64.48 10.14 41.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER 72.8 -53.19 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.297 -1.119 . . . . 0.0 109.823 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' CYS . 8.9 mt -41.2 -33.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 3.3 t 68.25 105.44 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.584 ' NH1' ' CB ' ' A' ' 12' ' ' LEU . 18.3 mtt85 -52.67 -18.52 1.83 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.046 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.481 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 60.3 p -112.8 67.71 1.0 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD2' ' SD ' ' A' ' 128' ' ' MET . 45.6 Cg_endo -72.59 -12.33 26.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.902 1.475 . . . . 0.0 110.082 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' CB ' ' HE3' ' A' ' 128' ' ' MET . . . -76.97 4.89 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 24' ' ' ILE . 23.2 p -69.77 -37.62 76.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.785 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -68.98 -43.06 75.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.917 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' HG13 ' A' ' 62' ' ' VAL . . . -70.55 -51.78 19.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.656 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -55.62 -46.93 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -1.153 . . . . 0.0 110.274 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.585 ' CB ' ' CG1' ' A' ' 35' ' ' ILE . 78.4 m -71.87 -48.59 44.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.115 -0.99 . . . . 0.0 110.053 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.529 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 10.1 mmt180 -49.35 -45.35 45.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.28 -24.09 32.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.259 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.5 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -73.88 -22.71 59.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.605 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.481 ' O ' ' C ' ' A' ' 30' ' ' GLY . 4.7 m -142.14 -33.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.978 -1.076 . . . . 0.0 110.713 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 38.47 44.91 1.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 54.4 t0 -178.55 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.961 -1.317 . . . . 0.0 110.853 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' O ' HD23 ' A' ' 33' ' ' LEU . 12.3 mmtm -141.73 -143.34 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.4 mt -147.77 -34.53 0.24 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.416 -0.802 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.811 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.1 pp -30.05 -31.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.824 -0.548 . . . . 0.0 111.829 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.642 ' N ' ' O ' ' A' ' 33' ' ' LEU . 1.5 mp -62.47 87.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.998 -1.064 . . . . 0.0 110.939 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -130.39 162.47 29.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.96 . . . . 0.0 109.064 178.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -141.9 139.98 32.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.96 -1.088 . . . . 0.0 110.668 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.546 ' HB1' ' CG ' ' A' ' 8' ' ' LEU . . . -167.78 -176.24 3.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.354 -0.842 . . . . 0.0 110.33 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.499 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . 174.84 164.07 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 40' ' ' THR . 13.7 t -94.12 71.67 3.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.42 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.39 76.68 0.57 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.67 -57.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -1.141 . . . . 0.0 110.296 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -87.59 93.26 9.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 69' ' ' ALA . 34.9 t -125.95 -3.76 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.243 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.27 41.74 2.08 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.453 ' O ' ' HB3' ' A' ' 48' ' ' SER . 5.2 pt20 -161.78 -109.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 4.4 t 64.84 70.78 0.59 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.053 -1.03 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.38 66.05 1.56 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.459 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 4.2 p-10 -89.19 31.48 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.489 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -76.0 -34.19 59.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.898 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 6.9 mmt85 -70.76 -47.79 57.77 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -56.69 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.533 -0.729 . . . . 0.0 109.349 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.547 ' NE2' ' N ' ' A' ' 55' ' ' LYS . 5.2 pp0? -56.97 -35.29 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.125 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.611 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.4 -65.92 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 109.13 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.611 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 41.4 t -49.69 -36.22 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.28 -0.887 . . . . 0.0 108.83 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -53.86 -52.76 59.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 11.3 ttpt -71.13 -21.23 62.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.472 ' OG ' ' CE ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -86.6 -8.73 57.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.947 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.25 -17.74 12.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.865 . . . . 0.0 108.84 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 122.14 44.21 0.37 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 54.3 t -158.37 144.87 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -1.087 . . . . 0.0 110.22 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.62 135.63 40.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.42 ' CD1' ' HB3' ' A' ' 54' ' ' GLN . 29.2 pt -92.76 -171.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 110.117 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -129.95 -51.46 1.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 110.194 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.52 149.03 3.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -111.91 99.48 8.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 111.9 24.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.468 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . -93.91 102.5 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.199 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -122.79 158.14 30.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.92 143.81 57.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 10.7 tt -84.61 87.94 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.5 m -58.9 169.59 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -65.73 -9.09 24.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.02 59.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 110.26 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.408 ' CG ' HG13 ' A' ' 72' ' ' ILE . 31.5 m-20 -49.69 -30.04 8.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.563 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -57.49 -41.27 80.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 110.17 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.98 -33.97 10.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER -44.35 -31.23 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.331 -0.856 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 11.9 m-85 -130.94 152.34 50.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.465 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.446 ' CB ' ' HB3' ' A' ' 5' ' ' LYS . 3.9 m-20 -68.52 -47.07 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.442 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 53.9 t -130.85 156.68 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.527 ' CD1' HG12 ' A' ' 106' ' ' VAL . 1.6 mp -118.33 139.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.283 -0.886 . . . . 0.0 109.877 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 9' ' ' PHE . . . -100.28 116.88 33.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.904 . . . . 0.0 110.385 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.401 ' O ' HD11 ' A' ' 108' ' ' LEU . . . -109.82 99.56 8.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 109.919 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.528 ' CD2' ' SG ' ' A' ' 11' ' ' CYS . 1.1 mp -60.78 -61.77 2.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.541 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.549 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.54 171.79 11.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' SER . 21.0 mt-30 -83.59 -40.69 18.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -42.64 -37.86 1.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' CB ' ' A' ' 87' ' ' ASP . 1.4 mp -71.97 -54.52 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -19.58 62.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 0.0 110.349 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -86.61 -58.38 2.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.285 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.245 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 95' ' ' ASN . 2.5 tt -43.48 -43.28 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.541 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 1.1 t-20 -60.89 -31.78 71.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' ASP . 19.5 t -64.36 -12.34 41.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.507 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.9 ptt? -123.17 -18.35 6.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -55.09 154.3 10.61 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.494 ' HD3' ' CD2' ' A' ' 77' ' ' PHE . 47.9 Cg_endo -73.36 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -125.42 101.13 6.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.53 ' N ' ' ND2' ' A' ' 101' ' ' ASN . 1.6 m120 64.06 110.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.257 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.0 m -150.23 -164.41 2.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.87 . . . . 0.0 110.209 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.83 32.55 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 77' ' ' PHE . . . -160.68 -177.09 5.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.231 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 16.4 pttm -176.53 158.23 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.527 HG12 ' CD1' ' A' ' 83' ' ' ILE . 3.6 m -111.59 151.33 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 m -138.87 147.43 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.197 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 85' ' ' ALA . 21.6 tp -81.6 126.05 31.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.223 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -93.46 89.76 6.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 0.0 110.211 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 56.52 162.77 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.473 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 45.8 Cg_endo -74.0 174.93 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.096 1.577 . . . . 0.0 110.275 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.7 Cg_endo -73.25 51.48 2.11 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.954 1.502 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 114' ' ' GLY . 19.2 m-20 -122.32 -63.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 113' ' ' ASN . . . -44.25 -73.03 0.28 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 115' ' ' VAL . 18.1 m -70.41 123.7 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.33 158.55 27.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.933 . . . . 0.0 110.256 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.566 ' HB2' ' CE2' ' A' ' 119' ' ' TYR . 8.2 p-10 -73.22 123.78 89.88 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -73.06 -89.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.008 1.53 . . . . 0.0 110.621 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 117' ' ' ASP . 12.3 m-30 58.21 -142.68 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.537 ' O ' ' CB ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -69.44 149.6 48.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.413 -0.805 . . . . 0.0 109.994 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER 71.56 3.89 4.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.38 -0.825 . . . . 0.0 110.166 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 121' ' ' SER . 73.7 m 42.19 -94.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.177 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' SER . 0.5 OUTLIER 44.98 49.06 9.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -175.39 -41.05 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 23.5 m-85 -41.58 -49.61 9.67 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.13 . . . . 0.0 110.527 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.33 -59.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.585 1.308 . . . . 0.0 110.194 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 64.9 m -53.16 -48.17 68.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.646 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 124' ' ' GLY . 7.9 ttp -50.02 -58.92 4.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.376 -0.827 . . . . 0.0 109.968 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.656 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 88.3 t80 -50.56 -50.54 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.0 -56.19 11.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 m -57.9 -46.5 84.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.571 ' CG2' HG12 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -45.38 -56.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -60.65 -45.88 92.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.54 ' O ' ' CD ' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -65.21 -13.04 57.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 14.8 mt-10 -90.0 -37.32 14.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.498 ' O ' ' CB ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -90.99 -3.69 57.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.931 . . . . 0.0 110.355 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 3.1 mttt -83.48 -50.2 0.68 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -0.961 . . . . 0.0 110.026 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 51.0 Cg_endo -80.08 -13.14 12.84 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.097 1.577 . . . . 0.0 110.414 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.534 ' C ' ' CD1' ' A' ' 139' ' ' PHE . 5.3 t80 -103.72 -48.74 3.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.507 ' CD2' HD12 ' A' ' 146' ' ' ILE . 0.5 OUTLIER -73.31 1.1 10.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.287 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 137' ' ' LYS . 21.0 m -104.22 -57.05 2.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 111.004 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' GLY . 7.3 mt-10 -105.2 -45.13 4.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.11 -0.994 . . . . 0.0 111.224 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -37.24 -29.65 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.211 -0.931 . . . . 0.0 110.434 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 145' ' ' LEU . . . 132.03 76.58 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -159.16 -38.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -1.218 . . . . 0.0 110.182 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 140' ' ' LEU . 22.3 mt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.249 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.305 0.574 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -72.21 -161.35 0.08 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 108.701 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.584 ' O ' HG21 ' A' ' 34' ' ' ILE . 23.6 mtmt -157.32 -159.68 0.87 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.921 -1.112 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.032 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -142.41 123.23 14.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 111.251 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.597 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 5.6 t -115.72 131.69 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.548 -0.72 . . . . 0.0 109.463 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 4.1 tp -90.66 92.1 8.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.916 . . . . 0.0 110.806 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CZ ' ' CG1' ' A' ' 7' ' ' VAL . 18.3 m-85 -82.99 106.85 15.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.525 ' HB ' ' CB ' ' A' ' 38' ' ' ALA . 14.0 p -125.47 173.87 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.528 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' CA ' ' CD1' ' A' ' 90' ' ' ILE . 26.5 p -163.41 -38.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER 168.76 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.123 -0.986 . . . . 0.0 110.295 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -91.03 -9.98 63.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 3.3 t-20 68.63 33.21 3.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -1.172 . . . . 0.0 110.224 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.466 HD13 ' HB2' ' A' ' 44' ' ' HIS . 84.6 mt -108.74 -91.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.8 t -95.74 64.53 2.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.882 . . . . 0.0 110.113 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.526 ' HG2' ' CD2' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 171.6 52.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.064 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.544 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER 172.39 -55.37 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.3 Cg_endo -71.79 -13.65 29.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.9 1.474 . . . . 0.0 110.383 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HB3' ' CE ' ' A' ' 128' ' ' MET . . . -65.64 -12.6 54.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.58 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 17.4 m -72.39 -29.32 63.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.48 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.517 ' HA ' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -70.34 -43.09 70.97 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.518 ' HA2' ' CD ' ' A' ' 26' ' ' ARG . . . -71.07 -45.57 49.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.59 HD12 ' CE1' ' A' ' 129' ' ' PHE . 6.1 tp -64.96 -43.19 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -1.167 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.521 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 55.9 m -65.12 -49.86 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.319 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.518 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.9 ptm180 -68.15 -26.19 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.309 -0.87 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 1.3 m-20 -85.81 -25.56 26.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.042 -1.036 . . . . 0.0 110.277 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 3.0 tmm? -92.4 -21.91 19.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.489 ' CG2' ' HG3' ' A' ' 32' ' ' LYS . 57.6 t -127.72 -12.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.197 -0.939 . . . . 0.0 110.617 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.43 -22.13 36.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -149.48 -87.05 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.39 -1.065 . . . . 0.0 110.235 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HG3' ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER 58.16 122.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.277 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 35' ' ' ILE . 6.0 mp -98.12 -114.81 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.032 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.8 OUTLIER 32.49 33.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 0.0 111.338 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 33' ' ' LEU . 1.7 mt -104.49 95.12 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.963 -1.085 . . . . 0.0 110.602 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' OD2' ' CE2' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -126.37 99.96 6.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.7 p -79.12 130.58 35.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.213 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . . . -122.33 -173.06 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.32 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . . . 171.16 109.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -69.41 -12.1 61.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -124.0 93.93 4.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.15 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.58 87.06 0.67 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -141.1 22.24 2.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -1.111 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.512 ' HA ' ' NE2' ' A' ' 47' ' ' GLN . 85.5 m-70 -141.16 40.4 1.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.94 . . . . 0.0 110.147 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 69' ' ' ALA . 11.1 t -90.63 169.29 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.214 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.31 37.84 18.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.512 ' NE2' ' HA ' ' A' ' 44' ' ' HIS . 12.2 pt20 -169.52 -148.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 60.88 131.98 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.189 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.42 70.6 1.39 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.63 13.18 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.26 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.04 -33.53 59.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.605 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.68 -44.73 55.82 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.388 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.558 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 3.4 t -63.57 -48.94 75.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.519 -0.738 . . . . 0.0 109.618 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 0.8 OUTLIER -62.74 -42.91 99.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.574 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.26 -69.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.571 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.574 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 27.6 m -49.9 -32.97 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.141 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.528 ' CB ' ' HB ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -55.51 -54.16 47.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.8 . . . . 0.0 109.487 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -29.95 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.6 t -77.78 -12.16 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.0 m-20 -113.68 -33.44 5.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 142.19 62.99 0.03 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 54.7 t -158.77 59.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -1.106 . . . . 0.0 110.107 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.426 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -73.16 130.99 41.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 63' ' ' ASP . 14.9 pt -145.38 -172.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.151 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -103.12 -61.96 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.062 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 65' ' ' SER . 12.3 mmmt -150.12 -178.4 6.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.079 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 67' ' ' GLN . 12.2 mm-40 -135.57 95.66 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.196 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -108.41 75.97 1.01 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' A' ' 45' ' ' VAL . . . -44.17 106.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 110.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -101.94 159.23 15.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.122 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 60.8 tt0 -71.93 156.46 39.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.499 ' CG1' ' OD2' ' A' ' 76' ' ' ASP . 12.5 tt -79.92 159.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.484 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.8 p -119.68 176.13 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -19.7 61.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.65 84.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.594 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 39.2 m-20 -47.53 -36.49 10.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.136 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.587 ' CD2' ' HG2' ' A' ' 98' ' ' LYS . 20.8 m-85 -94.55 16.34 15.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.137 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.18 11.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -137.11 -149.51 0.32 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.112 -0.992 . . . . 0.0 109.682 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER 36.67 -149.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.443 -0.786 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -140.06 -34.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 15.8 t -139.75 149.59 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 110.714 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.7 mt -121.76 126.61 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.828 . . . . 0.0 109.859 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 109' ' ' PHE . . . -120.26 135.09 55.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -108.43 160.38 15.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.531 ' CD2' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -105.06 2.7 29.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.965 . . . . 0.0 110.244 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.445 ' O ' HG21 ' A' ' 90' ' ' ILE . 22.9 t70 -137.85 174.14 10.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -89.66 -66.71 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.086 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -47.16 -40.69 16.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.529 ' CD1' ' CA ' ' A' ' 11' ' ' CYS . 6.3 tt -52.35 -39.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.043 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.505 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -81.58 -34.79 30.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.077 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -20.07 63.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -103.14 -44.64 5.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.514 HG13 ' CE ' ' A' ' 97' ' ' MET . 2.7 tt -48.15 -36.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.491 ' N ' HG23 ' A' ' 94' ' ' ILE . 38.4 p30 -69.98 -11.47 60.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 9.5 t -75.41 -26.86 58.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.514 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.3 ptt? -96.34 -34.99 11.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.587 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -45.22 145.58 1.78 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.26 -174.35 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.989 1.52 . . . . 0.0 110.34 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.63 -4.1 11.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.963 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.88 48.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.5 p -124.84 -161.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.52 -142.16 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.262 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 56.86 -159.27 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.188 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 106' ' ' VAL . 7.9 tttt -173.41 148.11 1.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 0.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.403 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 4.0 m -101.01 133.64 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.05 161.4 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.421 ' CD2' ' OD1' ' A' ' 110' ' ' ASN . 8.5 tp -83.51 149.21 26.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -136.3 85.71 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.236 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 109' ' ' PHE . 2.0 p-10 -177.39 146.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.478 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.58 174.78 12.04 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.004 1.528 . . . . 0.0 110.373 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.1 Cg_endo -72.84 52.77 2.22 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.437 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.98 -50.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.96 91.86 1.41 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.531 HG11 ' CD2' ' A' ' 86' ' ' LEU . 99.0 t -56.24 114.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.9 t70 57.63 168.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.948 . . . . 0.0 110.178 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.523 ' N ' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 171.61 -56.83 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.331 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 117' ' ' ASP . 46.1 Cg_endo -72.72 -37.69 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.995 1.524 . . . . 0.0 110.542 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 57.89 179.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.6 t80 60.32 25.75 15.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.234 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 t -163.89 -164.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.22 18.31 22.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.962 . . . . 0.0 110.21 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -90.53 34.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.189 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -147.23 -45.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.617 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 4.4 m-30 -50.42 -46.32 84.37 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.29 -1.124 . . . . 0.0 110.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 48.5 Cg_endo -74.65 -51.4 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.716 1.377 . . . . 0.0 110.171 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' MET . 3.3 m -58.99 -55.56 33.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.527 ' HA ' ' CG1' ' A' ' 115' ' ' VAL . 10.2 ttp -44.9 -40.58 6.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.367 -0.833 . . . . 0.0 110.084 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.59 ' CE1' HD12 ' A' ' 24' ' ' ILE . 37.1 t80 -70.35 -62.01 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.995 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.72 -47.27 15.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.92 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 71.6 m -70.88 -42.19 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.981 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.539 ' CG2' HG12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -50.72 -43.11 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.941 . . . . 0.0 109.851 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.514 ' HA ' ' HE1' ' A' ' 136' ' ' MET . 1.1 t -85.29 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.516 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.95 -18.31 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.49 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 39.1 tp10 -98.28 -18.29 18.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.514 ' HE1' ' HA ' ' A' ' 133' ' ' SER . 3.9 ttp -101.45 -0.53 35.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 110.2 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -82.51 -48.29 0.87 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.933 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.3 -11.5 14.56 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.055 1.555 . . . . 0.0 110.326 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.579 ' CZ ' ' O ' ' A' ' 143' ' ' HIS . 68.4 t80 -101.92 -61.98 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 146' ' ' ILE . 6.5 tp -52.73 -25.43 11.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.552 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 23.3 m -76.99 -40.91 45.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 110.373 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.3 -66.42 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.659 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.579 ' O ' ' CZ ' ' A' ' 139' ' ' PHE . 12.7 t-80 -96.89 60.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -0.933 . . . . 0.0 110.733 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 145' ' ' LEU . . . -176.16 -34.05 0.04 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER 172.06 -91.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.499 -1.001 . . . . 0.0 109.912 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.552 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.139 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.438 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.36 0.6 . . . . 0.0 110.339 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.548 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -155.81 -48.1 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 110.684 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.548 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 5.2 mttt 68.83 -154.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 110.913 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.829 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -159.56 135.42 8.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.316 0.579 . . . . 0.0 109.977 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.607 HG22 ' CD2' ' A' ' 9' ' ' PHE . 3.5 m -104.07 115.43 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.503 -0.748 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 36' ' ' ASP . 14.9 tp -66.37 89.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 110.089 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.607 ' CD2' HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -78.64 101.45 7.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.542 ' CG1' ' HA ' ' A' ' 39' ' ' ALA . 15.2 t -116.9 157.05 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.759 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 11.9 t -145.85 -78.87 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -175.38 69.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.341 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 137.74 -21.85 3.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.52 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 4.8 t-20 71.15 1.45 3.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -1.132 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.59 -36.79 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.932 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 29.5 p -137.63 167.18 22.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.927 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.536 ' CG ' HD22 ' A' ' 86' ' ' LEU . 51.2 mtm180 56.22 43.04 27.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -0.968 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -173.31 -60.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 45.0 Cg_endo -71.78 -10.86 27.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.888 1.468 . . . . 0.0 110.33 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 132' ' ' ILE . . . -75.72 -16.79 60.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.047 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.586 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 37.0 t -66.45 -55.42 15.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -43.37 -36.69 1.99 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 109.346 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -71.88 -50.26 19.5 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 129' ' ' PHE . 2.4 tp -55.86 -45.17 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.747 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.569 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 54.3 m -72.16 -30.47 65.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -66.91 -37.1 83.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.895 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 62' ' ' VAL . 22.1 t70 -82.81 -34.99 26.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 110.107 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.523 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -78.72 -28.16 45.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 110.406 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.531 ' CG2' ' HD3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -163.7 41.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.79 94.51 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' VAL . 3.8 t0 170.5 -25.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 110.128 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.531 ' HD3' ' CG2' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -98.76 -138.94 0.31 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 110.022 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -152.88 -83.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.829 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 37.01 26.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.42 -0.8 . . . . 0.0 110.92 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.557 ' CD1' ' O ' ' A' ' 33' ' ' LEU . 7.4 mt -131.55 132.64 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.158 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.577 ' OD1' ' CE2' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -145.03 90.05 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 179.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -67.19 124.68 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -141.45 176.03 9.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.542 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -159.61 -162.53 1.04 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.152 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.414 ' O ' ' OG ' ' A' ' 41' ' ' SER . 1.8 t -177.59 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 40' ' ' THR . 58.4 m -165.26 110.51 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 108.34 2.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.35 -41.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 44' ' ' HIS . 6.1 p80 -155.79 81.5 1.02 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.403 HG13 ' CB ' ' A' ' 69' ' ' ALA . 8.3 t -118.79 -20.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 110.303 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.15 31.7 8.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.512 ' HG3' ' N ' ' A' ' 48' ' ' SER . 17.7 pt20 -164.5 -140.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -1.116 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.512 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.61 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.174 -0.954 . . . . 0.0 110.15 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.34 107.48 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.012 1.533 . . . . 0.0 110.538 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -94.26 21.31 7.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 3.7 m -71.08 -27.9 63.96 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.189 -0.944 . . . . 0.0 108.748 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.576 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -74.38 -43.45 56.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.214 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -63.66 -54.92 28.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.483 -0.76 . . . . 0.0 109.6 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 20.0 mt-30 -61.58 -40.31 94.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.261 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.608 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.09 -71.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.832 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.608 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 14.9 p -50.03 -34.28 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.494 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.548 ' CA ' HG12 ' A' ' 62' ' ' VAL . 1.3 m -55.45 -53.71 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.507 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -69.43 -24.35 63.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.862 . . . . 0.0 109.566 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.58 -11.72 58.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.813 . . . . 0.0 109.993 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -111.45 -31.72 6.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 0.0 109.182 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.517 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 130.03 73.63 0.13 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.549 HG11 ' CE2' ' A' ' 129' ' ' PHE . 2.2 p 173.34 137.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.289 -1.124 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -119.41 137.2 53.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.203 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.449 ' CD1' ' SG ' ' A' ' 57' ' ' CYS . 34.1 mt -120.58 -34.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.202 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.4 OUTLIER 53.66 97.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 65' ' ' SER . 3.6 mmmt 60.05 145.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.271 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.43 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 5.4 mm-40 -107.53 -52.58 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 67.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.94 . . . . 0.0 110.159 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -57.28 152.53 13.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 mtp-105 -137.1 -163.75 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 110.271 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -132.43 128.01 36.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.9 tt -50.32 159.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.178 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 50.9 p -126.97 169.93 12.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -1.92 20.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.206 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.14 -8.64 21.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 20.5 p-10 -47.21 -37.25 10.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 39.5 m-85 -69.41 -17.04 63.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 m -123.06 13.44 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.203 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 3.5 tptt -94.82 -23.7 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.663 ' CD1' ' CB ' ' A' ' 6' ' ' ALA . 93.8 m-85 -147.35 -140.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.869 . . . . 0.0 109.983 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 4.0 m-20 -137.06 -23.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.054 -1.028 . . . . 0.0 111.029 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 7' ' ' VAL . 39.1 t -113.42 138.76 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 0.0 110.509 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.492 HD11 ' CB ' ' A' ' 104' ' ' ALA . 47.4 mt -146.3 133.89 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.433 -0.792 . . . . 0.0 109.777 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -162.03 163.09 28.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.661 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' CB ' ' HB ' ' A' ' 90' ' ' ILE . . . -126.5 159.87 32.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.536 HD22 ' CG ' ' A' ' 17' ' ' ARG . 1.3 tp -85.64 -37.36 19.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.479 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -101.74 -176.26 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.194 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.8 mm-40 -92.45 -39.0 11.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 88' ' ' GLN . 15.6 m -42.75 -41.0 3.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.511 ' CG1' ' O ' ' A' ' 11' ' ' CYS . 2.1 mp -65.46 -40.08 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.91 . . . . 0.0 110.099 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 tp -67.64 -32.4 73.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.6 t -79.99 -30.62 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.246 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 96' ' ' SER . 1.8 m-20 -87.83 -54.58 4.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.256 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' A' ' 95' ' ' ASN . 3.9 tt -46.69 -40.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.516 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.63 -8.81 56.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 2.7 m -96.78 -0.93 47.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.151 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.515 ' CE ' HG13 ' A' ' 94' ' ' ILE . 1.7 ptt? -122.56 -10.0 8.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 8.4 mtpt -63.59 143.75 97.88 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 45.9 Cg_endo -73.14 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.028 1.541 . . . . 0.0 110.419 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.4 m -105.61 28.38 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.421 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.1 p-10 -178.51 126.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 110.24 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 101' ' ' ASN . 83.5 m -149.56 -161.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.01 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.492 ' CB ' HD11 ' A' ' 83' ' ' ILE . . . -105.82 -152.07 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -148.75 111.15 4.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.167 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 71.1 t -87.39 125.46 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 110.088 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 84' ' ' ALA . 3.6 t -135.11 159.07 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -119.19 108.17 14.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -55.27 -170.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.26 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 109' ' ' PHE . 37.5 p-10 -42.57 166.04 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.495 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.9 Cg_endo -74.64 175.02 11.66 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.912 1.48 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.5 Cg_endo -71.74 54.45 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.996 1.524 . . . . 0.0 110.38 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.67 -29.95 4.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.876 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -107.45 -92.45 2.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.537 ' CG1' ' CB ' ' A' ' 131' ' ' SER . 29.0 m -41.12 128.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 110.168 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -157.78 -65.7 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.452 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 0.5 OUTLIER 61.53 82.76 0.22 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.12 176.64 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.006 1.53 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 119' ' ' TYR . 67.7 m-85 -118.95 24.15 10.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -130.17 -34.68 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 110.335 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -145.62 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 110.246 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 p -153.97 54.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.137 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' A' ' 127' ' ' THR . 4.0 p30 -124.41 -6.14 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.265 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 117' ' ' ASP . . . -93.85 -22.37 25.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 13.5 m-85 -55.03 -49.81 90.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.331 -1.099 . . . . 0.0 110.365 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -73.34 -35.67 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.84 1.442 . . . . 0.0 110.385 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.48 ' HA ' ' HB1' ' A' ' 130' ' ' ALA . 2.5 m -63.06 -51.96 64.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.55 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 3.1 ttp -44.52 -55.42 5.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 11.1 t80 -68.23 -33.59 74.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 127' ' ' THR . . . -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.182 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.537 ' CB ' ' CG1' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -86.89 -43.45 12.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.057 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.565 ' CG2' HG12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -57.85 -23.21 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -0.761 . . . . 0.0 109.472 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.529 ' OG ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.32 -42.81 6.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.987 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 14.3 mttp -75.41 -5.69 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 131' ' ' SER . 70.3 mm-40 -129.2 34.34 4.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.15 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.539 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -116.21 -12.18 11.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 1.1 mttp -81.53 -47.4 1.06 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.44 0.33 10.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.99 1.521 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 62.8 t80 -108.06 -77.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.546 ' CD1' ' CD1' ' A' ' 145' ' ' LEU . 8.5 tp -51.16 -24.46 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.345 -0.847 . . . . 0.0 110.438 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 146' ' ' ILE . 32.2 m -82.01 -30.61 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -105.22 -14.06 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.453 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.687 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 6.9 m80 -84.71 39.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.101 -0.999 . . . . 0.0 110.302 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.7 60.86 6.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.546 ' CD1' ' CD1' ' A' ' 140' ' ' LEU . 1.1 mt -163.67 34.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 110.021 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.513 ' CG2' ' O ' ' A' ' 141' ' ' THR . 2.0 tp . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.227 0.537 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -83.15 149.96 26.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.254 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.548 ' O ' HG23 ' A' ' 34' ' ' ILE . 23.1 mtpp -130.23 -155.62 0.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 110.982 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.1 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -147.23 117.2 7.22 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.546 0.689 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.578 HG12 ' CZ ' ' A' ' 9' ' ' PHE . 21.9 t -108.2 126.62 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.578 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.547 ' CD2' ' HB3' ' A' ' 38' ' ' ALA . 6.8 tp -98.13 80.95 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 0.0 110.752 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.578 ' CZ ' HG12 ' A' ' 7' ' ' VAL . 69.5 m-85 -62.2 133.65 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.518 ' CG1' HD13 ' A' ' 90' ' ' ILE . 8.6 p -156.45 166.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.616 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.518 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 1.1 p -146.78 -98.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 109.904 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.58 86.7 2.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.101 -1.0 . . . . 0.0 110.185 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.581 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 85.37 -11.53 60.87 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 t30 74.75 -164.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -1.123 . . . . 0.0 109.782 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.56 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 11.7 mm 58.12 13.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 2.0 t -174.89 175.33 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.955 . . . . 0.0 110.207 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.557 ' CB ' HD21 ' A' ' 86' ' ' LEU . 1.1 mtp180 70.72 -56.24 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.351 -0.843 . . . . 0.0 110.013 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.554 ' HB2' ' CD1' ' A' ' 86' ' ' LEU . 3.2 m -175.44 55.62 0.14 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 16' ' ' CYS . 50.0 Cg_endo -76.39 -1.14 11.15 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.971 1.511 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.545 ' CB ' ' CE ' ' A' ' 128' ' ' MET . . . -100.12 7.01 44.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.348 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.573 ' SG ' ' CD1' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -59.73 -37.83 80.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.125 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -50.42 66.96 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.68 -0.638 . . . . 0.0 109.726 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' ARG . . . -62.97 -58.27 12.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -55.13 -29.33 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -1.205 . . . . 0.0 109.91 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.493 ' O ' HG23 ' A' ' 29' ' ' VAL . 1.3 m -69.09 -60.7 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.253 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 23' ' ' GLY . 11.6 ptm180 -61.1 -28.73 69.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.509 ' CB ' ' HA ' ' A' ' 62' ' ' VAL . 11.4 t70 -81.17 -53.06 6.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -55.58 -38.73 69.75 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.312 -0.867 . . . . 0.0 110.278 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.542 ' HB ' ' CG ' ' A' ' 32' ' ' LYS . 4.4 m -84.54 -38.56 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.226 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.47 ' N ' ' CG2' ' A' ' 29' ' ' VAL . . . 106.0 -64.29 0.29 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.03 50.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -1.147 . . . . 0.0 110.251 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.542 ' CG ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -95.48 -132.82 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.569 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 4.9 mp -149.57 -120.63 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.383 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.1 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.0 29.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.812 . . . . 0.0 111.609 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.633 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -96.24 97.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.888 -1.133 . . . . 0.0 110.147 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.578 ' OD1' ' CE1' ' A' ' 80' ' ' PHE . 6.3 m-20 -135.76 144.27 45.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.5 p -137.56 151.34 48.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.432 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.547 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . . . -146.22 -172.9 4.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 110.361 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.45 ' HA ' HG21 ' A' ' 10' ' ' VAL . . . -169.4 100.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 41' ' ' SER . 25.8 p -54.48 -68.17 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 0.0 110.274 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.503 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.2 OUTLIER -64.71 -177.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.54 36.86 0.58 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -78.96 -31.64 45.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -1.147 . . . . 0.0 110.187 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -116.62 70.74 0.77 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -138.28 142.6 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 86.32 25.98 34.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' SER . 13.0 pt20 -176.96 -141.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -1.131 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 0.9 OUTLIER 59.03 108.31 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.62 100.37 0.8 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.012 1.532 . . . . 0.0 110.471 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 22.3 m-20 -87.33 27.12 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.231 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -75.02 -27.55 60.14 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.186 -0.946 . . . . 0.0 109.137 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -74.2 -51.77 14.47 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.442 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -63.01 -46.74 86.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 109.655 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 1.8 tt0 -62.76 -42.47 99.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.169 -0.957 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 3.5 ttpp -57.76 -67.13 0.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.704 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.564 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 4.8 p -50.86 -33.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.237 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.552 ' CA ' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.37 -55.6 31.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.463 -0.773 . . . . 0.0 109.504 179.424 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -29.89 71.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 t -78.24 -14.46 59.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -111.7 -35.13 5.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.2 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 127.58 84.81 0.48 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.552 HG13 ' CA ' ' A' ' 57' ' ' CYS . 1.5 p 169.26 80.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.369 -1.077 . . . . 0.0 110.041 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -59.96 157.53 12.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.352 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.477 HG22 HD12 ' A' ' 64' ' ' ILE . 39.3 mt -148.81 -64.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.097 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER 66.54 96.78 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.47 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.56 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.286 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -105.48 -145.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.7 70.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -93.75 139.12 31.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -171.42 175.36 4.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -75.96 106.49 7.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.479 HD12 ' CB ' ' A' ' 38' ' ' ALA . 19.8 tt -46.23 157.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.41 159.9 37.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -55.38 -19.3 8.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.14 -12.89 44.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.98 -15.79 61.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.578 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 17.1 m-30 -81.73 -8.04 59.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.223 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.7 p -117.73 -48.98 2.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.582 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -51.37 -27.09 8.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.18 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 9.3 m-85 -134.1 157.09 47.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.252 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -104.25 -8.17 19.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.27 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.511 HG12 ' CE1' ' A' ' 143' ' ' HIS . 6.0 t -138.95 141.86 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.233 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.51 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 51.9 mt -123.84 143.36 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.516 ' CB ' ' CD1' ' A' ' 9' ' ' PHE . . . -114.64 120.51 40.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 90' ' ' ILE . . . -111.22 113.62 26.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.557 HD21 ' CB ' ' A' ' 17' ' ' ARG . 2.2 mp -51.18 -83.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.492 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t0 -71.96 -179.43 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.241 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -84.41 -45.29 12.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 1.5 t -45.21 -51.14 11.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.956 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.528 ' CG1' HD12 ' A' ' 94' ' ' ILE . 6.8 tt -52.95 -47.16 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.363 -0.835 . . . . 0.0 110.086 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -58.16 -53.21 60.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -55.28 -54.87 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.845 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 96' ' ' SER . 29.1 m-20 -47.67 -60.32 2.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 110.147 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.538 ' HA ' ' CE ' ' A' ' 97' ' ' MET . 15.0 mt -58.74 -47.05 90.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -67.02 -16.13 64.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.557 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -80.82 -28.89 36.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.538 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 10.2 ptt? -97.07 -30.25 13.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.118 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -41.76 144.59 0.79 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 110.446 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.525 ' HD2' ' CE ' ' A' ' 98' ' ' LYS . 44.1 Cg_endo -71.37 177.39 6.74 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.13 1.595 . . . . 0.0 110.387 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.413 ' C ' ' OD1' ' A' ' 101' ' ' ASN . 0.9 OUTLIER -98.2 21.2 11.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 7.4 m120 -143.87 -137.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.102 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.31 -176.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 110.067 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.476 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -131.55 35.37 3.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.28 -171.52 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 146.04 11.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.492 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 37.8 t -112.17 127.0 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.545 ' CG2' ' N ' ' A' ' 108' ' ' LEU . 1.2 p -122.4 171.42 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.545 ' N ' ' CG2' ' A' ' 107' ' ' VAL . 6.0 tp -99.74 150.31 22.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.828 . . . . 0.0 110.138 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 135' ' ' GLU . 25.3 t80 -124.96 97.58 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 109' ' ' PHE . 18.8 t-20 60.14 144.9 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.55 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.3 Cg_endo -74.51 176.97 9.0 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.529 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.1 Cg_endo -72.18 3.05 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.027 1.54 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.47 -37.81 15.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 110.123 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 115' ' ' VAL . . . -78.49 -76.41 0.93 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 29.9 m -59.27 -150.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -1.1 . . . . 0.0 110.118 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 6.0 t0 63.77 135.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.442 ' OD1' ' SG ' ' A' ' 16' ' ' CYS . 1.2 p30 -170.23 157.63 5.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.963 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 -27.74 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.036 1.545 . . . . 0.0 110.448 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 56.3 34.92 24.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -110.41 -32.97 6.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 m -122.22 -86.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.5 ' O ' ' CD ' ' A' ' 126' ' ' PRO . 89.9 p -155.0 19.05 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.402 ' O ' HG21 ' A' ' 127' ' ' THR . 0.9 OUTLIER -83.11 4.6 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 110.18 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -105.8 -45.99 1.24 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 12.8 m-85 -50.01 -45.69 81.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 110.566 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.9 Cg_endo -73.68 -51.02 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.573 1.302 . . . . 0.0 110.287 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 66.0 p -69.11 -56.59 7.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.23 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.545 ' CE ' ' CB ' ' A' ' 20' ' ' ALA . 8.8 ttp -41.33 -68.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 87.5 t80 -59.22 -44.04 92.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.119 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 126' ' ' PRO . . . -44.56 -64.16 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.972 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.445 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -63.4 -45.3 91.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 109.953 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.584 ' CG2' ' CG1' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -40.7 -56.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.856 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.528 ' N ' HG21 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -74.38 -47.36 34.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.225 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 3.8 tppt? -47.94 -22.79 0.64 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.578 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -125.57 31.34 5.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.986 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.52 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -115.21 -22.08 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.156 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.502 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 3.9 mttp -87.92 -52.36 0.39 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.72 5.64 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.521 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 41.3 t80 -93.82 -76.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 140' ' ' LEU . 3.5 pp -65.66 -30.8 71.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.514 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.516 ' HA ' ' CG2' ' A' ' 146' ' ' ILE . 22.3 m -56.06 -33.53 65.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 110.251 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.09 -34.87 7.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.16 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.519 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 0.2 OUTLIER -44.33 -27.85 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 110.107 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.51 ' O ' ' HD2' ' A' ' 5' ' ' LYS . . . 127.08 67.8 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.5 tp -156.36 -54.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 0.0 110.227 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.516 ' CG2' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.174 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.343 0.592 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.563 ' HG2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.84 -164.74 0.54 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.401 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.563 ' N ' ' HG2' ' A' ' 4' ' ' LYS . 24.7 mttm -156.02 -160.86 1.05 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 110.77 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.015 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -144.59 122.81 12.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.442 -0.787 . . . . 0.0 111.056 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.622 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 43.5 t -113.21 128.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 109.669 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.488 HD21 ' CD1' ' A' ' 72' ' ' ILE . 13.2 tp -86.93 85.87 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.485 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.622 ' CZ ' ' CG1' ' A' ' 7' ' ' VAL . 34.0 m-85 -76.24 100.43 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.541 ' CG1' HD12 ' A' ' 90' ' ' ILE . 1.5 p -120.54 168.96 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.521 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 19.4 t -154.14 -53.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.058 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER 176.58 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.501 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -104.31 -15.85 20.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.555 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 6.6 t-20 67.96 38.7 2.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -1.198 . . . . 0.0 110.205 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -114.76 -2.52 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 110.076 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 m -137.2 45.45 2.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 110.13 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.555 ' NH2' ' HA ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -146.7 -57.35 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 110.176 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.528 ' CB ' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -45.21 -56.57 9.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.139 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 18' ' ' SER . 46.9 Cg_endo -74.88 -0.96 10.55 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.928 1.488 . . . . 0.0 110.295 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -103.66 -44.98 4.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 110.213 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 60.9 m -74.21 -38.62 63.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.066 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.459 ' HG3' HG22 ' A' ' 35' ' ' ILE . 2.5 tt0 -69.68 -45.68 67.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 110.242 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.527 ' HA3' ' CG1' ' A' ' 62' ' ' VAL . . . -71.23 -46.65 41.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.593 HG22 ' CG2' ' A' ' 132' ' ' ILE . 0.9 OUTLIER -61.29 -43.8 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.14 . . . . 0.0 110.355 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.553 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 58.3 m -69.71 -40.02 76.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 1.8 mmt-85 -67.5 -32.87 73.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD2' ' HA3' ' A' ' 61' ' ' GLY . 1.2 t70 -85.19 -48.69 8.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.039 . . . . 0.0 110.622 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.501 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -74.83 -21.58 59.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.745 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.538 HG11 ' CG ' ' A' ' 32' ' ' LYS . 2.3 t -119.98 -24.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.783 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 106.28 -60.97 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 13.7 t70 -178.27 94.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 110.215 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.538 ' CG ' HG11 ' A' ' 29' ' ' VAL . 12.5 mmtm -119.86 -130.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.105 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 35' ' ' ILE . 5.2 mp -149.81 -118.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 110.643 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.015 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.17 29.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.459 -0.775 . . . . 0.0 111.496 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 33' ' ' LEU . 1.1 mt -104.26 90.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.007 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.58 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 55.1 m-20 -121.79 97.49 5.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.68 134.72 36.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.491 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . -137.04 168.35 19.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.487 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.474 ' O ' ' CG2' ' A' ' 72' ' ' ILE . . . -140.38 142.83 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 110.08 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.54 ' CG2' HG13 ' A' ' 90' ' ' ILE . 11.8 p -103.7 41.57 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 40' ' ' THR . 2.4 p 170.16 103.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.86 58.05 0.99 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.59 -62.06 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -1.158 . . . . 0.0 110.189 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 102.4 9.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.288 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.6 t -142.07 139.53 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.227 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.07 60.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 48' ' ' SER . 5.3 pt20 -123.52 -140.39 0.31 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 110.243 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.459 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 66.21 126.36 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.36 90.36 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.349 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 2.5 t0 -99.26 24.03 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.259 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -76.47 -30.43 57.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.219 -0.925 . . . . 0.0 109.197 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.9 OUTLIER -74.16 -48.95 25.88 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.444 -0.785 . . . . 0.0 109.29 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.38 71.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 109.483 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -61.1 -42.13 97.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.267 179.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.601 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -54.74 -66.05 0.47 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.363 -0.836 . . . . 0.0 109.304 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.601 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.6 t -50.28 -35.06 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.939 . . . . 0.0 108.983 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.479 ' C ' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -54.87 -51.11 66.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 109.427 179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -69.52 -28.55 66.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.719 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.3 -11.14 59.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -112.44 -26.49 8.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.549 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 131.17 80.18 0.2 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 66.5 t -158.89 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -1.108 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.466 ' O ' HG21 ' A' ' 64' ' ' ILE . 32.1 p-10 -97.97 104.66 16.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.466 HG21 ' O ' ' A' ' 63' ' ' ASP . 13.6 pt -143.24 -171.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.36 125.97 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.061 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.466 ' OE1' ' HD3' ' A' ' 19' ' ' PRO . 33.9 mm-40 -84.38 96.07 8.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.345 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -89.66 74.41 7.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.118 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 68' ' ' ARG . . . -41.9 126.63 3.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.9 tmm_? -106.06 151.45 24.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -90.62 144.14 26.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.903 . . . . 0.0 110.241 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.488 ' CD1' HD21 ' A' ' 8' ' ' LEU . 16.5 tt -82.69 170.45 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 110.121 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -147.51 161.07 41.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -59.42 -14.84 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' O ' ' CE ' ' A' ' 79' ' ' LYS . . . -80.48 -12.02 59.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.165 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -47.96 -21.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.366 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.552 ' CD1' ' HE3' ' A' ' 98' ' ' LYS . 18.9 m-85 -76.92 52.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.113 -0.992 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.516 ' C ' ' CD ' ' A' ' 79' ' ' LYS . 1.1 p 175.02 31.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.344 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' CD ' ' C ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -135.74 -35.69 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.284 -0.885 . . . . 0.0 110.034 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 36' ' ' ASP . 9.5 m-85 -123.32 156.46 35.27 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.549 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 1.3 m-20 -71.64 -36.63 70.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 83' ' ' ILE . 50.4 t -140.8 156.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.039 . . . . 0.0 110.69 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.477 HG12 HD23 ' A' ' 8' ' ' LEU . 9.5 mt -118.45 133.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -107.24 134.63 50.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 110.443 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.411 ' CA ' HD13 ' A' ' 90' ' ' ILE . . . -116.55 125.68 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 11' ' ' CYS . 2.7 mp -78.99 -78.47 0.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 5.6 m-20 -56.91 178.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.415 ' HG3' ' HD3' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -89.11 -55.15 3.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.2 m -45.62 -48.93 14.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.541 HD12 ' CG1' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -46.26 -49.69 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -49.62 72.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.835 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.0 t -60.88 -17.26 49.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.846 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -87.32 -67.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.527 ' HA ' ' CE ' ' A' ' 97' ' ' MET . 6.6 mt -44.75 -54.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.549 -0.72 . . . . 0.0 109.871 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -60.09 -14.9 19.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.697 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -81.7 -34.99 30.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.527 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 21.1 ptt? -96.53 -27.85 14.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.552 ' HE3' ' CD1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -40.71 139.32 1.17 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.66 -163.98 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.087 1.572 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -110.87 20.98 16.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.282 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -169.98 121.33 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.2 p -172.59 170.54 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 41.59 1.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -162.27 131.61 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.13 173.59 6.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 0.0 110.136 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.417 ' CG2' ' HD2' ' A' ' 98' ' ' LYS . 64.5 t -118.95 142.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -134.61 161.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.231 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.91 105.51 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.144 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.563 ' CZ ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -54.57 -57.18 12.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.463 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 18.7 p30 -162.11 164.11 17.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.483 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -73.96 175.21 11.14 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.133 1.596 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.0 Cg_endo -72.41 52.45 1.98 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.941 1.495 . . . . 0.0 110.422 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.41 -7.15 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.95 -91.18 1.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.485 ' CG1' ' HG2' ' A' ' 128' ' ' MET . 14.3 t -85.86 136.85 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.071 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.431 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 35.1 t70 -167.79 33.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.545 ' N ' ' CD ' ' A' ' 118' ' ' PRO . 55.8 m-20 43.76 49.39 5.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 117' ' ' ASP . 46.0 Cg_endo -72.72 139.9 31.52 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.02 1.537 . . . . 0.0 110.499 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.431 ' CE2' ' O ' ' A' ' 117' ' ' ASP . 49.5 m-85 -132.93 44.8 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.113 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -107.35 -35.98 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.139 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.7 m -159.16 -147.35 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.483 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 28.8 m -60.85 -25.74 66.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 123' ' ' ASP . 10.9 p30 -46.59 123.03 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.265 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 132.99 -27.0 3.51 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -98.42 -45.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.264 -1.139 . . . . 0.0 110.764 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 48.4 Cg_endo -82.6 -73.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.586 1.308 . . . . 0.0 110.643 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 126' ' ' PRO . 1.1 t -42.95 -33.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 124' ' ' GLY . 4.0 tmm? -62.05 -69.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 24' ' ' ILE . 5.8 t80 -49.22 -50.21 39.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.976 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -50.87 -47.56 60.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.5 t -64.78 -46.96 79.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.797 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.593 ' CG2' HG22 ' A' ' 24' ' ' ILE . 15.2 mm -47.51 -55.97 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 0.1 OUTLIER -63.89 -47.85 78.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.821 . . . . 0.0 110.146 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -52.99 -25.88 13.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.897 . . . . 0.0 110.145 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.563 ' O ' ' CZ ' ' A' ' 109' ' ' PHE . 80.6 mm-40 -116.88 14.94 15.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.554 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.79 -22.14 7.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 1.8 mtpm? -84.52 -47.9 0.67 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.1 Cg_endo -78.36 -4.59 14.36 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.013 1.533 . . . . 0.0 110.344 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 139' ' ' PHE . 4.6 t80 -108.03 -48.87 3.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.424 HD13 HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -64.46 -9.58 19.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.228 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.514 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 4.3 m -73.8 -72.1 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -105.16 -5.66 20.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.68 22.86 15.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.163 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.508 ' O ' ' CE ' ' A' ' 5' ' ' LYS . . . -173.14 -54.64 0.05 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 144' ' ' GLY . 5.4 mp -149.77 -88.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -1.124 . . . . 0.0 110.126 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.514 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 1.7 tp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.149 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.283 0.563 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.456 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -85.63 156.72 20.58 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.551 ' O ' HG21 ' A' ' 34' ' ' ILE . 3.2 mtpt -133.53 -163.99 1.43 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.022 -1.049 . . . . 0.0 111.029 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.082 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -148.86 116.45 6.23 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.534 ' CG2' HD12 ' A' ' 34' ' ' ILE . 3.3 t -104.13 125.54 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.703 . . . . 0.0 109.159 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 13.5 tp -89.92 84.7 6.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 110.697 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.587 ' CG ' ' SG ' ' A' ' 21' ' ' CYS . 26.0 m-85 -67.27 108.72 2.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -0.95 . . . . 0.0 109.469 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 39' ' ' ALA . 20.0 t -126.38 154.81 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.563 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.523 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 1.8 p -145.16 -108.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.854 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.477 HD21 ' OD2' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -118.51 82.24 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 0.0 110.104 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 77.37 0.39 71.83 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.5 t30 71.97 -158.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -1.087 . . . . 0.0 109.899 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 8.4 mm 58.06 12.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.237 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 177.19 176.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.117 -0.99 . . . . 0.0 110.504 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.541 ' C ' ' CD2' ' A' ' 86' ' ' LEU . 1.0 OUTLIER 71.72 -60.0 0.53 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.775 . . . . 0.0 110.237 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.583 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -139.73 48.07 1.46 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.9 Cg_endo -77.82 -10.64 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.924 1.486 . . . . 0.0 110.054 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -97.5 6.99 47.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 110.43 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.587 ' SG ' ' CG ' ' A' ' 9' ' ' PHE . 1.4 m -62.78 -45.14 94.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.07 -1.019 . . . . 0.0 109.352 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HG2' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.83 -47.4 85.88 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.55 -0.719 . . . . 0.0 109.88 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.5 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -68.49 -59.52 6.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.641 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -43.0 -46.91 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -1.19 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.607 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 78.1 m -69.36 -37.44 77.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.48 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 13.6 mmt180 -62.04 -45.18 94.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.337 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 -45.79 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 6.0 mmt -63.24 -41.32 99.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.524 ' CG2' ' HD3' ' A' ' 32' ' ' LYS . 3.5 m -158.77 36.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.405 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 25' ' ' CYS . . . -49.87 -22.67 4.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.82 -20.79 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.356 -1.085 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.524 ' HD3' ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -104.77 -139.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.931 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.8 mt -147.77 -95.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.228 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.082 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 32.39 33.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 0.0 111.568 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' LEU . 3.5 mt -110.69 94.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.892 -1.13 . . . . 0.0 110.487 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.568 ' OD1' ' CE1' ' A' ' 80' ' ' PHE . 42.3 m-20 -126.05 104.48 8.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 m -95.15 130.94 41.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -157.29 -172.79 4.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.482 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -164.06 146.55 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.125 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 40' ' ' THR . 14.0 t -93.87 64.74 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.177 -0.952 . . . . 0.0 110.256 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.485 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . 12.5 t -149.17 -75.66 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.242 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . 74.59 106.32 0.09 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 1.2 m-85 -170.04 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -1.146 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -123.98 23.88 8.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.229 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 69' ' ' ALA . 3.7 m -65.03 -9.19 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 110.403 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . -104.48 41.12 2.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 48' ' ' SER . 6.9 pt20 -177.92 -142.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.119 . . . . 0.0 110.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.465 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 67.45 98.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.56 83.53 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.004 1.529 . . . . 0.0 110.427 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -89.09 32.3 0.83 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -29.4 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 108.923 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.456 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -73.72 -52.46 13.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.74 . . . . 0.0 109.306 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.625 ' N ' ' CZ ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -61.25 -48.22 82.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.622 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -61.27 -43.71 98.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.136 -0.978 . . . . 0.0 109.256 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 1.3 tptt -54.25 -65.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.393 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.581 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 24.3 m -53.75 -32.24 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.227 -0.921 . . . . 0.0 109.03 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.516 ' N ' HG21 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -54.98 -55.63 28.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.429 -0.795 . . . . 0.0 109.29 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -33.31 75.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -11.21 60.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -0.836 . . . . 0.0 109.971 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.4 m-80 -113.32 -32.07 6.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 145.12 55.01 0.02 OUTLIER Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 53.8 t -158.66 89.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.135 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.415 ' O ' HG21 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -90.29 103.55 16.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.446 HG23 HG13 ' A' ' 62' ' ' VAL . 41.2 pt -138.12 -161.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.29 133.89 0.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.237 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt 52.12 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' ARG . 6.0 mm-40 -44.72 -39.83 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 48.23 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.464 ' HB2' ' CG1' ' A' ' 45' ' ' VAL . . . -102.18 155.63 18.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -152.73 158.39 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -79.77 124.63 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 4.2 tt -72.78 96.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.173 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -155.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.176 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.19 -7.24 59.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.79 -18.05 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.27 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 8.4 p-10 -61.01 -15.47 32.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.584 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 14.1 m-85 -82.81 2.04 36.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.152 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -47.88 -31.42 5.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.267 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 6' ' ' ALA . 11.3 m-85 -134.94 156.07 49.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.33 -10.6 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.432 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.552 HG13 ' CD2' ' A' ' 143' ' ' HIS . 99.5 t -132.55 140.99 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.928 . . . . 0.0 110.387 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -128.07 130.86 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.37 137.42 49.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.938 . . . . 0.0 110.249 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.52 137.92 51.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.541 ' CD2' ' C ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -96.69 -34.36 11.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.096 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.477 ' OD2' HD21 ' A' ' 12' ' ' LEU . 1.1 m-20 -111.57 -170.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 110.17 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -97.27 -36.9 10.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 p -43.96 -36.37 2.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.138 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 87' ' ' ASP . 1.6 mp -73.12 -63.98 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.88 -17.61 2.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.252 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -95.61 -32.81 12.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.395 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -95.82 -56.9 2.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.539 HG12 ' CE ' ' A' ' 97' ' ' MET . 0.1 OUTLIER -47.29 -34.35 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.172 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 42.8 m-20 -78.48 -7.85 57.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.251 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -83.13 -18.54 39.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.913 . . . . 0.0 110.189 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' HG12 ' A' ' 94' ' ' ILE . 2.9 ptt? -102.16 -36.34 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -56.0 136.62 73.47 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.16 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.19 -90.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.981 1.516 . . . . 0.0 110.503 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 102' ' ' CYS . 26.3 m -153.12 -101.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 110.107 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.4 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 100' ' ' SER . 0.2 OUTLIER -90.57 -169.95 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.75 29.41 4.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.82 154.33 1.89 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -121.25 150.45 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.54 145.39 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.15 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 139' ' ' PHE . 11.1 m -135.34 142.35 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.94 128.18 34.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.137 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -85.33 -36.04 21.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.161 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.466 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 6.8 p30 175.76 166.3 0.4 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 110' ' ' ASN . 46.9 Cg_endo -74.5 174.86 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.013 1.533 . . . . 0.0 110.188 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.09 53.07 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.964 1.507 . . . . 0.0 110.437 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -143.04 -41.92 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.55 -74.06 0.68 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.461 HG23 ' OD1' ' A' ' 110' ' ' ASN . 31.2 m -56.26 116.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.7 t70 -81.46 146.55 30.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.43 ' OD2' ' CZ ' ' A' ' 17' ' ' ARG . 19.4 m-20 -111.52 81.91 3.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.468 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -73.34 116.51 4.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.955 1.503 . . . . 0.0 110.459 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -111.96 -38.2 4.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.46 56.0 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.097 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.93 139.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.1 m -47.91 -29.1 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.257 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.27 121.94 11.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 114.73 -57.36 0.47 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 53' ' ' SER . 6.3 m-30 -34.49 -53.82 0.96 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.645 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.15 -59.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.651 1.343 . . . . 0.0 110.322 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 116' ' ' ASP . 97.1 m -53.37 -48.74 68.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 124' ' ' GLY . 4.8 ttp -48.85 -69.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.817 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 9.0 t80 -43.81 -54.56 5.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.796 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 134' ' ' LYS . . . -51.85 -39.67 59.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.682 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 74.9 m -66.38 -57.75 6.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.616 ' CG2' HG21 ' A' ' 24' ' ' ILE . 12.0 mm -44.26 -47.97 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.44 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 2.5 t -71.22 -61.28 1.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 110.62 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -44.72 -23.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -112.43 14.92 20.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.973 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.529 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.7 -22.75 7.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -82.35 -47.06 0.94 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.111 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.5 Cg_endo -78.15 -8.77 16.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.862 1.454 . . . . 0.0 110.285 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.67 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 71.6 t80 -103.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.283 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 145' ' ' LEU . 3.2 tp -52.74 -24.56 8.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 80.0 m -88.19 -27.89 21.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.445 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.22 -12.41 16.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.154 -0.966 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.67 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 3.5 t60 -84.59 39.69 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.21 45.69 87.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.519 HD13 ' CD1' ' A' ' 140' ' ' LEU . 1.4 mt -133.95 -58.53 0.85 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -1.133 . . . . 0.0 110.415 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 140' ' ' LEU . 4.2 mp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.149 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.248 0.547 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.542 ' HG2' ' CG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.8 156.89 24.68 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 41.1 mtpt -127.03 -161.25 1.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.981 -1.075 . . . . 0.0 111.158 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.082 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.26 122.79 11.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.481 0.658 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.532 ' CG2' HD12 ' A' ' 34' ' ' ILE . 24.2 t -113.03 121.89 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.791 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 38' ' ' ALA . 13.0 tp -94.85 81.45 3.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.405 -0.809 . . . . 0.0 110.398 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 7.5 p90 -74.36 140.41 44.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.151 -0.968 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 11' ' ' CYS . 1.4 p -170.94 171.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 110.366 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.56 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 46.9 t -140.74 -57.95 0.52 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 41' ' ' SER . 13.4 mt -155.56 -44.5 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.16 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -125.73 -3.95 6.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.537 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 3.6 t-20 64.67 30.21 12.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -1.148 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 70.8 mt -98.75 -35.8 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' SD ' ' A' ' 128' ' ' MET . 0.9 OUTLIER -104.57 18.68 21.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -135.86 -32.02 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -0.95 . . . . 0.0 110.311 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.542 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -62.15 -58.0 20.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 46.5 Cg_endo -73.08 -5.39 17.11 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.945 1.497 . . . . 0.0 110.456 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -107.03 -40.83 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.551 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 65.8 m -72.66 -36.88 68.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER -66.04 -45.15 82.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 110.075 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' ASP . . . -70.78 -50.54 24.01 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.598 HD13 ' CD2' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -54.49 -44.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -1.213 . . . . 0.0 110.2 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.571 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 1.4 m -67.43 -52.55 38.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.21 -27.43 61.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.295 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -87.76 -30.08 20.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.379 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.476 ' HE1' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -78.81 -24.28 44.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.387 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.481 ' HB ' ' HG3' ' A' ' 32' ' ' LYS . 19.5 m -119.32 -25.6 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 112.34 -63.16 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 18.9 p30 -179.76 70.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 7.9 mmtt -102.76 -135.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 110.116 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.548 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 32.7 mt -128.09 -119.31 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -0.974 . . . . 0.0 110.328 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.082 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 34.8 30.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 111.198 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.556 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -103.09 103.53 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.062 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.567 ' OD1' ' CE1' ' A' ' 80' ' ' PHE . 49.1 m-20 -136.71 132.63 35.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.147 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -108.48 144.89 35.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 8' ' ' LEU . . . -134.07 179.06 6.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.36 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . . . -172.53 89.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.195 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.458 ' O ' ' CB ' ' A' ' 41' ' ' SER . 3.5 m -85.72 83.08 7.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.231 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER 172.07 -53.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.236 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 56.97 104.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -145.91 -44.96 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.157 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.476 ' HA ' ' NE2' ' A' ' 47' ' ' GLN . 34.1 m-70 -124.23 27.44 7.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.412 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . 3.1 m -62.91 144.65 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.208 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 71.41 29.03 68.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.476 ' NE2' ' HA ' ' A' ' 44' ' ' HIS . 13.3 pt20 -177.39 -139.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -1.122 . . . . 0.0 110.08 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.467 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 68.01 119.5 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.185 -0.947 . . . . 0.0 110.229 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HD2' ' CE1' ' A' ' 119' ' ' TYR . 47.0 Cg_endo -69.37 73.56 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.056 1.556 . . . . 0.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.497 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 1.4 t0 -94.2 33.74 1.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.107 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -71.72 -24.21 61.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.226 -0.921 . . . . 0.0 108.977 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -72.05 -52.19 18.1 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.269 179.362 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -62.59 -50.17 72.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -0.772 . . . . 0.0 109.639 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.567 ' NE2' ' CD1' ' A' ' 64' ' ' ILE . 0.7 OUTLIER -58.93 -43.97 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.5 ttpp -56.6 -68.65 0.2 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.658 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.555 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 19.5 m -48.35 -33.85 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.515 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -58.17 -52.13 66.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.17 -13.9 60.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.738 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -92.75 -12.29 31.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 110.117 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -117.15 -30.58 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 137.44 84.36 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 41.9 t -158.65 120.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -1.137 . . . . 0.0 110.126 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.506 ' O ' ' CG2' ' A' ' 64' ' ' ILE . 3.0 m-20 -90.17 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.954 . . . . 0.0 110.114 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.567 ' CD1' ' NE2' ' A' ' 54' ' ' GLN . 12.0 pt -158.71 143.56 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 12.2 p -168.17 31.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 65' ' ' SER . 65.6 mmtt -149.2 -73.66 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.171 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 19' ' ' PRO . 1.7 mp0 60.26 105.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 57.32 1.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.412 ' HB2' ' CB ' ' A' ' 45' ' ' VAL . . . -45.12 134.56 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 1.7 ptt-85 -166.22 156.97 12.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -79.15 135.07 36.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.245 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.463 HG13 ' OD2' ' A' ' 76' ' ' ASP . 19.7 tt -60.66 154.67 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -120.57 -65.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.164 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.63 -34.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.174 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.29 -15.49 16.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.463 ' OD2' HG13 ' A' ' 72' ' ' ILE . 5.4 m-20 -60.7 -23.19 64.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 22.3 m-85 -88.47 10.72 19.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -130.23 -62.44 0.94 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.551 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -45.52 -24.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.567 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 7.4 m-85 -131.3 154.28 48.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -104.14 -20.82 13.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 69.2 t -122.05 137.77 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 106' ' ' VAL . 3.3 mt -124.62 138.76 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.102 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 109' ' ' PHE . . . -121.6 126.09 48.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -108.66 152.29 25.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.468 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 1.4 tp -95.51 -43.58 7.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' HG21 ' A' ' 90' ' ' ILE . 27.0 t0 -103.94 168.72 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.298 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -81.0 -47.3 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.913 . . . . 0.0 110.215 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.2 t -43.29 -59.49 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.478 ' CD1' HG22 ' A' ' 10' ' ' VAL . 8.9 tt -46.66 -35.49 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -72.07 -45.59 60.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.196 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 t -62.25 -30.5 71.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 97' ' ' MET . 72.1 m-20 -88.76 -53.68 4.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.509 ' CG1' ' HE1' ' A' ' 97' ' ' MET . 3.8 tt -49.17 -37.25 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.463 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 1.9 t-20 -79.57 -16.2 56.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 47.8 t -87.43 -4.21 59.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.509 ' HE1' ' CG1' ' A' ' 94' ' ' ILE . 1.5 ptt? -113.27 -11.63 13.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.572 ' HE3' ' CG ' ' A' ' 77' ' ' PHE . 13.4 mtpt -60.36 146.25 84.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.0 -171.78 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.055 1.555 . . . . 0.0 110.485 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.4 t -100.07 -5.64 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.162 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 6.4 p30 -128.34 59.18 1.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.18 176.03 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.38 16.51 2.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.66 -170.81 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.198 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -146.35 151.96 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.5 t -117.1 146.0 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 83' ' ' ILE . 35.5 m -144.94 161.13 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 142.6 27.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.555 ' CE1' ' HE1' ' A' ' 136' ' ' MET . 0.1 OUTLIER -94.58 -45.78 7.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.533 ' HB3' ' CG2' ' A' ' 115' ' ' VAL . 48.7 m-80 -131.14 161.27 62.79 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.41 169.53 22.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.995 1.524 . . . . 0.0 110.317 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.37 50.09 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.955 1.503 . . . . 0.0 110.435 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -104.87 -37.98 6.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.99 84.24 0.13 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 110' ' ' ASN . 59.0 t -119.12 -3.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 117' ' ' ASP . 6.6 p-10 -131.05 156.45 45.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.183 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 116' ' ' ASP . 2.7 p30 -175.95 150.22 1.08 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.56 -90.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.026 1.54 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.549 ' CE1' ' HD2' ' A' ' 49' ' ' PRO . 7.8 m-30 -95.97 -70.46 0.71 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER 58.93 149.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.8 p -160.0 21.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.3 26.47 6.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -134.05 -45.32 0.11 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 27.0 m-85 -47.31 -46.59 57.34 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.244 -1.151 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -72.23 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.641 1.337 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.467 ' OG1' ' HA2' ' A' ' 124' ' ' GLY . 3.0 p -52.14 -48.02 65.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.536 ' O ' ' CG2' ' A' ' 132' ' ' ILE . 17.1 ttp -42.86 -76.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 110.355 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.598 ' CD2' HD13 ' A' ' 24' ' ' ILE . 4.6 t80 -53.1 -55.14 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 126' ' ' PRO . . . -47.03 -24.22 0.59 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.7 t -89.35 -61.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -52.59 -20.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.818 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.548 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -91.41 -56.12 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.808 . . . . 0.0 109.603 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -51.36 -24.4 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.688 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.47 50.37 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 110.034 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.612 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -117.87 -24.13 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.651 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -83.32 -40.82 0.81 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.461 -0.774 . . . . 0.0 110.29 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.3 Cg_endo -79.76 -6.55 14.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.711 1.374 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.551 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 27.3 t80 -81.77 -69.0 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 139' ' ' PHE . 0.9 OUTLIER -67.62 -22.85 65.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.533 HG21 ' CG2' ' A' ' 146' ' ' ILE . 2.6 m -67.55 -31.93 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.016 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.86 -24.81 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 139' ' ' PHE . 14.7 m80 -66.39 -9.04 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . 114.79 58.98 0.36 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.494 ' CD1' ' HD3' ' A' ' 5' ' ' LYS . 1.8 mt -162.65 61.14 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.058 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.294 0.569 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.483 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -72.55 -144.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 109.315 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 33' ' ' LEU . 5.1 mtpt -143.2 150.24 39.08 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.663 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.778 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.93 113.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.478 -0.764 . . . . 0.0 109.917 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.542 ' HA ' ' CG1' ' A' ' 82' ' ' VAL . 28.5 t -102.99 134.13 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.547 ' CD2' HG12 ' A' ' 83' ' ' ILE . 7.8 tp -89.53 80.78 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.432 -0.792 . . . . 0.0 110.329 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.574 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 15.1 m-85 -68.48 110.43 4.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.575 ' CG2' ' CB ' ' A' ' 38' ' ' ALA . 49.0 t -135.1 153.54 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.897 . . . . 0.0 110.545 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 17' ' ' ARG . 45.5 t -140.05 -56.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER 177.0 -60.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -0.908 . . . . 0.0 110.381 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -82.57 -8.29 86.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.493 ' CB ' ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER 67.26 27.45 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.211 . . . . 0.0 110.076 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 16' ' ' CYS . 93.6 mt -133.64 -36.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.23 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 79.8 m -42.71 -49.63 5.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.178 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HD3' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -98.46 128.63 44.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.117 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.579 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER 172.36 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 46.4 Cg_endo -73.59 -26.33 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.872 1.459 . . . . 0.0 110.332 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 129' ' ' PHE . . . -106.74 -27.22 10.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 4.2 t -79.02 -59.65 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.248 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 44.8 tt0 -56.41 -27.63 57.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.435 -0.791 . . . . 0.0 109.163 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.525 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -74.83 -55.59 5.29 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 2.4 tp -52.71 -43.73 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.26 . . . . 0.0 109.835 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.566 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 73.2 m -74.7 -32.88 62.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 0.0 110.292 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 15.1 mmt180 -66.93 -39.75 87.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.949 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -79.59 -40.59 29.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.136 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.49 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 18.7 mmt -71.41 -41.3 69.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 28' ' ' MET . 16.6 m -156.77 45.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -58.9 -19.12 42.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.12 27.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -1.089 . . . . 0.0 110.403 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -150.75 -130.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.76 ' O ' HG13 ' A' ' 34' ' ' ILE . 4.7 mp -129.26 -112.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.778 ' CA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 57.19 1.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.74 -0.6 . . . . 0.0 111.157 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 7.0 mt -114.07 103.71 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.88 -1.138 . . . . 0.0 110.95 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.595 ' OD1' ' CE1' ' A' ' 80' ' ' PHE . 10.3 m-20 -139.11 102.49 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.811 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.78 133.79 34.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 10' ' ' VAL . . . -147.7 166.58 27.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.337 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . 169.81 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' A' ' 41' ' ' SER . 5.1 t -56.01 97.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 40' ' ' THR . 0.1 OUTLIER 174.68 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 110.199 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 44' ' ' HIS . . . 71.19 -106.32 1.86 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 52.86 -87.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.579 ' CD2' ' NE2' ' A' ' 47' ' ' GLN . 40.2 m170 -66.13 -7.81 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.475 HG21 ' CB ' ' A' ' 69' ' ' ALA . 2.1 p -49.44 129.85 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.261 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -27.04 20.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.579 ' NE2' ' CD2' ' A' ' 44' ' ' HIS . 3.0 pt20 -116.14 -134.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -1.144 . . . . 0.0 110.296 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.3 OUTLIER 70.17 135.68 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.129 -0.982 . . . . 0.0 110.135 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.42 81.7 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.972 1.511 . . . . 0.0 110.422 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 31.8 p-10 -82.59 8.45 11.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -26.96 61.05 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 108.981 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.5 -48.66 31.59 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.31 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.519 ' HB2' ' CG ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -63.16 -49.85 72.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 0.0 109.65 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -60.33 -46.74 88.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.97 . . . . 0.0 109.411 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 7.5 ttpt -54.84 -69.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.82 . . . . 0.0 109.588 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.564 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 7.7 p -49.34 -34.92 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.265 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.543 ' CA ' HG13 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -54.89 -50.97 67.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 109.379 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -73.52 -22.18 60.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -12.94 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.0 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 129' ' ' PHE . 11.2 m120 -111.23 -14.93 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.408 -0.808 . . . . 0.0 109.036 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.569 ' O ' ' CZ ' ' A' ' 129' ' ' PHE . . . 96.41 100.98 1.94 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.566 ' HB ' ' CE1' ' A' ' 129' ' ' PHE . 13.9 p -172.11 145.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -86.03 118.05 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 8.1 pt -130.23 173.07 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.152 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 51.6 p -165.96 29.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.54 149.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 110.228 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.431 ' OE1' ' CB ' ' A' ' 18' ' ' SER . 2.2 pt20 -165.43 -150.94 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.023 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.63 -178.65 7.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' CB ' HG21 ' A' ' 45' ' ' VAL . . . -106.51 122.82 47.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -110.47 25.6 11.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.108 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.548 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 3.4 pt20 38.24 -152.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 110.441 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.499 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 13.2 tt -133.22 164.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.0 p -125.46 -78.67 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 75' ' ' ALA . 2.3 pttp -164.88 -36.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -56.61 -20.4 20.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 110.226 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.6 p30 -42.59 -28.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 23.8 m-85 -70.69 -42.13 71.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.262 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.521 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -96.52 -48.55 5.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 4.2 tptt -44.49 -25.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 0.0 110.255 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 9.8 m-85 -133.07 -179.76 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.473 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.16 -29.37 4.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.844 . . . . 0.0 110.375 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.542 ' CG1' ' HA ' ' A' ' 7' ' ' VAL . 6.0 p -129.54 142.39 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.162 -0.961 . . . . 0.0 110.379 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.547 HG12 ' CD2' ' A' ' 8' ' ' LEU . 3.1 mt -113.78 134.22 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.1 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 9' ' ' PHE . . . -111.0 122.37 47.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.477 ' HA ' HD11 ' A' ' 90' ' ' ILE . . . -104.12 137.12 42.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.516 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 5.1 tp -108.5 11.55 26.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -152.19 174.32 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.246 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.11 -57.92 3.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.148 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -51.44 42.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.985 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.536 ' CG1' HD11 ' A' ' 94' ' ' ILE . 3.7 tt -44.58 -51.13 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.88 -55.79 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.7 t -54.49 -18.43 4.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.937 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' SER . 22.2 m-20 -85.28 -69.28 0.67 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 0.0 110.213 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.536 HD11 ' CG1' ' A' ' 90' ' ' ILE . 3.2 mt -47.92 -53.14 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.432 -0.793 . . . . 0.0 109.982 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -59.11 -15.35 13.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.61 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -80.74 -40.69 24.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.995 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.525 ' CE ' HG21 ' A' ' 94' ' ' ILE . 6.9 ptt? -85.2 -26.9 26.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.567 ' CE ' ' CE1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -42.84 139.68 2.04 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.177 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.18 -161.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.052 1.554 . . . . 0.0 110.42 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 t -102.54 -4.56 25.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.213 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -155.8 111.01 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.216 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.419 ' SG ' ' NZ ' ' A' ' 98' ' ' LYS . 31.8 p -137.6 -159.31 0.94 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.521 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -132.31 31.82 4.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.112 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.86 37.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.124 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.85 162.18 18.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.456 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 90.3 t -116.09 130.04 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.54 164.04 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -108.24 131.13 55.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.088 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CD1' ' CE1' ' A' ' 139' ' ' PHE . 2.9 t80 -74.8 -61.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.476 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.7 OUTLIER -152.96 175.46 2.96 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.142 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.501 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 48.0 Cg_endo -75.15 175.9 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.042 1.548 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.37 4.86 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.937 1.493 . . . . 0.0 110.661 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.94 -1.48 16.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.256 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 116' ' ' ASP . . . -116.99 -107.24 2.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.566 ' CG2' ' CB ' ' A' ' 131' ' ' SER . 17.2 t -72.69 75.28 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -1.14 . . . . 0.0 110.214 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -155.1 138.83 16.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -112.74 110.83 51.9 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.455 ' CG ' ' HB3' ' A' ' 122' ' ' SER . 46.3 Cg_endo -73.04 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.95 1.5 . . . . 0.0 110.496 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.436 ' O ' ' C ' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -166.93 146.67 5.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.319 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.439 ' O ' ' OG ' ' A' ' 122' ' ' SER . 2.7 t80 42.26 -139.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -43.29 116.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.455 ' HB3' ' CG ' ' A' ' 118' ' ' PRO . 4.7 m -155.17 -177.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.331 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -136.94 20.85 3.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.106 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 116' ' ' ASP . . . -99.49 -23.63 10.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 9.9 m-85 -44.02 -57.26 6.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.085 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 44.4 Cg_endo -70.77 -44.11 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.905 1.476 . . . . 0.0 110.105 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.497 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 27.9 m -61.44 -27.45 68.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.545 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 30.7 ttp -60.1 -70.22 0.18 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.273 -0.892 . . . . 0.0 109.832 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 75.4 t80 -67.9 -21.87 65.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.79 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -65.95 -42.13 90.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 110.004 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.566 ' CB ' ' CG2' ' A' ' 115' ' ' VAL . 14.8 t -84.3 -31.69 24.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.274 -0.892 . . . . 0.0 108.787 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.59 HG22 ' CB ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -67.75 -27.83 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.682 -0.636 . . . . 0.0 109.395 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.542 ' O ' ' CE ' ' A' ' 136' ' ' MET . 24.9 p -103.18 -23.85 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.795 . . . . 0.0 110.272 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -88.6 -18.94 26.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.08 -1.013 . . . . 0.0 110.339 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CG ' ' HG2' ' A' ' 138' ' ' PRO . 3.3 tt0 -124.31 40.01 3.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.381 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.568 ' HG2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -84.46 -20.41 31.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.968 . . . . 0.0 110.496 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -87.11 -44.48 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.865 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -76.48 2.98 6.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.609 1.321 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.587 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 71.7 t80 -108.05 -70.03 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.473 HD23 ' CE ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -62.54 -44.07 97.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.217 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.532 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 1.9 m -64.56 -10.33 25.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.36 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 138' ' ' PRO . 13.8 mm-40 -104.7 -46.95 4.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.302 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.587 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -44.46 -24.57 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.134 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.446 ' C ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.83 35.94 0.5 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.446 HD21 ' HD2' ' A' ' 5' ' ' LYS . 19.1 mt -137.45 -94.53 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.532 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 2.4 tp . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.26 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.53 0.681 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -117.96 144.41 45.53 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.451 ' O ' HG21 ' A' ' 34' ' ' ILE . 4.4 mttt -119.1 -155.95 0.63 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.024 -1.048 . . . . 0.0 110.879 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.688 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.99 148.73 51.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.66 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 16.7 t -139.06 113.29 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.794 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 36' ' ' ASP . 5.0 tp -78.7 101.34 7.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.453 -0.779 . . . . 0.0 110.784 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 36.8 m-85 -87.33 106.65 18.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 38' ' ' ALA . 6.0 t -134.1 177.73 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 110.959 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.549 ' SG ' ' CB ' ' A' ' 17' ' ' ARG . 1.7 p 169.6 53.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.786 . . . . 0.0 110.146 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 16.6 mt 54.77 -89.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' CYS . . . -89.91 80.22 1.47 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 38' ' ' ALA . 1.8 t-20 -58.44 -44.49 89.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -1.178 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.517 ' CG2' ' HE3' ' A' ' 66' ' ' LYS . 9.4 mt -38.78 -30.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 110.303 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 17' ' ' ARG . 26.8 p -125.38 34.99 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 109.811 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.582 ' C ' HD21 ' A' ' 86' ' ' LEU . 43.8 mtt180 -157.27 80.81 0.91 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 110.175 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.614 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER 56.78 43.09 1.04 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 111.022 179.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 18' ' ' SER . 45.3 Cg_endo -73.66 -21.44 19.12 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.743 1.391 . . . . 0.0 109.781 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 65' ' ' SER . . . -89.01 7.33 35.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.558 ' CB ' HD13 ' A' ' 132' ' ' ILE . 0.7 OUTLIER -56.41 -40.21 74.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.124 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -60.68 -44.22 96.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.281 0.562 . . . . 0.0 110.035 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' ILE . . . -74.14 -63.8 2.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.654 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 0.8 OUTLIER -42.36 -46.0 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 110.166 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' CB ' HG13 ' A' ' 35' ' ' ILE . 69.0 m -72.98 -39.74 65.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 110.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 3.2 mmt180 -55.1 -34.88 64.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.736 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -88.95 -32.47 17.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 0.0 110.127 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.14 -27.01 60.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.411 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 32' ' ' LYS . 10.1 t -123.79 -22.89 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.234 -0.916 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.04 -168.62 18.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.98 80.71 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -1.118 . . . . 0.0 110.133 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 29' ' ' VAL . 7.5 mmtp -112.96 -137.77 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ILE . 18.1 mt -122.5 -40.13 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.22 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.6 pp -33.3 -32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.762 . . . . 0.0 110.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.579 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -76.92 88.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 110.526 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.559 ' CB ' ' HA ' ' A' ' 8' ' ' LEU . 7.1 m-20 -124.35 71.4 1.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.907 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.6 t -73.04 131.2 41.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 14' ' ' ASN . . . -144.05 -171.9 3.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.256 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.443 ' HA ' HG11 ' A' ' 10' ' ' VAL . . . -166.37 145.69 5.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 40' ' ' THR . 11.1 t -125.68 76.67 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 -59.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.46 36.77 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.99 -57.59 1.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -1.169 . . . . 0.0 110.212 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.407 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -85.78 63.61 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 68' ' ' ARG . 2.1 p -148.07 149.79 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.331 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.05 21.62 27.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 48' ' ' SER . 6.5 pt20 -173.82 -149.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.18 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.83 120.79 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.219 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.24 89.08 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.977 1.514 . . . . 0.0 110.455 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.7 p30 -88.43 14.47 9.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -74.1 -37.54 64.12 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.125 -0.984 . . . . 0.0 108.719 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.43 -37.96 68.45 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.345 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.48 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 6.3 m -65.63 -59.55 3.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.458 -0.776 . . . . 0.0 109.811 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 63.9 mt-30 -57.95 -44.15 86.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.165 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -53.34 -72.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.49 -0.756 . . . . 0.0 109.701 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.592 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 43.5 t -43.69 -38.17 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.362 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.568 ' CA ' HG11 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -55.28 -50.54 69.28 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.437 -0.79 . . . . 0.0 109.427 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -67.37 -28.08 67.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -83.29 -9.01 59.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.11 -31.4 7.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 135.18 60.39 0.06 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.568 HG11 ' CA ' ' A' ' 57' ' ' CYS . 1.9 p 173.69 139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -1.163 . . . . 0.0 110.129 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -91.52 142.71 27.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.589 ' CG2' ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER 68.63 -175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.589 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 5.6 t 179.66 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.073 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.517 ' HE3' ' CG2' ' A' ' 15' ' ' ILE . 4.9 mmmt -115.72 -168.69 1.45 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.936 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.3 pt20 177.67 144.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.531 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -61.95 79.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.089 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 45' ' ' VAL . . . -49.0 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.347 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 68' ' ' ARG . 2.6 ptt-85 -103.09 -149.04 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -103.28 146.54 28.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.216 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.9 tt -82.43 173.73 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 34.1 m -100.96 6.52 43.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' THR . 14.5 mtmt 68.19 5.23 4.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.3 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.59 -3.16 58.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.948 . . . . 0.0 110.331 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.578 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 11.9 p-10 -65.47 -24.61 67.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.58 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 21.3 m-85 -86.69 16.13 5.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 110.228 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.34 -15.23 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.576 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.624 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -127.25 -145.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.125 -0.985 . . . . 0.0 110.033 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.6 OUTLIER 37.87 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.448 -0.782 . . . . 0.0 110.676 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -135.53 -43.52 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.464 ' CG1' HG22 ' A' ' 7' ' ' VAL . 11.8 p -137.24 159.6 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 110.626 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 1.7 mp -124.42 122.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.55 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . . . -108.54 131.12 55.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.58 161.65 19.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD21 ' C ' ' A' ' 17' ' ' ARG . 7.1 tp -93.22 -43.37 8.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.526 ' CB ' HD11 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -102.2 177.47 4.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.395 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 89' ' ' SER . 14.8 mt-30 -89.87 -38.25 13.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 88' ' ' GLN . 23.2 t -42.36 -39.87 2.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.526 HD11 ' CB ' ' A' ' 87' ' ' ASP . 1.5 mp -65.97 -53.59 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.488 HD13 ' CG2' ' A' ' 106' ' ' VAL . 0.5 OUTLIER -63.77 -16.03 60.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.214 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 t -88.37 -39.22 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.373 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.41 -22.32 21.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.53 HG13 ' CE ' ' A' ' 97' ' ' MET . 2.8 tt -68.41 -37.86 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' SER . 29.2 p30 -70.2 -18.59 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 48.0 t -78.0 -34.65 50.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.53 ' CE ' HG13 ' A' ' 94' ' ' ILE . 19.8 ptt? -93.29 -30.22 15.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.047 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 7.7 mmmt -38.98 141.52 0.6 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.478 -0.764 . . . . 0.0 110.704 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.496 ' HD2' ' HE3' ' A' ' 98' ' ' LYS . 46.4 Cg_endo -72.43 -179.79 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.18 1.621 . . . . 0.0 110.567 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -114.26 19.88 15.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.6 OUTLIER -153.14 78.92 1.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.281 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 6.4 p -143.56 -172.1 3.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.92 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 102' ' ' CYS . 1.1 mpt_? -135.34 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -163.76 165.43 23.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -141.61 170.11 16.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.488 ' CG2' HD13 ' A' ' 91' ' ' LEU . 33.0 m -111.52 167.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 106' ' ' VAL . 28.1 m -154.25 157.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 110.225 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.61 125.96 39.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -89.61 93.25 9.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 110.17 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 109' ' ' PHE . 0.8 OUTLIER 65.62 159.31 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.56 174.44 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.04 1.547 . . . . 0.0 110.383 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.4 52.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.94 1.495 . . . . 0.0 110.403 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.24 -59.33 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.59 -46.87 65.61 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 131' ' ' SER . 30.2 m -92.18 46.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -137.24 113.63 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -140.19 142.7 30.92 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 -13.65 26.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.069 1.563 . . . . 0.0 110.494 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.6 t80 50.14 38.89 18.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.64 -50.28 65.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -139.35 -69.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.02 44.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -103.7 -7.96 20.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.173 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -90.67 -40.03 5.74 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.624 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 5.4 m-30 -45.06 -47.5 31.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.148 -1.207 . . . . 0.0 110.472 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -72.42 -57.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.575 1.302 . . . . 0.0 110.382 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.482 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 15.5 m -64.57 -57.22 9.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.185 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 124' ' ' GLY . 7.6 ttp -40.43 -69.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.654 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 75.3 t80 -55.93 -44.75 78.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.045 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -46.94 -59.77 2.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.94 . . . . 0.0 110.014 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.501 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -65.14 -45.2 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 110.024 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' CG2' HG22 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -43.27 -53.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.826 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.511 ' N ' HG23 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -80.75 -37.77 29.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 5.2 tttt -50.08 -32.29 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 8.3 mm-40 -103.97 -5.59 22.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.189 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.537 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.7 OUTLIER -82.78 14.24 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -104.71 -63.39 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.448 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 44.5 Cg_endo -72.26 -4.39 15.13 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.786 1.414 . . . . 0.0 110.471 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -93.1 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -45.52 -28.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 110.143 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.549 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 7.5 m -47.55 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.817 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -106.44 -0.27 24.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 110.792 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 33.77 5.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 111.16 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.497 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . 173.42 -27.37 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.485 -1.341 . . . . 0.0 109.901 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER 175.02 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.234 -1.156 . . . . 0.0 110.363 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.549 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 7.3 tp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.116 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.223 0.535 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -82.99 -179.05 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.847 . . . . 0.0 109.237 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 34' ' ' ILE . 17.1 mttm -142.73 -161.34 1.23 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.065 -1.022 . . . . 0.0 110.676 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.101 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -141.18 121.92 14.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 34' ' ' ILE . 2.7 t -111.22 123.0 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.765 . . . . 0.0 109.329 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.506 ' CD2' ' HB2' ' A' ' 38' ' ' ALA . 6.5 tp -93.52 84.88 4.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.439 -0.788 . . . . 0.0 110.757 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.523 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 55.7 m-85 -60.79 123.73 18.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 38' ' ' ALA . 25.1 t -124.97 168.82 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.719 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.55 ' CB ' ' HB3' ' A' ' 17' ' ' ARG . 20.9 p -169.02 -141.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.911 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 76.07 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 14' ' ' ASN . . . 129.04 -6.89 6.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.463 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 6.2 t-20 41.71 37.62 0.78 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -1.145 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.479 ' O ' ' HG3' ' A' ' 19' ' ' PRO . 3.2 mt -144.22 -59.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 15' ' ' ILE . 56.1 m -106.0 59.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.55 ' HB3' ' CB ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -153.5 -50.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.468 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -152.13 47.76 0.43 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.038 -1.039 . . . . 0.0 110.743 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 18' ' ' SER . 47.7 Cg_endo -74.65 -16.0 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.843 1.444 . . . . 0.0 110.113 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB3' ' HE3' ' A' ' 128' ' ' MET . . . -91.97 6.63 45.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.523 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . 55.5 m -63.96 -35.01 79.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' HG2' ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -68.83 -55.54 10.83 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.526 -0.734 . . . . 0.0 110.177 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' HG23 ' A' ' 62' ' ' VAL . . . -62.28 -51.81 53.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.625 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 8.9 tp -56.3 -44.27 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 110.308 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.566 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 23.1 m -64.96 -35.52 81.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.238 -0.914 . . . . 0.0 110.054 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.477 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.4 mtt-85 -66.44 -45.12 80.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 110.124 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -34.9 58.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -74.96 -46.86 32.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 28' ' ' MET . 13.6 m -150.93 45.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.22 -28.55 0.86 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.47 85.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -1.145 . . . . 0.0 110.061 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 34' ' ' ILE . 21.6 mttt -65.98 -23.25 66.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.138 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.581 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER 67.66 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.101 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER 30.07 37.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.553 -0.717 . . . . 0.0 111.66 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.674 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -92.0 93.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.906 -1.121 . . . . 0.0 110.361 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 10.0 m-20 -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -168.86 163.15 11.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 110.372 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.506 ' HB2' ' CD2' ' A' ' 8' ' ' LEU . . . -169.26 -164.68 0.47 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -174.92 -176.95 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -151.28 25.01 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -0.75 5.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . 49.88 -104.04 0.1 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER 64.64 119.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.248 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.532 ' CD2' ' CD ' ' A' ' 47' ' ' GLN . 35.8 m170 55.66 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.309 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 69' ' ' ALA . 80.9 t 52.42 80.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.07 6.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.532 ' CD ' ' CD2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -148.75 13.86 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.247 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' HD13 ' A' ' 15' ' ' ILE . 2.7 t -106.97 111.64 63.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.58 100.72 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.408 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.6 p30 -86.16 26.03 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.424 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -32.06 61.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.257 -0.902 . . . . 0.0 108.92 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.9 mtt180 -71.83 -52.23 18.49 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.213 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -52.59 65.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.43 -0.794 . . . . 0.0 109.359 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 6.8 tt0 -54.24 -56.42 18.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 3.9 ttpp -44.85 -66.89 0.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.393 -0.817 . . . . 0.0 109.52 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.565 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 91.8 t -45.32 -36.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.547 ' CB ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.7 -42.15 92.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.439 -0.788 . . . . 0.0 109.042 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 1.6 mmtp -71.76 -27.74 63.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.416 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.42 -9.33 54.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -109.8 -26.61 9.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.195 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 115.43 81.26 0.92 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.547 HG13 ' CB ' ' A' ' 57' ' ' CYS . 2.1 p 174.66 170.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -1.1 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -156.03 144.13 19.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.426 ' CG1' ' HG3' ' A' ' 54' ' ' GLN . 2.3 pt -133.51 164.89 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -115.58 76.05 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.947 . . . . 0.0 110.256 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 65' ' ' SER . 4.6 mttt 60.53 152.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.948 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -105.3 -64.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.09 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -49.12 157.59 0.43 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -0.891 . . . . 0.0 110.178 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -147.95 33.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 3.1 pt20 37.58 -153.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 3.9 tt -153.73 129.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.211 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 174.24 6.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -72.94 -5.98 42.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -77.19 -34.2 56.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -42.65 -48.41 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.534 ' CE1' ' HD2' ' A' ' 98' ' ' LYS . 14.6 m-30 -47.3 -30.42 3.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.8 m -117.56 29.61 7.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 9.6 tppt? -124.88 -9.36 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 79' ' ' LYS . 69.5 m-85 -140.3 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -124.34 -44.56 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 110.385 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 41.3 t -131.73 137.18 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.499 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.46 HG12 HD21 ' A' ' 8' ' ' LEU . 54.4 mt -116.45 142.11 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.817 . . . . 0.0 110.044 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 107' ' ' VAL . . . -127.66 162.66 26.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 90' ' ' ILE . . . -142.99 145.58 33.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.538 HD22 ' CG ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -70.56 -79.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.539 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 7.3 m-20 -78.92 175.74 10.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 110.467 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.463 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.6 mm-40 -74.22 -41.46 61.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.8 t -40.13 -50.61 2.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.012 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.551 ' O ' ' CD1' ' A' ' 94' ' ' ILE . 1.7 mt -61.37 -58.48 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.508 ' CA ' HD11 ' A' ' 94' ' ' ILE . 3.1 tp -42.25 -60.97 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.119 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 96' ' ' SER . 46.6 t -55.33 -39.44 70.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.965 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 96' ' ' SER . 0.3 OUTLIER -54.3 -55.38 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.067 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 90' ' ' ILE . 1.5 mp -57.89 -56.77 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -63.99 -19.23 65.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.844 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 92' ' ' SER . 1.0 OUTLIER -71.85 -8.86 56.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.47 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 7.6 mtm -125.88 -48.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.534 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 9.7 mtpt -41.82 138.14 1.82 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.96 -160.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.006 1.53 . . . . 0.0 110.581 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.1 m -106.56 5.32 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -134.97 104.95 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -174.01 4.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 28.8 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.59 176.38 10.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 110.182 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -143.23 166.12 25.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.13 -0.981 . . . . 0.0 110.282 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.4 t -117.27 132.64 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.476 ' CG1' ' NE2' ' A' ' 143' ' ' HIS . 32.1 m -128.21 153.61 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.512 ' HG ' ' N ' ' A' ' 109' ' ' PHE . 0.5 OUTLIER -100.95 146.98 26.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 3.3 t80 -106.73 110.58 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.091 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 59.0 166.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.049 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 170.09 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.001 1.527 . . . . 0.0 110.278 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.9 51.93 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.398 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -156.56 -46.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.8 -67.65 2.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.1 t -98.84 100.7 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -1.114 . . . . 0.0 110.116 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -174.87 88.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.24 130.33 7.58 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 -90.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.939 1.494 . . . . 0.0 110.487 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.04 21.16 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.182 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -65.47 117.02 7.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.7 t 52.18 -143.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.168 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.91 39.55 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -93.52 32.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -124.48 -49.2 0.21 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.632 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 5.6 m-85 -41.65 -48.95 10.06 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.249 -1.147 . . . . 0.0 110.305 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.9 Cg_endo -71.45 -56.97 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.597 1.314 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 128' ' ' MET . 16.7 m -59.76 -51.87 67.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 124' ' ' GLY . 12.1 ttp -41.29 -63.71 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.284 -0.885 . . . . 0.0 109.96 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.625 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 94.2 t80 -56.63 -42.1 78.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.617 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -46.12 -57.43 4.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.774 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 132' ' ' ILE . 11.2 p -71.44 -43.97 65.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.523 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.582 ' CG2' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -42.1 -37.61 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.689 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.545 ' CB ' HD12 ' A' ' 24' ' ' ILE . 1.4 p -97.19 -42.36 7.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.3 OUTLIER -44.93 -46.54 11.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -102.72 41.71 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.202 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.542 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -116.49 -2.35 12.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.264 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.608 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -104.88 -63.57 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 46.9 Cg_endo -73.58 1.14 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.75 1.395 . . . . 0.0 110.488 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.523 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 31.9 t80 -87.88 -68.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 139' ' ' PHE . 4.0 pp -74.03 -23.71 59.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.51 ' O ' ' CD1' ' A' ' 146' ' ' ILE . 3.3 m -59.74 -43.04 94.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 144' ' ' GLY . 49.7 mt-10 -96.0 -37.33 10.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.476 ' NE2' ' CG1' ' A' ' 107' ' ' VAL . 1.2 m80 -44.01 -25.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 124.66 68.32 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.525 ' CD2' ' HD2' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -155.66 18.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 141' ' ' THR . 23.6 pt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.192 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' OE1' ' CB ' ' A' ' 32' ' ' LYS . 14.7 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.53 0.681 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.576 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -64.04 -69.53 0.27 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.512 -0.742 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.576 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 14.3 mttm -152.34 -155.59 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.981 . . . . 0.0 111.353 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.903 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.95 152.91 36.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.712 -0.618 . . . . 0.0 110.234 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 15.1 t -111.62 127.26 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 83' ' ' ILE . 10.2 tp -90.01 81.86 6.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 136' ' ' MET . 27.3 m-85 -68.82 117.49 10.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.943 . . . . 0.0 109.46 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 38' ' ' ALA . 52.7 t -130.9 161.04 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.601 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.498 ' HB3' HD23 ' A' ' 86' ' ' LEU . 28.6 p -159.38 39.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.102 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.526 HD11 ' CZ ' ' A' ' 17' ' ' ARG . 1.2 mt 59.38 60.49 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.267 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 132.13 -24.72 3.97 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.49 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 13.5 t30 59.28 14.88 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -1.168 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.52 ' CA ' ' HB3' ' A' ' 19' ' ' PRO . 12.9 mt -123.17 -1.54 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 22.5 p -144.21 165.61 27.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.237 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.558 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 71.05 -56.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 110.416 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.551 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 8.0 t -152.97 50.36 0.6 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.792 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.1 Cg_endo -78.17 -19.27 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.864 1.455 . . . . 0.0 110.066 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -86.76 6.73 30.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -0.79 . . . . 0.0 110.279 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 21.4 p -58.21 -28.96 65.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.337 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 26' ' ' ARG . 0.6 OUTLIER -67.66 -40.15 84.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.594 -0.691 . . . . 0.0 110.191 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.485 ' HA3' ' CG1' ' A' ' 62' ' ' VAL . . . -74.73 -49.69 10.28 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.67 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 1.1 tp -57.84 -44.35 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 0.0 110.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.49 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -71.34 -43.37 67.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.314 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 2.7 mmm180 -58.97 -38.3 78.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.22 -39.67 47.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.117 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.446 ' O ' HG12 ' A' ' 29' ' ' VAL . 21.8 mtp -67.69 -51.09 53.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 28' ' ' MET . 14.0 m -151.3 44.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.319 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -63.54 -20.78 64.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -67.19 -7.37 23.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.412 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.534 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . 6.5 mttm -116.27 -137.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.05 -1.031 . . . . 0.0 110.272 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.785 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.2 mt -120.34 -122.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.903 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 49.46 3.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.621 -0.674 . . . . 0.0 111.644 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.539 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -104.09 95.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.832 -1.167 . . . . 0.0 110.547 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.603 ' OD2' ' CE1' ' A' ' 80' ' ' PHE . 3.1 m-20 -137.05 106.8 6.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.2 m -89.57 127.63 35.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.158 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -144.43 166.64 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HA ' HG11 ' A' ' 10' ' ' VAL . . . -166.3 106.5 0.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 41' ' ' SER . 3.2 t -80.59 86.28 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 40' ' ' THR . 12.5 p 177.33 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 94.15 1.01 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -155.83 -40.54 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -1.136 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.27 92.91 4.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.88 . . . . 0.0 110.226 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.5 t -148.19 160.73 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.257 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.46 24.99 7.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 48' ' ' SER . 13.1 pt20 -159.87 -148.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 47' ' ' GLN . 0.5 OUTLIER 61.39 90.78 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 110.21 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.36 80.53 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.957 1.503 . . . . 0.0 110.439 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -93.01 33.71 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.304 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.3 m -75.52 -31.52 60.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 108.908 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -73.01 -48.96 31.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.313 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.568 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -61.81 -51.34 68.64 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.664 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.534 ' NE2' ' N ' ' A' ' 55' ' ' LYS . 4.6 pp0? -64.2 -33.86 76.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 8.3 ttpt -60.04 -67.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.581 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 27.5 m -53.51 -35.08 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.066 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.8 m -53.6 -50.79 64.89 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.425 -0.797 . . . . 0.0 109.261 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -31.8 71.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.492 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 t -77.05 -10.14 59.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.84 . . . . 0.0 110.034 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -112.89 -26.91 8.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.126 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.532 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 135.67 53.74 0.06 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 65.1 t -158.3 109.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -108.87 125.15 51.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 54' ' ' GLN . 19.5 pt -106.22 174.63 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -131.3 -50.73 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 0.0 110.174 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -140.33 86.23 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.9 59.76 5.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -125.73 99.57 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -44.45 159.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.222 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -160.38 40.45 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 110.235 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HB3' ' O ' ' A' ' 70' ' ' ARG . 32.2 tt0 63.05 126.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.256 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -68.85 123.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.892 . . . . 0.0 110.14 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.533 ' O ' ' CD1' ' A' ' 72' ' ' ILE . 22.8 p -73.56 -175.82 2.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.895 . . . . 0.0 110.333 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 -15.93 25.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.21 -20.85 63.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.551 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 21.7 p-10 -52.03 -29.97 23.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.569 ' CE1' ' HD2' ' A' ' 98' ' ' LYS . 19.6 m-85 -86.19 49.05 1.71 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.268 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 1.3 t 171.66 -61.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.244 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.547 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -42.24 -27.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 110.228 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CD1' ' CB ' ' A' ' 6' ' ' ALA . 8.1 m-85 -131.02 -135.13 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.079 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -177.95 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 0.0 110.644 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 16.3 t -104.5 84.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.015 -1.053 . . . . 0.0 110.463 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.521 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.9 mp -72.68 114.22 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.961 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.67 124.33 41.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.09 126.95 53.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.558 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 1.1 mp -64.47 -54.42 32.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.352 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.471 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -103.29 -165.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 0.0 110.22 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 96.1 mt-30 -94.83 -36.84 11.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -42.84 -45.35 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mp -62.5 -47.2 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.205 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.11 -30.87 71.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.119 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.2 t -79.49 -30.8 42.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 96' ' ' SER . 3.3 m-20 -79.69 -55.27 5.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.524 ' HA ' ' CE ' ' A' ' 97' ' ' MET . 10.0 tt -47.58 -43.64 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 110.203 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.513 ' N ' HG21 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.08 -23.65 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -67.53 -10.35 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.183 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.524 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 6.4 mtm -116.64 -50.96 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.569 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 11.3 mtpt -40.78 129.75 1.89 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 110.432 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.436 ' HG2' ' OD1' ' A' ' 101' ' ' ASN . 46.3 Cg_endo -72.72 -163.54 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.025 1.539 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -101.16 28.72 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 22.9 p30 -150.79 94.2 2.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.06 179.04 8.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.82 6.73 4.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.267 -0.896 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -105.9 122.87 47.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.457 ' O ' HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -86.49 162.27 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.504 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 27.9 m -125.23 127.15 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.25 159.41 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 86' ' ' LEU . 3.5 tt -116.79 141.35 48.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.157 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 9' ' ' PHE . 7.5 m-85 -103.77 113.14 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 2.0 t30 58.66 144.77 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.533 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 46.3 Cg_endo -74.27 176.06 10.12 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.052 1.554 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.7 Cg_endo -71.74 53.83 1.92 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.892 1.47 . . . . 0.0 110.383 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -158.44 19.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.211 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 116' ' ' ASP . . . -135.91 -90.52 0.31 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.3 t -60.63 83.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -1.166 . . . . 0.0 110.19 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 114' ' ' GLY . 22.4 t70 -129.68 131.12 46.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.469 ' OD2' ' HA3' ' A' ' 124' ' ' GLY . 23.4 t0 -159.83 102.09 1.45 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.34 -89.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.994 1.523 . . . . 0.0 110.461 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.04 32.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.208 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 121' ' ' SER . 0.1 OUTLIER -93.03 102.25 14.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 58.94 173.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.35 65.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -115.94 129.42 56.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.159 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 128' ' ' MET . . . 112.31 -34.82 4.97 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.65 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 9.9 m-30 -41.31 -49.72 8.81 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.3 Cg_endo -70.87 -64.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.547 1.288 . . . . 0.0 110.436 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.464 ' OG1' ' HA2' ' A' ' 124' ' ' GLY . 21.4 p -53.33 -54.96 28.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.895 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.485 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 ttp -42.28 -69.72 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 110.024 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.67 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 61.9 t80 -44.0 -49.66 8.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.757 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -47.92 -47.04 32.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.8 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -74.31 -33.68 63.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.882 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.545 ' CG2' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -55.32 -45.5 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.615 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.453 ' HB2' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -83.71 -38.14 21.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.302 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 131' ' ' SER . 62.7 mm-40 -90.56 -30.33 17.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 9' ' ' PHE . 13.7 mtm -99.65 4.45 45.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -86.85 -51.04 0.45 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 0.0 110.017 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.88 -6.67 14.28 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.99 1.521 . . . . 0.0 110.435 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.639 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 85.2 t80 -108.16 -78.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.53 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.502 ' HB3' ' O ' ' A' ' 136' ' ' MET . 15.9 tp -44.14 -24.62 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.486 ' HA ' ' HB ' ' A' ' 146' ' ' ILE . 4.6 m -89.11 -31.58 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.963 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 138' ' ' PRO . 3.3 mm-40 -105.09 -39.09 6.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 110.284 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.639 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 14.3 t-80 -40.39 -29.39 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.0 60.87 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.472 ' HB3' HD12 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -154.87 -39.83 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -1.142 . . . . 0.0 110.183 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 141' ' ' THR . 53.6 mt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.218 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.333 0.587 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.573 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -70.46 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.874 . . . . 0.0 108.758 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.573 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 9.3 mtpp -159.01 -164.42 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.977 -1.077 . . . . 0.0 110.493 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.763 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.91 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.566 -0.709 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.588 HG21 ' CD2' ' A' ' 9' ' ' PHE . 2.1 m -90.55 138.66 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.976 . . . . 0.0 110.169 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.571 ' HG ' ' CB ' ' A' ' 38' ' ' ALA . 7.4 tp -89.89 88.15 7.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 110.129 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.588 ' CD2' HG21 ' A' ' 7' ' ' VAL . 5.5 m-85 -72.69 114.16 10.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.543 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 2.1 p -165.8 171.26 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.67 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.542 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 10.1 t 175.27 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 51.08 49.66 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 0.0 110.09 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 16' ' ' CYS . . . 175.21 70.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.534 ' CA ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -44.74 -45.35 9.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -1.14 . . . . 0.0 110.136 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 45' ' ' VAL . 25.9 mt -61.33 -12.35 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 19.8 m -99.67 153.4 19.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.538 ' HG2' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER 61.5 11.07 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.387 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.62 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -91.96 -64.26 0.16 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.976 . . . . 0.0 110.172 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.62 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 47.8 Cg_endo -74.27 -1.4 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.793 1.417 . . . . 0.0 110.299 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.506 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -103.15 -47.4 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.451 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.456 ' HA ' HD13 ' A' ' 132' ' ' ILE . 60.4 m -70.25 -38.51 75.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.978 . . . . 0.0 109.969 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.84 -44.28 96.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . -70.06 -48.5 39.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.698 ' CD1' ' CD2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -53.0 -53.0 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -1.143 . . . . 0.0 110.038 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 63.9 m -69.4 -62.15 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 22.6 mmt180 -47.47 -22.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 23.8 t0 -85.81 -45.01 11.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 2.0 mtt -83.16 -1.72 53.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.0 110.425 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 25' ' ' CYS . 3.0 m -131.0 -28.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.947 . . . . 0.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 100.09 -58.75 0.76 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 17.5 p30 178.32 102.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -1.144 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' HG3' ' N ' ' A' ' 33' ' ' LEU . 13.3 ptpt -152.96 -136.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.799 ' O ' HG13 ' A' ' 34' ' ' ILE . 5.1 mp -112.78 -127.61 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.799 HG13 ' O ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER 51.62 4.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.598 -0.689 . . . . 0.0 111.157 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 25' ' ' CYS . 3.2 mt -127.48 113.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 0.0 110.717 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.581 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 8.2 m-20 -142.79 111.73 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.74 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.55 127.68 32.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.262 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.571 ' CB ' ' HG ' ' A' ' 8' ' ' LEU . . . -128.58 177.48 6.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.534 ' HB3' ' CA ' ' A' ' 14' ' ' ASN . . . -167.79 96.31 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.159 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.522 ' CG2' HG13 ' A' ' 90' ' ' ILE . 74.7 p -41.98 -35.19 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 m -116.97 -167.19 1.26 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.86 77.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -128.02 0.02 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 0.0 110.256 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 0.4 OUTLIER -122.42 -11.41 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.292 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.456 ' HA ' ' CD1' ' A' ' 15' ' ' ILE . 34.3 m -62.48 159.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.246 -0.909 . . . . 0.0 110.299 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.06 21.91 64.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.516 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 6.5 pt20 -173.7 -148.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -1.134 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 48' ' ' SER . 0.8 OUTLIER 64.43 112.41 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.35 87.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.928 1.488 . . . . 0.0 110.451 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -86.16 30.49 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.103 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -73.86 -27.46 61.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.23 -0.919 . . . . 0.0 109.005 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -71.61 -54.9 8.91 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.288 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.573 ' CB ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -59.7 -51.22 70.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 109.37 179.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -60.86 -41.61 96.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.5 ttpt -52.83 -66.36 0.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.58 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 52.6 t -50.61 -37.34 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.895 . . . . 0.0 109.115 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.546 ' CB ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -52.02 -52.65 49.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.488 -0.758 . . . . 0.0 109.409 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 -27.28 64.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 2.0 t -78.64 -11.48 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 109.896 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.36 -19.95 13.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' O ' HG12 ' A' ' 62' ' ' VAL . . . 106.16 97.07 2.48 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.6 HG12 ' CE2' ' A' ' 129' ' ' PHE . 16.1 m -154.76 -147.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.154 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 62' ' ' VAL . 5.7 t0 179.43 117.07 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.326 -0.859 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.523 ' HB ' ' NE2' ' A' ' 67' ' ' GLN . 15.0 pt -146.65 -37.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.334 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 64' ' ' ILE . 2.3 t 68.75 -67.0 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 16.0 mmtt -136.05 -174.03 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.29 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.523 ' NE2' ' HB ' ' A' ' 64' ' ' ILE . 98.7 mm-40 -139.49 -77.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.17 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.87 84.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . -76.95 179.05 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.221 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -153.11 29.92 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.263 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 50.7 tt0 55.93 162.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.961 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.464 ' N ' ' HG2' ' A' ' 71' ' ' GLN . 5.3 tt -62.69 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.225 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.429 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -149.91 147.35 27.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 110.172 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -13.97 10.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -89.9 -9.65 48.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.461 ' OD2' HD23 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -44.55 -42.88 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.05 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.585 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 35.5 m-85 -59.31 -17.42 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.2 t -113.05 -44.15 3.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.057 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.605 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 18.0 tptt -45.89 -27.95 1.0 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.071 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 27.7 m-85 -144.78 179.25 7.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 110.196 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -114.87 -13.58 11.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 110.583 -179.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 76.9 t -128.74 143.67 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 0.0 110.465 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.513 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 1.9 mp -116.71 119.92 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -100.41 110.92 23.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 110.654 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.429 ' CB ' ' CG2' ' A' ' 90' ' ' ILE . . . -104.74 133.21 49.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.023 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 2.6 tp -82.41 -31.15 29.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.279 -0.888 . . . . 0.0 110.49 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.475 ' OD1' ' CG2' ' A' ' 90' ' ' ILE . 21.9 p-10 -118.65 178.81 4.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.977 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.52 -41.34 13.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.145 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.2 m -45.09 -48.0 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.035 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.522 HG13 ' CG2' ' A' ' 40' ' ' THR . 6.5 tt -53.65 -39.46 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.032 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -70.7 -42.16 71.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.917 . . . . 0.0 110.089 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.7 t -63.43 -30.93 71.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 96' ' ' SER . 59.3 m-20 -88.54 -57.44 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.532 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.1 tt -46.04 -32.9 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 110.182 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.454 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 8.0 t-20 -78.67 -15.19 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.6 OUTLIER -85.35 -9.2 57.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.212 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.532 ' CE ' HG13 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -112.44 -21.51 11.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.145 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -49.48 151.73 2.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.192 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 100' ' ' SER . 44.3 Cg_endo -72.03 -52.19 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.966 1.508 . . . . 0.0 110.399 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 168.28 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.49 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 40.4 m-80 -163.81 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.364 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.56 -150.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 109.951 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -133.47 63.24 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -156.36 156.05 33.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.8 139.67 53.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.164 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.497 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 61.6 t -94.22 139.2 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 83' ' ' ILE . 16.1 m -136.53 142.63 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.02 132.56 38.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.16 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 10.1 t80 -87.05 -20.84 26.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.45 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 3.6 p-10 -177.48 164.66 1.37 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.0 Cg_endo -74.49 174.31 12.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.017 1.535 . . . . 0.0 110.348 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.77 51.57 2.34 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -111.63 -44.43 3.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.31 102.86 0.99 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.426 HG11 ' OD1' ' A' ' 110' ' ' ASN . 7.9 p -122.52 -9.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.483 ' HB2' HD22 ' A' ' 86' ' ' LEU . 8.2 t70 -117.02 -127.96 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.09 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -157.09 86.24 2.81 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.31 55.56 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.068 1.562 . . . . 0.0 110.45 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.468 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 1.1 m-85 46.45 -159.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.468 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 2.6 t80 67.06 9.15 6.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 2.2 t 171.75 165.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.115 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -111.14 -17.99 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 123' ' ' ASP . 2.9 p30 -67.02 68.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 122' ' ' SER . . . -176.77 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.629 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 15.5 m-85 -41.39 -51.37 8.52 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.341 -1.093 . . . . 0.0 110.471 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -72.42 -56.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.754 1.397 . . . . 0.0 110.334 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.8 m -52.74 -42.82 65.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.587 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 24.8 ttp -49.69 -77.04 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 0.0 109.764 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.698 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 4.4 t80 -46.6 -54.55 9.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.114 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -50.84 -23.96 3.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.4 t -91.31 -57.29 2.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.338 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -54.71 -19.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.823 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.522 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 1.8 t -99.11 -50.19 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 109.77 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 12.0 tttt -59.31 -17.24 27.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.926 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.461 ' O ' ' HD2' ' A' ' 138' ' ' PRO . 1.4 tt0 -116.6 10.29 14.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.872 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.576 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 3.4 tpt -81.29 8.45 9.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 110.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.5 mtmt -88.6 -52.25 0.37 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.1 Cg_endo -76.66 6.79 3.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.97 1.511 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.57 ' CD2' ' HE3' ' A' ' 136' ' ' MET . 60.1 t80 -96.28 -60.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.153 -0.967 . . . . 0.0 110.366 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 145' ' ' LEU . 3.9 pp -84.6 -13.68 50.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.391 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 137' ' ' LYS . 3.4 m -69.31 -32.57 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.141 -0.974 . . . . 0.0 110.156 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 143' ' ' HIS . 16.5 mm-40 -102.45 -38.78 7.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.203 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 142' ' ' GLU . 0.9 OUTLIER -43.59 -32.7 1.0 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.307 -0.87 . . . . 0.0 110.236 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.97 73.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 1.5 mt -163.05 -62.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.462 ' CG1' ' HA ' ' A' ' 141' ' ' THR . 26.5 pt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.236 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.244 0.545 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -84.19 150.74 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 179.263 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 34' ' ' ILE . 8.4 mtpt -134.48 -155.74 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 110.761 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.11 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.54 134.73 43.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 110.697 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 84' ' ' ALA . 73.0 t -124.01 123.98 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.724 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.488 HD12 ' CE2' ' A' ' 80' ' ' PHE . 5.6 tp -80.79 103.41 10.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.67 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.64 102.86 13.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.552 ' CG2' ' CB ' ' A' ' 38' ' ' ALA . 57.4 t -129.45 169.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.394 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.511 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 39.7 t -158.52 -65.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.492 ' CB ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER 169.93 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 99.96 -26.91 22.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 t-20 70.53 3.28 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.334 -1.098 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.525 HG22 ' CB ' ' A' ' 48' ' ' SER . 97.7 mt -101.17 -39.81 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 59.7 m -121.89 153.37 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.989 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.528 ' CA ' HD21 ' A' ' 86' ' ' LEU . 11.0 mtm105 55.79 55.61 6.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.908 . . . . 0.0 110.1 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 176.1 -57.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.422 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.0 Cg_endo -72.08 -12.29 27.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.001 1.527 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -94.75 -11.48 28.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.065 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.519 ' SG ' ' CD1' ' A' ' 132' ' ' ILE . 28.3 m -64.75 -43.91 91.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 1.9 mt-10 -48.0 -52.85 18.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.499 -0.75 . . . . 0.0 109.717 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -64.27 -45.27 93.98 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -48.92 -52.27 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -1.097 . . . . 0.0 109.847 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.484 ' N ' HG21 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -64.83 -43.89 91.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.064 179.868 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HA ' ' N ' ' A' ' 31' ' ' ASP . 16.6 mtt85 -53.27 -44.54 68.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 -16.54 37.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.518 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 2.9 mmt -83.32 -30.39 27.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.31 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' CG ' ' A' ' 32' ' ' LYS . 2.5 m -161.24 24.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 64.35 37.39 94.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.9 t70 68.7 85.31 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.14 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 33' ' ' LEU . 12.2 mmtt -88.9 36.17 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.974 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.758 ' C ' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER 71.91 -144.07 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 110.066 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.11 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 1.5 pp 35.65 22.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.492 -0.755 . . . . 0.0 112.032 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.632 ' N ' ' O ' ' A' ' 33' ' ' LEU . 1.2 mt -97.31 90.47 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.081 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 4.1 m-20 -122.95 79.43 1.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.312 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.16 130.94 44.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 110.039 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.552 ' CB ' ' CG2' ' A' ' 10' ' ' VAL . . . -145.71 -176.33 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . . . -148.06 150.14 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.192 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 41' ' ' SER . 69.3 p -83.1 -77.92 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.472 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.39 76.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 110.193 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.03 97.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.45 -10.24 11.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -1.162 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -117.68 98.51 6.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.174 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 69' ' ' ALA . 9.1 t -123.58 148.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.77 26.05 1.75 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 12.18 4.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -1.128 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.541 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -117.6 178.98 0.89 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 48' ' ' SER . 45.7 Cg_endo -69.21 -57.65 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 3.9 m-20 67.2 -54.86 0.46 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 m -71.84 -22.81 61.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.219 -0.925 . . . . 0.0 109.099 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.589 ' HG2' ' CE2' ' A' ' 125' ' ' PHE . 19.6 tpp180 -73.58 -57.65 3.85 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.386 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.547 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -59.76 -48.76 80.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.163 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 1.0 OUTLIER -60.99 -40.3 92.97 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.14 179.205 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.609 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -55.32 -64.06 0.96 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.609 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 5.7 p -52.25 -34.72 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.041 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.509 ' N ' HG11 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -55.73 -50.68 69.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.76 . . . . 0.0 109.388 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -68.06 -31.8 71.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 109.713 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.9 t -78.3 -11.27 59.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 0.0 109.987 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.542 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 5.4 m-20 -111.53 -34.75 5.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.313 -0.867 . . . . 0.0 109.11 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 138.32 73.55 0.05 OUTLIER Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.566 HG21 ' CE2' ' A' ' 129' ' ' PHE . 42.5 t -158.59 142.24 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -1.149 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 18.9 p30 -142.56 104.64 4.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.495 ' CD1' ' NE2' ' A' ' 67' ' ' GLN . 41.6 pt -108.39 -146.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.455 ' N ' HG13 ' A' ' 64' ' ' ILE . 11.0 p -145.78 -45.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.344 -0.848 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HD2' ' OG ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -150.54 150.07 30.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.495 ' NE2' ' CD1' ' A' ' 64' ' ' ILE . 2.3 mt-30 -130.27 116.89 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.447 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 1.8 ptm180 -151.93 123.6 7.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.459 ' HA ' ' OD1' ' A' ' 14' ' ' ASN . . . -70.63 121.91 18.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.154 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -132.44 15.25 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.508 ' CG ' ' N ' ' A' ' 72' ' ' ILE . 12.1 tt0 53.96 168.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.508 ' N ' ' CG ' ' A' ' 71' ' ' GLN . 16.6 tt -94.44 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -0.877 . . . . 0.0 110.277 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 7.3 m -109.75 15.68 22.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.5 mmtt 66.24 5.38 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.284 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -88.01 -24.07 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.286 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -43.54 -29.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.469 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.1 m-85 -71.21 -27.2 63.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -123.18 9.23 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.153 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.467 ' C ' ' CD1' ' A' ' 80' ' ' PHE . 5.4 tptt -107.3 -36.83 6.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 5.9 m-30 -114.78 -142.59 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.78 -38.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.519 HG11 ' N ' ' A' ' 83' ' ' ILE . 72.4 t -124.3 151.79 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.519 ' N ' HG11 ' A' ' 82' ' ' VAL . 2.7 mt -129.78 114.92 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.53 ' HB3' ' CG1' ' A' ' 7' ' ' VAL . . . -98.14 138.36 35.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.98 141.53 49.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.199 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.528 HD21 ' CA ' ' A' ' 17' ' ' ARG . 5.0 tp -95.04 4.52 53.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.505 ' CB ' HD11 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -146.41 -156.08 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -117.77 -42.76 2.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -44.51 -28.69 0.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.511 ' CG1' ' O ' ' A' ' 11' ' ' CYS . 1.4 mp -70.9 -48.77 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.885 . . . . 0.0 110.126 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.446 HD12 HG13 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -68.61 -27.35 65.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.208 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 t -78.48 -40.51 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 96' ' ' SER . 40.1 m-20 -83.7 -50.54 8.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.522 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.4 tt -45.43 -41.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.515 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 3.5 t-20 -66.53 -7.84 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.229 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 57.2 m -86.79 -22.85 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.522 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.7 ptt? -104.98 -35.4 7.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.48 ' N ' ' HG3' ' A' ' 97' ' ' MET . 8.7 mtpt -42.24 122.8 2.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.155 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.97 -172.31 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.901 1.474 . . . . 0.0 110.455 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.21 13.4 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.887 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -137.41 91.47 2.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.0 p -149.65 177.07 10.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.39 27.03 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.2 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 138.17 52.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.7 156.63 17.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 83' ' ' ILE . 6.1 t -112.58 158.25 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.0 m -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.69 142.18 27.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.551 ' CE2' ' HE2' ' A' ' 136' ' ' MET . 0.1 OUTLIER -90.91 -64.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.414 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 10.5 p30 -141.78 164.17 36.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.4 Cg_endo -74.39 174.73 12.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.945 1.497 . . . . 0.0 110.281 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.09 52.45 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.65 -40.14 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.092 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.22 -67.89 1.98 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.555 ' CG1' ' CB ' ' A' ' 131' ' ' SER . 21.8 m -103.51 86.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -1.196 . . . . 0.0 110.063 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.416 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 9.9 t70 -67.52 160.85 26.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.79 67.84 4.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.1 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 116' ' ' ASP . 46.0 Cg_endo -72.8 162.99 39.69 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.05 1.553 . . . . 0.0 110.539 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.71 163.77 27.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.163 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 50.83 26.82 2.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 122' ' ' SER . 26.0 t -155.53 -168.7 2.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.415 ' N ' ' OG ' ' A' ' 121' ' ' SER . 44.2 p -141.28 75.63 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -29.98 2.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 128' ' ' MET . . . -101.72 -34.7 4.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.626 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 12.3 m-85 -41.34 -55.38 5.33 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -1.128 . . . . 0.0 110.278 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -71.92 -60.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.835 1.439 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 131' ' ' SER . 9.8 m -49.83 -44.16 49.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.173 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.549 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 25.1 ttp -50.95 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.21 -0.931 . . . . 0.0 109.788 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -45.81 -59.05 3.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.904 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -46.46 -26.45 0.86 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 110.037 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.555 ' CB ' ' CG1' ' A' ' 115' ' ' VAL . 1.1 m -87.92 -71.39 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -42.17 -25.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 179.072 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.494 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 22.9 t -90.22 -60.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -51.61 -22.29 3.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.056 -1.028 . . . . 0.0 110.119 -179.918 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.533 ' HB3' ' CE1' ' A' ' 109' ' ' PHE . 0.8 OUTLIER -110.89 11.3 22.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.815 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.58 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -88.15 -3.84 58.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.564 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.8 mttt -90.55 -47.64 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.996 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.5 Cg_endo -75.37 1.84 7.47 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.631 1.332 . . . . 0.0 110.557 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.621 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 4.5 t80 -105.67 -47.25 3.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.037 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.534 ' CD1' HD11 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -78.3 -53.71 7.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.509 ' CG2' ' OXT' ' A' ' 146' ' ' ILE . 5.0 m -44.65 -26.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 143' ' ' HIS . 39.3 mt-10 -104.61 -40.3 6.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.621 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -43.05 -26.83 0.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.087 -1.008 . . . . 0.0 110.195 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 127.18 67.32 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.452 HD11 HD21 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -161.19 -70.72 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 110.114 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.509 ' OXT' ' CG2' ' A' ' 141' ' ' THR . 2.0 tt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.283 0.563 . . . . 5.6399999999999997 110.246 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.37 118.89 18.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 3.8399999999999999 110.158 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.11 -174.29 2.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 4.21 110.46 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -119.4 143.19 47.59 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.092 -0.707 . . . . 4.3899999999999997 109.092 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' A' ' 33' ' ' LEU . 15.3 mttt -115.19 -131.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.138 -0.976 . . . . 3.02 110.708 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.805 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . -176.79 103.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.438 -0.789 . . . . 1.6699999999999999 109.672 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.517 ' CG1' ' HB2' ' A' ' 84' ' ' ALA . 41.4 t -90.32 138.65 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 1.8500000000000001 110.495 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 5.7 tp -87.0 94.56 9.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 1.72 110.019 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.575 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 2.4 m-85 -78.44 104.33 8.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 3.21 110.063 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' CG2' ' CB ' ' A' ' 38' ' ' ALA . 30.5 t -123.46 163.11 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 1.97 110.296 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 1.5 p -149.99 -53.53 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 2.54 110.39 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 173.88 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.139 -0.975 . . . . 2.5299999999999998 110.237 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . 136.21 -4.9 3.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.724 -1.35 . . . . 1.99 109.724 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.52 ' N ' ' HB3' ' A' ' 39' ' ' ALA . 5.0 t30 69.43 38.13 1.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -1.148 . . . . 2.6299999999999999 110.262 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 15' ' ' ILE . 12.5 mt -136.49 -39.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 1.9199999999999999 110.235 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 88.3 m -90.39 107.79 19.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 3.6699999999999999 110.178 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.551 ' CB ' ' O ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER 73.55 -4.19 2.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 3.8599999999999999 110.392 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -84.42 -51.53 0.57 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 4.7699999999999996 110.66 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 18' ' ' SER . 47.3 Cg_endo -75.22 3.48 5.69 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.817 1.43 . . . . 2.9399999999999999 110.619 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.526 ' HB1' ' CE ' ' A' ' 128' ' ' MET . . . -98.85 -19.01 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 1.74 110.209 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . 22.0 m -71.55 -36.98 71.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 2.1400000000000001 109.991 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -63.04 -38.38 90.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 2.2799999999999998 110.015 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -76.72 -56.01 4.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.636 -1.386 . . . . 0.87 109.636 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 129' ' ' PHE . 5.7 tp -50.11 -44.78 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -1.198 . . . . 1.71 110.129 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.579 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 69.4 m -72.22 -53.31 12.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 1.79 110.042 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -43.53 -41.03 4.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 2.7999999999999998 109.99 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -33.66 26.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 2.0600000000000001 110.243 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -59.12 -44.37 92.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 2.9300000000000002 110.468 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.466 HG12 ' HD2' ' A' ' 32' ' ' LYS . 5.6 t -108.3 -32.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.96 . . . . 2.6000000000000001 110.517 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 123.55 -54.1 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.546 -1.422 . . . . 2.52 109.546 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.6 t70 179.61 90.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 3.5899999999999999 110.254 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HD2' HG12 ' A' ' 29' ' ' VAL . 15.0 mttt -141.61 -137.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 3.8300000000000001 110.173 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.793 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.9 mt -116.39 -123.07 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 4.1399999999999997 110.07 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.805 ' CA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 50.45 5.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.53 -0.731 . . . . 2.4300000000000002 111.305 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 25' ' ' CYS . 3.5 mt -121.2 109.27 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.95 -1.094 . . . . 2.7400000000000002 110.724 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.593 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 6.7 m-20 -143.1 91.75 2.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.8799999999999999 109.986 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 2.8 m -69.4 137.97 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.9399999999999999 110.221 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' CB ' ' CG2' ' A' ' 10' ' ' VAL . . . -151.61 177.18 10.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 1.51 110.315 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB3' ' N ' ' A' ' 14' ' ' ASN . . . -162.71 144.99 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 1.53 110.176 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -109.0 38.93 2.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 2.2799999999999998 110.193 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -160.72 87.04 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 2.25 110.214 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.26 68.7 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.517 -1.433 . . . . 2.1600000000000001 109.517 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' SER . 2.1 m-85 -108.39 -61.05 1.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -1.164 . . . . 3.7000000000000002 110.172 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -92.05 91.22 7.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 3.0099999999999998 110.191 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 64.5 t -136.06 162.77 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 2.4700000000000002 110.229 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.61 37.12 55.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 1.8500000000000001 109.561 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.487 ' HG3' ' N ' ' A' ' 48' ' ' SER . 11.1 pt20 -172.11 -144.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -1.127 . . . . 1.9399999999999999 110.196 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.6 OUTLIER 57.27 110.7 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 2.29 110.167 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.46 92.37 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.012 1.533 . . . . 2.0899999999999999 110.45 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 1.2 m-20 -86.48 19.02 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 2.8399999999999999 110.207 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -75.43 -27.93 59.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.247 -0.908 . . . . 1.8100000000000001 109.077 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 45.0 mtt180 -72.6 -51.65 18.8 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.822 -0.751 . . . . 3.7000000000000002 109.369 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 t -63.55 -49.83 71.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -0.794 . . . . 1.9099999999999999 109.615 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -60.42 -39.92 89.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.274 -0.891 . . . . 2.8100000000000001 109.305 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -59.42 -67.68 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 3.6000000000000001 109.542 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.576 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 22.0 t -48.41 -34.21 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 2.5299999999999998 109.239 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.509 ' SG ' ' CG1' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.22 -54.93 41.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 1.6000000000000001 109.605 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -68.54 -20.36 64.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 3.0600000000000001 109.706 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.464 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 2.4 t -87.65 -13.58 42.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.357 -0.839 . . . . 1.8600000000000001 110.103 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -114.77 -30.7 6.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 2.1000000000000001 109.326 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 136.22 79.73 0.1 OUTLIER Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.922 -1.271 . . . . 1.29 109.922 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 40.6 t -159.61 123.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -1.079 . . . . 2.2799999999999998 110.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.14 105.05 14.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 2.46 110.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.493 HG13 ' N ' ' A' ' 65' ' ' SER . 35.6 pt -120.73 -145.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 2.46 110.237 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.493 ' N ' HG13 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -170.03 -64.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 4.1200000000000001 110.229 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 65' ' ' SER . 15.7 mmtt -142.25 145.93 34.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 6.1799999999999997 110.126 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.463 ' HA ' ' OE1' ' A' ' 67' ' ' GLN . 32.3 mm-40 -122.11 56.65 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 2.77 110.258 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ALA . 1.5 ttp85 -69.18 71.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 4.71 110.182 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 13' ' ' GLY . . . -42.51 136.28 2.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 1.8 110.236 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 ptt-85 -140.34 158.44 44.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 2.73 110.203 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.55 145.32 55.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 2.2400000000000002 110.197 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 72' ' ' ILE . 6.6 tt -89.96 128.76 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 1.9099999999999999 110.213 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.2 p -86.22 -142.75 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 2.6000000000000001 110.213 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -109.43 -5.98 15.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 3.8900000000000001 110.222 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -75.19 -21.34 58.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.8100000000000001 110.247 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 4.2 p-10 -44.68 -28.81 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 2.46 110.194 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 25.1 m-85 -79.63 -46.49 17.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 2.3500000000000001 110.248 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -95.06 8.42 43.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 2.21 110.209 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.59 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 14.0 tptt -102.62 -2.76 27.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 3.2000000000000002 110.228 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.593 ' CD2' ' CG ' ' A' ' 36' ' ' ASP . 91.8 m-85 -151.62 -157.56 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 2.5499999999999998 110.298 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.3 -26.28 2.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 2.3300000000000001 110.551 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.556 HG12 ' CD2' ' A' ' 143' ' ' HIS . 97.0 t -136.94 150.88 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.052 . . . . 1.77 110.576 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.52 HG21 ' CD1' ' A' ' 94' ' ' ILE . 1.7 mp -123.24 116.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.824 . . . . 1.3899999999999999 109.902 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -103.12 118.82 37.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 1.4399999999999999 110.483 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.61 112.72 24.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 1.3400000000000001 110.065 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 5.0 mp -59.48 -84.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 1.75 110.356 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.515 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -62.77 159.81 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 2.02 110.273 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 2.48 110.184 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -52.81 -40.16 63.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 2.0899999999999999 110.165 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.527 ' CG2' HG11 ' A' ' 10' ' ' VAL . 2.8 mt -65.2 -51.73 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 2.3100000000000001 110.189 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -61.29 -43.55 98.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 1.49 110.378 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 t -64.81 -48.62 73.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.917 . . . . 1.5700000000000001 110.264 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -64.65 -63.67 1.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 1.73 110.265 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.52 ' CD1' HG21 ' A' ' 83' ' ' ILE . 6.1 tt -42.76 -38.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 2.0699999999999998 110.248 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.498 ' N ' HG22 ' A' ' 94' ' ' ILE . 28.6 t-20 -71.9 -24.9 61.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 2.27 110.214 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 93' ' ' ASP . 42.7 t -76.88 -2.02 31.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 1.6399999999999999 110.225 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.516 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.0 ptt? -123.97 -25.33 4.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 1.53 110.219 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 1.4 mtpt -49.04 143.02 9.16 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 1.6499999999999999 110.26 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.09 -159.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.991 1.522 . . . . 1.6000000000000001 110.438 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.84 2.62 15.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.86 . . . . 2.29 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -149.16 108.11 3.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 3.8799999999999999 110.263 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.4 p -149.48 -173.79 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.887 . . . . 2.3700000000000001 110.222 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 17.08 7.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 3.25 110.218 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.46 157.93 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 1.25 110.208 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -115.43 157.23 24.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.281 -0.887 . . . . 3.1400000000000001 110.177 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.451 HG11 HG23 ' A' ' 83' ' ' ILE . 39.6 t -118.61 114.51 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 1.98 110.185 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' CE1' ' A' ' 143' ' ' HIS . 27.6 m -121.58 148.19 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 2.0499999999999998 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 109' ' ' PHE . 1.3 tp -85.68 152.8 22.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 1.95 110.181 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.515 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 4.4 t80 -115.82 109.3 17.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 2.9900000000000002 110.268 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.479 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER 57.79 156.25 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 3.6200000000000001 110.28 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.479 ' HD2' ' ND2' ' A' ' 110' ' ' ASN . 47.0 Cg_endo -74.83 174.26 13.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.039 1.547 . . . . 3.1899999999999999 110.28 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.85 52.33 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 4.71 110.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -145.9 -47.03 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 3.1299999999999999 110.251 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.39 -102.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 2.8300000000000001 109.552 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.503 ' CG2' HD21 ' A' ' 86' ' ' LEU . 30.8 m -54.55 105.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 2.25 110.225 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -148.22 29.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 4.1500000000000004 110.247 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.512 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 6.9 t0 -48.95 112.41 2.43 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 4.1399999999999997 110.199 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 46.8 Cg_endo -72.73 -93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.939 1.494 . . . . 4.2699999999999996 110.427 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 168.12 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 4.1699999999999999 110.178 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.19 -46.99 0.34 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 6.4299999999999997 110.254 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.59 167.07 10.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 2.5899999999999999 110.227 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.566 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -88.24 32.68 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 2.9300000000000002 110.185 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.91 16.61 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 2.1600000000000001 110.221 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -118.91 -44.12 0.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.497 -1.441 . . . . 1.6299999999999999 109.497 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.626 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 5.2 m-85 -44.17 -48.15 23.76 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.169 . . . . 2.79 110.396 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.7 Cg_endo -72.59 -54.53 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.625 1.329 . . . . 1.1899999999999999 110.349 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 128' ' ' MET . 23.1 m -62.13 -53.88 49.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 2.1099999999999999 110.142 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.533 ' HG3' ' CG ' ' A' ' 17' ' ' ARG . 10.7 ttp -41.85 -65.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 1.3700000000000001 110.108 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 50.2 t80 -56.25 -44.78 80.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 2.3100000000000001 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -44.06 -59.73 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 1.6699999999999999 109.99 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 25.7 m -70.75 -42.31 70.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.9199999999999999 109.867 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.572 ' CG2' ' CG1' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -41.58 -43.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 2.04 109.904 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.532 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.2 -40.49 7.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 1.8500000000000001 110.241 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 33.5 tttt -55.47 -16.64 3.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 3.9500000000000002 110.227 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.468 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 4.2 tp10 -117.9 16.13 14.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 3.0899999999999999 109.809 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.55 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -102.97 -21.2 13.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 3.3399999999999999 110.162 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 19.4 mttt -81.93 -47.04 1.01 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 3.6299999999999999 110.148 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -77.79 -2.52 12.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.982 1.517 . . . . 1.2 110.271 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 143' ' ' HIS . 48.8 t80 -111.03 -72.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 2.5600000000000001 110.116 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.528 ' CD1' HD12 ' A' ' 34' ' ' ILE . 1.8 tp -47.83 -49.34 29.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 2.1400000000000001 110.052 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.514 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 6.7 m -58.3 -29.19 65.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.72 110.349 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -106.84 5.93 28.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 2.2999999999999998 110.397 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.69 ' CE1' ' CE2' ' A' ' 139' ' ' PHE . 0.5 OUTLIER -96.33 -6.16 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.129 -0.982 . . . . 2.9300000000000002 110.348 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 124.77 28.47 1.15 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 2.6800000000000002 109.726 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.47 HD13 HG22 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -144.36 -103.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -1.182 . . . . 2.8399999999999999 110.191 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.527 ' CD1' ' OXT' ' A' ' 146' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.0 -1.0 . . . . 3.4300000000000002 110.148 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.226 0.536 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 1' ' ' ALA . . . 67.09 17.37 10.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 2' ' ' ALA . 0.7 OUTLIER -102.54 -161.06 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.26 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -119.42 145.07 46.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' O ' HG21 ' A' ' 34' ' ' ILE . 16.0 mtmt -125.7 -156.21 0.72 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.058 -1.026 . . . . 0.0 110.975 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.655 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -124.88 157.13 36.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.678 -0.639 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.621 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 13.6 t -138.75 121.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.554 HD13 ' CD2' ' A' ' 80' ' ' PHE . 7.7 tp -76.91 103.39 6.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.568 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 18.3 m-85 -83.16 86.28 7.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 38' ' ' ALA . 6.7 t -93.86 154.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 16' ' ' CYS . 59.2 m -146.72 -71.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.136 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 175.96 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.262 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 80.47 -2.3 78.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.514 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 67.86 8.42 6.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mt -118.61 -22.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.151 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 119' ' ' TYR . 14.5 m -86.09 111.64 20.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.267 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.584 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 1.1 mpt_? 60.9 12.28 3.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.522 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -78.85 -55.18 1.0 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.465 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 18' ' ' SER . 47.4 Cg_endo -74.23 1.34 7.39 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.844 1.444 . . . . 0.0 110.576 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -97.54 -28.34 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.347 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.559 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 63.8 m -74.1 -33.95 63.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -63.78 -45.66 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.462 -0.773 . . . . 0.0 110.304 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.77 -51.58 6.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.613 ' CD1' ' CB ' ' A' ' 133' ' ' SER . 1.1 tt -52.01 -45.22 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 0.0 110.357 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.596 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 88.4 m -75.76 -51.85 11.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.179 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 3.6 mtp85 -44.12 -40.95 5.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.904 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -80.48 -43.01 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -58.38 -52.6 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 0.0 110.437 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.8 -34.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.369 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.38 -82.84 0.33 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 16.4 t0 -156.39 85.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -1.09 . . . . 0.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 31' ' ' ASP . 18.0 mmtm -129.8 -139.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.125 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.5 mt -119.15 -33.02 4.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.987 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.4 pp -32.17 -31.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.647 -0.658 . . . . 0.0 111.145 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.6 ' N ' ' O ' ' A' ' 33' ' ' LEU . 1.7 mt -73.96 88.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.483 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.579 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 49.0 m-20 -127.33 68.75 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.117 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -54.77 139.41 39.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.479 ' HB2' ' HG ' ' A' ' 8' ' ' LEU . . . -153.73 -179.09 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' CB ' ' A' ' 14' ' ' ASN . . . -150.07 -173.7 4.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.416 ' HA ' HG23 ' A' ' 72' ' ' ILE . 5.3 t -162.04 67.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.908 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 -68.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 110.206 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -22.6 39.63 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 45' ' ' VAL . 9.8 m-85 -62.69 -63.44 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.44 70.88 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 43' ' ' PHE . 44.5 t -144.75 142.27 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.95 18.98 58.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -168.11 -142.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 110.255 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.1 108.36 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.208 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 103.06 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.072 1.564 . . . . 0.0 110.486 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 61.5 m-20 -95.99 20.51 9.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -74.39 -27.76 60.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.949 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.586 ' HB3' ' CG ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -74.01 -52.07 13.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.296 179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.486 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 1.0 OUTLIER -61.37 -51.67 67.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.486 ' NE2' HG12 ' A' ' 64' ' ' ILE . 0.6 OUTLIER -61.37 -41.01 96.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 109.263 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -54.2 -66.16 0.45 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.416 -0.803 . . . . 0.0 109.467 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.582 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 10.0 p -53.41 -32.01 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.911 . . . . 0.0 109.216 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.519 ' SG ' ' CG1' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -56.3 -52.12 65.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.534 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -24.34 60.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.302 -0.874 . . . . 0.0 109.651 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.74 -12.42 58.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.3 m120 -114.59 -29.07 6.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 131.71 81.02 0.2 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 26.0 t -160.36 133.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -1.131 . . . . 0.0 110.14 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -122.15 93.15 3.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 0.0 110.2 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.486 HG12 ' NE2' ' A' ' 54' ' ' GLN . 26.0 pt -97.54 165.5 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.83 37.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.48 85.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 0.0 110.183 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.521 ' NE2' ' HB3' ' A' ' 19' ' ' PRO . 5.0 mp0 -105.18 -79.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.148 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' ALA . 7.3 ttp180 43.61 75.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 110.242 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 68' ' ' ARG . . . -42.43 149.22 0.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.87 -170.44 3.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -107.66 155.43 20.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.416 HG23 ' HA ' ' A' ' 40' ' ' THR . 18.5 tt -98.68 155.78 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.02 168.99 9.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -16.31 23.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -22.57 62.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.182 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 28.4 p-10 -48.38 -37.88 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.241 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CE2' ' HD3' ' A' ' 99' ' ' PRO . 20.8 m-85 -65.85 -10.87 42.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 110.21 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.414 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 27.7 t -144.52 30.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.585 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 15.7 tptt -111.17 -5.33 14.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.585 ' CD2' ' HB3' ' A' ' 79' ' ' LYS . 87.0 m-85 -151.7 -139.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.235 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 -53.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.918 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 74.6 t -119.13 111.04 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.467 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.454 ' HB ' HG21 ' A' ' 106' ' ' VAL . 3.9 mt -84.29 110.39 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.053 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.73 135.78 38.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 110.386 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.43 121.75 41.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.584 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 2.2 mp -66.09 -80.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.439 ' CB ' ' CD1' ' A' ' 90' ' ' ILE . 1.3 t0 -67.4 178.72 1.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.254 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -85.88 -35.07 20.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -51.46 -33.51 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 110.229 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 11' ' ' CYS . 1.9 mt -71.02 -52.53 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.5 OUTLIER -64.12 -34.4 77.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.23 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 t -77.86 -46.97 19.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 89' ' ' SER . 5.4 m-20 -67.09 -57.41 6.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 95' ' ' ASN . 3.9 tt -46.37 -40.82 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.514 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 8.3 t-20 -68.23 -24.93 64.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 93' ' ' ASP . 8.5 t -73.19 -17.08 61.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.458 ' CE ' HG13 ' A' ' 94' ' ' ILE . 9.3 ptt? -109.68 -27.14 9.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 2.3 mtpt -42.73 138.65 2.21 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.557 ' HD3' ' CE2' ' A' ' 77' ' ' PHE . 46.0 Cg_endo -73.26 -160.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.094 1.576 . . . . 0.0 110.422 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.497 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 26.3 t -113.36 15.78 19.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 110.153 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 100' ' ' SER . 4.8 m-80 -155.02 104.95 2.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.2 p -137.33 -179.91 6.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.89 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.414 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -127.05 -5.54 6.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.52 -168.06 1.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.253 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.64 150.45 41.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.454 HG21 ' HB ' ' A' ' 83' ' ' ILE . 45.1 t -116.37 142.6 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.209 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.1 m -151.64 155.36 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.523 ' CG ' ' OD1' ' A' ' 110' ' ' ASN . 1.6 tp -89.28 142.2 27.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.545 ' CE1' ' HE2' ' A' ' 136' ' ' MET . 36.1 t80 -129.11 76.14 1.7 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.523 ' OD1' ' CG ' ' A' ' 108' ' ' LEU . 6.8 p-10 -176.9 166.24 1.42 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.7 Cg_endo -75.53 175.89 10.69 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.043 1.549 . . . . 0.0 110.296 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.509 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.0 Cg_endo -73.72 4.72 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.932 1.491 . . . . 0.0 110.489 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -122.36 -14.86 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.217 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.04 141.56 8.91 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 4.0 m -80.06 4.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -1.138 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 14.5 t70 178.01 169.4 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.237 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.563 ' CB ' ' CD ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -179.8 -59.35 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 117' ' ' ASP . 46.9 Cg_endo -73.13 88.76 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.94 1.494 . . . . 0.0 110.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.567 ' CE1' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -65.78 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.942 . . . . 0.0 110.17 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.474 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 1.7 t80 66.66 -62.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 119' ' ' TYR . 52.4 p -70.47 144.73 51.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.46 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 5.5 p -80.89 48.59 1.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.72 42.45 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -159.65 -37.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.627 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 47.5 m-85 -52.15 -44.98 93.94 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -1.163 . . . . 0.0 110.572 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 46.8 Cg_endo -74.13 -59.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.685 1.36 . . . . 0.0 110.286 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -55.3 -43.12 74.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.58 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 27.1 ttp -48.6 -80.55 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.605 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 6.1 t80 -49.01 -55.51 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.088 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -44.21 -28.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 110.513 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.8 m -88.85 -60.32 1.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.558 HG12 ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -50.46 -19.48 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.268 179.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.613 ' CB ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -98.15 -48.68 5.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.894 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 1.9 mmmm -71.02 -2.71 16.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 110.131 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.15 5.22 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.839 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.545 ' HE2' ' CE1' ' A' ' 109' ' ' PHE . 1.5 tpt -82.97 11.77 5.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.394 -0.816 . . . . 0.0 110.193 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.524 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 2.3 mmtt -90.51 -55.16 0.28 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.213 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 48.2 Cg_endo -76.26 -2.87 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.539 ' CD1' ' HE1' ' A' ' 136' ' ' MET . 25.1 t80 -108.16 -51.92 2.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.259 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.508 ' HA ' ' HA3' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -71.67 -55.95 6.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.545 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 56.3 m -41.93 -36.71 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 110.468 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.22 -63.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.724 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -100.96 63.72 1.03 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.752 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 145' ' ' LEU . . . -179.8 -32.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.533 ' HG ' ' CG2' ' A' ' 146' ' ' ILE . 0.6 OUTLIER 172.56 -91.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.472 -1.016 . . . . 0.0 109.864 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.545 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 1.1 tp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.129 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.254 0.55 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.466 ' HB2' ' HG3' ' A' ' 3' ' ' GLU . . . 63.46 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.915 . . . . 0.0 110.265 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.466 ' HG3' ' HB2' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -120.94 157.12 30.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.349 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.558 ' HG2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -76.58 -175.31 3.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.293 -0.879 . . . . 0.0 109.05 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.558 ' N ' ' HG2' ' A' ' 4' ' ' LYS . 33.0 mtpt -145.9 177.37 8.98 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.901 -1.124 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.723 ' HA ' HG13 ' A' ' 34' ' ' ILE . . . -145.77 124.4 12.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.066 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 18.7 t -114.43 125.37 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.53 HD11 ' CE2' ' A' ' 80' ' ' PHE . 50.2 tp -79.24 98.94 6.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.64 ' CZ ' ' CG1' ' A' ' 7' ' ' VAL . 96.7 m-85 -85.98 104.63 15.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 38' ' ' ALA . 3.8 t -103.11 149.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.446 ' SG ' HD21 ' A' ' 86' ' ' LEU . 24.2 m -127.08 -151.33 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.92 . . . . 0.0 110.021 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.12 -30.46 21.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -144.18 9.99 2.0 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 43.5 t-20 59.26 49.68 8.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 0.0 110.29 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 13' ' ' GLY . 15.3 mt -136.75 -57.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.2 t -124.37 -138.42 0.29 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.288 -0.883 . . . . 0.0 110.133 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.38 -55.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.392 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.52 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 1.3 m -161.08 53.65 0.49 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.477 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.0 Cg_endo -75.31 -23.78 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.031 1.542 . . . . 0.0 110.308 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' CB ' ' SG ' ' A' ' 57' ' ' CYS . . . -78.49 6.82 7.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' CE2' ' A' ' 9' ' ' PHE . 6.0 t -61.24 -32.04 71.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.447 ' HA ' ' HB ' ' A' ' 35' ' ' ILE . 2.1 tt0 -56.03 -54.05 49.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -76.48 -39.31 30.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.672 ' CD1' ' CD2' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -53.87 -47.21 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.243 . . . . 0.0 110.037 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.591 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -79.28 -49.97 11.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 9.0 mtt180 -54.23 -31.0 52.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.68 -40.83 12.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.496 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.515 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.55 -30.95 70.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.701 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.533 ' CG2' HD22 ' A' ' 33' ' ' LEU . 83.1 t -124.72 -22.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.92 -82.4 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.462 ' C ' ' CG ' ' A' ' 32' ' ' LYS . 2.7 m-20 -149.76 68.14 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.261 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.546 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 2.0 mtpm? -148.9 37.86 0.81 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER 166.6 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.437 -0.789 . . . . 0.0 109.591 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.723 HG13 ' HA ' ' A' ' 6' ' ' ALA . 2.7 pp -42.59 168.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.634 ' CG2' ' CD1' ' A' ' 9' ' ' PHE . 4.7 mp -121.06 102.32 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 80' ' ' PHE . 9.4 m-20 -88.31 114.21 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.062 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.7 m -75.17 116.3 15.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.032 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' HB3' HG23 ' A' ' 10' ' ' VAL . . . -120.85 175.18 6.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.511 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . . . -161.16 149.3 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.454 HG22 HG23 ' A' ' 90' ' ' ILE . 5.2 t -116.75 -2.45 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.09 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.28 170.81 13.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 110.145 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.52 50.15 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -17.36 32.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -1.165 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.401 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -141.97 80.47 1.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.5 t -134.44 146.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.07 58.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 48' ' ' SER . 1.3 pt20 -158.94 -146.79 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -1.147 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 65.12 99.68 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 100.89 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.083 1.57 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 1.6 t0 -89.72 26.83 1.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -76.32 -31.92 58.42 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.225 -0.922 . . . . 0.0 109.051 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -70.31 -49.7 46.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.262 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.581 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.3 t -63.35 -53.49 51.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.573 -0.704 . . . . 0.0 109.683 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.555 ' NE2' ' N ' ' A' ' 55' ' ' LYS . 4.1 pp0? -61.04 -31.2 70.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.257 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.4 -66.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.383 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.571 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 35.7 m -52.79 -33.36 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.203 -0.935 . . . . 0.0 109.115 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.516 ' SG ' ' CB ' ' A' ' 20' ' ' ALA . 32.0 m -57.47 -53.07 62.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 109.508 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -23.17 63.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.99 -11.9 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 110.061 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.6 m-80 -112.44 -23.77 10.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.212 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 124.17 75.79 0.29 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 55.0 t -158.09 102.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -1.145 . . . . 0.0 110.205 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -78.34 74.26 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.988 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.452 HG22 ' CG1' ' A' ' 62' ' ' VAL . 3.4 pt -60.1 -173.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -160.22 70.07 0.41 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.22 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 90.3 mm-40 -56.52 -60.0 4.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.218 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.38 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.269 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.453 ' HB2' ' CG1' ' A' ' 15' ' ' ILE . . . -60.59 131.4 50.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -140.44 152.23 45.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.245 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.06 144.18 38.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.195 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.7 tt -75.8 145.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.1 t -89.72 -146.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.13 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -118.6 -5.29 10.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.31 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.67 -8.43 31.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.1 -47.63 12.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.231 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 53.5 m-85 -48.61 -36.71 16.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.9 t -102.07 -16.04 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.16 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -66.25 -25.56 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.194 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.564 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 7.4 m-85 -132.28 169.6 16.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.1 -33.78 20.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.377 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.551 HG12 ' CD2' ' A' ' 143' ' ' HIS . 47.6 t -134.23 153.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.31 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 4.8 mt -129.75 128.3 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -126.12 143.37 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.67 156.49 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.58 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 1.2 tp -85.3 -52.88 5.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.479 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 3.7 m-20 -99.56 -174.87 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.905 . . . . 0.0 110.244 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.58 -35.74 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -46.13 -41.27 12.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 87' ' ' ASP . 1.4 mp -71.02 -54.15 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.152 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -15.81 30.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 t -93.26 -41.26 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.18 -16.88 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.182 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.52 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.3 tt -74.14 -40.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.168 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.501 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 29.6 p30 -68.12 -9.76 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.65 -38.71 23.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.883 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.52 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.1 ptt? -84.1 -34.3 24.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.239 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -52.62 126.55 40.09 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 100' ' ' SER . 45.2 Cg_endo -73.39 -87.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.053 1.554 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 169.74 -23.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.4 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.84 43.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.128 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.8 p -99.47 -145.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.267 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 27.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.03 32.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.45 146.05 45.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 9.8 m -108.41 132.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 m -131.27 156.51 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.256 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.4 tp -92.46 102.4 14.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.123 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -81.09 82.61 6.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.134 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 7.7 t30 -170.09 142.16 1.84 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.495 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 47.5 Cg_endo -74.35 175.01 11.56 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.94 1.495 . . . . 0.0 110.35 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.02 52.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.977 1.514 . . . . 0.0 110.434 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.59 -37.18 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.206 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 101.54 2.51 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.66 98.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -1.209 . . . . 0.0 110.118 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.23 148.03 26.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 110.197 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 87.73 6.52 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.89 173.47 13.48 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.005 1.529 . . . . 0.0 110.406 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -115.75 161.92 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.23 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 50.38 41.65 25.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.155 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -150.89 -174.76 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.3 p -143.79 40.17 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.892 . . . . 0.0 110.174 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.32 54.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.556 ' HA2' ' CG2' ' A' ' 127' ' ' THR . . . -179.08 -32.84 0.06 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.606 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 8.1 m-85 -41.76 -50.29 10.05 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 110.731 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 43.4 Cg_endo -71.38 -74.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.81 1.426 . . . . 0.0 110.975 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.556 ' CG2' ' HA2' ' A' ' 124' ' ' GLY . 15.1 t -39.95 -40.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.168 -0.958 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.59 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 9.6 ttp -55.17 -78.95 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.188 -0.945 . . . . 0.0 109.823 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.672 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 2.7 t80 -42.6 -51.29 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.167 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' N ' ' HD1' ' A' ' 129' ' ' PHE . . . -58.81 -22.41 58.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.5 t -90.32 -51.28 5.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.04 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.547 HD13 ' CA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -61.8 -16.96 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.578 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 2.3 t -96.0 -51.05 4.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.557 -0.714 . . . . 0.0 109.849 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.22 -20.84 65.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.974 . . . . 0.0 110.111 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 131' ' ' SER . 0.2 OUTLIER -76.93 -30.17 55.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.552 ' CE ' ' HA ' ' A' ' 133' ' ' SER . 0.6 OUTLIER -77.57 5.23 9.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.209 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.525 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 3.0 mmtt -89.24 -54.65 0.31 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.35 -10.73 17.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.041 1.548 . . . . 0.0 110.426 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 32.9 t80 -102.17 -77.23 0.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 136' ' ' MET . 14.6 tp -40.81 -62.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.382 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.525 HG22 ' CD1' ' A' ' 146' ' ' ILE . 30.6 m -41.66 -29.13 0.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LEU . 3.3 mm-40 -101.59 -25.82 13.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.551 ' CD2' HG12 ' A' ' 82' ' ' VAL . 1.5 t60 -66.32 -21.66 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.02 36.42 0.18 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.515 ' CD2' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -173.38 93.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 110.14 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.525 ' CD1' HG22 ' A' ' 141' ' ' THR . 4.2 tp . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.246 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.307 0.575 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . . . 55.63 172.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.51 ' O ' ' CD2' ' A' ' 145' ' ' LEU . 2.2 mm-40 -99.97 168.04 10.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.04 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -80.47 171.2 15.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.309 -0.869 . . . . 0.0 108.762 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.452 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 9.4 mtpp -151.8 164.12 37.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.86 -1.15 . . . . 0.0 111.26 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.839 ' HA ' ' CG1' ' A' ' 34' ' ' ILE . . . -105.91 99.93 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.75 -0.593 . . . . 0.0 109.773 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.569 ' CG1' ' CE1' ' A' ' 9' ' ' PHE . 12.6 t -104.01 108.35 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 38' ' ' ALA . 29.7 tp -92.56 111.04 22.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.616 ' CD1' ' CG2' ' A' ' 35' ' ' ILE . 12.5 m-85 -85.97 128.48 34.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.814 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 39' ' ' ALA . 10.9 p -143.37 172.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -0.981 . . . . 0.0 110.633 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.617 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 16.8 t -153.6 -69.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 110.126 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER 172.99 84.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.919 . . . . 0.0 110.285 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 134.06 -31.67 2.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 6.4 t30 72.15 -0.15 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -1.183 . . . . 0.0 110.352 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.458 HG23 ' OH ' ' A' ' 119' ' ' TYR . 23.4 mt -96.71 -85.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -85.27 44.17 1.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 9.7 mmt180 -115.73 69.14 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.451 ' OG ' HD23 ' A' ' 86' ' ' LEU . 16.5 m 44.18 57.29 13.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.9 . . . . 0.0 110.323 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.473 ' HD2' ' SD ' ' A' ' 128' ' ' MET . 43.7 Cg_endo -71.2 -13.18 30.88 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.971 1.511 . . . . 0.0 110.067 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -82.16 6.71 15.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.778 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.572 ' CB ' HG22 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -63.76 -38.78 92.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.647 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.57 -44.93 80.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.805 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.9 -54.65 13.44 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.634 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 4.8 tp -50.86 -44.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -1.174 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.597 ' CB ' ' HB ' ' A' ' 35' ' ' ILE . 5.8 t -71.31 -32.12 68.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -62.56 -55.42 27.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -34.11 66.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 110.492 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.532 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 6.1 ttm -73.05 -59.33 2.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 31' ' ' ASP . 11.5 m -141.53 46.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 0.0 110.396 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . -59.59 78.14 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER 165.55 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -1.102 . . . . 0.0 110.123 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' O ' ' CB ' ' A' ' 33' ' ' LEU . 11.6 mttp -139.42 112.93 8.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.737 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.574 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 77.54 65.02 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.043 0.925 . . . . 0.0 109.167 -179.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.839 ' CG1' ' HA ' ' A' ' 6' ' ' ALA . 2.6 pp -59.57 145.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.82 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.616 ' CG2' ' CD1' ' A' ' 9' ' ' PHE . 8.5 mt -119.31 89.87 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 69.1 m-20 -85.19 178.27 7.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 111.006 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 5.7 p -130.55 123.22 29.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -133.06 -160.45 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.125 -0.985 . . . . 0.0 110.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . . . -171.55 144.43 1.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.455 ' OG1' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -81.3 -49.16 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.158 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.6 t -128.28 141.29 51.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.0 97.56 0.24 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.97 23.53 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.326 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.88 26.79 5.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 69' ' ' ALA . 16.0 m -64.96 125.27 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.258 -0.901 . . . . 0.0 110.304 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.68 34.0 0.62 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -101.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -1.114 . . . . 0.0 110.172 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.9 t 61.26 71.69 0.76 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.206 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.51 66.42 1.62 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.0 1.526 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 21.5 m-20 -92.22 35.84 0.99 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 110.367 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -31.62 58.48 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mpt_? -73.94 -48.77 28.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.299 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -62.25 -48.21 80.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.459 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 0.0 OUTLIER -64.65 -36.37 84.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 109.262 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.3 ttpt -58.75 -64.74 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.258 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.583 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 9.0 p -54.81 -35.53 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.581 ' CA ' ' CG2' ' A' ' 62' ' ' VAL . 4.3 m -53.51 -54.11 41.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.777 . . . . 0.0 109.411 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 54' ' ' GLN . 15.6 mtmt -69.03 -27.42 65.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 t -77.57 -14.08 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.89 -32.36 6.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.533 ' O ' ' CG1' ' A' ' 62' ' ' VAL . . . 114.1 85.68 1.37 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.581 ' CG2' ' CA ' ' A' ' 57' ' ' CYS . 2.5 m -162.65 87.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -1.084 . . . . 0.0 110.111 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -52.85 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.452 ' CG2' ' O ' ' A' ' 62' ' ' VAL . 1.2 pt -103.71 -158.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -144.75 -170.94 3.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.155 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 68' ' ' ARG . 21.2 mmtt -80.42 4.16 19.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 76.6 mm-40 59.75 -75.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 65.91 104.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' O ' HG12 ' A' ' 45' ' ' VAL . . . -61.43 113.13 2.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.433 ' CD ' ' O ' ' A' ' 71' ' ' GLN . 8.0 tmm_? -135.98 143.45 44.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.203 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.433 ' O ' ' CD ' ' A' ' 70' ' ' ARG . 1.6 tt0 -72.53 139.47 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.248 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.0 tt -95.46 136.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 178.79 6.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.47 4.05 33.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.88 -12.33 55.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 7.6 p-10 -49.97 -24.42 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.141 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.2 m-85 -75.83 -10.11 59.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 110.142 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.55 -45.48 4.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 80' ' ' PHE . 7.9 tptp -57.81 -51.2 70.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.488 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 11.8 m-85 -115.57 144.23 44.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.349 -0.845 . . . . 0.0 110.13 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 56.0 m-20 -91.32 -24.04 19.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 7' ' ' VAL . 9.9 t -113.71 138.71 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.239 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.54 115.38 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.066 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.472 ' HB1' ' CD2' ' A' ' 9' ' ' PHE . . . -91.5 141.63 28.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB1' HD11 ' A' ' 91' ' ' LEU . . . -117.27 141.25 48.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.516 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.4 OUTLIER -73.33 -52.55 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -107.97 -178.92 3.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.03 -28.39 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.253 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.52 -59.8 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.182 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 11' ' ' CYS . 4.3 tt -51.39 -38.59 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.486 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -74.03 -27.52 60.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.479 ' O ' ' ND2' ' A' ' 95' ' ' ASN . 40.0 t -78.64 -29.38 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 0.0 110.2 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.98 -45.22 8.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.53 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.4 tt -48.45 -36.03 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 92' ' ' SER . 20.8 p30 -71.71 -8.99 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -77.72 -20.07 54.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.181 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.53 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.0 ptt? -102.78 -25.28 13.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -53.38 139.59 47.2 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.185 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.16 169.72 21.56 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.996 1.524 . . . . 0.0 110.415 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -71.58 -6.5 41.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.06 68.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.238 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 30.7 p -83.95 164.0 19.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.19 38.66 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 81' ' ' ASP . . . -157.61 161.42 38.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -122.73 132.41 54.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.9 . . . . 0.0 110.158 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.517 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 10.3 m -96.84 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.357 -0.839 . . . . 0.0 110.187 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 t -96.74 161.66 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.45 113.13 26.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 42.7 t80 -83.73 122.96 29.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.49 170.09 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.504 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.6 Cg_endo -75.8 175.62 11.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.026 1.54 . . . . 0.0 110.227 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.57 4.44 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.02 1.537 . . . . 0.0 110.514 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -54.3 -64.43 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 110.145 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.96 130.99 2.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.3 t -124.3 26.52 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 117' ' ' ASP . 1.0 OUTLIER -148.83 -40.91 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.243 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER 66.79 145.3 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.149 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 119' ' ' TYR . 45.9 Cg_endo -73.39 73.29 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.458 ' OH ' HG23 ' A' ' 15' ' ' ILE . 26.0 m-85 51.22 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.271 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 121' ' ' SER . 1.7 t80 -152.13 94.53 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' TYR . 6.2 t 43.23 -145.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 15.1 m -70.25 -19.68 63.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.239 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 128' ' ' MET . . . 142.17 -71.5 0.4 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 3.2 m-85 -42.66 -48.6 13.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.149 . . . . 0.0 110.325 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.638 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -72.97 -55.0 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.671 1.353 . . . . 0.0 110.396 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 128' ' ' MET . 67.2 m -63.23 -53.26 55.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.186 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 124' ' ' GLY . 10.7 ttp -40.85 -70.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 66.7 t80 -58.31 -45.47 87.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -43.22 -67.32 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.869 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -65.12 -39.95 93.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.2 -0.938 . . . . 0.0 109.754 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.548 ' CG2' HD11 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -42.26 -42.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.819 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.532 ' CB ' HD13 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -98.26 -42.92 7.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.335 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 3.4 mmtt -47.5 -30.19 3.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.2 OUTLIER -105.65 -2.98 22.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.544 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.8 OUTLIER -84.98 20.21 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.59 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -105.17 -65.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.153 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 48.3 Cg_endo -73.09 -1.54 10.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.753 1.396 . . . . 0.0 110.492 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.488 ' CD2' ' CE ' ' A' ' 136' ' ' MET . 92.9 t80 -77.02 -76.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 110.339 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.536 ' CD1' HD11 ' A' ' 146' ' ' ILE . 3.1 pp -71.46 -33.51 69.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.297 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 146' ' ' ILE . 85.8 m -57.13 -30.11 64.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 144' ' ' GLY . 5.0 mm-40 -104.81 -44.99 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.424 ' CD2' ' O ' ' A' ' 139' ' ' PHE . 14.9 m-70 -43.51 -25.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.068 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 126.96 66.8 0.15 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.545 ' CD1' ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -153.17 -45.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -1.106 . . . . 0.0 110.226 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.536 HD11 ' CD1' ' A' ' 140' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.254 0.55 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.01 85.71 6.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.898 . . . . 0.0 110.145 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -62.14 -147.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.266 -0.896 . . . . 0.0 110.363 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.572 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -160.68 -42.86 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 110.446 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 2.0 ptpt 37.43 -155.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.699 -0.626 . . . . 0.0 110.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.788 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . -159.91 138.43 10.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.497 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 2.8 m -103.16 112.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.403 -0.811 . . . . 0.0 109.56 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -59.44 95.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.98 . . . . 0.0 110.328 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' CD2' HG21 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -85.79 108.97 18.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.301 -0.874 . . . . 0.0 109.303 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.547 ' HB ' ' CB ' ' A' ' 38' ' ' ALA . 6.8 p -137.86 171.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 111.088 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 23.9 t -162.74 55.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.895 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.61 ' O ' ' N ' ' A' ' 14' ' ' ASN . 3.8 mm? 59.54 -158.55 0.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.888 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.74 86.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.61 ' N ' ' O ' ' A' ' 12' ' ' LEU . 1.7 p-10 -134.46 5.8 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -1.209 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.615 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 2.9 mt 57.47 31.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 110.747 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.555 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 50.4 m 53.55 117.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.123 -0.986 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -83.21 66.66 8.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.633 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -68.24 -44.94 38.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.789 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 18' ' ' SER . 47.0 Cg_endo -74.51 -2.9 13.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.712 1.375 . . . . 0.0 110.781 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . . . -102.77 -62.27 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.183 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.565 ' SG ' ' CG ' ' A' ' 9' ' ' PHE . 95.4 m -76.52 -48.29 19.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -65.79 -34.19 77.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.801 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' A' ' 26' ' ' ARG . . . -73.73 -57.16 5.07 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.6 ' CB ' ' CG2' ' A' ' 132' ' ' ILE . 8.7 tp -54.22 -40.43 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -1.174 . . . . 0.0 110.075 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 8.5 t -75.43 -67.08 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.531 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 ptm180 -41.82 -33.53 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' CG ' ' A' ' 26' ' ' ARG . 5.8 t70 -85.18 -36.32 21.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.452 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 4.9 ttt -84.29 -0.23 51.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.445 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.498 ' CG1' ' HG3' ' A' ' 32' ' ' LYS . 21.2 t -130.13 -43.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.321 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.16 65.54 0.16 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 72.7 m-20 47.81 77.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -1.196 . . . . 0.0 110.282 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' HG3' ' CG1' ' A' ' 29' ' ' VAL . 23.6 mmtm -128.54 -137.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.148 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.747 ' O ' HG13 ' A' ' 34' ' ' ILE . 96.4 mt -140.93 -95.12 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.788 ' CA ' ' HA ' ' A' ' 6' ' ' ALA . 0.7 OUTLIER 41.79 18.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.597 -0.69 . . . . 0.0 111.234 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.539 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -157.95 144.08 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.761 -1.212 . . . . 0.0 110.798 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.572 ' OD2' ' CD1' ' A' ' 80' ' ' PHE . 6.7 m-20 -146.54 105.0 3.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.4 p -68.63 125.74 27.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 110.52 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.547 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . . . -127.2 -169.4 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 110.192 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 10' ' ' VAL . . . -174.79 88.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.499 ' OG1' ' CD1' ' A' ' 72' ' ' ILE . 18.4 m -71.3 87.96 0.84 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.4 p -159.6 -50.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.1 48.49 25.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.54 -47.06 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -1.132 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.402 ' O ' HG13 ' A' ' 15' ' ' ILE . 49.5 m-70 -94.01 44.0 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 46' ' ' GLY . 88.2 t -111.79 156.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 64.59 28.09 72.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 48' ' ' SER . 4.3 pt20 -170.34 -147.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -1.124 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.444 ' OG ' HD11 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 61.06 108.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.59 99.62 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.513 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -90.5 27.76 1.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.153 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.4 m -74.95 -27.87 60.36 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.268 -0.895 . . . . 0.0 109.043 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HB3' ' CD2' ' A' ' 125' ' ' PHE . 11.0 mmt180 -73.48 -51.41 17.23 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.361 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.478 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 9.6 p -62.7 -50.85 69.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.781 . . . . 0.0 109.608 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.472 ' HA ' ' CD1' ' A' ' 64' ' ' ILE . 1.1 tt0 -61.43 -39.39 90.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.256 -0.903 . . . . 0.0 109.31 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -59.23 -70.12 0.17 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 109.59 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.557 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 35.8 m -48.82 -32.7 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.955 . . . . 0.0 109.19 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.466 ' C ' ' HB ' ' A' ' 62' ' ' VAL . 1.2 m -58.41 -52.48 65.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.845 . . . . 0.0 109.491 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -24.41 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.5 t -86.01 -10.78 54.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 8.8 m120 -114.93 -32.32 5.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.549 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 140.88 86.08 0.1 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 20.8 t -161.5 138.37 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -1.102 . . . . 0.0 110.058 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.493 ' CB ' ' HD3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -103.11 95.94 6.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.284 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.508 HG22 ' CG1' ' A' ' 62' ' ' VAL . 6.3 pt -137.52 -171.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 p -176.91 -40.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.273 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 140.88 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.56 133.58 0.62 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -89.43 -141.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.106 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.23 153.2 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -141.18 -148.37 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.501 ' N ' ' HG3' ' A' ' 70' ' ' ARG . 7.6 tt0 -136.09 162.25 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.952 . . . . 0.0 110.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.499 ' CD1' ' OG1' ' A' ' 40' ' ' THR . 14.9 mt -77.1 -72.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.156 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER 65.78 -145.59 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -100.39 -14.44 18.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.42 74.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.883 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -53.53 -46.71 70.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.188 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.606 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 26.2 m-85 -67.23 60.57 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.032 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER 169.71 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.933 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 2.8 tptt -73.48 -1.31 17.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.65 ' CD1' ' HB1' ' A' ' 6' ' ' ALA . 79.8 m-85 -154.97 -153.1 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.473 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -130.25 -13.69 3.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 0.0 110.79 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 83' ' ' ILE . 58.8 t -133.72 157.62 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.675 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 8' ' ' LEU . 1.7 mp -145.54 115.93 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.476 -0.765 . . . . 0.0 109.511 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 9' ' ' PHE . . . -106.14 132.01 52.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 111.134 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.522 ' CB ' HG23 ' A' ' 90' ' ' ILE . . . -108.35 124.87 51.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.497 -0.752 . . . . 0.0 109.687 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 5.4 mp -58.14 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 90' ' ' ILE . 67.8 m-20 -67.8 -175.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.438 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' SER . 16.2 mt-30 -84.28 -43.36 14.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -43.12 -56.48 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.075 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.534 ' CD1' HG11 ' A' ' 10' ' ' VAL . 4.8 tt -49.81 -41.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -71.15 -41.13 70.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 t -62.75 -37.89 88.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -0.92 . . . . 0.0 110.216 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.4 OUTLIER -85.57 -55.72 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.542 ' CG2' ' N ' ' A' ' 95' ' ' ASN . 12.9 tt -44.83 -42.79 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 110.184 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.542 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 20.1 t-20 -75.55 -11.78 60.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' ASP . 11.0 t -95.69 6.54 48.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.558 ' HE3' ' CZ ' ' A' ' 77' ' ' PHE . 2.4 ptt? -128.83 -32.31 2.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.243 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.606 ' CE ' ' CD1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -42.63 150.78 0.41 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.291 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.03 1.542 . . . . 0.0 110.411 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.07 29.05 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 80.22 1.43 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.9 p -155.4 -174.28 4.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 110.196 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.458 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -139.65 48.91 1.81 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.46 178.61 4.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.87 137.56 48.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.69 130.39 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 108' ' ' LEU . 1.2 p -129.79 171.35 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.92 . . . . 0.0 110.279 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.561 ' N ' ' CG2' ' A' ' 107' ' ' VAL . 22.4 tp -105.69 156.1 18.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 110.167 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.435 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 43.0 t80 -149.4 106.81 3.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.962 . . . . 0.0 110.219 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' PHE . 0.7 OUTLIER -171.16 106.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 115' ' ' VAL . 47.6 Cg_endo -74.49 175.82 10.52 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.119 1.589 . . . . 0.0 110.266 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.8 Cg_endo -71.53 54.24 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.926 1.487 . . . . 0.0 110.484 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.62 -40.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.147 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.3 133.0 6.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.527 ' CG2' ' HD2' ' A' ' 111' ' ' PRO . 5.5 t -121.34 -9.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -1.118 . . . . 0.0 110.177 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 1.5 p30 -55.93 133.12 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.92 109.98 31.7 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 116' ' ' ASP . 47.0 Cg_endo -73.68 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.978 1.515 . . . . 0.0 110.496 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.581 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 50.2 t80 -154.39 36.92 0.42 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -119.8 -11.47 9.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 123' ' ' ASP . 0.4 OUTLIER 174.95 166.55 0.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 74.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.241 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 121' ' ' SER . 1.0 OUTLIER -125.57 0.22 7.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 110.232 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -115.85 -44.09 0.65 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.654 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 8.6 m-85 -44.58 -47.96 27.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.186 -1.185 . . . . 0.0 110.358 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.7 Cg_endo -72.91 -51.72 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.72 1.379 . . . . 0.0 110.201 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 128' ' ' MET . 3.7 m -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.493 ' N ' ' O ' ' A' ' 124' ' ' GLY . 9.3 ttp -42.1 -65.9 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.106 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.503 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 44.9 t80 -56.12 -45.31 79.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -44.64 -62.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 0.5 OUTLIER -59.14 -47.61 84.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.6 ' CG2' ' CB ' ' A' ' 24' ' ' ILE . 4.3 mm -42.14 -65.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.868 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.53 ' O ' ' CE ' ' A' ' 136' ' ' MET . 1.7 p -71.35 -21.73 62.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -0.828 . . . . 0.0 110.43 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 2.7 tttp -63.5 -34.7 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.025 . . . . 0.0 110.109 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -132.22 66.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.328 -0.857 . . . . 0.0 110.442 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.53 ' CE ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -118.22 -5.29 10.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 110.08 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.0 mttt -87.48 -49.67 0.45 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 110.382 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -77.45 -8.08 17.11 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.888 1.467 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.698 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 10.7 t80 -88.08 -50.17 6.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 145' ' ' LEU . 28.2 tp -82.12 -30.09 31.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.531 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 54.9 m -71.01 -24.06 62.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.966 . . . . 0.0 110.328 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -104.06 -44.16 5.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.913 . . . . 0.0 110.208 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.698 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -45.68 -39.11 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.273 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 148.06 53.43 0.02 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.6 OUTLIER -160.6 -98.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.168 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.531 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 1.5 tp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.193 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.201 0.524 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.69 175.76 5.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.252 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.05 160.73 14.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.33 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.04 -159.47 0.06 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 108.725 178.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 22.7 mttp -158.13 -164.29 1.47 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 110.62 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.037 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.93 119.43 8.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 110.803 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.533 ' CG2' HD12 ' A' ' 34' ' ' ILE . 5.8 t -114.14 121.55 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.543 -0.723 . . . . 0.0 109.79 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 3.6 tp -97.52 86.75 3.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.247 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 18' ' ' SER . 7.5 p90 -72.92 143.58 47.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.977 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 38' ' ' ALA . 46.9 t -142.83 155.68 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 110.28 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.487 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 8.1 t -139.56 -60.68 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 110.128 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 -55.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.176 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -131.79 21.44 4.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER 64.8 21.46 12.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -1.13 . . . . 0.0 110.265 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 45' ' ' VAL . 10.2 mt -121.47 -27.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.179 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -106.1 123.8 48.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.127 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.584 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 40.4 mtt180 66.91 -53.97 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.603 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -42.1 -51.56 10.27 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.027 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.2 Cg_endo -72.35 -7.08 20.3 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.816 1.429 . . . . 0.0 110.563 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' ARG . . . -93.39 -21.17 19.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.584 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 16.8 t -70.05 -55.53 9.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.48 ' HG3' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -44.28 -37.04 3.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.437 -0.789 . . . . 0.0 109.43 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.94 -52.57 8.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.632 ' CD1' ' CE2' ' A' ' 129' ' ' PHE . 2.8 tp -55.06 -34.29 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -1.23 . . . . 0.0 109.941 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.4 m -73.14 -52.79 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 110.04 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -31.02 63.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' OD2' HG22 ' A' ' 62' ' ' VAL . 19.1 m-20 -87.95 -58.61 2.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.087 -1.008 . . . . 0.0 110.088 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.7 OUTLIER -50.74 -27.05 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 32' ' ' LYS . 6.7 t -105.82 -33.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 110.223 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.45 -68.39 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -174.65 38.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -1.157 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 32' ' ' LYS . 4.1 mptp? -75.07 -113.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.579 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 80.2 mt -152.92 -107.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.932 -1.105 . . . . 0.0 110.26 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.037 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 33.46 31.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 111.653 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.579 ' CD1' ' O ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -102.24 102.43 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 110.112 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.58 ' OD2' ' CD1' ' A' ' 80' ' ' PHE . 50.5 m-20 -135.84 140.67 44.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 110.02 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.578 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 10.2 t -124.17 143.4 50.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.482 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.533 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . -146.21 167.53 23.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -154.98 154.53 32.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -134.76 80.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 t -170.02 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.17 32.57 4.28 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -114.72 -36.38 4.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.128 . . . . 0.0 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.489 ' NE2' ' OG ' ' A' ' 48' ' ' SER . 2.0 t60 -122.61 84.3 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.231 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.483 HG11 ' CB ' ' A' ' 69' ' ' ALA . 46.1 t -146.15 135.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.86 76.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.37 51.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.382 -1.069 . . . . 0.0 110.192 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.489 ' OG ' ' NE2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -154.79 129.53 4.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.53 106.67 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.971 1.511 . . . . 0.0 110.4 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.3 p-10 -90.82 22.49 3.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.8 m -71.98 -28.16 63.23 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.22 -0.925 . . . . 0.0 108.794 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.605 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 5.0 mmt180 -74.5 -45.23 47.26 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -63.57 -53.64 48.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 19.8 mt-30 -61.95 -41.44 97.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.323 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.7 ttpp -55.2 -69.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 109.485 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.565 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 37.4 t -48.28 -36.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.591 ' CB ' ' CG1' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.547 -0.721 . . . . 0.0 109.513 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -24.55 61.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.383 -0.823 . . . . 0.0 109.481 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -81.27 -13.06 58.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.481 ' ND2' HG11 ' A' ' 56' ' ' VAL . 16.9 m-80 -111.91 -31.04 7.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.291 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 119.5 94.56 1.54 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.591 ' CG1' ' CB ' ' A' ' 57' ' ' CYS . 9.8 p -178.71 151.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -1.114 . . . . 0.0 110.065 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -127.3 140.78 51.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.247 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 54' ' ' GLN . 7.4 pt -124.73 163.58 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.139 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -112.27 -34.14 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 110.223 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' C ' ' CD ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -166.88 150.33 6.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.261 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.411 ' OE1' ' HB2' ' A' ' 50' ' ' ASP . 1.6 mt-30 -132.16 74.85 1.6 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 110.28 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.424 ' NH1' ' HG2' ' A' ' 68' ' ' ARG . 33.5 ttp85 -126.29 111.14 14.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.483 ' CB ' HG11 ' A' ' 45' ' ' VAL . . . -53.8 144.44 18.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.187 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.99 39.38 0.84 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' CA ' ' OE1' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 54.46 -164.15 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.267 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 73' ' ' THR . 15.4 tt -121.93 -39.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.508 ' N ' HG23 ' A' ' 72' ' ' ILE . 1.0 OUTLIER 63.72 157.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -67.37 -23.6 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.214 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -58.77 -26.69 64.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.269 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 24.6 p-10 -48.31 -34.75 11.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.46 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 44.7 m-85 -73.14 -39.09 65.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.242 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.52 -52.85 4.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -44.85 -26.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.214 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.58 ' CD1' ' OD2' ' A' ' 36' ' ' ASP . 9.3 m-85 -134.2 172.58 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.68 -20.26 9.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 58.4 t -125.56 139.15 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.9 . . . . 0.0 110.361 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 105' ' ' LYS . 1.4 mp -123.67 144.23 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 110.082 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . . . -123.05 118.8 28.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.88 116.97 32.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.091 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.584 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 4.2 mp -62.86 -85.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.426 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.45 ' HB2' HD13 ' A' ' 90' ' ' ILE . 79.2 m-20 -73.53 -177.63 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 89' ' ' SER . 14.1 mt-30 -79.05 -40.85 30.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 110.183 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 4.3 m -42.02 -40.37 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.298 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 10' ' ' VAL . 3.8 mt -69.36 -48.14 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -61.56 -41.63 97.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 t -73.47 -40.41 64.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 96' ' ' SER . 82.9 m-20 -65.52 -61.97 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 95' ' ' ASN . 3.7 tt -42.71 -43.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.525 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 3.0 t-20 -61.88 -33.03 73.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.973 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -67.47 -13.59 62.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 4.4 ptt? -122.34 -24.79 4.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 110.143 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 94' ' ' ILE . 0.3 OUTLIER -43.09 140.48 1.99 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -159.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.06 1.558 . . . . 0.0 110.397 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 m -129.37 3.99 5.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -152.38 88.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.4 p -144.32 -169.46 3.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.04 48.4 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.61 164.77 25.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.246 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.444 ' O ' HD13 ' A' ' 83' ' ' ILE . 33.8 tttt -123.58 160.51 26.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.163 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.84 106.94 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 83' ' ' ILE . 26.7 m -109.69 143.71 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.8 114.8 21.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -50.13 -69.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.953 . . . . 0.0 110.172 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.466 ' HB3' ' HD2' ' A' ' 111' ' ' PRO . 13.3 m-80 -147.19 166.91 14.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.48 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.6 Cg_endo -74.49 174.94 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.966 1.508 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.3 Cg_endo -72.86 52.81 2.23 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.921 1.485 . . . . 0.0 110.481 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -149.1 -36.86 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.07 -96.99 0.04 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.517 HG13 ' CB ' ' A' ' 131' ' ' SER . 4.7 m -62.67 136.65 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -1.139 . . . . 0.0 110.309 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.77 149.46 14.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -168.29 108.04 0.55 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 46.5 Cg_endo -73.15 -1.0 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' PRO . 1.2 m-85 61.31 24.83 14.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -126.88 -38.23 2.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.28 -176.01 3.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 122' ' ' SER . 1.8 t -87.6 22.67 2.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 0.0 110.166 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.32 62.34 5.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.73 -31.31 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.605 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 8.9 m-85 -56.4 -54.02 57.73 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.326 -1.103 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.6 Cg_endo -71.88 -43.39 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.867 1.456 . . . . 0.0 110.375 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 130' ' ' ALA . 2.7 m -62.81 -35.73 80.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.577 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 25.6 ttp -52.51 -69.97 0.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.9 . . . . 0.0 109.92 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.632 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 30.7 t80 -62.93 -30.9 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.702 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -56.98 -35.91 69.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.977 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.517 ' CB ' HG13 ' A' ' 115' ' ' VAL . 5.6 m -87.29 -42.76 12.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.572 HG22 ' CB ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -56.47 -27.25 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.805 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.466 ' HB3' HD12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -102.06 -40.58 6.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.407 -0.808 . . . . 0.0 110.201 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -76.35 -4.91 44.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 131' ' ' SER . 6.0 mm-40 -126.19 18.82 7.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.504 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 1.8 tpt -96.17 7.97 45.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.349 -0.845 . . . . 0.0 110.245 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.543 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -86.59 -49.09 0.5 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.298 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.95 7.4 4.35 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.874 1.46 . . . . 0.0 110.591 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.603 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 5.6 t80 -107.96 -51.19 2.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.355 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' HG ' HD11 ' A' ' 145' ' ' LEU . 4.2 tt -83.51 -15.04 50.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.339 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.518 ' CG2' ' OXT' ' A' ' 146' ' ' ILE . 24.7 m -82.8 -28.05 30.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -105.14 -25.48 12.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.286 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.603 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -52.74 -18.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.481 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 115.75 51.81 0.41 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 144' ' ' GLY . 11.9 mt -143.41 -52.78 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.518 ' OXT' ' CG2' ' A' ' 141' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.229 0.538 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.07 113.88 25.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -87.95 154.28 20.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.113 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.582 ' C ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -80.9 -55.42 4.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.545 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' CG ' ' C ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER 35.21 -155.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.729 . . . . 0.0 110.541 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.767 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . -166.12 156.53 12.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 0.0 109.958 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 84' ' ' ALA . 89.0 t -120.92 103.51 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.908 . . . . 0.0 109.903 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 36' ' ' ASP . 16.6 tp -59.48 94.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 110.026 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.491 ' CE2' ' SD ' ' A' ' 136' ' ' MET . 0.4 OUTLIER -78.31 103.89 8.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.93 . . . . 0.0 109.818 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 39' ' ' ALA . 61.3 t -124.67 161.75 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.445 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB2' HD12 ' A' ' 86' ' ' LEU . 39.3 t -165.14 64.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 6.9 mt 57.09 33.59 23.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 147.0 -32.34 1.42 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 65.3 7.62 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -1.138 . . . . 0.0 110.102 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.486 HG21 HD12 ' A' ' 15' ' ' ILE . 44.6 mt -96.51 -5.51 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 110.353 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 35.6 m -144.43 -173.25 3.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.456 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.582 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 1.9 mmt85 64.49 -78.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.556 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.515 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 9.1 m -129.83 55.66 19.87 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 110.699 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.6 Cg_endo -79.79 0.57 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.987 1.519 . . . . 0.0 110.004 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.523 ' CB ' HG13 ' A' ' 132' ' ' ILE . . . -96.0 6.8 48.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.425 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 9.1 p -58.78 -35.54 72.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 64' ' ' ILE . 1.4 tp10 -65.43 -48.54 72.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.67 -0.644 . . . . 0.0 109.866 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.583 ' CA ' ' CG1' ' A' ' 62' ' ' VAL . . . -69.83 -57.8 6.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.612 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 5.3 tp -47.44 -43.47 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -1.163 . . . . 0.0 109.922 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.541 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 7.3 t -65.33 -51.53 59.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.412 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 15.3 mmt-85 -52.62 -40.62 62.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.145 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -76.0 -30.51 58.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.48 -57.96 3.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.485 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 32' ' ' LYS . 61.9 t -87.09 -18.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.552 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 104.4 -66.91 0.29 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 53.8 t0 -176.25 57.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -1.13 . . . . 0.0 110.111 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -120.79 -100.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.815 ' O ' HG13 ' A' ' 34' ' ' ILE . 21.3 mt -143.95 -125.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.815 HG13 ' O ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER 70.81 -17.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.987 -0.446 . . . . 0.0 111.102 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.513 ' N ' HG13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -136.83 144.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.808 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.585 ' OD2' ' CZ ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -155.35 94.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.461 ' HB2' ' OE1' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -63.82 125.92 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 110.116 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' A' ' 10' ' ' VAL . . . -149.76 170.43 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.552 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.521 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -138.72 145.37 40.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.053 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 t -118.67 -9.65 10.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.31 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 t -112.36 109.48 19.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -55.97 101.58 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 2.5 m-85 -162.12 160.43 27.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -1.169 . . . . 0.0 110.264 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 63.19 25.21 14.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.6 t -85.25 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 37.68 6.37 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 48' ' ' SER . 4.3 pt20 179.59 -108.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -1.118 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.3 OUTLIER 65.6 93.62 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.074 -1.016 . . . . 0.0 110.184 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 45.1 Cg_endo -69.11 -62.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.672 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 2.8 m-20 71.46 -5.95 1.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.241 -0.912 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -74.32 -27.54 60.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.177 -0.952 . . . . 0.0 108.975 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -52.85 12.52 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.336 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HA ' ' HE3' ' A' ' 128' ' ' MET . 1.7 t -61.57 -53.69 52.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -57.98 -42.46 85.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.584 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -51.85 -65.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.653 ' CG2' ' CG ' ' A' ' 125' ' ' PHE . 53.0 t -49.46 -35.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 109.113 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.526 ' SG ' ' CG1' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -57.27 -46.71 82.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.57 -0.706 . . . . 0.0 109.642 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -79.63 -17.86 52.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.479 ' HB2' ' CE ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -88.95 -12.25 42.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -116.37 -24.17 8.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.586 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.5 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 117.21 62.34 0.31 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.583 ' CG1' ' CA ' ' A' ' 23' ' ' GLY . 46.0 t -155.63 170.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' N ' HG11 ' A' ' 62' ' ' VAL . 58.6 t0 -157.02 121.21 4.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 110.267 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.497 ' HB ' ' NE2' ' A' ' 54' ' ' GLN . 18.1 mt -108.82 170.62 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.147 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.39 -68.69 0.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -145.08 128.02 16.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 10.7 pt20 -142.26 98.43 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.217 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -140.05 -162.69 1.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.174 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.87 123.65 50.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.229 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.78 33.02 1.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 60.02 158.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 76' ' ' ASP . 21.0 tt -138.87 152.5 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -112.57 -163.92 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HA ' ' CE2' ' A' ' 77' ' ' PHE . 4.1 mttp -69.7 -5.21 23.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.16 81.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.0 110.124 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 77' ' ' PHE . 38.4 p-10 -47.84 -31.46 5.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.58 ' CE1' ' HD2' ' A' ' 98' ' ' LYS . 13.1 m-85 -72.45 -25.74 61.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.0 p -127.29 41.86 3.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.202 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.545 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 37.8 tptt -123.19 -13.52 7.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.585 ' CZ ' ' OD2' ' A' ' 36' ' ' ASP . 97.5 m-85 -151.74 -122.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 65.4 t0 -151.59 -40.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.045 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 83' ' ' ILE . 81.7 t -127.04 152.84 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.169 -0.957 . . . . 0.0 110.47 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.49 ' N ' HG11 ' A' ' 82' ' ' VAL . 1.7 mp -131.71 134.06 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 110.022 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.492 ' HB3' ' CE1' ' A' ' 109' ' ' PHE . . . -104.49 127.87 52.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.551 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' HB1' HD12 ' A' ' 91' ' ' LEU . . . -109.68 105.74 15.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.582 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 2.2 mp -50.36 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.505 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.534 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -81.5 -177.4 6.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.37 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -85.44 -40.8 16.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.37 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -41.67 -38.43 1.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' A' ' 87' ' ' ASP . 1.5 mp -69.62 -55.63 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.185 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -58.1 -28.74 64.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 t -78.39 -41.91 31.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 5.6 m-20 -80.92 -60.15 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.29 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 90' ' ' ILE . 4.7 tt -49.87 -25.3 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.301 -0.875 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 58.4 t-20 -90.37 -22.87 21.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.208 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -6.59 28.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.471 ' HE2' ' HA ' ' A' ' 94' ' ' ILE . 6.2 mtm -108.81 -51.67 2.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -40.47 132.6 1.67 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.412 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 100' ' ' SER . 46.4 Cg_endo -73.51 0.66 7.79 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.06 1.558 . . . . 0.0 110.502 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER 68.02 19.22 9.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.131 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.12 67.76 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 95.4 m -132.21 -159.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.41 25.83 10.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.27 -175.46 3.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.89 . . . . 0.0 110.192 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.37 158.2 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 19.3 t -127.13 124.58 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.139 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -122.17 144.0 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -77.11 133.81 38.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 110.173 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 1.9 m-85 -106.44 127.44 53.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.315 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 109' ' ' PHE . 0.9 OUTLIER 64.54 176.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -74.83 175.3 11.36 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 110.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.9 Cg_endo -72.26 53.86 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.051 1.553 . . . . 0.0 110.433 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.88 -38.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.03 145.12 11.19 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 17' ' ' ARG . 18.5 m -70.34 153.84 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -1.105 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.44 ' CB ' HG23 ' A' ' 127' ' ' THR . 42.9 t0 -42.09 134.58 2.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.369 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.8 p-10 -94.94 113.1 60.53 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.544 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 46.3 Cg_endo -73.7 58.31 3.91 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.936 1.492 . . . . 0.0 110.616 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 121' ' ' SER . 3.7 t80 -117.03 142.61 46.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.095 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 49.1 t80 61.0 -73.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.196 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 119' ' ' TYR . 2.2 m -89.89 118.33 29.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.84 89.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.77 9.64 1.55 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.258 -0.901 . . . . 0.0 110.183 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.544 ' CA ' ' HB3' ' A' ' 118' ' ' PRO . . . -118.88 -22.24 3.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.653 ' CG ' ' CG2' ' A' ' 56' ' ' VAL . 2.8 m-85 -34.1 -59.34 0.54 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.521 -0.988 . . . . 0.0 110.49 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.0 Cg_endo -72.12 -52.48 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.869 1.457 . . . . 0.0 110.318 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 128' ' ' MET . 8.8 m -58.18 -57.66 11.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.375 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.538 ' N ' ' O ' ' A' ' 124' ' ' GLY . 8.1 ttp -40.31 -48.85 2.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.612 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 48.7 t80 -70.17 -62.1 1.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 129' ' ' PHE . . . -43.05 -56.39 3.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.53 ' HB3' ' CG1' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -60.88 -45.07 96.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.926 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.538 HG21 ' CG1' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -46.76 -47.52 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.592 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 134' ' ' LYS . 0.4 OUTLIER -78.85 -59.26 2.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.297 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.498 ' N ' ' OG ' ' A' ' 133' ' ' SER . 3.2 mmtt -45.19 -29.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 131' ' ' SER . 27.0 mt-10 -74.97 -31.55 61.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.203 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.533 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 18.0 mtm -103.48 9.32 37.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 6.5 mtpt -82.28 -48.74 0.88 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 51.5 Cg_endo -81.11 -9.07 12.94 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.148 1.604 . . . . 0.0 110.402 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.68 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 47.4 t80 -107.97 -77.96 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.583 ' CD1' ' CD2' ' A' ' 145' ' ' LEU . 13.8 tp -44.03 -24.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 11.8 m -87.07 -29.13 22.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 110.353 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 139' ' ' PHE . 4.7 mm-40 -105.2 -13.9 15.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.405 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.68 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 4.6 t60 -84.94 40.27 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.64 38.08 90.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.583 ' CD2' ' CD1' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.8 -31.08 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.106 . . . . 0.0 110.305 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 140' ' ' LEU . 18.2 mm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.228 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.262 0.553 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.47 -54.19 46.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.174 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.2 158.22 29.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.078 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.68 -162.54 0.43 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.534 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 18.5 mttt -148.44 -164.5 2.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.729 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -130.74 148.92 52.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.183 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.593 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 5.5 m -147.06 136.87 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.945 -1.097 . . . . 0.0 110.226 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.9 OUTLIER -89.65 118.31 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 0.0 110.945 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.487 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m-85 -93.85 96.06 9.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.555 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 16.0 t -100.65 156.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.444 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.491 ' CB ' ' OG ' ' A' ' 18' ' ' SER . 47.8 t -150.0 -65.9 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.015 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 177.05 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.174 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 85.92 -4.75 85.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 8.7 t30 59.7 29.87 19.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -1.158 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 48' ' ' SER . 26.9 mt -113.0 -20.4 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 110.376 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 18' ' ' SER . 9.6 p -131.59 132.77 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.546 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 3.7 mtm180 65.46 -59.56 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.196 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.615 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -44.83 -50.7 24.6 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.428 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.6 Cg_endo -72.13 -19.97 25.57 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.848 1.446 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' HB3' ' CE ' ' A' ' 128' ' ' MET . . . -69.78 -23.56 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.98 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.54 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 21.4 m -67.39 -32.88 74.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.863 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HA ' ' CG1' ' A' ' 35' ' ' ILE . 1.6 tt0 -57.77 -54.89 41.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.912 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.09 -45.95 77.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.618 ' CD1' ' CD2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -54.66 -54.36 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -1.202 . . . . 0.0 110.191 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.597 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 79.4 m -60.29 -50.8 72.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.036 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.493 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 25.5 mtt-85 -45.82 -52.63 10.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -20.0 60.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.558 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.07 -45.82 32.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.831 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 32' ' ' LYS . 63.1 t -137.05 -12.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.034 . . . . 0.0 111.258 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 29' ' ' VAL . . . 59.31 122.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' GLY . 11.8 t0 40.42 77.36 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.187 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' CG ' ' CG1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -131.05 11.19 5.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.547 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.8 mt 65.01 -63.05 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.285 -0.884 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.5 pp -27.39 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.454 -0.779 . . . . 0.0 111.047 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' LEU . 7.8 tt -64.03 87.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 121.368 -0.832 . . . . 0.0 111.079 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.616 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 18.6 m-20 -126.83 66.82 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 109.692 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.28 150.07 18.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 110.397 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.471 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . . . -163.9 -171.62 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -150.17 120.9 7.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.485 HG21 ' N ' ' A' ' 41' ' ' SER . 10.8 t -67.06 -39.45 86.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.485 ' N ' HG21 ' A' ' 40' ' ' THR . 3.3 t -127.87 133.02 49.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . -67.76 -79.9 0.23 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 66.05 -73.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER -90.15 91.06 8.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.4 t -130.29 173.28 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 110.137 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 57.97 18.35 33.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.632 ' O ' ' CB ' ' A' ' 48' ' ' SER . 3.1 pt20 -177.68 152.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -1.124 . . . . 0.0 110.168 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.632 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 2.2 t 159.12 105.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.263 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 47.4 Cg_endo -69.78 70.78 1.57 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.104 1.581 . . . . 0.0 110.28 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.5 p30 -83.92 16.32 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.9 m -75.53 -32.58 60.52 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.185 -0.947 . . . . 0.0 109.007 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -74.1 -55.74 5.74 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.294 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.558 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -58.67 -53.43 58.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.454 -0.778 . . . . 0.0 109.501 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.502 ' HG3' ' CD1' ' A' ' 64' ' ' ILE . 12.1 tt0 -57.51 -45.56 84.82 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.25 -0.906 . . . . 0.0 109.508 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.569 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.2 ttpp -50.83 -65.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.422 -0.799 . . . . 0.0 109.793 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.569 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 11.3 p -56.55 -34.0 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.633 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.518 ' N ' HG12 ' A' ' 56' ' ' VAL . 1.3 m -56.66 -47.47 79.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.696 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -73.8 -30.46 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.361 -0.837 . . . . 0.0 109.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 m -77.96 -12.05 59.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.003 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -116.08 -27.01 7.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.855 . . . . 0.0 109.38 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 139.25 98.78 0.42 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 13.0 t -162.63 168.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -1.065 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.509 ' N ' ' CG1' ' A' ' 62' ' ' VAL . 12.5 t0 -153.37 67.17 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.502 ' CD1' ' HG3' ' A' ' 54' ' ' GLN . 11.8 pt -116.55 -173.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.187 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -153.68 88.74 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.19 153.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.359 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -171.93 126.99 0.59 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.358 -0.839 . . . . 0.0 110.194 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 mtm105 -99.87 -89.15 0.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . 176.94 79.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 ttp-105 -76.6 141.2 41.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.62 151.88 44.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.162 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 39' ' ' ALA . 19.4 tt -90.8 172.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t -124.4 172.2 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -78.33 2.85 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.112 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.02 -13.28 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' CG ' ' CG1' ' A' ' 72' ' ' ILE . 2.9 m-20 -52.92 -42.11 65.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -45.13 -55.77 5.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 26.82 3.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.622 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -104.64 -11.14 17.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 110.237 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.622 ' CE1' ' CG ' ' A' ' 79' ' ' LYS . 77.9 m-85 -143.07 -137.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -128.2 -53.42 1.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.471 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.56 HG12 ' CE1' ' A' ' 143' ' ' HIS . 48.9 t -133.26 123.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.195 -0.941 . . . . 0.0 110.451 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.514 HG23 ' CD1' ' A' ' 94' ' ' ILE . 5.7 mt -90.63 105.74 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.9 143.58 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.429 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -103.49 147.91 26.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.546 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 2.8 tp -98.64 31.77 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.519 ' CB ' HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER 174.31 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 110.178 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -59.93 -43.57 94.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.243 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 87' ' ' ASP . 1.9 mp -57.67 -63.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.153 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.4 OUTLIER -53.09 -37.14 61.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.151 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -70.83 -26.89 63.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.236 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -92.06 -61.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.255 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.514 ' CD1' HG23 ' A' ' 83' ' ' ILE . 5.6 tt -45.63 -39.89 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.501 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 4.6 t-20 -71.89 -15.18 62.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -76.37 -12.36 60.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.226 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.444 ' HE1' ' HA ' ' A' ' 94' ' ' ILE . 8.2 mtm -109.64 -52.04 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 5.6 mtpt -40.85 134.85 1.67 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 110.443 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.14 -169.59 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.069 1.562 . . . . 0.0 110.424 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.7 t -91.35 23.91 3.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 6.5 p-10 -176.79 123.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.4 p -143.59 -151.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -116.37 -18.63 10.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.104 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 -149.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -157.66 169.31 24.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.19 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 106' ' ' VAL . 29.0 m -128.07 146.43 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 108' ' ' LEU . 78.6 t -144.01 170.19 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.94 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.492 ' CD2' ' O ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -109.52 121.91 46.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.181 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 132' ' ' ILE . 11.6 t80 -48.49 -51.52 26.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.536 ' CB ' ' HD2' ' A' ' 111' ' ' PRO . 1.1 m-20 -176.52 -178.26 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 110' ' ' ASN . 46.7 Cg_endo -74.67 175.03 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.012 1.533 . . . . 0.0 110.302 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.2 52.94 2.41 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.959 1.505 . . . . 0.0 110.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -124.69 -27.3 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.75 -89.98 1.25 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 115' ' ' VAL . 19.5 m -75.9 103.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -1.156 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 15.6 p-10 -137.08 -156.63 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER 55.78 72.74 0.96 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 112.03 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.995 1.524 . . . . 0.0 110.508 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.499 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 12.4 m-85 50.48 -138.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 119' ' ' TYR . 27.5 p -168.79 -151.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 82.7 p -90.32 -138.56 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 122' ' ' SER . 2.3 t70 67.06 17.09 10.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' A' ' 126' ' ' PRO . . . -144.29 -42.08 0.05 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.611 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 11.8 m-85 -42.08 -50.47 10.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.11 . . . . 0.0 110.473 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 44.6 Cg_endo -72.0 -56.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.619 1.326 . . . . 0.0 110.247 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -55.75 -43.66 76.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 110.006 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.589 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 14.0 ttp -50.69 -75.71 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.618 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 4.6 t80 -46.67 -55.6 7.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.236 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -52.7 -22.56 5.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.4 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 128' ' ' MET . 3.2 m -90.12 -55.82 3.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.412 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.556 ' CG2' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -60.09 -15.33 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 0.0 109.028 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.504 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 2.0 t -101.93 -49.96 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 110.139 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -59.23 -30.85 68.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.108 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' OE2' ' ND2' ' A' ' 110' ' ' ASN . 6.1 mt-10 -102.75 22.37 13.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.562 ' HE3' ' CD2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -89.61 1.36 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.25 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 77.0 mttt -91.88 -42.13 0.37 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 111.353 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.2 Cg_endo -76.41 4.79 5.16 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.403 1.212 . . . . 0.0 110.733 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.562 ' CD2' ' HE3' ' A' ' 136' ' ' MET . 39.2 t80 -108.08 -71.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -58.98 -55.0 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.116 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.47 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 16.2 m -61.04 -12.87 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 144' ' ' GLY . 27.8 mt-10 -105.06 -55.33 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.56 ' CE1' HG12 ' A' ' 82' ' ' VAL . 3.1 t-80 -42.34 -26.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 130.84 46.62 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 140' ' ' LEU . 15.0 mt -144.66 -98.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -1.186 . . . . 0.0 110.27 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.47 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 2.9 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.206 0.527 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 54.73 68.05 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.148 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 3' ' ' GLU . 4.8 mm-40 -99.98 166.17 11.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.13 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.514 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -82.38 156.02 24.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 178.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' A' ' 144' ' ' GLY . 26.7 mttt -139.37 -165.79 1.93 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.989 -1.07 . . . . 0.0 110.867 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.19 156.79 29.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 110.516 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.733 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 40.0 t -141.95 113.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.668 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 80' ' ' PHE . 26.2 tp -82.64 81.45 8.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 111.02 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.519 ' HA ' ' CB ' ' A' ' 84' ' ' ALA . 16.6 m-85 -55.84 126.39 25.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.086 -1.009 . . . . 0.0 109.367 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 38' ' ' ALA . 73.8 t -142.03 161.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 110.767 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 86' ' ' LEU . 1.1 t -153.36 -58.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.413 -0.805 . . . . 0.0 110.191 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.584 ' CB ' ' NH1' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 169.84 150.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.463 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 64.48 10.14 41.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER 72.8 -53.19 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.297 -1.119 . . . . 0.0 109.823 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' CYS . 8.9 mt -41.2 -33.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 3.3 t 68.25 105.44 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.584 ' NH1' ' CB ' ' A' ' 12' ' ' LEU . 18.3 mtt85 -52.67 -18.52 1.83 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.046 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.481 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 60.3 p -112.8 67.71 1.0 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD2' ' SD ' ' A' ' 128' ' ' MET . 45.6 Cg_endo -72.59 -12.33 26.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.902 1.475 . . . . 0.0 110.082 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' CB ' ' HE3' ' A' ' 128' ' ' MET . . . -76.97 4.89 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 24' ' ' ILE . 23.2 p -69.77 -37.62 76.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.785 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -68.98 -43.06 75.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.917 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' HG13 ' A' ' 62' ' ' VAL . . . -70.55 -51.78 19.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.656 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -55.62 -46.93 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -1.153 . . . . 0.0 110.274 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.585 ' CB ' ' CG1' ' A' ' 35' ' ' ILE . 78.4 m -71.87 -48.59 44.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.115 -0.99 . . . . 0.0 110.053 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.529 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 10.1 mmt180 -49.35 -45.35 45.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.28 -24.09 32.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.259 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.5 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -73.88 -22.71 59.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.605 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.481 ' O ' ' C ' ' A' ' 30' ' ' GLY . 4.7 m -142.14 -33.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.978 -1.076 . . . . 0.0 110.713 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 38.47 44.91 1.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 54.4 t0 -178.55 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.961 -1.317 . . . . 0.0 110.853 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' O ' HD23 ' A' ' 33' ' ' LEU . 12.3 mmtm -141.73 -143.34 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.4 mt -147.77 -34.53 0.24 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.416 -0.802 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.811 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.1 pp -30.05 -31.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.824 -0.548 . . . . 0.0 111.829 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.642 ' N ' ' O ' ' A' ' 33' ' ' LEU . 1.5 mp -62.47 87.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.998 -1.064 . . . . 0.0 110.939 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -130.39 162.47 29.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.96 . . . . 0.0 109.064 178.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -141.9 139.98 32.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.96 -1.088 . . . . 0.0 110.668 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.546 ' HB1' ' CG ' ' A' ' 8' ' ' LEU . . . -167.78 -176.24 3.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.354 -0.842 . . . . 0.0 110.33 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.499 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . 174.84 164.07 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 40' ' ' THR . 13.7 t -94.12 71.67 3.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.42 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.39 76.68 0.57 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.67 -57.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -1.141 . . . . 0.0 110.296 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -87.59 93.26 9.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 69' ' ' ALA . 34.9 t -125.95 -3.76 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.243 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.27 41.74 2.08 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.453 ' O ' ' HB3' ' A' ' 48' ' ' SER . 5.2 pt20 -161.78 -109.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 4.4 t 64.84 70.78 0.59 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.053 -1.03 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.38 66.05 1.56 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.459 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 4.2 p-10 -89.19 31.48 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.489 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -76.0 -34.19 59.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.898 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 6.9 mmt85 -70.76 -47.79 57.77 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -56.69 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.533 -0.729 . . . . 0.0 109.349 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.547 ' NE2' ' N ' ' A' ' 55' ' ' LYS . 5.2 pp0? -56.97 -35.29 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.125 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.611 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.4 -65.92 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 109.13 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.611 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 41.4 t -49.69 -36.22 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.28 -0.887 . . . . 0.0 108.83 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -53.86 -52.76 59.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 11.3 ttpt -71.13 -21.23 62.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.472 ' OG ' ' CE ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -86.6 -8.73 57.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.947 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.25 -17.74 12.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.865 . . . . 0.0 108.84 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 122.14 44.21 0.37 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 54.3 t -158.37 144.87 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -1.087 . . . . 0.0 110.22 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.62 135.63 40.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.42 ' CD1' ' HB3' ' A' ' 54' ' ' GLN . 29.2 pt -92.76 -171.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 110.117 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -129.95 -51.46 1.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 110.194 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.52 149.03 3.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -111.91 99.48 8.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 111.9 24.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.468 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . -93.91 102.5 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.199 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -122.79 158.14 30.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.92 143.81 57.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 10.7 tt -84.61 87.94 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.5 m -58.9 169.59 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -65.73 -9.09 24.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.02 59.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 110.26 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.408 ' CG ' HG13 ' A' ' 72' ' ' ILE . 31.5 m-20 -49.69 -30.04 8.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.563 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -57.49 -41.27 80.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 110.17 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.98 -33.97 10.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER -44.35 -31.23 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.331 -0.856 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 11.9 m-85 -130.94 152.34 50.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.465 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' CB ' ' HB3' ' A' ' 5' ' ' LYS . 3.9 m-20 -68.52 -47.07 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.442 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 53.9 t -130.85 156.68 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.527 ' CD1' HG12 ' A' ' 106' ' ' VAL . 1.6 mp -118.33 139.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.283 -0.886 . . . . 0.0 109.877 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 9' ' ' PHE . . . -100.28 116.88 33.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.904 . . . . 0.0 110.385 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.401 ' O ' HD11 ' A' ' 108' ' ' LEU . . . -109.82 99.56 8.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 109.919 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.528 ' CD2' ' SG ' ' A' ' 11' ' ' CYS . 1.1 mp -60.78 -61.77 2.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.541 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.549 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.54 171.79 11.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' SER . 21.0 mt-30 -83.59 -40.69 18.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -42.64 -37.86 1.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' CB ' ' A' ' 87' ' ' ASP . 1.4 mp -71.97 -54.52 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -19.58 62.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 0.0 110.349 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -86.61 -58.38 2.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.285 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.245 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 95' ' ' ASN . 2.5 tt -43.48 -43.28 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.541 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 1.1 t-20 -60.89 -31.78 71.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' ASP . 19.5 t -64.36 -12.34 41.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.507 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.9 ptt? -123.17 -18.35 6.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -55.09 154.3 10.61 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.494 ' HD3' ' CD2' ' A' ' 77' ' ' PHE . 47.9 Cg_endo -73.36 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -125.42 101.13 6.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.53 ' N ' ' ND2' ' A' ' 101' ' ' ASN . 1.6 m120 64.06 110.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.257 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.0 m -150.23 -164.41 2.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.87 . . . . 0.0 110.209 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.83 32.55 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 77' ' ' PHE . . . -160.68 -177.09 5.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.231 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 16.4 pttm -176.53 158.23 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.527 HG12 ' CD1' ' A' ' 83' ' ' ILE . 3.6 m -111.59 151.33 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 m -138.87 147.43 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.197 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 85' ' ' ALA . 21.6 tp -81.6 126.05 31.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.223 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -93.46 89.76 6.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 0.0 110.211 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 56.52 162.77 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.473 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 45.8 Cg_endo -74.0 174.93 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.096 1.577 . . . . 0.0 110.275 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.7 Cg_endo -73.25 51.48 2.11 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.954 1.502 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 114' ' ' GLY . 19.2 m-20 -122.32 -63.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 113' ' ' ASN . . . -44.25 -73.03 0.28 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 115' ' ' VAL . 18.1 m -70.41 123.7 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.33 158.55 27.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.933 . . . . 0.0 110.256 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.566 ' HB2' ' CE2' ' A' ' 119' ' ' TYR . 8.2 p-10 -73.22 123.78 89.88 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -73.06 -89.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.008 1.53 . . . . 0.0 110.621 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 117' ' ' ASP . 12.3 m-30 58.21 -142.68 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.537 ' O ' ' CB ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -69.44 149.6 48.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.413 -0.805 . . . . 0.0 109.994 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER 71.56 3.89 4.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.38 -0.825 . . . . 0.0 110.166 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 121' ' ' SER . 73.7 m 42.19 -94.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.177 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' SER . 0.5 OUTLIER 44.98 49.06 9.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -175.39 -41.05 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 23.5 m-85 -41.58 -49.61 9.67 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.13 . . . . 0.0 110.527 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.33 -59.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.585 1.308 . . . . 0.0 110.194 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 64.9 m -53.16 -48.17 68.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.646 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 124' ' ' GLY . 7.9 ttp -50.02 -58.92 4.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.376 -0.827 . . . . 0.0 109.968 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.656 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 88.3 t80 -50.56 -50.54 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.0 -56.19 11.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 m -57.9 -46.5 84.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.571 ' CG2' HG12 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -45.38 -56.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -60.65 -45.88 92.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.54 ' O ' ' CD ' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -65.21 -13.04 57.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 14.8 mt-10 -90.0 -37.32 14.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.498 ' O ' ' CB ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -90.99 -3.69 57.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.931 . . . . 0.0 110.355 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 3.1 mttt -83.48 -50.2 0.68 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -0.961 . . . . 0.0 110.026 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 51.0 Cg_endo -80.08 -13.14 12.84 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.097 1.577 . . . . 0.0 110.414 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.534 ' C ' ' CD1' ' A' ' 139' ' ' PHE . 5.3 t80 -103.72 -48.74 3.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.507 ' CD2' HD12 ' A' ' 146' ' ' ILE . 0.5 OUTLIER -73.31 1.1 10.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.287 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 137' ' ' LYS . 21.0 m -104.22 -57.05 2.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 111.004 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' GLY . 7.3 mt-10 -105.2 -45.13 4.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.11 -0.994 . . . . 0.0 111.224 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -37.24 -29.65 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.211 -0.931 . . . . 0.0 110.434 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 145' ' ' LEU . . . 132.03 76.58 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -159.16 -38.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -1.218 . . . . 0.0 110.182 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 140' ' ' LEU . 22.3 mt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.249 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.243 0.544 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 1' ' ' ALA . . . 58.24 86.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -101.91 153.08 20.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 110.313 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -72.21 -161.35 0.08 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 108.701 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.584 ' O ' HG21 ' A' ' 34' ' ' ILE . 23.6 mtmt -157.32 -159.68 0.87 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.921 -1.112 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.032 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -142.41 123.23 14.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 111.251 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.597 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 5.6 t -115.72 131.69 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.548 -0.72 . . . . 0.0 109.463 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 4.1 tp -90.66 92.1 8.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.916 . . . . 0.0 110.806 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CZ ' ' CG1' ' A' ' 7' ' ' VAL . 18.3 m-85 -82.99 106.85 15.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.525 ' HB ' ' CB ' ' A' ' 38' ' ' ALA . 14.0 p -125.47 173.87 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.528 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' CA ' ' CD1' ' A' ' 90' ' ' ILE . 26.5 p -163.41 -38.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER 168.76 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.123 -0.986 . . . . 0.0 110.295 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -91.03 -9.98 63.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 3.3 t-20 68.63 33.21 3.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -1.172 . . . . 0.0 110.224 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.466 HD13 ' HB2' ' A' ' 44' ' ' HIS . 84.6 mt -108.74 -91.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.8 t -95.74 64.53 2.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.882 . . . . 0.0 110.113 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.526 ' HG2' ' CD2' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 171.6 52.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.064 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.544 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER 172.39 -55.37 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.3 Cg_endo -71.79 -13.65 29.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.9 1.474 . . . . 0.0 110.383 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HB3' ' CE ' ' A' ' 128' ' ' MET . . . -65.64 -12.6 54.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.58 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 17.4 m -72.39 -29.32 63.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.48 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.517 ' HA ' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -70.34 -43.09 70.97 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.518 ' HA2' ' CD ' ' A' ' 26' ' ' ARG . . . -71.07 -45.57 49.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.59 HD12 ' CE1' ' A' ' 129' ' ' PHE . 6.1 tp -64.96 -43.19 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -1.167 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.521 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 55.9 m -65.12 -49.86 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.319 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.518 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.9 ptm180 -68.15 -26.19 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.309 -0.87 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 1.3 m-20 -85.81 -25.56 26.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.042 -1.036 . . . . 0.0 110.277 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 3.0 tmm? -92.4 -21.91 19.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.489 ' CG2' ' HG3' ' A' ' 32' ' ' LYS . 57.6 t -127.72 -12.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.197 -0.939 . . . . 0.0 110.617 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.43 -22.13 36.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -149.48 -87.05 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.39 -1.065 . . . . 0.0 110.235 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HG3' ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER 58.16 122.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.277 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 35' ' ' ILE . 6.0 mp -98.12 -114.81 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.032 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.8 OUTLIER 32.49 33.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 0.0 111.338 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 33' ' ' LEU . 1.7 mt -104.49 95.12 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.963 -1.085 . . . . 0.0 110.602 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' OD2' ' CE2' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -126.37 99.96 6.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.7 p -79.12 130.58 35.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.213 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . . . -122.33 -173.06 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.32 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . . . 171.16 109.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -69.41 -12.1 61.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -124.0 93.93 4.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.15 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.58 87.06 0.67 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -141.1 22.24 2.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -1.111 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.512 ' HA ' ' NE2' ' A' ' 47' ' ' GLN . 85.5 m-70 -141.16 40.4 1.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.94 . . . . 0.0 110.147 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 69' ' ' ALA . 11.1 t -90.63 169.29 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.214 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.31 37.84 18.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.512 ' NE2' ' HA ' ' A' ' 44' ' ' HIS . 12.2 pt20 -169.52 -148.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 60.88 131.98 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.189 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.42 70.6 1.39 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.63 13.18 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.26 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.04 -33.53 59.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.605 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.68 -44.73 55.82 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.388 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.558 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 3.4 t -63.57 -48.94 75.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.519 -0.738 . . . . 0.0 109.618 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 0.8 OUTLIER -62.74 -42.91 99.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.574 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.26 -69.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.571 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.574 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 27.6 m -49.9 -32.97 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.141 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.528 ' CB ' ' HB ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -55.51 -54.16 47.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.8 . . . . 0.0 109.487 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -29.95 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.6 t -77.78 -12.16 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.0 m-20 -113.68 -33.44 5.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 142.19 62.99 0.03 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 54.7 t -158.77 59.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -1.106 . . . . 0.0 110.107 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.426 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -73.16 130.99 41.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 63' ' ' ASP . 14.9 pt -145.38 -172.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.151 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -103.12 -61.96 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.062 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 65' ' ' SER . 12.3 mmmt -150.12 -178.4 6.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.079 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 67' ' ' GLN . 12.2 mm-40 -135.57 95.66 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.196 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -108.41 75.97 1.01 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' A' ' 45' ' ' VAL . . . -44.17 106.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 110.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -101.94 159.23 15.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.122 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 60.8 tt0 -71.93 156.46 39.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.499 ' CG1' ' OD2' ' A' ' 76' ' ' ASP . 12.5 tt -79.92 159.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.484 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.8 p -119.68 176.13 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -19.7 61.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.65 84.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.594 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 39.2 m-20 -47.53 -36.49 10.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.136 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.587 ' CD2' ' HG2' ' A' ' 98' ' ' LYS . 20.8 m-85 -94.55 16.34 15.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.137 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.18 11.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -137.11 -149.51 0.32 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.112 -0.992 . . . . 0.0 109.682 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER 36.67 -149.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.443 -0.786 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -140.06 -34.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 15.8 t -139.75 149.59 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 110.714 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.7 mt -121.76 126.61 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.828 . . . . 0.0 109.859 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 109' ' ' PHE . . . -120.26 135.09 55.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -108.43 160.38 15.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.531 ' CD2' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -105.06 2.7 29.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.965 . . . . 0.0 110.244 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.445 ' O ' HG21 ' A' ' 90' ' ' ILE . 22.9 t70 -137.85 174.14 10.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -89.66 -66.71 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.086 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -47.16 -40.69 16.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.529 ' CD1' ' CA ' ' A' ' 11' ' ' CYS . 6.3 tt -52.35 -39.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.043 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.505 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -81.58 -34.79 30.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.077 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -20.07 63.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -103.14 -44.64 5.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.514 HG13 ' CE ' ' A' ' 97' ' ' MET . 2.7 tt -48.15 -36.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.491 ' N ' HG23 ' A' ' 94' ' ' ILE . 38.4 p30 -69.98 -11.47 60.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 9.5 t -75.41 -26.86 58.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.514 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.3 ptt? -96.34 -34.99 11.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.587 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -45.22 145.58 1.78 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.26 -174.35 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.989 1.52 . . . . 0.0 110.34 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.63 -4.1 11.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.963 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.88 48.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.5 p -124.84 -161.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.52 -142.16 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.262 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 56.86 -159.27 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.188 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 106' ' ' VAL . 7.9 tttt -173.41 148.11 1.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 0.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.403 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 4.0 m -101.01 133.64 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.05 161.4 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.421 ' CD2' ' OD1' ' A' ' 110' ' ' ASN . 8.5 tp -83.51 149.21 26.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -136.3 85.71 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.236 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 109' ' ' PHE . 2.0 p-10 -177.39 146.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.478 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.58 174.78 12.04 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.004 1.528 . . . . 0.0 110.373 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.1 Cg_endo -72.84 52.77 2.22 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.437 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.98 -50.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.96 91.86 1.41 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.531 HG11 ' CD2' ' A' ' 86' ' ' LEU . 99.0 t -56.24 114.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.9 t70 57.63 168.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.948 . . . . 0.0 110.178 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.523 ' N ' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 171.61 -56.83 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.331 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 117' ' ' ASP . 46.1 Cg_endo -72.72 -37.69 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.995 1.524 . . . . 0.0 110.542 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 57.89 179.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.6 t80 60.32 25.75 15.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.234 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 t -163.89 -164.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.22 18.31 22.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.962 . . . . 0.0 110.21 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -90.53 34.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.189 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -147.23 -45.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.617 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 4.4 m-30 -50.42 -46.32 84.37 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.29 -1.124 . . . . 0.0 110.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 48.5 Cg_endo -74.65 -51.4 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.716 1.377 . . . . 0.0 110.171 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' MET . 3.3 m -58.99 -55.56 33.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.527 ' HA ' ' CG1' ' A' ' 115' ' ' VAL . 10.2 ttp -44.9 -40.58 6.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.367 -0.833 . . . . 0.0 110.084 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.59 ' CE1' HD12 ' A' ' 24' ' ' ILE . 37.1 t80 -70.35 -62.01 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.995 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.72 -47.27 15.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.92 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 71.6 m -70.88 -42.19 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.981 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.539 ' CG2' HG12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -50.72 -43.11 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.941 . . . . 0.0 109.851 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.514 ' HA ' ' HE1' ' A' ' 136' ' ' MET . 1.1 t -85.29 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.516 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.95 -18.31 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.49 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 39.1 tp10 -98.28 -18.29 18.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.514 ' HE1' ' HA ' ' A' ' 133' ' ' SER . 3.9 ttp -101.45 -0.53 35.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 110.2 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -82.51 -48.29 0.87 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.933 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.3 -11.5 14.56 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.055 1.555 . . . . 0.0 110.326 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.579 ' CZ ' ' O ' ' A' ' 143' ' ' HIS . 68.4 t80 -101.92 -61.98 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 146' ' ' ILE . 6.5 tp -52.73 -25.43 11.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.552 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 23.3 m -76.99 -40.91 45.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 110.373 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.3 -66.42 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.659 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.579 ' O ' ' CZ ' ' A' ' 139' ' ' PHE . 12.7 t-80 -96.89 60.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -0.933 . . . . 0.0 110.733 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 145' ' ' LEU . . . -176.16 -34.05 0.04 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER 172.06 -91.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.499 -1.001 . . . . 0.0 109.912 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.552 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.139 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.245 0.545 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.45 97.98 5.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.14 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.438 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -149.98 -154.06 0.53 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.248 -0.907 . . . . 0.0 110.339 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.548 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -155.81 -48.1 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 110.684 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.548 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 5.2 mttt 68.83 -154.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 110.913 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.829 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -159.56 135.42 8.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.316 0.579 . . . . 0.0 109.977 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.607 HG22 ' CD2' ' A' ' 9' ' ' PHE . 3.5 m -104.07 115.43 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.503 -0.748 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 36' ' ' ASP . 14.9 tp -66.37 89.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 110.089 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.607 ' CD2' HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -78.64 101.45 7.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.542 ' CG1' ' HA ' ' A' ' 39' ' ' ALA . 15.2 t -116.9 157.05 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.759 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 11.9 t -145.85 -78.87 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -175.38 69.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.341 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 137.74 -21.85 3.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.52 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 4.8 t-20 71.15 1.45 3.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -1.132 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.59 -36.79 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.932 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 29.5 p -137.63 167.18 22.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.927 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.536 ' CG ' HD22 ' A' ' 86' ' ' LEU . 51.2 mtm180 56.22 43.04 27.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -0.968 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -173.31 -60.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 45.0 Cg_endo -71.78 -10.86 27.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.888 1.468 . . . . 0.0 110.33 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 132' ' ' ILE . . . -75.72 -16.79 60.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.047 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.586 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 37.0 t -66.45 -55.42 15.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -43.37 -36.69 1.99 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 109.346 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -71.88 -50.26 19.5 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 129' ' ' PHE . 2.4 tp -55.86 -45.17 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.747 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.569 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 54.3 m -72.16 -30.47 65.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -66.91 -37.1 83.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.895 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 62' ' ' VAL . 22.1 t70 -82.81 -34.99 26.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 110.107 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.523 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -78.72 -28.16 45.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 110.406 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.531 ' CG2' ' HD3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -163.7 41.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.79 94.51 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' VAL . 3.8 t0 170.5 -25.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 110.128 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.531 ' HD3' ' CG2' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -98.76 -138.94 0.31 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 110.022 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -152.88 -83.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.829 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 37.01 26.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.42 -0.8 . . . . 0.0 110.92 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' CD1' ' O ' ' A' ' 33' ' ' LEU . 7.4 mt -131.55 132.64 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.158 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.577 ' OD1' ' CE2' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -145.03 90.05 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 179.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -67.19 124.68 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -141.45 176.03 9.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.542 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -159.61 -162.53 1.04 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.152 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.414 ' O ' ' OG ' ' A' ' 41' ' ' SER . 1.8 t -177.59 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 40' ' ' THR . 58.4 m -165.26 110.51 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 108.34 2.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.35 -41.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 44' ' ' HIS . 6.1 p80 -155.79 81.5 1.02 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.403 HG13 ' CB ' ' A' ' 69' ' ' ALA . 8.3 t -118.79 -20.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 110.303 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.15 31.7 8.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.512 ' HG3' ' N ' ' A' ' 48' ' ' SER . 17.7 pt20 -164.5 -140.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -1.116 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.512 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.61 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.174 -0.954 . . . . 0.0 110.15 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.34 107.48 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.012 1.533 . . . . 0.0 110.538 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -94.26 21.31 7.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 3.7 m -71.08 -27.9 63.96 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.189 -0.944 . . . . 0.0 108.748 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.576 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -74.38 -43.45 56.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.214 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -63.66 -54.92 28.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.483 -0.76 . . . . 0.0 109.6 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 20.0 mt-30 -61.58 -40.31 94.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.261 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.608 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.09 -71.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.832 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.608 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 14.9 p -50.03 -34.28 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.494 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.548 ' CA ' HG12 ' A' ' 62' ' ' VAL . 1.3 m -55.45 -53.71 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.507 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -69.43 -24.35 63.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.862 . . . . 0.0 109.566 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.58 -11.72 58.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.813 . . . . 0.0 109.993 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -111.45 -31.72 6.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 0.0 109.182 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.517 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 130.03 73.63 0.13 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.549 HG11 ' CE2' ' A' ' 129' ' ' PHE . 2.2 p 173.34 137.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.289 -1.124 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -119.41 137.2 53.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.203 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.449 ' CD1' ' SG ' ' A' ' 57' ' ' CYS . 34.1 mt -120.58 -34.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.202 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.4 OUTLIER 53.66 97.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 65' ' ' SER . 3.6 mmmt 60.05 145.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.271 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.43 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 5.4 mm-40 -107.53 -52.58 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 67.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.94 . . . . 0.0 110.159 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -57.28 152.53 13.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 mtp-105 -137.1 -163.75 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 110.271 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -132.43 128.01 36.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.9 tt -50.32 159.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.178 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 50.9 p -126.97 169.93 12.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -1.92 20.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.206 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.14 -8.64 21.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 20.5 p-10 -47.21 -37.25 10.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 39.5 m-85 -69.41 -17.04 63.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 m -123.06 13.44 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.203 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 3.5 tptt -94.82 -23.7 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.663 ' CD1' ' CB ' ' A' ' 6' ' ' ALA . 93.8 m-85 -147.35 -140.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.869 . . . . 0.0 109.983 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 4.0 m-20 -137.06 -23.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.054 -1.028 . . . . 0.0 111.029 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 7' ' ' VAL . 39.1 t -113.42 138.76 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 0.0 110.509 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.492 HD11 ' CB ' ' A' ' 104' ' ' ALA . 47.4 mt -146.3 133.89 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.433 -0.792 . . . . 0.0 109.777 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -162.03 163.09 28.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.661 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' CB ' ' HB ' ' A' ' 90' ' ' ILE . . . -126.5 159.87 32.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.536 HD22 ' CG ' ' A' ' 17' ' ' ARG . 1.3 tp -85.64 -37.36 19.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.479 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -101.74 -176.26 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.194 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.8 mm-40 -92.45 -39.0 11.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 88' ' ' GLN . 15.6 m -42.75 -41.0 3.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.511 ' CG1' ' O ' ' A' ' 11' ' ' CYS . 2.1 mp -65.46 -40.08 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.91 . . . . 0.0 110.099 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 tp -67.64 -32.4 73.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.6 t -79.99 -30.62 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.246 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 96' ' ' SER . 1.8 m-20 -87.83 -54.58 4.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.256 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' A' ' 95' ' ' ASN . 3.9 tt -46.69 -40.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.516 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.63 -8.81 56.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 2.7 m -96.78 -0.93 47.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.151 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.515 ' CE ' HG13 ' A' ' 94' ' ' ILE . 1.7 ptt? -122.56 -10.0 8.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 8.4 mtpt -63.59 143.75 97.88 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 45.9 Cg_endo -73.14 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.028 1.541 . . . . 0.0 110.419 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.4 m -105.61 28.38 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.421 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.1 p-10 -178.51 126.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 110.24 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 101' ' ' ASN . 83.5 m -149.56 -161.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.01 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.492 ' CB ' HD11 ' A' ' 83' ' ' ILE . . . -105.82 -152.07 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -148.75 111.15 4.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.167 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 71.1 t -87.39 125.46 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 110.088 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 84' ' ' ALA . 3.6 t -135.11 159.07 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -119.19 108.17 14.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -55.27 -170.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.26 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 109' ' ' PHE . 37.5 p-10 -42.57 166.04 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.495 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.9 Cg_endo -74.64 175.02 11.66 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.912 1.48 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.5 Cg_endo -71.74 54.45 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.996 1.524 . . . . 0.0 110.38 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.67 -29.95 4.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.876 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -107.45 -92.45 2.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.537 ' CG1' ' CB ' ' A' ' 131' ' ' SER . 29.0 m -41.12 128.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 110.168 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -157.78 -65.7 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.452 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 0.5 OUTLIER 61.53 82.76 0.22 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.12 176.64 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.006 1.53 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 119' ' ' TYR . 67.7 m-85 -118.95 24.15 10.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -130.17 -34.68 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 110.335 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -145.62 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 110.246 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 p -153.97 54.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.137 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' A' ' 127' ' ' THR . 4.0 p30 -124.41 -6.14 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.265 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 117' ' ' ASP . . . -93.85 -22.37 25.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 13.5 m-85 -55.03 -49.81 90.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.331 -1.099 . . . . 0.0 110.365 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -73.34 -35.67 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.84 1.442 . . . . 0.0 110.385 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.48 ' HA ' ' HB1' ' A' ' 130' ' ' ALA . 2.5 m -63.06 -51.96 64.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.55 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 3.1 ttp -44.52 -55.42 5.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 11.1 t80 -68.23 -33.59 74.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 127' ' ' THR . . . -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.182 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.537 ' CB ' ' CG1' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -86.89 -43.45 12.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.057 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.565 ' CG2' HG12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -57.85 -23.21 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -0.761 . . . . 0.0 109.472 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.529 ' OG ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.32 -42.81 6.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.987 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 14.3 mttp -75.41 -5.69 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 131' ' ' SER . 70.3 mm-40 -129.2 34.34 4.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.15 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.539 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -116.21 -12.18 11.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 1.1 mttp -81.53 -47.4 1.06 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.44 0.33 10.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.99 1.521 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 62.8 t80 -108.06 -77.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.546 ' CD1' ' CD1' ' A' ' 145' ' ' LEU . 8.5 tp -51.16 -24.46 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.345 -0.847 . . . . 0.0 110.438 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 146' ' ' ILE . 32.2 m -82.01 -30.61 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -105.22 -14.06 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.453 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.687 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 6.9 m80 -84.71 39.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.101 -0.999 . . . . 0.0 110.302 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.7 60.86 6.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.546 ' CD1' ' CD1' ' A' ' 140' ' ' LEU . 1.1 mt -163.67 34.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 110.021 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.513 ' CG2' ' O ' ' A' ' 141' ' ' THR . 2.0 tp . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.229 0.538 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.79 138.35 32.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.69 149.46 28.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.271 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -83.15 149.96 26.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.254 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.548 ' O ' HG23 ' A' ' 34' ' ' ILE . 23.1 mtpp -130.23 -155.62 0.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 110.982 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.1 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -147.23 117.2 7.22 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.546 0.689 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.578 HG12 ' CZ ' ' A' ' 9' ' ' PHE . 21.9 t -108.2 126.62 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.578 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.547 ' CD2' ' HB3' ' A' ' 38' ' ' ALA . 6.8 tp -98.13 80.95 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 0.0 110.752 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' CZ ' HG12 ' A' ' 7' ' ' VAL . 69.5 m-85 -62.2 133.65 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.518 ' CG1' HD13 ' A' ' 90' ' ' ILE . 8.6 p -156.45 166.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.616 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.518 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 1.1 p -146.78 -98.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 109.904 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.58 86.7 2.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.101 -1.0 . . . . 0.0 110.185 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.581 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 85.37 -11.53 60.87 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 t30 74.75 -164.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -1.123 . . . . 0.0 109.782 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.56 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 11.7 mm 58.12 13.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 2.0 t -174.89 175.33 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.955 . . . . 0.0 110.207 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.557 ' CB ' HD21 ' A' ' 86' ' ' LEU . 1.1 mtp180 70.72 -56.24 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.351 -0.843 . . . . 0.0 110.013 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.554 ' HB2' ' CD1' ' A' ' 86' ' ' LEU . 3.2 m -175.44 55.62 0.14 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 16' ' ' CYS . 50.0 Cg_endo -76.39 -1.14 11.15 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.971 1.511 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.545 ' CB ' ' CE ' ' A' ' 128' ' ' MET . . . -100.12 7.01 44.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.348 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.573 ' SG ' ' CD1' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -59.73 -37.83 80.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.125 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -50.42 66.96 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.68 -0.638 . . . . 0.0 109.726 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' ARG . . . -62.97 -58.27 12.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -55.13 -29.33 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -1.205 . . . . 0.0 109.91 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.493 ' O ' HG23 ' A' ' 29' ' ' VAL . 1.3 m -69.09 -60.7 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.253 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 23' ' ' GLY . 11.6 ptm180 -61.1 -28.73 69.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.509 ' CB ' ' HA ' ' A' ' 62' ' ' VAL . 11.4 t70 -81.17 -53.06 6.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -55.58 -38.73 69.75 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.312 -0.867 . . . . 0.0 110.278 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.542 ' HB ' ' CG ' ' A' ' 32' ' ' LYS . 4.4 m -84.54 -38.56 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.226 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.47 ' N ' ' CG2' ' A' ' 29' ' ' VAL . . . 106.0 -64.29 0.29 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.03 50.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -1.147 . . . . 0.0 110.251 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.542 ' CG ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -95.48 -132.82 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.569 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 4.9 mp -149.57 -120.63 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.383 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.1 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.0 29.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.812 . . . . 0.0 111.609 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.633 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -96.24 97.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.888 -1.133 . . . . 0.0 110.147 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.578 ' OD1' ' CE1' ' A' ' 80' ' ' PHE . 6.3 m-20 -135.76 144.27 45.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.5 p -137.56 151.34 48.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.432 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.547 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . . . -146.22 -172.9 4.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 110.361 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.45 ' HA ' HG21 ' A' ' 10' ' ' VAL . . . -169.4 100.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 41' ' ' SER . 25.8 p -54.48 -68.17 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 0.0 110.274 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.503 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.2 OUTLIER -64.71 -177.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.54 36.86 0.58 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -78.96 -31.64 45.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -1.147 . . . . 0.0 110.187 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -116.62 70.74 0.77 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -138.28 142.6 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 86.32 25.98 34.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' SER . 13.0 pt20 -176.96 -141.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -1.131 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 0.9 OUTLIER 59.03 108.31 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.62 100.37 0.8 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.012 1.532 . . . . 0.0 110.471 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 22.3 m-20 -87.33 27.12 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.231 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -75.02 -27.55 60.14 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.186 -0.946 . . . . 0.0 109.137 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -74.2 -51.77 14.47 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.442 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -63.01 -46.74 86.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 109.655 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 1.8 tt0 -62.76 -42.47 99.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.169 -0.957 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 3.5 ttpp -57.76 -67.13 0.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.704 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.564 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 4.8 p -50.86 -33.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.237 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.552 ' CA ' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.37 -55.6 31.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.463 -0.773 . . . . 0.0 109.504 179.424 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -29.89 71.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 t -78.24 -14.46 59.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -111.7 -35.13 5.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.2 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 127.58 84.81 0.48 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.552 HG13 ' CA ' ' A' ' 57' ' ' CYS . 1.5 p 169.26 80.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.369 -1.077 . . . . 0.0 110.041 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -59.96 157.53 12.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.352 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.477 HG22 HD12 ' A' ' 64' ' ' ILE . 39.3 mt -148.81 -64.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.097 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER 66.54 96.78 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.47 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.56 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.286 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -105.48 -145.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.7 70.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -93.75 139.12 31.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -171.42 175.36 4.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -75.96 106.49 7.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.479 HD12 ' CB ' ' A' ' 38' ' ' ALA . 19.8 tt -46.23 157.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.41 159.9 37.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -55.38 -19.3 8.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.14 -12.89 44.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.98 -15.79 61.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.578 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 17.1 m-30 -81.73 -8.04 59.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.223 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.7 p -117.73 -48.98 2.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.582 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -51.37 -27.09 8.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.18 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 9.3 m-85 -134.1 157.09 47.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.252 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -104.25 -8.17 19.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.27 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.511 HG12 ' CE1' ' A' ' 143' ' ' HIS . 6.0 t -138.95 141.86 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.233 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.51 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 51.9 mt -123.84 143.36 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.516 ' CB ' ' CD1' ' A' ' 9' ' ' PHE . . . -114.64 120.51 40.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 90' ' ' ILE . . . -111.22 113.62 26.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.557 HD21 ' CB ' ' A' ' 17' ' ' ARG . 2.2 mp -51.18 -83.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.492 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t0 -71.96 -179.43 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.241 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -84.41 -45.29 12.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 1.5 t -45.21 -51.14 11.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.956 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.528 ' CG1' HD12 ' A' ' 94' ' ' ILE . 6.8 tt -52.95 -47.16 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.363 -0.835 . . . . 0.0 110.086 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -58.16 -53.21 60.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -55.28 -54.87 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.845 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 96' ' ' SER . 29.1 m-20 -47.67 -60.32 2.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 110.147 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.538 ' HA ' ' CE ' ' A' ' 97' ' ' MET . 15.0 mt -58.74 -47.05 90.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -67.02 -16.13 64.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.557 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -80.82 -28.89 36.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.538 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 10.2 ptt? -97.07 -30.25 13.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.118 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -41.76 144.59 0.79 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 110.446 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.525 ' HD2' ' CE ' ' A' ' 98' ' ' LYS . 44.1 Cg_endo -71.37 177.39 6.74 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.13 1.595 . . . . 0.0 110.387 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.413 ' C ' ' OD1' ' A' ' 101' ' ' ASN . 0.9 OUTLIER -98.2 21.2 11.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 7.4 m120 -143.87 -137.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.102 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.31 -176.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 110.067 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.476 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -131.55 35.37 3.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.28 -171.52 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 146.04 11.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.492 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 37.8 t -112.17 127.0 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.545 ' CG2' ' N ' ' A' ' 108' ' ' LEU . 1.2 p -122.4 171.42 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.545 ' N ' ' CG2' ' A' ' 107' ' ' VAL . 6.0 tp -99.74 150.31 22.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.828 . . . . 0.0 110.138 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 135' ' ' GLU . 25.3 t80 -124.96 97.58 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 109' ' ' PHE . 18.8 t-20 60.14 144.9 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.55 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.3 Cg_endo -74.51 176.97 9.0 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.529 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.1 Cg_endo -72.18 3.05 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.027 1.54 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.47 -37.81 15.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 110.123 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 115' ' ' VAL . . . -78.49 -76.41 0.93 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 29.9 m -59.27 -150.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -1.1 . . . . 0.0 110.118 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 6.0 t0 63.77 135.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.442 ' OD1' ' SG ' ' A' ' 16' ' ' CYS . 1.2 p30 -170.23 157.63 5.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.963 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 -27.74 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.036 1.545 . . . . 0.0 110.448 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 56.3 34.92 24.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -110.41 -32.97 6.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 m -122.22 -86.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.5 ' O ' ' CD ' ' A' ' 126' ' ' PRO . 89.9 p -155.0 19.05 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.402 ' O ' HG21 ' A' ' 127' ' ' THR . 0.9 OUTLIER -83.11 4.6 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 110.18 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -105.8 -45.99 1.24 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 12.8 m-85 -50.01 -45.69 81.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 110.566 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.9 Cg_endo -73.68 -51.02 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.573 1.302 . . . . 0.0 110.287 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 66.0 p -69.11 -56.59 7.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.23 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.545 ' CE ' ' CB ' ' A' ' 20' ' ' ALA . 8.8 ttp -41.33 -68.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 87.5 t80 -59.22 -44.04 92.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.119 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 126' ' ' PRO . . . -44.56 -64.16 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.972 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.445 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -63.4 -45.3 91.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 109.953 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.584 ' CG2' ' CG1' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -40.7 -56.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.856 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.528 ' N ' HG21 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -74.38 -47.36 34.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.225 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 3.8 tppt? -47.94 -22.79 0.64 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.578 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -125.57 31.34 5.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.986 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.52 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -115.21 -22.08 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.156 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.502 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 3.9 mttp -87.92 -52.36 0.39 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.72 5.64 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.521 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 41.3 t80 -93.82 -76.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 140' ' ' LEU . 3.5 pp -65.66 -30.8 71.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.514 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.516 ' HA ' ' CG2' ' A' ' 146' ' ' ILE . 22.3 m -56.06 -33.53 65.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 110.251 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.09 -34.87 7.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.16 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.519 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 0.2 OUTLIER -44.33 -27.85 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 110.107 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.51 ' O ' ' HD2' ' A' ' 5' ' ' LYS . . . 127.08 67.8 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.5 tp -156.36 -54.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 0.0 110.227 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.516 ' CG2' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.174 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.261 0.553 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.35 -40.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 110.215 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.59 158.27 30.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.22 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.563 ' HG2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.84 -164.74 0.54 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.401 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.563 ' N ' ' HG2' ' A' ' 4' ' ' LYS . 24.7 mttm -156.02 -160.86 1.05 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 110.77 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.015 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -144.59 122.81 12.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.442 -0.787 . . . . 0.0 111.056 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.622 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 43.5 t -113.21 128.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 109.669 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.488 HD21 ' CD1' ' A' ' 72' ' ' ILE . 13.2 tp -86.93 85.87 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.485 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.622 ' CZ ' ' CG1' ' A' ' 7' ' ' VAL . 34.0 m-85 -76.24 100.43 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.541 ' CG1' HD12 ' A' ' 90' ' ' ILE . 1.5 p -120.54 168.96 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.521 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 19.4 t -154.14 -53.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.058 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER 176.58 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.501 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -104.31 -15.85 20.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.555 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 6.6 t-20 67.96 38.7 2.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -1.198 . . . . 0.0 110.205 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -114.76 -2.52 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 110.076 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 m -137.2 45.45 2.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 110.13 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.555 ' NH2' ' HA ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -146.7 -57.35 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 110.176 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.528 ' CB ' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -45.21 -56.57 9.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.139 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 18' ' ' SER . 46.9 Cg_endo -74.88 -0.96 10.55 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.928 1.488 . . . . 0.0 110.295 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -103.66 -44.98 4.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 110.213 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 60.9 m -74.21 -38.62 63.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.066 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.459 ' HG3' HG22 ' A' ' 35' ' ' ILE . 2.5 tt0 -69.68 -45.68 67.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 110.242 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.527 ' HA3' ' CG1' ' A' ' 62' ' ' VAL . . . -71.23 -46.65 41.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.593 HG22 ' CG2' ' A' ' 132' ' ' ILE . 0.9 OUTLIER -61.29 -43.8 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.14 . . . . 0.0 110.355 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 58.3 m -69.71 -40.02 76.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 1.8 mmt-85 -67.5 -32.87 73.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD2' ' HA3' ' A' ' 61' ' ' GLY . 1.2 t70 -85.19 -48.69 8.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.039 . . . . 0.0 110.622 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.501 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -74.83 -21.58 59.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.745 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.538 HG11 ' CG ' ' A' ' 32' ' ' LYS . 2.3 t -119.98 -24.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.783 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 106.28 -60.97 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 13.7 t70 -178.27 94.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 110.215 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.538 ' CG ' HG11 ' A' ' 29' ' ' VAL . 12.5 mmtm -119.86 -130.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.105 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 35' ' ' ILE . 5.2 mp -149.81 -118.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 110.643 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.015 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.17 29.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.459 -0.775 . . . . 0.0 111.496 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 33' ' ' LEU . 1.1 mt -104.26 90.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.007 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.58 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 55.1 m-20 -121.79 97.49 5.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.68 134.72 36.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.491 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . -137.04 168.35 19.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.487 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.474 ' O ' ' CG2' ' A' ' 72' ' ' ILE . . . -140.38 142.83 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 110.08 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.54 ' CG2' HG13 ' A' ' 90' ' ' ILE . 11.8 p -103.7 41.57 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 40' ' ' THR . 2.4 p 170.16 103.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.86 58.05 0.99 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.59 -62.06 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -1.158 . . . . 0.0 110.189 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 102.4 9.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.288 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.6 t -142.07 139.53 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.227 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.07 60.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 48' ' ' SER . 5.3 pt20 -123.52 -140.39 0.31 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 110.243 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.459 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 66.21 126.36 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.36 90.36 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.349 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 2.5 t0 -99.26 24.03 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.259 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -76.47 -30.43 57.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.219 -0.925 . . . . 0.0 109.197 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.9 OUTLIER -74.16 -48.95 25.88 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.444 -0.785 . . . . 0.0 109.29 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.38 71.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 109.483 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -61.1 -42.13 97.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.267 179.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.601 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -54.74 -66.05 0.47 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.363 -0.836 . . . . 0.0 109.304 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.601 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.6 t -50.28 -35.06 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.939 . . . . 0.0 108.983 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.479 ' C ' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -54.87 -51.11 66.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 109.427 179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -69.52 -28.55 66.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.719 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.3 -11.14 59.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -112.44 -26.49 8.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.549 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 131.17 80.18 0.2 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 66.5 t -158.89 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -1.108 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.466 ' O ' HG21 ' A' ' 64' ' ' ILE . 32.1 p-10 -97.97 104.66 16.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.466 HG21 ' O ' ' A' ' 63' ' ' ASP . 13.6 pt -143.24 -171.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.36 125.97 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.061 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.466 ' OE1' ' HD3' ' A' ' 19' ' ' PRO . 33.9 mm-40 -84.38 96.07 8.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.345 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -89.66 74.41 7.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.118 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 68' ' ' ARG . . . -41.9 126.63 3.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.9 tmm_? -106.06 151.45 24.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -90.62 144.14 26.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.903 . . . . 0.0 110.241 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.488 ' CD1' HD21 ' A' ' 8' ' ' LEU . 16.5 tt -82.69 170.45 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 110.121 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -147.51 161.07 41.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -59.42 -14.84 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' O ' ' CE ' ' A' ' 79' ' ' LYS . . . -80.48 -12.02 59.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.165 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -47.96 -21.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.366 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.552 ' CD1' ' HE3' ' A' ' 98' ' ' LYS . 18.9 m-85 -76.92 52.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.113 -0.992 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.516 ' C ' ' CD ' ' A' ' 79' ' ' LYS . 1.1 p 175.02 31.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.344 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' CD ' ' C ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -135.74 -35.69 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.284 -0.885 . . . . 0.0 110.034 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 36' ' ' ASP . 9.5 m-85 -123.32 156.46 35.27 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.549 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 1.3 m-20 -71.64 -36.63 70.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 83' ' ' ILE . 50.4 t -140.8 156.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.039 . . . . 0.0 110.69 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.477 HG12 HD23 ' A' ' 8' ' ' LEU . 9.5 mt -118.45 133.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -107.24 134.63 50.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 110.443 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.411 ' CA ' HD13 ' A' ' 90' ' ' ILE . . . -116.55 125.68 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 11' ' ' CYS . 2.7 mp -78.99 -78.47 0.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 5.6 m-20 -56.91 178.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.415 ' HG3' ' HD3' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -89.11 -55.15 3.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.2 m -45.62 -48.93 14.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.541 HD12 ' CG1' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -46.26 -49.69 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -49.62 72.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.835 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.0 t -60.88 -17.26 49.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.846 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -87.32 -67.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.527 ' HA ' ' CE ' ' A' ' 97' ' ' MET . 6.6 mt -44.75 -54.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.549 -0.72 . . . . 0.0 109.871 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -60.09 -14.9 19.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.697 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -81.7 -34.99 30.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.527 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 21.1 ptt? -96.53 -27.85 14.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.552 ' HE3' ' CD1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -40.71 139.32 1.17 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.66 -163.98 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.087 1.572 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -110.87 20.98 16.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.282 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -169.98 121.33 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.2 p -172.59 170.54 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 41.59 1.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -162.27 131.61 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.13 173.59 6.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 0.0 110.136 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.417 ' CG2' ' HD2' ' A' ' 98' ' ' LYS . 64.5 t -118.95 142.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -134.61 161.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.231 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.91 105.51 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.144 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.563 ' CZ ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -54.57 -57.18 12.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.463 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 18.7 p30 -162.11 164.11 17.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.483 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -73.96 175.21 11.14 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.133 1.596 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.0 Cg_endo -72.41 52.45 1.98 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.941 1.495 . . . . 0.0 110.422 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.41 -7.15 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.95 -91.18 1.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.485 ' CG1' ' HG2' ' A' ' 128' ' ' MET . 14.3 t -85.86 136.85 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.071 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.431 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 35.1 t70 -167.79 33.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.545 ' N ' ' CD ' ' A' ' 118' ' ' PRO . 55.8 m-20 43.76 49.39 5.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 117' ' ' ASP . 46.0 Cg_endo -72.72 139.9 31.52 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.02 1.537 . . . . 0.0 110.499 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.431 ' CE2' ' O ' ' A' ' 117' ' ' ASP . 49.5 m-85 -132.93 44.8 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.113 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -107.35 -35.98 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.139 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.7 m -159.16 -147.35 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.483 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 28.8 m -60.85 -25.74 66.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 123' ' ' ASP . 10.9 p30 -46.59 123.03 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.265 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 132.99 -27.0 3.51 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -98.42 -45.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.264 -1.139 . . . . 0.0 110.764 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 48.4 Cg_endo -82.6 -73.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.586 1.308 . . . . 0.0 110.643 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 126' ' ' PRO . 1.1 t -42.95 -33.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 124' ' ' GLY . 4.0 tmm? -62.05 -69.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 24' ' ' ILE . 5.8 t80 -49.22 -50.21 39.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.976 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -50.87 -47.56 60.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.5 t -64.78 -46.96 79.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.797 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.593 ' CG2' HG22 ' A' ' 24' ' ' ILE . 15.2 mm -47.51 -55.97 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 0.1 OUTLIER -63.89 -47.85 78.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.821 . . . . 0.0 110.146 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -52.99 -25.88 13.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.897 . . . . 0.0 110.145 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.563 ' O ' ' CZ ' ' A' ' 109' ' ' PHE . 80.6 mm-40 -116.88 14.94 15.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.554 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.79 -22.14 7.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 1.8 mtpm? -84.52 -47.9 0.67 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.1 Cg_endo -78.36 -4.59 14.36 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.013 1.533 . . . . 0.0 110.344 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 139' ' ' PHE . 4.6 t80 -108.03 -48.87 3.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.424 HD13 HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -64.46 -9.58 19.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.228 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.514 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 4.3 m -73.8 -72.1 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -105.16 -5.66 20.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.68 22.86 15.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.163 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.508 ' O ' ' CE ' ' A' ' 5' ' ' LYS . . . -173.14 -54.64 0.05 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 144' ' ' GLY . 5.4 mp -149.77 -88.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -1.124 . . . . 0.0 110.126 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.514 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 1.7 tp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.149 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.428 ' O ' ' HB1' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.287 0.565 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 1' ' ' ALA . . . 56.2 165.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -99.88 171.52 7.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.254 -0.904 . . . . 0.0 110.085 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -85.63 156.72 20.58 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.551 ' O ' HG21 ' A' ' 34' ' ' ILE . 3.2 mtpt -133.53 -163.99 1.43 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.022 -1.049 . . . . 0.0 111.029 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.082 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -148.86 116.45 6.23 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.534 ' CG2' HD12 ' A' ' 34' ' ' ILE . 3.3 t -104.13 125.54 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.703 . . . . 0.0 109.159 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 13.5 tp -89.92 84.7 6.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 110.697 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.587 ' CG ' ' SG ' ' A' ' 21' ' ' CYS . 26.0 m-85 -67.27 108.72 2.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -0.95 . . . . 0.0 109.469 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 39' ' ' ALA . 20.0 t -126.38 154.81 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.563 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.523 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 1.8 p -145.16 -108.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.854 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.477 HD21 ' OD2' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -118.51 82.24 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 0.0 110.104 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 77.37 0.39 71.83 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.5 t30 71.97 -158.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -1.087 . . . . 0.0 109.899 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 8.4 mm 58.06 12.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.237 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 177.19 176.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.117 -0.99 . . . . 0.0 110.504 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.541 ' C ' ' CD2' ' A' ' 86' ' ' LEU . 1.0 OUTLIER 71.72 -60.0 0.53 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.775 . . . . 0.0 110.237 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.583 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -139.73 48.07 1.46 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.9 Cg_endo -77.82 -10.64 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.924 1.486 . . . . 0.0 110.054 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -97.5 6.99 47.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 110.43 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.587 ' SG ' ' CG ' ' A' ' 9' ' ' PHE . 1.4 m -62.78 -45.14 94.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.07 -1.019 . . . . 0.0 109.352 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HG2' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.83 -47.4 85.88 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.55 -0.719 . . . . 0.0 109.88 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.5 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -68.49 -59.52 6.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.641 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -43.0 -46.91 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -1.19 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.607 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 78.1 m -69.36 -37.44 77.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.48 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 13.6 mmt180 -62.04 -45.18 94.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.337 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 -45.79 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 6.0 mmt -63.24 -41.32 99.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.524 ' CG2' ' HD3' ' A' ' 32' ' ' LYS . 3.5 m -158.77 36.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.405 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 25' ' ' CYS . . . -49.87 -22.67 4.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.82 -20.79 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.356 -1.085 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' HD3' ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -104.77 -139.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.931 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.8 mt -147.77 -95.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.228 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.082 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 32.39 33.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 0.0 111.568 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' LEU . 3.5 mt -110.69 94.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.892 -1.13 . . . . 0.0 110.487 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.568 ' OD1' ' CE1' ' A' ' 80' ' ' PHE . 42.3 m-20 -126.05 104.48 8.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 m -95.15 130.94 41.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -157.29 -172.79 4.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.482 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -164.06 146.55 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.125 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 40' ' ' THR . 14.0 t -93.87 64.74 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.177 -0.952 . . . . 0.0 110.256 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.485 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . 12.5 t -149.17 -75.66 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.242 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . 74.59 106.32 0.09 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 1.2 m-85 -170.04 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -1.146 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -123.98 23.88 8.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.229 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 69' ' ' ALA . 3.7 m -65.03 -9.19 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 110.403 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . -104.48 41.12 2.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 48' ' ' SER . 6.9 pt20 -177.92 -142.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.119 . . . . 0.0 110.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.465 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 67.45 98.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.56 83.53 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.004 1.529 . . . . 0.0 110.427 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -89.09 32.3 0.83 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -29.4 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 108.923 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.456 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -73.72 -52.46 13.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.74 . . . . 0.0 109.306 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.625 ' N ' ' CZ ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -61.25 -48.22 82.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.622 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -61.27 -43.71 98.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.136 -0.978 . . . . 0.0 109.256 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 1.3 tptt -54.25 -65.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.393 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.581 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 24.3 m -53.75 -32.24 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.227 -0.921 . . . . 0.0 109.03 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.516 ' N ' HG21 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -54.98 -55.63 28.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.429 -0.795 . . . . 0.0 109.29 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -33.31 75.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -11.21 60.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -0.836 . . . . 0.0 109.971 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.4 m-80 -113.32 -32.07 6.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 145.12 55.01 0.02 OUTLIER Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 53.8 t -158.66 89.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.135 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.415 ' O ' HG21 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -90.29 103.55 16.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.446 HG23 HG13 ' A' ' 62' ' ' VAL . 41.2 pt -138.12 -161.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.29 133.89 0.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.237 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt 52.12 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' ARG . 6.0 mm-40 -44.72 -39.83 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 48.23 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.464 ' HB2' ' CG1' ' A' ' 45' ' ' VAL . . . -102.18 155.63 18.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -152.73 158.39 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -79.77 124.63 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 4.2 tt -72.78 96.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.173 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -155.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.176 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.19 -7.24 59.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.79 -18.05 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.27 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 8.4 p-10 -61.01 -15.47 32.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.584 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 14.1 m-85 -82.81 2.04 36.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.152 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -47.88 -31.42 5.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.267 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 6' ' ' ALA . 11.3 m-85 -134.94 156.07 49.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.33 -10.6 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.432 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.552 HG13 ' CD2' ' A' ' 143' ' ' HIS . 99.5 t -132.55 140.99 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.928 . . . . 0.0 110.387 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -128.07 130.86 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.37 137.42 49.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.938 . . . . 0.0 110.249 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.52 137.92 51.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.541 ' CD2' ' C ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -96.69 -34.36 11.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.096 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.477 ' OD2' HD21 ' A' ' 12' ' ' LEU . 1.1 m-20 -111.57 -170.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 110.17 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -97.27 -36.9 10.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 p -43.96 -36.37 2.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.138 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 87' ' ' ASP . 1.6 mp -73.12 -63.98 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.88 -17.61 2.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.252 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -95.61 -32.81 12.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.395 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -95.82 -56.9 2.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.539 HG12 ' CE ' ' A' ' 97' ' ' MET . 0.1 OUTLIER -47.29 -34.35 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.172 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 42.8 m-20 -78.48 -7.85 57.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.251 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -83.13 -18.54 39.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.913 . . . . 0.0 110.189 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' HG12 ' A' ' 94' ' ' ILE . 2.9 ptt? -102.16 -36.34 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -56.0 136.62 73.47 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.16 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.19 -90.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.981 1.516 . . . . 0.0 110.503 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 102' ' ' CYS . 26.3 m -153.12 -101.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 110.107 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.4 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 100' ' ' SER . 0.2 OUTLIER -90.57 -169.95 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.75 29.41 4.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.82 154.33 1.89 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -121.25 150.45 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.54 145.39 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.15 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 139' ' ' PHE . 11.1 m -135.34 142.35 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.94 128.18 34.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.137 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -85.33 -36.04 21.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.161 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.466 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 6.8 p30 175.76 166.3 0.4 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 110' ' ' ASN . 46.9 Cg_endo -74.5 174.86 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.013 1.533 . . . . 0.0 110.188 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.09 53.07 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.964 1.507 . . . . 0.0 110.437 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -143.04 -41.92 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.55 -74.06 0.68 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.461 HG23 ' OD1' ' A' ' 110' ' ' ASN . 31.2 m -56.26 116.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.7 t70 -81.46 146.55 30.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.43 ' OD2' ' CZ ' ' A' ' 17' ' ' ARG . 19.4 m-20 -111.52 81.91 3.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.468 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -73.34 116.51 4.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.955 1.503 . . . . 0.0 110.459 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -111.96 -38.2 4.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.46 56.0 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.097 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.93 139.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.1 m -47.91 -29.1 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.257 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.27 121.94 11.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 114.73 -57.36 0.47 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 53' ' ' SER . 6.3 m-30 -34.49 -53.82 0.96 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.645 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.15 -59.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.651 1.343 . . . . 0.0 110.322 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 116' ' ' ASP . 97.1 m -53.37 -48.74 68.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 124' ' ' GLY . 4.8 ttp -48.85 -69.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.817 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 9.0 t80 -43.81 -54.56 5.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.796 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 134' ' ' LYS . . . -51.85 -39.67 59.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.682 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 74.9 m -66.38 -57.75 6.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.616 ' CG2' HG21 ' A' ' 24' ' ' ILE . 12.0 mm -44.26 -47.97 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.44 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 2.5 t -71.22 -61.28 1.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 110.62 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -44.72 -23.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -112.43 14.92 20.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.973 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.529 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.7 -22.75 7.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -82.35 -47.06 0.94 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.111 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.5 Cg_endo -78.15 -8.77 16.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.862 1.454 . . . . 0.0 110.285 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.67 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 71.6 t80 -103.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.283 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 145' ' ' LEU . 3.2 tp -52.74 -24.56 8.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 80.0 m -88.19 -27.89 21.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.445 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.22 -12.41 16.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.154 -0.966 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.67 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 3.5 t60 -84.59 39.69 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.21 45.69 87.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.519 HD13 ' CD1' ' A' ' 140' ' ' LEU . 1.4 mt -133.95 -58.53 0.85 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -1.133 . . . . 0.0 110.415 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 140' ' ' LEU . 4.2 mp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.149 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.261 0.553 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.96 152.94 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 110.211 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.62 143.84 45.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.392 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.542 ' HG2' ' CG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.8 156.89 24.68 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 41.1 mtpt -127.03 -161.25 1.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.981 -1.075 . . . . 0.0 111.158 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.082 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.26 122.79 11.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.481 0.658 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.532 ' CG2' HD12 ' A' ' 34' ' ' ILE . 24.2 t -113.03 121.89 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.791 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 38' ' ' ALA . 13.0 tp -94.85 81.45 3.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.405 -0.809 . . . . 0.0 110.398 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 7.5 p90 -74.36 140.41 44.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.151 -0.968 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 11' ' ' CYS . 1.4 p -170.94 171.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 110.366 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.56 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 46.9 t -140.74 -57.95 0.52 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 41' ' ' SER . 13.4 mt -155.56 -44.5 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.16 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -125.73 -3.95 6.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.537 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 3.6 t-20 64.67 30.21 12.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -1.148 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 70.8 mt -98.75 -35.8 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' SD ' ' A' ' 128' ' ' MET . 0.9 OUTLIER -104.57 18.68 21.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -135.86 -32.02 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -0.95 . . . . 0.0 110.311 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.542 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -62.15 -58.0 20.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 46.5 Cg_endo -73.08 -5.39 17.11 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.945 1.497 . . . . 0.0 110.456 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -107.03 -40.83 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.551 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 65.8 m -72.66 -36.88 68.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER -66.04 -45.15 82.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 110.075 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' ASP . . . -70.78 -50.54 24.01 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.598 HD13 ' CD2' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -54.49 -44.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -1.213 . . . . 0.0 110.2 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.571 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 1.4 m -67.43 -52.55 38.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.21 -27.43 61.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.295 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -87.76 -30.08 20.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.379 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.476 ' HE1' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -78.81 -24.28 44.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.387 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.481 ' HB ' ' HG3' ' A' ' 32' ' ' LYS . 19.5 m -119.32 -25.6 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 112.34 -63.16 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 18.9 p30 -179.76 70.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 7.9 mmtt -102.76 -135.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 110.116 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.548 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 32.7 mt -128.09 -119.31 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -0.974 . . . . 0.0 110.328 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.082 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 34.8 30.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 111.198 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.556 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -103.09 103.53 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.062 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.567 ' OD1' ' CE1' ' A' ' 80' ' ' PHE . 49.1 m-20 -136.71 132.63 35.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.147 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -108.48 144.89 35.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 8' ' ' LEU . . . -134.07 179.06 6.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.36 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . . . -172.53 89.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.195 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.458 ' O ' ' CB ' ' A' ' 41' ' ' SER . 3.5 m -85.72 83.08 7.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.231 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER 172.07 -53.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.236 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 56.97 104.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -145.91 -44.96 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.157 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.476 ' HA ' ' NE2' ' A' ' 47' ' ' GLN . 34.1 m-70 -124.23 27.44 7.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.412 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . 3.1 m -62.91 144.65 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.208 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 71.41 29.03 68.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.476 ' NE2' ' HA ' ' A' ' 44' ' ' HIS . 13.3 pt20 -177.39 -139.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -1.122 . . . . 0.0 110.08 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.467 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 68.01 119.5 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.185 -0.947 . . . . 0.0 110.229 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HD2' ' CE1' ' A' ' 119' ' ' TYR . 47.0 Cg_endo -69.37 73.56 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.056 1.556 . . . . 0.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.497 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 1.4 t0 -94.2 33.74 1.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.107 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -71.72 -24.21 61.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.226 -0.921 . . . . 0.0 108.977 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -72.05 -52.19 18.1 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.269 179.362 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -62.59 -50.17 72.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -0.772 . . . . 0.0 109.639 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.567 ' NE2' ' CD1' ' A' ' 64' ' ' ILE . 0.7 OUTLIER -58.93 -43.97 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.5 ttpp -56.6 -68.65 0.2 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.658 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.555 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 19.5 m -48.35 -33.85 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.515 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -58.17 -52.13 66.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.17 -13.9 60.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.738 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -92.75 -12.29 31.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 110.117 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -117.15 -30.58 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 137.44 84.36 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 41.9 t -158.65 120.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -1.137 . . . . 0.0 110.126 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.506 ' O ' ' CG2' ' A' ' 64' ' ' ILE . 3.0 m-20 -90.17 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.954 . . . . 0.0 110.114 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.567 ' CD1' ' NE2' ' A' ' 54' ' ' GLN . 12.0 pt -158.71 143.56 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 12.2 p -168.17 31.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 65' ' ' SER . 65.6 mmtt -149.2 -73.66 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.171 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 19' ' ' PRO . 1.7 mp0 60.26 105.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 57.32 1.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.412 ' HB2' ' CB ' ' A' ' 45' ' ' VAL . . . -45.12 134.56 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 1.7 ptt-85 -166.22 156.97 12.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -79.15 135.07 36.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.245 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.463 HG13 ' OD2' ' A' ' 76' ' ' ASP . 19.7 tt -60.66 154.67 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -120.57 -65.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.164 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.63 -34.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.174 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.29 -15.49 16.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.463 ' OD2' HG13 ' A' ' 72' ' ' ILE . 5.4 m-20 -60.7 -23.19 64.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 22.3 m-85 -88.47 10.72 19.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -130.23 -62.44 0.94 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.551 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -45.52 -24.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.567 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 7.4 m-85 -131.3 154.28 48.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -104.14 -20.82 13.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 69.2 t -122.05 137.77 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 106' ' ' VAL . 3.3 mt -124.62 138.76 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.102 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 109' ' ' PHE . . . -121.6 126.09 48.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -108.66 152.29 25.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.468 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 1.4 tp -95.51 -43.58 7.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' HG21 ' A' ' 90' ' ' ILE . 27.0 t0 -103.94 168.72 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.298 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -81.0 -47.3 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.913 . . . . 0.0 110.215 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.2 t -43.29 -59.49 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.478 ' CD1' HG22 ' A' ' 10' ' ' VAL . 8.9 tt -46.66 -35.49 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -72.07 -45.59 60.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.196 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 t -62.25 -30.5 71.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 97' ' ' MET . 72.1 m-20 -88.76 -53.68 4.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.509 ' CG1' ' HE1' ' A' ' 97' ' ' MET . 3.8 tt -49.17 -37.25 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.463 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 1.9 t-20 -79.57 -16.2 56.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 47.8 t -87.43 -4.21 59.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.509 ' HE1' ' CG1' ' A' ' 94' ' ' ILE . 1.5 ptt? -113.27 -11.63 13.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.572 ' HE3' ' CG ' ' A' ' 77' ' ' PHE . 13.4 mtpt -60.36 146.25 84.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.0 -171.78 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.055 1.555 . . . . 0.0 110.485 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.4 t -100.07 -5.64 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.162 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 6.4 p30 -128.34 59.18 1.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.18 176.03 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.38 16.51 2.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.66 -170.81 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.198 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -146.35 151.96 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.5 t -117.1 146.0 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 83' ' ' ILE . 35.5 m -144.94 161.13 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 142.6 27.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.555 ' CE1' ' HE1' ' A' ' 136' ' ' MET . 0.1 OUTLIER -94.58 -45.78 7.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.533 ' HB3' ' CG2' ' A' ' 115' ' ' VAL . 48.7 m-80 -131.14 161.27 62.79 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.41 169.53 22.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.995 1.524 . . . . 0.0 110.317 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.37 50.09 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.955 1.503 . . . . 0.0 110.435 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -104.87 -37.98 6.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.99 84.24 0.13 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 110' ' ' ASN . 59.0 t -119.12 -3.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 117' ' ' ASP . 6.6 p-10 -131.05 156.45 45.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.183 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 116' ' ' ASP . 2.7 p30 -175.95 150.22 1.08 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.56 -90.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.026 1.54 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.549 ' CE1' ' HD2' ' A' ' 49' ' ' PRO . 7.8 m-30 -95.97 -70.46 0.71 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER 58.93 149.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.8 p -160.0 21.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.3 26.47 6.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -134.05 -45.32 0.11 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 27.0 m-85 -47.31 -46.59 57.34 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.244 -1.151 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -72.23 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.641 1.337 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.467 ' OG1' ' HA2' ' A' ' 124' ' ' GLY . 3.0 p -52.14 -48.02 65.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.536 ' O ' ' CG2' ' A' ' 132' ' ' ILE . 17.1 ttp -42.86 -76.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 110.355 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.598 ' CD2' HD13 ' A' ' 24' ' ' ILE . 4.6 t80 -53.1 -55.14 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 126' ' ' PRO . . . -47.03 -24.22 0.59 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.7 t -89.35 -61.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -52.59 -20.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.818 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.548 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -91.41 -56.12 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.808 . . . . 0.0 109.603 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -51.36 -24.4 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.688 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.47 50.37 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 110.034 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.612 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -117.87 -24.13 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.651 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -83.32 -40.82 0.81 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.461 -0.774 . . . . 0.0 110.29 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.3 Cg_endo -79.76 -6.55 14.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.711 1.374 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.551 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 27.3 t80 -81.77 -69.0 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 139' ' ' PHE . 0.9 OUTLIER -67.62 -22.85 65.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.533 HG21 ' CG2' ' A' ' 146' ' ' ILE . 2.6 m -67.55 -31.93 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.016 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.86 -24.81 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 139' ' ' PHE . 14.7 m80 -66.39 -9.04 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . 114.79 58.98 0.36 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.494 ' CD1' ' HD3' ' A' ' 5' ' ' LYS . 1.8 mt -162.65 61.14 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.058 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.272 0.558 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.31 67.09 1.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.09 137.68 56.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 110.524 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.483 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -72.55 -144.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 109.315 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 33' ' ' LEU . 5.1 mtpt -143.2 150.24 39.08 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.663 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.778 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.93 113.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.478 -0.764 . . . . 0.0 109.917 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.542 ' HA ' ' CG1' ' A' ' 82' ' ' VAL . 28.5 t -102.99 134.13 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.547 ' CD2' HG12 ' A' ' 83' ' ' ILE . 7.8 tp -89.53 80.78 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.432 -0.792 . . . . 0.0 110.329 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.574 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 15.1 m-85 -68.48 110.43 4.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.575 ' CG2' ' CB ' ' A' ' 38' ' ' ALA . 49.0 t -135.1 153.54 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.897 . . . . 0.0 110.545 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 17' ' ' ARG . 45.5 t -140.05 -56.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER 177.0 -60.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -0.908 . . . . 0.0 110.381 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -82.57 -8.29 86.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' CB ' ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER 67.26 27.45 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.211 . . . . 0.0 110.076 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 16' ' ' CYS . 93.6 mt -133.64 -36.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.23 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 79.8 m -42.71 -49.63 5.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.178 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HD3' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -98.46 128.63 44.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.117 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.579 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER 172.36 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 46.4 Cg_endo -73.59 -26.33 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.872 1.459 . . . . 0.0 110.332 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 129' ' ' PHE . . . -106.74 -27.22 10.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 4.2 t -79.02 -59.65 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.248 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 44.8 tt0 -56.41 -27.63 57.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.435 -0.791 . . . . 0.0 109.163 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.525 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -74.83 -55.59 5.29 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 2.4 tp -52.71 -43.73 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.26 . . . . 0.0 109.835 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.566 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 73.2 m -74.7 -32.88 62.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 0.0 110.292 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 15.1 mmt180 -66.93 -39.75 87.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.949 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -79.59 -40.59 29.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.136 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.49 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 18.7 mmt -71.41 -41.3 69.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 28' ' ' MET . 16.6 m -156.77 45.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -58.9 -19.12 42.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.12 27.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -1.089 . . . . 0.0 110.403 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -150.75 -130.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.76 ' O ' HG13 ' A' ' 34' ' ' ILE . 4.7 mp -129.26 -112.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.778 ' CA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 57.19 1.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.74 -0.6 . . . . 0.0 111.157 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 7.0 mt -114.07 103.71 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.88 -1.138 . . . . 0.0 110.95 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.595 ' OD1' ' CE1' ' A' ' 80' ' ' PHE . 10.3 m-20 -139.11 102.49 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.811 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.78 133.79 34.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 10' ' ' VAL . . . -147.7 166.58 27.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.337 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . 169.81 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' A' ' 41' ' ' SER . 5.1 t -56.01 97.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 40' ' ' THR . 0.1 OUTLIER 174.68 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 110.199 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 44' ' ' HIS . . . 71.19 -106.32 1.86 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 52.86 -87.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.579 ' CD2' ' NE2' ' A' ' 47' ' ' GLN . 40.2 m170 -66.13 -7.81 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.475 HG21 ' CB ' ' A' ' 69' ' ' ALA . 2.1 p -49.44 129.85 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.261 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -27.04 20.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.579 ' NE2' ' CD2' ' A' ' 44' ' ' HIS . 3.0 pt20 -116.14 -134.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -1.144 . . . . 0.0 110.296 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.3 OUTLIER 70.17 135.68 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.129 -0.982 . . . . 0.0 110.135 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.42 81.7 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.972 1.511 . . . . 0.0 110.422 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 31.8 p-10 -82.59 8.45 11.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -26.96 61.05 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 108.981 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.5 -48.66 31.59 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.31 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.519 ' HB2' ' CG ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -63.16 -49.85 72.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 0.0 109.65 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -60.33 -46.74 88.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.97 . . . . 0.0 109.411 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 7.5 ttpt -54.84 -69.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.82 . . . . 0.0 109.588 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.564 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 7.7 p -49.34 -34.92 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.265 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.543 ' CA ' HG13 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -54.89 -50.97 67.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 109.379 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -73.52 -22.18 60.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -12.94 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.0 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 129' ' ' PHE . 11.2 m120 -111.23 -14.93 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.408 -0.808 . . . . 0.0 109.036 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.569 ' O ' ' CZ ' ' A' ' 129' ' ' PHE . . . 96.41 100.98 1.94 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.566 ' HB ' ' CE1' ' A' ' 129' ' ' PHE . 13.9 p -172.11 145.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -86.03 118.05 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 8.1 pt -130.23 173.07 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.152 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 51.6 p -165.96 29.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.54 149.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 110.228 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.431 ' OE1' ' CB ' ' A' ' 18' ' ' SER . 2.2 pt20 -165.43 -150.94 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.023 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.63 -178.65 7.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' CB ' HG21 ' A' ' 45' ' ' VAL . . . -106.51 122.82 47.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -110.47 25.6 11.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.108 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.548 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 3.4 pt20 38.24 -152.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 110.441 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.499 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 13.2 tt -133.22 164.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.0 p -125.46 -78.67 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 75' ' ' ALA . 2.3 pttp -164.88 -36.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -56.61 -20.4 20.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 110.226 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.6 p30 -42.59 -28.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 23.8 m-85 -70.69 -42.13 71.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.262 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.521 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -96.52 -48.55 5.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 4.2 tptt -44.49 -25.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 0.0 110.255 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 9.8 m-85 -133.07 -179.76 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.473 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.16 -29.37 4.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.844 . . . . 0.0 110.375 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.542 ' CG1' ' HA ' ' A' ' 7' ' ' VAL . 6.0 p -129.54 142.39 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.162 -0.961 . . . . 0.0 110.379 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.547 HG12 ' CD2' ' A' ' 8' ' ' LEU . 3.1 mt -113.78 134.22 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.1 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 9' ' ' PHE . . . -111.0 122.37 47.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.477 ' HA ' HD11 ' A' ' 90' ' ' ILE . . . -104.12 137.12 42.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.516 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 5.1 tp -108.5 11.55 26.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -152.19 174.32 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.246 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.11 -57.92 3.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.148 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -51.44 42.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.985 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.536 ' CG1' HD11 ' A' ' 94' ' ' ILE . 3.7 tt -44.58 -51.13 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.88 -55.79 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.7 t -54.49 -18.43 4.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.937 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' SER . 22.2 m-20 -85.28 -69.28 0.67 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 0.0 110.213 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.536 HD11 ' CG1' ' A' ' 90' ' ' ILE . 3.2 mt -47.92 -53.14 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.432 -0.793 . . . . 0.0 109.982 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -59.11 -15.35 13.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.61 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -80.74 -40.69 24.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.995 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.525 ' CE ' HG21 ' A' ' 94' ' ' ILE . 6.9 ptt? -85.2 -26.9 26.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.567 ' CE ' ' CE1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -42.84 139.68 2.04 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.177 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.18 -161.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.052 1.554 . . . . 0.0 110.42 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 t -102.54 -4.56 25.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.213 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -155.8 111.01 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.216 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.419 ' SG ' ' NZ ' ' A' ' 98' ' ' LYS . 31.8 p -137.6 -159.31 0.94 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.521 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -132.31 31.82 4.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.112 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.86 37.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.124 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.85 162.18 18.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.456 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 90.3 t -116.09 130.04 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.54 164.04 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -108.24 131.13 55.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.088 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CD1' ' CE1' ' A' ' 139' ' ' PHE . 2.9 t80 -74.8 -61.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.476 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.7 OUTLIER -152.96 175.46 2.96 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.142 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.501 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 48.0 Cg_endo -75.15 175.9 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.042 1.548 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.37 4.86 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.937 1.493 . . . . 0.0 110.661 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.94 -1.48 16.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.256 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 116' ' ' ASP . . . -116.99 -107.24 2.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.566 ' CG2' ' CB ' ' A' ' 131' ' ' SER . 17.2 t -72.69 75.28 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -1.14 . . . . 0.0 110.214 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -155.1 138.83 16.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -112.74 110.83 51.9 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.455 ' CG ' ' HB3' ' A' ' 122' ' ' SER . 46.3 Cg_endo -73.04 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.95 1.5 . . . . 0.0 110.496 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.436 ' O ' ' C ' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -166.93 146.67 5.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.319 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.439 ' O ' ' OG ' ' A' ' 122' ' ' SER . 2.7 t80 42.26 -139.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -43.29 116.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.455 ' HB3' ' CG ' ' A' ' 118' ' ' PRO . 4.7 m -155.17 -177.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.331 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -136.94 20.85 3.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.106 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 116' ' ' ASP . . . -99.49 -23.63 10.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 9.9 m-85 -44.02 -57.26 6.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.085 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 44.4 Cg_endo -70.77 -44.11 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.905 1.476 . . . . 0.0 110.105 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.497 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 27.9 m -61.44 -27.45 68.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.545 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 30.7 ttp -60.1 -70.22 0.18 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.273 -0.892 . . . . 0.0 109.832 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 75.4 t80 -67.9 -21.87 65.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.79 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -65.95 -42.13 90.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 110.004 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.566 ' CB ' ' CG2' ' A' ' 115' ' ' VAL . 14.8 t -84.3 -31.69 24.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.274 -0.892 . . . . 0.0 108.787 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.59 HG22 ' CB ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -67.75 -27.83 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.682 -0.636 . . . . 0.0 109.395 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.542 ' O ' ' CE ' ' A' ' 136' ' ' MET . 24.9 p -103.18 -23.85 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.795 . . . . 0.0 110.272 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -88.6 -18.94 26.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.08 -1.013 . . . . 0.0 110.339 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CG ' ' HG2' ' A' ' 138' ' ' PRO . 3.3 tt0 -124.31 40.01 3.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.381 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.568 ' HG2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -84.46 -20.41 31.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.968 . . . . 0.0 110.496 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -87.11 -44.48 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.865 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -76.48 2.98 6.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.609 1.321 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.587 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 71.7 t80 -108.05 -70.03 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.473 HD23 ' CE ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -62.54 -44.07 97.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.217 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.532 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 1.9 m -64.56 -10.33 25.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.36 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 138' ' ' PRO . 13.8 mm-40 -104.7 -46.95 4.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.302 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.587 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -44.46 -24.57 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.134 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.446 ' C ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.83 35.94 0.5 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.446 HD21 ' HD2' ' A' ' 5' ' ' LYS . 19.1 mt -137.45 -94.53 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.532 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 2.4 tp . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.26 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.301 0.572 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.39 45.38 0.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -178.03 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.491 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -117.96 144.41 45.53 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' O ' HG21 ' A' ' 34' ' ' ILE . 4.4 mttt -119.1 -155.95 0.63 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.024 -1.048 . . . . 0.0 110.879 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.688 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.99 148.73 51.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.66 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 16.7 t -139.06 113.29 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.794 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 36' ' ' ASP . 5.0 tp -78.7 101.34 7.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.453 -0.779 . . . . 0.0 110.784 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 36.8 m-85 -87.33 106.65 18.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 38' ' ' ALA . 6.0 t -134.1 177.73 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 110.959 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.549 ' SG ' ' CB ' ' A' ' 17' ' ' ARG . 1.7 p 169.6 53.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.786 . . . . 0.0 110.146 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 16.6 mt 54.77 -89.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' CYS . . . -89.91 80.22 1.47 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 38' ' ' ALA . 1.8 t-20 -58.44 -44.49 89.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -1.178 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.517 ' CG2' ' HE3' ' A' ' 66' ' ' LYS . 9.4 mt -38.78 -30.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 110.303 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 17' ' ' ARG . 26.8 p -125.38 34.99 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 109.811 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.582 ' C ' HD21 ' A' ' 86' ' ' LEU . 43.8 mtt180 -157.27 80.81 0.91 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 110.175 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.614 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER 56.78 43.09 1.04 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 111.022 179.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 18' ' ' SER . 45.3 Cg_endo -73.66 -21.44 19.12 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.743 1.391 . . . . 0.0 109.781 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 65' ' ' SER . . . -89.01 7.33 35.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.558 ' CB ' HD13 ' A' ' 132' ' ' ILE . 0.7 OUTLIER -56.41 -40.21 74.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.124 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -60.68 -44.22 96.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.281 0.562 . . . . 0.0 110.035 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' ILE . . . -74.14 -63.8 2.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.654 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 0.8 OUTLIER -42.36 -46.0 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 110.166 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' CB ' HG13 ' A' ' 35' ' ' ILE . 69.0 m -72.98 -39.74 65.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 110.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 3.2 mmt180 -55.1 -34.88 64.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.736 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -88.95 -32.47 17.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 0.0 110.127 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.14 -27.01 60.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.411 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 32' ' ' LYS . 10.1 t -123.79 -22.89 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.234 -0.916 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.04 -168.62 18.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.98 80.71 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -1.118 . . . . 0.0 110.133 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 29' ' ' VAL . 7.5 mmtp -112.96 -137.77 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ILE . 18.1 mt -122.5 -40.13 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.22 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.6 pp -33.3 -32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.762 . . . . 0.0 110.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.579 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -76.92 88.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 110.526 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.559 ' CB ' ' HA ' ' A' ' 8' ' ' LEU . 7.1 m-20 -124.35 71.4 1.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.907 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.6 t -73.04 131.2 41.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 14' ' ' ASN . . . -144.05 -171.9 3.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.256 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.443 ' HA ' HG11 ' A' ' 10' ' ' VAL . . . -166.37 145.69 5.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 40' ' ' THR . 11.1 t -125.68 76.67 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 -59.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.46 36.77 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.99 -57.59 1.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -1.169 . . . . 0.0 110.212 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.407 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -85.78 63.61 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 68' ' ' ARG . 2.1 p -148.07 149.79 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.331 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.05 21.62 27.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 48' ' ' SER . 6.5 pt20 -173.82 -149.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.18 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.83 120.79 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.219 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.24 89.08 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.977 1.514 . . . . 0.0 110.455 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.7 p30 -88.43 14.47 9.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -74.1 -37.54 64.12 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.125 -0.984 . . . . 0.0 108.719 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.43 -37.96 68.45 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.345 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.48 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 6.3 m -65.63 -59.55 3.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.458 -0.776 . . . . 0.0 109.811 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 63.9 mt-30 -57.95 -44.15 86.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.165 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -53.34 -72.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.49 -0.756 . . . . 0.0 109.701 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.592 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 43.5 t -43.69 -38.17 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.362 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.568 ' CA ' HG11 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -55.28 -50.54 69.28 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.437 -0.79 . . . . 0.0 109.427 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -67.37 -28.08 67.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -83.29 -9.01 59.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.11 -31.4 7.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 135.18 60.39 0.06 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.568 HG11 ' CA ' ' A' ' 57' ' ' CYS . 1.9 p 173.69 139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -1.163 . . . . 0.0 110.129 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -91.52 142.71 27.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.589 ' CG2' ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER 68.63 -175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.589 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 5.6 t 179.66 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.073 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.517 ' HE3' ' CG2' ' A' ' 15' ' ' ILE . 4.9 mmmt -115.72 -168.69 1.45 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.936 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.3 pt20 177.67 144.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.531 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -61.95 79.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.089 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 45' ' ' VAL . . . -49.0 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.347 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 68' ' ' ARG . 2.6 ptt-85 -103.09 -149.04 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -103.28 146.54 28.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.216 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.9 tt -82.43 173.73 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 34.1 m -100.96 6.52 43.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' THR . 14.5 mtmt 68.19 5.23 4.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.3 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.59 -3.16 58.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.948 . . . . 0.0 110.331 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.578 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 11.9 p-10 -65.47 -24.61 67.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.58 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 21.3 m-85 -86.69 16.13 5.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 110.228 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.34 -15.23 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.576 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.624 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -127.25 -145.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.125 -0.985 . . . . 0.0 110.033 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.6 OUTLIER 37.87 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.448 -0.782 . . . . 0.0 110.676 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -135.53 -43.52 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.464 ' CG1' HG22 ' A' ' 7' ' ' VAL . 11.8 p -137.24 159.6 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 110.626 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 1.7 mp -124.42 122.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.55 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . . . -108.54 131.12 55.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.58 161.65 19.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD21 ' C ' ' A' ' 17' ' ' ARG . 7.1 tp -93.22 -43.37 8.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.526 ' CB ' HD11 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -102.2 177.47 4.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.395 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 89' ' ' SER . 14.8 mt-30 -89.87 -38.25 13.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 88' ' ' GLN . 23.2 t -42.36 -39.87 2.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.526 HD11 ' CB ' ' A' ' 87' ' ' ASP . 1.5 mp -65.97 -53.59 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.488 HD13 ' CG2' ' A' ' 106' ' ' VAL . 0.5 OUTLIER -63.77 -16.03 60.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.214 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 t -88.37 -39.22 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.373 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.41 -22.32 21.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.53 HG13 ' CE ' ' A' ' 97' ' ' MET . 2.8 tt -68.41 -37.86 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' SER . 29.2 p30 -70.2 -18.59 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 48.0 t -78.0 -34.65 50.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.53 ' CE ' HG13 ' A' ' 94' ' ' ILE . 19.8 ptt? -93.29 -30.22 15.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.047 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 7.7 mmmt -38.98 141.52 0.6 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.478 -0.764 . . . . 0.0 110.704 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.496 ' HD2' ' HE3' ' A' ' 98' ' ' LYS . 46.4 Cg_endo -72.43 -179.79 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.18 1.621 . . . . 0.0 110.567 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -114.26 19.88 15.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.6 OUTLIER -153.14 78.92 1.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.281 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 6.4 p -143.56 -172.1 3.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.92 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 102' ' ' CYS . 1.1 mpt_? -135.34 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -163.76 165.43 23.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -141.61 170.11 16.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.488 ' CG2' HD13 ' A' ' 91' ' ' LEU . 33.0 m -111.52 167.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 106' ' ' VAL . 28.1 m -154.25 157.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 110.225 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.61 125.96 39.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -89.61 93.25 9.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 110.17 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 109' ' ' PHE . 0.8 OUTLIER 65.62 159.31 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.56 174.44 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.04 1.547 . . . . 0.0 110.383 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.4 52.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.94 1.495 . . . . 0.0 110.403 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.24 -59.33 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.59 -46.87 65.61 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 131' ' ' SER . 30.2 m -92.18 46.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -137.24 113.63 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -140.19 142.7 30.92 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 -13.65 26.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.069 1.563 . . . . 0.0 110.494 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.6 t80 50.14 38.89 18.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.64 -50.28 65.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -139.35 -69.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.02 44.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -103.7 -7.96 20.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.173 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -90.67 -40.03 5.74 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.624 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 5.4 m-30 -45.06 -47.5 31.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.148 -1.207 . . . . 0.0 110.472 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -72.42 -57.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.575 1.302 . . . . 0.0 110.382 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.482 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 15.5 m -64.57 -57.22 9.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.185 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 124' ' ' GLY . 7.6 ttp -40.43 -69.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.654 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 75.3 t80 -55.93 -44.75 78.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.045 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -46.94 -59.77 2.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.94 . . . . 0.0 110.014 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.501 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -65.14 -45.2 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 110.024 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' CG2' HG22 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -43.27 -53.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.826 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.511 ' N ' HG23 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -80.75 -37.77 29.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 5.2 tttt -50.08 -32.29 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 8.3 mm-40 -103.97 -5.59 22.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.189 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.537 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.7 OUTLIER -82.78 14.24 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -104.71 -63.39 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.448 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 44.5 Cg_endo -72.26 -4.39 15.13 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.786 1.414 . . . . 0.0 110.471 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -93.1 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -45.52 -28.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 110.143 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.549 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 7.5 m -47.55 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.817 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -106.44 -0.27 24.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 110.792 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 33.77 5.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 111.16 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.497 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . 173.42 -27.37 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.485 -1.341 . . . . 0.0 109.901 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER 175.02 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.234 -1.156 . . . . 0.0 110.363 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.549 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 7.3 tp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.116 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.265 0.555 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 175.39 112.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.227 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 158.21 30.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.266 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -82.99 -179.05 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.847 . . . . 0.0 109.237 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 34' ' ' ILE . 17.1 mttm -142.73 -161.34 1.23 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.065 -1.022 . . . . 0.0 110.676 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.101 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -141.18 121.92 14.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 34' ' ' ILE . 2.7 t -111.22 123.0 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.765 . . . . 0.0 109.329 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.506 ' CD2' ' HB2' ' A' ' 38' ' ' ALA . 6.5 tp -93.52 84.88 4.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.439 -0.788 . . . . 0.0 110.757 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 55.7 m-85 -60.79 123.73 18.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 38' ' ' ALA . 25.1 t -124.97 168.82 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.719 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.55 ' CB ' ' HB3' ' A' ' 17' ' ' ARG . 20.9 p -169.02 -141.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.911 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 76.07 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 14' ' ' ASN . . . 129.04 -6.89 6.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.463 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 6.2 t-20 41.71 37.62 0.78 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -1.145 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.479 ' O ' ' HG3' ' A' ' 19' ' ' PRO . 3.2 mt -144.22 -59.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 15' ' ' ILE . 56.1 m -106.0 59.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.55 ' HB3' ' CB ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -153.5 -50.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.468 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -152.13 47.76 0.43 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.038 -1.039 . . . . 0.0 110.743 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 18' ' ' SER . 47.7 Cg_endo -74.65 -16.0 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.843 1.444 . . . . 0.0 110.113 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB3' ' HE3' ' A' ' 128' ' ' MET . . . -91.97 6.63 45.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.523 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . 55.5 m -63.96 -35.01 79.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' HG2' ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -68.83 -55.54 10.83 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.526 -0.734 . . . . 0.0 110.177 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' HG23 ' A' ' 62' ' ' VAL . . . -62.28 -51.81 53.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.625 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 8.9 tp -56.3 -44.27 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 110.308 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.566 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 23.1 m -64.96 -35.52 81.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.238 -0.914 . . . . 0.0 110.054 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.477 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.4 mtt-85 -66.44 -45.12 80.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 110.124 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -34.9 58.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -74.96 -46.86 32.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 28' ' ' MET . 13.6 m -150.93 45.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.22 -28.55 0.86 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.47 85.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -1.145 . . . . 0.0 110.061 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 34' ' ' ILE . 21.6 mttt -65.98 -23.25 66.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.138 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.581 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER 67.66 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.101 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER 30.07 37.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.553 -0.717 . . . . 0.0 111.66 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.674 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -92.0 93.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.906 -1.121 . . . . 0.0 110.361 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 10.0 m-20 -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -168.86 163.15 11.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 110.372 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.506 ' HB2' ' CD2' ' A' ' 8' ' ' LEU . . . -169.26 -164.68 0.47 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -174.92 -176.95 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -151.28 25.01 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -0.75 5.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . 49.88 -104.04 0.1 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER 64.64 119.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.248 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.532 ' CD2' ' CD ' ' A' ' 47' ' ' GLN . 35.8 m170 55.66 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.309 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 69' ' ' ALA . 80.9 t 52.42 80.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.07 6.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.532 ' CD ' ' CD2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -148.75 13.86 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.247 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' HD13 ' A' ' 15' ' ' ILE . 2.7 t -106.97 111.64 63.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.58 100.72 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.408 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.6 p30 -86.16 26.03 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.424 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -32.06 61.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.257 -0.902 . . . . 0.0 108.92 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.9 mtt180 -71.83 -52.23 18.49 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.213 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -52.59 65.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.43 -0.794 . . . . 0.0 109.359 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 6.8 tt0 -54.24 -56.42 18.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 3.9 ttpp -44.85 -66.89 0.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.393 -0.817 . . . . 0.0 109.52 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.565 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 91.8 t -45.32 -36.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.547 ' CB ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.7 -42.15 92.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.439 -0.788 . . . . 0.0 109.042 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 1.6 mmtp -71.76 -27.74 63.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.416 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.42 -9.33 54.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -109.8 -26.61 9.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.195 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 115.43 81.26 0.92 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.547 HG13 ' CB ' ' A' ' 57' ' ' CYS . 2.1 p 174.66 170.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -1.1 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -156.03 144.13 19.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.426 ' CG1' ' HG3' ' A' ' 54' ' ' GLN . 2.3 pt -133.51 164.89 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -115.58 76.05 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.947 . . . . 0.0 110.256 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 65' ' ' SER . 4.6 mttt 60.53 152.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.948 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -105.3 -64.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.09 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -49.12 157.59 0.43 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -0.891 . . . . 0.0 110.178 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -147.95 33.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 3.1 pt20 37.58 -153.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 3.9 tt -153.73 129.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.211 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 174.24 6.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -72.94 -5.98 42.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -77.19 -34.2 56.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -42.65 -48.41 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.534 ' CE1' ' HD2' ' A' ' 98' ' ' LYS . 14.6 m-30 -47.3 -30.42 3.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.8 m -117.56 29.61 7.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 9.6 tppt? -124.88 -9.36 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 79' ' ' LYS . 69.5 m-85 -140.3 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -124.34 -44.56 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 110.385 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 41.3 t -131.73 137.18 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.499 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.46 HG12 HD21 ' A' ' 8' ' ' LEU . 54.4 mt -116.45 142.11 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.817 . . . . 0.0 110.044 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 107' ' ' VAL . . . -127.66 162.66 26.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 90' ' ' ILE . . . -142.99 145.58 33.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.538 HD22 ' CG ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -70.56 -79.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.539 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 7.3 m-20 -78.92 175.74 10.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 110.467 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.463 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.6 mm-40 -74.22 -41.46 61.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.8 t -40.13 -50.61 2.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.012 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.551 ' O ' ' CD1' ' A' ' 94' ' ' ILE . 1.7 mt -61.37 -58.48 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.508 ' CA ' HD11 ' A' ' 94' ' ' ILE . 3.1 tp -42.25 -60.97 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.119 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 96' ' ' SER . 46.6 t -55.33 -39.44 70.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.965 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 96' ' ' SER . 0.3 OUTLIER -54.3 -55.38 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.067 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 90' ' ' ILE . 1.5 mp -57.89 -56.77 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -63.99 -19.23 65.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.844 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 92' ' ' SER . 1.0 OUTLIER -71.85 -8.86 56.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.47 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 7.6 mtm -125.88 -48.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.534 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 9.7 mtpt -41.82 138.14 1.82 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.96 -160.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.006 1.53 . . . . 0.0 110.581 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.1 m -106.56 5.32 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -134.97 104.95 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -174.01 4.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 28.8 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.59 176.38 10.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 110.182 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -143.23 166.12 25.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.13 -0.981 . . . . 0.0 110.282 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.4 t -117.27 132.64 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.476 ' CG1' ' NE2' ' A' ' 143' ' ' HIS . 32.1 m -128.21 153.61 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.512 ' HG ' ' N ' ' A' ' 109' ' ' PHE . 0.5 OUTLIER -100.95 146.98 26.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 3.3 t80 -106.73 110.58 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.091 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 59.0 166.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.049 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 170.09 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.001 1.527 . . . . 0.0 110.278 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.9 51.93 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.398 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -156.56 -46.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.8 -67.65 2.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.1 t -98.84 100.7 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -1.114 . . . . 0.0 110.116 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -174.87 88.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.24 130.33 7.58 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 -90.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.939 1.494 . . . . 0.0 110.487 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.04 21.16 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.182 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -65.47 117.02 7.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.7 t 52.18 -143.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.168 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.91 39.55 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -93.52 32.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -124.48 -49.2 0.21 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.632 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 5.6 m-85 -41.65 -48.95 10.06 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.249 -1.147 . . . . 0.0 110.305 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.9 Cg_endo -71.45 -56.97 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.597 1.314 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 128' ' ' MET . 16.7 m -59.76 -51.87 67.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 124' ' ' GLY . 12.1 ttp -41.29 -63.71 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.284 -0.885 . . . . 0.0 109.96 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.625 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 94.2 t80 -56.63 -42.1 78.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.617 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -46.12 -57.43 4.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.774 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 132' ' ' ILE . 11.2 p -71.44 -43.97 65.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.523 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.582 ' CG2' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -42.1 -37.61 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.689 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.545 ' CB ' HD12 ' A' ' 24' ' ' ILE . 1.4 p -97.19 -42.36 7.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.3 OUTLIER -44.93 -46.54 11.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -102.72 41.71 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.202 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.542 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -116.49 -2.35 12.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.264 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.608 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -104.88 -63.57 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 46.9 Cg_endo -73.58 1.14 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.75 1.395 . . . . 0.0 110.488 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.523 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 31.9 t80 -87.88 -68.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 139' ' ' PHE . 4.0 pp -74.03 -23.71 59.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.51 ' O ' ' CD1' ' A' ' 146' ' ' ILE . 3.3 m -59.74 -43.04 94.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 144' ' ' GLY . 49.7 mt-10 -96.0 -37.33 10.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.476 ' NE2' ' CG1' ' A' ' 107' ' ' VAL . 1.2 m80 -44.01 -25.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 124.66 68.32 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.525 ' CD2' ' HD2' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -155.66 18.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 141' ' ' THR . 23.6 pt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.192 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.24 0.543 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 46.51 -145.65 0.21 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.87 . . . . 0.0 110.189 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' OE1' ' CB ' ' A' ' 32' ' ' LYS . 14.7 tt0 -152.46 172.85 15.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 110.359 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.576 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -64.04 -69.53 0.27 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.512 -0.742 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.576 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 14.3 mttm -152.34 -155.59 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.981 . . . . 0.0 111.353 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.903 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.95 152.91 36.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.712 -0.618 . . . . 0.0 110.234 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 15.1 t -111.62 127.26 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 83' ' ' ILE . 10.2 tp -90.01 81.86 6.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 136' ' ' MET . 27.3 m-85 -68.82 117.49 10.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.943 . . . . 0.0 109.46 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 38' ' ' ALA . 52.7 t -130.9 161.04 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.601 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.498 ' HB3' HD23 ' A' ' 86' ' ' LEU . 28.6 p -159.38 39.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.102 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.526 HD11 ' CZ ' ' A' ' 17' ' ' ARG . 1.2 mt 59.38 60.49 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.267 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 132.13 -24.72 3.97 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.49 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 13.5 t30 59.28 14.88 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -1.168 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.52 ' CA ' ' HB3' ' A' ' 19' ' ' PRO . 12.9 mt -123.17 -1.54 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 22.5 p -144.21 165.61 27.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.237 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.558 ' CB ' ' CD2' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 71.05 -56.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 110.416 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.551 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 8.0 t -152.97 50.36 0.6 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.792 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.1 Cg_endo -78.17 -19.27 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.864 1.455 . . . . 0.0 110.066 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -86.76 6.73 30.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -0.79 . . . . 0.0 110.279 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 21.4 p -58.21 -28.96 65.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.337 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 26' ' ' ARG . 0.6 OUTLIER -67.66 -40.15 84.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.594 -0.691 . . . . 0.0 110.191 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.485 ' HA3' ' CG1' ' A' ' 62' ' ' VAL . . . -74.73 -49.69 10.28 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.67 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 1.1 tp -57.84 -44.35 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 0.0 110.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.49 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -71.34 -43.37 67.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.314 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 2.7 mmm180 -58.97 -38.3 78.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.22 -39.67 47.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.117 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.446 ' O ' HG12 ' A' ' 29' ' ' VAL . 21.8 mtp -67.69 -51.09 53.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 28' ' ' MET . 14.0 m -151.3 44.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.319 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -63.54 -20.78 64.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -67.19 -7.37 23.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.412 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . 6.5 mttm -116.27 -137.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.05 -1.031 . . . . 0.0 110.272 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.785 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.2 mt -120.34 -122.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.903 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 49.46 3.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.621 -0.674 . . . . 0.0 111.644 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.539 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -104.09 95.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.832 -1.167 . . . . 0.0 110.547 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' OD2' ' CE1' ' A' ' 80' ' ' PHE . 3.1 m-20 -137.05 106.8 6.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.2 m -89.57 127.63 35.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.158 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -144.43 166.64 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HA ' HG11 ' A' ' 10' ' ' VAL . . . -166.3 106.5 0.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 41' ' ' SER . 3.2 t -80.59 86.28 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 40' ' ' THR . 12.5 p 177.33 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 94.15 1.01 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -155.83 -40.54 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -1.136 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.27 92.91 4.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.88 . . . . 0.0 110.226 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.5 t -148.19 160.73 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.257 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.46 24.99 7.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 48' ' ' SER . 13.1 pt20 -159.87 -148.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 47' ' ' GLN . 0.5 OUTLIER 61.39 90.78 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 110.21 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.36 80.53 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.957 1.503 . . . . 0.0 110.439 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -93.01 33.71 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.304 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.3 m -75.52 -31.52 60.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 108.908 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -73.01 -48.96 31.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.313 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.568 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -61.81 -51.34 68.64 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.664 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' NE2' ' N ' ' A' ' 55' ' ' LYS . 4.6 pp0? -64.2 -33.86 76.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 8.3 ttpt -60.04 -67.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.581 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 27.5 m -53.51 -35.08 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.066 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.8 m -53.6 -50.79 64.89 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.425 -0.797 . . . . 0.0 109.261 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -31.8 71.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.492 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 t -77.05 -10.14 59.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.84 . . . . 0.0 110.034 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -112.89 -26.91 8.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.126 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.532 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 135.67 53.74 0.06 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 65.1 t -158.3 109.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -108.87 125.15 51.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 54' ' ' GLN . 19.5 pt -106.22 174.63 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -131.3 -50.73 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 0.0 110.174 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -140.33 86.23 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.9 59.76 5.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -125.73 99.57 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -44.45 159.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.222 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -160.38 40.45 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 110.235 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HB3' ' O ' ' A' ' 70' ' ' ARG . 32.2 tt0 63.05 126.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.256 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -68.85 123.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.892 . . . . 0.0 110.14 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.533 ' O ' ' CD1' ' A' ' 72' ' ' ILE . 22.8 p -73.56 -175.82 2.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.895 . . . . 0.0 110.333 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 -15.93 25.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.21 -20.85 63.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.551 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 21.7 p-10 -52.03 -29.97 23.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.569 ' CE1' ' HD2' ' A' ' 98' ' ' LYS . 19.6 m-85 -86.19 49.05 1.71 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.268 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 1.3 t 171.66 -61.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.244 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.547 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -42.24 -27.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 110.228 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CD1' ' CB ' ' A' ' 6' ' ' ALA . 8.1 m-85 -131.02 -135.13 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.079 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -177.95 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 0.0 110.644 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 16.3 t -104.5 84.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.015 -1.053 . . . . 0.0 110.463 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.521 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.9 mp -72.68 114.22 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.961 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.67 124.33 41.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.09 126.95 53.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.558 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 1.1 mp -64.47 -54.42 32.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.352 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.471 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -103.29 -165.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 0.0 110.22 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 96.1 mt-30 -94.83 -36.84 11.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -42.84 -45.35 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mp -62.5 -47.2 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.205 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.11 -30.87 71.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.119 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.2 t -79.49 -30.8 42.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 96' ' ' SER . 3.3 m-20 -79.69 -55.27 5.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.524 ' HA ' ' CE ' ' A' ' 97' ' ' MET . 10.0 tt -47.58 -43.64 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 110.203 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.513 ' N ' HG21 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.08 -23.65 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -67.53 -10.35 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.183 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.524 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 6.4 mtm -116.64 -50.96 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.569 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 11.3 mtpt -40.78 129.75 1.89 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 110.432 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.436 ' HG2' ' OD1' ' A' ' 101' ' ' ASN . 46.3 Cg_endo -72.72 -163.54 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.025 1.539 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -101.16 28.72 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 22.9 p30 -150.79 94.2 2.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.06 179.04 8.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.82 6.73 4.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.267 -0.896 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -105.9 122.87 47.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.457 ' O ' HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -86.49 162.27 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.504 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 27.9 m -125.23 127.15 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.25 159.41 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 86' ' ' LEU . 3.5 tt -116.79 141.35 48.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.157 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 9' ' ' PHE . 7.5 m-85 -103.77 113.14 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 2.0 t30 58.66 144.77 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.533 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 46.3 Cg_endo -74.27 176.06 10.12 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.052 1.554 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.7 Cg_endo -71.74 53.83 1.92 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.892 1.47 . . . . 0.0 110.383 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -158.44 19.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.211 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 116' ' ' ASP . . . -135.91 -90.52 0.31 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.3 t -60.63 83.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -1.166 . . . . 0.0 110.19 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 114' ' ' GLY . 22.4 t70 -129.68 131.12 46.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.469 ' OD2' ' HA3' ' A' ' 124' ' ' GLY . 23.4 t0 -159.83 102.09 1.45 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.34 -89.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.994 1.523 . . . . 0.0 110.461 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.04 32.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.208 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 121' ' ' SER . 0.1 OUTLIER -93.03 102.25 14.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 58.94 173.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.35 65.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -115.94 129.42 56.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.159 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 128' ' ' MET . . . 112.31 -34.82 4.97 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.65 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 9.9 m-30 -41.31 -49.72 8.81 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.3 Cg_endo -70.87 -64.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.547 1.288 . . . . 0.0 110.436 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.464 ' OG1' ' HA2' ' A' ' 124' ' ' GLY . 21.4 p -53.33 -54.96 28.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.895 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.485 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 ttp -42.28 -69.72 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 110.024 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.67 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 61.9 t80 -44.0 -49.66 8.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.757 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -47.92 -47.04 32.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.8 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -74.31 -33.68 63.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.882 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.545 ' CG2' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -55.32 -45.5 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.615 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.453 ' HB2' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -83.71 -38.14 21.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.302 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 131' ' ' SER . 62.7 mm-40 -90.56 -30.33 17.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 9' ' ' PHE . 13.7 mtm -99.65 4.45 45.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -86.85 -51.04 0.45 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 0.0 110.017 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.88 -6.67 14.28 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.99 1.521 . . . . 0.0 110.435 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.639 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 85.2 t80 -108.16 -78.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.53 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.502 ' HB3' ' O ' ' A' ' 136' ' ' MET . 15.9 tp -44.14 -24.62 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.486 ' HA ' ' HB ' ' A' ' 146' ' ' ILE . 4.6 m -89.11 -31.58 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.963 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 138' ' ' PRO . 3.3 mm-40 -105.09 -39.09 6.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 110.284 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.639 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 14.3 t-80 -40.39 -29.39 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.0 60.87 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.472 ' HB3' HD12 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -154.87 -39.83 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -1.142 . . . . 0.0 110.183 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 141' ' ' THR . 53.6 mt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.218 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.261 0.553 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.69 115.21 30.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 110.221 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.19 163.63 16.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.258 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.573 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -70.46 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.874 . . . . 0.0 108.758 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.573 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 9.3 mtpp -159.01 -164.42 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.977 -1.077 . . . . 0.0 110.493 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.763 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.91 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.566 -0.709 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.588 HG21 ' CD2' ' A' ' 9' ' ' PHE . 2.1 m -90.55 138.66 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.976 . . . . 0.0 110.169 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.571 ' HG ' ' CB ' ' A' ' 38' ' ' ALA . 7.4 tp -89.89 88.15 7.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 110.129 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.588 ' CD2' HG21 ' A' ' 7' ' ' VAL . 5.5 m-85 -72.69 114.16 10.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.543 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 2.1 p -165.8 171.26 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.67 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.542 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 10.1 t 175.27 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 51.08 49.66 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 0.0 110.09 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 16' ' ' CYS . . . 175.21 70.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' CA ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -44.74 -45.35 9.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -1.14 . . . . 0.0 110.136 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 45' ' ' VAL . 25.9 mt -61.33 -12.35 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 19.8 m -99.67 153.4 19.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.538 ' HG2' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER 61.5 11.07 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.387 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.62 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -91.96 -64.26 0.16 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.976 . . . . 0.0 110.172 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.62 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 47.8 Cg_endo -74.27 -1.4 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.793 1.417 . . . . 0.0 110.299 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.506 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -103.15 -47.4 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.451 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.456 ' HA ' HD13 ' A' ' 132' ' ' ILE . 60.4 m -70.25 -38.51 75.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.978 . . . . 0.0 109.969 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.84 -44.28 96.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . -70.06 -48.5 39.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.698 ' CD1' ' CD2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -53.0 -53.0 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -1.143 . . . . 0.0 110.038 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 63.9 m -69.4 -62.15 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 22.6 mmt180 -47.47 -22.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 23.8 t0 -85.81 -45.01 11.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 2.0 mtt -83.16 -1.72 53.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.0 110.425 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 25' ' ' CYS . 3.0 m -131.0 -28.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.947 . . . . 0.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 100.09 -58.75 0.76 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 17.5 p30 178.32 102.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -1.144 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' HG3' ' N ' ' A' ' 33' ' ' LEU . 13.3 ptpt -152.96 -136.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.799 ' O ' HG13 ' A' ' 34' ' ' ILE . 5.1 mp -112.78 -127.61 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.799 HG13 ' O ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER 51.62 4.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.598 -0.689 . . . . 0.0 111.157 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 25' ' ' CYS . 3.2 mt -127.48 113.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 0.0 110.717 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.581 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 8.2 m-20 -142.79 111.73 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.74 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.55 127.68 32.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.262 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.571 ' CB ' ' HG ' ' A' ' 8' ' ' LEU . . . -128.58 177.48 6.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' HB3' ' CA ' ' A' ' 14' ' ' ASN . . . -167.79 96.31 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.159 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.522 ' CG2' HG13 ' A' ' 90' ' ' ILE . 74.7 p -41.98 -35.19 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 m -116.97 -167.19 1.26 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.86 77.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -128.02 0.02 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 0.0 110.256 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 0.4 OUTLIER -122.42 -11.41 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.292 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.456 ' HA ' ' CD1' ' A' ' 15' ' ' ILE . 34.3 m -62.48 159.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.246 -0.909 . . . . 0.0 110.299 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.06 21.91 64.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.516 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 6.5 pt20 -173.7 -148.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -1.134 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 48' ' ' SER . 0.8 OUTLIER 64.43 112.41 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.35 87.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.928 1.488 . . . . 0.0 110.451 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -86.16 30.49 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.103 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -73.86 -27.46 61.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.23 -0.919 . . . . 0.0 109.005 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -71.61 -54.9 8.91 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.288 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.573 ' CB ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -59.7 -51.22 70.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 109.37 179.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -60.86 -41.61 96.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.5 ttpt -52.83 -66.36 0.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.58 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 52.6 t -50.61 -37.34 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.895 . . . . 0.0 109.115 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.546 ' CB ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -52.02 -52.65 49.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.488 -0.758 . . . . 0.0 109.409 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 -27.28 64.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 2.0 t -78.64 -11.48 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 109.896 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.36 -19.95 13.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' O ' HG12 ' A' ' 62' ' ' VAL . . . 106.16 97.07 2.48 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.6 HG12 ' CE2' ' A' ' 129' ' ' PHE . 16.1 m -154.76 -147.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.154 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 62' ' ' VAL . 5.7 t0 179.43 117.07 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.326 -0.859 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.523 ' HB ' ' NE2' ' A' ' 67' ' ' GLN . 15.0 pt -146.65 -37.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.334 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 64' ' ' ILE . 2.3 t 68.75 -67.0 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 16.0 mmtt -136.05 -174.03 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.29 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.523 ' NE2' ' HB ' ' A' ' 64' ' ' ILE . 98.7 mm-40 -139.49 -77.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.17 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.87 84.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . -76.95 179.05 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.221 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -153.11 29.92 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.263 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 50.7 tt0 55.93 162.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.961 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.464 ' N ' ' HG2' ' A' ' 71' ' ' GLN . 5.3 tt -62.69 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.225 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.429 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -149.91 147.35 27.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 110.172 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -13.97 10.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -89.9 -9.65 48.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.461 ' OD2' HD23 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -44.55 -42.88 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.05 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.585 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 35.5 m-85 -59.31 -17.42 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.2 t -113.05 -44.15 3.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.057 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.605 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 18.0 tptt -45.89 -27.95 1.0 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.071 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 27.7 m-85 -144.78 179.25 7.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 110.196 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -114.87 -13.58 11.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 110.583 -179.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 76.9 t -128.74 143.67 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 0.0 110.465 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.513 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 1.9 mp -116.71 119.92 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -100.41 110.92 23.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 110.654 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.429 ' CB ' ' CG2' ' A' ' 90' ' ' ILE . . . -104.74 133.21 49.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.023 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 2.6 tp -82.41 -31.15 29.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.279 -0.888 . . . . 0.0 110.49 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.475 ' OD1' ' CG2' ' A' ' 90' ' ' ILE . 21.9 p-10 -118.65 178.81 4.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.977 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.52 -41.34 13.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.145 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.2 m -45.09 -48.0 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.035 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.522 HG13 ' CG2' ' A' ' 40' ' ' THR . 6.5 tt -53.65 -39.46 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.032 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -70.7 -42.16 71.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.917 . . . . 0.0 110.089 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.7 t -63.43 -30.93 71.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 96' ' ' SER . 59.3 m-20 -88.54 -57.44 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.532 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.1 tt -46.04 -32.9 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 110.182 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.454 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 8.0 t-20 -78.67 -15.19 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.6 OUTLIER -85.35 -9.2 57.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.212 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.532 ' CE ' HG13 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -112.44 -21.51 11.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.145 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -49.48 151.73 2.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.192 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 100' ' ' SER . 44.3 Cg_endo -72.03 -52.19 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.966 1.508 . . . . 0.0 110.399 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 168.28 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.49 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 40.4 m-80 -163.81 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.364 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.56 -150.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 109.951 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -133.47 63.24 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -156.36 156.05 33.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.8 139.67 53.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.164 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.497 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 61.6 t -94.22 139.2 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 83' ' ' ILE . 16.1 m -136.53 142.63 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.02 132.56 38.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.16 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 110' ' ' ASN . 10.1 t80 -87.05 -20.84 26.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.45 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 3.6 p-10 -177.48 164.66 1.37 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.0 Cg_endo -74.49 174.31 12.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.017 1.535 . . . . 0.0 110.348 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.77 51.57 2.34 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -111.63 -44.43 3.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.31 102.86 0.99 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.426 HG11 ' OD1' ' A' ' 110' ' ' ASN . 7.9 p -122.52 -9.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.483 ' HB2' HD22 ' A' ' 86' ' ' LEU . 8.2 t70 -117.02 -127.96 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.09 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -157.09 86.24 2.81 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.31 55.56 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.068 1.562 . . . . 0.0 110.45 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.468 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 1.1 m-85 46.45 -159.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.468 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 2.6 t80 67.06 9.15 6.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 2.2 t 171.75 165.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.115 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -111.14 -17.99 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 123' ' ' ASP . 2.9 p30 -67.02 68.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 122' ' ' SER . . . -176.77 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.629 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 15.5 m-85 -41.39 -51.37 8.52 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.341 -1.093 . . . . 0.0 110.471 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -72.42 -56.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.754 1.397 . . . . 0.0 110.334 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.8 m -52.74 -42.82 65.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.587 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 24.8 ttp -49.69 -77.04 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 0.0 109.764 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.698 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 4.4 t80 -46.6 -54.55 9.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.114 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -50.84 -23.96 3.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.4 t -91.31 -57.29 2.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.338 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -54.71 -19.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.823 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.522 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 1.8 t -99.11 -50.19 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 109.77 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 12.0 tttt -59.31 -17.24 27.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.926 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.461 ' O ' ' HD2' ' A' ' 138' ' ' PRO . 1.4 tt0 -116.6 10.29 14.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.872 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.576 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 3.4 tpt -81.29 8.45 9.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 110.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.5 mtmt -88.6 -52.25 0.37 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.1 Cg_endo -76.66 6.79 3.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.97 1.511 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.57 ' CD2' ' HE3' ' A' ' 136' ' ' MET . 60.1 t80 -96.28 -60.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.153 -0.967 . . . . 0.0 110.366 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 145' ' ' LEU . 3.9 pp -84.6 -13.68 50.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.391 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 137' ' ' LYS . 3.4 m -69.31 -32.57 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.141 -0.974 . . . . 0.0 110.156 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 143' ' ' HIS . 16.5 mm-40 -102.45 -38.78 7.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.203 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 142' ' ' GLU . 0.9 OUTLIER -43.59 -32.7 1.0 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.307 -0.87 . . . . 0.0 110.236 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.97 73.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 1.5 mt -163.05 -62.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.462 ' CG1' ' HA ' ' A' ' 141' ' ' THR . 26.5 pt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.236 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.307 0.575 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.31 47.97 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.182 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.56 157.08 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.268 -0.895 . . . . 0.0 110.274 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -84.19 150.74 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 179.263 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 34' ' ' ILE . 8.4 mtpt -134.48 -155.74 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 110.761 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.11 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.54 134.73 43.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 110.697 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 84' ' ' ALA . 73.0 t -124.01 123.98 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.724 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.488 HD12 ' CE2' ' A' ' 80' ' ' PHE . 5.6 tp -80.79 103.41 10.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.67 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.64 102.86 13.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.552 ' CG2' ' CB ' ' A' ' 38' ' ' ALA . 57.4 t -129.45 169.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.394 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.511 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 39.7 t -158.52 -65.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' CB ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER 169.93 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 99.96 -26.91 22.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 t-20 70.53 3.28 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.334 -1.098 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.525 HG22 ' CB ' ' A' ' 48' ' ' SER . 97.7 mt -101.17 -39.81 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 59.7 m -121.89 153.37 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.989 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.528 ' CA ' HD21 ' A' ' 86' ' ' LEU . 11.0 mtm105 55.79 55.61 6.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.908 . . . . 0.0 110.1 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 176.1 -57.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.422 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.0 Cg_endo -72.08 -12.29 27.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.001 1.527 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -94.75 -11.48 28.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.065 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.519 ' SG ' ' CD1' ' A' ' 132' ' ' ILE . 28.3 m -64.75 -43.91 91.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 1.9 mt-10 -48.0 -52.85 18.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.499 -0.75 . . . . 0.0 109.717 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -64.27 -45.27 93.98 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -48.92 -52.27 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -1.097 . . . . 0.0 109.847 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.484 ' N ' HG21 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -64.83 -43.89 91.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.064 179.868 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HA ' ' N ' ' A' ' 31' ' ' ASP . 16.6 mtt85 -53.27 -44.54 68.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 -16.54 37.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.518 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 2.9 mmt -83.32 -30.39 27.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.31 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' CG ' ' A' ' 32' ' ' LYS . 2.5 m -161.24 24.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 64.35 37.39 94.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.9 t70 68.7 85.31 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.14 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 33' ' ' LEU . 12.2 mmtt -88.9 36.17 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.974 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.758 ' C ' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER 71.91 -144.07 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 110.066 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.11 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 1.5 pp 35.65 22.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.492 -0.755 . . . . 0.0 112.032 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.632 ' N ' ' O ' ' A' ' 33' ' ' LEU . 1.2 mt -97.31 90.47 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.081 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 4.1 m-20 -122.95 79.43 1.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.312 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.16 130.94 44.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 110.039 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.552 ' CB ' ' CG2' ' A' ' 10' ' ' VAL . . . -145.71 -176.33 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . . . -148.06 150.14 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.192 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 41' ' ' SER . 69.3 p -83.1 -77.92 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.472 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.39 76.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 110.193 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.03 97.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.45 -10.24 11.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -1.162 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -117.68 98.51 6.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.174 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 69' ' ' ALA . 9.1 t -123.58 148.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.77 26.05 1.75 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 12.18 4.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -1.128 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.541 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -117.6 178.98 0.89 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 48' ' ' SER . 45.7 Cg_endo -69.21 -57.65 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 3.9 m-20 67.2 -54.86 0.46 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 m -71.84 -22.81 61.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.219 -0.925 . . . . 0.0 109.099 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.589 ' HG2' ' CE2' ' A' ' 125' ' ' PHE . 19.6 tpp180 -73.58 -57.65 3.85 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.386 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.547 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -59.76 -48.76 80.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.163 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 1.0 OUTLIER -60.99 -40.3 92.97 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.14 179.205 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.609 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -55.32 -64.06 0.96 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.609 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 5.7 p -52.25 -34.72 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.041 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.509 ' N ' HG11 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -55.73 -50.68 69.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.76 . . . . 0.0 109.388 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -68.06 -31.8 71.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 109.713 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.9 t -78.3 -11.27 59.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 0.0 109.987 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.542 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 5.4 m-20 -111.53 -34.75 5.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.313 -0.867 . . . . 0.0 109.11 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . 138.32 73.55 0.05 OUTLIER Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.566 HG21 ' CE2' ' A' ' 129' ' ' PHE . 42.5 t -158.59 142.24 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -1.149 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 18.9 p30 -142.56 104.64 4.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.495 ' CD1' ' NE2' ' A' ' 67' ' ' GLN . 41.6 pt -108.39 -146.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.455 ' N ' HG13 ' A' ' 64' ' ' ILE . 11.0 p -145.78 -45.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.344 -0.848 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HD2' ' OG ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -150.54 150.07 30.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.495 ' NE2' ' CD1' ' A' ' 64' ' ' ILE . 2.3 mt-30 -130.27 116.89 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.447 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 1.8 ptm180 -151.93 123.6 7.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.459 ' HA ' ' OD1' ' A' ' 14' ' ' ASN . . . -70.63 121.91 18.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.154 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -132.44 15.25 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.508 ' CG ' ' N ' ' A' ' 72' ' ' ILE . 12.1 tt0 53.96 168.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.508 ' N ' ' CG ' ' A' ' 71' ' ' GLN . 16.6 tt -94.44 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -0.877 . . . . 0.0 110.277 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 7.3 m -109.75 15.68 22.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.5 mmtt 66.24 5.38 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.284 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -88.01 -24.07 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.286 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -43.54 -29.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.469 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.1 m-85 -71.21 -27.2 63.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -123.18 9.23 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.153 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.467 ' C ' ' CD1' ' A' ' 80' ' ' PHE . 5.4 tptt -107.3 -36.83 6.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 5.9 m-30 -114.78 -142.59 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.78 -38.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.519 HG11 ' N ' ' A' ' 83' ' ' ILE . 72.4 t -124.3 151.79 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.519 ' N ' HG11 ' A' ' 82' ' ' VAL . 2.7 mt -129.78 114.92 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.53 ' HB3' ' CG1' ' A' ' 7' ' ' VAL . . . -98.14 138.36 35.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.98 141.53 49.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.199 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.528 HD21 ' CA ' ' A' ' 17' ' ' ARG . 5.0 tp -95.04 4.52 53.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.505 ' CB ' HD11 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -146.41 -156.08 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -117.77 -42.76 2.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -44.51 -28.69 0.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.511 ' CG1' ' O ' ' A' ' 11' ' ' CYS . 1.4 mp -70.9 -48.77 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.885 . . . . 0.0 110.126 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.446 HD12 HG13 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -68.61 -27.35 65.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.208 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 t -78.48 -40.51 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 96' ' ' SER . 40.1 m-20 -83.7 -50.54 8.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.522 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.4 tt -45.43 -41.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.515 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 3.5 t-20 -66.53 -7.84 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.229 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 57.2 m -86.79 -22.85 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.522 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.7 ptt? -104.98 -35.4 7.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.48 ' N ' ' HG3' ' A' ' 97' ' ' MET . 8.7 mtpt -42.24 122.8 2.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.155 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.97 -172.31 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.901 1.474 . . . . 0.0 110.455 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.21 13.4 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.887 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -137.41 91.47 2.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.0 p -149.65 177.07 10.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.39 27.03 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.2 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 138.17 52.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.7 156.63 17.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 83' ' ' ILE . 6.1 t -112.58 158.25 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.0 m -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.69 142.18 27.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.551 ' CE2' ' HE2' ' A' ' 136' ' ' MET . 0.1 OUTLIER -90.91 -64.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.414 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 10.5 p30 -141.78 164.17 36.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.4 Cg_endo -74.39 174.73 12.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.945 1.497 . . . . 0.0 110.281 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.09 52.45 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.65 -40.14 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.092 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.22 -67.89 1.98 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.555 ' CG1' ' CB ' ' A' ' 131' ' ' SER . 21.8 m -103.51 86.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -1.196 . . . . 0.0 110.063 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.416 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 9.9 t70 -67.52 160.85 26.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.79 67.84 4.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.1 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 116' ' ' ASP . 46.0 Cg_endo -72.8 162.99 39.69 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.05 1.553 . . . . 0.0 110.539 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.71 163.77 27.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.163 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 50.83 26.82 2.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 122' ' ' SER . 26.0 t -155.53 -168.7 2.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.415 ' N ' ' OG ' ' A' ' 121' ' ' SER . 44.2 p -141.28 75.63 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -29.98 2.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 128' ' ' MET . . . -101.72 -34.7 4.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.626 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 12.3 m-85 -41.34 -55.38 5.33 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -1.128 . . . . 0.0 110.278 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -71.92 -60.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.835 1.439 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 131' ' ' SER . 9.8 m -49.83 -44.16 49.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.173 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.549 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 25.1 ttp -50.95 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.21 -0.931 . . . . 0.0 109.788 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -45.81 -59.05 3.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.904 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -46.46 -26.45 0.86 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 110.037 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.555 ' CB ' ' CG1' ' A' ' 115' ' ' VAL . 1.1 m -87.92 -71.39 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -42.17 -25.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 179.072 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.494 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 22.9 t -90.22 -60.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -51.61 -22.29 3.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.056 -1.028 . . . . 0.0 110.119 -179.918 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.533 ' HB3' ' CE1' ' A' ' 109' ' ' PHE . 0.8 OUTLIER -110.89 11.3 22.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.815 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.58 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -88.15 -3.84 58.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.564 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.8 mttt -90.55 -47.64 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.996 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.5 Cg_endo -75.37 1.84 7.47 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.631 1.332 . . . . 0.0 110.557 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.621 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 4.5 t80 -105.67 -47.25 3.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.037 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.534 ' CD1' HD11 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -78.3 -53.71 7.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.509 ' CG2' ' OXT' ' A' ' 146' ' ' ILE . 5.0 m -44.65 -26.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 143' ' ' HIS . 39.3 mt-10 -104.61 -40.3 6.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.621 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -43.05 -26.83 0.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.087 -1.008 . . . . 0.0 110.195 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 127.18 67.32 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.452 HD11 HD21 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -161.19 -70.72 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 110.114 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.509 ' OXT' ' CG2' ' A' ' 141' ' ' THR . 2.0 tt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.691 0.758 . . . . 4.21 110.46 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.752 ' HA ' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -119.4 143.19 47.59 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.092 -0.707 . . . . 4.04 109.092 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 15.3 mttt -115.19 -131.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.138 -0.976 . . . . 2.5800000000000001 110.708 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.822 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . -176.79 103.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.438 -0.789 . . . . 0.97999999999999998 109.672 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.807 ' CG1' ' HB2' ' A' ' 84' ' ' ALA . 41.4 t -90.32 138.65 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 1.24 110.495 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.777 HD12 ' HB2' ' A' ' 36' ' ' ASP . 5.7 tp -87.0 94.56 9.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 1.03 110.019 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.591 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 2.4 m-85 -78.44 104.33 8.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 2.3900000000000001 110.063 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.017 HG22 ' C ' ' A' ' 38' ' ' ALA . 30.5 t -123.46 163.11 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 1.4099999999999999 110.296 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 1.5 p -149.99 -53.53 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 2.0899999999999999 110.39 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 173.88 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.139 -0.975 . . . . 1.98 110.237 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.866 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . 136.21 -4.9 3.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.724 -1.35 . . . . 1.99 109.724 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.498 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 5.0 t30 69.43 38.13 1.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -1.148 . . . . 2.6299999999999999 110.262 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 44' ' ' HIS . 12.5 mt -136.49 -39.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 1.6200000000000001 110.235 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 88.3 m -90.39 107.79 19.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 3.4199999999999999 110.178 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.554 ' CG ' ' HG3' ' A' ' 128' ' ' MET . 0.9 OUTLIER 73.55 -4.19 2.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 3.54 110.392 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -84.42 -51.53 0.57 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 4.4500000000000002 110.66 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 18' ' ' SER . 47.3 Cg_endo -75.22 3.48 5.69 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.817 1.43 . . . . 2.3999999999999999 110.619 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.657 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -98.85 -19.01 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 1.21 110.209 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 132' ' ' ILE . 22.0 m -71.55 -36.98 71.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 1.5900000000000001 109.991 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.715 ' HA ' HG21 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -63.04 -38.38 90.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 2.2799999999999998 110.015 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.803 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -76.72 -56.01 4.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.636 -1.386 . . . . 0.81000000000000005 109.636 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 133' ' ' SER . 5.7 tp -50.11 -44.78 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -1.198 . . . . 1.1299999999999999 110.129 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.95 ' HB3' HD11 ' A' ' 35' ' ' ILE . 69.4 m -72.22 -53.31 12.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 1.3999999999999999 110.042 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -43.53 -41.03 4.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 2.4199999999999999 109.99 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -33.66 26.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 2.0600000000000001 110.243 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -59.12 -44.37 92.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 2.3900000000000001 110.468 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.584 HG11 ' HD2' ' A' ' 32' ' ' LYS . 5.6 t -108.3 -32.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.96 . . . . 2.2000000000000002 110.517 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 123.55 -54.1 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.546 -1.422 . . . . 2.29 109.546 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.6 t70 179.61 90.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 3.5899999999999999 110.254 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.584 ' HD2' HG11 ' A' ' 29' ' ' VAL . 15.0 mttt -141.61 -137.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 3.5 110.173 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.81 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.9 mt -116.39 -123.07 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 3.7200000000000002 110.07 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.028 HD13 HD13 ' A' ' 140' ' ' LEU . 0.5 OUTLIER 50.45 5.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.53 -0.731 . . . . 1.99 111.305 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.95 HD11 ' HB3' ' A' ' 25' ' ' CYS . 3.5 mt -121.2 109.27 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.95 -1.094 . . . . 2.21 110.724 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.777 ' HB2' HD12 ' A' ' 8' ' ' LEU . 6.7 m-20 -143.1 91.75 2.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.8799999999999999 109.986 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 2.8 m -69.4 137.97 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.6200000000000001 110.221 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.017 ' C ' HG22 ' A' ' 10' ' ' VAL . . . -151.61 177.18 10.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.94999999999999996 110.315 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -162.71 144.99 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 1.23 110.176 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -109.0 38.93 2.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 1.9399999999999999 110.193 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -160.72 87.04 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 1.8600000000000001 110.214 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.26 68.7 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.517 -1.433 . . . . 2.1600000000000001 109.517 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' SER . 2.1 m-85 -108.39 -61.05 1.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -1.164 . . . . 3.0299999999999998 110.172 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.421 ' O ' HD11 ' A' ' 15' ' ' ILE . 2.2 m170 -92.05 91.22 7.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 2.6200000000000001 110.191 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 64.5 t -136.06 162.77 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 1.98 110.229 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.418 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 53.61 37.12 55.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 1.6299999999999999 109.561 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 48' ' ' SER . 11.1 pt20 -172.11 -144.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -1.127 . . . . 1.77 110.196 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HG ' ' HH ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER 57.27 110.7 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 1.8600000000000001 110.167 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.8 Cg_endo -69.46 92.37 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.012 1.533 . . . . 1.78 110.45 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 1.2 m-20 -86.48 19.02 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 2.8399999999999999 110.207 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -75.43 -27.93 59.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.247 -0.908 . . . . 1.4299999999999999 109.077 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.603 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 45.0 mtt180 -72.6 -51.65 18.8 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.822 -0.751 . . . . 3.2200000000000002 109.369 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 t -63.55 -49.83 71.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -0.794 . . . . 1.51 109.615 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.511 ' CD ' HD11 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -60.42 -39.92 89.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.274 -0.891 . . . . 2.2000000000000002 109.305 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -59.42 -67.68 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 3.23 109.542 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.57 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 22.0 t -48.41 -34.21 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 1.8999999999999999 109.239 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.936 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.22 -54.93 41.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 1.25 109.605 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -68.54 -20.36 64.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 2.6400000000000001 109.706 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 2.4 t -87.65 -13.58 42.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.357 -0.839 . . . . 1.49 110.103 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -114.77 -30.7 6.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 1.6000000000000001 109.326 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.707 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 136.22 79.73 0.1 OUTLIER Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.922 -1.271 . . . . 1.25 109.922 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.936 HG11 ' SG ' ' A' ' 57' ' ' CYS . 40.6 t -159.61 123.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -1.079 . . . . 1.8 110.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.14 105.05 14.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 2.46 110.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.691 HD12 HE21 ' A' ' 67' ' ' GLN . 35.6 pt -120.73 -145.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 2.0299999999999998 110.237 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.488 ' N ' HG13 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -170.03 -64.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 3.6800000000000002 110.229 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' A' ' 65' ' ' SER . 15.7 mmtt -142.25 145.93 34.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 5.8300000000000001 110.126 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.691 HE21 HD12 ' A' ' 64' ' ' ILE . 32.3 mm-40 -122.11 56.65 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 2.77 110.258 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ALA . 1.5 ttp85 -69.18 71.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 4.2599999999999998 110.182 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB1' ' O ' ' A' ' 13' ' ' GLY . . . -42.51 136.28 2.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 1.3799999999999999 110.236 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 ptt-85 -140.34 158.44 44.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 2.1499999999999999 110.203 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.55 145.32 55.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 2.2400000000000002 110.197 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 72' ' ' ILE . 6.6 tt -89.96 128.76 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 1.49 110.213 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.2 p -86.22 -142.75 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 2.1099999999999999 110.213 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -109.43 -5.98 15.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 3.4100000000000001 110.222 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -75.19 -21.34 58.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.3300000000000001 110.247 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 4.2 p-10 -44.68 -28.81 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 2.46 110.194 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.578 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 25.1 m-85 -79.63 -46.49 17.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 1.55 110.248 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -95.06 8.42 43.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 1.9299999999999999 110.209 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.59 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 14.0 tptt -102.62 -2.76 27.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 2.7799999999999998 110.228 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.788 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 91.8 m-85 -151.62 -157.56 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 1.71 110.298 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.3 -26.28 2.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 2.3300000000000001 110.551 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' A' ' 143' ' ' HIS . 97.0 t -136.94 150.88 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.052 . . . . 1.26 110.576 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.676 HG21 ' CD1' ' A' ' 94' ' ' ILE . 1.7 mp -123.24 116.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.824 . . . . 0.83999999999999997 109.902 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.807 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -103.12 118.82 37.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.80000000000000004 110.483 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -109.61 112.72 24.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.78000000000000003 110.065 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 5.0 mp -59.48 -84.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 1.23 110.356 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.62 ' O ' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -62.77 159.81 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 2.02 110.273 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 2.0899999999999999 110.184 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -52.81 -40.16 63.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 1.6200000000000001 110.165 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 87' ' ' ASP . 2.8 mt -65.2 -51.73 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 1.7 110.189 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.539 HD12 ' HB3' ' A' ' 85' ' ' ALA . 0.5 OUTLIER -61.29 -43.55 98.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.92000000000000004 110.378 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 t -64.81 -48.62 73.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.917 . . . . 1.1899999999999999 110.264 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -64.65 -63.67 1.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 1.73 110.265 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.676 ' CD1' HG21 ' A' ' 83' ' ' ILE . 6.1 tt -42.76 -38.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 1.4299999999999999 110.248 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.496 ' N ' HG23 ' A' ' 94' ' ' ILE . 28.6 t-20 -71.9 -24.9 61.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 1.9399999999999999 110.214 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 93' ' ' ASP . 42.7 t -76.88 -2.02 31.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 1.3999999999999999 110.225 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.0 ptt? -123.97 -25.33 4.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 1.1200000000000001 110.219 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 1.4 mtpt -49.04 143.02 9.16 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 1.04 110.26 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.09 -159.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.991 1.522 . . . . 1.4399999999999999 110.438 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.84 2.62 15.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.86 . . . . 2.0800000000000001 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -149.16 108.11 3.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 3.3799999999999999 110.263 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.4 p -149.48 -173.79 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.887 . . . . 1.95 110.222 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 17.08 7.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 2.8399999999999999 110.218 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.46 157.93 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.88 110.208 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -115.43 157.23 24.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.281 -0.887 . . . . 2.5699999999999998 110.177 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.6 t -118.61 114.51 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 1.4299999999999999 110.185 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.569 HG11 ' CE1' ' A' ' 143' ' ' HIS . 27.6 m -121.58 148.19 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 1.4099999999999999 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 109' ' ' PHE . 1.3 tp -85.68 152.8 22.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 1.45 110.181 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.522 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 4.4 t80 -115.82 109.3 17.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 2.1699999999999999 110.268 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.494 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER 57.79 156.25 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 2.8399999999999999 110.28 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.494 ' HD2' ' ND2' ' A' ' 110' ' ' ASN . 47.0 Cg_endo -74.83 174.26 13.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.039 1.547 . . . . 2.6299999999999999 110.28 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.85 52.33 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 4.0899999999999999 110.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -145.9 -47.03 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 2.9500000000000002 110.251 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.39 -102.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 2.1499999999999999 109.552 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 115' ' ' VAL . 30.8 m -54.55 105.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 1.9199999999999999 110.225 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -148.22 29.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 4.1500000000000004 110.247 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.512 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 6.9 t0 -48.95 112.41 2.43 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 4.1399999999999997 110.199 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 46.8 Cg_endo -72.73 -93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.939 1.494 . . . . 3.5600000000000001 110.427 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 168.12 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 3.8700000000000001 110.178 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.19 -46.99 0.34 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 6.1500000000000004 110.254 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.59 167.07 10.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 2.27 110.227 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.548 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -88.24 32.68 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 2.6299999999999999 110.185 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.91 16.61 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 2.1600000000000001 110.221 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -118.91 -44.12 0.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.497 -1.441 . . . . 1.3200000000000001 109.497 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 5.2 m-85 -44.17 -48.15 23.76 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.169 . . . . 2.0899999999999999 110.396 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 46.7 Cg_endo -72.59 -54.53 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.625 1.329 . . . . 1.0800000000000001 110.349 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 23.1 m -62.13 -53.88 49.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 1.6000000000000001 110.142 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.657 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 10.7 ttp -41.85 -65.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 1.0900000000000001 110.108 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 50.2 t80 -56.25 -44.78 80.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 1.48 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -44.06 -59.73 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 1.1100000000000001 109.99 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 25.7 m -70.75 -42.31 70.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.6299999999999999 109.867 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.791 HD11 ' SG ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -41.58 -43.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 1.5 109.904 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.777 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.2 -40.49 7.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 1.5900000000000001 110.241 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 33.5 tttt -55.47 -16.64 3.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 3.5699999999999998 110.227 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.479 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 4.2 tp10 -117.9 16.13 14.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 3.0899999999999999 109.809 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.553 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -102.97 -21.2 13.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 2.8799999999999999 110.162 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 19.4 mttt -81.93 -47.04 1.01 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 3.1200000000000001 110.148 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -77.79 -2.52 12.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.982 1.517 . . . . 1.04 110.271 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 143' ' ' HIS . 48.8 t80 -111.03 -72.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 1.77 110.116 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.028 HD13 HD13 ' A' ' 34' ' ' ILE . 1.8 tp -47.83 -49.34 29.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 1.6100000000000001 110.052 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.742 HG23 ' OXT' ' A' ' 146' ' ' ILE . 6.7 m -58.3 -29.19 65.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.1699999999999999 110.349 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -106.84 5.93 28.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 2.2999999999999998 110.397 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.915 ' CD2' HG11 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -96.33 -6.16 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.129 -0.982 . . . . 2.21 110.348 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.469 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 124.77 28.47 1.15 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 2.1499999999999999 109.726 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -144.36 -103.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -1.182 . . . . 2.3799999999999999 110.191 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.953 HD13 ' OXT' ' A' ' 146' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.0 -1.0 . . . . 3.0600000000000001 110.148 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.558 0.694 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -119.42 145.07 46.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 34' ' ' ILE . 16.0 mtmt -125.7 -156.21 0.72 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.058 -1.026 . . . . 0.0 110.975 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.863 ' HB1' ' OD2' ' A' ' 36' ' ' ASP . . . -124.88 157.13 36.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.678 -0.639 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.689 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 13.6 t -138.75 121.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.692 HD13 ' CD2' ' A' ' 80' ' ' PHE . 7.7 tp -76.91 103.39 6.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 18.3 m-85 -83.16 86.28 7.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 38' ' ' ALA . 6.7 t -93.86 154.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.883 ' SG ' HD22 ' A' ' 86' ' ' LEU . 59.2 m -146.72 -71.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.136 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.447 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 175.96 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.262 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 80.47 -2.3 78.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.51 ' CB ' ' HB2' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 67.86 8.42 6.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.744 HG23 ' OD2' ' A' ' 50' ' ' ASP . 24.5 mt -118.61 -22.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.151 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 11' ' ' CYS . 14.5 m -86.09 111.64 20.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.267 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.61 ' HB2' HD22 ' A' ' 86' ' ' LEU . 1.1 mpt_? 60.9 12.28 3.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.535 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -78.85 -55.18 1.0 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.465 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 47.4 Cg_endo -74.23 1.34 7.39 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.844 1.444 . . . . 0.0 110.576 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -97.54 -28.34 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.347 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.826 ' HA ' HD11 ' A' ' 132' ' ' ILE . 63.8 m -74.1 -33.95 63.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.722 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -63.78 -45.66 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.462 -0.773 . . . . 0.0 110.304 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -76.77 -51.58 6.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.152 HD12 ' CD2' ' A' ' 129' ' ' PHE . 1.1 tt -52.01 -45.22 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 0.0 110.357 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.596 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 88.4 m -75.76 -51.85 11.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.179 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 3.6 mtp85 -44.12 -40.95 5.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.904 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -80.48 -43.01 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.721 ' SD ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -58.38 -52.6 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 0.0 110.437 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.504 HG13 HD22 ' A' ' 145' ' ' LEU . 2.8 t -87.8 -34.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.369 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.38 -82.84 0.33 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.446 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 16.4 t0 -156.39 85.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -1.09 . . . . 0.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 31' ' ' ASP . 18.0 mmtm -129.8 -139.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.125 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.5 mt -119.15 -33.02 4.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.987 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.706 ' CA ' ' HA ' ' A' ' 6' ' ' ALA . 2.4 pp -32.17 -31.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.647 -0.658 . . . . 0.0 111.145 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.722 HG23 ' HA ' ' A' ' 22' ' ' GLU . 1.7 mt -73.96 88.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.483 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.863 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 49.0 m-20 -127.33 68.75 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.117 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -54.77 139.41 39.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.766 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -153.73 -179.09 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 14' ' ' ASN . . . -150.07 -173.7 4.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 40' ' ' THR . 5.3 t -162.04 67.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.908 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 -68.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 110.206 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -22.6 39.63 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 45' ' ' VAL . 9.8 m-85 -62.69 -63.44 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.44 70.88 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.859 HG22 ' HB1' ' A' ' 69' ' ' ALA . 44.5 t -144.75 142.27 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.95 18.98 58.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -168.11 -142.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 110.255 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 15' ' ' ILE . 0.6 OUTLIER 62.1 108.36 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.208 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 103.06 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.072 1.564 . . . . 0.0 110.486 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' A' ' 15' ' ' ILE . 61.5 m-20 -95.99 20.51 9.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -74.39 -27.76 60.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.949 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.595 ' HB3' ' CG ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -74.01 -52.07 13.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.296 179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.512 ' O ' HG12 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -61.37 -51.67 67.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 12.3 tp60 -61.37 -41.01 96.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 109.263 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -54.2 -66.16 0.45 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.416 -0.803 . . . . 0.0 109.467 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.575 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 10.0 p -53.41 -32.01 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.911 . . . . 0.0 109.216 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.959 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -56.3 -52.12 65.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.534 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -24.34 60.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.302 -0.874 . . . . 0.0 109.651 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -81.74 -12.42 58.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.3 m120 -114.59 -29.07 6.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.732 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 131.71 81.02 0.2 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.959 HG11 ' SG ' ' A' ' 57' ' ' CYS . 26.0 t -160.36 133.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -1.131 . . . . 0.0 110.14 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -122.15 93.15 3.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 0.0 110.2 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.472 HD12 ' OE1' ' A' ' 67' ' ' GLN . 26.0 pt -97.54 165.5 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.83 37.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.48 85.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 0.0 110.183 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.546 ' NE2' ' HB3' ' A' ' 19' ' ' PRO . 5.0 mp0 -105.18 -79.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.148 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' ALA . 7.3 ttp180 43.61 75.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 110.242 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.859 ' HB1' HG22 ' A' ' 45' ' ' VAL . . . -42.43 149.22 0.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.87 -170.44 3.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -107.66 155.43 20.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.68 155.78 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.02 168.99 9.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -16.31 23.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -22.57 62.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.182 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 28.4 p-10 -48.38 -37.88 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.241 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CE2' ' HD3' ' A' ' 99' ' ' PRO . 20.8 m-85 -65.85 -10.87 42.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 110.21 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.414 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 27.7 t -144.52 30.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.58 ' CG ' ' CE2' ' A' ' 80' ' ' PHE . 15.7 tptt -111.17 -5.33 14.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.692 ' CD2' HD13 ' A' ' 8' ' ' LEU . 87.0 m-85 -151.7 -139.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.235 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 -53.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.918 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 74.6 t -119.13 111.04 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.467 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.443 ' HB ' HG22 ' A' ' 106' ' ' VAL . 3.9 mt -84.29 110.39 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.053 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.73 135.78 38.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 110.386 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -117.43 121.75 41.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.883 HD22 ' SG ' ' A' ' 11' ' ' CYS . 2.2 mp -66.09 -80.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.451 ' C ' HD12 ' A' ' 90' ' ' ILE . 1.3 t0 -67.4 178.72 1.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.254 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -85.88 -35.07 20.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -51.46 -33.51 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 110.229 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.9 mt -71.02 -52.53 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.5 OUTLIER -64.12 -34.4 77.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.23 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 t -77.86 -46.97 19.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 89' ' ' SER . 5.4 m-20 -67.09 -57.41 6.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 90' ' ' ILE . 3.9 tt -46.37 -40.82 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.53 ' N ' HG23 ' A' ' 94' ' ' ILE . 8.3 t-20 -68.23 -24.93 64.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 93' ' ' ASP . 8.5 t -73.19 -17.08 61.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.537 ' HE1' HG13 ' A' ' 94' ' ' ILE . 9.3 ptt? -109.68 -27.14 9.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 2.3 mtpt -42.73 138.65 2.21 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.591 ' HD3' ' CE2' ' A' ' 77' ' ' PHE . 46.0 Cg_endo -73.26 -160.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.094 1.576 . . . . 0.0 110.422 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.3 t -113.36 15.78 19.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 110.153 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -155.02 104.95 2.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.2 p -137.33 -179.91 6.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.89 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.414 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -127.05 -5.54 6.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.52 -168.06 1.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.253 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.64 150.45 41.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 83' ' ' ILE . 45.1 t -116.37 142.6 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.209 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 106' ' ' VAL . 13.1 m -151.64 155.36 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.523 ' CG ' ' OD1' ' A' ' 110' ' ' ASN . 1.6 tp -89.28 142.2 27.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 132' ' ' ILE . 36.1 t80 -129.11 76.14 1.7 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.523 ' OD1' ' CG ' ' A' ' 108' ' ' LEU . 6.8 p-10 -176.9 166.24 1.42 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.7 Cg_endo -75.53 175.89 10.69 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.043 1.549 . . . . 0.0 110.296 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.0 Cg_endo -73.72 4.72 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.932 1.491 . . . . 0.0 110.489 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -122.36 -14.86 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.217 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.04 141.56 8.91 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 4.0 m -80.06 4.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -1.138 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 14.5 t70 178.01 169.4 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.237 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.563 ' CB ' ' CD ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -179.8 -59.35 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 117' ' ' ASP . 46.9 Cg_endo -73.13 88.76 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.94 1.494 . . . . 0.0 110.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.525 ' CE1' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -65.78 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.942 . . . . 0.0 110.17 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.474 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 1.7 t80 66.66 -62.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 119' ' ' TYR . 52.4 p -70.47 144.73 51.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.465 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 5.5 p -80.89 48.59 1.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.72 42.45 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -159.65 -37.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.649 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 47.5 m-85 -52.15 -44.98 93.94 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -1.163 . . . . 0.0 110.572 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 46.8 Cg_endo -74.13 -59.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.685 1.36 . . . . 0.0 110.286 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -55.3 -43.12 74.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.722 ' O ' HG22 ' A' ' 132' ' ' ILE . 27.1 ttp -48.6 -80.55 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 1.152 ' CD2' HD12 ' A' ' 24' ' ' ILE . 6.1 t80 -49.01 -55.51 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.088 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -44.21 -28.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 110.513 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.8 m -88.85 -60.32 1.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.943 HG12 HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -50.46 -19.48 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.268 179.293 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 1.048 ' CB ' HD11 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -98.15 -48.68 5.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.894 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 1.9 mmmm -71.02 -2.71 16.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 110.131 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.15 5.22 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.839 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.673 ' HA ' ' HE3' ' A' ' 136' ' ' MET . 1.5 tpt -82.97 11.77 5.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.394 -0.816 . . . . 0.0 110.193 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.534 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 2.3 mmtt -90.51 -55.16 0.28 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.213 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 48.2 Cg_endo -76.26 -2.87 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CD1' ' CE ' ' A' ' 136' ' ' MET . 25.1 t80 -108.16 -51.92 2.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.259 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.721 HD22 ' SD ' ' A' ' 28' ' ' MET . 0.8 OUTLIER -71.67 -55.95 6.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.586 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 56.3 m -41.93 -36.71 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 110.468 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.22 -63.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.724 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -100.96 63.72 1.03 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.752 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -179.8 -32.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.015 ' HG ' HG22 ' A' ' 146' ' ' ILE . 0.6 OUTLIER 172.56 -91.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.472 -1.016 . . . . 0.0 109.864 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.015 HG22 ' HG ' ' A' ' 145' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.129 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.241 0.543 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.568 ' HE3' ' CA ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -76.58 -175.31 3.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.293 -0.879 . . . . 0.0 109.05 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.759 ' CD ' HD12 ' A' ' 145' ' ' LEU . 33.0 mtpt -145.9 177.37 8.98 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.901 -1.124 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.061 ' HB1' HD11 ' A' ' 34' ' ' ILE . . . -145.77 124.4 12.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.066 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 18.7 t -114.43 125.37 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.965 HD11 ' HB2' ' A' ' 38' ' ' ALA . 50.2 tp -79.24 98.94 6.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 1.116 ' CD1' HG23 ' A' ' 35' ' ' ILE . 96.7 m-85 -85.98 104.63 15.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.893 HG22 ' HB3' ' A' ' 38' ' ' ALA . 3.8 t -103.11 149.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.659 ' SG ' HD22 ' A' ' 86' ' ' LEU . 24.2 m -127.08 -151.33 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.92 . . . . 0.0 110.021 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -87.12 -30.46 21.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -144.18 9.99 2.0 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.99 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 43.5 t-20 59.26 49.68 8.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 0.0 110.29 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 69' ' ' ALA . 15.3 mt -136.75 -57.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.2 t -124.37 -138.42 0.29 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.288 -0.883 . . . . 0.0 110.133 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.85 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.38 -55.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.392 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.76 ' HB2' HD21 ' A' ' 86' ' ' LEU . 1.3 m -161.08 53.65 0.49 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.477 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.0 Cg_endo -75.31 -23.78 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.031 1.542 . . . . 0.0 110.308 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.999 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . . . -78.49 6.82 7.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.976 ' HB3' HG21 ' A' ' 35' ' ' ILE . 6.0 t -61.24 -32.04 71.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.819 ' HA ' HD13 ' A' ' 35' ' ' ILE . 2.1 tt0 -56.03 -54.05 49.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -76.48 -39.31 30.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.969 HD12 ' CD2' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -53.87 -47.21 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.243 . . . . 0.0 110.037 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.897 ' CB ' HD11 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.28 -49.97 11.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 9.0 mtt180 -54.23 -31.0 52.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.68 -40.83 12.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.496 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.55 -30.95 70.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.701 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.789 ' CB ' HD21 ' A' ' 33' ' ' LEU . 83.1 t -124.72 -22.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.92 -82.4 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.462 ' C ' ' CG ' ' A' ' 32' ' ' LYS . 2.7 m-20 -149.76 68.14 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.261 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.77 ' O ' HD23 ' A' ' 33' ' ' LEU . 2.0 mtpm? -148.9 37.86 0.81 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 29' ' ' VAL . 0.4 OUTLIER 166.6 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.437 -0.789 . . . . 0.0 109.591 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.061 HD11 ' HB1' ' A' ' 6' ' ' ALA . 2.7 pp -42.59 168.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.116 HG23 ' CD1' ' A' ' 9' ' ' PHE . 4.7 mp -121.06 102.32 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 80' ' ' PHE . 9.4 m-20 -88.31 114.21 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.062 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.7 m -75.17 116.3 15.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.032 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.965 ' HB2' HD11 ' A' ' 8' ' ' LEU . . . -120.85 175.18 6.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.99 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -161.16 149.3 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 t -116.75 -2.45 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.09 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.28 170.81 13.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 110.145 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.52 50.15 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -17.36 32.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -1.165 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.443 ' O ' HD11 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -141.97 80.47 1.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 69' ' ' ALA . 86.5 t -134.44 146.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.07 58.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 48' ' ' SER . 1.3 pt20 -158.94 -146.79 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -1.147 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 65.12 99.68 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 100.89 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.083 1.57 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 1.6 t0 -89.72 26.83 1.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.547 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -76.32 -31.92 58.42 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.225 -0.922 . . . . 0.0 109.051 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -70.31 -49.7 46.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.262 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.531 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.3 t -63.35 -53.49 51.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.573 -0.704 . . . . 0.0 109.683 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.682 ' HB2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -61.04 -31.2 70.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.257 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.4 -66.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.383 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.557 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 35.7 m -52.79 -33.36 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.203 -0.935 . . . . 0.0 109.115 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.999 ' SG ' ' HB2' ' A' ' 20' ' ' ALA . 32.0 m -57.47 -53.07 62.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 109.508 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -23.17 63.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.99 -11.9 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 110.061 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.6 m-80 -112.44 -23.77 10.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.212 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 124.17 75.79 0.29 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.659 HG11 ' CB ' ' A' ' 20' ' ' ALA . 55.0 t -158.09 102.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -1.145 . . . . 0.0 110.205 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -78.34 74.26 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.988 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 54' ' ' GLN . 3.4 pt -60.1 -173.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -160.22 70.07 0.41 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.22 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 90.3 mm-40 -56.52 -60.0 4.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.218 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.38 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.269 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.644 ' HB2' HG12 ' A' ' 15' ' ' ILE . . . -60.59 131.4 50.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -140.44 152.23 45.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.245 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.06 144.18 38.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.195 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.592 HD12 ' HB1' ' A' ' 38' ' ' ALA . 19.7 tt -75.8 145.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.281 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.778 HG22 ' OD1' ' A' ' 76' ' ' ASP . 9.1 t -89.72 -146.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.13 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -118.6 -5.29 10.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.31 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.63 ' H ' HG23 ' A' ' 73' ' ' THR . . . -96.67 -8.43 31.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.778 ' OD1' HG22 ' A' ' 73' ' ' THR . 1.1 m-20 -45.1 -47.63 12.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.587 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 53.5 m-85 -48.61 -36.71 16.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.9 t -102.07 -16.04 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.16 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -66.25 -25.56 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.194 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.878 ' CE2' HD13 ' A' ' 8' ' ' LEU . 7.4 m-85 -132.28 169.6 16.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.1 -33.78 20.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.377 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' CD2' ' A' ' 143' ' ' HIS . 47.6 t -134.23 153.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.31 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.521 HG23 ' HB3' ' A' ' 8' ' ' LEU . 4.8 mt -129.75 128.3 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 109' ' ' PHE . . . -126.12 143.37 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.464 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -113.67 156.49 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.85 HD23 ' HB3' ' A' ' 17' ' ' ARG . 1.2 tp -85.3 -52.88 5.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 3.7 m-20 -99.56 -174.87 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.905 . . . . 0.0 110.244 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.58 -35.74 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -46.13 -41.27 12.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 87' ' ' ASP . 1.4 mp -71.02 -54.15 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.152 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -60.49 -15.81 30.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 t -93.26 -41.26 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.18 -16.88 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.182 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.543 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.3 tt -74.14 -40.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.168 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.524 ' N ' HG23 ' A' ' 94' ' ' ILE . 29.6 p30 -68.12 -9.76 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.65 -38.71 23.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.883 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.543 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.1 ptt? -84.1 -34.3 24.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.239 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -52.62 126.55 40.09 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 100' ' ' SER . 45.2 Cg_endo -73.39 -87.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.053 1.554 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 169.74 -23.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.4 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.84 43.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.128 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.8 p -99.47 -145.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.267 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 27.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.03 32.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.45 146.05 45.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 9.8 m -108.41 132.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' ALA . 22.6 m -131.27 156.51 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.256 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.427 ' HB2' HD13 ' A' ' 91' ' ' LEU . 26.4 tp -92.46 102.4 14.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.123 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.58 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . 4.9 t80 -81.09 82.61 6.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.134 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 7.7 t30 -170.09 142.16 1.84 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.497 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.5 Cg_endo -74.35 175.01 11.56 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.94 1.495 . . . . 0.0 110.35 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.02 52.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.977 1.514 . . . . 0.0 110.434 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.59 -37.18 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.206 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 101.54 2.51 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.474 HG23 ' OD1' ' A' ' 110' ' ' ASN . 71.4 t -57.66 98.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -1.209 . . . . 0.0 110.118 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.23 148.03 26.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 110.197 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 87.73 6.52 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.89 173.47 13.48 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.005 1.529 . . . . 0.0 110.406 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -115.75 161.92 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.23 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 50.38 41.65 25.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.155 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -150.89 -174.76 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.3 p -143.79 40.17 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.892 . . . . 0.0 110.174 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.32 54.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.56 ' HA2' ' CG2' ' A' ' 127' ' ' THR . . . -179.08 -32.84 0.06 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.623 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 8.1 m-85 -41.76 -50.29 10.05 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 110.731 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 43.4 Cg_endo -71.38 -74.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.81 1.426 . . . . 0.0 110.975 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.56 ' CG2' ' HA2' ' A' ' 124' ' ' GLY . 15.1 t -39.95 -40.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.168 -0.958 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.797 ' O ' HG22 ' A' ' 132' ' ' ILE . 9.6 ttp -55.17 -78.95 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.188 -0.945 . . . . 0.0 109.823 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.969 ' CD2' HD12 ' A' ' 24' ' ' ILE . 2.7 t80 -42.6 -51.29 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.167 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.441 ' N ' ' HD1' ' A' ' 129' ' ' PHE . . . -58.81 -22.41 58.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.5 t -90.32 -51.28 5.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.04 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.886 HD11 ' CB ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -61.8 -16.96 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.786 ' HB2' HD11 ' A' ' 24' ' ' ILE . 2.3 t -96.0 -51.05 4.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.557 -0.714 . . . . 0.0 109.849 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.22 -20.84 65.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.974 . . . . 0.0 110.111 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 131' ' ' SER . 0.2 OUTLIER -76.93 -30.17 55.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.587 ' CE ' ' HA ' ' A' ' 133' ' ' SER . 0.6 OUTLIER -77.57 5.23 9.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.209 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.538 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 3.0 mmtt -89.24 -54.65 0.31 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.35 -10.73 17.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.041 1.548 . . . . 0.0 110.426 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 32.9 t80 -102.17 -77.23 0.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.616 HD21 HD22 ' A' ' 33' ' ' LEU . 14.6 tp -40.81 -62.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.382 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.845 HG23 HD12 ' A' ' 146' ' ' ILE . 30.6 m -41.66 -29.13 0.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LEU . 3.3 mm-40 -101.59 -25.82 13.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 1.5 t60 -66.32 -21.66 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.02 36.42 0.18 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.759 HD12 ' CD ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -173.38 93.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 110.14 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.845 HD12 HG23 ' A' ' 141' ' ' THR . 4.2 tp . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.246 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.51 ' O ' ' CD2' ' A' ' 145' ' ' LEU . 2.2 mm-40 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.249 0.547 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -80.47 171.2 15.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.309 -0.869 . . . . 0.0 108.762 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 9.4 mtpp -151.8 164.12 37.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.86 -1.15 . . . . 0.0 111.26 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.872 ' HA ' ' CG1' ' A' ' 34' ' ' ILE . . . -105.91 99.93 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.75 -0.593 . . . . 0.0 109.773 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 33' ' ' LEU . 12.6 t -104.01 108.35 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 38' ' ' ALA . 29.7 tp -92.56 111.04 22.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 1.071 ' CD1' HG23 ' A' ' 35' ' ' ILE . 12.5 m-85 -85.97 128.48 34.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.814 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.688 HG23 ' C ' ' A' ' 38' ' ' ALA . 10.9 p -143.37 172.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -0.981 . . . . 0.0 110.633 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.946 ' O ' HD12 ' A' ' 90' ' ' ILE . 16.8 t -153.6 -69.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 110.126 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 172.99 84.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.919 . . . . 0.0 110.285 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.67 ' H ' ' HB1' ' A' ' 39' ' ' ALA . . . 134.06 -31.67 2.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 6.4 t30 72.15 -0.15 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -1.183 . . . . 0.0 110.352 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.551 HG23 ' OG ' ' A' ' 48' ' ' SER . 23.4 mt -96.71 -85.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -85.27 44.17 1.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.613 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 9.7 mmt180 -115.73 69.14 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.849 ' OG ' HD21 ' A' ' 86' ' ' LEU . 16.5 m 44.18 57.29 13.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.9 . . . . 0.0 110.323 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HB3' ' OE1' ' A' ' 67' ' ' GLN . 43.7 Cg_endo -71.2 -13.18 30.88 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.971 1.511 . . . . 0.0 110.067 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.56 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -82.16 6.71 15.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.778 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.954 ' HB3' HG22 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -63.76 -38.78 92.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.647 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -66.57 -44.93 80.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.805 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.9 -54.65 13.44 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.634 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 4.8 tp -50.86 -44.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -1.174 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.707 ' HB2' HD12 ' A' ' 35' ' ' ILE . 5.8 t -71.31 -32.12 68.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -62.56 -55.42 27.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -34.11 66.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 110.492 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.56 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 6.1 ttm -73.05 -59.33 2.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG21 HD22 ' A' ' 140' ' ' LEU . 11.5 m -141.53 46.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 0.0 110.396 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . -59.59 78.14 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER 165.55 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -1.102 . . . . 0.0 110.123 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.914 ' HB3' HD11 ' A' ' 145' ' ' LEU . 11.6 mttp -139.42 112.93 8.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.737 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.989 HD22 ' HB3' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 77.54 65.02 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.043 0.925 . . . . 0.0 109.167 -179.11 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.872 ' CG1' ' HA ' ' A' ' 6' ' ' ALA . 2.6 pp -59.57 145.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.82 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.071 HG23 ' CD1' ' A' ' 9' ' ' PHE . 8.5 mt -119.31 89.87 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 69.1 m-20 -85.19 178.27 7.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 111.006 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 5.7 p -130.55 123.22 29.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.688 ' C ' HG23 ' A' ' 10' ' ' VAL . . . -133.06 -160.45 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.125 -0.985 . . . . 0.0 110.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.67 ' HB1' ' H ' ' A' ' 13' ' ' GLY . . . -171.55 144.43 1.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.524 ' OG1' HD22 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -81.3 -49.16 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.158 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.6 t -128.28 141.29 51.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.0 97.56 0.24 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.97 23.53 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.326 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.88 26.79 5.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 45' ' ' VAL . 16.0 m -64.96 125.27 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.258 -0.901 . . . . 0.0 110.304 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.68 34.0 0.62 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -101.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -1.114 . . . . 0.0 110.172 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 15' ' ' ILE . 2.9 t 61.26 71.69 0.76 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.206 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.51 66.42 1.62 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.0 1.526 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 21.5 m-20 -92.22 35.84 0.99 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 110.367 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -31.62 58.48 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mpt_? -73.94 -48.77 28.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.299 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -62.25 -48.21 80.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.459 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 1.5 tt0 -64.65 -36.37 84.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 109.262 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.3 ttpt -58.75 -64.74 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.258 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.579 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 9.0 p -54.81 -35.53 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.802 ' O ' HG22 ' A' ' 62' ' ' VAL . 4.3 m -53.51 -54.11 41.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.777 . . . . 0.0 109.411 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 54' ' ' GLN . 15.6 mtmt -69.03 -27.42 65.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 t -77.57 -14.08 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.89 -32.36 6.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.814 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 114.1 85.68 1.37 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.991 ' O ' HG23 ' A' ' 64' ' ' ILE . 2.5 m -162.65 87.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -1.084 . . . . 0.0 110.111 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -52.85 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.991 HG23 ' O ' ' A' ' 62' ' ' VAL . 1.2 pt -103.71 -158.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' HD12 ' A' ' 64' ' ' ILE . 68.7 m -144.75 -170.94 3.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.155 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 68' ' ' ARG . 21.2 mmtt -80.42 4.16 19.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 76.6 mm-40 59.75 -75.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 65.91 104.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 14' ' ' ASN . . . -61.43 113.13 2.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.433 ' CD ' ' O ' ' A' ' 71' ' ' GLN . 8.0 tmm_? -135.98 143.45 44.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.203 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.433 ' O ' ' CD ' ' A' ' 70' ' ' ARG . 1.6 tt0 -72.53 139.47 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.248 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.445 HD11 ' CB ' ' A' ' 76' ' ' ASP . 4.0 tt -95.46 136.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 178.79 6.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.47 4.05 33.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.88 -12.33 55.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 7.6 p-10 -49.97 -24.42 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.141 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.593 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.2 m-85 -75.83 -10.11 59.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 110.142 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.55 -45.48 4.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 80' ' ' PHE . 7.9 tptp -57.81 -51.2 70.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 11.8 m-85 -115.57 144.23 44.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.349 -0.845 . . . . 0.0 110.13 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.408 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 56.0 m-20 -91.32 -24.04 19.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 9.9 t -113.71 138.71 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.239 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.6 mt -137.54 115.38 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.066 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.497 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . . . -91.5 141.63 28.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.27 141.25 48.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.203 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.849 HD21 ' OG ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -73.33 -52.55 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -107.97 -178.92 3.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.03 -28.39 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.253 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.52 -59.8 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.182 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.946 HD12 ' O ' ' A' ' 11' ' ' CYS . 4.3 tt -51.39 -38.59 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.486 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -74.03 -27.52 60.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.479 ' O ' ' ND2' ' A' ' 95' ' ' ASN . 40.0 t -78.64 -29.38 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 0.0 110.2 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.98 -45.22 8.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.558 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.4 tt -48.45 -36.03 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 92' ' ' SER . 20.8 p30 -71.71 -8.99 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -77.72 -20.07 54.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.181 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.558 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.0 ptt? -102.78 -25.28 13.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.593 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -53.38 139.59 47.2 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.185 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.16 169.72 21.56 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.996 1.524 . . . . 0.0 110.415 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -71.58 -6.5 41.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.06 68.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.238 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 30.7 p -83.95 164.0 19.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.19 38.66 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 81' ' ' ASP . . . -157.61 161.42 38.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -122.73 132.41 54.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.9 . . . . 0.0 110.158 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.3 m -96.84 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.357 -0.839 . . . . 0.0 110.187 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 t -96.74 161.66 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.45 113.13 26.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 42.7 t80 -83.73 122.96 29.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.49 170.09 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.6 Cg_endo -75.8 175.62 11.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.026 1.54 . . . . 0.0 110.227 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.57 4.44 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.02 1.537 . . . . 0.0 110.514 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -54.3 -64.43 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 110.145 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.96 130.99 2.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 128' ' ' MET . 10.3 t -124.3 26.52 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 117' ' ' ASP . 1.0 OUTLIER -148.83 -40.91 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.243 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER 66.79 145.3 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.149 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 119' ' ' TYR . 45.9 Cg_endo -73.39 73.29 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 118' ' ' PRO . 26.0 m-85 51.22 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.271 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 121' ' ' SER . 1.7 t80 -152.13 94.53 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' TYR . 6.2 t 43.23 -145.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.465 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 15.1 m -70.25 -19.68 63.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.239 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 128' ' ' MET . . . 142.17 -71.5 0.4 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 3.2 m-85 -42.66 -48.6 13.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.149 . . . . 0.0 110.325 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -72.97 -55.0 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.671 1.353 . . . . 0.0 110.396 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 128' ' ' MET . 67.2 m -63.23 -53.26 55.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.186 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 124' ' ' GLY . 10.7 ttp -40.85 -70.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 66.7 t80 -58.31 -45.47 87.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -43.22 -67.32 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.869 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -65.12 -39.95 93.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.2 -0.938 . . . . 0.0 109.754 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -42.26 -42.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.819 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.554 ' CB ' HD11 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -98.26 -42.92 7.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.335 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 131' ' ' SER . 3.4 mmtt -47.5 -30.19 3.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.2 OUTLIER -105.65 -2.98 22.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.551 ' HB2' ' HA ' ' A' ' 133' ' ' SER . 0.8 OUTLIER -84.98 20.21 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.59 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -105.17 -65.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.153 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 48.3 Cg_endo -73.09 -1.54 10.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.753 1.396 . . . . 0.0 110.492 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.517 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 92.9 t80 -77.02 -76.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 110.339 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.989 ' HB3' HD22 ' A' ' 33' ' ' LEU . 3.1 pp -71.46 -33.51 69.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.297 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.513 HG23 HG22 ' A' ' 146' ' ' ILE . 85.8 m -57.13 -30.11 64.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 144' ' ' GLY . 5.0 mm-40 -104.81 -44.99 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.424 ' CD2' ' O ' ' A' ' 139' ' ' PHE . 14.9 m-70 -43.51 -25.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.068 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 126.96 66.8 0.15 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.914 HD11 ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -153.17 -45.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -1.106 . . . . 0.0 110.226 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.618 HD12 ' CD1' ' A' ' 140' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.441 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.354 0.597 . . . . 0.0 110.363 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.572 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -160.68 -42.86 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 110.446 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 2.0 ptpt 37.43 -155.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.699 -0.626 . . . . 0.0 110.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.836 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -159.91 138.43 10.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.497 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.8 m -103.16 112.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.403 -0.811 . . . . 0.0 109.56 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -59.44 95.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.98 . . . . 0.0 110.328 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.9 OUTLIER -85.79 108.97 18.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.301 -0.874 . . . . 0.0 109.303 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.075 HG13 ' CD1' ' A' ' 90' ' ' ILE . 6.8 p -137.86 171.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 111.088 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.795 ' HA ' HD12 ' A' ' 90' ' ' ILE . 23.9 t -162.74 55.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.895 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.655 HD23 ' HB ' ' A' ' 90' ' ' ILE . 3.8 mm? 59.54 -158.55 0.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.888 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.74 86.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.646 ' ND2' ' O ' ' A' ' 12' ' ' LEU . 13.1 p30 -134.46 5.8 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -1.209 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.853 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.9 mt 57.47 31.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 110.747 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 15' ' ' ILE . 50.4 m 53.55 117.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.123 -0.986 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.734 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -83.21 66.66 8.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.646 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -68.24 -44.94 38.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.789 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.661 ' HA ' HG21 ' A' ' 64' ' ' ILE . 47.0 Cg_endo -74.51 -2.9 13.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.712 1.375 . . . . 0.0 110.781 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.864 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -102.77 -62.27 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.183 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.556 ' SG ' ' CG ' ' A' ' 9' ' ' PHE . 95.4 m -76.52 -48.29 19.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -65.79 -34.19 77.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.801 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.827 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -73.73 -57.16 5.07 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.848 HG12 HG22 ' A' ' 132' ' ' ILE . 8.7 tp -54.22 -40.43 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -1.174 . . . . 0.0 110.075 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 8.5 t -75.43 -67.08 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 ptm180 -41.82 -33.53 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' CG ' ' A' ' 26' ' ' ARG . 5.8 t70 -85.18 -36.32 21.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.452 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.489 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 4.9 ttt -84.29 -0.23 51.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.445 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' A' ' 32' ' ' LYS . 21.2 t -130.13 -43.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.321 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.16 65.54 0.16 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 72.7 m-20 47.81 77.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -1.196 . . . . 0.0 110.282 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.596 ' HG3' HG12 ' A' ' 29' ' ' VAL . 23.6 mmtm -128.54 -137.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.148 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.763 ' O ' HG13 ' A' ' 34' ' ' ILE . 96.4 mt -140.93 -95.12 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.028 HD13 HD13 ' A' ' 140' ' ' LEU . 0.7 OUTLIER 41.79 18.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.597 -0.69 . . . . 0.0 111.234 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -157.95 144.08 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.761 -1.212 . . . . 0.0 110.798 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.945 ' O ' HD13 ' A' ' 8' ' ' LEU . 6.7 m-20 -146.54 105.0 3.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.4 p -68.63 125.74 27.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 110.52 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.049 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -127.2 -169.4 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 110.192 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG23 ' A' ' 10' ' ' VAL . . . -174.79 88.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.878 ' OG1' HD12 ' A' ' 72' ' ' ILE . 18.4 m -71.3 87.96 0.84 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.4 p -159.6 -50.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.1 48.49 25.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.54 -47.06 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -1.132 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.429 ' O ' HG13 ' A' ' 15' ' ' ILE . 49.5 m-70 -94.01 44.0 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.79 156.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 28.09 72.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 48' ' ' SER . 4.3 pt20 -170.34 -147.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -1.124 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.441 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER 61.06 108.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.6 Cg_endo -69.59 99.62 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.513 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -90.5 27.76 1.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.153 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.4 m -74.95 -27.87 60.36 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.268 -0.895 . . . . 0.0 109.043 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.672 ' O ' HG22 ' A' ' 56' ' ' VAL . 11.0 mmt180 -73.48 -51.41 17.23 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.361 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 9.6 p -62.7 -50.85 69.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.781 . . . . 0.0 109.608 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HA ' ' CD1' ' A' ' 64' ' ' ILE . 1.1 tt0 -61.43 -39.39 90.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.256 -0.903 . . . . 0.0 109.31 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -59.23 -70.12 0.17 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 109.59 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 52' ' ' ARG . 35.8 m -48.82 -32.7 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.955 . . . . 0.0 109.19 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 62' ' ' VAL . 1.2 m -58.41 -52.48 65.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.845 . . . . 0.0 109.491 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -24.41 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.5 t -86.01 -10.78 54.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 23.8 m-80 -114.93 -32.32 5.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.775 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 140.88 86.08 0.1 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.827 HG13 ' HA3' ' A' ' 23' ' ' GLY . 20.8 t -161.5 138.37 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -1.102 . . . . 0.0 110.058 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -103.11 95.94 6.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.284 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.661 HG21 ' HA ' ' A' ' 19' ' ' PRO . 6.3 pt -137.52 -171.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 p -176.91 -40.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.273 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 140.88 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.56 133.58 0.62 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -89.43 -141.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.106 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.23 153.2 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.51 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -141.18 -148.37 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.51 ' N ' ' HG3' ' A' ' 70' ' ' ARG . 7.6 tt0 -136.09 162.25 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.952 . . . . 0.0 110.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.878 HD12 ' OG1' ' A' ' 40' ' ' THR . 14.9 mt -77.1 -72.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.156 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER 65.78 -145.59 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -100.39 -14.44 18.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.42 74.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.883 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -53.53 -46.71 70.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.188 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.606 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 26.2 m-85 -67.23 60.57 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.032 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER 169.71 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.933 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 2.8 tptt -73.48 -1.31 17.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.825 ' CD1' ' HB3' ' A' ' 6' ' ' ALA . 79.8 m-85 -154.97 -153.1 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -130.25 -13.69 3.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 0.0 110.79 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.637 ' CB ' HG12 ' A' ' 7' ' ' VAL . 58.8 t -133.72 157.62 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.675 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 8' ' ' LEU . 1.7 mp -145.54 115.93 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.476 -0.765 . . . . 0.0 109.511 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.14 132.01 52.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 111.134 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 1.034 ' HB1' HG23 ' A' ' 90' ' ' ILE . . . -108.35 124.87 51.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.497 -0.752 . . . . 0.0 109.687 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.663 HD22 ' HB2' ' A' ' 11' ' ' CYS . 5.4 mp -58.14 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' ILE . 67.8 m-20 -67.8 -175.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.438 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' SER . 16.2 mt-30 -84.28 -43.36 14.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -43.12 -56.48 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.075 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.075 ' CD1' HG13 ' A' ' 10' ' ' VAL . 4.8 tt -49.81 -41.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.586 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -71.15 -41.13 70.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 t -62.75 -37.89 88.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -0.92 . . . . 0.0 110.216 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.4 OUTLIER -85.57 -55.72 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.586 ' CG2' ' HA ' ' A' ' 91' ' ' LEU . 12.9 tt -44.83 -42.79 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 110.184 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.567 ' N ' HG23 ' A' ' 94' ' ' ILE . 20.1 t-20 -75.55 -11.78 60.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' ASP . 11.0 t -95.69 6.54 48.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.592 ' HE2' ' CZ ' ' A' ' 77' ' ' PHE . 2.4 ptt? -128.83 -32.31 2.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.243 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.606 ' CE ' ' CD1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -42.63 150.78 0.41 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.291 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.03 1.542 . . . . 0.0 110.411 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.07 29.05 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 80.22 1.43 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.9 p -155.4 -174.28 4.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 110.196 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.458 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -139.65 48.91 1.81 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.46 178.61 4.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.87 137.56 48.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.69 130.39 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 108' ' ' LEU . 1.2 p -129.79 171.35 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.92 . . . . 0.0 110.279 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.561 ' N ' ' CG2' ' A' ' 107' ' ' VAL . 22.4 tp -105.69 156.1 18.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 110.167 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 43.0 t80 -149.4 106.81 3.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.962 . . . . 0.0 110.219 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' PHE . 0.7 OUTLIER -171.16 106.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 115' ' ' VAL . 47.6 Cg_endo -74.49 175.82 10.52 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.119 1.589 . . . . 0.0 110.266 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.8 Cg_endo -71.53 54.24 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.926 1.487 . . . . 0.0 110.484 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.62 -40.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.147 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.3 133.0 6.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.582 HG22 ' CB ' ' A' ' 131' ' ' SER . 5.5 t -121.34 -9.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -1.118 . . . . 0.0 110.177 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 1.5 p30 -55.93 133.12 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.92 109.98 31.7 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 116' ' ' ASP . 47.0 Cg_endo -73.68 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.978 1.515 . . . . 0.0 110.496 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.581 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 50.2 t80 -154.39 36.92 0.42 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -119.8 -11.47 9.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 123' ' ' ASP . 0.4 OUTLIER 174.95 166.55 0.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 74.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.241 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 121' ' ' SER . 1.0 OUTLIER -125.57 0.22 7.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 110.232 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -115.85 -44.09 0.65 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.657 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 8.6 m-85 -44.58 -47.96 27.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.186 -1.185 . . . . 0.0 110.358 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.657 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.7 Cg_endo -72.91 -51.72 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.72 1.379 . . . . 0.0 110.201 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.7 m -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.864 ' CE ' ' HB2' ' A' ' 20' ' ' ALA . 9.3 ttp -42.1 -65.9 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.106 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.668 ' CE1' HD13 ' A' ' 24' ' ' ILE . 44.9 t80 -56.12 -45.31 79.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -44.64 -62.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.582 ' CB ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -59.14 -47.61 84.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.848 HG22 HG12 ' A' ' 24' ' ' ILE . 4.3 mm -42.14 -65.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.868 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.715 ' CB ' HD11 ' A' ' 24' ' ' ILE . 1.7 p -71.35 -21.73 62.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -0.828 . . . . 0.0 110.43 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 2.7 tttp -63.5 -34.7 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.025 . . . . 0.0 110.109 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -132.22 66.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.328 -0.857 . . . . 0.0 110.442 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.53 ' CE ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -118.22 -5.29 10.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 110.08 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.0 mttt -87.48 -49.67 0.45 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 110.382 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -77.45 -8.08 17.11 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.888 1.467 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.698 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 10.7 t80 -88.08 -50.17 6.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.028 HD13 HD13 ' A' ' 34' ' ' ILE . 28.2 tp -82.12 -30.09 31.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.507 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 54.9 m -71.01 -24.06 62.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.966 . . . . 0.0 110.328 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -104.06 -44.16 5.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.913 . . . . 0.0 110.208 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.698 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -45.68 -39.11 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.273 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.573 ' C ' HD12 ' A' ' 145' ' ' LEU . . . 148.06 53.43 0.02 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.688 HD22 HD11 ' A' ' 140' ' ' LEU . 0.6 OUTLIER -160.6 -98.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.168 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.507 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 1.5 tp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.193 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.331 0.586 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.04 -159.47 0.06 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 108.725 178.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.757 ' H ' HG22 ' A' ' 34' ' ' ILE . 22.7 mttp -158.13 -164.29 1.47 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 110.62 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.021 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.93 119.43 8.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 110.803 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.957 ' HB ' HD12 ' A' ' 34' ' ' ILE . 5.8 t -114.14 121.55 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.543 -0.723 . . . . 0.0 109.79 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.861 HD21 ' CB ' ' A' ' 38' ' ' ALA . 3.6 tp -97.52 86.75 3.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.247 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 7.5 p90 -72.92 143.58 47.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.977 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.005 HG13 ' O ' ' A' ' 38' ' ' ALA . 46.9 t -142.83 155.68 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 110.28 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.938 ' HB2' HD22 ' A' ' 86' ' ' LEU . 8.1 t -139.56 -60.68 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 110.128 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 -55.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.176 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -131.79 21.44 4.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER 64.8 21.46 12.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -1.13 . . . . 0.0 110.265 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.458 HD11 ' HA ' ' A' ' 45' ' ' VAL . 10.2 mt -121.47 -27.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.179 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -106.1 123.8 48.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.127 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.843 ' HD2' HD23 ' A' ' 86' ' ' LEU . 40.4 mtt180 66.91 -53.97 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.617 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -42.1 -51.56 10.27 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.027 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.2 Cg_endo -72.35 -7.08 20.3 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.816 1.429 . . . . 0.0 110.563 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.62 ' C ' HD13 ' A' ' 132' ' ' ILE . . . -93.39 -21.17 19.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.598 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 16.8 t -70.05 -55.53 9.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.516 ' HG3' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -44.28 -37.04 3.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.437 -0.789 . . . . 0.0 109.43 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.94 -52.57 8.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.899 HD11 ' HB2' ' A' ' 133' ' ' SER . 2.8 tp -55.06 -34.29 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -1.23 . . . . 0.0 109.941 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 34' ' ' ILE . 1.4 m -73.14 -52.79 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 110.04 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -31.02 63.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -87.95 -58.61 2.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.087 -1.008 . . . . 0.0 110.088 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.7 OUTLIER -50.74 -27.05 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.701 HG12 ' HD3' ' A' ' 32' ' ' LYS . 6.7 t -105.82 -33.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 110.223 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.45 -68.39 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -174.65 38.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -1.157 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.701 ' HD3' HG12 ' A' ' 29' ' ' VAL . 4.1 mptp? -75.07 -113.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 35' ' ' ILE . 80.2 mt -152.92 -107.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.932 -1.105 . . . . 0.0 110.26 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.021 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 33.46 31.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 111.653 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -102.24 102.43 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 110.112 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.616 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 50.5 m-20 -135.84 140.67 44.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 110.02 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.576 ' CB ' ' CE1' ' A' ' 9' ' ' PHE . 10.2 t -124.17 143.4 50.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.482 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.005 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -146.21 167.53 23.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -154.98 154.53 32.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -134.76 80.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 t -170.02 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.17 32.57 4.28 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -114.72 -36.38 4.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.128 . . . . 0.0 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 48' ' ' SER . 2.0 t60 -122.61 84.3 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.231 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.101 HG13 ' HB3' ' A' ' 69' ' ' ALA . 46.1 t -146.15 135.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.86 76.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.37 51.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.382 -1.069 . . . . 0.0 110.192 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.487 ' OG ' ' NE2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -154.79 129.53 4.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.53 106.67 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.971 1.511 . . . . 0.0 110.4 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.546 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.3 p-10 -90.82 22.49 3.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.8 m -71.98 -28.16 63.23 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.22 -0.925 . . . . 0.0 108.794 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.605 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 5.0 mmt180 -74.5 -45.23 47.26 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -63.57 -53.64 48.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 78.4 mt-30 -61.95 -41.44 97.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.323 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.7 ttpp -55.2 -69.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 109.485 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.56 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 37.4 t -48.28 -36.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.873 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.547 -0.721 . . . . 0.0 109.513 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -24.55 61.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.383 -0.823 . . . . 0.0 109.481 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -81.27 -13.06 58.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -111.91 -31.04 7.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.291 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 119.5 94.56 1.54 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.873 HG11 ' SG ' ' A' ' 57' ' ' CYS . 9.8 p -178.71 151.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -1.114 . . . . 0.0 110.065 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -127.3 140.78 51.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.247 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.434 ' CD1' ' HG2' ' A' ' 54' ' ' GLN . 7.4 pt -124.73 163.58 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.139 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -112.27 -34.14 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 110.223 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' C ' ' CD ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -166.88 150.33 6.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.261 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 50' ' ' ASP . 1.6 mt-30 -132.16 74.85 1.6 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 110.28 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 68' ' ' ARG . 33.5 ttp85 -126.29 111.14 14.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.101 ' HB3' HG13 ' A' ' 45' ' ' VAL . . . -53.8 144.44 18.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.187 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.99 39.38 0.84 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' CA ' ' OE1' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 54.46 -164.15 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.267 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.564 HD12 ' HB1' ' A' ' 38' ' ' ALA . 15.4 tt -121.93 -39.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.504 ' N ' HG23 ' A' ' 72' ' ' ILE . 1.0 OUTLIER 63.72 157.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -67.37 -23.6 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.214 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -58.77 -26.69 64.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.269 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.554 ' HB2' HD22 ' A' ' 8' ' ' LEU . 24.6 p-10 -48.31 -34.75 11.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 44.7 m-85 -73.14 -39.09 65.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.242 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.52 -52.85 4.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -44.85 -26.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.214 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.58 ' CD1' ' OD2' ' A' ' 36' ' ' ASP . 9.3 m-85 -134.2 172.58 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.68 -20.26 9.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 58.4 t -125.56 139.15 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.9 . . . . 0.0 110.361 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 107' ' ' VAL . 1.4 mp -123.67 144.23 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 110.082 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.783 ' HB1' ' CD2' ' A' ' 109' ' ' PHE . . . -123.05 118.8 28.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.88 116.97 32.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.091 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.938 HD22 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mp -62.86 -85.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.426 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.409 ' N ' HD12 ' A' ' 90' ' ' ILE . 79.2 m-20 -73.53 -177.63 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 89' ' ' SER . 14.1 mt-30 -79.05 -40.85 30.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 110.183 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 4.3 m -42.02 -40.37 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.298 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.511 HD11 ' O ' ' A' ' 11' ' ' CYS . 3.8 mt -69.36 -48.14 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.56 -41.63 97.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 t -73.47 -40.41 64.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 96' ' ' SER . 82.9 m-20 -65.52 -61.97 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.594 HG23 ' N ' ' A' ' 95' ' ' ASN . 3.7 tt -42.71 -43.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.594 ' N ' HG23 ' A' ' 94' ' ' ILE . 3.0 t-20 -61.88 -33.03 73.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.973 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -67.47 -13.59 62.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.446 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 4.4 ptt? -122.34 -24.79 4.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 110.143 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 94' ' ' ILE . 0.3 OUTLIER -43.09 140.48 1.99 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -159.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.06 1.558 . . . . 0.0 110.397 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 m -129.37 3.99 5.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -152.38 88.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.4 p -144.32 -169.46 3.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.04 48.4 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 77' ' ' PHE . . . -131.61 164.77 25.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 33.8 tttt -123.58 160.51 26.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.163 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.84 106.94 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 83' ' ' ILE . 26.7 m -109.69 143.71 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.613 HD12 HD22 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -83.8 114.8 21.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.783 ' CD2' ' HB1' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -50.13 -69.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.953 . . . . 0.0 110.172 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.448 ' HB3' ' HD2' ' A' ' 111' ' ' PRO . 9.5 m120 -147.19 166.91 14.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.495 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.6 Cg_endo -74.49 174.94 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.966 1.508 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.3 Cg_endo -72.86 52.81 2.23 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.921 1.485 . . . . 0.0 110.481 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -149.1 -36.86 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.07 -96.99 0.04 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.865 HG12 ' HB2' ' A' ' 131' ' ' SER . 4.7 m -62.67 136.65 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -1.139 . . . . 0.0 110.309 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.77 149.46 14.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -168.29 108.04 0.55 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 46.5 Cg_endo -73.15 -1.0 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 118' ' ' PRO . 1.2 m-85 61.31 24.83 14.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -126.88 -38.23 2.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.28 -176.01 3.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 122' ' ' SER . 1.8 t -87.6 22.67 2.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 0.0 110.166 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.32 62.34 5.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.73 -31.31 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.605 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 8.9 m-85 -56.4 -54.02 57.73 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.326 -1.103 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.6 Cg_endo -71.88 -43.39 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.867 1.456 . . . . 0.0 110.375 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.483 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 2.7 m -62.81 -35.73 80.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.58 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 25.6 ttp -52.51 -69.97 0.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.9 . . . . 0.0 109.92 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.632 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 30.7 t80 -62.93 -30.9 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.702 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -56.98 -35.91 69.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.977 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.865 ' HB2' HG12 ' A' ' 115' ' ' VAL . 5.6 m -87.29 -42.76 12.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.62 HD13 ' C ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -56.47 -27.25 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.805 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.899 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -102.06 -40.58 6.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.407 -0.808 . . . . 0.0 110.201 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -76.35 -4.91 44.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 131' ' ' SER . 6.0 mm-40 -126.19 18.82 7.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.503 ' HG3' ' O ' ' A' ' 136' ' ' MET . 1.8 tpt -96.17 7.97 45.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.349 -0.845 . . . . 0.0 110.245 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -86.59 -49.09 0.5 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.298 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.95 7.4 4.35 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.874 1.46 . . . . 0.0 110.591 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.603 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 5.6 t80 -107.96 -51.19 2.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.355 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 146' ' ' ILE . 4.2 tt -83.51 -15.04 50.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.339 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.942 HG23 ' OXT' ' A' ' 146' ' ' ILE . 24.7 m -82.8 -28.05 30.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -105.14 -25.48 12.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.286 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.603 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -52.74 -18.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 115.75 51.81 0.41 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 144' ' ' GLY . 11.9 mt -143.41 -52.78 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.942 ' OXT' HG23 ' A' ' 141' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.415 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.287 0.565 . . . . 0.0 110.113 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.582 ' C ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -80.9 -55.42 4.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.545 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' CG ' ' C ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER 35.21 -155.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.729 . . . . 0.0 110.541 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.88 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . . . -166.12 156.53 12.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 0.0 109.958 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG1' ' HB2' ' A' ' 84' ' ' ALA . 89.0 t -120.92 103.51 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.908 . . . . 0.0 109.903 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.729 ' HB3' HG23 ' A' ' 83' ' ' ILE . 16.6 tp -59.48 94.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 110.026 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.491 ' CE2' ' SD ' ' A' ' 136' ' ' MET . 0.4 OUTLIER -78.31 103.89 8.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.93 . . . . 0.0 109.818 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.828 HG13 ' O ' ' A' ' 38' ' ' ALA . 61.3 t -124.67 161.75 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.445 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.73 ' CB ' HD22 ' A' ' 86' ' ' LEU . 39.3 t -165.14 64.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 6.9 mt 57.09 33.59 23.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 147.0 -32.34 1.42 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 65.3 7.62 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -1.138 . . . . 0.0 110.102 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.7 HD13 ' OG ' ' A' ' 48' ' ' SER . 44.6 mt -96.51 -5.51 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 110.353 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 35.6 m -144.43 -173.25 3.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.456 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.674 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.9 mmt85 64.49 -78.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.556 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 86' ' ' LEU . 9.1 m -129.83 55.66 19.87 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 110.699 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.6 Cg_endo -79.79 0.57 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.987 1.519 . . . . 0.0 110.004 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -96.0 6.8 48.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.425 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 9.1 p -58.78 -35.54 72.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.803 ' HB3' HG23 ' A' ' 64' ' ' ILE . 1.4 tp10 -65.43 -48.54 72.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.67 -0.644 . . . . 0.0 109.866 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.583 ' CA ' ' CG1' ' A' ' 62' ' ' VAL . . . -69.83 -57.8 6.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 132' ' ' ILE . 5.3 tp -47.44 -43.47 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -1.163 . . . . 0.0 109.922 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.616 ' HB2' HD13 ' A' ' 35' ' ' ILE . 7.3 t -65.33 -51.53 59.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.412 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 15.3 mmt-85 -52.62 -40.62 62.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.145 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -76.0 -30.51 58.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.48 -57.96 3.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.485 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.745 HG11 ' HB2' ' A' ' 32' ' ' LYS . 61.9 t -87.09 -18.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.552 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 104.4 -66.91 0.29 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 53.8 t0 -176.25 57.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -1.13 . . . . 0.0 110.111 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.858 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.79 -100.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 32' ' ' LYS . 21.3 mt -143.95 -125.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.851 HG23 ' C ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER 70.81 -17.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.987 -0.446 . . . . 0.0 111.102 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -136.83 144.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.808 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.726 ' HB3' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -155.35 94.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -63.82 125.92 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 110.116 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.828 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -149.76 170.43 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.552 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.801 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -138.72 145.37 40.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.053 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.583 ' HA ' HG22 ' A' ' 72' ' ' ILE . 8.2 t -118.67 -9.65 10.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.31 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 t -112.36 109.48 19.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -55.97 101.58 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 2.5 m-85 -162.12 160.43 27.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -1.169 . . . . 0.0 110.264 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER 63.19 25.21 14.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.6 t -85.25 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 37.68 6.37 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 48' ' ' SER . 2.7 pt20 179.59 -108.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -1.118 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.7 ' OG ' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 65.6 93.62 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.074 -1.016 . . . . 0.0 110.184 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 45.1 Cg_endo -69.11 -62.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.672 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 2.8 m-20 71.46 -5.95 1.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.241 -0.912 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -74.32 -27.54 60.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.177 -0.952 . . . . 0.0 108.975 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -52.85 12.52 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.336 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -61.57 -53.69 52.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 13.5 mm-40 -57.98 -42.46 85.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -51.85 -65.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.901 HG21 ' HA ' ' A' ' 125' ' ' PHE . 53.0 t -49.46 -35.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 109.113 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.526 ' SG ' ' CG1' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -57.27 -46.71 82.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.57 -0.706 . . . . 0.0 109.642 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -79.63 -17.86 52.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.509 ' HB2' ' CE ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -88.95 -12.25 42.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -116.37 -24.17 8.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.586 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.59 ' C ' HG23 ' A' ' 62' ' ' VAL . . . 117.21 62.34 0.31 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.59 HG23 ' C ' ' A' ' 61' ' ' GLY . 46.0 t -155.63 170.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.529 ' N ' HG12 ' A' ' 62' ' ' VAL . 58.6 t0 -157.02 121.21 4.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 110.267 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 22' ' ' GLU . 18.1 mt -108.82 170.62 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.147 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -106.39 -68.69 0.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -145.08 128.02 16.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 10.7 pt20 -142.26 98.43 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.217 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HA ' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -140.05 -162.69 1.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.174 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.87 123.65 50.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.229 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.78 33.02 1.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 60.02 158.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 76' ' ' ASP . 21.0 tt -138.87 152.5 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -112.57 -163.92 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 77' ' ' PHE . 4.1 mttp -69.7 -5.21 23.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.16 81.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.0 110.124 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.799 ' HB3' HD11 ' A' ' 72' ' ' ILE . 38.4 p-10 -47.84 -31.46 5.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 74' ' ' LYS . 13.1 m-85 -72.45 -25.74 61.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.0 p -127.29 41.86 3.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.202 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' CG ' ' CE2' ' A' ' 80' ' ' PHE . 37.8 tptt -123.19 -13.52 7.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.88 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 97.5 m-85 -151.74 -122.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 65.4 t0 -151.59 -40.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.045 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.76 HG11 ' HZ ' ' A' ' 139' ' ' PHE . 81.7 t -127.04 152.84 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.169 -0.957 . . . . 0.0 110.47 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 8' ' ' LEU . 1.7 mp -131.71 134.06 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 110.022 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -104.49 127.87 52.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.551 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.68 105.74 15.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.73 HD22 ' CB ' ' A' ' 11' ' ' CYS . 2.2 mp -50.36 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.505 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.422 ' C ' HD12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -81.5 -177.4 6.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.37 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -85.44 -40.8 16.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.37 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -41.67 -38.43 1.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.873 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.5 mp -69.62 -55.63 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.185 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.0 HD22 HD23 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -58.1 -28.74 64.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 t -78.39 -41.91 31.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 5.6 m-20 -80.92 -60.15 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.29 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 90' ' ' ILE . 4.7 tt -49.87 -25.3 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.301 -0.875 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 58.4 t-20 -90.37 -22.87 21.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.208 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -6.59 28.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.456 ' HE2' ' O ' ' A' ' 94' ' ' ILE . 6.2 mtm -108.81 -51.67 2.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.568 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -40.47 132.6 1.67 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.412 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 100' ' ' SER . 46.4 Cg_endo -73.51 0.66 7.79 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.06 1.558 . . . . 0.0 110.502 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER 68.02 19.22 9.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.131 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.12 67.76 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 95.4 m -132.21 -159.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.41 25.83 10.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.27 -175.46 3.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.89 . . . . 0.0 110.192 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.37 158.2 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.539 HG12 HD12 ' A' ' 91' ' ' LEU . 19.3 t -127.13 124.58 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.139 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -122.17 144.0 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.0 HD23 HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -77.11 133.81 38.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 110.173 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.605 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 1.9 m-85 -106.44 127.44 53.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.315 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 109' ' ' PHE . 0.2 OUTLIER 64.54 176.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -74.83 175.3 11.36 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 110.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.9 Cg_endo -72.26 53.86 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.051 1.553 . . . . 0.0 110.433 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.88 -38.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.03 145.12 11.19 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.557 HG11 ' CB ' ' A' ' 131' ' ' SER . 18.5 m -70.34 153.84 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -1.105 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.456 ' CB ' HG21 ' A' ' 127' ' ' THR . 42.9 t0 -42.09 134.58 2.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.369 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.8 p-10 -94.94 113.1 60.53 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.534 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 46.3 Cg_endo -73.7 58.31 3.91 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.936 1.492 . . . . 0.0 110.616 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 121' ' ' SER . 3.7 t80 -117.03 142.61 46.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.095 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.512 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 49.1 t80 61.0 -73.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.196 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 119' ' ' TYR . 2.2 m -89.89 118.33 29.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.84 89.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.77 9.64 1.55 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.258 -0.901 . . . . 0.0 110.183 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -118.88 -22.24 3.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.901 ' HA ' HG21 ' A' ' 56' ' ' VAL . 2.8 m-85 -34.1 -59.34 0.54 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.521 -0.988 . . . . 0.0 110.49 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.0 Cg_endo -72.12 -52.48 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.869 1.457 . . . . 0.0 110.318 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.456 HG21 ' CB ' ' A' ' 116' ' ' ASP . 8.8 m -58.18 -57.66 11.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.375 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.572 ' CE ' ' HB2' ' A' ' 20' ' ' ALA . 8.1 ttp -40.31 -48.85 2.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.612 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 48.7 t80 -70.17 -62.1 1.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 129' ' ' PHE . . . -43.05 -56.39 3.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.557 ' CB ' HG11 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -60.88 -45.07 96.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.926 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -46.76 -47.52 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.592 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 134' ' ' LYS . 0.4 OUTLIER -78.85 -59.26 2.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.297 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.498 ' N ' ' OG ' ' A' ' 133' ' ' SER . 3.2 mmtt -45.19 -29.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 131' ' ' SER . 27.0 mt-10 -74.97 -31.55 61.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.203 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.551 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 18.0 mtm -103.48 9.32 37.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 6.5 mtpt -82.28 -48.74 0.88 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 51.5 Cg_endo -81.11 -9.07 12.94 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.148 1.604 . . . . 0.0 110.402 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.76 ' HZ ' HG11 ' A' ' 82' ' ' VAL . 47.4 t80 -107.97 -77.96 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.061 ' CD1' HD22 ' A' ' 145' ' ' LEU . 13.8 tp -44.03 -24.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 11.8 m -87.07 -29.13 22.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 110.353 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 139' ' ' PHE . 4.7 mm-40 -105.2 -13.9 15.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.405 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.484 ' ND1' ' CZ ' ' A' ' 139' ' ' PHE . 4.3 t-160 -84.94 40.27 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.64 38.08 90.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.061 HD22 ' CD1' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.8 -31.08 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.106 . . . . 0.0 110.305 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 18.2 mm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.228 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.26 0.553 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.406 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -79.68 -162.54 0.43 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.534 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 34' ' ' ILE . 18.5 mttt -148.44 -164.5 2.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.783 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -130.74 148.92 52.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.183 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 34' ' ' ILE . 5.5 m -147.06 136.87 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.945 -1.097 . . . . 0.0 110.226 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.9 OUTLIER -89.65 118.31 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 0.0 110.945 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.497 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m-85 -93.85 96.06 9.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.555 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.534 ' CG2' HD23 ' A' ' 8' ' ' LEU . 16.0 t -100.65 156.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.444 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.491 ' CB ' ' OG ' ' A' ' 18' ' ' SER . 47.8 t -150.0 -65.9 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.015 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 177.05 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.174 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 85.92 -4.75 85.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.963 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 8.7 t30 59.7 29.87 19.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -1.158 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.925 HD13 ' HB2' ' A' ' 48' ' ' SER . 26.9 mt -113.0 -20.4 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 110.376 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 18' ' ' SER . 9.6 p -131.59 132.77 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.859 ' CB ' HD23 ' A' ' 86' ' ' LEU . 3.7 mtm180 65.46 -59.56 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.196 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.632 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -44.83 -50.7 24.6 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.428 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.6 Cg_endo -72.13 -19.97 25.57 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.848 1.446 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.569 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -69.78 -23.56 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.98 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.996 ' HA ' HD11 ' A' ' 132' ' ' ILE . 21.4 m -67.39 -32.88 74.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.863 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.738 ' HA ' HD11 ' A' ' 35' ' ' ILE . 1.6 tt0 -57.77 -54.89 41.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.912 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.697 ' HA3' HG22 ' A' ' 62' ' ' VAL . . . -67.09 -45.95 77.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.873 HD12 ' CE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -54.66 -54.36 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -1.202 . . . . 0.0 110.191 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.702 ' N ' HG22 ' A' ' 24' ' ' ILE . 79.4 m -60.29 -50.8 72.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.036 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.51 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 25.5 mtt-85 -45.82 -52.63 10.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -20.0 60.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.57 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.07 -45.82 32.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.831 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.554 ' CG1' ' HB3' ' A' ' 32' ' ' LYS . 63.1 t -137.05 -12.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.034 . . . . 0.0 111.258 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 29' ' ' VAL . . . 59.31 122.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' GLY . 11.8 t0 40.42 77.36 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.187 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.74 ' HG3' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -131.05 11.19 5.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.547 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.8 mt 65.01 -63.05 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.285 -0.884 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.963 HD12 ' N ' ' A' ' 35' ' ' ILE . 2.5 pp -27.39 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.454 -0.779 . . . . 0.0 111.047 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.963 ' N ' HD12 ' A' ' 34' ' ' ILE . 7.8 tt -64.03 87.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 121.368 -0.832 . . . . 0.0 111.079 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 18.6 m-20 -126.83 66.82 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 109.692 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.28 150.07 18.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 110.397 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -163.9 -171.62 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.963 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -150.17 120.9 7.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.578 ' HA ' HG21 ' A' ' 72' ' ' ILE . 10.8 t -67.06 -39.45 86.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.519 ' N ' HG23 ' A' ' 40' ' ' THR . 3.3 t -127.87 133.02 49.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . -67.76 -79.9 0.23 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 66.05 -73.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.526 ' HB3' HD12 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -90.15 91.06 8.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 46' ' ' GLY . 50.4 t -130.29 173.28 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 110.137 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.566 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 57.97 18.35 33.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.632 ' O ' ' CB ' ' A' ' 48' ' ' SER . 3.1 pt20 -177.68 152.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -1.124 . . . . 0.0 110.168 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.925 ' HB2' HD13 ' A' ' 15' ' ' ILE . 2.2 t 159.12 105.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.263 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 47.4 Cg_endo -69.78 70.78 1.57 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.104 1.581 . . . . 0.0 110.28 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.5 p30 -83.92 16.32 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.9 m -75.53 -32.58 60.52 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.185 -0.947 . . . . 0.0 109.007 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.638 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -74.1 -55.74 5.74 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.294 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -58.67 -53.43 58.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.454 -0.778 . . . . 0.0 109.501 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.93 ' HG3' HD11 ' A' ' 64' ' ' ILE . 12.1 tt0 -57.51 -45.56 84.82 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.25 -0.906 . . . . 0.0 109.508 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.2 ttpp -50.83 -65.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.422 -0.799 . . . . 0.0 109.793 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.573 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 11.3 p -56.55 -34.0 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.633 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.711 ' CB ' HG21 ' A' ' 62' ' ' VAL . 1.3 m -56.66 -47.47 79.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.696 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -73.8 -30.46 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.361 -0.837 . . . . 0.0 109.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 m -77.96 -12.05 59.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.003 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -116.08 -27.01 7.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.855 . . . . 0.0 109.38 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.81 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 139.25 98.78 0.42 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 61' ' ' GLY . 13.0 t -162.63 168.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -1.065 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.51 ' HB3' ' CD ' ' A' ' 26' ' ' ARG . 12.5 t0 -153.37 67.17 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.93 HD11 ' HG3' ' A' ' 54' ' ' GLN . 11.8 pt -116.55 -173.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.187 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -153.68 88.74 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' N ' ' HD3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 58.19 153.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.359 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.427 ' NE2' HD12 ' A' ' 64' ' ' ILE . 3.0 pt20 -171.93 126.99 0.59 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.358 -0.839 . . . . 0.0 110.194 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 1.2 mtm105 -99.87 -89.15 0.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 68' ' ' ARG . . . 176.94 79.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 ttp-105 -76.6 141.2 41.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.424 ' HG3' ' N ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.62 151.88 44.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.162 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.578 HG21 ' HA ' ' A' ' 40' ' ' THR . 19.4 tt -90.8 172.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t -124.4 172.2 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -78.33 2.85 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.112 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.02 -13.28 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' CG ' ' CG1' ' A' ' 72' ' ' ILE . 2.9 m-20 -52.92 -42.11 65.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -45.13 -55.77 5.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 26.82 3.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.622 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -104.64 -11.14 17.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 110.237 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.622 ' CE1' ' CG ' ' A' ' 79' ' ' LYS . 77.9 m-85 -143.07 -137.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -128.2 -53.42 1.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.471 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 48.9 t -133.26 123.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.195 -0.941 . . . . 0.0 110.451 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.898 HG21 HD11 ' A' ' 94' ' ' ILE . 5.7 mt -90.63 105.74 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.9 143.58 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.429 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -103.49 147.91 26.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.859 HD23 ' CB ' ' A' ' 17' ' ' ARG . 2.8 tp -98.64 31.77 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.934 ' O ' HD21 ' A' ' 108' ' ' LEU . 0.4 OUTLIER 174.31 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 110.178 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -59.93 -43.57 94.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.243 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.589 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 1.9 mp -57.67 -63.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.153 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.4 OUTLIER -53.09 -37.14 61.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.151 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -70.83 -26.89 63.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.236 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -92.06 -61.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.255 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.898 HD11 HG21 ' A' ' 83' ' ' ILE . 5.6 tt -45.63 -39.89 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.503 ' N ' HG23 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -71.89 -15.18 62.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -76.37 -12.36 60.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.226 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.453 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 8.2 mtm -109.64 -52.04 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 5.6 mtpt -40.85 134.85 1.67 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 110.443 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.14 -169.59 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.069 1.562 . . . . 0.0 110.424 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.7 t -91.35 23.91 3.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 6.5 p-10 -176.79 123.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.4 p -143.59 -151.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -116.37 -18.63 10.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.104 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 -149.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -157.66 169.31 24.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.19 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.487 HG12 ' HB ' ' A' ' 83' ' ' ILE . 29.0 m -128.07 146.43 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 108' ' ' LEU . 78.6 t -144.01 170.19 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.94 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.934 HD21 ' O ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -109.52 121.91 46.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.181 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 132' ' ' ILE . 11.6 t80 -48.49 -51.52 26.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 111' ' ' PRO . 1.1 m-20 -176.52 -178.26 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 110' ' ' ASN . 46.7 Cg_endo -74.67 175.03 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.012 1.533 . . . . 0.0 110.302 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.2 52.94 2.41 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.959 1.505 . . . . 0.0 110.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -124.69 -27.3 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.75 -89.98 1.25 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 115' ' ' VAL . 19.5 m -75.9 103.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -1.156 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 15.6 p-10 -137.08 -156.63 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER 55.78 72.74 0.96 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 112.03 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.995 1.524 . . . . 0.0 110.508 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.499 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 12.4 m-85 50.48 -138.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 119' ' ' TYR . 27.5 p -168.79 -151.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 82.7 p -90.32 -138.56 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 122' ' ' SER . 2.3 t70 67.06 17.09 10.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.431 ' C ' ' HD2' ' A' ' 126' ' ' PRO . . . -144.29 -42.08 0.05 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.638 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 11.8 m-85 -42.08 -50.47 10.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.11 . . . . 0.0 110.473 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.6 Cg_endo -72.0 -56.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.619 1.326 . . . . 0.0 110.247 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -55.75 -43.66 76.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 110.006 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.724 ' O ' HG22 ' A' ' 132' ' ' ILE . 14.0 ttp -50.69 -75.71 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.873 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.6 t80 -46.67 -55.6 7.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.236 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -52.7 -22.56 5.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.4 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 128' ' ' MET . 3.2 m -90.12 -55.82 3.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.412 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.996 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -60.09 -15.33 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 0.0 109.028 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.731 ' HB2' HD11 ' A' ' 24' ' ' ILE . 2.0 t -101.93 -49.96 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 110.139 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -59.23 -30.85 68.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.108 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' OE2' ' ND2' ' A' ' 110' ' ' ASN . 6.1 mt-10 -102.75 22.37 13.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.647 ' HE1' ' HB3' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -89.61 1.36 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.25 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 77.0 mttt -91.88 -42.13 0.37 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 111.353 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.2 Cg_endo -76.41 4.79 5.16 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.403 1.212 . . . . 0.0 110.733 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.647 ' HB3' ' HE1' ' A' ' 136' ' ' MET . 39.2 t80 -108.08 -71.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -58.98 -55.0 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.116 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 137' ' ' LYS . 16.2 m -61.04 -12.87 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 144' ' ' GLY . 27.8 mt-10 -105.06 -55.33 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.542 ' NE2' HG21 ' A' ' 107' ' ' VAL . 3.1 t-80 -42.34 -26.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 130.84 46.62 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 15.0 mt -144.66 -98.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -1.186 . . . . 0.0 110.27 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.437 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 2.9 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.441 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 4.8 mm-40 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.272 0.558 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -82.38 156.02 24.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 178.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 34' ' ' ILE . 26.7 mttt -139.37 -165.79 1.93 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.989 -1.07 . . . . 0.0 110.867 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.855 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.19 156.79 29.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 110.516 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.802 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 40.0 t -141.95 113.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.668 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.951 HD13 ' CE2' ' A' ' 80' ' ' PHE . 26.2 tp -82.64 81.45 8.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 111.02 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.994 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 16.6 m-85 -55.84 126.39 25.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.086 -1.009 . . . . 0.0 109.367 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.948 HG22 ' O ' ' A' ' 38' ' ' ALA . 73.8 t -142.03 161.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 110.767 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.672 ' SG ' HD23 ' A' ' 86' ' ' LEU . 1.1 t -153.36 -58.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.413 -0.805 . . . . 0.0 110.191 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.584 ' CB ' ' NH1' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 169.84 150.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.463 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 64.48 10.14 41.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 72.8 -53.19 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.297 -1.119 . . . . 0.0 109.823 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' CYS . 8.9 mt -41.2 -33.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 3.3 t 68.25 105.44 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.584 ' NH1' ' CB ' ' A' ' 12' ' ' LEU . 18.3 mtt85 -52.67 -18.52 1.83 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.046 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.493 ' HB3' HD21 ' A' ' 86' ' ' LEU . 60.3 p -112.8 67.71 1.0 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 17' ' ' ARG . 45.6 Cg_endo -72.59 -12.33 26.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.902 1.475 . . . . 0.0 110.082 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.707 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -76.97 4.89 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 23.2 p -69.77 -37.62 76.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.785 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -68.98 -43.06 75.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.917 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -70.55 -51.78 19.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.821 HD12 ' CE1' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -55.62 -46.93 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -1.153 . . . . 0.0 110.274 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.657 ' O ' HG22 ' A' ' 29' ' ' VAL . 78.4 m -71.87 -48.59 44.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.115 -0.99 . . . . 0.0 110.053 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.529 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 10.1 mmt180 -49.35 -45.35 45.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.28 -24.09 32.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.259 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.558 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -73.88 -22.71 59.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.605 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 25' ' ' CYS . 4.7 m -142.14 -33.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.978 -1.076 . . . . 0.0 110.713 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 38.47 44.91 1.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 54.4 t0 -178.55 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.961 -1.317 . . . . 0.0 110.853 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' C ' ' HG ' ' A' ' 33' ' ' LEU . 12.3 mmtm -141.73 -143.34 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.4 mt -147.77 -34.53 0.24 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.416 -0.802 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.1 pp -30.05 -31.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.824 -0.548 . . . . 0.0 111.829 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.666 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.5 mp -62.47 87.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.998 -1.064 . . . . 0.0 110.939 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -130.39 162.47 29.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.96 . . . . 0.0 109.064 178.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.5 m -141.9 139.98 32.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.96 -1.088 . . . . 0.0 110.668 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.948 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -167.78 -176.24 3.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.354 -0.842 . . . . 0.0 110.33 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . . . 174.84 164.07 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 40' ' ' THR . 13.7 t -94.12 71.67 3.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.42 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.39 76.68 0.57 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.67 -57.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -1.141 . . . . 0.0 110.296 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -87.59 93.26 9.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 69' ' ' ALA . 34.9 t -125.95 -3.76 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.243 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.27 41.74 2.08 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 48' ' ' SER . 6.6 pt20 -161.78 -109.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 4.4 t 64.84 70.78 0.59 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.053 -1.03 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.38 66.05 1.56 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.459 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 4.2 p-10 -89.19 31.48 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.524 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -76.0 -34.19 59.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.898 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 6.9 mmt85 -70.76 -47.79 57.77 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -56.69 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.533 -0.729 . . . . 0.0 109.349 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.718 ' HB3' HD13 ' A' ' 64' ' ' ILE . 5.2 pp0? -56.97 -35.29 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.125 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.4 -65.92 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 109.13 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.604 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 41.4 t -49.69 -36.22 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.28 -0.887 . . . . 0.0 108.83 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -53.86 -52.76 59.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 62' ' ' VAL . 11.3 ttpt -71.13 -21.23 62.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.472 ' OG ' ' CE ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -86.6 -8.73 57.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.947 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -112.25 -17.74 12.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.865 . . . . 0.0 108.84 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 122.14 44.21 0.37 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 61' ' ' GLY . 54.3 t -158.37 144.87 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -1.087 . . . . 0.0 110.22 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.62 135.63 40.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.718 HD13 ' HB3' ' A' ' 54' ' ' GLN . 29.2 pt -92.76 -171.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 110.117 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -129.95 -51.46 1.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 110.194 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.52 149.03 3.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -111.91 99.48 8.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 111.9 24.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -93.91 102.5 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.199 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -122.79 158.14 30.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.92 143.81 57.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 72' ' ' ILE . 10.7 tt -84.61 87.94 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 74' ' ' LYS . 25.5 m -58.9 169.59 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 73' ' ' THR . 2.1 mtpp -65.73 -9.09 24.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.02 59.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 110.26 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' CG ' HG13 ' A' ' 72' ' ' ILE . 31.5 m-20 -49.69 -30.04 8.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -57.49 -41.27 80.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 110.17 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.98 -33.97 10.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER -44.35 -31.23 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.331 -0.856 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.951 ' CE2' HD13 ' A' ' 8' ' ' LEU . 11.9 m-85 -130.94 152.34 50.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.465 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.595 ' H ' ' HB3' ' A' ' 6' ' ' ALA . 3.9 m-20 -68.52 -47.07 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.442 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' A' ' 139' ' ' PHE . 53.9 t -130.85 156.68 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.937 HD13 HG12 ' A' ' 106' ' ' VAL . 1.6 mp -118.33 139.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.283 -0.886 . . . . 0.0 109.877 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.994 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -100.28 116.88 33.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.904 . . . . 0.0 110.385 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.68 ' O ' HD12 ' A' ' 108' ' ' LEU . . . -109.82 99.56 8.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 109.919 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.672 HD23 ' SG ' ' A' ' 11' ' ' CYS . 1.1 mp -60.78 -61.77 2.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.541 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.524 ' CB ' ' CD1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.54 171.79 11.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' SER . 21.0 mt-30 -83.59 -40.69 18.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -42.64 -37.86 1.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.557 HD11 ' O ' ' A' ' 11' ' ' CYS . 1.4 mp -71.97 -54.52 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.96 -19.58 62.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 0.0 110.349 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -86.61 -58.38 2.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.285 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.245 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.586 HG23 ' N ' ' A' ' 95' ' ' ASN . 2.5 tt -43.48 -43.28 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.586 ' N ' HG23 ' A' ' 94' ' ' ILE . 1.1 t-20 -60.89 -31.78 71.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' ASP . 19.5 t -64.36 -12.34 41.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.53 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.9 ptt? -123.17 -18.35 6.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.562 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -55.09 154.3 10.61 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.52 ' HD3' ' CD2' ' A' ' 77' ' ' PHE . 47.9 Cg_endo -73.36 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -125.42 101.13 6.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 100' ' ' SER . 3.8 m-20 64.06 110.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.257 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.0 m -150.23 -164.41 2.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.87 . . . . 0.0 110.209 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.83 32.55 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 77' ' ' PHE . . . -160.68 -177.09 5.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.231 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 16.4 pttm -176.53 158.23 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.937 HG12 HD13 ' A' ' 83' ' ' ILE . 3.6 m -111.59 151.33 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 m -138.87 147.43 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.197 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' O ' ' A' ' 85' ' ' ALA . 21.6 tp -81.6 126.05 31.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.223 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -93.46 89.76 6.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 0.0 110.211 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 56.52 162.77 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 45.8 Cg_endo -74.0 174.93 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.096 1.577 . . . . 0.0 110.275 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.7 Cg_endo -73.25 51.48 2.11 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.954 1.502 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 114' ' ' GLY . 19.2 m-20 -122.32 -63.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 127' ' ' THR . . . -44.25 -73.03 0.28 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.534 HG21 ' HG ' ' A' ' 86' ' ' LEU . 18.1 m -70.41 123.7 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.33 158.55 27.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.933 . . . . 0.0 110.256 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.574 ' HB2' ' CE2' ' A' ' 119' ' ' TYR . 8.2 p-10 -73.22 123.78 89.88 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -73.06 -89.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.008 1.53 . . . . 0.0 110.621 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 117' ' ' ASP . 12.3 m-30 58.21 -142.68 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.537 ' O ' ' CB ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -69.44 149.6 48.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.413 -0.805 . . . . 0.0 109.994 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER 71.56 3.89 4.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.38 -0.825 . . . . 0.0 110.166 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.537 ' HG ' ' HE2' ' A' ' 125' ' ' PHE . 73.7 m 42.19 -94.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.177 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' SER . 0.5 OUTLIER 44.98 49.06 9.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -175.39 -41.05 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.65 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 23.5 m-85 -41.58 -49.61 9.67 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.13 . . . . 0.0 110.527 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.33 -59.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.585 1.308 . . . . 0.0 110.194 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 114' ' ' GLY . 64.9 m -53.16 -48.17 68.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.646 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.707 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 7.9 ttp -50.02 -58.92 4.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.376 -0.827 . . . . 0.0 109.968 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.821 ' CE1' HD12 ' A' ' 24' ' ' ILE . 88.3 t80 -50.56 -50.54 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.0 -56.19 11.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 m -57.9 -46.5 84.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -45.38 -56.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.655 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -60.65 -45.88 92.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.54 ' O ' ' CD ' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -65.21 -13.04 57.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 14.8 mt-10 -90.0 -37.32 14.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.503 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -90.99 -3.69 57.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.931 . . . . 0.0 110.355 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 3.1 mttt -83.48 -50.2 0.68 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -0.961 . . . . 0.0 110.026 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 51.0 Cg_endo -80.08 -13.14 12.84 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.097 1.577 . . . . 0.0 110.414 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' A' ' 82' ' ' VAL . 5.3 t80 -103.72 -48.74 3.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -73.31 1.1 10.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.287 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 142' ' ' GLU . 21.0 m -104.22 -57.05 2.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 111.004 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' GLY . 7.3 mt-10 -105.2 -45.13 4.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.11 -0.994 . . . . 0.0 111.224 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -37.24 -29.65 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.211 -0.931 . . . . 0.0 110.434 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.863 ' O ' HD22 ' A' ' 145' ' ' LEU . . . 132.03 76.58 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -159.16 -38.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -1.218 . . . . 0.0 110.182 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.474 HD11 HD23 ' A' ' 140' ' ' LEU . 22.3 mt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.249 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.305 0.574 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.757 ' HG2' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -72.21 -161.35 0.08 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 108.701 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 1.027 ' C ' HG22 ' A' ' 34' ' ' ILE . 23.6 mtmt -157.32 -159.68 0.87 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.921 -1.112 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.0 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -142.41 123.23 14.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 111.251 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.963 HG11 ' CZ ' ' A' ' 9' ' ' PHE . 5.6 t -115.72 131.69 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.548 -0.72 . . . . 0.0 109.463 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 4.1 tp -90.66 92.1 8.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.916 . . . . 0.0 110.806 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.963 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 18.3 m-85 -82.99 106.85 15.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.014 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 14.0 p -125.47 173.87 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.528 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.751 ' O ' HD12 ' A' ' 90' ' ' ILE . 26.5 p -163.41 -38.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.616 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 168.76 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.123 -0.986 . . . . 0.0 110.295 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.742 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -91.03 -9.98 63.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 3.3 t-20 68.63 33.21 3.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -1.172 . . . . 0.0 110.224 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 16' ' ' CYS . 84.6 mt -108.74 -91.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.514 ' N ' HG22 ' A' ' 15' ' ' ILE . 5.8 t -95.74 64.53 2.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.882 . . . . 0.0 110.113 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.55 ' CB ' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER 171.6 52.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.064 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER 172.39 -55.37 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.3 Cg_endo -71.79 -13.65 29.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.9 1.474 . . . . 0.0 110.383 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -65.64 -12.6 54.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 17.4 m -72.39 -29.32 63.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.48 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HA ' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -70.34 -43.09 70.97 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.776 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -71.07 -45.57 49.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.744 HG21 HG23 ' A' ' 132' ' ' ILE . 6.1 tp -64.96 -43.19 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -1.167 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.606 ' N ' HG23 ' A' ' 24' ' ' ILE . 55.9 m -65.12 -49.86 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.319 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.516 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.9 ptm180 -68.15 -26.19 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.309 -0.87 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 1.3 m-20 -85.81 -25.56 26.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.042 -1.036 . . . . 0.0 110.277 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 3.0 tmm? -92.4 -21.91 19.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.564 HG11 ' HG2' ' A' ' 32' ' ' LYS . 57.6 t -127.72 -12.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.197 -0.939 . . . . 0.0 110.617 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.43 -22.13 36.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -149.48 -87.05 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.39 -1.065 . . . . 0.0 110.235 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HG2' HG11 ' A' ' 29' ' ' VAL . 0.1 OUTLIER 58.16 122.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.277 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.757 HD13 ' HG2' ' A' ' 4' ' ' LYS . 6.0 mp -98.12 -114.81 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.027 HG22 ' C ' ' A' ' 5' ' ' LYS . 0.8 OUTLIER 32.49 33.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 0.0 111.338 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.7 mt -104.49 95.12 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.963 -1.085 . . . . 0.0 110.602 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' OD2' ' CE2' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -126.37 99.96 6.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 9.7 p -79.12 130.58 35.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.213 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.014 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -122.33 -173.06 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.32 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 38' ' ' ALA . . . 171.16 109.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -69.41 -12.1 61.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -124.0 93.93 4.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.15 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.58 87.06 0.67 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -141.1 22.24 2.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -1.111 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.424 ' HA ' ' CD ' ' A' ' 47' ' ' GLN . 85.5 m-70 -141.16 40.4 1.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.94 . . . . 0.0 110.147 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.654 HG22 ' HB3' ' A' ' 69' ' ' ALA . 11.1 t -90.63 169.29 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.214 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.408 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 48.31 37.84 18.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.471 ' HG3' ' N ' ' A' ' 48' ' ' SER . 3.2 pt20 -169.52 -148.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.471 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 60.88 131.98 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.189 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.42 70.6 1.39 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.63 13.18 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.26 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.04 -33.53 59.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.87 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -73.68 -44.73 55.82 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.388 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.548 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 3.4 t -63.57 -48.94 75.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.519 -0.738 . . . . 0.0 109.618 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 16.3 tp60 -62.74 -42.91 99.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.26 -69.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.571 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 52' ' ' ARG . 27.6 m -49.9 -32.97 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.141 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.811 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -55.51 -54.16 47.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.8 . . . . 0.0 109.487 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -29.95 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.6 t -77.78 -12.16 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.0 m-20 -113.68 -33.44 5.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 142.19 62.99 0.03 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.811 HG11 ' SG ' ' A' ' 57' ' ' CYS . 54.7 t -158.77 59.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -1.106 . . . . 0.0 110.107 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 0.2 OUTLIER -73.16 130.99 41.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.9 pt -145.38 -172.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.151 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -103.12 -61.96 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.062 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 65' ' ' SER . 12.3 mmmt -150.12 -178.4 6.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.079 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 67' ' ' GLN . 12.2 mm-40 -135.57 95.66 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.196 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -108.41 75.97 1.01 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 13' ' ' GLY . . . -44.17 106.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 110.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.491 ' HG2' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -101.94 159.23 15.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.122 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 60.8 tt0 -71.93 156.46 39.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.501 HG12 ' OD2' ' A' ' 76' ' ' ASP . 12.5 tt -79.92 159.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.446 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.8 p -119.68 176.13 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -19.7 61.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' A' ' 79' ' ' LYS . . . -64.7 -36.65 84.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.231 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.6 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 39.2 m-20 -47.53 -36.49 10.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.136 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.592 ' CD2' ' HG2' ' A' ' 98' ' ' LYS . 20.8 m-85 -94.55 16.34 15.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.137 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.18 11.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.619 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -137.11 -149.51 0.32 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.112 -0.992 . . . . 0.0 109.682 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER 36.67 -149.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.443 -0.786 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -140.06 -34.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.604 HG11 ' HZ ' ' A' ' 139' ' ' PHE . 15.8 t -139.75 149.59 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 110.714 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 8' ' ' LEU . 16.7 mt -121.76 126.61 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.828 . . . . 0.0 109.859 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 109' ' ' PHE . . . -120.26 135.09 55.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 90' ' ' ILE . . . -108.43 160.38 15.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.59 HD21 HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -105.06 2.7 29.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.965 . . . . 0.0 110.244 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 90' ' ' ILE . 22.9 t70 -137.85 174.14 10.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -89.66 -66.71 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.086 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -47.16 -40.69 16.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 11' ' ' CYS . 6.3 tt -52.35 -39.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.043 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.533 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.7 OUTLIER -81.58 -34.79 30.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.077 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -20.07 63.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -103.14 -44.64 5.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.537 HG13 ' CE ' ' A' ' 97' ' ' MET . 2.7 tt -48.15 -36.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.468 ' N ' HG23 ' A' ' 94' ' ' ILE . 38.4 p30 -69.98 -11.47 60.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 9.5 t -75.41 -26.86 58.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.537 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.3 ptt? -96.34 -34.99 11.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -45.22 145.58 1.78 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.26 -174.35 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.989 1.52 . . . . 0.0 110.34 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.63 -4.1 11.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.963 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.88 48.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.5 p -124.84 -161.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -132.52 -142.16 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.262 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 103' ' ' ARG . . . 56.86 -159.27 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 106' ' ' VAL . 7.9 tttt -173.41 148.11 1.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 0.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 106' ' ' VAL . 4.0 m -101.01 133.64 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.05 161.4 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.459 HD21 ' OD1' ' A' ' 110' ' ' ASN . 8.5 tp -83.51 149.21 26.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.727 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -136.3 85.71 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.236 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.459 ' OD1' HD21 ' A' ' 108' ' ' LEU . 2.0 p-10 -177.39 146.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.58 174.78 12.04 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.004 1.528 . . . . 0.0 110.373 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.1 Cg_endo -72.84 52.77 2.22 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.437 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.98 -50.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.96 91.86 1.41 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.844 HG13 ' HA ' ' A' ' 128' ' ' MET . 99.0 t -56.24 114.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.9 t70 57.63 168.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.948 . . . . 0.0 110.178 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.535 ' N ' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 171.61 -56.83 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.331 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 117' ' ' ASP . 46.1 Cg_endo -72.72 -37.69 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.995 1.524 . . . . 0.0 110.542 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 57.89 179.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.6 t80 60.32 25.75 15.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.234 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 t -163.89 -164.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.22 18.31 22.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.962 . . . . 0.0 110.21 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -90.53 34.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.189 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -147.23 -45.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.785 ' HB3' HG21 ' A' ' 56' ' ' VAL . 4.4 m-30 -50.42 -46.32 84.37 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.29 -1.124 . . . . 0.0 110.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 48.5 Cg_endo -74.65 -51.4 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.716 1.377 . . . . 0.0 110.171 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' MET . 3.3 m -58.99 -55.56 33.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.844 ' HA ' HG13 ' A' ' 115' ' ' VAL . 10.2 ttp -44.9 -40.58 6.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.367 -0.833 . . . . 0.0 110.084 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.528 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 37.1 t80 -70.35 -62.01 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.995 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.72 -47.27 15.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.92 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.792 ' CB ' HG22 ' A' ' 115' ' ' VAL . 71.6 m -70.88 -42.19 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.981 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.744 HG23 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -50.72 -43.11 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.941 . . . . 0.0 109.851 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.579 ' HA ' ' HE3' ' A' ' 136' ' ' MET . 1.1 t -85.29 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.516 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.95 -18.31 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.49 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 39.1 tp10 -98.28 -18.29 18.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.579 ' HE3' ' HA ' ' A' ' 133' ' ' SER . 3.9 ttp -101.45 -0.53 35.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 110.2 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -82.51 -48.29 0.87 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.933 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.3 -11.5 14.56 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.055 1.555 . . . . 0.0 110.326 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.604 ' HZ ' HG11 ' A' ' 82' ' ' VAL . 68.4 t80 -101.92 -61.98 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 146' ' ' ILE . 6.5 tp -52.73 -25.43 11.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.592 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 23.3 m -76.99 -40.91 45.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 110.373 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.3 -66.42 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.659 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.579 ' O ' ' CZ ' ' A' ' 139' ' ' PHE . 12.7 t-80 -96.89 60.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -0.933 . . . . 0.0 110.733 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 145' ' ' LEU . . . -176.16 -34.05 0.04 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER 172.06 -91.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.499 -1.001 . . . . 0.0 109.912 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.592 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.139 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.36 0.6 . . . . 0.0 110.339 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.917 ' HE2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -155.81 -48.1 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 110.684 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.952 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.2 mttt 68.83 -154.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 110.913 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.892 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -159.56 135.42 8.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.316 0.579 . . . . 0.0 109.977 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.887 HG12 HG11 ' A' ' 82' ' ' VAL . 3.5 m -104.07 115.43 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.503 -0.748 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.848 HD12 ' HB3' ' A' ' 36' ' ' ASP . 14.9 tp -66.37 89.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 110.089 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.585 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -78.64 101.45 7.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.045 HG22 ' HB3' ' A' ' 38' ' ' ALA . 15.2 t -116.9 157.05 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.759 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 11.9 t -145.85 -78.87 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -175.38 69.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.341 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.64 ' HA3' ' CE1' ' A' ' 44' ' ' HIS . . . 137.74 -21.85 3.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 4.8 t-20 71.15 1.45 3.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -1.132 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.571 HG13 ' CD2' ' A' ' 44' ' ' HIS . 18.5 mm -89.59 -36.79 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.932 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 29.5 p -137.63 167.18 22.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.927 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.546 ' CG ' HD23 ' A' ' 86' ' ' LEU . 51.2 mtm180 56.22 43.04 27.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -0.968 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -173.31 -60.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 45.0 Cg_endo -71.78 -10.86 27.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.888 1.468 . . . . 0.0 110.33 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.751 ' HB3' HD12 ' A' ' 132' ' ' ILE . . . -75.72 -16.79 60.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.047 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 37.0 t -66.45 -55.42 15.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.799 ' HG3' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -43.37 -36.69 1.99 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 109.346 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -71.88 -50.26 19.5 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.987 HD11 ' OG ' ' A' ' 133' ' ' SER . 2.4 tp -55.86 -45.17 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.747 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.95 ' CB ' HD11 ' A' ' 35' ' ' ILE . 54.3 m -72.16 -30.47 65.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.562 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 0.1 OUTLIER -66.91 -37.1 83.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.895 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.402 ' HB2' ' HA ' ' A' ' 62' ' ' VAL . 22.1 t70 -82.81 -34.99 26.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 110.107 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.837 ' O ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -78.72 -28.16 45.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 110.406 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.837 HG13 ' O ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -163.7 41.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.79 94.51 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' VAL . 3.8 t0 170.5 -25.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 110.128 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.574 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.76 -138.94 0.31 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 110.022 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -152.88 -83.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.892 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 37.01 26.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.42 -0.8 . . . . 0.0 110.92 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.95 HD11 ' CB ' ' A' ' 25' ' ' CYS . 7.4 mt -131.55 132.64 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.158 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.848 ' HB3' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -145.03 90.05 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 179.235 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -67.19 124.68 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.045 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -141.45 176.03 9.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.701 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -159.61 -162.53 1.04 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.152 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -177.59 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -165.26 110.51 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 108.34 2.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.35 -41.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.64 ' CE1' ' HA3' ' A' ' 13' ' ' GLY . 24.5 p-80 -155.79 81.5 1.02 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 t -118.79 -20.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 110.303 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.15 31.7 8.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.502 ' HG3' ' N ' ' A' ' 48' ' ' SER . 17.7 pt20 -164.5 -140.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -1.116 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.502 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.61 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.174 -0.954 . . . . 0.0 110.15 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.9 Cg_endo -69.34 107.48 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.012 1.533 . . . . 0.0 110.538 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -94.26 21.31 7.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 3.7 m -71.08 -27.9 63.96 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.189 -0.944 . . . . 0.0 108.748 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -74.38 -43.45 56.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.214 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -54.92 28.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.483 -0.76 . . . . 0.0 109.6 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 20.0 mt-30 -61.58 -40.31 94.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.261 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.602 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.09 -71.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.832 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 52' ' ' ARG . 14.9 p -50.03 -34.28 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.494 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 64' ' ' ILE . 1.3 m -55.45 -53.71 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.507 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -69.43 -24.35 63.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.862 . . . . 0.0 109.566 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -82.58 -11.72 58.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.813 . . . . 0.0 109.993 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -111.45 -31.72 6.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 0.0 109.182 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 130.03 73.63 0.13 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 129' ' ' PHE . 2.2 p 173.34 137.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.289 -1.124 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -119.41 137.2 53.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.203 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.76 HD11 ' SG ' ' A' ' 57' ' ' CYS . 34.1 mt -120.58 -34.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.202 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER 53.66 97.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 65' ' ' SER . 3.6 mmmt 60.05 145.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.271 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.417 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 5.4 mm-40 -107.53 -52.58 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 67.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.94 . . . . 0.0 110.159 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -57.28 152.53 13.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 mtp-105 -137.1 -163.75 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 110.271 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -132.43 128.01 36.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 72' ' ' ILE . 11.9 tt -50.32 159.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.178 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 50.9 p -126.97 169.93 12.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -1.92 20.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.206 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.14 -8.64 21.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.543 ' HB2' HD22 ' A' ' 8' ' ' LEU . 20.5 p-10 -47.21 -37.25 10.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 39.5 m-85 -69.41 -17.04 63.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 m -123.06 13.44 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.203 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 3.5 tptt -94.82 -23.7 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.708 ' CD1' ' HB3' ' A' ' 6' ' ' ALA . 93.8 m-85 -147.35 -140.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.869 . . . . 0.0 109.983 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 4.0 m-20 -137.06 -23.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.054 -1.028 . . . . 0.0 111.029 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.887 HG11 HG12 ' A' ' 7' ' ' VAL . 39.1 t -113.42 138.76 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 0.0 110.509 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.652 HD12 ' CB ' ' A' ' 104' ' ' ALA . 47.4 mt -146.3 133.89 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.433 -0.792 . . . . 0.0 109.777 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -162.03 163.09 28.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.661 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.5 ' HB1' HD13 ' A' ' 90' ' ' ILE . . . -126.5 159.87 32.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.824 ' HG ' HG21 ' A' ' 115' ' ' VAL . 1.3 tp -85.64 -37.36 19.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -101.74 -176.26 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.194 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.8 mm-40 -92.45 -39.0 11.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 88' ' ' GLN . 15.6 m -42.75 -41.0 3.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.605 HD12 ' H ' ' A' ' 90' ' ' ILE . 2.1 mp -65.46 -40.08 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.91 . . . . 0.0 110.099 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.617 HD13 ' HB2' ' A' ' 108' ' ' LEU . 2.0 tp -67.64 -32.4 73.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.6 t -79.99 -30.62 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.246 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 96' ' ' SER . 1.8 m-20 -87.83 -54.58 4.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.256 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.633 HG13 ' HE1' ' A' ' 97' ' ' MET . 3.9 tt -46.69 -40.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.63 -8.81 56.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 2.7 m -96.78 -0.93 47.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.151 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.633 ' HE1' HG13 ' A' ' 94' ' ' ILE . 1.7 ptt? -122.56 -10.0 8.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 8.4 mtpt -63.59 143.75 97.88 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.411 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 45.9 Cg_endo -73.14 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.028 1.541 . . . . 0.0 110.419 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.4 m -105.61 28.38 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.416 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.1 p-10 -178.51 126.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 110.24 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 101' ' ' ASN . 83.5 m -149.56 -161.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.01 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.652 ' CB ' HD12 ' A' ' 83' ' ' ILE . . . -105.82 -152.07 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -148.75 111.15 4.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.167 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 71.1 t -87.39 125.46 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 110.088 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ALA . 3.6 t -135.11 159.07 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.617 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -119.19 108.17 14.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -55.27 -170.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.26 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.549 HD21 ' N ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -42.57 166.04 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.197 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.503 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.9 Cg_endo -74.64 175.02 11.66 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.912 1.48 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.5 Cg_endo -71.74 54.45 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.996 1.524 . . . . 0.0 110.38 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.67 -29.95 4.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.876 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -107.45 -92.45 2.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.824 HG21 ' HG ' ' A' ' 86' ' ' LEU . 29.0 m -41.12 128.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 110.168 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -157.78 -65.7 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.42 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 0.5 OUTLIER 61.53 82.76 0.22 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.12 176.64 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.006 1.53 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 119' ' ' TYR . 67.7 m-85 -118.95 24.15 10.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -130.17 -34.68 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 110.335 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -145.62 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 110.246 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 p -153.97 54.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.137 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' A' ' 127' ' ' THR . 4.0 p30 -124.41 -6.14 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.265 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 117' ' ' ASP . . . -93.85 -22.37 25.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.619 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 13.5 m-85 -55.03 -49.81 90.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.331 -1.099 . . . . 0.0 110.365 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -73.34 -35.67 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.84 1.442 . . . . 0.0 110.385 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 123' ' ' ASP . 2.5 m -63.06 -51.96 64.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 20' ' ' ALA . 3.1 ttp -44.52 -55.42 5.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 11.1 t80 -68.23 -33.59 74.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.182 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.754 ' CB ' HG13 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -86.89 -43.45 12.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.057 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -57.85 -23.21 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -0.761 . . . . 0.0 109.472 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.987 ' OG ' HD11 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.32 -42.81 6.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.987 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 14.3 mttp -75.41 -5.69 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 131' ' ' SER . 70.3 mm-40 -129.2 34.34 4.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.15 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.55 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -116.21 -12.18 11.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.1 mttp -81.53 -47.4 1.06 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.44 0.33 10.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.99 1.521 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 62.8 t80 -108.06 -77.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.098 HD12 HD13 ' A' ' 145' ' ' LEU . 8.5 tp -51.16 -24.46 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.345 -0.847 . . . . 0.0 110.438 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.842 HG23 HD13 ' A' ' 146' ' ' ILE . 32.2 m -82.01 -30.61 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -105.22 -14.06 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.453 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.687 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 6.9 m80 -84.71 39.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.101 -0.999 . . . . 0.0 110.302 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.7 60.86 6.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.098 HD13 HD12 ' A' ' 140' ' ' LEU . 1.1 mt -163.67 34.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 110.021 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.842 HD13 HG23 ' A' ' 141' ' ' THR . 2.0 tp . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.227 0.537 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.514 ' HG3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.15 149.96 26.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.254 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.682 ' H ' HG22 ' A' ' 34' ' ' ILE . 23.1 mtpp -130.23 -155.62 0.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 110.982 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.077 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -147.23 117.2 7.22 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.546 0.689 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.893 ' HB ' HD12 ' A' ' 34' ' ' ILE . 21.9 t -108.2 126.62 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.578 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 38' ' ' ALA . 6.8 tp -98.13 80.95 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 0.0 110.752 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.949 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 69.5 m-85 -62.2 133.65 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.054 HG13 HD11 ' A' ' 90' ' ' ILE . 8.6 p -156.45 166.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.616 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.668 ' CA ' HD12 ' A' ' 90' ' ' ILE . 1.1 p -146.78 -98.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 109.904 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.58 86.7 2.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.101 -1.0 . . . . 0.0 110.185 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.581 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 85.37 -11.53 60.87 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 t30 74.75 -164.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -1.123 . . . . 0.0 109.782 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 15' ' ' ILE . 11.7 mm 58.12 13.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 2.0 t -174.89 175.33 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.955 . . . . 0.0 110.207 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.738 ' CB ' HD22 ' A' ' 86' ' ' LEU . 1.1 mtp180 70.72 -56.24 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.351 -0.843 . . . . 0.0 110.013 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.751 ' CB ' HD21 ' A' ' 86' ' ' LEU . 3.2 m -175.44 55.62 0.14 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.484 ' HD3' ' C ' ' A' ' 16' ' ' CYS . 50.0 Cg_endo -76.39 -1.14 11.15 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.971 1.511 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.926 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -100.12 7.01 44.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.348 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.677 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -59.73 -37.83 80.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.125 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -50.42 66.96 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.68 -0.638 . . . . 0.0 109.726 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.667 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -62.97 -58.27 12.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.983 HG21 HG23 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -55.13 -29.33 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -1.205 . . . . 0.0 109.91 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.3 m -69.09 -60.7 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.253 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 23' ' ' GLY . 11.6 ptm180 -61.1 -28.73 69.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.513 ' CB ' ' HA ' ' A' ' 62' ' ' VAL . 11.4 t70 -81.17 -53.06 6.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -55.58 -38.73 69.75 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.312 -0.867 . . . . 0.0 110.278 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 25' ' ' CYS . 4.4 m -84.54 -38.56 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.226 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.49 ' N ' HG23 ' A' ' 29' ' ' VAL . . . 106.0 -64.29 0.29 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.03 50.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -1.147 . . . . 0.0 110.251 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.778 ' C ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -95.48 -132.82 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 35' ' ' ILE . 4.9 mp -149.57 -120.63 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.383 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.077 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.0 29.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.812 . . . . 0.0 111.609 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.827 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -96.24 97.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.888 -1.133 . . . . 0.0 110.147 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.641 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 6.3 m-20 -135.76 144.27 45.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.5 p -137.56 151.34 48.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.432 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.786 ' O ' HG23 ' A' ' 10' ' ' VAL . . . -146.22 -172.9 4.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 110.361 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG23 ' A' ' 10' ' ' VAL . . . -169.4 100.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 41' ' ' SER . 25.8 p -54.48 -68.17 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 0.0 110.274 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.506 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.2 OUTLIER -64.71 -177.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.54 36.86 0.58 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -78.96 -31.64 45.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -1.147 . . . . 0.0 110.187 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.432 ' ND1' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -116.62 70.74 0.77 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -138.28 142.6 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 86.32 25.98 34.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 48' ' ' SER . 13.0 pt20 -176.96 -141.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -1.131 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 0.9 OUTLIER 59.03 108.31 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.62 100.37 0.8 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.012 1.532 . . . . 0.0 110.471 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.505 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 22.3 m-20 -87.33 27.12 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.231 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -75.02 -27.55 60.14 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.186 -0.946 . . . . 0.0 109.137 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.782 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -74.2 -51.77 14.47 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.442 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -63.01 -46.74 86.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 109.655 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 1.8 tt0 -62.76 -42.47 99.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.169 -0.957 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 3.5 ttpp -57.76 -67.13 0.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.704 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 52' ' ' ARG . 4.8 p -50.86 -33.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.237 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.679 ' CB ' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.37 -55.6 31.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.463 -0.773 . . . . 0.0 109.504 179.424 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -29.89 71.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 5.7 t -78.24 -14.46 59.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -111.7 -35.13 5.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.2 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.563 ' C ' HG12 ' A' ' 62' ' ' VAL . . . 127.58 84.81 0.48 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.926 HG23 ' N ' ' A' ' 24' ' ' ILE . 1.5 p 169.26 80.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.369 -1.077 . . . . 0.0 110.041 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -59.96 157.53 12.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.352 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.47 HG12 ' HA3' ' A' ' 23' ' ' GLY . 39.3 mt -148.81 -64.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.097 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER 66.54 96.78 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.47 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.56 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.286 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.422 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 21.4 mm100 -105.48 -145.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.7 70.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . . . -93.75 139.12 31.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -171.42 175.36 4.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -75.96 106.49 7.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.757 HD12 ' HB1' ' A' ' 38' ' ' ALA . 19.8 tt -46.23 157.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.41 159.9 37.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -55.38 -19.3 8.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.14 -12.89 44.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.98 -15.79 61.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.607 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 17.1 m-30 -81.73 -8.04 59.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.223 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.7 p -117.73 -48.98 2.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.582 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -51.37 -27.09 8.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.18 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.678 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 9.3 m-85 -134.1 157.09 47.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.252 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -104.25 -8.17 19.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.27 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.51 ' CG1' ' CE1' ' A' ' 143' ' ' HIS . 6.0 t -138.95 141.86 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.233 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.51 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 51.9 mt -123.84 143.36 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.949 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -114.64 120.51 40.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.851 ' HB1' HG23 ' A' ' 90' ' ' ILE . . . -111.22 113.62 26.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 18' ' ' SER . 2.2 mp -51.18 -83.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.492 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t0 -71.96 -179.43 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.241 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -84.41 -45.29 12.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 1.5 t -45.21 -51.14 11.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.956 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.054 HD11 HG13 ' A' ' 10' ' ' VAL . 6.8 tt -52.95 -47.16 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.363 -0.835 . . . . 0.0 110.086 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -58.16 -53.21 60.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -55.28 -54.87 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.845 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' SER . 29.1 m-20 -47.67 -60.32 2.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 110.147 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.667 HG23 ' CE ' ' A' ' 97' ' ' MET . 15.0 mt -58.74 -47.05 90.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -67.02 -16.13 64.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.557 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -80.82 -28.89 36.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.667 ' CE ' HG23 ' A' ' 94' ' ' ILE . 10.2 ptt? -97.07 -30.25 13.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.118 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -41.76 144.59 0.79 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 110.446 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.527 ' HD2' ' CE ' ' A' ' 98' ' ' LYS . 44.1 Cg_endo -71.37 177.39 6.74 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.13 1.595 . . . . 0.0 110.387 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.413 ' C ' ' OD1' ' A' ' 101' ' ' ASN . 0.9 OUTLIER -98.2 21.2 11.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 7.4 m120 -143.87 -137.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.102 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.31 -176.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 110.067 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.476 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -131.55 35.37 3.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.28 -171.52 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 146.04 11.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.483 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 37.8 t -112.17 127.0 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 108' ' ' LEU . 1.2 p -122.4 171.42 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.553 ' N ' HG22 ' A' ' 107' ' ' VAL . 6.0 tp -99.74 150.31 22.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.828 . . . . 0.0 110.138 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 135' ' ' GLU . 25.3 t80 -124.96 97.58 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 109' ' ' PHE . 18.8 t-20 60.14 144.9 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.561 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.3 Cg_endo -74.51 176.97 9.0 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.529 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.1 Cg_endo -72.18 3.05 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.027 1.54 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.47 -37.81 15.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 110.123 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 115' ' ' VAL . . . -78.49 -76.41 0.93 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 29.9 m -59.27 -150.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -1.1 . . . . 0.0 110.118 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 6.0 t0 63.77 135.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.442 ' OD1' ' SG ' ' A' ' 16' ' ' CYS . 1.2 p30 -170.23 157.63 5.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.963 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 -27.74 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.036 1.545 . . . . 0.0 110.448 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 56.3 34.92 24.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -110.41 -32.97 6.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 m -122.22 -86.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.5 ' O ' ' CD ' ' A' ' 126' ' ' PRO . 89.9 p -155.0 19.05 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.11 4.6 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 110.18 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -105.8 -45.99 1.24 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 12.8 m-85 -50.01 -45.69 81.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 110.566 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.736 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 45.9 Cg_endo -73.68 -51.02 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.573 1.302 . . . . 0.0 110.287 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 128' ' ' MET . 66.0 p -69.11 -56.59 7.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.23 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.63 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 8.8 ttp -41.33 -68.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 87.5 t80 -59.22 -44.04 92.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.119 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -44.56 -64.16 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.972 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -63.4 -45.3 91.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 109.953 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.983 HG23 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -40.7 -56.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.856 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.585 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -74.38 -47.36 34.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.225 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 3.8 tppt? -47.94 -22.79 0.64 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.578 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -125.57 31.34 5.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.986 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.533 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -115.21 -22.08 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.156 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 3.9 mttp -87.92 -52.36 0.39 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.72 5.64 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.521 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 41.3 t80 -93.82 -76.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.753 HD13 HD23 ' A' ' 145' ' ' LEU . 3.5 pp -65.66 -30.8 71.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.514 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.627 ' N ' HD12 ' A' ' 140' ' ' LEU . 22.3 m -56.06 -33.53 65.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 110.251 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.09 -34.87 7.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.16 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.534 ' NE2' HG11 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -44.33 -27.85 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 110.107 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.534 ' O ' ' HD2' ' A' ' 5' ' ' LYS . . . 127.08 67.8 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.753 HD23 HD13 ' A' ' 140' ' ' LEU . 26.5 tp -156.36 -54.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 0.0 110.227 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.764 ' C ' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.174 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.343 0.592 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.555 ' HG2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.84 -164.74 0.54 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.401 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.914 ' C ' HG22 ' A' ' 34' ' ' ILE . 24.7 mttm -156.02 -160.86 1.05 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 110.77 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.009 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -144.59 122.81 12.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.442 -0.787 . . . . 0.0 111.056 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.921 HG11 ' CZ ' ' A' ' 9' ' ' PHE . 43.5 t -113.21 128.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 109.669 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 80' ' ' PHE . 13.2 tp -86.93 85.87 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.485 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.921 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 34.0 m-85 -76.24 100.43 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.948 HG13 HD11 ' A' ' 90' ' ' ILE . 1.5 p -120.54 168.96 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.573 ' O ' HD12 ' A' ' 12' ' ' LEU . 19.4 t -154.14 -53.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.058 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER 176.58 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.501 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -104.31 -15.85 20.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.925 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 6.6 t-20 67.96 38.7 2.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -1.198 . . . . 0.0 110.205 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.653 HD13 ' CB ' ' A' ' 48' ' ' SER . 17.9 mt -114.76 -2.52 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 110.076 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 m -137.2 45.45 2.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 110.13 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HD3' HD22 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -146.7 -57.35 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 110.176 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.539 ' CB ' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -45.21 -56.57 9.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.139 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.83 ' HB3' HD12 ' A' ' 64' ' ' ILE . 46.9 Cg_endo -74.88 -0.96 10.55 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.928 1.488 . . . . 0.0 110.295 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.735 ' HB1' HG13 ' A' ' 132' ' ' ILE . . . -103.66 -44.98 4.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 110.213 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.562 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 60.9 m -74.21 -38.62 63.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.066 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.62 ' HG3' HG21 ' A' ' 35' ' ' ILE . 2.5 tt0 -69.68 -45.68 67.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 110.242 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.842 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -71.23 -46.65 41.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.628 HG12 HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -61.29 -43.8 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.14 . . . . 0.0 110.355 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.577 ' N ' HG23 ' A' ' 24' ' ' ILE . 58.3 m -69.71 -40.02 76.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 1.8 mmt-85 -67.5 -32.87 73.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.417 ' OD2' ' HA3' ' A' ' 61' ' ' GLY . 1.2 t70 -85.19 -48.69 8.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.039 . . . . 0.0 110.622 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -74.83 -21.58 59.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.745 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.784 HG11 ' HG3' ' A' ' 32' ' ' LYS . 2.3 t -119.98 -24.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.783 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 106.28 -60.97 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 13.7 t70 -178.27 94.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 110.215 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.796 ' C ' HD12 ' A' ' 33' ' ' LEU . 12.5 mmtm -119.86 -130.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.105 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.796 HD12 ' C ' ' A' ' 32' ' ' LYS . 5.2 mp -149.81 -118.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 110.643 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.009 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.17 29.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.459 -0.775 . . . . 0.0 111.496 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.784 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.1 mt -104.26 90.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.007 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 55.1 m-20 -121.79 97.49 5.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.68 134.72 36.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.832 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -137.04 168.35 19.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.487 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.925 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -140.38 142.83 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 110.08 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.911 HG21 HG13 ' A' ' 90' ' ' ILE . 11.8 p -103.7 41.57 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 40' ' ' THR . 2.4 p 170.16 103.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.86 58.05 0.99 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -88.59 -62.06 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -1.158 . . . . 0.0 110.189 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 102.4 9.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.288 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 69' ' ' ALA . 73.6 t -142.07 139.53 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.227 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.07 60.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 48' ' ' SER . 5.3 pt20 -123.52 -140.39 0.31 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 110.243 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.653 ' CB ' HD13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 66.21 126.36 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.36 90.36 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.349 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 2.5 t0 -99.26 24.03 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.259 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -76.47 -30.43 57.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.219 -0.925 . . . . 0.0 109.197 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.9 OUTLIER -74.16 -48.95 25.88 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.444 -0.785 . . . . 0.0 109.29 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.38 71.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 109.483 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 2.6 tt0 -61.1 -42.13 97.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.267 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -54.74 -66.05 0.47 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.363 -0.836 . . . . 0.0 109.304 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.592 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.6 t -50.28 -35.06 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.939 . . . . 0.0 108.983 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.729 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -54.87 -51.11 66.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 109.427 179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -69.52 -28.55 66.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.719 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.3 -11.14 59.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -112.44 -26.49 8.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 131.17 80.18 0.2 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.842 HG13 ' HA3' ' A' ' 23' ' ' GLY . 66.5 t -158.89 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -1.108 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 32.1 p-10 -97.97 104.66 16.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 19' ' ' PRO . 13.6 pt -143.24 -171.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.36 125.97 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.061 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.458 ' OE1' ' HD3' ' A' ' 19' ' ' PRO . 33.9 mm-40 -84.38 96.07 8.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.345 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -89.66 74.41 7.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.118 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.868 ' HB3' HG13 ' A' ' 45' ' ' VAL . . . -41.9 126.63 3.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.9 tmm_? -106.06 151.45 24.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -90.62 144.14 26.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.903 . . . . 0.0 110.241 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 39' ' ' ALA . 16.5 tt -82.69 170.45 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 110.121 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.51 161.07 41.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -59.42 -14.84 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' O ' ' CE ' ' A' ' 79' ' ' LYS . . . -80.48 -12.02 59.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.165 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -47.96 -21.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.366 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.536 ' CD1' ' HE3' ' A' ' 98' ' ' LYS . 18.9 m-85 -76.92 52.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.113 -0.992 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.516 ' C ' ' CD ' ' A' ' 79' ' ' LYS . 1.1 p 175.02 31.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.344 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' CD ' ' C ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -135.74 -35.69 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.284 -0.885 . . . . 0.0 110.034 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.764 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 9.5 m-85 -123.32 156.46 35.27 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.549 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 1.3 m-20 -71.64 -36.63 70.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 50.4 t -140.8 156.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.039 . . . . 0.0 110.69 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 8' ' ' LEU . 9.5 mt -118.45 133.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.494 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -107.24 134.63 50.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 110.443 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.55 125.68 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.648 HD22 ' HD3' ' A' ' 17' ' ' ARG . 2.7 mp -78.99 -78.47 0.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 5.6 m-20 -56.91 178.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.473 ' HG3' ' HD3' ' A' ' 112' ' ' PRO . 8.4 mm-40 -89.11 -55.15 3.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.2 m -45.62 -48.93 14.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.948 HD11 HG13 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -46.26 -49.69 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.71 HD13 ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -63.54 -49.62 72.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.835 179.65 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.0 t -60.88 -17.26 49.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.846 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -87.32 -67.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 90' ' ' ILE . 6.6 mt -44.75 -54.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.549 -0.72 . . . . 0.0 109.871 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -14.9 19.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.697 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -81.7 -34.99 30.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 21.1 ptt? -96.53 -27.85 14.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE3' ' CD1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -40.71 139.32 1.17 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.66 -163.98 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.087 1.572 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -110.87 20.98 16.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.282 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -169.98 121.33 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.2 p -172.59 170.54 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 41.59 1.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -162.27 131.61 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.13 173.59 6.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 0.0 110.136 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.442 ' CG2' ' HD2' ' A' ' 98' ' ' LYS . 64.5 t -118.95 142.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -134.61 161.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.231 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.71 ' HG ' HD13 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -103.91 105.51 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.144 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.563 ' CZ ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -54.57 -57.18 12.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 18.7 p30 -162.11 164.11 17.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -73.96 175.21 11.14 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.133 1.596 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.0 Cg_endo -72.41 52.45 1.98 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.941 1.495 . . . . 0.0 110.422 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.41 -7.15 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.95 -91.18 1.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.949 HG22 ' HA ' ' A' ' 128' ' ' MET . 14.3 t -85.86 136.85 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.071 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.432 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 35.1 t70 -167.79 33.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.545 ' N ' ' CD ' ' A' ' 118' ' ' PRO . 55.8 m-20 43.76 49.39 5.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 117' ' ' ASP . 46.0 Cg_endo -72.72 139.9 31.52 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.02 1.537 . . . . 0.0 110.499 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.431 ' CE2' ' O ' ' A' ' 117' ' ' ASP . 49.5 m-85 -132.93 44.8 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.113 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -107.35 -35.98 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.139 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.7 m -159.16 -147.35 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.526 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 28.8 m -60.85 -25.74 66.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 123' ' ' ASP . 10.9 p30 -46.59 123.03 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.265 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 132.99 -27.0 3.51 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -98.42 -45.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.264 -1.139 . . . . 0.0 110.764 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 125' ' ' PHE . 48.4 Cg_endo -82.6 -73.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.586 1.308 . . . . 0.0 110.643 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 126' ' ' PRO . 1.1 t -42.95 -33.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.949 ' HA ' HG22 ' A' ' 115' ' ' VAL . 4.0 tmm? -62.05 -69.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 24' ' ' ILE . 5.8 t80 -49.22 -50.21 39.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.976 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -50.87 -47.56 60.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.427 ' CB ' HG23 ' A' ' 115' ' ' VAL . 38.5 t -64.78 -46.96 79.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.797 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.735 HG13 ' HB1' ' A' ' 20' ' ' ALA . 15.2 mm -47.51 -55.97 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 0.1 OUTLIER -63.89 -47.85 78.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.821 . . . . 0.0 110.146 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -52.99 -25.88 13.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.897 . . . . 0.0 110.145 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.563 ' O ' ' CZ ' ' A' ' 109' ' ' PHE . 80.6 mm-40 -116.88 14.94 15.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.564 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.79 -22.14 7.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.8 mtpm? -84.52 -47.9 0.67 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.1 Cg_endo -78.36 -4.59 14.36 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.013 1.533 . . . . 0.0 110.344 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 139' ' ' PHE . 4.6 t80 -108.03 -48.87 3.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.46 -9.58 19.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.228 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 4.3 m -73.8 -72.1 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.423 ' N ' HG22 ' A' ' 141' ' ' THR . 2.2 mt-10 -105.16 -5.66 20.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.68 22.86 15.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.163 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.835 ' C ' HD12 ' A' ' 145' ' ' LEU . . . -173.14 -54.64 0.05 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.835 HD12 ' C ' ' A' ' 144' ' ' GLY . 5.4 mp -149.77 -88.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -1.124 . . . . 0.0 110.126 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 1.7 tp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.149 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.283 0.563 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -85.63 156.72 20.58 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.734 ' H ' HG22 ' A' ' 34' ' ' ILE . 3.2 mtpt -133.53 -163.99 1.43 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.022 -1.049 . . . . 0.0 111.029 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.074 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -148.86 116.45 6.23 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.864 ' HB ' HD12 ' A' ' 34' ' ' ILE . 3.3 t -104.13 125.54 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.703 . . . . 0.0 109.159 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.739 HD13 ' CD2' ' A' ' 80' ' ' PHE . 13.5 tp -89.92 84.7 6.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 110.697 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.587 ' CG ' ' SG ' ' A' ' 21' ' ' CYS . 26.0 m-85 -67.27 108.72 2.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -0.95 . . . . 0.0 109.469 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.981 HG13 ' HA ' ' A' ' 39' ' ' ALA . 20.0 t -126.38 154.81 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.563 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 1.8 p -145.16 -108.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.854 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.617 HD23 ' OD2' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -118.51 82.24 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 0.0 110.104 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 77.37 0.39 71.83 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.5 t30 71.97 -158.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -1.087 . . . . 0.0 109.899 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 15' ' ' ILE . 8.4 mm 58.06 12.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.237 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 177.19 176.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.117 -0.99 . . . . 0.0 110.504 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.715 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER 71.72 -60.0 0.53 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.775 . . . . 0.0 110.237 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.606 ' OG ' HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -139.73 48.07 1.46 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.9 Cg_endo -77.82 -10.64 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.924 1.486 . . . . 0.0 110.054 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -97.5 6.99 47.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 110.43 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.803 ' SG ' HD12 ' A' ' 132' ' ' ILE . 1.4 m -62.78 -45.14 94.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.07 -1.019 . . . . 0.0 109.352 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.547 ' HG2' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.83 -47.4 85.88 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.55 -0.719 . . . . 0.0 109.88 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.841 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -68.49 -59.52 6.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.109 HD12 ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -43.0 -46.91 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -1.19 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.755 ' HB2' HD11 ' A' ' 35' ' ' ILE . 78.1 m -69.36 -37.44 77.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 13.6 mmt180 -62.04 -45.18 94.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.337 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 -45.79 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.69 ' O ' HG13 ' A' ' 29' ' ' VAL . 6.0 mmt -63.24 -41.32 99.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 28' ' ' MET . 3.5 m -158.77 36.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.405 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 25' ' ' CYS . . . -49.87 -22.67 4.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.82 -20.79 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.356 -1.085 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.658 ' HE2' HD11 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -104.77 -139.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.931 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.8 mt -147.77 -95.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.228 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.074 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 32.39 33.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 0.0 111.568 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 25' ' ' CYS . 3.5 mt -110.69 94.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.892 -1.13 . . . . 0.0 110.487 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.691 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 42.3 m-20 -126.05 104.48 8.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 m -95.15 130.94 41.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.772 ' C ' HG22 ' A' ' 10' ' ' VAL . . . -157.29 -172.79 4.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.482 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.981 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -164.06 146.55 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.125 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 40' ' ' THR . 14.0 t -93.87 64.74 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.177 -0.952 . . . . 0.0 110.256 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.508 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . 12.5 t -149.17 -75.66 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.242 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . 74.59 106.32 0.09 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 1.2 m-85 -170.04 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -1.146 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -123.98 23.88 8.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.229 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m -65.03 -9.19 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 110.403 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . -104.48 41.12 2.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' O ' ' CB ' ' A' ' 48' ' ' SER . 6.9 pt20 -177.92 -142.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.119 . . . . 0.0 110.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 67.45 98.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.56 83.53 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.004 1.529 . . . . 0.0 110.427 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -89.09 32.3 0.83 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -29.4 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 108.923 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' C ' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.72 -52.46 13.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.74 . . . . 0.0 109.306 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.625 ' N ' ' CZ ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -61.25 -48.22 82.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.622 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -61.27 -43.71 98.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.136 -0.978 . . . . 0.0 109.256 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 1.3 tptt -54.25 -65.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.393 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.859 HG11 ' HD2' ' A' ' 125' ' ' PHE . 24.3 m -53.75 -32.24 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.227 -0.921 . . . . 0.0 109.03 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.791 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -54.98 -55.63 28.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.429 -0.795 . . . . 0.0 109.29 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -33.31 75.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -11.21 60.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -0.836 . . . . 0.0 109.971 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.4 m-80 -113.32 -32.07 6.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 145.12 55.01 0.02 OUTLIER Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.841 HG13 ' HA3' ' A' ' 23' ' ' GLY . 53.8 t -158.66 89.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.135 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.29 103.55 16.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.436 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 41.2 pt -138.12 -161.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.29 133.89 0.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.237 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt 52.12 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' ARG . 6.0 mm-40 -44.72 -39.83 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 48.23 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . . . -102.18 155.63 18.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -152.73 158.39 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -79.77 124.63 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.2 tt -72.78 96.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.173 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -155.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.176 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.19 -7.24 59.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.79 -18.05 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.27 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 8.4 p-10 -61.01 -15.47 32.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.647 ' HE1' HD11 ' A' ' 94' ' ' ILE . 14.1 m-85 -82.81 2.04 36.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.152 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -47.88 -31.42 5.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.267 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.739 ' CD2' HD13 ' A' ' 8' ' ' LEU . 11.3 m-85 -134.94 156.07 49.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.33 -10.6 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.432 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.65 ' CG1' HG22 ' A' ' 7' ' ' VAL . 99.5 t -132.55 140.99 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.928 . . . . 0.0 110.387 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.447 ' HB ' HG12 ' A' ' 106' ' ' VAL . 53.1 mt -128.07 130.86 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -111.37 137.42 49.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.938 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.52 137.92 51.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.715 HD23 ' HB3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -96.69 -34.36 11.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.096 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.617 ' OD2' HD23 ' A' ' 12' ' ' LEU . 1.1 m-20 -111.57 -170.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 110.17 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -97.27 -36.9 10.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 p -43.96 -36.37 2.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.138 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.639 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.6 mp -73.12 -63.98 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.478 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -53.88 -17.61 2.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.252 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -95.61 -32.81 12.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.395 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -95.82 -56.9 2.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.712 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -47.29 -34.35 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.172 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 42.8 m-20 -78.48 -7.85 57.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.251 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -83.13 -18.54 39.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.913 . . . . 0.0 110.189 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.556 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 2.9 ptt? -102.16 -36.34 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -56.0 136.62 73.47 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.16 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.19 -90.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.981 1.516 . . . . 0.0 110.503 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 102' ' ' CYS . 26.3 m -153.12 -101.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 110.107 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.4 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 100' ' ' SER . 0.2 OUTLIER -90.57 -169.95 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.75 29.41 4.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.82 154.33 1.89 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -121.25 150.45 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.447 HG12 ' HB ' ' A' ' 83' ' ' ILE . 12.8 m -105.54 145.39 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.15 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.468 HG21 ' CE1' ' A' ' 139' ' ' PHE . 11.1 m -135.34 142.35 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.478 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -85.94 128.18 34.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.137 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -85.33 -36.04 21.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.161 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.474 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 6.8 p30 175.76 166.3 0.4 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.9 Cg_endo -74.5 174.86 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.013 1.533 . . . . 0.0 110.188 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.09 53.07 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.964 1.507 . . . . 0.0 110.437 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -143.04 -41.92 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.55 -74.06 0.68 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 115' ' ' VAL . 31.2 m -56.26 116.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.7 t70 -81.46 146.55 30.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.43 ' OD2' ' CZ ' ' A' ' 17' ' ' ARG . 19.4 m-20 -111.52 81.91 3.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -73.34 116.51 4.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.955 1.503 . . . . 0.0 110.459 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -111.96 -38.2 4.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.46 56.0 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.097 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.93 139.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.1 m -47.91 -29.1 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.257 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.27 121.94 11.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 114.73 -57.36 0.47 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.859 ' HD2' HG11 ' A' ' 56' ' ' VAL . 6.3 m-30 -34.49 -53.82 0.96 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.645 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.15 -59.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.651 1.343 . . . . 0.0 110.322 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 116' ' ' ASP . 97.1 m -53.37 -48.74 68.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.588 ' HE1' ' HG2' ' A' ' 19' ' ' PRO . 4.8 ttp -48.85 -69.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.817 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 1.109 ' CE1' HD12 ' A' ' 24' ' ' ILE . 9.0 t80 -43.81 -54.56 5.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.796 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 134' ' ' LYS . . . -51.85 -39.67 59.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.682 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.532 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 74.9 m -66.38 -57.75 6.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.803 HD12 ' SG ' ' A' ' 21' ' ' CYS . 12.0 mm -44.26 -47.97 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 2.5 t -71.22 -61.28 1.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 110.62 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -44.72 -23.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -112.43 14.92 20.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.973 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.541 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.7 -22.75 7.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -82.35 -47.06 0.94 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.111 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.5 Cg_endo -78.15 -8.77 16.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.862 1.454 . . . . 0.0 110.285 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.67 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 71.6 t80 -103.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.283 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.053 HD12 HD13 ' A' ' 145' ' ' LEU . 3.2 tp -52.74 -24.56 8.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 80.0 m -88.19 -27.89 21.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.445 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.22 -12.41 16.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.154 -0.966 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.67 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 3.5 t60 -84.59 39.69 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.21 45.69 87.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.053 HD13 HD12 ' A' ' 140' ' ' LEU . 1.4 mt -133.95 -58.53 0.85 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -1.133 . . . . 0.0 110.415 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.2 mp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.149 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.248 0.547 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.588 ' CG ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.8 156.89 24.68 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.685 ' H ' HG22 ' A' ' 34' ' ' ILE . 41.1 mtpt -127.03 -161.25 1.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.981 -1.075 . . . . 0.0 111.158 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.072 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.26 122.79 11.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.481 0.658 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' A' ' 34' ' ' ILE . 24.2 t -113.03 121.89 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.791 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.839 ' CG ' ' HB2' ' A' ' 38' ' ' ALA . 13.0 tp -94.85 81.45 3.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.405 -0.809 . . . . 0.0 110.398 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 7.5 p90 -74.36 140.41 44.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.151 -0.968 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.821 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 1.4 p -170.94 171.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 110.366 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.912 ' O ' HD12 ' A' ' 90' ' ' ILE . 46.9 t -140.74 -57.95 0.52 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.517 ' HA ' HD23 ' A' ' 12' ' ' LEU . 13.4 mt -155.56 -44.5 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.16 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -125.73 -3.95 6.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.997 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.6 t-20 64.67 30.21 12.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -1.148 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 70.8 mt -98.75 -35.8 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' SD ' ' A' ' 128' ' ' MET . 0.9 OUTLIER -104.57 18.68 21.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 1.023 ' HG2' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -135.86 -32.02 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -0.95 . . . . 0.0 110.311 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.542 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -62.15 -58.0 20.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 46.5 Cg_endo -73.08 -5.39 17.11 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.945 1.497 . . . . 0.0 110.456 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -107.03 -40.83 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.873 ' HA ' HD11 ' A' ' 132' ' ' ILE . 65.8 m -72.66 -36.88 68.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER -66.04 -45.15 82.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 110.075 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.546 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -70.78 -50.54 24.01 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.057 HD11 ' HB2' ' A' ' 133' ' ' SER . 0.3 OUTLIER -54.49 -44.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -1.213 . . . . 0.0 110.2 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.913 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.4 m -67.43 -52.55 38.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.21 -27.43 61.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.295 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -87.76 -30.08 20.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.379 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -78.81 -24.28 44.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.387 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.913 HG22 ' O ' ' A' ' 25' ' ' CYS . 19.5 m -119.32 -25.6 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 112.34 -63.16 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 18.9 p30 -179.76 70.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.809 ' O ' HD23 ' A' ' 33' ' ' LEU . 7.9 mmtt -102.76 -135.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 110.116 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 35' ' ' ILE . 32.7 mt -128.09 -119.31 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -0.974 . . . . 0.0 110.328 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.072 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 34.8 30.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 111.198 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -103.09 103.53 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.062 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.749 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 49.1 m-20 -136.71 132.63 35.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.147 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -108.48 144.89 35.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.839 ' HB2' ' CG ' ' A' ' 8' ' ' LEU . . . -134.07 179.06 6.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.36 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.997 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -172.53 89.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.195 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 40' ' ' THR . 3.5 m -85.72 83.08 7.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.231 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER 172.07 -53.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.236 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 56.97 104.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -145.91 -44.96 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.157 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.49 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 34.1 m-70 -124.23 27.44 7.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.454 ' H ' HG13 ' A' ' 45' ' ' VAL . 3.1 m -62.91 144.65 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.208 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 71.41 29.03 68.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 44' ' ' HIS . 3.8 pt20 -177.39 -139.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -1.122 . . . . 0.0 110.08 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 68.01 119.5 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.185 -0.947 . . . . 0.0 110.229 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.547 ' HD2' ' CE1' ' A' ' 119' ' ' TYR . 47.0 Cg_endo -69.37 73.56 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.056 1.556 . . . . 0.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.4 t0 -94.2 33.74 1.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.107 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -71.72 -24.21 61.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.226 -0.921 . . . . 0.0 108.977 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -72.05 -52.19 18.1 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.269 179.362 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.527 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -62.59 -50.17 72.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -0.772 . . . . 0.0 109.639 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 6.8 mm-40 -58.93 -43.97 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.553 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.5 ttpp -56.6 -68.65 0.2 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.658 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.553 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 19.5 m -48.35 -33.85 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.811 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.17 -52.13 66.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.17 -13.9 60.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.738 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -92.75 -12.29 31.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 110.117 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -117.15 -30.58 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.673 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 137.44 84.36 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.811 HG11 ' SG ' ' A' ' 57' ' ' CYS . 41.9 t -158.65 120.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -1.137 . . . . 0.0 110.126 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 64' ' ' ILE . 3.0 m-20 -90.17 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.954 . . . . 0.0 110.114 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 63' ' ' ASP . 12.0 pt -158.71 143.56 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 12.2 p -168.17 31.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 65' ' ' SER . 65.6 mmtt -149.2 -73.66 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.171 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 1.7 mp0 60.26 105.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 57.32 1.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -45.12 134.56 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.801 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 1.7 ptt-85 -166.22 156.97 12.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 2.3 pt20 -79.15 135.07 36.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.459 HG13 ' OD2' ' A' ' 76' ' ' ASP . 19.7 tt -60.66 154.67 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -120.57 -65.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.164 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.63 -34.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.174 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.29 -15.49 16.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.459 ' OD2' HG13 ' A' ' 72' ' ' ILE . 5.4 m-20 -60.7 -23.19 64.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 22.3 m-85 -88.47 10.72 19.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -130.23 -62.44 0.94 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.551 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -45.52 -24.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 7.4 m-85 -131.3 154.28 48.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -104.14 -20.82 13.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 69.2 t -122.05 137.77 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.852 ' O ' HG22 ' A' ' 107' ' ' VAL . 3.3 mt -124.62 138.76 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.102 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' PHE . . . -121.6 126.09 48.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -108.66 152.29 25.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.023 HD22 ' HG2' ' A' ' 17' ' ' ARG . 1.4 tp -95.51 -43.58 7.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' HG22 ' A' ' 90' ' ' ILE . 27.0 t0 -103.94 168.72 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.298 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -81.0 -47.3 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.913 . . . . 0.0 110.215 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.2 t -43.29 -59.49 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.912 HD12 ' O ' ' A' ' 11' ' ' CYS . 8.9 tt -46.66 -35.49 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -72.07 -45.59 60.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.196 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 t -62.25 -30.5 71.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 97' ' ' MET . 72.1 m-20 -88.76 -53.68 4.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.485 ' O ' ' HG3' ' A' ' 97' ' ' MET . 3.8 tt -49.17 -37.25 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.497 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 1.9 t-20 -79.57 -16.2 56.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 47.8 t -87.43 -4.21 59.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.499 ' HE2' ' HZ ' ' A' ' 77' ' ' PHE . 1.5 ptt? -113.27 -11.63 13.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.571 ' HE3' ' CG ' ' A' ' 77' ' ' PHE . 13.4 mtpt -60.36 146.25 84.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.0 -171.78 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.055 1.555 . . . . 0.0 110.485 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.4 t -100.07 -5.64 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.162 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 6.4 p30 -128.34 59.18 1.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.18 176.03 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.38 16.51 2.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.66 -170.81 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.198 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -146.35 151.96 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.5 t -117.1 146.0 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 83' ' ' ILE . 35.5 m -144.94 161.13 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 142.6 27.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 0.1 OUTLIER -94.58 -45.78 7.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.979 ' HB3' HG21 ' A' ' 115' ' ' VAL . 48.7 m-80 -131.14 161.27 62.79 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.41 169.53 22.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.995 1.524 . . . . 0.0 110.317 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.37 50.09 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.955 1.503 . . . . 0.0 110.435 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -104.87 -37.98 6.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.99 84.24 0.13 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.979 HG21 ' HB3' ' A' ' 110' ' ' ASN . 59.0 t -119.12 -3.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.666 ' HB3' HD23 ' A' ' 86' ' ' LEU . 6.6 p-10 -131.05 156.45 45.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.183 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -175.95 150.22 1.08 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.56 -90.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.026 1.54 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.547 ' CE1' ' HD2' ' A' ' 49' ' ' PRO . 7.8 m-30 -95.97 -70.46 0.71 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER 58.93 149.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.404 ' HA ' ' CD2' ' A' ' 125' ' ' PHE . 53.8 p -160.0 21.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.3 26.47 6.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -134.05 -45.32 0.11 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.657 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 27.0 m-85 -47.31 -46.59 57.34 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.244 -1.151 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -72.23 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.641 1.337 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.458 ' OG1' ' HA2' ' A' ' 124' ' ' GLY . 3.0 p -52.14 -48.02 65.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.729 ' O ' HG22 ' A' ' 132' ' ' ILE . 17.1 ttp -42.86 -76.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 110.355 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 1.014 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.6 t80 -53.1 -55.14 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.407 ' N ' ' HD1' ' A' ' 129' ' ' PHE . . . -47.03 -24.22 0.59 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.404 ' HB3' HG13 ' A' ' 115' ' ' VAL . 2.7 t -89.35 -61.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.873 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -52.59 -20.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.818 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 1.057 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -91.41 -56.12 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.808 . . . . 0.0 109.603 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -51.36 -24.4 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.688 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.47 50.37 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 110.034 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.633 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -117.87 -24.13 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.651 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -83.32 -40.82 0.81 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.461 -0.774 . . . . 0.0 110.29 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.3 Cg_endo -79.76 -6.55 14.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.711 1.374 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.551 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 27.3 t80 -81.77 -69.0 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 136' ' ' MET . 0.9 OUTLIER -67.62 -22.85 65.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 146' ' ' ILE . 2.6 m -67.55 -31.93 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.016 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.86 -24.81 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 139' ' ' PHE . 14.7 m80 -66.39 -9.04 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . 114.79 58.98 0.36 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.581 ' H ' HD13 ' A' ' 146' ' ' ILE . 1.8 mt -162.65 61.14 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.058 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.294 0.569 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -72.55 -144.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 109.315 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.958 ' HB3' HG22 ' A' ' 34' ' ' ILE . 5.1 mtpt -143.2 150.24 39.08 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.663 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.793 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.93 113.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.478 -0.764 . . . . 0.0 109.917 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.697 HG22 ' CG1' ' A' ' 82' ' ' VAL . 28.5 t -102.99 134.13 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.745 HD13 ' CD2' ' A' ' 80' ' ' PHE . 7.8 tp -89.53 80.78 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.432 -0.792 . . . . 0.0 110.329 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.574 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 15.1 m-85 -68.48 110.43 4.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.039 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 49.0 t -135.1 153.54 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.897 . . . . 0.0 110.545 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.501 ' HB2' ' HD3' ' A' ' 17' ' ' ARG . 45.5 t -140.05 -56.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER 177.0 -60.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -0.908 . . . . 0.0 110.381 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -82.57 -8.29 86.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.807 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.3 OUTLIER 67.26 27.45 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.211 . . . . 0.0 110.076 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.641 HG21 ' OG ' ' A' ' 48' ' ' SER . 93.6 mt -133.64 -36.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.23 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 79.8 m -42.71 -49.63 5.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.178 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.772 ' HD3' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -98.46 128.63 44.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.117 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.579 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER 172.36 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.799 ' O ' HG22 ' A' ' 64' ' ' ILE . 46.4 Cg_endo -73.59 -26.33 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.872 1.459 . . . . 0.0 110.332 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB1' ' HB2' ' A' ' 129' ' ' PHE . . . -106.74 -27.22 10.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 4.2 t -79.02 -59.65 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.248 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 44.8 tt0 -56.41 -27.63 57.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.435 -0.791 . . . . 0.0 109.163 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -74.83 -55.59 5.29 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.788 HD11 ' CB ' ' A' ' 133' ' ' SER . 2.4 tp -52.71 -43.73 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.26 . . . . 0.0 109.835 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.827 ' SG ' HD11 ' A' ' 34' ' ' ILE . 73.2 m -74.7 -32.88 62.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 0.0 110.292 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.565 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 15.1 mmt180 -66.93 -39.75 87.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.949 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -79.59 -40.59 29.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.136 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.582 ' O ' HG13 ' A' ' 29' ' ' VAL . 18.7 mmt -71.41 -41.3 69.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 28' ' ' MET . 16.6 m -156.77 45.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -58.9 -19.12 42.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -84.12 27.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -1.089 . . . . 0.0 110.403 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.447 ' C ' HD12 ' A' ' 33' ' ' LEU . 52.6 mttt -150.75 -130.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.777 ' O ' HG13 ' A' ' 34' ' ' ILE . 4.7 mp -129.26 -112.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.958 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER 57.19 1.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.74 -0.6 . . . . 0.0 111.157 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.687 HD11 ' HB2' ' A' ' 25' ' ' CYS . 7.0 mt -114.07 103.71 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.88 -1.138 . . . . 0.0 110.95 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.597 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 10.3 m-20 -139.11 102.49 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.811 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.78 133.79 34.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.039 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . . . -147.7 166.58 27.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.337 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.807 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . . . 169.81 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 40' ' ' THR . 5.1 t -56.01 97.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 40' ' ' THR . 0.1 OUTLIER 174.68 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 110.199 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 44' ' ' HIS . . . 71.19 -106.32 1.86 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 52.86 -87.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.529 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 2.8 m-70 -66.13 -7.81 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.757 HG23 ' HB3' ' A' ' 69' ' ' ALA . 2.1 p -49.44 129.85 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.261 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -27.04 20.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -116.14 -134.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -1.144 . . . . 0.0 110.296 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.641 ' OG ' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 70.17 135.68 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.129 -0.982 . . . . 0.0 110.135 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.42 81.7 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.972 1.511 . . . . 0.0 110.422 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 31.8 p-10 -82.59 8.45 11.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -73.59 -26.96 61.05 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 108.981 179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.5 -48.66 31.59 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.31 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.536 ' HB2' ' CG ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -63.16 -49.85 72.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 0.0 109.65 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -60.33 -46.74 88.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.97 . . . . 0.0 109.411 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 7.5 ttpt -54.84 -69.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.82 . . . . 0.0 109.588 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.744 HG22 ' OD1' ' A' ' 60' ' ' ASN . 7.7 p -49.34 -34.92 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.265 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.952 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -54.89 -50.97 67.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 109.379 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -73.52 -22.18 60.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -12.94 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.0 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.744 ' OD1' HG22 ' A' ' 56' ' ' VAL . 11.2 m120 -111.23 -14.93 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.408 -0.808 . . . . 0.0 109.036 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.569 ' O ' ' CZ ' ' A' ' 129' ' ' PHE . . . 96.41 100.98 1.94 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.952 HG12 ' O ' ' A' ' 57' ' ' CYS . 13.9 p -172.11 145.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -86.03 118.05 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.799 HG22 ' O ' ' A' ' 19' ' ' PRO . 8.1 pt -130.23 173.07 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.152 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 51.6 p -165.96 29.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.54 149.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 110.228 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.431 ' OE1' ' CB ' ' A' ' 18' ' ' SER . 2.2 pt20 -165.43 -150.94 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.023 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.63 -178.65 7.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB3' HG23 ' A' ' 45' ' ' VAL . . . -106.51 122.82 47.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -110.47 25.6 11.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.108 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.548 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 3.4 pt20 38.24 -152.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 110.441 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.493 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 13.2 tt -133.22 164.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.0 p -125.46 -78.67 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 75' ' ' ALA . 2.3 pttp -164.88 -36.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -56.61 -20.4 20.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 110.226 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.6 p30 -42.59 -28.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 23.8 m-85 -70.69 -42.13 71.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.262 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.521 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -96.52 -48.55 5.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 4.2 tptt -44.49 -25.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 0.0 110.255 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.745 ' CD2' HD13 ' A' ' 8' ' ' LEU . 9.8 m-85 -133.07 -179.76 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.473 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.16 -29.37 4.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.844 . . . . 0.0 110.375 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.88 HG21 ' CD2' ' A' ' 143' ' ' HIS . 6.0 p -129.54 142.39 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.162 -0.961 . . . . 0.0 110.379 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.569 HG12 ' CD2' ' A' ' 8' ' ' LEU . 3.1 mt -113.78 134.22 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.1 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.0 122.37 47.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.12 137.12 42.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.772 HD22 ' HD3' ' A' ' 17' ' ' ARG . 5.1 tp -108.5 11.55 26.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -152.19 174.32 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.246 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.11 -57.92 3.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.148 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -51.44 42.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.985 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.918 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.7 tt -44.58 -51.13 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.607 ' H ' HG23 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -61.88 -55.79 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.7 t -54.49 -18.43 4.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.937 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 96' ' ' SER . 22.2 m-20 -85.28 -69.28 0.67 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 0.0 110.213 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 90' ' ' ILE . 3.2 mt -47.92 -53.14 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.432 -0.793 . . . . 0.0 109.982 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -59.11 -15.35 13.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.61 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -80.74 -40.69 24.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.995 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.747 ' CE ' HG23 ' A' ' 94' ' ' ILE . 6.9 ptt? -85.2 -26.9 26.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.567 ' CE ' ' CE1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -42.84 139.68 2.04 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.177 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.18 -161.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.052 1.554 . . . . 0.0 110.42 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 t -102.54 -4.56 25.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.213 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -155.8 111.01 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.216 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.411 ' SG ' ' NZ ' ' A' ' 98' ' ' LYS . 31.8 p -137.6 -159.31 0.94 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.521 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -132.31 31.82 4.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.112 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.86 37.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.124 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.85 162.18 18.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.527 HG22 HD13 ' A' ' 83' ' ' ILE . 90.3 t -116.09 130.04 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.54 164.04 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -108.24 131.13 55.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.088 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CD1' ' CE1' ' A' ' 139' ' ' PHE . 2.9 t80 -74.8 -61.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.96 175.46 2.96 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.142 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.518 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 48.0 Cg_endo -75.15 175.9 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.042 1.548 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.37 4.86 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.937 1.493 . . . . 0.0 110.661 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.94 -1.48 16.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.256 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 116' ' ' ASP . . . -116.99 -107.24 2.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.614 HG13 ' HA ' ' A' ' 128' ' ' MET . 17.2 t -72.69 75.28 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -1.14 . . . . 0.0 110.214 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -155.1 138.83 16.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -112.74 110.83 51.9 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.463 ' HG2' ' OG ' ' A' ' 122' ' ' SER . 46.3 Cg_endo -73.04 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.95 1.5 . . . . 0.0 110.496 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.436 ' O ' ' C ' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -166.93 146.67 5.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.319 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.436 ' C ' ' O ' ' A' ' 119' ' ' TYR . 2.7 t80 42.26 -139.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -43.29 116.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' A' ' 118' ' ' PRO . 4.7 m -155.17 -177.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.331 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -136.94 20.85 3.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.106 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 116' ' ' ASP . . . -99.49 -23.63 10.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 9.9 m-85 -44.02 -57.26 6.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.085 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.4 Cg_endo -70.77 -44.11 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.905 1.476 . . . . 0.0 110.105 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 27.9 m -61.44 -27.45 68.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.614 ' HA ' HG13 ' A' ' 115' ' ' VAL . 30.7 ttp -60.1 -70.22 0.18 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.273 -0.892 . . . . 0.0 109.832 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.767 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 75.4 t80 -67.9 -21.87 65.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.79 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -65.95 -42.13 90.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 110.004 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.604 ' CB ' HG22 ' A' ' 115' ' ' VAL . 14.8 t -84.3 -31.69 24.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.274 -0.892 . . . . 0.0 108.787 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.769 HG23 HG12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -67.75 -27.83 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.682 -0.636 . . . . 0.0 109.395 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.788 ' CB ' HD11 ' A' ' 24' ' ' ILE . 24.9 p -103.18 -23.85 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.795 . . . . 0.0 110.272 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -88.6 -18.94 26.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.08 -1.013 . . . . 0.0 110.339 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.545 ' CG ' ' HG2' ' A' ' 138' ' ' PRO . 3.3 tt0 -124.31 40.01 3.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.381 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.576 ' HG2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -84.46 -20.41 31.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.968 . . . . 0.0 110.496 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -87.11 -44.48 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.865 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -76.48 2.98 6.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.609 1.321 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.587 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 71.7 t80 -108.05 -70.03 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.537 HD21 ' CE ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -62.54 -44.07 97.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.217 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.627 HG23 HD12 ' A' ' 146' ' ' ILE . 1.9 m -64.56 -10.33 25.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.36 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 138' ' ' PRO . 13.8 mm-40 -104.7 -46.95 4.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.302 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.88 ' CD2' HG21 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -44.46 -24.57 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.134 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.453 ' C ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.83 35.94 0.5 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.491 HD22 ' HG2' ' A' ' 5' ' ' LYS . 19.1 mt -137.45 -94.53 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.627 HD12 HG23 ' A' ' 141' ' ' THR . 2.4 tp . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.26 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.53 0.681 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -117.96 144.41 45.53 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 34' ' ' ILE . 4.4 mttt -119.1 -155.95 0.63 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.024 -1.048 . . . . 0.0 110.879 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.99 148.73 51.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.715 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 16.7 t -139.06 113.29 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.794 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.055 HD12 ' HB3' ' A' ' 36' ' ' ASP . 5.0 tp -78.7 101.34 7.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.453 -0.779 . . . . 0.0 110.784 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.516 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 36.8 m-85 -87.33 106.65 18.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.717 HG22 ' HB3' ' A' ' 38' ' ' ALA . 6.0 t -134.1 177.73 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 110.959 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 10' ' ' VAL . 1.7 p 169.6 53.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.786 . . . . 0.0 110.146 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 16.6 mt 54.77 -89.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' CYS . . . -89.91 80.22 1.47 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 38' ' ' ALA . 1.8 t-20 -58.44 -44.49 89.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -1.178 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.576 HG23 ' HE3' ' A' ' 66' ' ' LYS . 9.4 mt -38.78 -30.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 110.303 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 17' ' ' ARG . 26.8 p -125.38 34.99 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 109.811 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.644 ' HB3' HD23 ' A' ' 86' ' ' LEU . 43.8 mtt180 -157.27 80.81 0.91 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 110.175 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.614 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER 56.78 43.09 1.04 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 111.022 179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 18' ' ' SER . 45.3 Cg_endo -73.66 -21.44 19.12 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.743 1.391 . . . . 0.0 109.781 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.798 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -89.01 7.33 35.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.679 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.7 OUTLIER -56.41 -40.21 74.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.124 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.966 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -60.68 -44.22 96.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.281 0.562 . . . . 0.0 110.035 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' ILE . . . -74.14 -63.8 2.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.917 HG21 HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -42.36 -46.0 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 110.166 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.624 ' N ' HG23 ' A' ' 24' ' ' ILE . 69.0 m -72.98 -39.74 65.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 110.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 3.2 mmt180 -55.1 -34.88 64.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.736 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -88.95 -32.47 17.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 0.0 110.127 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.14 -27.01 60.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.411 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.651 HG12 ' HG3' ' A' ' 32' ' ' LYS . 10.1 t -123.79 -22.89 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.234 -0.916 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.04 -168.62 18.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.98 80.71 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -1.118 . . . . 0.0 110.133 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.651 ' HG3' HG12 ' A' ' 29' ' ' VAL . 7.5 mmtp -112.96 -137.77 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ILE . 18.1 mt -122.5 -40.13 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.22 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.839 HD11 ' CD1' ' A' ' 35' ' ' ILE . 2.6 pp -33.3 -32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.762 . . . . 0.0 110.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.966 HG23 ' HA ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -76.92 88.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 110.526 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 1.055 ' HB3' HD12 ' A' ' 8' ' ' LEU . 7.1 m-20 -124.35 71.4 1.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.907 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.6 t -73.04 131.2 41.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.717 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -144.05 -171.9 3.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.256 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -166.37 145.69 5.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 40' ' ' THR . 11.1 t -125.68 76.67 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 -59.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.46 36.77 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.99 -57.59 1.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -1.169 . . . . 0.0 110.212 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.423 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -85.78 63.61 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 68' ' ' ARG . 2.1 p -148.07 149.79 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.331 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.05 21.62 27.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 48' ' ' SER . 6.5 pt20 -173.82 -149.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.18 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.83 120.79 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.219 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.24 89.08 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.977 1.514 . . . . 0.0 110.455 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.7 p30 -88.43 14.47 9.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -74.1 -37.54 64.12 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.125 -0.984 . . . . 0.0 108.719 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.43 -37.96 68.45 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.345 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.53 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 6.3 m -65.63 -59.55 3.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.458 -0.776 . . . . 0.0 109.811 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 63.9 mt-30 -57.95 -44.15 86.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.165 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -53.34 -72.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.49 -0.756 . . . . 0.0 109.701 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' ' 125' ' ' PHE . 43.5 t -43.69 -38.17 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.362 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.578 ' CA ' HG13 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -55.28 -50.54 69.28 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.437 -0.79 . . . . 0.0 109.427 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -67.37 -28.08 67.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -83.29 -9.01 59.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.11 -31.4 7.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 135.18 60.39 0.06 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 129' ' ' PHE . 1.9 p 173.69 139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -1.163 . . . . 0.0 110.129 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -91.52 142.71 27.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.731 HG23 ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER 68.63 -175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.731 ' N ' HG23 ' A' ' 64' ' ' ILE . 5.6 t 179.66 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.073 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.576 ' HE3' HG23 ' A' ' 15' ' ' ILE . 4.9 mmmt -115.72 -168.69 1.45 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.936 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.3 pt20 177.67 144.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -61.95 79.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.089 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 45' ' ' VAL . . . -49.0 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.347 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 68' ' ' ARG . 2.6 ptt-85 -103.09 -149.04 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -103.28 146.54 28.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.216 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.526 HD11 ' HB3' ' A' ' 76' ' ' ASP . 19.9 tt -82.43 173.73 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.269 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.482 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 34.1 m -100.96 6.52 43.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 73' ' ' THR . 14.5 mtmt 68.19 5.23 4.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.3 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.59 -3.16 58.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.948 . . . . 0.0 110.331 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.596 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 11.9 p-10 -65.47 -24.61 67.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.608 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 21.3 m-85 -86.69 16.13 5.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 110.228 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.34 -15.23 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.576 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.641 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -127.25 -145.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.125 -0.985 . . . . 0.0 110.033 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.641 ' CD1' ' HB3' ' A' ' 79' ' ' LYS . 0.6 OUTLIER 37.87 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.448 -0.782 . . . . 0.0 110.676 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -135.53 -43.52 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 6' ' ' ALA . 11.8 p -137.24 159.6 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 110.626 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.694 ' HB ' HG12 ' A' ' 106' ' ' VAL . 1.7 mp -124.42 122.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . . . -108.54 131.12 55.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.58 161.65 19.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.644 HD23 ' HB3' ' A' ' 17' ' ' ARG . 7.1 tp -93.22 -43.37 8.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.414 ' C ' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -102.2 177.47 4.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.395 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.499 ' HG3' HD11 ' A' ' 108' ' ' LEU . 14.8 mt-30 -89.87 -38.25 13.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 88' ' ' GLN . 23.2 t -42.36 -39.87 2.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.5 mp -65.97 -53.59 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -63.77 -16.03 60.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.214 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 t -88.37 -39.22 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.373 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.41 -22.32 21.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.843 HD13 HG11 ' A' ' 106' ' ' VAL . 2.8 tt -68.41 -37.86 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' SER . 29.2 p30 -70.2 -18.59 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 48.0 t -78.0 -34.65 50.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.553 ' CE ' HG13 ' A' ' 94' ' ' ILE . 19.8 ptt? -93.29 -30.22 15.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.047 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.608 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 7.7 mmmt -38.98 141.52 0.6 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.478 -0.764 . . . . 0.0 110.704 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.489 ' HD2' ' HD2' ' A' ' 98' ' ' LYS . 46.4 Cg_endo -72.43 -179.79 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.18 1.621 . . . . 0.0 110.567 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -114.26 19.88 15.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.6 OUTLIER -153.14 78.92 1.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.281 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 6.4 p -143.56 -172.1 3.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.92 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.444 ' HD2' ' C ' ' A' ' 102' ' ' CYS . 1.1 mpt_? -135.34 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -163.76 165.43 23.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -141.61 170.11 16.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.843 HG11 HD13 ' A' ' 94' ' ' ILE . 33.0 m -111.52 167.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.52 HG13 ' C ' ' A' ' 106' ' ' VAL . 28.1 m -154.25 157.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 110.225 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.499 HD11 ' HG3' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -94.61 125.96 39.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -89.61 93.25 9.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 110.17 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.559 ' ND2' ' OE2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 65.62 159.31 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.472 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.56 174.44 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.04 1.547 . . . . 0.0 110.383 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.4 52.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.94 1.495 . . . . 0.0 110.403 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.24 -59.33 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.59 -46.87 65.61 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.774 HG12 ' HB2' ' A' ' 131' ' ' SER . 30.2 m -92.18 46.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -137.24 113.63 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -140.19 142.7 30.92 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 -13.65 26.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.069 1.563 . . . . 0.0 110.494 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.6 t80 50.14 38.89 18.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.64 -50.28 65.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -139.35 -69.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.02 44.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -103.7 -7.96 20.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.173 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -90.67 -40.03 5.74 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.641 ' HB3' HG11 ' A' ' 56' ' ' VAL . 5.4 m-30 -45.06 -47.5 31.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.148 -1.207 . . . . 0.0 110.472 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -72.42 -57.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.575 1.302 . . . . 0.0 110.382 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 15.5 m -64.57 -57.22 9.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.185 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.662 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 7.6 ttp -40.43 -69.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.755 ' CE1' HD12 ' A' ' 24' ' ' ILE . 75.3 t80 -55.93 -44.75 78.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.045 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -46.94 -59.77 2.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.94 . . . . 0.0 110.014 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.774 ' HB2' HG12 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -65.14 -45.2 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 110.024 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.917 HG23 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -43.27 -53.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.826 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.624 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -80.75 -37.77 29.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 5.2 tttt -50.08 -32.29 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 8.3 mm-40 -103.97 -5.59 22.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.189 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' A' ' 133' ' ' SER . 0.7 OUTLIER -82.78 14.24 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -104.71 -63.39 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.448 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 44.5 Cg_endo -72.26 -4.39 15.13 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.786 1.414 . . . . 0.0 110.471 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.657 ' CE2' HG11 ' A' ' 7' ' ' VAL . 34.1 t80 -93.1 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.997 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -45.52 -28.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 110.143 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 7.5 m -47.55 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.817 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 141' ' ' THR . 11.7 mt-10 -106.44 -0.27 24.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 110.792 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 33.77 5.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 111.16 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.697 ' HA3' HD13 ' A' ' 140' ' ' LEU . . . 173.42 -27.37 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.485 -1.341 . . . . 0.0 109.901 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.997 ' HB3' HD12 ' A' ' 140' ' ' LEU . 0.3 OUTLIER 175.02 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.234 -1.156 . . . . 0.0 110.363 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.774 HG22 ' CD2' ' A' ' 145' ' ' LEU . 7.3 tp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.116 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.223 0.535 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -82.99 -179.05 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.847 . . . . 0.0 109.237 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 1.019 ' C ' HG22 ' A' ' 34' ' ' ILE . 17.1 mttm -142.73 -161.34 1.23 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.065 -1.022 . . . . 0.0 110.676 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.031 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -141.18 121.92 14.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.996 ' HB ' HD12 ' A' ' 34' ' ' ILE . 2.7 t -111.22 123.0 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.765 . . . . 0.0 109.329 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 10' ' ' VAL . 6.5 tp -93.52 84.88 4.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.439 -0.788 . . . . 0.0 110.757 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.53 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 55.7 m-85 -60.79 123.73 18.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 8' ' ' LEU . 25.1 t -124.97 168.82 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.719 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.854 ' HB3' HD13 ' A' ' 86' ' ' LEU . 20.9 p -169.02 -141.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.911 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 76.07 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 14' ' ' ASN . . . 129.04 -6.89 6.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 13' ' ' GLY . 6.2 t-20 41.71 37.62 0.78 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -1.145 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.73 HD13 ' HB3' ' A' ' 48' ' ' SER . 3.2 mt -144.22 -59.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 15' ' ' ILE . 56.1 m -106.0 59.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.83 ' CB ' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -153.5 -50.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.468 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -152.13 47.76 0.43 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.038 -1.039 . . . . 0.0 110.743 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 18' ' ' SER . 47.7 Cg_endo -74.65 -16.0 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.843 1.444 . . . . 0.0 110.113 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.916 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -91.97 6.63 45.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.871 ' SG ' HD11 ' A' ' 132' ' ' ILE . 55.5 m -63.96 -35.01 79.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.642 ' HG2' HG23 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -68.83 -55.54 10.83 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.526 -0.734 . . . . 0.0 110.177 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' A' ' 63' ' ' ASP . . . -62.28 -51.81 53.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.784 HD11 ' CB ' ' A' ' 133' ' ' SER . 8.9 tp -56.3 -44.27 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 110.308 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.566 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 23.1 m -64.96 -35.52 81.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.238 -0.914 . . . . 0.0 110.054 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.4 mtt-85 -66.44 -45.12 80.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 110.124 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -34.9 58.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -74.96 -46.86 32.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 30' ' ' GLY . 13.6 m -150.93 45.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.22 -28.55 0.86 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.47 85.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -1.145 . . . . 0.0 110.061 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 34' ' ' ILE . 21.6 mttt -65.98 -23.25 66.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.138 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.941 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 67.66 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.031 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER 30.07 37.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.553 -0.717 . . . . 0.0 111.66 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.941 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -92.0 93.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.906 -1.121 . . . . 0.0 110.361 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.582 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 10.0 m-20 -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -168.86 163.15 11.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 110.372 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -169.26 -164.68 0.47 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' O ' HG22 ' A' ' 72' ' ' ILE . . . -174.92 -176.95 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -151.28 25.01 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -0.75 5.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . 49.88 -104.04 0.1 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 64.64 119.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.248 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.468 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 4.2 m-70 55.66 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.309 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 69' ' ' ALA . 80.9 t 52.42 80.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.07 6.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.468 ' HG3' ' HB3' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -148.75 13.86 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.247 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.73 ' HB3' HD13 ' A' ' 15' ' ' ILE . 2.7 t -106.97 111.64 63.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 47.1 Cg_endo -69.58 100.72 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.6 p30 -86.16 26.03 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.424 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -32.06 61.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.257 -0.902 . . . . 0.0 108.92 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.9 mtt180 -71.83 -52.23 18.49 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.213 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -52.59 65.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.43 -0.794 . . . . 0.0 109.359 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 6.8 tt0 -54.24 -56.42 18.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HE3' HG23 ' A' ' 56' ' ' VAL . 3.9 ttpp -44.85 -66.89 0.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.393 -0.817 . . . . 0.0 109.52 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.871 HG21 ' CB ' ' A' ' 125' ' ' PHE . 91.8 t -45.32 -36.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.639 ' CB ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.7 -42.15 92.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.439 -0.788 . . . . 0.0 109.042 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 1.6 mmtp -71.76 -27.74 63.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.416 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.42 -9.33 54.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -109.8 -26.61 9.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.195 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 115.43 81.26 0.92 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.639 HG13 ' CB ' ' A' ' 57' ' ' CYS . 2.1 p 174.66 170.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -1.1 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.567 ' N ' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -156.03 144.13 19.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.435 ' CG1' ' HG3' ' A' ' 54' ' ' GLN . 2.3 pt -133.51 164.89 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -115.58 76.05 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.947 . . . . 0.0 110.256 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 65' ' ' SER . 4.6 mttt 60.53 152.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.948 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -105.3 -64.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.09 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.767 ' HB3' HG22 ' A' ' 45' ' ' VAL . . . -49.12 157.59 0.43 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -0.891 . . . . 0.0 110.178 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -147.95 33.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 8.4 pt20 37.58 -153.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 72' ' ' ILE . 3.9 tt -153.73 129.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.211 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 174.24 6.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -72.94 -5.98 42.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -77.19 -34.2 56.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -42.65 -48.41 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.544 ' CE2' ' HG2' ' A' ' 98' ' ' LYS . 14.6 m-30 -47.3 -30.42 3.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.8 m -117.56 29.61 7.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.541 ' C ' ' CD1' ' A' ' 80' ' ' PHE . 9.6 tppt? -124.88 -9.36 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 79' ' ' LYS . 69.5 m-85 -140.3 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -124.34 -44.56 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 110.385 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 41.3 t -131.73 137.18 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.499 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' O ' HG22 ' A' ' 107' ' ' VAL . 54.4 mt -116.45 142.11 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.817 . . . . 0.0 110.044 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 107' ' ' VAL . . . -127.66 162.66 26.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -142.99 145.58 33.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -70.56 -79.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.539 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.427 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 7.3 m-20 -78.92 175.74 10.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 110.467 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.463 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.6 mm-40 -74.22 -41.46 61.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.8 t -40.13 -50.61 2.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.012 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.768 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.7 mt -61.37 -58.48 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 108' ' ' LEU . 3.1 tp -42.25 -60.97 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.119 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 96' ' ' SER . 46.6 t -55.33 -39.44 70.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.965 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 96' ' ' SER . 0.3 OUTLIER -54.3 -55.38 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.067 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.5 mp -57.89 -56.77 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -63.99 -19.23 65.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.844 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 92' ' ' SER . 1.0 OUTLIER -71.85 -8.86 56.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.5 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 7.6 mtm -125.88 -48.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.544 ' HG2' ' CE2' ' A' ' 77' ' ' PHE . 9.7 mtpt -41.82 138.14 1.82 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.96 -160.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.006 1.53 . . . . 0.0 110.581 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.1 m -106.56 5.32 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -134.97 104.95 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -174.01 4.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 28.8 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -148.59 176.38 10.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 110.182 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 104' ' ' ALA . 34.7 mtmt -143.23 166.12 25.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.13 -0.981 . . . . 0.0 110.282 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.4 t -117.27 132.64 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.9 HG11 ' CD2' ' A' ' 143' ' ' HIS . 32.1 m -128.21 153.61 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.575 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -100.95 146.98 26.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 3.3 t80 -106.73 110.58 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.091 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 59.0 166.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.049 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 170.09 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.001 1.527 . . . . 0.0 110.278 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.9 51.93 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.398 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -156.56 -46.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.8 -67.65 2.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.589 HG22 ' OG ' ' A' ' 131' ' ' SER . 10.1 t -98.84 100.7 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -1.114 . . . . 0.0 110.116 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -174.87 88.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.24 130.33 7.58 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 -90.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.939 1.494 . . . . 0.0 110.487 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.04 21.16 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.182 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -65.47 117.02 7.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.7 t 52.18 -143.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.168 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.91 39.55 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -93.52 32.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -124.48 -49.2 0.21 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.871 ' CB ' HG21 ' A' ' 56' ' ' VAL . 5.6 m-85 -41.65 -48.95 10.06 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.249 -1.147 . . . . 0.0 110.305 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.9 Cg_endo -71.45 -56.97 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.597 1.314 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 16.7 m -59.76 -51.87 67.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 124' ' ' GLY . 12.1 ttp -41.29 -63.71 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.284 -0.885 . . . . 0.0 109.96 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.716 ' CE1' HD13 ' A' ' 24' ' ' ILE . 94.2 t80 -56.63 -42.1 78.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.617 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -46.12 -57.43 4.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.774 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.589 ' OG ' HG22 ' A' ' 115' ' ' VAL . 11.2 p -71.44 -43.97 65.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.523 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.916 HG13 ' HB3' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -42.1 -37.61 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.689 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.784 ' CB ' HD11 ' A' ' 24' ' ' ILE . 1.4 p -97.19 -42.36 7.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.3 OUTLIER -44.93 -46.54 11.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -102.72 41.71 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.202 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.63 ' HE2' ' HA ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -116.49 -2.35 12.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.264 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.608 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -104.88 -63.57 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 46.9 Cg_endo -73.58 1.14 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.75 1.395 . . . . 0.0 110.488 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.523 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 31.9 t80 -87.88 -68.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 140' ' ' LEU . 4.0 pp -74.03 -23.71 59.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.592 HG23 HG21 ' A' ' 146' ' ' ILE . 3.3 m -59.74 -43.04 94.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 144' ' ' GLY . 49.7 mt-10 -96.0 -37.33 10.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.9 ' CD2' HG11 ' A' ' 107' ' ' VAL . 1.2 m80 -44.01 -25.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 124.66 68.32 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -155.66 18.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.592 HG21 HG23 ' A' ' 141' ' ' THR . 23.6 pt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.192 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' OE1' ' CB ' ' A' ' 32' ' ' LYS . 14.7 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.53 0.681 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.591 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -64.04 -69.53 0.27 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.512 -0.742 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 14.3 mttm -152.34 -155.59 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.981 . . . . 0.0 111.353 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.986 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.95 152.91 36.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.712 -0.618 . . . . 0.0 110.234 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.652 HG23 ' HB ' ' A' ' 34' ' ' ILE . 15.1 t -111.62 127.26 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 83' ' ' ILE . 10.2 tp -90.01 81.86 6.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 136' ' ' MET . 27.3 m-85 -68.82 117.49 10.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.943 . . . . 0.0 109.46 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 38' ' ' ALA . 52.7 t -130.9 161.04 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.601 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.876 ' HB3' HD22 ' A' ' 86' ' ' LEU . 28.6 p -159.38 39.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.102 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 90' ' ' ILE . 1.2 mt 59.38 60.49 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.267 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.882 ' H ' ' HB1' ' A' ' 39' ' ' ALA . . . 132.13 -24.72 3.97 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.922 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 13.5 t30 59.28 14.88 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -1.168 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.541 ' CA ' ' HB3' ' A' ' 19' ' ' PRO . 12.9 mt -123.17 -1.54 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 22.5 p -144.21 165.61 27.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.237 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.795 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.8 OUTLIER 71.05 -56.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 110.416 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.878 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.0 t -152.97 50.36 0.6 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.792 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.1 Cg_endo -78.17 -19.27 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.864 1.455 . . . . 0.0 110.066 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.671 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -86.76 6.73 30.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -0.79 . . . . 0.0 110.279 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.602 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 21.4 p -58.21 -28.96 65.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.337 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 26' ' ' ARG . 0.6 OUTLIER -67.66 -40.15 84.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.594 -0.691 . . . . 0.0 110.191 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -74.73 -49.69 10.28 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.807 HG21 HG23 ' A' ' 132' ' ' ILE . 1.1 tp -57.84 -44.35 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 0.0 110.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.742 ' SG ' HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -71.34 -43.37 67.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.314 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 2.7 mmm180 -58.97 -38.3 78.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.22 -39.67 47.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.117 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.525 ' C ' HG13 ' A' ' 29' ' ' VAL . 21.8 mtp -67.69 -51.09 53.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 28' ' ' MET . 14.0 m -151.3 44.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.319 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -63.54 -20.78 64.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -67.19 -7.37 23.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.412 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.534 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . 6.5 mttm -116.27 -137.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.05 -1.031 . . . . 0.0 110.272 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.814 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.2 mt -120.34 -122.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.986 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 49.46 3.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.621 -0.674 . . . . 0.0 111.644 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -104.09 95.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.832 -1.167 . . . . 0.0 110.547 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.875 ' OD1' ' HB1' ' A' ' 6' ' ' ALA . 3.1 m-20 -137.05 106.8 6.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.424 ' OG ' ' HG2' ' A' ' 22' ' ' GLU . 19.2 m -89.57 127.63 35.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.158 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.888 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -144.43 166.64 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.922 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -166.3 106.5 0.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' THR . 3.2 t -80.59 86.28 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 40' ' ' THR . 12.5 p 177.33 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 94.15 1.01 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -155.83 -40.54 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -1.136 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.27 92.91 4.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.88 . . . . 0.0 110.226 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 69' ' ' ALA . 38.5 t -148.19 160.73 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.257 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.46 24.99 7.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 48' ' ' SER . 13.1 pt20 -159.87 -148.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' GLN . 0.5 OUTLIER 61.39 90.78 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 110.21 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.36 80.53 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.957 1.503 . . . . 0.0 110.439 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -93.01 33.71 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.304 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.502 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 1.3 m -75.52 -31.52 60.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 108.908 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.613 ' O ' HG22 ' A' ' 56' ' ' VAL . 52.3 mtt180 -73.01 -48.96 31.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.313 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.585 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -61.81 -51.34 68.64 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.664 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.522 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -64.2 -33.86 76.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HE2' HG13 ' A' ' 56' ' ' VAL . 8.3 ttpt -60.04 -67.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 125' ' ' PHE . 27.5 m -53.51 -35.08 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.066 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.8 m -53.6 -50.79 64.89 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.425 -0.797 . . . . 0.0 109.261 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -31.8 71.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.492 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 1.2 t -77.05 -10.14 59.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.84 . . . . 0.0 110.034 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -112.89 -26.91 8.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.126 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 135.67 53.74 0.06 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.671 HG11 ' HB1' ' A' ' 20' ' ' ALA . 65.1 t -158.3 109.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -108.87 125.15 51.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.5 pt -106.22 174.63 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -131.3 -50.73 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 0.0 110.174 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -140.33 86.23 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.9 59.76 5.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -125.73 99.57 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' GLY . . . -44.45 159.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.222 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -160.38 40.45 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 110.235 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 70' ' ' ARG . 32.2 tt0 63.05 126.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.256 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -68.85 123.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.892 . . . . 0.0 110.14 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.61 ' N ' HD13 ' A' ' 72' ' ' ILE . 22.8 p -73.56 -175.82 2.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.895 . . . . 0.0 110.333 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 -15.93 25.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.21 -20.85 63.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.59 ' HB3' HD11 ' A' ' 72' ' ' ILE . 21.7 p-10 -52.03 -29.97 23.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE1' ' HD2' ' A' ' 98' ' ' LYS . 19.6 m-85 -86.19 49.05 1.71 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.268 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 1.3 t 171.66 -61.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.244 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.547 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -42.24 -27.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 110.228 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.832 ' CB ' ' HB3' ' A' ' 6' ' ' ALA . 8.1 m-85 -131.02 -135.13 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.079 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -177.95 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 0.0 110.644 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 16.3 t -104.5 84.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.015 -1.053 . . . . 0.0 110.463 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.849 HG21 ' CD1' ' A' ' 94' ' ' ILE . 2.9 mp -72.68 114.22 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.961 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -97.67 124.33 41.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -117.09 126.95 53.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.878 HD21 ' HB2' ' A' ' 18' ' ' SER . 1.1 mp -64.47 -54.42 32.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.352 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.46 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -103.29 -165.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 0.0 110.22 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 96.1 mt-30 -94.83 -36.84 11.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -42.84 -45.35 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.565 HD12 ' H ' ' A' ' 90' ' ' ILE . 2.2 mp -62.5 -47.2 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.205 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.11 -30.87 71.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.119 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.2 t -79.49 -30.8 42.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 96' ' ' SER . 3.3 m-20 -79.69 -55.27 5.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 83' ' ' ILE . 10.0 tt -47.58 -43.64 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 110.203 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.605 ' N ' HG23 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.08 -23.65 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -67.53 -10.35 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.183 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.561 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 6.4 mtm -116.64 -50.96 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.567 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 11.3 mtpt -40.78 129.75 1.89 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 110.432 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.445 ' HG2' ' OD1' ' A' ' 101' ' ' ASN . 46.3 Cg_endo -72.72 -163.54 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.025 1.539 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -101.16 28.72 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 22.9 p30 -150.79 94.2 2.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.06 179.04 8.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.82 6.73 4.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.267 -0.896 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -105.9 122.87 47.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.49 162.27 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.698 HG12 ' HB ' ' A' ' 83' ' ' ILE . 27.9 m -125.23 127.15 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.25 159.41 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 109' ' ' PHE . 3.5 tt -116.79 141.35 48.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.157 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.575 ' N ' HD23 ' A' ' 108' ' ' LEU . 7.5 m-85 -103.77 113.14 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 2.0 t30 58.66 144.77 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.533 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 46.3 Cg_endo -74.27 176.06 10.12 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.052 1.554 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.7 Cg_endo -71.74 53.83 1.92 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.892 1.47 . . . . 0.0 110.383 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -158.44 19.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.211 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 116' ' ' ASP . . . -135.91 -90.52 0.31 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 131' ' ' SER . 8.3 t -60.63 83.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -1.166 . . . . 0.0 110.19 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 114' ' ' GLY . 22.4 t70 -129.68 131.12 46.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.466 ' OD2' ' HA3' ' A' ' 124' ' ' GLY . 23.4 t0 -159.83 102.09 1.45 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.34 -89.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.994 1.523 . . . . 0.0 110.461 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.04 32.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.208 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 121' ' ' SER . 0.1 OUTLIER -93.03 102.25 14.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 58.94 173.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.35 65.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -115.94 129.42 56.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.159 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 112.31 -34.82 4.97 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.692 ' HB3' HG21 ' A' ' 56' ' ' VAL . 9.9 m-30 -41.31 -49.72 8.81 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.68 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.3 Cg_endo -70.87 -64.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.547 1.288 . . . . 0.0 110.436 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.571 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 21.4 p -53.33 -54.96 28.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.895 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.5 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 ttp -42.28 -69.72 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 110.024 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 24' ' ' ILE . 61.9 t80 -44.0 -49.66 8.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.757 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -47.92 -47.04 32.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.8 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -74.31 -33.68 63.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.882 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.807 HG23 HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -55.32 -45.5 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.615 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.555 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -83.71 -38.14 21.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.302 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 131' ' ' SER . 62.7 mm-40 -90.56 -30.33 17.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 9' ' ' PHE . 13.7 mtm -99.65 4.45 45.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -86.85 -51.04 0.45 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 0.0 110.017 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.88 -6.67 14.28 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.99 1.521 . . . . 0.0 110.435 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.513 ' CE1' ' CG ' ' A' ' 143' ' ' HIS . 85.2 t80 -108.16 -78.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.53 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 34' ' ' ILE . 15.9 tp -44.14 -24.62 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.481 ' HA ' ' HB ' ' A' ' 146' ' ' ILE . 4.6 m -89.11 -31.58 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.963 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 138' ' ' PRO . 3.3 mm-40 -105.09 -39.09 6.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 110.284 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.513 ' CG ' ' CE1' ' A' ' 139' ' ' PHE . 60.0 t60 -40.39 -29.39 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.0 60.87 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.53 HD22 HG21 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -154.87 -39.83 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -1.142 . . . . 0.0 110.183 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 146' ' ' ILE . 53.6 mt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.218 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.333 0.587 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.731 ' HG2' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.46 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.874 . . . . 0.0 108.758 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.687 ' HB2' HG22 ' A' ' 34' ' ' ILE . 9.3 mtpp -159.01 -164.42 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.977 -1.077 . . . . 0.0 110.493 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.763 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.91 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.566 -0.709 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.011 HG22 ' O ' ' A' ' 34' ' ' ILE . 2.1 m -90.55 138.66 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.976 . . . . 0.0 110.169 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.694 ' HG ' ' HB2' ' A' ' 38' ' ' ALA . 7.4 tp -89.89 88.15 7.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 110.129 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.645 ' CE2' HG21 ' A' ' 7' ' ' VAL . 5.5 m-85 -72.69 114.16 10.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.752 HG13 HD11 ' A' ' 90' ' ' ILE . 2.1 p -165.8 171.26 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.67 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.732 ' HA ' HD12 ' A' ' 90' ' ' ILE . 10.1 t 175.27 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 51.08 49.66 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 0.0 110.09 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.21 70.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.73 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -44.74 -45.35 9.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -1.14 . . . . 0.0 110.136 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 45' ' ' VAL . 25.9 mt -61.33 -12.35 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 19.8 m -99.67 153.4 19.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.966 ' HG2' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 61.5 11.07 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.387 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.626 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 0.4 OUTLIER -91.96 -64.26 0.16 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.976 . . . . 0.0 110.172 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.62 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 47.8 Cg_endo -74.27 -1.4 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.793 1.417 . . . . 0.0 110.299 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -103.15 -47.4 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.451 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.864 ' HA ' HD11 ' A' ' 132' ' ' ILE . 60.4 m -70.25 -38.51 75.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.978 . . . . 0.0 109.969 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.84 -44.28 96.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . -70.06 -48.5 39.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 ' CE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -53.0 -53.0 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -1.143 . . . . 0.0 110.038 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.937 ' HB3' HD11 ' A' ' 35' ' ' ILE . 63.9 m -69.4 -62.15 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 22.6 mmt180 -47.47 -22.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 23.8 t0 -85.81 -45.01 11.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 2.0 mtt -83.16 -1.72 53.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.0 110.425 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 25' ' ' CYS . 3.0 m -131.0 -28.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.947 . . . . 0.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 100.09 -58.75 0.76 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 17.5 p30 178.32 102.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -1.144 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.595 ' C ' HD12 ' A' ' 33' ' ' LEU . 13.3 ptpt -152.96 -136.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.009 ' O ' HD12 ' A' ' 35' ' ' ILE . 5.1 mp -112.78 -127.61 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.011 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.6 OUTLIER 51.62 4.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.598 -0.689 . . . . 0.0 111.157 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.009 HD12 ' O ' ' A' ' 33' ' ' LEU . 3.2 mt -127.48 113.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 0.0 110.717 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 8.2 m-20 -142.79 111.73 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.74 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.55 127.68 32.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.262 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' CG1' ' A' ' 10' ' ' VAL . . . -128.58 177.48 6.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -167.79 96.31 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.159 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.544 ' CG2' HG13 ' A' ' 90' ' ' ILE . 74.7 p -41.98 -35.19 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 m -116.97 -167.19 1.26 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.86 77.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -128.02 0.02 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 0.0 110.256 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 0.4 OUTLIER -122.42 -11.41 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.292 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.615 ' HA ' HD11 ' A' ' 15' ' ' ILE . 34.3 m -62.48 159.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.246 -0.909 . . . . 0.0 110.299 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.06 21.91 64.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.516 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 6.5 pt20 -173.7 -148.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -1.134 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 48' ' ' SER . 0.8 OUTLIER 64.43 112.41 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.35 87.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.928 1.488 . . . . 0.0 110.451 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -86.16 30.49 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.103 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -73.86 -27.46 61.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.23 -0.919 . . . . 0.0 109.005 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.605 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -71.61 -54.9 8.91 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.288 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.573 ' CB ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -59.7 -51.22 70.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 109.37 179.16 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 1.3 tt0 -60.86 -41.61 96.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.603 ' HE3' HG23 ' A' ' 56' ' ' VAL . 1.5 ttpt -52.83 -66.36 0.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' HE3' ' A' ' 55' ' ' LYS . 52.6 t -50.61 -37.34 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.895 . . . . 0.0 109.115 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -52.02 -52.65 49.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.488 -0.758 . . . . 0.0 109.409 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 -27.28 64.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.528 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 2.0 t -78.64 -11.48 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 109.896 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.36 -19.95 13.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.589 ' C ' HG13 ' A' ' 62' ' ' VAL . . . 106.16 97.07 2.48 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.731 HG12 ' CE2' ' A' ' 129' ' ' PHE . 16.1 m -154.76 -147.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.154 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.447 ' C ' HG23 ' A' ' 64' ' ' ILE . 5.7 t0 179.43 117.07 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.326 -0.859 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 65' ' ' SER . 15.0 pt -146.65 -37.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.334 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 64' ' ' ILE . 2.3 t 68.75 -67.0 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 64' ' ' ILE . 16.0 mmtt -136.05 -174.03 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.29 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.626 ' NE2' ' HB3' ' A' ' 18' ' ' SER . 30.1 mm100 -139.49 -77.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.17 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.87 84.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.73 ' HB1' ' CG ' ' A' ' 14' ' ' ASN . . . -76.95 179.05 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.221 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -153.11 29.92 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.263 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 50.7 tt0 55.93 162.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.961 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.476 HG13 ' OD2' ' A' ' 76' ' ' ASP . 5.3 tt -62.69 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.225 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.429 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -149.91 147.35 27.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 110.172 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -13.97 10.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -89.9 -9.65 48.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' OD2' HG13 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -44.55 -42.88 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.05 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 35.5 m-85 -59.31 -17.42 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 t -113.05 -44.15 3.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.057 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.605 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 18.0 tptt -45.89 -27.95 1.0 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.071 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 27.7 m-85 -144.78 179.25 7.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 110.196 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -114.87 -13.58 11.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 110.583 -179.715 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 76.9 t -128.74 143.67 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 0.0 110.465 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' VAL . 1.9 mp -116.71 119.92 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -100.41 110.92 23.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 110.654 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.932 ' HB1' HG21 ' A' ' 90' ' ' ILE . . . -104.74 133.21 49.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.023 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.966 HD22 ' HG2' ' A' ' 17' ' ' ARG . 2.6 tp -82.41 -31.15 29.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.279 -0.888 . . . . 0.0 110.49 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 90' ' ' ILE . 21.9 p-10 -118.65 178.81 4.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.977 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.52 -41.34 13.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.145 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.2 m -45.09 -48.0 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.035 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.932 HG21 ' HB1' ' A' ' 85' ' ' ALA . 6.5 tt -53.65 -39.46 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.032 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.509 ' N ' HG23 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -70.7 -42.16 71.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.917 . . . . 0.0 110.089 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.7 t -63.43 -30.93 71.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -88.54 -57.44 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.558 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.1 tt -46.04 -32.9 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 110.182 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.486 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 8.0 t-20 -78.67 -15.19 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -9.2 57.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.212 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.558 ' CE ' HG13 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -112.44 -21.51 11.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.145 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -49.48 151.73 2.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.192 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 100' ' ' SER . 44.3 Cg_endo -72.03 -52.19 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.966 1.508 . . . . 0.0 110.399 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 168.28 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.49 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 11.7 m120 -163.81 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.364 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.56 -150.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 109.951 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -133.47 63.24 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -156.36 156.05 33.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.8 139.67 53.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.164 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 61.6 t -94.22 139.2 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.673 HG11 ' NE2' ' A' ' 143' ' ' HIS . 16.1 m -136.53 142.63 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.02 132.56 38.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.16 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.493 ' HB3' HD12 ' A' ' 86' ' ' LEU . 10.1 t80 -87.05 -20.84 26.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 3.6 p-10 -177.48 164.66 1.37 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.0 Cg_endo -74.49 174.31 12.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.017 1.535 . . . . 0.0 110.348 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.77 51.57 2.34 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -111.63 -44.43 3.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.31 102.86 0.99 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.424 HG11 ' OD1' ' A' ' 110' ' ' ASN . 7.9 p -122.52 -9.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.687 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.2 t70 -117.02 -127.96 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.09 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -157.09 86.24 2.81 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.31 55.56 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.068 1.562 . . . . 0.0 110.45 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.468 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 1.1 m-85 46.45 -159.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.468 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 2.6 t80 67.06 9.15 6.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 2.2 t 171.75 165.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.115 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -111.14 -17.99 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 123' ' ' ASP . 2.9 p30 -67.02 68.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 122' ' ' SER . . . -176.77 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.67 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 15.5 m-85 -41.39 -51.37 8.52 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.341 -1.093 . . . . 0.0 110.471 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.67 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -72.42 -56.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.754 1.397 . . . . 0.0 110.334 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.8 m -52.74 -42.82 65.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.765 ' O ' HG22 ' A' ' 132' ' ' ILE . 24.8 ttp -49.69 -77.04 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 0.0 109.764 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 1.048 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.4 t80 -46.6 -54.55 9.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.114 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -50.84 -23.96 3.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.4 t -91.31 -57.29 2.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.338 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.864 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -54.71 -19.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.823 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.764 ' HB2' HD11 ' A' ' 24' ' ' ILE . 1.8 t -99.11 -50.19 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 109.77 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 12.0 tttt -59.31 -17.24 27.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.926 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HD2' ' A' ' 138' ' ' PRO . 1.4 tt0 -116.6 10.29 14.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.872 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.57 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 3.4 tpt -81.29 8.45 9.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 110.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.5 mtmt -88.6 -52.25 0.37 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.1 Cg_endo -76.66 6.79 3.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.97 1.511 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.57 ' CD2' ' CE ' ' A' ' 136' ' ' MET . 60.1 t80 -96.28 -60.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.153 -0.967 . . . . 0.0 110.366 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 140' ' ' LEU . 3.9 pp -84.6 -13.68 50.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.391 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 137' ' ' LYS . 3.4 m -69.31 -32.57 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.141 -0.974 . . . . 0.0 110.156 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 143' ' ' HIS . 16.5 mm-40 -102.45 -38.78 7.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.203 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.673 ' NE2' HG11 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -43.59 -32.7 1.0 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.307 -0.87 . . . . 0.0 110.236 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.97 73.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 145' ' ' LEU . 1.5 mt -163.05 -62.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 141' ' ' THR . 26.5 pt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.236 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.244 0.545 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.797 ' HG3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -84.19 150.74 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 179.263 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 34' ' ' ILE . 8.4 mtpt -134.48 -155.74 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 110.761 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.113 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.54 134.73 43.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 110.697 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.6 HG23 ' CG2' ' A' ' 34' ' ' ILE . 73.0 t -124.01 123.98 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.724 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.643 HD12 ' HB3' ' A' ' 36' ' ' ASP . 5.6 tp -80.79 103.41 10.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.67 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.64 102.86 13.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.033 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 57.4 t -129.45 169.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.394 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.54 ' N ' HG12 ' A' ' 10' ' ' VAL . 39.7 t -158.52 -65.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.583 HD11 ' CB ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 169.93 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 99.96 -26.91 22.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.641 ' ND2' ' HB2' ' A' ' 39' ' ' ALA . 2.6 t-20 70.53 3.28 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.334 -1.098 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.715 HD13 ' HB2' ' A' ' 48' ' ' SER . 97.7 mt -101.17 -39.81 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 59.7 m -121.89 153.37 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.989 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.973 ' CB ' HD23 ' A' ' 86' ' ' LEU . 11.0 mtm105 55.79 55.61 6.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.908 . . . . 0.0 110.1 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 176.1 -57.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.422 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.0 Cg_endo -72.08 -12.29 27.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.001 1.527 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.75 -11.48 28.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.065 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.662 ' HA ' HD11 ' A' ' 132' ' ' ILE . 28.3 m -64.75 -43.91 91.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 1.9 mt-10 -48.0 -52.85 18.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.499 -0.75 . . . . 0.0 109.717 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.966 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -64.27 -45.27 93.98 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.939 HD11 ' CD1' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -48.92 -52.27 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -1.097 . . . . 0.0 109.847 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.636 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -64.83 -43.89 91.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.064 179.868 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.474 ' HA ' ' N ' ' A' ' 31' ' ' ASP . 16.6 mtt85 -53.27 -44.54 68.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 -16.54 37.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.764 ' O ' HG13 ' A' ' 29' ' ' VAL . 2.9 mmt -83.32 -30.39 27.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.31 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 28' ' ' MET . 2.5 m -161.24 24.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 64.35 37.39 94.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.712 ' OD1' HD13 ' A' ' 35' ' ' ILE . 1.9 t70 68.7 85.31 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.14 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 29' ' ' VAL . 12.2 mmtt -88.9 36.17 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.974 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.916 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 71.91 -144.07 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 110.066 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.113 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 1.5 pp 35.65 22.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.492 -0.755 . . . . 0.0 112.032 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.2 mt -97.31 90.47 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.081 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' A' ' 8' ' ' LEU . 4.1 m-20 -122.95 79.43 1.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.312 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.16 130.94 44.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 110.039 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.033 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . . . -145.71 -176.33 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.665 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -148.06 150.14 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.192 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.826 ' CG2' HG23 ' A' ' 90' ' ' ILE . 69.3 p -83.1 -77.92 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.472 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.39 76.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 110.193 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.03 97.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.45 -10.24 11.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -1.162 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.692 ' O ' HD11 ' A' ' 15' ' ' ILE . 1.7 m-70 -117.68 98.51 6.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.174 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 69' ' ' ALA . 9.1 t -123.58 148.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.77 26.05 1.75 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 12.18 4.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -1.128 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.715 ' HB2' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -117.6 178.98 0.89 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 48' ' ' SER . 45.7 Cg_endo -69.21 -57.65 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 3.9 m-20 67.2 -54.86 0.46 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 m -71.84 -22.81 61.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.219 -0.925 . . . . 0.0 109.099 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HG2' ' CE2' ' A' ' 125' ' ' PHE . 19.6 tpp180 -73.58 -57.65 3.85 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.386 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.547 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -59.76 -48.76 80.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.163 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 20.0 tp60 -60.99 -40.3 92.97 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.14 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -55.32 -64.06 0.96 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.599 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 5.7 p -52.25 -34.72 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.041 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.847 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -55.73 -50.68 69.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.76 . . . . 0.0 109.388 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HG3' ' NE2' ' A' ' 54' ' ' GLN . 4.9 mmtt -68.06 -31.8 71.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 109.713 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.9 t -78.3 -11.27 59.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 0.0 109.987 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.566 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 5.4 m-20 -111.53 -34.75 5.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.313 -0.867 . . . . 0.0 109.11 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 138.32 73.55 0.05 OUTLIER Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.966 HG13 ' HA3' ' A' ' 23' ' ' GLY . 42.5 t -158.59 142.24 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -1.149 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 18.9 p30 -142.56 104.64 4.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 65' ' ' SER . 41.6 pt -108.39 -146.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.446 ' N ' HG13 ' A' ' 64' ' ' ILE . 11.0 p -145.78 -45.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.344 -0.848 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HD2' ' OG ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -150.54 150.07 30.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.27 116.89 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 1.8 ptm180 -151.93 123.6 7.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.639 ' HB3' HG22 ' A' ' 45' ' ' VAL . . . -70.63 121.91 18.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.154 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -132.44 15.25 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 72' ' ' ILE . 12.1 tt0 53.96 168.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 76' ' ' ASP . 16.6 tt -94.44 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -0.877 . . . . 0.0 110.277 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 7.3 m -109.75 15.68 22.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.5 mmtt 66.24 5.38 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.284 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -88.01 -24.07 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.286 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.826 ' HB3' HD11 ' A' ' 72' ' ' ILE . 5.2 p-10 -43.54 -29.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.1 m-85 -71.21 -27.2 63.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -123.18 9.23 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.153 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.467 ' C ' ' CD1' ' A' ' 80' ' ' PHE . 5.4 tptt -107.3 -36.83 6.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 5.9 m-30 -114.78 -142.59 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.78 -38.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 72.4 t -124.3 151.79 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.414 HG23 HD23 ' A' ' 8' ' ' LEU . 2.7 mt -129.78 114.92 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.482 ' HA ' HG23 ' A' ' 107' ' ' VAL . . . -98.14 138.36 35.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.98 141.53 49.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.199 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.973 HD23 ' CB ' ' A' ' 17' ' ' ARG . 5.0 tp -95.04 4.52 53.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.616 ' CB ' HD11 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -146.41 -156.08 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -117.77 -42.76 2.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.583 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -44.51 -28.69 0.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.826 HG23 ' CG2' ' A' ' 40' ' ' THR . 1.4 mp -70.9 -48.77 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.885 . . . . 0.0 110.126 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.425 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -68.61 -27.35 65.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.208 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 t -78.48 -40.51 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 96' ' ' SER . 40.1 m-20 -83.7 -50.54 8.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 95' ' ' ASN . 3.4 tt -45.43 -41.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.561 ' N ' HG23 ' A' ' 94' ' ' ILE . 3.5 t-20 -66.53 -7.84 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.229 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 57.2 m -86.79 -22.85 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.545 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.7 ptt? -104.98 -35.4 7.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 97' ' ' MET . 8.7 mtpt -42.24 122.8 2.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.155 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.97 -172.31 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.901 1.474 . . . . 0.0 110.455 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.21 13.4 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.887 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -137.41 91.47 2.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.0 p -149.65 177.07 10.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.39 27.03 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.2 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 138.17 52.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.7 156.63 17.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.445 ' C ' HG13 ' A' ' 107' ' ' VAL . 6.1 t -112.58 158.25 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.522 HG11 ' NE2' ' A' ' 143' ' ' HIS . 33.0 m -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.69 142.18 27.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.566 ' CE2' ' HE3' ' A' ' 136' ' ' MET . 0.1 OUTLIER -90.91 -64.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.44 ' OD1' HG22 ' A' ' 115' ' ' VAL . 10.5 p30 -141.78 164.17 36.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.484 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.4 Cg_endo -74.39 174.73 12.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.945 1.497 . . . . 0.0 110.281 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.09 52.45 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -152.65 -40.14 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.092 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.22 -67.89 1.98 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.568 HG23 ' HD3' ' A' ' 17' ' ' ARG . 21.8 m -103.51 86.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -1.196 . . . . 0.0 110.063 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.444 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 9.9 t70 -67.52 160.85 26.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.79 67.84 4.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.1 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 116' ' ' ASP . 46.0 Cg_endo -72.8 162.99 39.69 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.05 1.553 . . . . 0.0 110.539 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.71 163.77 27.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.163 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 50.83 26.82 2.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 122' ' ' SER . 26.0 t -155.53 -168.7 2.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.42 ' N ' ' OG ' ' A' ' 121' ' ' SER . 44.2 p -141.28 75.63 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -29.98 2.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 128' ' ' MET . . . -101.72 -34.7 4.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.676 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 12.3 m-85 -41.34 -55.38 5.33 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -1.128 . . . . 0.0 110.278 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.676 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -71.92 -60.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.835 1.439 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 131' ' ' SER . 9.8 m -49.83 -44.16 49.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.173 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.678 ' O ' HG22 ' A' ' 132' ' ' ILE . 25.1 ttp -50.95 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.21 -0.931 . . . . 0.0 109.788 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.939 ' CD1' HD11 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -45.81 -59.05 3.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.904 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -46.46 -26.45 0.86 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 110.037 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.555 ' CB ' ' CG1' ' A' ' 115' ' ' VAL . 1.1 m -87.92 -71.39 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -42.17 -25.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 179.072 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.516 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . 22.9 t -90.22 -60.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -51.61 -22.29 3.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.056 -1.028 . . . . 0.0 110.119 -179.918 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.528 ' HB3' ' CE1' ' A' ' 109' ' ' PHE . 0.8 OUTLIER -110.89 11.3 22.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.815 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.592 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -88.15 -3.84 58.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.8 mttt -90.55 -47.64 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.996 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.5 Cg_endo -75.37 1.84 7.47 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.631 1.332 . . . . 0.0 110.557 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.621 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 4.5 t80 -105.67 -47.25 3.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.037 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -78.3 -53.71 7.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.792 HG23 ' OXT' ' A' ' 146' ' ' ILE . 5.0 m -44.65 -26.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 143' ' ' HIS . 39.3 mt-10 -104.61 -40.3 6.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.621 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -43.05 -26.83 0.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.087 -1.008 . . . . 0.0 110.195 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 127.18 67.32 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.677 ' HB2' HD23 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -161.19 -70.72 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 110.114 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.792 ' OXT' HG23 ' A' ' 141' ' ' THR . 2.0 tt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.283 0.563 . . . . 5.2800000000000002 110.246 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.37 118.89 18.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 3.4900000000000002 110.158 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.11 -174.29 2.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 4.21 110.46 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.752 ' HA ' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -119.4 143.19 47.59 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.092 -0.707 . . . . 4.04 109.092 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 15.3 mttt -115.19 -131.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.138 -0.976 . . . . 2.5800000000000001 110.708 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.822 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . -176.79 103.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.438 -0.789 . . . . 0.97999999999999998 109.672 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.807 ' CG1' ' HB2' ' A' ' 84' ' ' ALA . 41.4 t -90.32 138.65 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 1.24 110.495 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.777 HD12 ' HB2' ' A' ' 36' ' ' ASP . 5.7 tp -87.0 94.56 9.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 1.03 110.019 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.591 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 2.4 m-85 -78.44 104.33 8.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 2.3900000000000001 110.063 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.017 HG22 ' C ' ' A' ' 38' ' ' ALA . 30.5 t -123.46 163.11 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 1.4099999999999999 110.296 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 1.5 p -149.99 -53.53 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 2.0899999999999999 110.39 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 173.88 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.139 -0.975 . . . . 1.98 110.237 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.866 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . 136.21 -4.9 3.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.724 -1.35 . . . . 1.99 109.724 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 5.0 t30 69.43 38.13 1.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -1.148 . . . . 2.6299999999999999 110.262 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 44' ' ' HIS . 12.5 mt -136.49 -39.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 1.6200000000000001 110.235 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 88.3 m -90.39 107.79 19.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 3.4199999999999999 110.178 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.554 ' CG ' ' HG3' ' A' ' 128' ' ' MET . 0.9 OUTLIER 73.55 -4.19 2.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 3.54 110.392 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -84.42 -51.53 0.57 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 4.4500000000000002 110.66 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 18' ' ' SER . 47.3 Cg_endo -75.22 3.48 5.69 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.817 1.43 . . . . 2.3999999999999999 110.619 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.657 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -98.85 -19.01 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 1.21 110.209 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 132' ' ' ILE . 22.0 m -71.55 -36.98 71.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 1.5900000000000001 109.991 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.715 ' HA ' HG21 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -63.04 -38.38 90.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 2.2799999999999998 110.015 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.803 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -76.72 -56.01 4.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.636 -1.386 . . . . 0.81000000000000005 109.636 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 133' ' ' SER . 5.7 tp -50.11 -44.78 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -1.198 . . . . 1.1299999999999999 110.129 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.95 ' HB3' HD11 ' A' ' 35' ' ' ILE . 69.4 m -72.22 -53.31 12.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 1.3999999999999999 110.042 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -43.53 -41.03 4.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 2.4199999999999999 109.99 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -33.66 26.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 2.0600000000000001 110.243 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -59.12 -44.37 92.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 2.3900000000000001 110.468 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.584 HG11 ' HD2' ' A' ' 32' ' ' LYS . 5.6 t -108.3 -32.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.96 . . . . 2.2000000000000002 110.517 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 123.55 -54.1 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.546 -1.422 . . . . 2.29 109.546 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.6 t70 179.61 90.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 3.5899999999999999 110.254 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.584 ' HD2' HG11 ' A' ' 29' ' ' VAL . 15.0 mttt -141.61 -137.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 3.5 110.173 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.81 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.9 mt -116.39 -123.07 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 3.7200000000000002 110.07 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.028 HD13 HD13 ' A' ' 140' ' ' LEU . 0.5 OUTLIER 50.45 5.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.53 -0.731 . . . . 1.99 111.305 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.95 HD11 ' HB3' ' A' ' 25' ' ' CYS . 3.5 mt -121.2 109.27 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.95 -1.094 . . . . 2.21 110.724 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.777 ' HB2' HD12 ' A' ' 8' ' ' LEU . 6.7 m-20 -143.1 91.75 2.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.8799999999999999 109.986 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 2.8 m -69.4 137.97 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.6200000000000001 110.221 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.017 ' C ' HG22 ' A' ' 10' ' ' VAL . . . -151.61 177.18 10.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.94999999999999996 110.315 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -162.71 144.99 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 1.23 110.176 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -109.0 38.93 2.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 1.9399999999999999 110.193 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -160.72 87.04 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 1.8600000000000001 110.214 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.26 68.7 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.517 -1.433 . . . . 2.1600000000000001 109.517 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' SER . 2.1 m-85 -108.39 -61.05 1.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -1.164 . . . . 3.0299999999999998 110.172 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.421 ' O ' HD11 ' A' ' 15' ' ' ILE . 2.2 m170 -92.05 91.22 7.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 2.6200000000000001 110.191 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 64.5 t -136.06 162.77 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 1.98 110.229 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.418 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 53.61 37.12 55.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 1.6299999999999999 109.561 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 48' ' ' SER . 11.1 pt20 -172.11 -144.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -1.127 . . . . 1.77 110.196 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HG ' ' HH ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER 57.27 110.7 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 1.8600000000000001 110.167 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.8 Cg_endo -69.46 92.37 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.012 1.533 . . . . 1.78 110.45 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 1.2 m-20 -86.48 19.02 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 2.8399999999999999 110.207 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -75.43 -27.93 59.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.247 -0.908 . . . . 1.4299999999999999 109.077 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.603 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 45.0 mtt180 -72.6 -51.65 18.8 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.822 -0.751 . . . . 3.2200000000000002 109.369 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 t -63.55 -49.83 71.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -0.794 . . . . 1.51 109.615 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' CD ' HD11 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -60.42 -39.92 89.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.274 -0.891 . . . . 2.2000000000000002 109.305 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -59.42 -67.68 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 3.23 109.542 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.57 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 22.0 t -48.41 -34.21 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 1.8999999999999999 109.239 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.936 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.22 -54.93 41.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 1.25 109.605 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -68.54 -20.36 64.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 2.6400000000000001 109.706 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 2.4 t -87.65 -13.58 42.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.357 -0.839 . . . . 1.49 110.103 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -114.77 -30.7 6.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 1.6000000000000001 109.326 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.707 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 136.22 79.73 0.1 OUTLIER Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.922 -1.271 . . . . 1.25 109.922 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.936 HG11 ' SG ' ' A' ' 57' ' ' CYS . 40.6 t -159.61 123.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -1.079 . . . . 1.8 110.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.14 105.05 14.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 2.46 110.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.691 HD12 HE21 ' A' ' 67' ' ' GLN . 35.6 pt -120.73 -145.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 2.0299999999999998 110.237 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.488 ' N ' HG13 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -170.03 -64.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 3.6800000000000002 110.229 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' A' ' 65' ' ' SER . 15.7 mmtt -142.25 145.93 34.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 5.8300000000000001 110.126 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.691 HE21 HD12 ' A' ' 64' ' ' ILE . 32.3 mm-40 -122.11 56.65 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 2.77 110.258 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ALA . 1.5 ttp85 -69.18 71.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 4.2599999999999998 110.182 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB1' ' O ' ' A' ' 13' ' ' GLY . . . -42.51 136.28 2.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 1.3799999999999999 110.236 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 ptt-85 -140.34 158.44 44.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 2.1499999999999999 110.203 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.55 145.32 55.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 2.2400000000000002 110.197 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 72' ' ' ILE . 6.6 tt -89.96 128.76 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 1.49 110.213 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.2 p -86.22 -142.75 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 2.1099999999999999 110.213 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -109.43 -5.98 15.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 3.4100000000000001 110.222 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -75.19 -21.34 58.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.3300000000000001 110.247 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 4.2 p-10 -44.68 -28.81 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 2.46 110.194 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.578 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 25.1 m-85 -79.63 -46.49 17.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 1.55 110.248 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -95.06 8.42 43.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 1.9299999999999999 110.209 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.59 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 14.0 tptt -102.62 -2.76 27.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 2.7799999999999998 110.228 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.788 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 91.8 m-85 -151.62 -157.56 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 1.71 110.298 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.3 -26.28 2.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 2.3300000000000001 110.551 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' A' ' 143' ' ' HIS . 97.0 t -136.94 150.88 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.052 . . . . 1.26 110.576 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.676 HG21 ' CD1' ' A' ' 94' ' ' ILE . 1.7 mp -123.24 116.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.824 . . . . 0.83999999999999997 109.902 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.807 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -103.12 118.82 37.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.80000000000000004 110.483 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -109.61 112.72 24.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.78000000000000003 110.065 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 5.0 mp -59.48 -84.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 1.23 110.356 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.62 ' O ' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -62.77 159.81 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 2.02 110.273 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 2.0899999999999999 110.184 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -52.81 -40.16 63.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 1.6200000000000001 110.165 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 87' ' ' ASP . 2.8 mt -65.2 -51.73 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 1.7 110.189 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.539 HD12 ' HB3' ' A' ' 85' ' ' ALA . 0.5 OUTLIER -61.29 -43.55 98.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.92000000000000004 110.378 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 t -64.81 -48.62 73.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.917 . . . . 1.1899999999999999 110.264 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -64.65 -63.67 1.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 1.73 110.265 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.676 ' CD1' HG21 ' A' ' 83' ' ' ILE . 6.1 tt -42.76 -38.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 1.4299999999999999 110.248 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.496 ' N ' HG23 ' A' ' 94' ' ' ILE . 28.6 t-20 -71.9 -24.9 61.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 1.9399999999999999 110.214 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 93' ' ' ASP . 42.7 t -76.88 -2.02 31.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 1.3999999999999999 110.225 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.0 ptt? -123.97 -25.33 4.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 1.1200000000000001 110.219 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 1.4 mtpt -49.04 143.02 9.16 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 1.04 110.26 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.09 -159.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.991 1.522 . . . . 1.4399999999999999 110.438 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.84 2.62 15.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.86 . . . . 2.0800000000000001 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -149.16 108.11 3.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 3.3799999999999999 110.263 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.4 p -149.48 -173.79 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.887 . . . . 1.95 110.222 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 17.08 7.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 2.8399999999999999 110.218 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.46 157.93 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.88 110.208 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -115.43 157.23 24.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.281 -0.887 . . . . 2.5699999999999998 110.177 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.6 t -118.61 114.51 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 1.4299999999999999 110.185 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.569 HG11 ' CE1' ' A' ' 143' ' ' HIS . 27.6 m -121.58 148.19 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 1.4099999999999999 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 109' ' ' PHE . 1.3 tp -85.68 152.8 22.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 1.45 110.181 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.522 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 4.4 t80 -115.82 109.3 17.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 2.1699999999999999 110.268 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.494 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER 57.79 156.25 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 2.8399999999999999 110.28 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.494 ' HD2' ' ND2' ' A' ' 110' ' ' ASN . 47.0 Cg_endo -74.83 174.26 13.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.039 1.547 . . . . 2.6299999999999999 110.28 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.85 52.33 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 4.0899999999999999 110.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -145.9 -47.03 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 2.9500000000000002 110.251 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.39 -102.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 2.1499999999999999 109.552 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 115' ' ' VAL . 30.8 m -54.55 105.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 1.9199999999999999 110.225 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -148.22 29.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 4.1500000000000004 110.247 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.512 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 6.9 t0 -48.95 112.41 2.43 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 4.1399999999999997 110.199 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 46.8 Cg_endo -72.73 -93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.939 1.494 . . . . 3.5600000000000001 110.427 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 168.12 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 3.8700000000000001 110.178 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.19 -46.99 0.34 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 6.1500000000000004 110.254 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.59 167.07 10.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 2.27 110.227 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.548 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -88.24 32.68 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 2.6299999999999999 110.185 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.91 16.61 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 2.1600000000000001 110.221 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -118.91 -44.12 0.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.497 -1.441 . . . . 1.3200000000000001 109.497 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 5.2 m-85 -44.17 -48.15 23.76 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.169 . . . . 2.0899999999999999 110.396 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 46.7 Cg_endo -72.59 -54.53 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.625 1.329 . . . . 1.0800000000000001 110.349 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 23.1 m -62.13 -53.88 49.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 1.6000000000000001 110.142 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.657 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 10.7 ttp -41.85 -65.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 1.0900000000000001 110.108 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 50.2 t80 -56.25 -44.78 80.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 1.48 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -44.06 -59.73 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 1.1100000000000001 109.99 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 25.7 m -70.75 -42.31 70.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.6299999999999999 109.867 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.791 HD11 ' SG ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -41.58 -43.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 1.5 109.904 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.777 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.2 -40.49 7.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 1.5900000000000001 110.241 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 33.5 tttt -55.47 -16.64 3.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 3.5699999999999998 110.227 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.479 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 4.2 tp10 -117.9 16.13 14.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 3.0899999999999999 109.809 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.553 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -102.97 -21.2 13.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 2.8799999999999999 110.162 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 19.4 mttt -81.93 -47.04 1.01 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 3.1200000000000001 110.148 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -77.79 -2.52 12.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.982 1.517 . . . . 1.04 110.271 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 143' ' ' HIS . 48.8 t80 -111.03 -72.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 1.77 110.116 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.028 HD13 HD13 ' A' ' 34' ' ' ILE . 1.8 tp -47.83 -49.34 29.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 1.6100000000000001 110.052 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.742 HG23 ' OXT' ' A' ' 146' ' ' ILE . 6.7 m -58.3 -29.19 65.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.1699999999999999 110.349 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -106.84 5.93 28.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 2.2999999999999998 110.397 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.915 ' CD2' HG11 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -96.33 -6.16 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.129 -0.982 . . . . 2.21 110.348 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.469 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 124.77 28.47 1.15 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 2.1499999999999999 109.726 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -144.36 -103.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -1.182 . . . . 2.3799999999999999 110.191 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.953 HD13 ' OXT' ' A' ' 146' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.0 -1.0 . . . . 3.0600000000000001 110.148 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.693 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.226 0.536 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 67.09 17.37 10.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 2' ' ' ALA . 0.7 OUTLIER -102.54 -161.06 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.26 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -119.42 145.07 46.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 34' ' ' ILE . 16.0 mtmt -125.7 -156.21 0.72 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.058 -1.026 . . . . 0.0 110.975 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.863 ' HB1' ' OD2' ' A' ' 36' ' ' ASP . . . -124.88 157.13 36.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.678 -0.639 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.689 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 13.6 t -138.75 121.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.692 HD13 ' CD2' ' A' ' 80' ' ' PHE . 7.7 tp -76.91 103.39 6.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 18.3 m-85 -83.16 86.28 7.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 38' ' ' ALA . 6.7 t -93.86 154.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.883 ' SG ' HD22 ' A' ' 86' ' ' LEU . 59.2 m -146.72 -71.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.136 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.447 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 175.96 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.262 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 80.47 -2.3 78.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.51 ' CB ' ' HB2' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 67.86 8.42 6.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.744 HG23 ' OD2' ' A' ' 50' ' ' ASP . 24.5 mt -118.61 -22.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.151 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 11' ' ' CYS . 14.5 m -86.09 111.64 20.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.267 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.61 ' HB2' HD22 ' A' ' 86' ' ' LEU . 1.1 mpt_? 60.9 12.28 3.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.535 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -78.85 -55.18 1.0 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.465 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 47.4 Cg_endo -74.23 1.34 7.39 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.844 1.444 . . . . 0.0 110.576 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -97.54 -28.34 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.347 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.826 ' HA ' HD11 ' A' ' 132' ' ' ILE . 63.8 m -74.1 -33.95 63.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.722 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -63.78 -45.66 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.462 -0.773 . . . . 0.0 110.304 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -76.77 -51.58 6.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.152 HD12 ' CD2' ' A' ' 129' ' ' PHE . 1.1 tt -52.01 -45.22 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 0.0 110.357 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.596 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 88.4 m -75.76 -51.85 11.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.179 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 3.6 mtp85 -44.12 -40.95 5.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.904 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -80.48 -43.01 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.721 ' SD ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -58.38 -52.6 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 0.0 110.437 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.504 HG13 HD22 ' A' ' 145' ' ' LEU . 2.8 t -87.8 -34.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.369 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.38 -82.84 0.33 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 16.4 t0 -156.39 85.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -1.09 . . . . 0.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 31' ' ' ASP . 18.0 mmtm -129.8 -139.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.125 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.5 mt -119.15 -33.02 4.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.987 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.706 ' CA ' ' HA ' ' A' ' 6' ' ' ALA . 2.4 pp -32.17 -31.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.647 -0.658 . . . . 0.0 111.145 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.722 HG23 ' HA ' ' A' ' 22' ' ' GLU . 1.7 mt -73.96 88.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.483 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.863 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 49.0 m-20 -127.33 68.75 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.117 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -54.77 139.41 39.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.766 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -153.73 -179.09 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 14' ' ' ASN . . . -150.07 -173.7 4.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 40' ' ' THR . 5.3 t -162.04 67.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.908 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 -68.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 110.206 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -22.6 39.63 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 45' ' ' VAL . 9.8 m-85 -62.69 -63.44 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.44 70.88 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.859 HG22 ' HB1' ' A' ' 69' ' ' ALA . 44.5 t -144.75 142.27 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.95 18.98 58.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -168.11 -142.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 110.255 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 15' ' ' ILE . 0.6 OUTLIER 62.1 108.36 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.208 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 103.06 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.072 1.564 . . . . 0.0 110.486 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' A' ' 15' ' ' ILE . 61.5 m-20 -95.99 20.51 9.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -74.39 -27.76 60.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.949 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.595 ' HB3' ' CG ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -74.01 -52.07 13.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.296 179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.512 ' O ' HG12 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -61.37 -51.67 67.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 12.3 tp60 -61.37 -41.01 96.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 109.263 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -54.2 -66.16 0.45 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.416 -0.803 . . . . 0.0 109.467 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.575 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 10.0 p -53.41 -32.01 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.911 . . . . 0.0 109.216 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.959 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -56.3 -52.12 65.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.534 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -24.34 60.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.302 -0.874 . . . . 0.0 109.651 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -81.74 -12.42 58.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.3 m120 -114.59 -29.07 6.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.732 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 131.71 81.02 0.2 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.959 HG11 ' SG ' ' A' ' 57' ' ' CYS . 26.0 t -160.36 133.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -1.131 . . . . 0.0 110.14 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -122.15 93.15 3.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 0.0 110.2 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.472 HD12 ' OE1' ' A' ' 67' ' ' GLN . 26.0 pt -97.54 165.5 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.83 37.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.48 85.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 0.0 110.183 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.546 ' NE2' ' HB3' ' A' ' 19' ' ' PRO . 5.0 mp0 -105.18 -79.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.148 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' ALA . 7.3 ttp180 43.61 75.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 110.242 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.859 ' HB1' HG22 ' A' ' 45' ' ' VAL . . . -42.43 149.22 0.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.87 -170.44 3.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -107.66 155.43 20.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.68 155.78 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.02 168.99 9.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -16.31 23.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -22.57 62.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.182 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 28.4 p-10 -48.38 -37.88 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.241 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CE2' ' HD3' ' A' ' 99' ' ' PRO . 20.8 m-85 -65.85 -10.87 42.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 110.21 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.414 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 27.7 t -144.52 30.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.58 ' CG ' ' CE2' ' A' ' 80' ' ' PHE . 15.7 tptt -111.17 -5.33 14.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.692 ' CD2' HD13 ' A' ' 8' ' ' LEU . 87.0 m-85 -151.7 -139.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.235 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 -53.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.918 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 74.6 t -119.13 111.04 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.467 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.443 ' HB ' HG22 ' A' ' 106' ' ' VAL . 3.9 mt -84.29 110.39 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.053 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.73 135.78 38.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 110.386 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -117.43 121.75 41.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.883 HD22 ' SG ' ' A' ' 11' ' ' CYS . 2.2 mp -66.09 -80.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.451 ' C ' HD12 ' A' ' 90' ' ' ILE . 1.3 t0 -67.4 178.72 1.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.254 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -85.88 -35.07 20.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -51.46 -33.51 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 110.229 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.9 mt -71.02 -52.53 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.5 OUTLIER -64.12 -34.4 77.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.23 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 t -77.86 -46.97 19.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 89' ' ' SER . 5.4 m-20 -67.09 -57.41 6.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 90' ' ' ILE . 3.9 tt -46.37 -40.82 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.53 ' N ' HG23 ' A' ' 94' ' ' ILE . 8.3 t-20 -68.23 -24.93 64.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 93' ' ' ASP . 8.5 t -73.19 -17.08 61.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.537 ' HE1' HG13 ' A' ' 94' ' ' ILE . 9.3 ptt? -109.68 -27.14 9.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 2.3 mtpt -42.73 138.65 2.21 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.591 ' HD3' ' CE2' ' A' ' 77' ' ' PHE . 46.0 Cg_endo -73.26 -160.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.094 1.576 . . . . 0.0 110.422 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.3 t -113.36 15.78 19.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 110.153 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -155.02 104.95 2.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.2 p -137.33 -179.91 6.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.89 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.414 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -127.05 -5.54 6.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.52 -168.06 1.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.253 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.64 150.45 41.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 83' ' ' ILE . 45.1 t -116.37 142.6 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.209 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 106' ' ' VAL . 13.1 m -151.64 155.36 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.523 ' CG ' ' OD1' ' A' ' 110' ' ' ASN . 1.6 tp -89.28 142.2 27.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 132' ' ' ILE . 36.1 t80 -129.11 76.14 1.7 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.523 ' OD1' ' CG ' ' A' ' 108' ' ' LEU . 6.8 p-10 -176.9 166.24 1.42 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.7 Cg_endo -75.53 175.89 10.69 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.043 1.549 . . . . 0.0 110.296 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.0 Cg_endo -73.72 4.72 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.932 1.491 . . . . 0.0 110.489 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -122.36 -14.86 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.217 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.04 141.56 8.91 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 4.0 m -80.06 4.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -1.138 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 14.5 t70 178.01 169.4 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.237 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.563 ' CB ' ' CD ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -179.8 -59.35 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 117' ' ' ASP . 46.9 Cg_endo -73.13 88.76 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.94 1.494 . . . . 0.0 110.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.525 ' CE1' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -65.78 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.942 . . . . 0.0 110.17 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.474 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 1.7 t80 66.66 -62.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 119' ' ' TYR . 52.4 p -70.47 144.73 51.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.465 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 5.5 p -80.89 48.59 1.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.72 42.45 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -159.65 -37.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.649 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 47.5 m-85 -52.15 -44.98 93.94 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -1.163 . . . . 0.0 110.572 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 46.8 Cg_endo -74.13 -59.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.685 1.36 . . . . 0.0 110.286 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -55.3 -43.12 74.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.722 ' O ' HG22 ' A' ' 132' ' ' ILE . 27.1 ttp -48.6 -80.55 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 1.152 ' CD2' HD12 ' A' ' 24' ' ' ILE . 6.1 t80 -49.01 -55.51 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.088 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -44.21 -28.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 110.513 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.8 m -88.85 -60.32 1.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.943 HG12 HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -50.46 -19.48 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.268 179.293 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 1.048 ' CB ' HD11 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -98.15 -48.68 5.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.894 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 1.9 mmmm -71.02 -2.71 16.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 110.131 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.15 5.22 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.839 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.673 ' HA ' ' HE3' ' A' ' 136' ' ' MET . 1.5 tpt -82.97 11.77 5.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.394 -0.816 . . . . 0.0 110.193 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.534 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 2.3 mmtt -90.51 -55.16 0.28 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.213 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 48.2 Cg_endo -76.26 -2.87 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CD1' ' CE ' ' A' ' 136' ' ' MET . 25.1 t80 -108.16 -51.92 2.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.259 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.721 HD22 ' SD ' ' A' ' 28' ' ' MET . 0.8 OUTLIER -71.67 -55.95 6.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.586 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 56.3 m -41.93 -36.71 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 110.468 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.22 -63.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.724 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -100.96 63.72 1.03 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.752 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -179.8 -32.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.015 ' HG ' HG22 ' A' ' 146' ' ' ILE . 0.6 OUTLIER 172.56 -91.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.472 -1.016 . . . . 0.0 109.864 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.015 HG22 ' HG ' ' A' ' 145' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.129 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.254 0.55 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 63.46 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.915 . . . . 0.0 110.265 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -120.94 157.12 30.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.349 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.568 ' HE3' ' CA ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -76.58 -175.31 3.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.293 -0.879 . . . . 0.0 109.05 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.759 ' CD ' HD12 ' A' ' 145' ' ' LEU . 33.0 mtpt -145.9 177.37 8.98 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.901 -1.124 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.061 ' HB1' HD11 ' A' ' 34' ' ' ILE . . . -145.77 124.4 12.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.066 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 18.7 t -114.43 125.37 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.965 HD11 ' HB2' ' A' ' 38' ' ' ALA . 50.2 tp -79.24 98.94 6.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 1.116 ' CD1' HG23 ' A' ' 35' ' ' ILE . 96.7 m-85 -85.98 104.63 15.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.893 HG22 ' HB3' ' A' ' 38' ' ' ALA . 3.8 t -103.11 149.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.659 ' SG ' HD22 ' A' ' 86' ' ' LEU . 24.2 m -127.08 -151.33 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.92 . . . . 0.0 110.021 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -87.12 -30.46 21.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -144.18 9.99 2.0 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.99 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 43.5 t-20 59.26 49.68 8.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 0.0 110.29 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 69' ' ' ALA . 15.3 mt -136.75 -57.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.2 t -124.37 -138.42 0.29 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.288 -0.883 . . . . 0.0 110.133 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.85 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.38 -55.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.392 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.76 ' HB2' HD21 ' A' ' 86' ' ' LEU . 1.3 m -161.08 53.65 0.49 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.477 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.0 Cg_endo -75.31 -23.78 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.031 1.542 . . . . 0.0 110.308 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.999 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . . . -78.49 6.82 7.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.976 ' HB3' HG21 ' A' ' 35' ' ' ILE . 6.0 t -61.24 -32.04 71.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.819 ' HA ' HD13 ' A' ' 35' ' ' ILE . 2.1 tt0 -56.03 -54.05 49.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -76.48 -39.31 30.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.969 HD12 ' CD2' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -53.87 -47.21 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.243 . . . . 0.0 110.037 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.897 ' CB ' HD11 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.28 -49.97 11.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 9.0 mtt180 -54.23 -31.0 52.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.68 -40.83 12.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.496 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.55 -30.95 70.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.701 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.789 ' CB ' HD21 ' A' ' 33' ' ' LEU . 83.1 t -124.72 -22.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.92 -82.4 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.462 ' C ' ' CG ' ' A' ' 32' ' ' LYS . 2.7 m-20 -149.76 68.14 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.261 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.77 ' O ' HD23 ' A' ' 33' ' ' LEU . 2.0 mtpm? -148.9 37.86 0.81 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 29' ' ' VAL . 0.4 OUTLIER 166.6 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.437 -0.789 . . . . 0.0 109.591 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.061 HD11 ' HB1' ' A' ' 6' ' ' ALA . 2.7 pp -42.59 168.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.116 HG23 ' CD1' ' A' ' 9' ' ' PHE . 4.7 mp -121.06 102.32 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 80' ' ' PHE . 9.4 m-20 -88.31 114.21 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.062 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.7 m -75.17 116.3 15.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.032 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.965 ' HB2' HD11 ' A' ' 8' ' ' LEU . . . -120.85 175.18 6.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.99 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -161.16 149.3 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 t -116.75 -2.45 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.09 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.28 170.81 13.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 110.145 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.52 50.15 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -17.36 32.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -1.165 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.443 ' O ' HD11 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -141.97 80.47 1.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 69' ' ' ALA . 86.5 t -134.44 146.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.07 58.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 48' ' ' SER . 1.3 pt20 -158.94 -146.79 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -1.147 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 65.12 99.68 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 100.89 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.083 1.57 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 1.6 t0 -89.72 26.83 1.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.547 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -76.32 -31.92 58.42 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.225 -0.922 . . . . 0.0 109.051 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -70.31 -49.7 46.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.262 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.531 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.3 t -63.35 -53.49 51.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.573 -0.704 . . . . 0.0 109.683 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.682 ' HB2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -61.04 -31.2 70.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.257 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.4 -66.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.383 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.557 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 35.7 m -52.79 -33.36 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.203 -0.935 . . . . 0.0 109.115 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.999 ' SG ' ' HB2' ' A' ' 20' ' ' ALA . 32.0 m -57.47 -53.07 62.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 109.508 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -23.17 63.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.99 -11.9 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 110.061 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.6 m-80 -112.44 -23.77 10.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.212 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 124.17 75.79 0.29 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.659 HG11 ' CB ' ' A' ' 20' ' ' ALA . 55.0 t -158.09 102.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -1.145 . . . . 0.0 110.205 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -78.34 74.26 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.988 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 54' ' ' GLN . 3.4 pt -60.1 -173.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -160.22 70.07 0.41 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.22 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 90.3 mm-40 -56.52 -60.0 4.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.218 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.38 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.269 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.644 ' HB2' HG12 ' A' ' 15' ' ' ILE . . . -60.59 131.4 50.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -140.44 152.23 45.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.245 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.06 144.18 38.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.195 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.592 HD12 ' HB1' ' A' ' 38' ' ' ALA . 19.7 tt -75.8 145.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.281 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.778 HG22 ' OD1' ' A' ' 76' ' ' ASP . 9.1 t -89.72 -146.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.13 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -118.6 -5.29 10.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.31 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.63 ' H ' HG23 ' A' ' 73' ' ' THR . . . -96.67 -8.43 31.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.778 ' OD1' HG22 ' A' ' 73' ' ' THR . 1.1 m-20 -45.1 -47.63 12.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.587 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 53.5 m-85 -48.61 -36.71 16.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.9 t -102.07 -16.04 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.16 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -66.25 -25.56 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.194 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.878 ' CE2' HD13 ' A' ' 8' ' ' LEU . 7.4 m-85 -132.28 169.6 16.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.1 -33.78 20.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.377 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' CD2' ' A' ' 143' ' ' HIS . 47.6 t -134.23 153.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.31 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.521 HG23 ' HB3' ' A' ' 8' ' ' LEU . 4.8 mt -129.75 128.3 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 109' ' ' PHE . . . -126.12 143.37 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.464 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -113.67 156.49 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.85 HD23 ' HB3' ' A' ' 17' ' ' ARG . 1.2 tp -85.3 -52.88 5.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 3.7 m-20 -99.56 -174.87 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.905 . . . . 0.0 110.244 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.58 -35.74 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -46.13 -41.27 12.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 87' ' ' ASP . 1.4 mp -71.02 -54.15 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.152 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -60.49 -15.81 30.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 t -93.26 -41.26 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.18 -16.88 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.182 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.543 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.3 tt -74.14 -40.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.168 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.524 ' N ' HG23 ' A' ' 94' ' ' ILE . 29.6 p30 -68.12 -9.76 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.65 -38.71 23.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.883 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.543 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.1 ptt? -84.1 -34.3 24.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.239 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -52.62 126.55 40.09 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 100' ' ' SER . 45.2 Cg_endo -73.39 -87.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.053 1.554 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 169.74 -23.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.4 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.84 43.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.128 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.8 p -99.47 -145.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.267 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 27.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.03 32.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.45 146.05 45.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 9.8 m -108.41 132.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' ALA . 22.6 m -131.27 156.51 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.256 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.427 ' HB2' HD13 ' A' ' 91' ' ' LEU . 26.4 tp -92.46 102.4 14.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.123 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.58 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . 4.9 t80 -81.09 82.61 6.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.134 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 7.7 t30 -170.09 142.16 1.84 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.497 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.5 Cg_endo -74.35 175.01 11.56 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.94 1.495 . . . . 0.0 110.35 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.02 52.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.977 1.514 . . . . 0.0 110.434 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.59 -37.18 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.206 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 101.54 2.51 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.474 HG23 ' OD1' ' A' ' 110' ' ' ASN . 71.4 t -57.66 98.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -1.209 . . . . 0.0 110.118 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.23 148.03 26.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 110.197 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 87.73 6.52 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.89 173.47 13.48 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.005 1.529 . . . . 0.0 110.406 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -115.75 161.92 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.23 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 50.38 41.65 25.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.155 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -150.89 -174.76 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.3 p -143.79 40.17 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.892 . . . . 0.0 110.174 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.32 54.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.56 ' HA2' ' CG2' ' A' ' 127' ' ' THR . . . -179.08 -32.84 0.06 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.623 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 8.1 m-85 -41.76 -50.29 10.05 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 110.731 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 43.4 Cg_endo -71.38 -74.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.81 1.426 . . . . 0.0 110.975 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.56 ' CG2' ' HA2' ' A' ' 124' ' ' GLY . 15.1 t -39.95 -40.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.168 -0.958 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.797 ' O ' HG22 ' A' ' 132' ' ' ILE . 9.6 ttp -55.17 -78.95 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.188 -0.945 . . . . 0.0 109.823 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.969 ' CD2' HD12 ' A' ' 24' ' ' ILE . 2.7 t80 -42.6 -51.29 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.167 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.441 ' N ' ' HD1' ' A' ' 129' ' ' PHE . . . -58.81 -22.41 58.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.5 t -90.32 -51.28 5.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.04 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.886 HD11 ' CB ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -61.8 -16.96 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.786 ' HB2' HD11 ' A' ' 24' ' ' ILE . 2.3 t -96.0 -51.05 4.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.557 -0.714 . . . . 0.0 109.849 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.22 -20.84 65.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.974 . . . . 0.0 110.111 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 131' ' ' SER . 0.2 OUTLIER -76.93 -30.17 55.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.587 ' CE ' ' HA ' ' A' ' 133' ' ' SER . 0.6 OUTLIER -77.57 5.23 9.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.209 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.538 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 3.0 mmtt -89.24 -54.65 0.31 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.35 -10.73 17.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.041 1.548 . . . . 0.0 110.426 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 32.9 t80 -102.17 -77.23 0.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.616 HD21 HD22 ' A' ' 33' ' ' LEU . 14.6 tp -40.81 -62.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.382 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.845 HG23 HD12 ' A' ' 146' ' ' ILE . 30.6 m -41.66 -29.13 0.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LEU . 3.3 mm-40 -101.59 -25.82 13.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 1.5 t60 -66.32 -21.66 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.02 36.42 0.18 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.759 HD12 ' CD ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -173.38 93.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 110.14 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.845 HD12 HG23 ' A' ' 141' ' ' THR . 4.2 tp . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.246 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.307 0.575 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 55.63 172.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.51 ' O ' ' CD2' ' A' ' 145' ' ' LEU . 2.2 mm-40 -99.97 168.04 10.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.04 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -80.47 171.2 15.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.309 -0.869 . . . . 0.0 108.762 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 9.4 mtpp -151.8 164.12 37.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.86 -1.15 . . . . 0.0 111.26 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.872 ' HA ' ' CG1' ' A' ' 34' ' ' ILE . . . -105.91 99.93 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.75 -0.593 . . . . 0.0 109.773 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 33' ' ' LEU . 12.6 t -104.01 108.35 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 38' ' ' ALA . 29.7 tp -92.56 111.04 22.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 1.071 ' CD1' HG23 ' A' ' 35' ' ' ILE . 12.5 m-85 -85.97 128.48 34.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.814 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.688 HG23 ' C ' ' A' ' 38' ' ' ALA . 10.9 p -143.37 172.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -0.981 . . . . 0.0 110.633 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.946 ' O ' HD12 ' A' ' 90' ' ' ILE . 16.8 t -153.6 -69.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 110.126 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 172.99 84.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.919 . . . . 0.0 110.285 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.67 ' H ' ' HB1' ' A' ' 39' ' ' ALA . . . 134.06 -31.67 2.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 6.4 t30 72.15 -0.15 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -1.183 . . . . 0.0 110.352 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.551 HG23 ' OG ' ' A' ' 48' ' ' SER . 23.4 mt -96.71 -85.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -85.27 44.17 1.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.613 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 9.7 mmt180 -115.73 69.14 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.849 ' OG ' HD21 ' A' ' 86' ' ' LEU . 16.5 m 44.18 57.29 13.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.9 . . . . 0.0 110.323 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HB3' ' OE1' ' A' ' 67' ' ' GLN . 43.7 Cg_endo -71.2 -13.18 30.88 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.971 1.511 . . . . 0.0 110.067 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.56 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -82.16 6.71 15.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.778 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.954 ' HB3' HG22 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -63.76 -38.78 92.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.647 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -66.57 -44.93 80.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.805 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.9 -54.65 13.44 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.634 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 4.8 tp -50.86 -44.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -1.174 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.707 ' HB2' HD12 ' A' ' 35' ' ' ILE . 5.8 t -71.31 -32.12 68.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -62.56 -55.42 27.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -34.11 66.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 110.492 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.56 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 6.1 ttm -73.05 -59.33 2.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG21 HD22 ' A' ' 140' ' ' LEU . 11.5 m -141.53 46.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 0.0 110.396 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . -59.59 78.14 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER 165.55 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -1.102 . . . . 0.0 110.123 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.914 ' HB3' HD11 ' A' ' 145' ' ' LEU . 11.6 mttp -139.42 112.93 8.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.737 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.989 HD22 ' HB3' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 77.54 65.02 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.043 0.925 . . . . 0.0 109.167 -179.11 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.872 ' CG1' ' HA ' ' A' ' 6' ' ' ALA . 2.6 pp -59.57 145.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.82 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.071 HG23 ' CD1' ' A' ' 9' ' ' PHE . 8.5 mt -119.31 89.87 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 69.1 m-20 -85.19 178.27 7.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 111.006 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 5.7 p -130.55 123.22 29.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.688 ' C ' HG23 ' A' ' 10' ' ' VAL . . . -133.06 -160.45 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.125 -0.985 . . . . 0.0 110.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.67 ' HB1' ' H ' ' A' ' 13' ' ' GLY . . . -171.55 144.43 1.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.524 ' OG1' HD22 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -81.3 -49.16 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.158 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.6 t -128.28 141.29 51.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.0 97.56 0.24 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.97 23.53 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.326 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.88 26.79 5.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 45' ' ' VAL . 16.0 m -64.96 125.27 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.258 -0.901 . . . . 0.0 110.304 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.68 34.0 0.62 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -101.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -1.114 . . . . 0.0 110.172 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 15' ' ' ILE . 2.9 t 61.26 71.69 0.76 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.206 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.51 66.42 1.62 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.0 1.526 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 21.5 m-20 -92.22 35.84 0.99 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 110.367 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -31.62 58.48 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mpt_? -73.94 -48.77 28.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.299 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -62.25 -48.21 80.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.459 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 1.5 tt0 -64.65 -36.37 84.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 109.262 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.3 ttpt -58.75 -64.74 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.258 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.579 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 9.0 p -54.81 -35.53 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.802 ' O ' HG22 ' A' ' 62' ' ' VAL . 4.3 m -53.51 -54.11 41.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.777 . . . . 0.0 109.411 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 54' ' ' GLN . 15.6 mtmt -69.03 -27.42 65.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 t -77.57 -14.08 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.89 -32.36 6.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.814 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 114.1 85.68 1.37 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.991 ' O ' HG23 ' A' ' 64' ' ' ILE . 2.5 m -162.65 87.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -1.084 . . . . 0.0 110.111 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -52.85 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.991 HG23 ' O ' ' A' ' 62' ' ' VAL . 1.2 pt -103.71 -158.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' HD12 ' A' ' 64' ' ' ILE . 68.7 m -144.75 -170.94 3.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.155 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 68' ' ' ARG . 21.2 mmtt -80.42 4.16 19.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 76.6 mm-40 59.75 -75.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 65.91 104.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 14' ' ' ASN . . . -61.43 113.13 2.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.433 ' CD ' ' O ' ' A' ' 71' ' ' GLN . 8.0 tmm_? -135.98 143.45 44.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.203 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.433 ' O ' ' CD ' ' A' ' 70' ' ' ARG . 1.6 tt0 -72.53 139.47 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.248 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.445 HD11 ' CB ' ' A' ' 76' ' ' ASP . 4.0 tt -95.46 136.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 178.79 6.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.47 4.05 33.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.88 -12.33 55.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 7.6 p-10 -49.97 -24.42 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.141 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.593 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.2 m-85 -75.83 -10.11 59.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 110.142 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.55 -45.48 4.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 80' ' ' PHE . 7.9 tptp -57.81 -51.2 70.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 11.8 m-85 -115.57 144.23 44.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.349 -0.845 . . . . 0.0 110.13 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.408 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 56.0 m-20 -91.32 -24.04 19.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 9.9 t -113.71 138.71 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.239 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.6 mt -137.54 115.38 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.066 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.497 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . . . -91.5 141.63 28.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.27 141.25 48.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.203 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.849 HD21 ' OG ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -73.33 -52.55 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -107.97 -178.92 3.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.03 -28.39 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.253 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.52 -59.8 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.182 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.946 HD12 ' O ' ' A' ' 11' ' ' CYS . 4.3 tt -51.39 -38.59 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.486 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -74.03 -27.52 60.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.479 ' O ' ' ND2' ' A' ' 95' ' ' ASN . 40.0 t -78.64 -29.38 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 0.0 110.2 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.98 -45.22 8.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.558 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.4 tt -48.45 -36.03 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 92' ' ' SER . 20.8 p30 -71.71 -8.99 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -77.72 -20.07 54.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.181 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.558 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.0 ptt? -102.78 -25.28 13.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.593 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -53.38 139.59 47.2 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.185 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.16 169.72 21.56 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.996 1.524 . . . . 0.0 110.415 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -71.58 -6.5 41.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.06 68.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.238 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 30.7 p -83.95 164.0 19.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.19 38.66 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 81' ' ' ASP . . . -157.61 161.42 38.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -122.73 132.41 54.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.9 . . . . 0.0 110.158 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.3 m -96.84 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.357 -0.839 . . . . 0.0 110.187 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 t -96.74 161.66 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.45 113.13 26.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 42.7 t80 -83.73 122.96 29.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.49 170.09 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.6 Cg_endo -75.8 175.62 11.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.026 1.54 . . . . 0.0 110.227 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.57 4.44 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.02 1.537 . . . . 0.0 110.514 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -54.3 -64.43 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 110.145 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.96 130.99 2.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 128' ' ' MET . 10.3 t -124.3 26.52 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 117' ' ' ASP . 1.0 OUTLIER -148.83 -40.91 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.243 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER 66.79 145.3 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.149 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 119' ' ' TYR . 45.9 Cg_endo -73.39 73.29 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 118' ' ' PRO . 26.0 m-85 51.22 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.271 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 121' ' ' SER . 1.7 t80 -152.13 94.53 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' TYR . 6.2 t 43.23 -145.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.465 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 15.1 m -70.25 -19.68 63.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.239 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 128' ' ' MET . . . 142.17 -71.5 0.4 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 3.2 m-85 -42.66 -48.6 13.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.149 . . . . 0.0 110.325 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -72.97 -55.0 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.671 1.353 . . . . 0.0 110.396 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 128' ' ' MET . 67.2 m -63.23 -53.26 55.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.186 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 124' ' ' GLY . 10.7 ttp -40.85 -70.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 66.7 t80 -58.31 -45.47 87.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -43.22 -67.32 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.869 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -65.12 -39.95 93.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.2 -0.938 . . . . 0.0 109.754 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -42.26 -42.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.819 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.554 ' CB ' HD11 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -98.26 -42.92 7.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.335 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 131' ' ' SER . 3.4 mmtt -47.5 -30.19 3.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.2 OUTLIER -105.65 -2.98 22.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.551 ' HB2' ' HA ' ' A' ' 133' ' ' SER . 0.8 OUTLIER -84.98 20.21 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.59 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -105.17 -65.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.153 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 48.3 Cg_endo -73.09 -1.54 10.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.753 1.396 . . . . 0.0 110.492 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.517 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 92.9 t80 -77.02 -76.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 110.339 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.989 ' HB3' HD22 ' A' ' 33' ' ' LEU . 3.1 pp -71.46 -33.51 69.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.297 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.513 HG23 HG22 ' A' ' 146' ' ' ILE . 85.8 m -57.13 -30.11 64.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 144' ' ' GLY . 5.0 mm-40 -104.81 -44.99 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.424 ' CD2' ' O ' ' A' ' 139' ' ' PHE . 14.9 m-70 -43.51 -25.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.068 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 126.96 66.8 0.15 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.914 HD11 ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -153.17 -45.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -1.106 . . . . 0.0 110.226 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.618 HD12 ' CD1' ' A' ' 140' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.254 0.55 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.01 85.71 6.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.898 . . . . 0.0 110.145 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.441 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -62.14 -147.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.266 -0.896 . . . . 0.0 110.363 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.572 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -160.68 -42.86 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 110.446 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 2.0 ptpt 37.43 -155.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.699 -0.626 . . . . 0.0 110.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.836 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -159.91 138.43 10.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.497 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.8 m -103.16 112.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.403 -0.811 . . . . 0.0 109.56 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -59.44 95.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.98 . . . . 0.0 110.328 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.9 OUTLIER -85.79 108.97 18.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.301 -0.874 . . . . 0.0 109.303 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.075 HG13 ' CD1' ' A' ' 90' ' ' ILE . 6.8 p -137.86 171.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 111.088 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.795 ' HA ' HD12 ' A' ' 90' ' ' ILE . 23.9 t -162.74 55.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.895 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.655 HD23 ' HB ' ' A' ' 90' ' ' ILE . 3.8 mm? 59.54 -158.55 0.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.888 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.74 86.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.646 ' ND2' ' O ' ' A' ' 12' ' ' LEU . 13.1 p30 -134.46 5.8 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -1.209 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.853 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.9 mt 57.47 31.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 110.747 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 15' ' ' ILE . 50.4 m 53.55 117.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.123 -0.986 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.734 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -83.21 66.66 8.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.646 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -68.24 -44.94 38.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.789 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.661 ' HA ' HG21 ' A' ' 64' ' ' ILE . 47.0 Cg_endo -74.51 -2.9 13.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.712 1.375 . . . . 0.0 110.781 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.864 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -102.77 -62.27 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.183 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.556 ' SG ' ' CG ' ' A' ' 9' ' ' PHE . 95.4 m -76.52 -48.29 19.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -65.79 -34.19 77.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.801 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.827 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -73.73 -57.16 5.07 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.848 HG12 HG22 ' A' ' 132' ' ' ILE . 8.7 tp -54.22 -40.43 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -1.174 . . . . 0.0 110.075 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 8.5 t -75.43 -67.08 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 ptm180 -41.82 -33.53 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' CG ' ' A' ' 26' ' ' ARG . 5.8 t70 -85.18 -36.32 21.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.452 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.489 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 4.9 ttt -84.29 -0.23 51.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.445 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' A' ' 32' ' ' LYS . 21.2 t -130.13 -43.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.321 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.16 65.54 0.16 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 72.7 m-20 47.81 77.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -1.196 . . . . 0.0 110.282 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.596 ' HG3' HG12 ' A' ' 29' ' ' VAL . 23.6 mmtm -128.54 -137.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.148 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.763 ' O ' HG13 ' A' ' 34' ' ' ILE . 96.4 mt -140.93 -95.12 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.028 HD13 HD13 ' A' ' 140' ' ' LEU . 0.7 OUTLIER 41.79 18.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.597 -0.69 . . . . 0.0 111.234 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -157.95 144.08 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.761 -1.212 . . . . 0.0 110.798 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.945 ' O ' HD13 ' A' ' 8' ' ' LEU . 6.7 m-20 -146.54 105.0 3.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.4 p -68.63 125.74 27.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 110.52 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.049 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -127.2 -169.4 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 110.192 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG23 ' A' ' 10' ' ' VAL . . . -174.79 88.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.878 ' OG1' HD12 ' A' ' 72' ' ' ILE . 18.4 m -71.3 87.96 0.84 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.4 p -159.6 -50.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.1 48.49 25.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.54 -47.06 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -1.132 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.429 ' O ' HG13 ' A' ' 15' ' ' ILE . 49.5 m-70 -94.01 44.0 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.79 156.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 28.09 72.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 48' ' ' SER . 4.3 pt20 -170.34 -147.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -1.124 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.441 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER 61.06 108.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.6 Cg_endo -69.59 99.62 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.513 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -90.5 27.76 1.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.153 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.4 m -74.95 -27.87 60.36 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.268 -0.895 . . . . 0.0 109.043 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.672 ' O ' HG22 ' A' ' 56' ' ' VAL . 11.0 mmt180 -73.48 -51.41 17.23 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.361 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 9.6 p -62.7 -50.85 69.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.781 . . . . 0.0 109.608 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HA ' ' CD1' ' A' ' 64' ' ' ILE . 1.1 tt0 -61.43 -39.39 90.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.256 -0.903 . . . . 0.0 109.31 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -59.23 -70.12 0.17 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 109.59 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 52' ' ' ARG . 35.8 m -48.82 -32.7 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.955 . . . . 0.0 109.19 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 62' ' ' VAL . 1.2 m -58.41 -52.48 65.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.845 . . . . 0.0 109.491 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -24.41 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.5 t -86.01 -10.78 54.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 23.8 m-80 -114.93 -32.32 5.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.775 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 140.88 86.08 0.1 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.827 HG13 ' HA3' ' A' ' 23' ' ' GLY . 20.8 t -161.5 138.37 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -1.102 . . . . 0.0 110.058 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -103.11 95.94 6.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.284 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.661 HG21 ' HA ' ' A' ' 19' ' ' PRO . 6.3 pt -137.52 -171.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 p -176.91 -40.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.273 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 140.88 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.56 133.58 0.62 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -89.43 -141.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.106 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.23 153.2 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.51 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -141.18 -148.37 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.51 ' N ' ' HG3' ' A' ' 70' ' ' ARG . 7.6 tt0 -136.09 162.25 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.952 . . . . 0.0 110.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.878 HD12 ' OG1' ' A' ' 40' ' ' THR . 14.9 mt -77.1 -72.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.156 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER 65.78 -145.59 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -100.39 -14.44 18.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.42 74.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.883 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -53.53 -46.71 70.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.188 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.606 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 26.2 m-85 -67.23 60.57 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.032 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER 169.71 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.933 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 2.8 tptt -73.48 -1.31 17.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.825 ' CD1' ' HB3' ' A' ' 6' ' ' ALA . 79.8 m-85 -154.97 -153.1 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -130.25 -13.69 3.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 0.0 110.79 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.637 ' CB ' HG12 ' A' ' 7' ' ' VAL . 58.8 t -133.72 157.62 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.675 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 8' ' ' LEU . 1.7 mp -145.54 115.93 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.476 -0.765 . . . . 0.0 109.511 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.14 132.01 52.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 111.134 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 1.034 ' HB1' HG23 ' A' ' 90' ' ' ILE . . . -108.35 124.87 51.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.497 -0.752 . . . . 0.0 109.687 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.663 HD22 ' HB2' ' A' ' 11' ' ' CYS . 5.4 mp -58.14 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' ILE . 67.8 m-20 -67.8 -175.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.438 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' SER . 16.2 mt-30 -84.28 -43.36 14.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -43.12 -56.48 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.075 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.075 ' CD1' HG13 ' A' ' 10' ' ' VAL . 4.8 tt -49.81 -41.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.586 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -71.15 -41.13 70.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 t -62.75 -37.89 88.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -0.92 . . . . 0.0 110.216 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.4 OUTLIER -85.57 -55.72 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.586 ' CG2' ' HA ' ' A' ' 91' ' ' LEU . 12.9 tt -44.83 -42.79 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 110.184 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.567 ' N ' HG23 ' A' ' 94' ' ' ILE . 20.1 t-20 -75.55 -11.78 60.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' ASP . 11.0 t -95.69 6.54 48.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.592 ' HE2' ' CZ ' ' A' ' 77' ' ' PHE . 2.4 ptt? -128.83 -32.31 2.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.243 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.606 ' CE ' ' CD1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -42.63 150.78 0.41 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.291 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.03 1.542 . . . . 0.0 110.411 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.07 29.05 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 80.22 1.43 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.9 p -155.4 -174.28 4.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 110.196 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.458 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -139.65 48.91 1.81 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.46 178.61 4.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.87 137.56 48.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.69 130.39 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 108' ' ' LEU . 1.2 p -129.79 171.35 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.92 . . . . 0.0 110.279 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.561 ' N ' ' CG2' ' A' ' 107' ' ' VAL . 22.4 tp -105.69 156.1 18.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 110.167 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 43.0 t80 -149.4 106.81 3.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.962 . . . . 0.0 110.219 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' PHE . 0.7 OUTLIER -171.16 106.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 115' ' ' VAL . 47.6 Cg_endo -74.49 175.82 10.52 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.119 1.589 . . . . 0.0 110.266 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.8 Cg_endo -71.53 54.24 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.926 1.487 . . . . 0.0 110.484 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.62 -40.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.147 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.3 133.0 6.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.582 HG22 ' CB ' ' A' ' 131' ' ' SER . 5.5 t -121.34 -9.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -1.118 . . . . 0.0 110.177 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 1.5 p30 -55.93 133.12 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.92 109.98 31.7 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 116' ' ' ASP . 47.0 Cg_endo -73.68 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.978 1.515 . . . . 0.0 110.496 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.581 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 50.2 t80 -154.39 36.92 0.42 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -119.8 -11.47 9.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 123' ' ' ASP . 0.4 OUTLIER 174.95 166.55 0.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 74.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.241 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 121' ' ' SER . 1.0 OUTLIER -125.57 0.22 7.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 110.232 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -115.85 -44.09 0.65 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.657 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 8.6 m-85 -44.58 -47.96 27.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.186 -1.185 . . . . 0.0 110.358 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.657 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.7 Cg_endo -72.91 -51.72 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.72 1.379 . . . . 0.0 110.201 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.7 m -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.864 ' CE ' ' HB2' ' A' ' 20' ' ' ALA . 9.3 ttp -42.1 -65.9 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.106 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.668 ' CE1' HD13 ' A' ' 24' ' ' ILE . 44.9 t80 -56.12 -45.31 79.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -44.64 -62.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.582 ' CB ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -59.14 -47.61 84.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.848 HG22 HG12 ' A' ' 24' ' ' ILE . 4.3 mm -42.14 -65.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.868 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.715 ' CB ' HD11 ' A' ' 24' ' ' ILE . 1.7 p -71.35 -21.73 62.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -0.828 . . . . 0.0 110.43 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 2.7 tttp -63.5 -34.7 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.025 . . . . 0.0 110.109 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -132.22 66.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.328 -0.857 . . . . 0.0 110.442 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.53 ' CE ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -118.22 -5.29 10.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 110.08 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.0 mttt -87.48 -49.67 0.45 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 110.382 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -77.45 -8.08 17.11 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.888 1.467 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.698 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 10.7 t80 -88.08 -50.17 6.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.028 HD13 HD13 ' A' ' 34' ' ' ILE . 28.2 tp -82.12 -30.09 31.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.507 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 54.9 m -71.01 -24.06 62.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.966 . . . . 0.0 110.328 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -104.06 -44.16 5.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.913 . . . . 0.0 110.208 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.698 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -45.68 -39.11 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.273 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.573 ' C ' HD12 ' A' ' 145' ' ' LEU . . . 148.06 53.43 0.02 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.688 HD22 HD11 ' A' ' 140' ' ' LEU . 0.6 OUTLIER -160.6 -98.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.168 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.507 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 1.5 tp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.193 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.201 0.524 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.69 175.76 5.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.252 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.05 160.73 14.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.33 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.04 -159.47 0.06 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 108.725 178.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.757 ' H ' HG22 ' A' ' 34' ' ' ILE . 22.7 mttp -158.13 -164.29 1.47 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 110.62 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.021 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.93 119.43 8.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 110.803 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.957 ' HB ' HD12 ' A' ' 34' ' ' ILE . 5.8 t -114.14 121.55 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.543 -0.723 . . . . 0.0 109.79 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.861 HD21 ' CB ' ' A' ' 38' ' ' ALA . 3.6 tp -97.52 86.75 3.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.247 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 7.5 p90 -72.92 143.58 47.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.977 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.005 HG13 ' O ' ' A' ' 38' ' ' ALA . 46.9 t -142.83 155.68 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 110.28 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.938 ' HB2' HD22 ' A' ' 86' ' ' LEU . 8.1 t -139.56 -60.68 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 110.128 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 -55.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.176 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -131.79 21.44 4.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER 64.8 21.46 12.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -1.13 . . . . 0.0 110.265 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.458 HD11 ' HA ' ' A' ' 45' ' ' VAL . 10.2 mt -121.47 -27.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.179 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -106.1 123.8 48.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.127 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.843 ' HD2' HD23 ' A' ' 86' ' ' LEU . 40.4 mtt180 66.91 -53.97 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.617 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -42.1 -51.56 10.27 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.027 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.2 Cg_endo -72.35 -7.08 20.3 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.816 1.429 . . . . 0.0 110.563 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.62 ' C ' HD13 ' A' ' 132' ' ' ILE . . . -93.39 -21.17 19.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.598 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 16.8 t -70.05 -55.53 9.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.516 ' HG3' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -44.28 -37.04 3.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.437 -0.789 . . . . 0.0 109.43 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.94 -52.57 8.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.899 HD11 ' HB2' ' A' ' 133' ' ' SER . 2.8 tp -55.06 -34.29 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -1.23 . . . . 0.0 109.941 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 34' ' ' ILE . 1.4 m -73.14 -52.79 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 110.04 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -31.02 63.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -87.95 -58.61 2.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.087 -1.008 . . . . 0.0 110.088 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.7 OUTLIER -50.74 -27.05 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.701 HG12 ' HD3' ' A' ' 32' ' ' LYS . 6.7 t -105.82 -33.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 110.223 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.45 -68.39 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -174.65 38.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -1.157 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.701 ' HD3' HG12 ' A' ' 29' ' ' VAL . 4.1 mptp? -75.07 -113.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 35' ' ' ILE . 80.2 mt -152.92 -107.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.932 -1.105 . . . . 0.0 110.26 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.021 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 33.46 31.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 111.653 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -102.24 102.43 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 110.112 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.616 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 50.5 m-20 -135.84 140.67 44.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 110.02 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.576 ' CB ' ' CE1' ' A' ' 9' ' ' PHE . 10.2 t -124.17 143.4 50.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.482 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.005 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -146.21 167.53 23.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -154.98 154.53 32.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -134.76 80.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 t -170.02 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.17 32.57 4.28 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -114.72 -36.38 4.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.128 . . . . 0.0 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 48' ' ' SER . 2.0 t60 -122.61 84.3 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.231 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.101 HG13 ' HB3' ' A' ' 69' ' ' ALA . 46.1 t -146.15 135.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.86 76.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.37 51.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.382 -1.069 . . . . 0.0 110.192 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.487 ' OG ' ' NE2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -154.79 129.53 4.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.53 106.67 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.971 1.511 . . . . 0.0 110.4 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.546 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.3 p-10 -90.82 22.49 3.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.8 m -71.98 -28.16 63.23 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.22 -0.925 . . . . 0.0 108.794 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.605 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 5.0 mmt180 -74.5 -45.23 47.26 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -63.57 -53.64 48.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 78.4 mt-30 -61.95 -41.44 97.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.323 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.7 ttpp -55.2 -69.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 109.485 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.56 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 37.4 t -48.28 -36.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.873 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.547 -0.721 . . . . 0.0 109.513 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -24.55 61.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.383 -0.823 . . . . 0.0 109.481 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -81.27 -13.06 58.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -111.91 -31.04 7.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.291 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 119.5 94.56 1.54 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.873 HG11 ' SG ' ' A' ' 57' ' ' CYS . 9.8 p -178.71 151.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -1.114 . . . . 0.0 110.065 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -127.3 140.78 51.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.247 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.434 ' CD1' ' HG2' ' A' ' 54' ' ' GLN . 7.4 pt -124.73 163.58 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.139 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -112.27 -34.14 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 110.223 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' C ' ' CD ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -166.88 150.33 6.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.261 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 50' ' ' ASP . 1.6 mt-30 -132.16 74.85 1.6 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 110.28 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 68' ' ' ARG . 33.5 ttp85 -126.29 111.14 14.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.101 ' HB3' HG13 ' A' ' 45' ' ' VAL . . . -53.8 144.44 18.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.187 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.99 39.38 0.84 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' CA ' ' OE1' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 54.46 -164.15 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.267 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.564 HD12 ' HB1' ' A' ' 38' ' ' ALA . 15.4 tt -121.93 -39.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.504 ' N ' HG23 ' A' ' 72' ' ' ILE . 1.0 OUTLIER 63.72 157.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -67.37 -23.6 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.214 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -58.77 -26.69 64.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.269 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.554 ' HB2' HD22 ' A' ' 8' ' ' LEU . 24.6 p-10 -48.31 -34.75 11.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 44.7 m-85 -73.14 -39.09 65.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.242 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.52 -52.85 4.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -44.85 -26.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.214 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.58 ' CD1' ' OD2' ' A' ' 36' ' ' ASP . 9.3 m-85 -134.2 172.58 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.68 -20.26 9.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 58.4 t -125.56 139.15 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.9 . . . . 0.0 110.361 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 107' ' ' VAL . 1.4 mp -123.67 144.23 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 110.082 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.783 ' HB1' ' CD2' ' A' ' 109' ' ' PHE . . . -123.05 118.8 28.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.88 116.97 32.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.091 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.938 HD22 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mp -62.86 -85.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.426 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.409 ' N ' HD12 ' A' ' 90' ' ' ILE . 79.2 m-20 -73.53 -177.63 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 89' ' ' SER . 14.1 mt-30 -79.05 -40.85 30.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 110.183 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 4.3 m -42.02 -40.37 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.298 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.511 HD11 ' O ' ' A' ' 11' ' ' CYS . 3.8 mt -69.36 -48.14 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.56 -41.63 97.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 t -73.47 -40.41 64.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 96' ' ' SER . 82.9 m-20 -65.52 -61.97 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.594 HG23 ' N ' ' A' ' 95' ' ' ASN . 3.7 tt -42.71 -43.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.594 ' N ' HG23 ' A' ' 94' ' ' ILE . 3.0 t-20 -61.88 -33.03 73.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.973 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -67.47 -13.59 62.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.446 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 4.4 ptt? -122.34 -24.79 4.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 110.143 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 94' ' ' ILE . 0.3 OUTLIER -43.09 140.48 1.99 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -159.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.06 1.558 . . . . 0.0 110.397 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 m -129.37 3.99 5.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -152.38 88.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.4 p -144.32 -169.46 3.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.04 48.4 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 77' ' ' PHE . . . -131.61 164.77 25.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 33.8 tttt -123.58 160.51 26.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.163 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.84 106.94 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 83' ' ' ILE . 26.7 m -109.69 143.71 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.613 HD12 HD22 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -83.8 114.8 21.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.783 ' CD2' ' HB1' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -50.13 -69.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.953 . . . . 0.0 110.172 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.448 ' HB3' ' HD2' ' A' ' 111' ' ' PRO . 9.5 m120 -147.19 166.91 14.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.495 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.6 Cg_endo -74.49 174.94 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.966 1.508 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.3 Cg_endo -72.86 52.81 2.23 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.921 1.485 . . . . 0.0 110.481 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -149.1 -36.86 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.07 -96.99 0.04 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.865 HG12 ' HB2' ' A' ' 131' ' ' SER . 4.7 m -62.67 136.65 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -1.139 . . . . 0.0 110.309 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.77 149.46 14.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -168.29 108.04 0.55 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 46.5 Cg_endo -73.15 -1.0 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 118' ' ' PRO . 1.2 m-85 61.31 24.83 14.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -126.88 -38.23 2.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.28 -176.01 3.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 122' ' ' SER . 1.8 t -87.6 22.67 2.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 0.0 110.166 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.32 62.34 5.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.73 -31.31 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.605 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 8.9 m-85 -56.4 -54.02 57.73 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.326 -1.103 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.6 Cg_endo -71.88 -43.39 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.867 1.456 . . . . 0.0 110.375 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.483 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 2.7 m -62.81 -35.73 80.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.58 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 25.6 ttp -52.51 -69.97 0.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.9 . . . . 0.0 109.92 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.632 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 30.7 t80 -62.93 -30.9 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.702 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -56.98 -35.91 69.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.977 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.865 ' HB2' HG12 ' A' ' 115' ' ' VAL . 5.6 m -87.29 -42.76 12.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.62 HD13 ' C ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -56.47 -27.25 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.805 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.899 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -102.06 -40.58 6.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.407 -0.808 . . . . 0.0 110.201 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -76.35 -4.91 44.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 131' ' ' SER . 6.0 mm-40 -126.19 18.82 7.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.503 ' HG3' ' O ' ' A' ' 136' ' ' MET . 1.8 tpt -96.17 7.97 45.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.349 -0.845 . . . . 0.0 110.245 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -86.59 -49.09 0.5 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.298 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.95 7.4 4.35 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.874 1.46 . . . . 0.0 110.591 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.603 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 5.6 t80 -107.96 -51.19 2.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.355 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 146' ' ' ILE . 4.2 tt -83.51 -15.04 50.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.339 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.942 HG23 ' OXT' ' A' ' 146' ' ' ILE . 24.7 m -82.8 -28.05 30.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -105.14 -25.48 12.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.286 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.603 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -52.74 -18.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 115.75 51.81 0.41 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 144' ' ' GLY . 11.9 mt -143.41 -52.78 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.942 ' OXT' HG23 ' A' ' 141' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.229 0.538 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.07 113.88 25.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -87.95 154.28 20.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.113 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.582 ' C ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -80.9 -55.42 4.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.545 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' CG ' ' C ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER 35.21 -155.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.729 . . . . 0.0 110.541 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.88 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . . . -166.12 156.53 12.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 0.0 109.958 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG1' ' HB2' ' A' ' 84' ' ' ALA . 89.0 t -120.92 103.51 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.908 . . . . 0.0 109.903 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.729 ' HB3' HG23 ' A' ' 83' ' ' ILE . 16.6 tp -59.48 94.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 110.026 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.491 ' CE2' ' SD ' ' A' ' 136' ' ' MET . 0.4 OUTLIER -78.31 103.89 8.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.93 . . . . 0.0 109.818 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.828 HG13 ' O ' ' A' ' 38' ' ' ALA . 61.3 t -124.67 161.75 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.445 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.73 ' CB ' HD22 ' A' ' 86' ' ' LEU . 39.3 t -165.14 64.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 6.9 mt 57.09 33.59 23.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 147.0 -32.34 1.42 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 65.3 7.62 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -1.138 . . . . 0.0 110.102 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.7 HD13 ' OG ' ' A' ' 48' ' ' SER . 44.6 mt -96.51 -5.51 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 110.353 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 35.6 m -144.43 -173.25 3.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.456 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.674 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.9 mmt85 64.49 -78.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.556 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 86' ' ' LEU . 9.1 m -129.83 55.66 19.87 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 110.699 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.6 Cg_endo -79.79 0.57 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.987 1.519 . . . . 0.0 110.004 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -96.0 6.8 48.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.425 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 9.1 p -58.78 -35.54 72.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.803 ' HB3' HG23 ' A' ' 64' ' ' ILE . 1.4 tp10 -65.43 -48.54 72.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.67 -0.644 . . . . 0.0 109.866 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.583 ' CA ' ' CG1' ' A' ' 62' ' ' VAL . . . -69.83 -57.8 6.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 132' ' ' ILE . 5.3 tp -47.44 -43.47 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -1.163 . . . . 0.0 109.922 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.616 ' HB2' HD13 ' A' ' 35' ' ' ILE . 7.3 t -65.33 -51.53 59.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.412 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 15.3 mmt-85 -52.62 -40.62 62.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.145 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -76.0 -30.51 58.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.48 -57.96 3.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.485 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.745 HG11 ' HB2' ' A' ' 32' ' ' LYS . 61.9 t -87.09 -18.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.552 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 104.4 -66.91 0.29 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 53.8 t0 -176.25 57.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -1.13 . . . . 0.0 110.111 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.858 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.79 -100.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 32' ' ' LYS . 21.3 mt -143.95 -125.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.851 HG23 ' C ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER 70.81 -17.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.987 -0.446 . . . . 0.0 111.102 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -136.83 144.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.808 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.726 ' HB3' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -155.35 94.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -63.82 125.92 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 110.116 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.828 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -149.76 170.43 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.552 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.801 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -138.72 145.37 40.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.053 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.583 ' HA ' HG22 ' A' ' 72' ' ' ILE . 8.2 t -118.67 -9.65 10.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.31 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 t -112.36 109.48 19.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -55.97 101.58 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 2.5 m-85 -162.12 160.43 27.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -1.169 . . . . 0.0 110.264 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER 63.19 25.21 14.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.6 t -85.25 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 37.68 6.37 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 48' ' ' SER . 2.7 pt20 179.59 -108.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -1.118 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.7 ' OG ' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 65.6 93.62 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.074 -1.016 . . . . 0.0 110.184 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 45.1 Cg_endo -69.11 -62.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.672 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 2.8 m-20 71.46 -5.95 1.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.241 -0.912 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -74.32 -27.54 60.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.177 -0.952 . . . . 0.0 108.975 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -52.85 12.52 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.336 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -61.57 -53.69 52.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 13.5 mm-40 -57.98 -42.46 85.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -51.85 -65.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.901 HG21 ' HA ' ' A' ' 125' ' ' PHE . 53.0 t -49.46 -35.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 109.113 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.526 ' SG ' ' CG1' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -57.27 -46.71 82.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.57 -0.706 . . . . 0.0 109.642 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -79.63 -17.86 52.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.509 ' HB2' ' CE ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -88.95 -12.25 42.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -116.37 -24.17 8.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.586 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.59 ' C ' HG23 ' A' ' 62' ' ' VAL . . . 117.21 62.34 0.31 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.59 HG23 ' C ' ' A' ' 61' ' ' GLY . 46.0 t -155.63 170.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' N ' HG12 ' A' ' 62' ' ' VAL . 58.6 t0 -157.02 121.21 4.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 110.267 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 22' ' ' GLU . 18.1 mt -108.82 170.62 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.147 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -106.39 -68.69 0.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -145.08 128.02 16.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 10.7 pt20 -142.26 98.43 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.217 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HA ' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -140.05 -162.69 1.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.174 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.87 123.65 50.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.229 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.78 33.02 1.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 60.02 158.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 76' ' ' ASP . 21.0 tt -138.87 152.5 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -112.57 -163.92 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 77' ' ' PHE . 4.1 mttp -69.7 -5.21 23.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.16 81.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.0 110.124 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.799 ' HB3' HD11 ' A' ' 72' ' ' ILE . 38.4 p-10 -47.84 -31.46 5.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 74' ' ' LYS . 13.1 m-85 -72.45 -25.74 61.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.0 p -127.29 41.86 3.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.202 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' CG ' ' CE2' ' A' ' 80' ' ' PHE . 37.8 tptt -123.19 -13.52 7.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.88 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 97.5 m-85 -151.74 -122.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 65.4 t0 -151.59 -40.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.045 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.76 HG11 ' HZ ' ' A' ' 139' ' ' PHE . 81.7 t -127.04 152.84 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.169 -0.957 . . . . 0.0 110.47 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 8' ' ' LEU . 1.7 mp -131.71 134.06 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 110.022 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -104.49 127.87 52.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.551 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.68 105.74 15.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.73 HD22 ' CB ' ' A' ' 11' ' ' CYS . 2.2 mp -50.36 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.505 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.422 ' C ' HD12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -81.5 -177.4 6.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.37 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -85.44 -40.8 16.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.37 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -41.67 -38.43 1.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.873 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.5 mp -69.62 -55.63 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.185 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.0 HD22 HD23 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -58.1 -28.74 64.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 t -78.39 -41.91 31.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 5.6 m-20 -80.92 -60.15 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.29 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 90' ' ' ILE . 4.7 tt -49.87 -25.3 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.301 -0.875 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 58.4 t-20 -90.37 -22.87 21.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.208 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -6.59 28.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.456 ' HE2' ' O ' ' A' ' 94' ' ' ILE . 6.2 mtm -108.81 -51.67 2.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.568 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -40.47 132.6 1.67 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.412 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 100' ' ' SER . 46.4 Cg_endo -73.51 0.66 7.79 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.06 1.558 . . . . 0.0 110.502 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER 68.02 19.22 9.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.131 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.12 67.76 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 95.4 m -132.21 -159.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.41 25.83 10.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.27 -175.46 3.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.89 . . . . 0.0 110.192 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.37 158.2 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.539 HG12 HD12 ' A' ' 91' ' ' LEU . 19.3 t -127.13 124.58 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.139 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -122.17 144.0 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.0 HD23 HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -77.11 133.81 38.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 110.173 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.605 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 1.9 m-85 -106.44 127.44 53.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.315 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 109' ' ' PHE . 0.2 OUTLIER 64.54 176.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -74.83 175.3 11.36 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 110.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.9 Cg_endo -72.26 53.86 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.051 1.553 . . . . 0.0 110.433 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.88 -38.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.03 145.12 11.19 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.557 HG11 ' CB ' ' A' ' 131' ' ' SER . 18.5 m -70.34 153.84 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -1.105 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.456 ' CB ' HG21 ' A' ' 127' ' ' THR . 42.9 t0 -42.09 134.58 2.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.369 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.8 p-10 -94.94 113.1 60.53 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.534 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 46.3 Cg_endo -73.7 58.31 3.91 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.936 1.492 . . . . 0.0 110.616 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 121' ' ' SER . 3.7 t80 -117.03 142.61 46.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.095 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.512 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 49.1 t80 61.0 -73.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.196 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 119' ' ' TYR . 2.2 m -89.89 118.33 29.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.84 89.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.77 9.64 1.55 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.258 -0.901 . . . . 0.0 110.183 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -118.88 -22.24 3.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.901 ' HA ' HG21 ' A' ' 56' ' ' VAL . 2.8 m-85 -34.1 -59.34 0.54 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.521 -0.988 . . . . 0.0 110.49 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.0 Cg_endo -72.12 -52.48 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.869 1.457 . . . . 0.0 110.318 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.456 HG21 ' CB ' ' A' ' 116' ' ' ASP . 8.8 m -58.18 -57.66 11.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.375 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.572 ' CE ' ' HB2' ' A' ' 20' ' ' ALA . 8.1 ttp -40.31 -48.85 2.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.612 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 48.7 t80 -70.17 -62.1 1.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 129' ' ' PHE . . . -43.05 -56.39 3.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.557 ' CB ' HG11 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -60.88 -45.07 96.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.926 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -46.76 -47.52 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.592 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 134' ' ' LYS . 0.4 OUTLIER -78.85 -59.26 2.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.297 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.498 ' N ' ' OG ' ' A' ' 133' ' ' SER . 3.2 mmtt -45.19 -29.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 131' ' ' SER . 27.0 mt-10 -74.97 -31.55 61.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.203 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.551 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 18.0 mtm -103.48 9.32 37.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 6.5 mtpt -82.28 -48.74 0.88 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 51.5 Cg_endo -81.11 -9.07 12.94 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.148 1.604 . . . . 0.0 110.402 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.76 ' HZ ' HG11 ' A' ' 82' ' ' VAL . 47.4 t80 -107.97 -77.96 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.061 ' CD1' HD22 ' A' ' 145' ' ' LEU . 13.8 tp -44.03 -24.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 11.8 m -87.07 -29.13 22.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 110.353 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 139' ' ' PHE . 4.7 mm-40 -105.2 -13.9 15.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.405 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.484 ' ND1' ' CZ ' ' A' ' 139' ' ' PHE . 4.3 t-160 -84.94 40.27 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.64 38.08 90.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.061 HD22 ' CD1' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.8 -31.08 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.106 . . . . 0.0 110.305 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 18.2 mm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.228 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.262 0.553 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.47 -54.19 46.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.174 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.2 158.22 29.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.078 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.406 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -79.68 -162.54 0.43 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.534 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 34' ' ' ILE . 18.5 mttt -148.44 -164.5 2.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.783 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -130.74 148.92 52.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.183 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 34' ' ' ILE . 5.5 m -147.06 136.87 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.945 -1.097 . . . . 0.0 110.226 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.9 OUTLIER -89.65 118.31 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 0.0 110.945 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.497 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m-85 -93.85 96.06 9.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.555 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.534 ' CG2' HD23 ' A' ' 8' ' ' LEU . 16.0 t -100.65 156.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.444 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.491 ' CB ' ' OG ' ' A' ' 18' ' ' SER . 47.8 t -150.0 -65.9 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.015 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 177.05 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.174 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 85.92 -4.75 85.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.963 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 8.7 t30 59.7 29.87 19.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -1.158 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.925 HD13 ' HB2' ' A' ' 48' ' ' SER . 26.9 mt -113.0 -20.4 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 110.376 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 18' ' ' SER . 9.6 p -131.59 132.77 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.859 ' CB ' HD23 ' A' ' 86' ' ' LEU . 3.7 mtm180 65.46 -59.56 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.196 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.632 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -44.83 -50.7 24.6 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.428 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.6 Cg_endo -72.13 -19.97 25.57 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.848 1.446 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.569 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -69.78 -23.56 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.98 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.996 ' HA ' HD11 ' A' ' 132' ' ' ILE . 21.4 m -67.39 -32.88 74.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.863 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.738 ' HA ' HD11 ' A' ' 35' ' ' ILE . 1.6 tt0 -57.77 -54.89 41.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.912 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.697 ' HA3' HG22 ' A' ' 62' ' ' VAL . . . -67.09 -45.95 77.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.873 HD12 ' CE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -54.66 -54.36 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -1.202 . . . . 0.0 110.191 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.702 ' N ' HG22 ' A' ' 24' ' ' ILE . 79.4 m -60.29 -50.8 72.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.036 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.51 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 25.5 mtt-85 -45.82 -52.63 10.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -20.0 60.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.57 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.07 -45.82 32.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.831 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.554 ' CG1' ' HB3' ' A' ' 32' ' ' LYS . 63.1 t -137.05 -12.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.034 . . . . 0.0 111.258 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 29' ' ' VAL . . . 59.31 122.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' GLY . 11.8 t0 40.42 77.36 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.187 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.74 ' HG3' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -131.05 11.19 5.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.547 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.8 mt 65.01 -63.05 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.285 -0.884 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.963 HD12 ' N ' ' A' ' 35' ' ' ILE . 2.5 pp -27.39 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.454 -0.779 . . . . 0.0 111.047 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.963 ' N ' HD12 ' A' ' 34' ' ' ILE . 7.8 tt -64.03 87.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 121.368 -0.832 . . . . 0.0 111.079 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 18.6 m-20 -126.83 66.82 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 109.692 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.28 150.07 18.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 110.397 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -163.9 -171.62 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.963 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -150.17 120.9 7.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.578 ' HA ' HG21 ' A' ' 72' ' ' ILE . 10.8 t -67.06 -39.45 86.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.519 ' N ' HG23 ' A' ' 40' ' ' THR . 3.3 t -127.87 133.02 49.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . -67.76 -79.9 0.23 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 66.05 -73.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.526 ' HB3' HD12 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -90.15 91.06 8.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 46' ' ' GLY . 50.4 t -130.29 173.28 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 110.137 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.566 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 57.97 18.35 33.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.632 ' O ' ' CB ' ' A' ' 48' ' ' SER . 3.1 pt20 -177.68 152.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -1.124 . . . . 0.0 110.168 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.925 ' HB2' HD13 ' A' ' 15' ' ' ILE . 2.2 t 159.12 105.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.263 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 47.4 Cg_endo -69.78 70.78 1.57 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.104 1.581 . . . . 0.0 110.28 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.5 p30 -83.92 16.32 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.9 m -75.53 -32.58 60.52 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.185 -0.947 . . . . 0.0 109.007 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.638 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -74.1 -55.74 5.74 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.294 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -58.67 -53.43 58.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.454 -0.778 . . . . 0.0 109.501 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.93 ' HG3' HD11 ' A' ' 64' ' ' ILE . 12.1 tt0 -57.51 -45.56 84.82 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.25 -0.906 . . . . 0.0 109.508 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.2 ttpp -50.83 -65.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.422 -0.799 . . . . 0.0 109.793 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.573 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 11.3 p -56.55 -34.0 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.633 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.711 ' CB ' HG21 ' A' ' 62' ' ' VAL . 1.3 m -56.66 -47.47 79.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.696 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -73.8 -30.46 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.361 -0.837 . . . . 0.0 109.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 m -77.96 -12.05 59.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.003 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -116.08 -27.01 7.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.855 . . . . 0.0 109.38 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.81 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 139.25 98.78 0.42 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 61' ' ' GLY . 13.0 t -162.63 168.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -1.065 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.51 ' HB3' ' CD ' ' A' ' 26' ' ' ARG . 12.5 t0 -153.37 67.17 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.93 HD11 ' HG3' ' A' ' 54' ' ' GLN . 11.8 pt -116.55 -173.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.187 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -153.68 88.74 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' N ' ' HD3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 58.19 153.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.359 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.427 ' NE2' HD12 ' A' ' 64' ' ' ILE . 3.0 pt20 -171.93 126.99 0.59 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.358 -0.839 . . . . 0.0 110.194 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 1.2 mtm105 -99.87 -89.15 0.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 68' ' ' ARG . . . 176.94 79.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 ttp-105 -76.6 141.2 41.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' HG3' ' N ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.62 151.88 44.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.162 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.578 HG21 ' HA ' ' A' ' 40' ' ' THR . 19.4 tt -90.8 172.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t -124.4 172.2 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -78.33 2.85 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.112 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.02 -13.28 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' CG ' ' CG1' ' A' ' 72' ' ' ILE . 2.9 m-20 -52.92 -42.11 65.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -45.13 -55.77 5.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 26.82 3.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.622 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -104.64 -11.14 17.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 110.237 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.622 ' CE1' ' CG ' ' A' ' 79' ' ' LYS . 77.9 m-85 -143.07 -137.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -128.2 -53.42 1.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.471 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 48.9 t -133.26 123.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.195 -0.941 . . . . 0.0 110.451 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.898 HG21 HD11 ' A' ' 94' ' ' ILE . 5.7 mt -90.63 105.74 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.9 143.58 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.429 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -103.49 147.91 26.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.859 HD23 ' CB ' ' A' ' 17' ' ' ARG . 2.8 tp -98.64 31.77 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.934 ' O ' HD21 ' A' ' 108' ' ' LEU . 0.4 OUTLIER 174.31 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 110.178 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -59.93 -43.57 94.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.243 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.589 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 1.9 mp -57.67 -63.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.153 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.4 OUTLIER -53.09 -37.14 61.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.151 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -70.83 -26.89 63.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.236 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -92.06 -61.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.255 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.898 HD11 HG21 ' A' ' 83' ' ' ILE . 5.6 tt -45.63 -39.89 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.503 ' N ' HG23 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -71.89 -15.18 62.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -76.37 -12.36 60.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.226 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.453 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 8.2 mtm -109.64 -52.04 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 5.6 mtpt -40.85 134.85 1.67 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 110.443 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.14 -169.59 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.069 1.562 . . . . 0.0 110.424 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.7 t -91.35 23.91 3.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 6.5 p-10 -176.79 123.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.4 p -143.59 -151.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -116.37 -18.63 10.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.104 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 -149.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -157.66 169.31 24.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.19 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.487 HG12 ' HB ' ' A' ' 83' ' ' ILE . 29.0 m -128.07 146.43 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 108' ' ' LEU . 78.6 t -144.01 170.19 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.94 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.934 HD21 ' O ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -109.52 121.91 46.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.181 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 132' ' ' ILE . 11.6 t80 -48.49 -51.52 26.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 111' ' ' PRO . 1.1 m-20 -176.52 -178.26 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 110' ' ' ASN . 46.7 Cg_endo -74.67 175.03 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.012 1.533 . . . . 0.0 110.302 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.2 52.94 2.41 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.959 1.505 . . . . 0.0 110.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -124.69 -27.3 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.75 -89.98 1.25 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 115' ' ' VAL . 19.5 m -75.9 103.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -1.156 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 15.6 p-10 -137.08 -156.63 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER 55.78 72.74 0.96 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 112.03 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.995 1.524 . . . . 0.0 110.508 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.499 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 12.4 m-85 50.48 -138.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 119' ' ' TYR . 27.5 p -168.79 -151.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 82.7 p -90.32 -138.56 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 122' ' ' SER . 2.3 t70 67.06 17.09 10.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.431 ' C ' ' HD2' ' A' ' 126' ' ' PRO . . . -144.29 -42.08 0.05 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.638 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 11.8 m-85 -42.08 -50.47 10.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.11 . . . . 0.0 110.473 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.6 Cg_endo -72.0 -56.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.619 1.326 . . . . 0.0 110.247 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -55.75 -43.66 76.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 110.006 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.724 ' O ' HG22 ' A' ' 132' ' ' ILE . 14.0 ttp -50.69 -75.71 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.873 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.6 t80 -46.67 -55.6 7.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.236 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -52.7 -22.56 5.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.4 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 128' ' ' MET . 3.2 m -90.12 -55.82 3.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.412 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.996 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -60.09 -15.33 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 0.0 109.028 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.731 ' HB2' HD11 ' A' ' 24' ' ' ILE . 2.0 t -101.93 -49.96 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 110.139 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -59.23 -30.85 68.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.108 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' OE2' ' ND2' ' A' ' 110' ' ' ASN . 6.1 mt-10 -102.75 22.37 13.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.647 ' HE1' ' HB3' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -89.61 1.36 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.25 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 77.0 mttt -91.88 -42.13 0.37 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 111.353 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.2 Cg_endo -76.41 4.79 5.16 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.403 1.212 . . . . 0.0 110.733 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.647 ' HB3' ' HE1' ' A' ' 136' ' ' MET . 39.2 t80 -108.08 -71.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -58.98 -55.0 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.116 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 137' ' ' LYS . 16.2 m -61.04 -12.87 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 144' ' ' GLY . 27.8 mt-10 -105.06 -55.33 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.542 ' NE2' HG21 ' A' ' 107' ' ' VAL . 3.1 t-80 -42.34 -26.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 130.84 46.62 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 15.0 mt -144.66 -98.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -1.186 . . . . 0.0 110.27 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.437 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 2.9 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.206 0.527 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 54.73 68.05 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.148 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.441 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 4.8 mm-40 -99.98 166.17 11.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.13 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -82.38 156.02 24.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 178.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 34' ' ' ILE . 26.7 mttt -139.37 -165.79 1.93 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.989 -1.07 . . . . 0.0 110.867 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.855 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.19 156.79 29.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 110.516 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.802 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 40.0 t -141.95 113.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.668 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.951 HD13 ' CE2' ' A' ' 80' ' ' PHE . 26.2 tp -82.64 81.45 8.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 111.02 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.994 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 16.6 m-85 -55.84 126.39 25.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.086 -1.009 . . . . 0.0 109.367 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.948 HG22 ' O ' ' A' ' 38' ' ' ALA . 73.8 t -142.03 161.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 110.767 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.672 ' SG ' HD23 ' A' ' 86' ' ' LEU . 1.1 t -153.36 -58.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.413 -0.805 . . . . 0.0 110.191 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.584 ' CB ' ' NH1' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 169.84 150.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.463 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 64.48 10.14 41.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 72.8 -53.19 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.297 -1.119 . . . . 0.0 109.823 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' CYS . 8.9 mt -41.2 -33.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 3.3 t 68.25 105.44 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.584 ' NH1' ' CB ' ' A' ' 12' ' ' LEU . 18.3 mtt85 -52.67 -18.52 1.83 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.046 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.493 ' HB3' HD21 ' A' ' 86' ' ' LEU . 60.3 p -112.8 67.71 1.0 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 17' ' ' ARG . 45.6 Cg_endo -72.59 -12.33 26.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.902 1.475 . . . . 0.0 110.082 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.707 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -76.97 4.89 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 23.2 p -69.77 -37.62 76.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.785 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -68.98 -43.06 75.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.917 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -70.55 -51.78 19.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.821 HD12 ' CE1' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -55.62 -46.93 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -1.153 . . . . 0.0 110.274 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.657 ' O ' HG22 ' A' ' 29' ' ' VAL . 78.4 m -71.87 -48.59 44.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.115 -0.99 . . . . 0.0 110.053 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.529 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 10.1 mmt180 -49.35 -45.35 45.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.28 -24.09 32.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.259 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.558 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -73.88 -22.71 59.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.605 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 25' ' ' CYS . 4.7 m -142.14 -33.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.978 -1.076 . . . . 0.0 110.713 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 38.47 44.91 1.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 54.4 t0 -178.55 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.961 -1.317 . . . . 0.0 110.853 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' C ' ' HG ' ' A' ' 33' ' ' LEU . 12.3 mmtm -141.73 -143.34 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.4 mt -147.77 -34.53 0.24 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.416 -0.802 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.1 pp -30.05 -31.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.824 -0.548 . . . . 0.0 111.829 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.666 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.5 mp -62.47 87.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.998 -1.064 . . . . 0.0 110.939 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -130.39 162.47 29.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.96 . . . . 0.0 109.064 178.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.5 m -141.9 139.98 32.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.96 -1.088 . . . . 0.0 110.668 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.948 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -167.78 -176.24 3.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.354 -0.842 . . . . 0.0 110.33 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . . . 174.84 164.07 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 40' ' ' THR . 13.7 t -94.12 71.67 3.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.42 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.39 76.68 0.57 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.67 -57.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -1.141 . . . . 0.0 110.296 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -87.59 93.26 9.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 69' ' ' ALA . 34.9 t -125.95 -3.76 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.243 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.27 41.74 2.08 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 48' ' ' SER . 6.6 pt20 -161.78 -109.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 4.4 t 64.84 70.78 0.59 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.053 -1.03 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.38 66.05 1.56 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.459 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 4.2 p-10 -89.19 31.48 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.524 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -76.0 -34.19 59.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.898 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 6.9 mmt85 -70.76 -47.79 57.77 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -56.69 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.533 -0.729 . . . . 0.0 109.349 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.718 ' HB3' HD13 ' A' ' 64' ' ' ILE . 5.2 pp0? -56.97 -35.29 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.125 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.4 -65.92 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 109.13 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.604 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 41.4 t -49.69 -36.22 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.28 -0.887 . . . . 0.0 108.83 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -53.86 -52.76 59.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 62' ' ' VAL . 11.3 ttpt -71.13 -21.23 62.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.472 ' OG ' ' CE ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -86.6 -8.73 57.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.947 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -112.25 -17.74 12.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.865 . . . . 0.0 108.84 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 122.14 44.21 0.37 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 61' ' ' GLY . 54.3 t -158.37 144.87 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -1.087 . . . . 0.0 110.22 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.62 135.63 40.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.718 HD13 ' HB3' ' A' ' 54' ' ' GLN . 29.2 pt -92.76 -171.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 110.117 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -129.95 -51.46 1.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 110.194 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.52 149.03 3.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -111.91 99.48 8.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 111.9 24.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -93.91 102.5 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.199 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -122.79 158.14 30.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.92 143.81 57.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 72' ' ' ILE . 10.7 tt -84.61 87.94 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 74' ' ' LYS . 25.5 m -58.9 169.59 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 73' ' ' THR . 2.1 mtpp -65.73 -9.09 24.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.02 59.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 110.26 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' CG ' HG13 ' A' ' 72' ' ' ILE . 31.5 m-20 -49.69 -30.04 8.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -57.49 -41.27 80.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 110.17 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.98 -33.97 10.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER -44.35 -31.23 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.331 -0.856 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.951 ' CE2' HD13 ' A' ' 8' ' ' LEU . 11.9 m-85 -130.94 152.34 50.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.465 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.595 ' H ' ' HB3' ' A' ' 6' ' ' ALA . 3.9 m-20 -68.52 -47.07 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.442 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' A' ' 139' ' ' PHE . 53.9 t -130.85 156.68 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.937 HD13 HG12 ' A' ' 106' ' ' VAL . 1.6 mp -118.33 139.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.283 -0.886 . . . . 0.0 109.877 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.994 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -100.28 116.88 33.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.904 . . . . 0.0 110.385 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.68 ' O ' HD12 ' A' ' 108' ' ' LEU . . . -109.82 99.56 8.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 109.919 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.672 HD23 ' SG ' ' A' ' 11' ' ' CYS . 1.1 mp -60.78 -61.77 2.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.541 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.524 ' CB ' ' CD1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.54 171.79 11.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' SER . 21.0 mt-30 -83.59 -40.69 18.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -42.64 -37.86 1.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.557 HD11 ' O ' ' A' ' 11' ' ' CYS . 1.4 mp -71.97 -54.52 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.96 -19.58 62.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 0.0 110.349 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -86.61 -58.38 2.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.285 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.245 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.586 HG23 ' N ' ' A' ' 95' ' ' ASN . 2.5 tt -43.48 -43.28 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.586 ' N ' HG23 ' A' ' 94' ' ' ILE . 1.1 t-20 -60.89 -31.78 71.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' ASP . 19.5 t -64.36 -12.34 41.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.53 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.9 ptt? -123.17 -18.35 6.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.562 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -55.09 154.3 10.61 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.52 ' HD3' ' CD2' ' A' ' 77' ' ' PHE . 47.9 Cg_endo -73.36 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -125.42 101.13 6.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 100' ' ' SER . 3.8 m-20 64.06 110.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.257 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.0 m -150.23 -164.41 2.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.87 . . . . 0.0 110.209 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.83 32.55 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 77' ' ' PHE . . . -160.68 -177.09 5.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.231 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 16.4 pttm -176.53 158.23 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.937 HG12 HD13 ' A' ' 83' ' ' ILE . 3.6 m -111.59 151.33 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 m -138.87 147.43 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.197 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' O ' ' A' ' 85' ' ' ALA . 21.6 tp -81.6 126.05 31.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.223 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -93.46 89.76 6.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 0.0 110.211 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 56.52 162.77 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 45.8 Cg_endo -74.0 174.93 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.096 1.577 . . . . 0.0 110.275 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.7 Cg_endo -73.25 51.48 2.11 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.954 1.502 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 114' ' ' GLY . 19.2 m-20 -122.32 -63.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 127' ' ' THR . . . -44.25 -73.03 0.28 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.534 HG21 ' HG ' ' A' ' 86' ' ' LEU . 18.1 m -70.41 123.7 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.33 158.55 27.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.933 . . . . 0.0 110.256 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.574 ' HB2' ' CE2' ' A' ' 119' ' ' TYR . 8.2 p-10 -73.22 123.78 89.88 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -73.06 -89.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.008 1.53 . . . . 0.0 110.621 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 117' ' ' ASP . 12.3 m-30 58.21 -142.68 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.537 ' O ' ' CB ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -69.44 149.6 48.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.413 -0.805 . . . . 0.0 109.994 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER 71.56 3.89 4.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.38 -0.825 . . . . 0.0 110.166 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.537 ' HG ' ' HE2' ' A' ' 125' ' ' PHE . 73.7 m 42.19 -94.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.177 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' SER . 0.5 OUTLIER 44.98 49.06 9.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -175.39 -41.05 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.65 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 23.5 m-85 -41.58 -49.61 9.67 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.13 . . . . 0.0 110.527 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.33 -59.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.585 1.308 . . . . 0.0 110.194 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 114' ' ' GLY . 64.9 m -53.16 -48.17 68.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.646 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.707 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 7.9 ttp -50.02 -58.92 4.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.376 -0.827 . . . . 0.0 109.968 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.821 ' CE1' HD12 ' A' ' 24' ' ' ILE . 88.3 t80 -50.56 -50.54 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.0 -56.19 11.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 m -57.9 -46.5 84.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -45.38 -56.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.655 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -60.65 -45.88 92.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.54 ' O ' ' CD ' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -65.21 -13.04 57.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 14.8 mt-10 -90.0 -37.32 14.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.503 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -90.99 -3.69 57.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.931 . . . . 0.0 110.355 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 3.1 mttt -83.48 -50.2 0.68 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -0.961 . . . . 0.0 110.026 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 51.0 Cg_endo -80.08 -13.14 12.84 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.097 1.577 . . . . 0.0 110.414 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' A' ' 82' ' ' VAL . 5.3 t80 -103.72 -48.74 3.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -73.31 1.1 10.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.287 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 142' ' ' GLU . 21.0 m -104.22 -57.05 2.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 111.004 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' GLY . 7.3 mt-10 -105.2 -45.13 4.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.11 -0.994 . . . . 0.0 111.224 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -37.24 -29.65 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.211 -0.931 . . . . 0.0 110.434 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.863 ' O ' HD22 ' A' ' 145' ' ' LEU . . . 132.03 76.58 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -159.16 -38.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -1.218 . . . . 0.0 110.182 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.474 HD11 HD23 ' A' ' 140' ' ' LEU . 22.3 mt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.249 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.243 0.544 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 58.24 86.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -101.91 153.08 20.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 110.313 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.757 ' HG2' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -72.21 -161.35 0.08 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 108.701 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 1.027 ' C ' HG22 ' A' ' 34' ' ' ILE . 23.6 mtmt -157.32 -159.68 0.87 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.921 -1.112 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.0 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -142.41 123.23 14.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 111.251 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.963 HG11 ' CZ ' ' A' ' 9' ' ' PHE . 5.6 t -115.72 131.69 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.548 -0.72 . . . . 0.0 109.463 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 4.1 tp -90.66 92.1 8.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.916 . . . . 0.0 110.806 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.963 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 18.3 m-85 -82.99 106.85 15.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.014 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 14.0 p -125.47 173.87 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.528 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.751 ' O ' HD12 ' A' ' 90' ' ' ILE . 26.5 p -163.41 -38.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.616 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 168.76 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.123 -0.986 . . . . 0.0 110.295 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.742 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -91.03 -9.98 63.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 3.3 t-20 68.63 33.21 3.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -1.172 . . . . 0.0 110.224 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 16' ' ' CYS . 84.6 mt -108.74 -91.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.514 ' N ' HG22 ' A' ' 15' ' ' ILE . 5.8 t -95.74 64.53 2.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.882 . . . . 0.0 110.113 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.55 ' CB ' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER 171.6 52.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.064 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER 172.39 -55.37 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.3 Cg_endo -71.79 -13.65 29.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.9 1.474 . . . . 0.0 110.383 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -65.64 -12.6 54.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 17.4 m -72.39 -29.32 63.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.48 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HA ' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -70.34 -43.09 70.97 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.776 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -71.07 -45.57 49.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.744 HG21 HG23 ' A' ' 132' ' ' ILE . 6.1 tp -64.96 -43.19 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -1.167 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.606 ' N ' HG23 ' A' ' 24' ' ' ILE . 55.9 m -65.12 -49.86 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.319 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.516 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.9 ptm180 -68.15 -26.19 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.309 -0.87 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 1.3 m-20 -85.81 -25.56 26.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.042 -1.036 . . . . 0.0 110.277 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 3.0 tmm? -92.4 -21.91 19.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.564 HG11 ' HG2' ' A' ' 32' ' ' LYS . 57.6 t -127.72 -12.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.197 -0.939 . . . . 0.0 110.617 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.43 -22.13 36.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -149.48 -87.05 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.39 -1.065 . . . . 0.0 110.235 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HG2' HG11 ' A' ' 29' ' ' VAL . 0.1 OUTLIER 58.16 122.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.277 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.757 HD13 ' HG2' ' A' ' 4' ' ' LYS . 6.0 mp -98.12 -114.81 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.027 HG22 ' C ' ' A' ' 5' ' ' LYS . 0.8 OUTLIER 32.49 33.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 0.0 111.338 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.7 mt -104.49 95.12 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.963 -1.085 . . . . 0.0 110.602 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' OD2' ' CE2' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -126.37 99.96 6.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 9.7 p -79.12 130.58 35.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.213 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.014 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -122.33 -173.06 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.32 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 38' ' ' ALA . . . 171.16 109.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -69.41 -12.1 61.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -124.0 93.93 4.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.15 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.58 87.06 0.67 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -141.1 22.24 2.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -1.111 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.424 ' HA ' ' CD ' ' A' ' 47' ' ' GLN . 85.5 m-70 -141.16 40.4 1.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.94 . . . . 0.0 110.147 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.654 HG22 ' HB3' ' A' ' 69' ' ' ALA . 11.1 t -90.63 169.29 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.214 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.408 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 48.31 37.84 18.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.471 ' HG3' ' N ' ' A' ' 48' ' ' SER . 3.2 pt20 -169.52 -148.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.471 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 60.88 131.98 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.189 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.42 70.6 1.39 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.63 13.18 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.26 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.04 -33.53 59.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.87 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -73.68 -44.73 55.82 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.388 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.548 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 3.4 t -63.57 -48.94 75.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.519 -0.738 . . . . 0.0 109.618 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 16.3 tp60 -62.74 -42.91 99.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.26 -69.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.571 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 52' ' ' ARG . 27.6 m -49.9 -32.97 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.141 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.811 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -55.51 -54.16 47.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.8 . . . . 0.0 109.487 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -29.95 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.6 t -77.78 -12.16 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.0 m-20 -113.68 -33.44 5.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 142.19 62.99 0.03 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.811 HG11 ' SG ' ' A' ' 57' ' ' CYS . 54.7 t -158.77 59.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -1.106 . . . . 0.0 110.107 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 0.2 OUTLIER -73.16 130.99 41.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.9 pt -145.38 -172.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.151 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -103.12 -61.96 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.062 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 65' ' ' SER . 12.3 mmmt -150.12 -178.4 6.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.079 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 67' ' ' GLN . 12.2 mm-40 -135.57 95.66 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.196 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -108.41 75.97 1.01 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 13' ' ' GLY . . . -44.17 106.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 110.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.491 ' HG2' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -101.94 159.23 15.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.122 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 60.8 tt0 -71.93 156.46 39.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.501 HG12 ' OD2' ' A' ' 76' ' ' ASP . 12.5 tt -79.92 159.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.446 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.8 p -119.68 176.13 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -19.7 61.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' A' ' 79' ' ' LYS . . . -64.7 -36.65 84.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.231 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.6 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 39.2 m-20 -47.53 -36.49 10.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.136 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.592 ' CD2' ' HG2' ' A' ' 98' ' ' LYS . 20.8 m-85 -94.55 16.34 15.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.137 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.18 11.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.619 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -137.11 -149.51 0.32 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.112 -0.992 . . . . 0.0 109.682 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER 36.67 -149.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.443 -0.786 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -140.06 -34.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.604 HG11 ' HZ ' ' A' ' 139' ' ' PHE . 15.8 t -139.75 149.59 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 110.714 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 8' ' ' LEU . 16.7 mt -121.76 126.61 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.828 . . . . 0.0 109.859 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 109' ' ' PHE . . . -120.26 135.09 55.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 90' ' ' ILE . . . -108.43 160.38 15.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.59 HD21 HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -105.06 2.7 29.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.965 . . . . 0.0 110.244 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 90' ' ' ILE . 22.9 t70 -137.85 174.14 10.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -89.66 -66.71 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.086 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -47.16 -40.69 16.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 11' ' ' CYS . 6.3 tt -52.35 -39.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.043 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.533 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.7 OUTLIER -81.58 -34.79 30.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.077 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -20.07 63.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -103.14 -44.64 5.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.537 HG13 ' CE ' ' A' ' 97' ' ' MET . 2.7 tt -48.15 -36.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.468 ' N ' HG23 ' A' ' 94' ' ' ILE . 38.4 p30 -69.98 -11.47 60.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 9.5 t -75.41 -26.86 58.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.537 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.3 ptt? -96.34 -34.99 11.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -45.22 145.58 1.78 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.26 -174.35 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.989 1.52 . . . . 0.0 110.34 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.63 -4.1 11.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.963 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.88 48.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.5 p -124.84 -161.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -132.52 -142.16 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.262 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 103' ' ' ARG . . . 56.86 -159.27 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 106' ' ' VAL . 7.9 tttt -173.41 148.11 1.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 0.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 106' ' ' VAL . 4.0 m -101.01 133.64 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.05 161.4 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.459 HD21 ' OD1' ' A' ' 110' ' ' ASN . 8.5 tp -83.51 149.21 26.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.727 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -136.3 85.71 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.236 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.459 ' OD1' HD21 ' A' ' 108' ' ' LEU . 2.0 p-10 -177.39 146.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.58 174.78 12.04 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.004 1.528 . . . . 0.0 110.373 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.1 Cg_endo -72.84 52.77 2.22 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.437 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.98 -50.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.96 91.86 1.41 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.844 HG13 ' HA ' ' A' ' 128' ' ' MET . 99.0 t -56.24 114.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.9 t70 57.63 168.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.948 . . . . 0.0 110.178 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.535 ' N ' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 171.61 -56.83 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.331 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 117' ' ' ASP . 46.1 Cg_endo -72.72 -37.69 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.995 1.524 . . . . 0.0 110.542 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 57.89 179.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.6 t80 60.32 25.75 15.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.234 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 t -163.89 -164.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.22 18.31 22.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.962 . . . . 0.0 110.21 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -90.53 34.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.189 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -147.23 -45.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.785 ' HB3' HG21 ' A' ' 56' ' ' VAL . 4.4 m-30 -50.42 -46.32 84.37 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.29 -1.124 . . . . 0.0 110.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 48.5 Cg_endo -74.65 -51.4 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.716 1.377 . . . . 0.0 110.171 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' MET . 3.3 m -58.99 -55.56 33.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.844 ' HA ' HG13 ' A' ' 115' ' ' VAL . 10.2 ttp -44.9 -40.58 6.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.367 -0.833 . . . . 0.0 110.084 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.528 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 37.1 t80 -70.35 -62.01 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.995 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.72 -47.27 15.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.92 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.792 ' CB ' HG22 ' A' ' 115' ' ' VAL . 71.6 m -70.88 -42.19 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.981 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.744 HG23 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -50.72 -43.11 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.941 . . . . 0.0 109.851 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.579 ' HA ' ' HE3' ' A' ' 136' ' ' MET . 1.1 t -85.29 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.516 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.95 -18.31 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.49 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 39.1 tp10 -98.28 -18.29 18.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.579 ' HE3' ' HA ' ' A' ' 133' ' ' SER . 3.9 ttp -101.45 -0.53 35.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 110.2 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -82.51 -48.29 0.87 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.933 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.3 -11.5 14.56 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.055 1.555 . . . . 0.0 110.326 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.604 ' HZ ' HG11 ' A' ' 82' ' ' VAL . 68.4 t80 -101.92 -61.98 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 146' ' ' ILE . 6.5 tp -52.73 -25.43 11.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.592 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 23.3 m -76.99 -40.91 45.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 110.373 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.3 -66.42 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.659 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.579 ' O ' ' CZ ' ' A' ' 139' ' ' PHE . 12.7 t-80 -96.89 60.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -0.933 . . . . 0.0 110.733 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 145' ' ' LEU . . . -176.16 -34.05 0.04 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER 172.06 -91.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.499 -1.001 . . . . 0.0 109.912 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.592 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.139 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.245 0.545 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.45 97.98 5.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.14 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -149.98 -154.06 0.53 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.248 -0.907 . . . . 0.0 110.339 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.917 ' HE2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -155.81 -48.1 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 110.684 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.952 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.2 mttt 68.83 -154.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 110.913 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.892 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -159.56 135.42 8.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.316 0.579 . . . . 0.0 109.977 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.887 HG12 HG11 ' A' ' 82' ' ' VAL . 3.5 m -104.07 115.43 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.503 -0.748 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.848 HD12 ' HB3' ' A' ' 36' ' ' ASP . 14.9 tp -66.37 89.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 110.089 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.585 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -78.64 101.45 7.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.045 HG22 ' HB3' ' A' ' 38' ' ' ALA . 15.2 t -116.9 157.05 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.759 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 11.9 t -145.85 -78.87 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -175.38 69.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.341 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.64 ' HA3' ' CE1' ' A' ' 44' ' ' HIS . . . 137.74 -21.85 3.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 4.8 t-20 71.15 1.45 3.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -1.132 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.571 HG13 ' CD2' ' A' ' 44' ' ' HIS . 18.5 mm -89.59 -36.79 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.932 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 29.5 p -137.63 167.18 22.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.927 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.546 ' CG ' HD23 ' A' ' 86' ' ' LEU . 51.2 mtm180 56.22 43.04 27.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -0.968 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -173.31 -60.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 45.0 Cg_endo -71.78 -10.86 27.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.888 1.468 . . . . 0.0 110.33 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.751 ' HB3' HD12 ' A' ' 132' ' ' ILE . . . -75.72 -16.79 60.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.047 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 37.0 t -66.45 -55.42 15.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.799 ' HG3' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -43.37 -36.69 1.99 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 109.346 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -71.88 -50.26 19.5 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.987 HD11 ' OG ' ' A' ' 133' ' ' SER . 2.4 tp -55.86 -45.17 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.747 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.95 ' CB ' HD11 ' A' ' 35' ' ' ILE . 54.3 m -72.16 -30.47 65.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.562 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 0.1 OUTLIER -66.91 -37.1 83.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.895 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' HB2' ' HA ' ' A' ' 62' ' ' VAL . 22.1 t70 -82.81 -34.99 26.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 110.107 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.837 ' O ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -78.72 -28.16 45.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 110.406 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.837 HG13 ' O ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -163.7 41.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.79 94.51 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' VAL . 3.8 t0 170.5 -25.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 110.128 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.76 -138.94 0.31 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 110.022 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -152.88 -83.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.892 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 37.01 26.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.42 -0.8 . . . . 0.0 110.92 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.95 HD11 ' CB ' ' A' ' 25' ' ' CYS . 7.4 mt -131.55 132.64 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.158 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.848 ' HB3' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -145.03 90.05 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 179.235 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -67.19 124.68 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.045 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -141.45 176.03 9.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.701 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -159.61 -162.53 1.04 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.152 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -177.59 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -165.26 110.51 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 108.34 2.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.35 -41.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.64 ' CE1' ' HA3' ' A' ' 13' ' ' GLY . 24.5 p-80 -155.79 81.5 1.02 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 t -118.79 -20.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 110.303 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.15 31.7 8.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.502 ' HG3' ' N ' ' A' ' 48' ' ' SER . 17.7 pt20 -164.5 -140.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -1.116 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.502 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.61 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.174 -0.954 . . . . 0.0 110.15 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.9 Cg_endo -69.34 107.48 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.012 1.533 . . . . 0.0 110.538 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -94.26 21.31 7.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 3.7 m -71.08 -27.9 63.96 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.189 -0.944 . . . . 0.0 108.748 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -74.38 -43.45 56.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.214 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -54.92 28.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.483 -0.76 . . . . 0.0 109.6 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 20.0 mt-30 -61.58 -40.31 94.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.261 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.602 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.09 -71.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.832 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 52' ' ' ARG . 14.9 p -50.03 -34.28 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.494 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 64' ' ' ILE . 1.3 m -55.45 -53.71 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.507 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -69.43 -24.35 63.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.862 . . . . 0.0 109.566 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -82.58 -11.72 58.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.813 . . . . 0.0 109.993 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -111.45 -31.72 6.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 0.0 109.182 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 130.03 73.63 0.13 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 129' ' ' PHE . 2.2 p 173.34 137.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.289 -1.124 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -119.41 137.2 53.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.203 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.76 HD11 ' SG ' ' A' ' 57' ' ' CYS . 34.1 mt -120.58 -34.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.202 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER 53.66 97.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 65' ' ' SER . 3.6 mmmt 60.05 145.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.271 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.417 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 5.4 mm-40 -107.53 -52.58 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 67.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.94 . . . . 0.0 110.159 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -57.28 152.53 13.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 mtp-105 -137.1 -163.75 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 110.271 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -132.43 128.01 36.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 72' ' ' ILE . 11.9 tt -50.32 159.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.178 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 50.9 p -126.97 169.93 12.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -1.92 20.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.206 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.14 -8.64 21.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.543 ' HB2' HD22 ' A' ' 8' ' ' LEU . 20.5 p-10 -47.21 -37.25 10.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 39.5 m-85 -69.41 -17.04 63.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 m -123.06 13.44 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.203 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 3.5 tptt -94.82 -23.7 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.708 ' CD1' ' HB3' ' A' ' 6' ' ' ALA . 93.8 m-85 -147.35 -140.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.869 . . . . 0.0 109.983 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 4.0 m-20 -137.06 -23.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.054 -1.028 . . . . 0.0 111.029 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.887 HG11 HG12 ' A' ' 7' ' ' VAL . 39.1 t -113.42 138.76 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 0.0 110.509 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.652 HD12 ' CB ' ' A' ' 104' ' ' ALA . 47.4 mt -146.3 133.89 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.433 -0.792 . . . . 0.0 109.777 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -162.03 163.09 28.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.661 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.5 ' HB1' HD13 ' A' ' 90' ' ' ILE . . . -126.5 159.87 32.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.824 ' HG ' HG21 ' A' ' 115' ' ' VAL . 1.3 tp -85.64 -37.36 19.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -101.74 -176.26 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.194 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.8 mm-40 -92.45 -39.0 11.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 88' ' ' GLN . 15.6 m -42.75 -41.0 3.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.605 HD12 ' H ' ' A' ' 90' ' ' ILE . 2.1 mp -65.46 -40.08 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.91 . . . . 0.0 110.099 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.617 HD13 ' HB2' ' A' ' 108' ' ' LEU . 2.0 tp -67.64 -32.4 73.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.6 t -79.99 -30.62 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.246 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 96' ' ' SER . 1.8 m-20 -87.83 -54.58 4.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.256 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.633 HG13 ' HE1' ' A' ' 97' ' ' MET . 3.9 tt -46.69 -40.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.63 -8.81 56.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 2.7 m -96.78 -0.93 47.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.151 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.633 ' HE1' HG13 ' A' ' 94' ' ' ILE . 1.7 ptt? -122.56 -10.0 8.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 8.4 mtpt -63.59 143.75 97.88 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.411 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 45.9 Cg_endo -73.14 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.028 1.541 . . . . 0.0 110.419 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.4 m -105.61 28.38 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.416 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.1 p-10 -178.51 126.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 110.24 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 101' ' ' ASN . 83.5 m -149.56 -161.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.01 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.652 ' CB ' HD12 ' A' ' 83' ' ' ILE . . . -105.82 -152.07 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -148.75 111.15 4.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.167 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 71.1 t -87.39 125.46 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 110.088 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ALA . 3.6 t -135.11 159.07 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.617 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -119.19 108.17 14.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -55.27 -170.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.26 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.549 HD21 ' N ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -42.57 166.04 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.197 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.503 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.9 Cg_endo -74.64 175.02 11.66 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.912 1.48 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.5 Cg_endo -71.74 54.45 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.996 1.524 . . . . 0.0 110.38 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.67 -29.95 4.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.876 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -107.45 -92.45 2.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.824 HG21 ' HG ' ' A' ' 86' ' ' LEU . 29.0 m -41.12 128.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 110.168 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -157.78 -65.7 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.42 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 0.5 OUTLIER 61.53 82.76 0.22 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.12 176.64 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.006 1.53 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 119' ' ' TYR . 67.7 m-85 -118.95 24.15 10.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -130.17 -34.68 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 110.335 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -145.62 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 110.246 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 p -153.97 54.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.137 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' A' ' 127' ' ' THR . 4.0 p30 -124.41 -6.14 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.265 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 117' ' ' ASP . . . -93.85 -22.37 25.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.619 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 13.5 m-85 -55.03 -49.81 90.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.331 -1.099 . . . . 0.0 110.365 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -73.34 -35.67 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.84 1.442 . . . . 0.0 110.385 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 123' ' ' ASP . 2.5 m -63.06 -51.96 64.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 20' ' ' ALA . 3.1 ttp -44.52 -55.42 5.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 11.1 t80 -68.23 -33.59 74.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.182 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.754 ' CB ' HG13 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -86.89 -43.45 12.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.057 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -57.85 -23.21 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -0.761 . . . . 0.0 109.472 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.987 ' OG ' HD11 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.32 -42.81 6.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.987 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 14.3 mttp -75.41 -5.69 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 131' ' ' SER . 70.3 mm-40 -129.2 34.34 4.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.15 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.55 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -116.21 -12.18 11.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.1 mttp -81.53 -47.4 1.06 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.44 0.33 10.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.99 1.521 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 62.8 t80 -108.06 -77.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.098 HD12 HD13 ' A' ' 145' ' ' LEU . 8.5 tp -51.16 -24.46 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.345 -0.847 . . . . 0.0 110.438 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.842 HG23 HD13 ' A' ' 146' ' ' ILE . 32.2 m -82.01 -30.61 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -105.22 -14.06 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.453 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.687 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 6.9 m80 -84.71 39.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.101 -0.999 . . . . 0.0 110.302 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.7 60.86 6.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.098 HD13 HD12 ' A' ' 140' ' ' LEU . 1.1 mt -163.67 34.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 110.021 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.842 HD13 HG23 ' A' ' 141' ' ' THR . 2.0 tp . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.229 0.538 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.79 138.35 32.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.69 149.46 28.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.271 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.514 ' HG3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.15 149.96 26.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.254 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.682 ' H ' HG22 ' A' ' 34' ' ' ILE . 23.1 mtpp -130.23 -155.62 0.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 110.982 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.077 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -147.23 117.2 7.22 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.546 0.689 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.893 ' HB ' HD12 ' A' ' 34' ' ' ILE . 21.9 t -108.2 126.62 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.578 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 38' ' ' ALA . 6.8 tp -98.13 80.95 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 0.0 110.752 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.949 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 69.5 m-85 -62.2 133.65 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.054 HG13 HD11 ' A' ' 90' ' ' ILE . 8.6 p -156.45 166.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.616 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.668 ' CA ' HD12 ' A' ' 90' ' ' ILE . 1.1 p -146.78 -98.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 109.904 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.58 86.7 2.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.101 -1.0 . . . . 0.0 110.185 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.581 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 85.37 -11.53 60.87 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 t30 74.75 -164.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -1.123 . . . . 0.0 109.782 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 15' ' ' ILE . 11.7 mm 58.12 13.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 2.0 t -174.89 175.33 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.955 . . . . 0.0 110.207 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.738 ' CB ' HD22 ' A' ' 86' ' ' LEU . 1.1 mtp180 70.72 -56.24 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.351 -0.843 . . . . 0.0 110.013 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.751 ' CB ' HD21 ' A' ' 86' ' ' LEU . 3.2 m -175.44 55.62 0.14 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.484 ' HD3' ' C ' ' A' ' 16' ' ' CYS . 50.0 Cg_endo -76.39 -1.14 11.15 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.971 1.511 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.926 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -100.12 7.01 44.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.348 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.677 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -59.73 -37.83 80.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.125 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -50.42 66.96 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.68 -0.638 . . . . 0.0 109.726 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.667 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -62.97 -58.27 12.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.983 HG21 HG23 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -55.13 -29.33 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -1.205 . . . . 0.0 109.91 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.3 m -69.09 -60.7 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.253 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 23' ' ' GLY . 11.6 ptm180 -61.1 -28.73 69.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.513 ' CB ' ' HA ' ' A' ' 62' ' ' VAL . 11.4 t70 -81.17 -53.06 6.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -55.58 -38.73 69.75 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.312 -0.867 . . . . 0.0 110.278 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 25' ' ' CYS . 4.4 m -84.54 -38.56 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.226 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.49 ' N ' HG23 ' A' ' 29' ' ' VAL . . . 106.0 -64.29 0.29 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.03 50.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -1.147 . . . . 0.0 110.251 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.778 ' C ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -95.48 -132.82 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 35' ' ' ILE . 4.9 mp -149.57 -120.63 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.383 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.077 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.0 29.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.812 . . . . 0.0 111.609 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.827 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -96.24 97.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.888 -1.133 . . . . 0.0 110.147 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.641 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 6.3 m-20 -135.76 144.27 45.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.5 p -137.56 151.34 48.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.432 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.786 ' O ' HG23 ' A' ' 10' ' ' VAL . . . -146.22 -172.9 4.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 110.361 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG23 ' A' ' 10' ' ' VAL . . . -169.4 100.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 41' ' ' SER . 25.8 p -54.48 -68.17 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 0.0 110.274 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.506 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.2 OUTLIER -64.71 -177.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.54 36.86 0.58 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -78.96 -31.64 45.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -1.147 . . . . 0.0 110.187 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.432 ' ND1' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -116.62 70.74 0.77 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -138.28 142.6 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 86.32 25.98 34.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 48' ' ' SER . 13.0 pt20 -176.96 -141.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -1.131 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 0.9 OUTLIER 59.03 108.31 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.62 100.37 0.8 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.012 1.532 . . . . 0.0 110.471 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.505 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 22.3 m-20 -87.33 27.12 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.231 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -75.02 -27.55 60.14 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.186 -0.946 . . . . 0.0 109.137 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.782 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -74.2 -51.77 14.47 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.442 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.404 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -63.01 -46.74 86.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 109.655 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 1.8 tt0 -62.76 -42.47 99.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.169 -0.957 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 3.5 ttpp -57.76 -67.13 0.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.704 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 52' ' ' ARG . 4.8 p -50.86 -33.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.237 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.679 ' CB ' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.37 -55.6 31.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.463 -0.773 . . . . 0.0 109.504 179.424 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -29.89 71.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 5.7 t -78.24 -14.46 59.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -111.7 -35.13 5.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.2 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.563 ' C ' HG12 ' A' ' 62' ' ' VAL . . . 127.58 84.81 0.48 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.926 HG23 ' N ' ' A' ' 24' ' ' ILE . 1.5 p 169.26 80.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.369 -1.077 . . . . 0.0 110.041 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -59.96 157.53 12.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.352 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.47 HG12 ' HA3' ' A' ' 23' ' ' GLY . 39.3 mt -148.81 -64.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.097 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER 66.54 96.78 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.47 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.56 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.286 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.422 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 21.4 mm100 -105.48 -145.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.7 70.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . . . -93.75 139.12 31.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -171.42 175.36 4.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -75.96 106.49 7.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.757 HD12 ' HB1' ' A' ' 38' ' ' ALA . 19.8 tt -46.23 157.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.41 159.9 37.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -55.38 -19.3 8.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.14 -12.89 44.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.98 -15.79 61.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.607 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 17.1 m-30 -81.73 -8.04 59.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.223 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.7 p -117.73 -48.98 2.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.582 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -51.37 -27.09 8.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.18 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.678 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 9.3 m-85 -134.1 157.09 47.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.252 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -104.25 -8.17 19.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.27 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.51 ' CG1' ' CE1' ' A' ' 143' ' ' HIS . 6.0 t -138.95 141.86 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.233 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.51 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 51.9 mt -123.84 143.36 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.949 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -114.64 120.51 40.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.851 ' HB1' HG23 ' A' ' 90' ' ' ILE . . . -111.22 113.62 26.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 18' ' ' SER . 2.2 mp -51.18 -83.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.492 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t0 -71.96 -179.43 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.241 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -84.41 -45.29 12.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 1.5 t -45.21 -51.14 11.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.956 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.054 HD11 HG13 ' A' ' 10' ' ' VAL . 6.8 tt -52.95 -47.16 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.363 -0.835 . . . . 0.0 110.086 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -58.16 -53.21 60.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -55.28 -54.87 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.845 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' SER . 29.1 m-20 -47.67 -60.32 2.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 110.147 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.667 HG23 ' CE ' ' A' ' 97' ' ' MET . 15.0 mt -58.74 -47.05 90.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -67.02 -16.13 64.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.557 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -80.82 -28.89 36.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.667 ' CE ' HG23 ' A' ' 94' ' ' ILE . 10.2 ptt? -97.07 -30.25 13.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.118 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -41.76 144.59 0.79 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 110.446 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.527 ' HD2' ' CE ' ' A' ' 98' ' ' LYS . 44.1 Cg_endo -71.37 177.39 6.74 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.13 1.595 . . . . 0.0 110.387 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.413 ' C ' ' OD1' ' A' ' 101' ' ' ASN . 0.9 OUTLIER -98.2 21.2 11.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 7.4 m120 -143.87 -137.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.102 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.31 -176.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 110.067 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.476 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -131.55 35.37 3.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.28 -171.52 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 146.04 11.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.483 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 37.8 t -112.17 127.0 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 108' ' ' LEU . 1.2 p -122.4 171.42 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.553 ' N ' HG22 ' A' ' 107' ' ' VAL . 6.0 tp -99.74 150.31 22.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.828 . . . . 0.0 110.138 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 135' ' ' GLU . 25.3 t80 -124.96 97.58 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 109' ' ' PHE . 18.8 t-20 60.14 144.9 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.561 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.3 Cg_endo -74.51 176.97 9.0 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.529 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.1 Cg_endo -72.18 3.05 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.027 1.54 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.47 -37.81 15.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 110.123 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 115' ' ' VAL . . . -78.49 -76.41 0.93 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 29.9 m -59.27 -150.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -1.1 . . . . 0.0 110.118 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 6.0 t0 63.77 135.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.442 ' OD1' ' SG ' ' A' ' 16' ' ' CYS . 1.2 p30 -170.23 157.63 5.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.963 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 -27.74 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.036 1.545 . . . . 0.0 110.448 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 56.3 34.92 24.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -110.41 -32.97 6.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 m -122.22 -86.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.5 ' O ' ' CD ' ' A' ' 126' ' ' PRO . 89.9 p -155.0 19.05 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.11 4.6 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 110.18 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -105.8 -45.99 1.24 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 12.8 m-85 -50.01 -45.69 81.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 110.566 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.736 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 45.9 Cg_endo -73.68 -51.02 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.573 1.302 . . . . 0.0 110.287 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 128' ' ' MET . 66.0 p -69.11 -56.59 7.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.23 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.63 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 8.8 ttp -41.33 -68.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 87.5 t80 -59.22 -44.04 92.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.119 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -44.56 -64.16 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.972 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -63.4 -45.3 91.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 109.953 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.983 HG23 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -40.7 -56.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.856 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.585 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -74.38 -47.36 34.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.225 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 3.8 tppt? -47.94 -22.79 0.64 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.578 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -125.57 31.34 5.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.986 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.533 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -115.21 -22.08 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.156 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 3.9 mttp -87.92 -52.36 0.39 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.72 5.64 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.521 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 41.3 t80 -93.82 -76.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.753 HD13 HD23 ' A' ' 145' ' ' LEU . 3.5 pp -65.66 -30.8 71.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.514 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.627 ' N ' HD12 ' A' ' 140' ' ' LEU . 22.3 m -56.06 -33.53 65.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 110.251 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.09 -34.87 7.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.16 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.534 ' NE2' HG11 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -44.33 -27.85 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 110.107 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.534 ' O ' ' HD2' ' A' ' 5' ' ' LYS . . . 127.08 67.8 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.753 HD23 HD13 ' A' ' 140' ' ' LEU . 26.5 tp -156.36 -54.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 0.0 110.227 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.764 ' C ' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.174 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.261 0.553 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.35 -40.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 110.215 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.59 158.27 30.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.22 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.555 ' HG2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.84 -164.74 0.54 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.401 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.914 ' C ' HG22 ' A' ' 34' ' ' ILE . 24.7 mttm -156.02 -160.86 1.05 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 110.77 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.009 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -144.59 122.81 12.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.442 -0.787 . . . . 0.0 111.056 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.921 HG11 ' CZ ' ' A' ' 9' ' ' PHE . 43.5 t -113.21 128.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 109.669 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 80' ' ' PHE . 13.2 tp -86.93 85.87 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.485 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.921 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 34.0 m-85 -76.24 100.43 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.948 HG13 HD11 ' A' ' 90' ' ' ILE . 1.5 p -120.54 168.96 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.573 ' O ' HD12 ' A' ' 12' ' ' LEU . 19.4 t -154.14 -53.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.058 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER 176.58 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.501 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -104.31 -15.85 20.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.925 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 6.6 t-20 67.96 38.7 2.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -1.198 . . . . 0.0 110.205 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.653 HD13 ' CB ' ' A' ' 48' ' ' SER . 17.9 mt -114.76 -2.52 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 110.076 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 m -137.2 45.45 2.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 110.13 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HD3' HD22 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -146.7 -57.35 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 110.176 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.539 ' CB ' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -45.21 -56.57 9.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.139 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.83 ' HB3' HD12 ' A' ' 64' ' ' ILE . 46.9 Cg_endo -74.88 -0.96 10.55 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.928 1.488 . . . . 0.0 110.295 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.735 ' HB1' HG13 ' A' ' 132' ' ' ILE . . . -103.66 -44.98 4.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 110.213 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.562 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 60.9 m -74.21 -38.62 63.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.066 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.62 ' HG3' HG21 ' A' ' 35' ' ' ILE . 2.5 tt0 -69.68 -45.68 67.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 110.242 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.842 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -71.23 -46.65 41.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.628 HG12 HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -61.29 -43.8 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.14 . . . . 0.0 110.355 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.577 ' N ' HG23 ' A' ' 24' ' ' ILE . 58.3 m -69.71 -40.02 76.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 1.8 mmt-85 -67.5 -32.87 73.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.417 ' OD2' ' HA3' ' A' ' 61' ' ' GLY . 1.2 t70 -85.19 -48.69 8.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.039 . . . . 0.0 110.622 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -74.83 -21.58 59.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.745 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.784 HG11 ' HG3' ' A' ' 32' ' ' LYS . 2.3 t -119.98 -24.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.783 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 106.28 -60.97 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 13.7 t70 -178.27 94.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 110.215 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.796 ' C ' HD12 ' A' ' 33' ' ' LEU . 12.5 mmtm -119.86 -130.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.105 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.796 HD12 ' C ' ' A' ' 32' ' ' LYS . 5.2 mp -149.81 -118.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 110.643 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.009 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.17 29.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.459 -0.775 . . . . 0.0 111.496 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.784 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.1 mt -104.26 90.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.007 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 55.1 m-20 -121.79 97.49 5.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.68 134.72 36.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.832 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -137.04 168.35 19.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.487 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.925 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -140.38 142.83 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 110.08 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.911 HG21 HG13 ' A' ' 90' ' ' ILE . 11.8 p -103.7 41.57 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 40' ' ' THR . 2.4 p 170.16 103.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.86 58.05 0.99 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -88.59 -62.06 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -1.158 . . . . 0.0 110.189 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 102.4 9.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.288 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 69' ' ' ALA . 73.6 t -142.07 139.53 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.227 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.07 60.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 48' ' ' SER . 5.3 pt20 -123.52 -140.39 0.31 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 110.243 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.653 ' CB ' HD13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 66.21 126.36 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.36 90.36 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.349 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 2.5 t0 -99.26 24.03 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.259 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -76.47 -30.43 57.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.219 -0.925 . . . . 0.0 109.197 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.9 OUTLIER -74.16 -48.95 25.88 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.444 -0.785 . . . . 0.0 109.29 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.38 71.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 109.483 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 2.6 tt0 -61.1 -42.13 97.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.267 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -54.74 -66.05 0.47 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.363 -0.836 . . . . 0.0 109.304 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.592 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.6 t -50.28 -35.06 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.939 . . . . 0.0 108.983 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.729 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -54.87 -51.11 66.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 109.427 179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -69.52 -28.55 66.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.719 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.3 -11.14 59.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -112.44 -26.49 8.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 131.17 80.18 0.2 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.842 HG13 ' HA3' ' A' ' 23' ' ' GLY . 66.5 t -158.89 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -1.108 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 32.1 p-10 -97.97 104.66 16.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 19' ' ' PRO . 13.6 pt -143.24 -171.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.36 125.97 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.061 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' OE1' ' HD3' ' A' ' 19' ' ' PRO . 33.9 mm-40 -84.38 96.07 8.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.345 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -89.66 74.41 7.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.118 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.868 ' HB3' HG13 ' A' ' 45' ' ' VAL . . . -41.9 126.63 3.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.9 tmm_? -106.06 151.45 24.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -90.62 144.14 26.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.903 . . . . 0.0 110.241 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 39' ' ' ALA . 16.5 tt -82.69 170.45 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 110.121 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.51 161.07 41.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -59.42 -14.84 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' O ' ' CE ' ' A' ' 79' ' ' LYS . . . -80.48 -12.02 59.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.165 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -47.96 -21.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.366 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.536 ' CD1' ' HE3' ' A' ' 98' ' ' LYS . 18.9 m-85 -76.92 52.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.113 -0.992 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.516 ' C ' ' CD ' ' A' ' 79' ' ' LYS . 1.1 p 175.02 31.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.344 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' CD ' ' C ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -135.74 -35.69 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.284 -0.885 . . . . 0.0 110.034 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.764 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 9.5 m-85 -123.32 156.46 35.27 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.549 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 1.3 m-20 -71.64 -36.63 70.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 50.4 t -140.8 156.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.039 . . . . 0.0 110.69 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 8' ' ' LEU . 9.5 mt -118.45 133.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.494 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -107.24 134.63 50.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 110.443 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.55 125.68 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.648 HD22 ' HD3' ' A' ' 17' ' ' ARG . 2.7 mp -78.99 -78.47 0.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 5.6 m-20 -56.91 178.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.473 ' HG3' ' HD3' ' A' ' 112' ' ' PRO . 8.4 mm-40 -89.11 -55.15 3.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.2 m -45.62 -48.93 14.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.948 HD11 HG13 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -46.26 -49.69 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.71 HD13 ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -63.54 -49.62 72.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.835 179.65 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.0 t -60.88 -17.26 49.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.846 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -87.32 -67.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 90' ' ' ILE . 6.6 mt -44.75 -54.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.549 -0.72 . . . . 0.0 109.871 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -14.9 19.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.697 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -81.7 -34.99 30.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 21.1 ptt? -96.53 -27.85 14.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE3' ' CD1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -40.71 139.32 1.17 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.66 -163.98 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.087 1.572 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -110.87 20.98 16.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.282 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -169.98 121.33 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.2 p -172.59 170.54 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 41.59 1.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -162.27 131.61 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.13 173.59 6.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 0.0 110.136 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.442 ' CG2' ' HD2' ' A' ' 98' ' ' LYS . 64.5 t -118.95 142.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -134.61 161.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.231 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.71 ' HG ' HD13 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -103.91 105.51 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.144 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.563 ' CZ ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -54.57 -57.18 12.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 18.7 p30 -162.11 164.11 17.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -73.96 175.21 11.14 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.133 1.596 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.0 Cg_endo -72.41 52.45 1.98 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.941 1.495 . . . . 0.0 110.422 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.41 -7.15 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.95 -91.18 1.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.949 HG22 ' HA ' ' A' ' 128' ' ' MET . 14.3 t -85.86 136.85 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.071 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.432 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 35.1 t70 -167.79 33.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.545 ' N ' ' CD ' ' A' ' 118' ' ' PRO . 55.8 m-20 43.76 49.39 5.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 117' ' ' ASP . 46.0 Cg_endo -72.72 139.9 31.52 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.02 1.537 . . . . 0.0 110.499 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.431 ' CE2' ' O ' ' A' ' 117' ' ' ASP . 49.5 m-85 -132.93 44.8 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.113 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -107.35 -35.98 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.139 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.7 m -159.16 -147.35 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.526 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 28.8 m -60.85 -25.74 66.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 123' ' ' ASP . 10.9 p30 -46.59 123.03 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.265 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 132.99 -27.0 3.51 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -98.42 -45.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.264 -1.139 . . . . 0.0 110.764 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 125' ' ' PHE . 48.4 Cg_endo -82.6 -73.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.586 1.308 . . . . 0.0 110.643 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 126' ' ' PRO . 1.1 t -42.95 -33.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.949 ' HA ' HG22 ' A' ' 115' ' ' VAL . 4.0 tmm? -62.05 -69.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 24' ' ' ILE . 5.8 t80 -49.22 -50.21 39.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.976 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -50.87 -47.56 60.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.427 ' CB ' HG23 ' A' ' 115' ' ' VAL . 38.5 t -64.78 -46.96 79.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.797 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.735 HG13 ' HB1' ' A' ' 20' ' ' ALA . 15.2 mm -47.51 -55.97 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 0.1 OUTLIER -63.89 -47.85 78.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.821 . . . . 0.0 110.146 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -52.99 -25.88 13.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.897 . . . . 0.0 110.145 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.563 ' O ' ' CZ ' ' A' ' 109' ' ' PHE . 80.6 mm-40 -116.88 14.94 15.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.564 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.79 -22.14 7.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.8 mtpm? -84.52 -47.9 0.67 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.1 Cg_endo -78.36 -4.59 14.36 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.013 1.533 . . . . 0.0 110.344 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 139' ' ' PHE . 4.6 t80 -108.03 -48.87 3.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.46 -9.58 19.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.228 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 4.3 m -73.8 -72.1 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.423 ' N ' HG22 ' A' ' 141' ' ' THR . 2.2 mt-10 -105.16 -5.66 20.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.68 22.86 15.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.163 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.835 ' C ' HD12 ' A' ' 145' ' ' LEU . . . -173.14 -54.64 0.05 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.835 HD12 ' C ' ' A' ' 144' ' ' GLY . 5.4 mp -149.77 -88.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -1.124 . . . . 0.0 110.126 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 1.7 tp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.149 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.287 0.565 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 56.2 165.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -99.88 171.52 7.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.254 -0.904 . . . . 0.0 110.085 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -85.63 156.72 20.58 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.734 ' H ' HG22 ' A' ' 34' ' ' ILE . 3.2 mtpt -133.53 -163.99 1.43 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.022 -1.049 . . . . 0.0 111.029 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.074 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -148.86 116.45 6.23 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.864 ' HB ' HD12 ' A' ' 34' ' ' ILE . 3.3 t -104.13 125.54 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.703 . . . . 0.0 109.159 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.739 HD13 ' CD2' ' A' ' 80' ' ' PHE . 13.5 tp -89.92 84.7 6.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 110.697 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.587 ' CG ' ' SG ' ' A' ' 21' ' ' CYS . 26.0 m-85 -67.27 108.72 2.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -0.95 . . . . 0.0 109.469 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.981 HG13 ' HA ' ' A' ' 39' ' ' ALA . 20.0 t -126.38 154.81 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.563 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 1.8 p -145.16 -108.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.854 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.617 HD23 ' OD2' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -118.51 82.24 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 0.0 110.104 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 77.37 0.39 71.83 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.5 t30 71.97 -158.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -1.087 . . . . 0.0 109.899 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 15' ' ' ILE . 8.4 mm 58.06 12.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.237 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 177.19 176.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.117 -0.99 . . . . 0.0 110.504 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.715 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER 71.72 -60.0 0.53 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.775 . . . . 0.0 110.237 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.606 ' OG ' HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -139.73 48.07 1.46 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.9 Cg_endo -77.82 -10.64 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.924 1.486 . . . . 0.0 110.054 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -97.5 6.99 47.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 110.43 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.803 ' SG ' HD12 ' A' ' 132' ' ' ILE . 1.4 m -62.78 -45.14 94.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.07 -1.019 . . . . 0.0 109.352 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.547 ' HG2' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.83 -47.4 85.88 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.55 -0.719 . . . . 0.0 109.88 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.841 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -68.49 -59.52 6.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.109 HD12 ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -43.0 -46.91 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -1.19 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.755 ' HB2' HD11 ' A' ' 35' ' ' ILE . 78.1 m -69.36 -37.44 77.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 13.6 mmt180 -62.04 -45.18 94.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.337 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 -45.79 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.69 ' O ' HG13 ' A' ' 29' ' ' VAL . 6.0 mmt -63.24 -41.32 99.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 28' ' ' MET . 3.5 m -158.77 36.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.405 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 25' ' ' CYS . . . -49.87 -22.67 4.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.82 -20.79 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.356 -1.085 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.658 ' HE2' HD11 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -104.77 -139.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.931 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.8 mt -147.77 -95.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.228 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.074 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 32.39 33.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 0.0 111.568 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 25' ' ' CYS . 3.5 mt -110.69 94.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.892 -1.13 . . . . 0.0 110.487 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.691 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 42.3 m-20 -126.05 104.48 8.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 m -95.15 130.94 41.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.772 ' C ' HG22 ' A' ' 10' ' ' VAL . . . -157.29 -172.79 4.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.482 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.981 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -164.06 146.55 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.125 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 40' ' ' THR . 14.0 t -93.87 64.74 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.177 -0.952 . . . . 0.0 110.256 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.508 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . 12.5 t -149.17 -75.66 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.242 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . 74.59 106.32 0.09 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 1.2 m-85 -170.04 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -1.146 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -123.98 23.88 8.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.229 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m -65.03 -9.19 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 110.403 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . -104.48 41.12 2.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' O ' ' CB ' ' A' ' 48' ' ' SER . 6.9 pt20 -177.92 -142.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.119 . . . . 0.0 110.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 67.45 98.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.56 83.53 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.004 1.529 . . . . 0.0 110.427 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -89.09 32.3 0.83 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -29.4 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 108.923 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' C ' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.72 -52.46 13.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.74 . . . . 0.0 109.306 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.625 ' N ' ' CZ ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -61.25 -48.22 82.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.622 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -61.27 -43.71 98.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.136 -0.978 . . . . 0.0 109.256 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 1.3 tptt -54.25 -65.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.393 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.859 HG11 ' HD2' ' A' ' 125' ' ' PHE . 24.3 m -53.75 -32.24 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.227 -0.921 . . . . 0.0 109.03 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.791 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -54.98 -55.63 28.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.429 -0.795 . . . . 0.0 109.29 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -33.31 75.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -11.21 60.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -0.836 . . . . 0.0 109.971 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.4 m-80 -113.32 -32.07 6.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 145.12 55.01 0.02 OUTLIER Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.841 HG13 ' HA3' ' A' ' 23' ' ' GLY . 53.8 t -158.66 89.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.135 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.29 103.55 16.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.436 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 41.2 pt -138.12 -161.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.29 133.89 0.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.237 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt 52.12 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' ARG . 6.0 mm-40 -44.72 -39.83 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 48.23 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . . . -102.18 155.63 18.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -152.73 158.39 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -79.77 124.63 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.2 tt -72.78 96.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.173 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -155.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.176 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.19 -7.24 59.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.79 -18.05 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.27 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 8.4 p-10 -61.01 -15.47 32.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.647 ' HE1' HD11 ' A' ' 94' ' ' ILE . 14.1 m-85 -82.81 2.04 36.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.152 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -47.88 -31.42 5.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.267 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.739 ' CD2' HD13 ' A' ' 8' ' ' LEU . 11.3 m-85 -134.94 156.07 49.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.33 -10.6 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.432 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.65 ' CG1' HG22 ' A' ' 7' ' ' VAL . 99.5 t -132.55 140.99 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.928 . . . . 0.0 110.387 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.447 ' HB ' HG12 ' A' ' 106' ' ' VAL . 53.1 mt -128.07 130.86 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -111.37 137.42 49.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.938 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.52 137.92 51.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.715 HD23 ' HB3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -96.69 -34.36 11.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.096 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.617 ' OD2' HD23 ' A' ' 12' ' ' LEU . 1.1 m-20 -111.57 -170.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 110.17 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -97.27 -36.9 10.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 p -43.96 -36.37 2.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.138 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.639 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.6 mp -73.12 -63.98 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.478 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -53.88 -17.61 2.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.252 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -95.61 -32.81 12.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.395 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -95.82 -56.9 2.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.712 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -47.29 -34.35 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.172 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 42.8 m-20 -78.48 -7.85 57.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.251 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -83.13 -18.54 39.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.913 . . . . 0.0 110.189 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.556 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 2.9 ptt? -102.16 -36.34 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -56.0 136.62 73.47 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.16 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.19 -90.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.981 1.516 . . . . 0.0 110.503 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 102' ' ' CYS . 26.3 m -153.12 -101.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 110.107 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.4 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 100' ' ' SER . 0.2 OUTLIER -90.57 -169.95 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.75 29.41 4.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.82 154.33 1.89 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -121.25 150.45 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.447 HG12 ' HB ' ' A' ' 83' ' ' ILE . 12.8 m -105.54 145.39 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.15 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.468 HG21 ' CE1' ' A' ' 139' ' ' PHE . 11.1 m -135.34 142.35 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.478 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -85.94 128.18 34.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.137 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -85.33 -36.04 21.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.161 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.474 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 6.8 p30 175.76 166.3 0.4 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.9 Cg_endo -74.5 174.86 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.013 1.533 . . . . 0.0 110.188 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.09 53.07 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.964 1.507 . . . . 0.0 110.437 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -143.04 -41.92 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.55 -74.06 0.68 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 115' ' ' VAL . 31.2 m -56.26 116.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.7 t70 -81.46 146.55 30.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.43 ' OD2' ' CZ ' ' A' ' 17' ' ' ARG . 19.4 m-20 -111.52 81.91 3.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -73.34 116.51 4.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.955 1.503 . . . . 0.0 110.459 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -111.96 -38.2 4.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.46 56.0 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.097 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.93 139.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.1 m -47.91 -29.1 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.257 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.27 121.94 11.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 114.73 -57.36 0.47 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.859 ' HD2' HG11 ' A' ' 56' ' ' VAL . 6.3 m-30 -34.49 -53.82 0.96 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.645 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.15 -59.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.651 1.343 . . . . 0.0 110.322 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 116' ' ' ASP . 97.1 m -53.37 -48.74 68.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.588 ' HE1' ' HG2' ' A' ' 19' ' ' PRO . 4.8 ttp -48.85 -69.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.817 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 1.109 ' CE1' HD12 ' A' ' 24' ' ' ILE . 9.0 t80 -43.81 -54.56 5.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.796 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 134' ' ' LYS . . . -51.85 -39.67 59.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.682 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.532 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 74.9 m -66.38 -57.75 6.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.803 HD12 ' SG ' ' A' ' 21' ' ' CYS . 12.0 mm -44.26 -47.97 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 2.5 t -71.22 -61.28 1.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 110.62 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -44.72 -23.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -112.43 14.92 20.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.973 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.541 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.7 -22.75 7.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -82.35 -47.06 0.94 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.111 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.5 Cg_endo -78.15 -8.77 16.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.862 1.454 . . . . 0.0 110.285 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.67 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 71.6 t80 -103.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.283 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.053 HD12 HD13 ' A' ' 145' ' ' LEU . 3.2 tp -52.74 -24.56 8.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 80.0 m -88.19 -27.89 21.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.445 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.22 -12.41 16.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.154 -0.966 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.67 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 3.5 t60 -84.59 39.69 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.21 45.69 87.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.053 HD13 HD12 ' A' ' 140' ' ' LEU . 1.4 mt -133.95 -58.53 0.85 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -1.133 . . . . 0.0 110.415 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.2 mp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.149 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.261 0.553 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.96 152.94 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 110.211 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.62 143.84 45.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.392 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.588 ' CG ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.8 156.89 24.68 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.685 ' H ' HG22 ' A' ' 34' ' ' ILE . 41.1 mtpt -127.03 -161.25 1.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.981 -1.075 . . . . 0.0 111.158 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.072 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.26 122.79 11.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.481 0.658 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' A' ' 34' ' ' ILE . 24.2 t -113.03 121.89 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.791 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.839 ' CG ' ' HB2' ' A' ' 38' ' ' ALA . 13.0 tp -94.85 81.45 3.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.405 -0.809 . . . . 0.0 110.398 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 7.5 p90 -74.36 140.41 44.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.151 -0.968 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.821 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 1.4 p -170.94 171.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 110.366 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.912 ' O ' HD12 ' A' ' 90' ' ' ILE . 46.9 t -140.74 -57.95 0.52 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.517 ' HA ' HD23 ' A' ' 12' ' ' LEU . 13.4 mt -155.56 -44.5 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.16 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -125.73 -3.95 6.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.997 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.6 t-20 64.67 30.21 12.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -1.148 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 70.8 mt -98.75 -35.8 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' SD ' ' A' ' 128' ' ' MET . 0.9 OUTLIER -104.57 18.68 21.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 1.023 ' HG2' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -135.86 -32.02 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -0.95 . . . . 0.0 110.311 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.542 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -62.15 -58.0 20.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 46.5 Cg_endo -73.08 -5.39 17.11 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.945 1.497 . . . . 0.0 110.456 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -107.03 -40.83 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.873 ' HA ' HD11 ' A' ' 132' ' ' ILE . 65.8 m -72.66 -36.88 68.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER -66.04 -45.15 82.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 110.075 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.546 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -70.78 -50.54 24.01 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.057 HD11 ' HB2' ' A' ' 133' ' ' SER . 0.3 OUTLIER -54.49 -44.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -1.213 . . . . 0.0 110.2 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.913 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.4 m -67.43 -52.55 38.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.21 -27.43 61.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.295 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -87.76 -30.08 20.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.379 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -78.81 -24.28 44.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.387 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.913 HG22 ' O ' ' A' ' 25' ' ' CYS . 19.5 m -119.32 -25.6 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 112.34 -63.16 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 18.9 p30 -179.76 70.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.809 ' O ' HD23 ' A' ' 33' ' ' LEU . 7.9 mmtt -102.76 -135.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 110.116 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 35' ' ' ILE . 32.7 mt -128.09 -119.31 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -0.974 . . . . 0.0 110.328 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.072 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 34.8 30.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 111.198 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -103.09 103.53 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.062 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.749 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 49.1 m-20 -136.71 132.63 35.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.147 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -108.48 144.89 35.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.839 ' HB2' ' CG ' ' A' ' 8' ' ' LEU . . . -134.07 179.06 6.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.36 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.997 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -172.53 89.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.195 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 40' ' ' THR . 3.5 m -85.72 83.08 7.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.231 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER 172.07 -53.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.236 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 56.97 104.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -145.91 -44.96 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.157 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.49 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 34.1 m-70 -124.23 27.44 7.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.454 ' H ' HG13 ' A' ' 45' ' ' VAL . 3.1 m -62.91 144.65 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.208 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 71.41 29.03 68.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 44' ' ' HIS . 3.8 pt20 -177.39 -139.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -1.122 . . . . 0.0 110.08 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 68.01 119.5 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.185 -0.947 . . . . 0.0 110.229 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.547 ' HD2' ' CE1' ' A' ' 119' ' ' TYR . 47.0 Cg_endo -69.37 73.56 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.056 1.556 . . . . 0.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.4 t0 -94.2 33.74 1.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.107 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -71.72 -24.21 61.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.226 -0.921 . . . . 0.0 108.977 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -72.05 -52.19 18.1 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.269 179.362 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.527 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -62.59 -50.17 72.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -0.772 . . . . 0.0 109.639 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 6.8 mm-40 -58.93 -43.97 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.553 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.5 ttpp -56.6 -68.65 0.2 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.658 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.553 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 19.5 m -48.35 -33.85 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.811 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.17 -52.13 66.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.17 -13.9 60.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.738 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -92.75 -12.29 31.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 110.117 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -117.15 -30.58 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.673 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 137.44 84.36 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.811 HG11 ' SG ' ' A' ' 57' ' ' CYS . 41.9 t -158.65 120.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -1.137 . . . . 0.0 110.126 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 64' ' ' ILE . 3.0 m-20 -90.17 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.954 . . . . 0.0 110.114 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 63' ' ' ASP . 12.0 pt -158.71 143.56 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 12.2 p -168.17 31.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 65' ' ' SER . 65.6 mmtt -149.2 -73.66 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.171 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 1.7 mp0 60.26 105.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 57.32 1.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -45.12 134.56 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.801 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 1.7 ptt-85 -166.22 156.97 12.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 2.3 pt20 -79.15 135.07 36.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.459 HG13 ' OD2' ' A' ' 76' ' ' ASP . 19.7 tt -60.66 154.67 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -120.57 -65.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.164 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.63 -34.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.174 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.29 -15.49 16.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.459 ' OD2' HG13 ' A' ' 72' ' ' ILE . 5.4 m-20 -60.7 -23.19 64.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 22.3 m-85 -88.47 10.72 19.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -130.23 -62.44 0.94 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.551 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -45.52 -24.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 7.4 m-85 -131.3 154.28 48.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -104.14 -20.82 13.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 69.2 t -122.05 137.77 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.852 ' O ' HG22 ' A' ' 107' ' ' VAL . 3.3 mt -124.62 138.76 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.102 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' PHE . . . -121.6 126.09 48.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -108.66 152.29 25.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.023 HD22 ' HG2' ' A' ' 17' ' ' ARG . 1.4 tp -95.51 -43.58 7.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' HG22 ' A' ' 90' ' ' ILE . 27.0 t0 -103.94 168.72 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.298 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -81.0 -47.3 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.913 . . . . 0.0 110.215 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.2 t -43.29 -59.49 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.912 HD12 ' O ' ' A' ' 11' ' ' CYS . 8.9 tt -46.66 -35.49 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -72.07 -45.59 60.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.196 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 t -62.25 -30.5 71.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 97' ' ' MET . 72.1 m-20 -88.76 -53.68 4.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.485 ' O ' ' HG3' ' A' ' 97' ' ' MET . 3.8 tt -49.17 -37.25 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.497 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 1.9 t-20 -79.57 -16.2 56.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 47.8 t -87.43 -4.21 59.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.499 ' HE2' ' HZ ' ' A' ' 77' ' ' PHE . 1.5 ptt? -113.27 -11.63 13.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.571 ' HE3' ' CG ' ' A' ' 77' ' ' PHE . 13.4 mtpt -60.36 146.25 84.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.0 -171.78 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.055 1.555 . . . . 0.0 110.485 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.4 t -100.07 -5.64 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.162 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 6.4 p30 -128.34 59.18 1.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.18 176.03 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.38 16.51 2.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.66 -170.81 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.198 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -146.35 151.96 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.5 t -117.1 146.0 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 83' ' ' ILE . 35.5 m -144.94 161.13 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 142.6 27.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 0.1 OUTLIER -94.58 -45.78 7.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.979 ' HB3' HG21 ' A' ' 115' ' ' VAL . 48.7 m-80 -131.14 161.27 62.79 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.41 169.53 22.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.995 1.524 . . . . 0.0 110.317 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.37 50.09 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.955 1.503 . . . . 0.0 110.435 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -104.87 -37.98 6.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.99 84.24 0.13 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.979 HG21 ' HB3' ' A' ' 110' ' ' ASN . 59.0 t -119.12 -3.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.666 ' HB3' HD23 ' A' ' 86' ' ' LEU . 6.6 p-10 -131.05 156.45 45.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.183 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -175.95 150.22 1.08 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.56 -90.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.026 1.54 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.547 ' CE1' ' HD2' ' A' ' 49' ' ' PRO . 7.8 m-30 -95.97 -70.46 0.71 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER 58.93 149.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.404 ' HA ' ' CD2' ' A' ' 125' ' ' PHE . 53.8 p -160.0 21.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.3 26.47 6.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -134.05 -45.32 0.11 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.657 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 27.0 m-85 -47.31 -46.59 57.34 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.244 -1.151 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -72.23 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.641 1.337 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.458 ' OG1' ' HA2' ' A' ' 124' ' ' GLY . 3.0 p -52.14 -48.02 65.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.729 ' O ' HG22 ' A' ' 132' ' ' ILE . 17.1 ttp -42.86 -76.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 110.355 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 1.014 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.6 t80 -53.1 -55.14 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.407 ' N ' ' HD1' ' A' ' 129' ' ' PHE . . . -47.03 -24.22 0.59 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.404 ' HB3' HG13 ' A' ' 115' ' ' VAL . 2.7 t -89.35 -61.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.873 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -52.59 -20.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.818 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 1.057 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -91.41 -56.12 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.808 . . . . 0.0 109.603 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -51.36 -24.4 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.688 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.47 50.37 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 110.034 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.633 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -117.87 -24.13 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.651 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -83.32 -40.82 0.81 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.461 -0.774 . . . . 0.0 110.29 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.3 Cg_endo -79.76 -6.55 14.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.711 1.374 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.551 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 27.3 t80 -81.77 -69.0 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 136' ' ' MET . 0.9 OUTLIER -67.62 -22.85 65.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 146' ' ' ILE . 2.6 m -67.55 -31.93 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.016 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.86 -24.81 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 139' ' ' PHE . 14.7 m80 -66.39 -9.04 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . 114.79 58.98 0.36 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.581 ' H ' HD13 ' A' ' 146' ' ' ILE . 1.8 mt -162.65 61.14 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.058 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.272 0.558 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 55.31 67.09 1.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.09 137.68 56.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 110.524 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -72.55 -144.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 109.315 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.958 ' HB3' HG22 ' A' ' 34' ' ' ILE . 5.1 mtpt -143.2 150.24 39.08 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.663 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.793 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.93 113.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.478 -0.764 . . . . 0.0 109.917 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.697 HG22 ' CG1' ' A' ' 82' ' ' VAL . 28.5 t -102.99 134.13 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.745 HD13 ' CD2' ' A' ' 80' ' ' PHE . 7.8 tp -89.53 80.78 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.432 -0.792 . . . . 0.0 110.329 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.574 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 15.1 m-85 -68.48 110.43 4.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.039 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 49.0 t -135.1 153.54 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.897 . . . . 0.0 110.545 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.501 ' HB2' ' HD3' ' A' ' 17' ' ' ARG . 45.5 t -140.05 -56.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER 177.0 -60.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -0.908 . . . . 0.0 110.381 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -82.57 -8.29 86.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.807 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.3 OUTLIER 67.26 27.45 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.211 . . . . 0.0 110.076 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.641 HG21 ' OG ' ' A' ' 48' ' ' SER . 93.6 mt -133.64 -36.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.23 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 79.8 m -42.71 -49.63 5.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.178 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.772 ' HD3' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -98.46 128.63 44.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.117 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.579 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER 172.36 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.799 ' O ' HG22 ' A' ' 64' ' ' ILE . 46.4 Cg_endo -73.59 -26.33 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.872 1.459 . . . . 0.0 110.332 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB1' ' HB2' ' A' ' 129' ' ' PHE . . . -106.74 -27.22 10.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 4.2 t -79.02 -59.65 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.248 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 44.8 tt0 -56.41 -27.63 57.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.435 -0.791 . . . . 0.0 109.163 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -74.83 -55.59 5.29 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.788 HD11 ' CB ' ' A' ' 133' ' ' SER . 2.4 tp -52.71 -43.73 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.26 . . . . 0.0 109.835 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.827 ' SG ' HD11 ' A' ' 34' ' ' ILE . 73.2 m -74.7 -32.88 62.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 0.0 110.292 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.565 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 15.1 mmt180 -66.93 -39.75 87.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.949 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -79.59 -40.59 29.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.136 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.582 ' O ' HG13 ' A' ' 29' ' ' VAL . 18.7 mmt -71.41 -41.3 69.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 28' ' ' MET . 16.6 m -156.77 45.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -58.9 -19.12 42.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -84.12 27.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -1.089 . . . . 0.0 110.403 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' C ' HD12 ' A' ' 33' ' ' LEU . 52.6 mttt -150.75 -130.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.777 ' O ' HG13 ' A' ' 34' ' ' ILE . 4.7 mp -129.26 -112.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.958 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER 57.19 1.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.74 -0.6 . . . . 0.0 111.157 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.687 HD11 ' HB2' ' A' ' 25' ' ' CYS . 7.0 mt -114.07 103.71 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.88 -1.138 . . . . 0.0 110.95 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.597 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 10.3 m-20 -139.11 102.49 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.811 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.78 133.79 34.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.039 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . . . -147.7 166.58 27.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.337 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.807 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . . . 169.81 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 40' ' ' THR . 5.1 t -56.01 97.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 40' ' ' THR . 0.1 OUTLIER 174.68 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 110.199 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 44' ' ' HIS . . . 71.19 -106.32 1.86 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 52.86 -87.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.529 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 2.8 m-70 -66.13 -7.81 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.757 HG23 ' HB3' ' A' ' 69' ' ' ALA . 2.1 p -49.44 129.85 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.261 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -27.04 20.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -116.14 -134.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -1.144 . . . . 0.0 110.296 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.641 ' OG ' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 70.17 135.68 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.129 -0.982 . . . . 0.0 110.135 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.42 81.7 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.972 1.511 . . . . 0.0 110.422 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 31.8 p-10 -82.59 8.45 11.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -73.59 -26.96 61.05 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 108.981 179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.5 -48.66 31.59 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.31 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.536 ' HB2' ' CG ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -63.16 -49.85 72.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 0.0 109.65 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -60.33 -46.74 88.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.97 . . . . 0.0 109.411 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 7.5 ttpt -54.84 -69.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.82 . . . . 0.0 109.588 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.744 HG22 ' OD1' ' A' ' 60' ' ' ASN . 7.7 p -49.34 -34.92 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.265 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.952 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -54.89 -50.97 67.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 109.379 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -73.52 -22.18 60.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -12.94 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.0 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.744 ' OD1' HG22 ' A' ' 56' ' ' VAL . 11.2 m120 -111.23 -14.93 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.408 -0.808 . . . . 0.0 109.036 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.569 ' O ' ' CZ ' ' A' ' 129' ' ' PHE . . . 96.41 100.98 1.94 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.952 HG12 ' O ' ' A' ' 57' ' ' CYS . 13.9 p -172.11 145.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -86.03 118.05 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.799 HG22 ' O ' ' A' ' 19' ' ' PRO . 8.1 pt -130.23 173.07 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.152 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 51.6 p -165.96 29.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.54 149.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 110.228 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.431 ' OE1' ' CB ' ' A' ' 18' ' ' SER . 2.2 pt20 -165.43 -150.94 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.023 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.63 -178.65 7.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB3' HG23 ' A' ' 45' ' ' VAL . . . -106.51 122.82 47.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -110.47 25.6 11.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.108 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.548 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 3.4 pt20 38.24 -152.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 110.441 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.493 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 13.2 tt -133.22 164.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.0 p -125.46 -78.67 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 75' ' ' ALA . 2.3 pttp -164.88 -36.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -56.61 -20.4 20.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 110.226 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.6 p30 -42.59 -28.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 23.8 m-85 -70.69 -42.13 71.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.262 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.521 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -96.52 -48.55 5.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 4.2 tptt -44.49 -25.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 0.0 110.255 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.745 ' CD2' HD13 ' A' ' 8' ' ' LEU . 9.8 m-85 -133.07 -179.76 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.473 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.16 -29.37 4.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.844 . . . . 0.0 110.375 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.88 HG21 ' CD2' ' A' ' 143' ' ' HIS . 6.0 p -129.54 142.39 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.162 -0.961 . . . . 0.0 110.379 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.569 HG12 ' CD2' ' A' ' 8' ' ' LEU . 3.1 mt -113.78 134.22 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.1 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.0 122.37 47.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.12 137.12 42.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.772 HD22 ' HD3' ' A' ' 17' ' ' ARG . 5.1 tp -108.5 11.55 26.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -152.19 174.32 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.246 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.11 -57.92 3.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.148 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -51.44 42.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.985 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.918 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.7 tt -44.58 -51.13 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.607 ' H ' HG23 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -61.88 -55.79 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.7 t -54.49 -18.43 4.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.937 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 96' ' ' SER . 22.2 m-20 -85.28 -69.28 0.67 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 0.0 110.213 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 90' ' ' ILE . 3.2 mt -47.92 -53.14 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.432 -0.793 . . . . 0.0 109.982 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -59.11 -15.35 13.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.61 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -80.74 -40.69 24.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.995 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.747 ' CE ' HG23 ' A' ' 94' ' ' ILE . 6.9 ptt? -85.2 -26.9 26.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.567 ' CE ' ' CE1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -42.84 139.68 2.04 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.177 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.18 -161.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.052 1.554 . . . . 0.0 110.42 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 t -102.54 -4.56 25.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.213 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -155.8 111.01 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.216 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.411 ' SG ' ' NZ ' ' A' ' 98' ' ' LYS . 31.8 p -137.6 -159.31 0.94 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.521 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -132.31 31.82 4.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.112 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.86 37.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.124 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.85 162.18 18.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.527 HG22 HD13 ' A' ' 83' ' ' ILE . 90.3 t -116.09 130.04 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.54 164.04 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -108.24 131.13 55.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.088 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CD1' ' CE1' ' A' ' 139' ' ' PHE . 2.9 t80 -74.8 -61.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.96 175.46 2.96 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.142 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.518 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 48.0 Cg_endo -75.15 175.9 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.042 1.548 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.37 4.86 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.937 1.493 . . . . 0.0 110.661 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.94 -1.48 16.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.256 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 116' ' ' ASP . . . -116.99 -107.24 2.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.614 HG13 ' HA ' ' A' ' 128' ' ' MET . 17.2 t -72.69 75.28 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -1.14 . . . . 0.0 110.214 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -155.1 138.83 16.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -112.74 110.83 51.9 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.463 ' HG2' ' OG ' ' A' ' 122' ' ' SER . 46.3 Cg_endo -73.04 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.95 1.5 . . . . 0.0 110.496 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.436 ' O ' ' C ' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -166.93 146.67 5.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.319 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.436 ' C ' ' O ' ' A' ' 119' ' ' TYR . 2.7 t80 42.26 -139.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -43.29 116.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' A' ' 118' ' ' PRO . 4.7 m -155.17 -177.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.331 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -136.94 20.85 3.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.106 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 116' ' ' ASP . . . -99.49 -23.63 10.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 9.9 m-85 -44.02 -57.26 6.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.085 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.4 Cg_endo -70.77 -44.11 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.905 1.476 . . . . 0.0 110.105 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 27.9 m -61.44 -27.45 68.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.614 ' HA ' HG13 ' A' ' 115' ' ' VAL . 30.7 ttp -60.1 -70.22 0.18 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.273 -0.892 . . . . 0.0 109.832 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.767 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 75.4 t80 -67.9 -21.87 65.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.79 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -65.95 -42.13 90.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 110.004 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.604 ' CB ' HG22 ' A' ' 115' ' ' VAL . 14.8 t -84.3 -31.69 24.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.274 -0.892 . . . . 0.0 108.787 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.769 HG23 HG12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -67.75 -27.83 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.682 -0.636 . . . . 0.0 109.395 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.788 ' CB ' HD11 ' A' ' 24' ' ' ILE . 24.9 p -103.18 -23.85 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.795 . . . . 0.0 110.272 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -88.6 -18.94 26.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.08 -1.013 . . . . 0.0 110.339 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.545 ' CG ' ' HG2' ' A' ' 138' ' ' PRO . 3.3 tt0 -124.31 40.01 3.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.381 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.576 ' HG2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -84.46 -20.41 31.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.968 . . . . 0.0 110.496 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -87.11 -44.48 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.865 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -76.48 2.98 6.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.609 1.321 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.587 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 71.7 t80 -108.05 -70.03 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.537 HD21 ' CE ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -62.54 -44.07 97.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.217 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.627 HG23 HD12 ' A' ' 146' ' ' ILE . 1.9 m -64.56 -10.33 25.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.36 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 138' ' ' PRO . 13.8 mm-40 -104.7 -46.95 4.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.302 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.88 ' CD2' HG21 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -44.46 -24.57 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.134 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.453 ' C ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.83 35.94 0.5 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.491 HD22 ' HG2' ' A' ' 5' ' ' LYS . 19.1 mt -137.45 -94.53 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.627 HD12 HG23 ' A' ' 141' ' ' THR . 2.4 tp . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.26 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.301 0.572 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.39 45.38 0.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -178.03 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.491 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -117.96 144.41 45.53 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 34' ' ' ILE . 4.4 mttt -119.1 -155.95 0.63 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.024 -1.048 . . . . 0.0 110.879 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.99 148.73 51.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.715 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 16.7 t -139.06 113.29 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.794 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.055 HD12 ' HB3' ' A' ' 36' ' ' ASP . 5.0 tp -78.7 101.34 7.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.453 -0.779 . . . . 0.0 110.784 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.516 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 36.8 m-85 -87.33 106.65 18.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.717 HG22 ' HB3' ' A' ' 38' ' ' ALA . 6.0 t -134.1 177.73 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 110.959 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 10' ' ' VAL . 1.7 p 169.6 53.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.786 . . . . 0.0 110.146 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 16.6 mt 54.77 -89.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' CYS . . . -89.91 80.22 1.47 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 38' ' ' ALA . 1.8 t-20 -58.44 -44.49 89.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -1.178 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.576 HG23 ' HE3' ' A' ' 66' ' ' LYS . 9.4 mt -38.78 -30.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 110.303 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 17' ' ' ARG . 26.8 p -125.38 34.99 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 109.811 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.644 ' HB3' HD23 ' A' ' 86' ' ' LEU . 43.8 mtt180 -157.27 80.81 0.91 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 110.175 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.614 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER 56.78 43.09 1.04 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 111.022 179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 18' ' ' SER . 45.3 Cg_endo -73.66 -21.44 19.12 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.743 1.391 . . . . 0.0 109.781 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.798 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -89.01 7.33 35.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.679 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.7 OUTLIER -56.41 -40.21 74.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.124 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.966 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -60.68 -44.22 96.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.281 0.562 . . . . 0.0 110.035 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' ILE . . . -74.14 -63.8 2.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.917 HG21 HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -42.36 -46.0 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 110.166 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.624 ' N ' HG23 ' A' ' 24' ' ' ILE . 69.0 m -72.98 -39.74 65.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 110.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 3.2 mmt180 -55.1 -34.88 64.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.736 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -88.95 -32.47 17.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 0.0 110.127 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.14 -27.01 60.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.411 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.651 HG12 ' HG3' ' A' ' 32' ' ' LYS . 10.1 t -123.79 -22.89 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.234 -0.916 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.04 -168.62 18.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.98 80.71 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -1.118 . . . . 0.0 110.133 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.651 ' HG3' HG12 ' A' ' 29' ' ' VAL . 7.5 mmtp -112.96 -137.77 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ILE . 18.1 mt -122.5 -40.13 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.22 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.839 HD11 ' CD1' ' A' ' 35' ' ' ILE . 2.6 pp -33.3 -32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.762 . . . . 0.0 110.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.966 HG23 ' HA ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -76.92 88.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 110.526 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 1.055 ' HB3' HD12 ' A' ' 8' ' ' LEU . 7.1 m-20 -124.35 71.4 1.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.907 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.6 t -73.04 131.2 41.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.717 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -144.05 -171.9 3.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.256 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -166.37 145.69 5.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 40' ' ' THR . 11.1 t -125.68 76.67 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 -59.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.46 36.77 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.99 -57.59 1.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -1.169 . . . . 0.0 110.212 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.423 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -85.78 63.61 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 68' ' ' ARG . 2.1 p -148.07 149.79 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.331 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.05 21.62 27.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 48' ' ' SER . 6.5 pt20 -173.82 -149.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.18 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.83 120.79 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.219 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.24 89.08 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.977 1.514 . . . . 0.0 110.455 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.7 p30 -88.43 14.47 9.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -74.1 -37.54 64.12 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.125 -0.984 . . . . 0.0 108.719 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.43 -37.96 68.45 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.345 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.53 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 6.3 m -65.63 -59.55 3.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.458 -0.776 . . . . 0.0 109.811 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 63.9 mt-30 -57.95 -44.15 86.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.165 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -53.34 -72.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.49 -0.756 . . . . 0.0 109.701 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' ' 125' ' ' PHE . 43.5 t -43.69 -38.17 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.362 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.578 ' CA ' HG13 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -55.28 -50.54 69.28 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.437 -0.79 . . . . 0.0 109.427 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -67.37 -28.08 67.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -83.29 -9.01 59.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.11 -31.4 7.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 135.18 60.39 0.06 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 129' ' ' PHE . 1.9 p 173.69 139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -1.163 . . . . 0.0 110.129 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -91.52 142.71 27.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.731 HG23 ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER 68.63 -175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.731 ' N ' HG23 ' A' ' 64' ' ' ILE . 5.6 t 179.66 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.073 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.576 ' HE3' HG23 ' A' ' 15' ' ' ILE . 4.9 mmmt -115.72 -168.69 1.45 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.936 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.3 pt20 177.67 144.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -61.95 79.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.089 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 45' ' ' VAL . . . -49.0 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.347 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 68' ' ' ARG . 2.6 ptt-85 -103.09 -149.04 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -103.28 146.54 28.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.216 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.526 HD11 ' HB3' ' A' ' 76' ' ' ASP . 19.9 tt -82.43 173.73 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.269 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.482 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 34.1 m -100.96 6.52 43.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 73' ' ' THR . 14.5 mtmt 68.19 5.23 4.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.3 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.59 -3.16 58.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.948 . . . . 0.0 110.331 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.596 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 11.9 p-10 -65.47 -24.61 67.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.608 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 21.3 m-85 -86.69 16.13 5.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 110.228 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.34 -15.23 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.576 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.641 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -127.25 -145.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.125 -0.985 . . . . 0.0 110.033 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.641 ' CD1' ' HB3' ' A' ' 79' ' ' LYS . 0.6 OUTLIER 37.87 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.448 -0.782 . . . . 0.0 110.676 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -135.53 -43.52 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 6' ' ' ALA . 11.8 p -137.24 159.6 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 110.626 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.694 ' HB ' HG12 ' A' ' 106' ' ' VAL . 1.7 mp -124.42 122.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . . . -108.54 131.12 55.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.58 161.65 19.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.644 HD23 ' HB3' ' A' ' 17' ' ' ARG . 7.1 tp -93.22 -43.37 8.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.414 ' C ' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -102.2 177.47 4.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.395 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.499 ' HG3' HD11 ' A' ' 108' ' ' LEU . 14.8 mt-30 -89.87 -38.25 13.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 88' ' ' GLN . 23.2 t -42.36 -39.87 2.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.5 mp -65.97 -53.59 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -63.77 -16.03 60.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.214 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 t -88.37 -39.22 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.373 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.41 -22.32 21.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.843 HD13 HG11 ' A' ' 106' ' ' VAL . 2.8 tt -68.41 -37.86 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' SER . 29.2 p30 -70.2 -18.59 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 48.0 t -78.0 -34.65 50.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.553 ' CE ' HG13 ' A' ' 94' ' ' ILE . 19.8 ptt? -93.29 -30.22 15.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.047 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.608 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 7.7 mmmt -38.98 141.52 0.6 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.478 -0.764 . . . . 0.0 110.704 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.489 ' HD2' ' HD2' ' A' ' 98' ' ' LYS . 46.4 Cg_endo -72.43 -179.79 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.18 1.621 . . . . 0.0 110.567 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -114.26 19.88 15.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.6 OUTLIER -153.14 78.92 1.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.281 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 6.4 p -143.56 -172.1 3.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.92 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.444 ' HD2' ' C ' ' A' ' 102' ' ' CYS . 1.1 mpt_? -135.34 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -163.76 165.43 23.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -141.61 170.11 16.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.843 HG11 HD13 ' A' ' 94' ' ' ILE . 33.0 m -111.52 167.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.52 HG13 ' C ' ' A' ' 106' ' ' VAL . 28.1 m -154.25 157.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 110.225 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.499 HD11 ' HG3' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -94.61 125.96 39.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -89.61 93.25 9.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 110.17 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.559 ' ND2' ' OE2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 65.62 159.31 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.472 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.56 174.44 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.04 1.547 . . . . 0.0 110.383 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.4 52.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.94 1.495 . . . . 0.0 110.403 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.24 -59.33 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.59 -46.87 65.61 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.774 HG12 ' HB2' ' A' ' 131' ' ' SER . 30.2 m -92.18 46.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -137.24 113.63 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -140.19 142.7 30.92 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 -13.65 26.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.069 1.563 . . . . 0.0 110.494 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.6 t80 50.14 38.89 18.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.64 -50.28 65.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -139.35 -69.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.02 44.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -103.7 -7.96 20.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.173 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -90.67 -40.03 5.74 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.641 ' HB3' HG11 ' A' ' 56' ' ' VAL . 5.4 m-30 -45.06 -47.5 31.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.148 -1.207 . . . . 0.0 110.472 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -72.42 -57.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.575 1.302 . . . . 0.0 110.382 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 15.5 m -64.57 -57.22 9.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.185 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.662 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 7.6 ttp -40.43 -69.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.755 ' CE1' HD12 ' A' ' 24' ' ' ILE . 75.3 t80 -55.93 -44.75 78.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.045 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -46.94 -59.77 2.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.94 . . . . 0.0 110.014 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.774 ' HB2' HG12 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -65.14 -45.2 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 110.024 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.917 HG23 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -43.27 -53.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.826 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.624 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -80.75 -37.77 29.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 5.2 tttt -50.08 -32.29 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 8.3 mm-40 -103.97 -5.59 22.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.189 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' A' ' 133' ' ' SER . 0.7 OUTLIER -82.78 14.24 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -104.71 -63.39 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.448 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 44.5 Cg_endo -72.26 -4.39 15.13 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.786 1.414 . . . . 0.0 110.471 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.657 ' CE2' HG11 ' A' ' 7' ' ' VAL . 34.1 t80 -93.1 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.997 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -45.52 -28.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 110.143 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 7.5 m -47.55 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.817 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 141' ' ' THR . 11.7 mt-10 -106.44 -0.27 24.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 110.792 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 33.77 5.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 111.16 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.697 ' HA3' HD13 ' A' ' 140' ' ' LEU . . . 173.42 -27.37 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.485 -1.341 . . . . 0.0 109.901 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.997 ' HB3' HD12 ' A' ' 140' ' ' LEU . 0.3 OUTLIER 175.02 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.234 -1.156 . . . . 0.0 110.363 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.774 HG22 ' CD2' ' A' ' 145' ' ' LEU . 7.3 tp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.116 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.265 0.555 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 1' ' ' ALA . . . 175.39 112.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.227 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 158.21 30.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.266 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -82.99 -179.05 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.847 . . . . 0.0 109.237 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 1.019 ' C ' HG22 ' A' ' 34' ' ' ILE . 17.1 mttm -142.73 -161.34 1.23 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.065 -1.022 . . . . 0.0 110.676 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.031 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -141.18 121.92 14.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.996 ' HB ' HD12 ' A' ' 34' ' ' ILE . 2.7 t -111.22 123.0 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.765 . . . . 0.0 109.329 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 10' ' ' VAL . 6.5 tp -93.52 84.88 4.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.439 -0.788 . . . . 0.0 110.757 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.53 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 55.7 m-85 -60.79 123.73 18.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 8' ' ' LEU . 25.1 t -124.97 168.82 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.719 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.854 ' HB3' HD13 ' A' ' 86' ' ' LEU . 20.9 p -169.02 -141.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.911 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 76.07 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 14' ' ' ASN . . . 129.04 -6.89 6.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 13' ' ' GLY . 6.2 t-20 41.71 37.62 0.78 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -1.145 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.73 HD13 ' HB3' ' A' ' 48' ' ' SER . 3.2 mt -144.22 -59.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 15' ' ' ILE . 56.1 m -106.0 59.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.83 ' CB ' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -153.5 -50.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.468 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -152.13 47.76 0.43 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.038 -1.039 . . . . 0.0 110.743 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 18' ' ' SER . 47.7 Cg_endo -74.65 -16.0 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.843 1.444 . . . . 0.0 110.113 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.916 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -91.97 6.63 45.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.871 ' SG ' HD11 ' A' ' 132' ' ' ILE . 55.5 m -63.96 -35.01 79.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.642 ' HG2' HG23 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -68.83 -55.54 10.83 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.526 -0.734 . . . . 0.0 110.177 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' A' ' 63' ' ' ASP . . . -62.28 -51.81 53.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.784 HD11 ' CB ' ' A' ' 133' ' ' SER . 8.9 tp -56.3 -44.27 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 110.308 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.566 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 23.1 m -64.96 -35.52 81.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.238 -0.914 . . . . 0.0 110.054 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.4 mtt-85 -66.44 -45.12 80.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 110.124 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -34.9 58.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -74.96 -46.86 32.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 30' ' ' GLY . 13.6 m -150.93 45.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.22 -28.55 0.86 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.47 85.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -1.145 . . . . 0.0 110.061 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 34' ' ' ILE . 21.6 mttt -65.98 -23.25 66.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.138 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.941 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 67.66 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.031 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER 30.07 37.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.553 -0.717 . . . . 0.0 111.66 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.941 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -92.0 93.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.906 -1.121 . . . . 0.0 110.361 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.582 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 10.0 m-20 -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -168.86 163.15 11.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 110.372 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -169.26 -164.68 0.47 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' O ' HG22 ' A' ' 72' ' ' ILE . . . -174.92 -176.95 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -151.28 25.01 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -0.75 5.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . 49.88 -104.04 0.1 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 64.64 119.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.248 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.468 ' HB3' ' HG3' ' A' ' 47' ' ' GLN . 4.2 m-70 55.66 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.309 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 69' ' ' ALA . 80.9 t 52.42 80.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.07 6.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.468 ' HG3' ' HB3' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -148.75 13.86 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.247 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.73 ' HB3' HD13 ' A' ' 15' ' ' ILE . 2.7 t -106.97 111.64 63.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 47.1 Cg_endo -69.58 100.72 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.6 p30 -86.16 26.03 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.424 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -32.06 61.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.257 -0.902 . . . . 0.0 108.92 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.9 mtt180 -71.83 -52.23 18.49 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.213 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -52.59 65.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.43 -0.794 . . . . 0.0 109.359 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 6.8 tt0 -54.24 -56.42 18.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HE3' HG23 ' A' ' 56' ' ' VAL . 3.9 ttpp -44.85 -66.89 0.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.393 -0.817 . . . . 0.0 109.52 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.871 HG21 ' CB ' ' A' ' 125' ' ' PHE . 91.8 t -45.32 -36.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.639 ' CB ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.7 -42.15 92.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.439 -0.788 . . . . 0.0 109.042 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 1.6 mmtp -71.76 -27.74 63.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.416 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.42 -9.33 54.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -109.8 -26.61 9.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.195 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 115.43 81.26 0.92 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.639 HG13 ' CB ' ' A' ' 57' ' ' CYS . 2.1 p 174.66 170.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -1.1 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.567 ' N ' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -156.03 144.13 19.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.435 ' CG1' ' HG3' ' A' ' 54' ' ' GLN . 2.3 pt -133.51 164.89 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -115.58 76.05 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.947 . . . . 0.0 110.256 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 65' ' ' SER . 4.6 mttt 60.53 152.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.948 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -105.3 -64.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.09 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.767 ' HB3' HG22 ' A' ' 45' ' ' VAL . . . -49.12 157.59 0.43 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -0.891 . . . . 0.0 110.178 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -147.95 33.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 8.4 pt20 37.58 -153.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 72' ' ' ILE . 3.9 tt -153.73 129.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.211 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 174.24 6.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -72.94 -5.98 42.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -77.19 -34.2 56.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -42.65 -48.41 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.544 ' CE2' ' HG2' ' A' ' 98' ' ' LYS . 14.6 m-30 -47.3 -30.42 3.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.8 m -117.56 29.61 7.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.541 ' C ' ' CD1' ' A' ' 80' ' ' PHE . 9.6 tppt? -124.88 -9.36 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 79' ' ' LYS . 69.5 m-85 -140.3 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -124.34 -44.56 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 110.385 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 41.3 t -131.73 137.18 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.499 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' O ' HG22 ' A' ' 107' ' ' VAL . 54.4 mt -116.45 142.11 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.817 . . . . 0.0 110.044 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 107' ' ' VAL . . . -127.66 162.66 26.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -142.99 145.58 33.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -70.56 -79.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.539 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.427 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 7.3 m-20 -78.92 175.74 10.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 110.467 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.463 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.6 mm-40 -74.22 -41.46 61.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.8 t -40.13 -50.61 2.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.012 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.768 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.7 mt -61.37 -58.48 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 108' ' ' LEU . 3.1 tp -42.25 -60.97 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.119 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 96' ' ' SER . 46.6 t -55.33 -39.44 70.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.965 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 96' ' ' SER . 0.3 OUTLIER -54.3 -55.38 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.067 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.5 mp -57.89 -56.77 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -63.99 -19.23 65.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.844 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 92' ' ' SER . 1.0 OUTLIER -71.85 -8.86 56.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.5 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 7.6 mtm -125.88 -48.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.544 ' HG2' ' CE2' ' A' ' 77' ' ' PHE . 9.7 mtpt -41.82 138.14 1.82 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.96 -160.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.006 1.53 . . . . 0.0 110.581 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.1 m -106.56 5.32 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -134.97 104.95 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -174.01 4.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 28.8 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -148.59 176.38 10.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 110.182 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 104' ' ' ALA . 34.7 mtmt -143.23 166.12 25.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.13 -0.981 . . . . 0.0 110.282 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.4 t -117.27 132.64 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.9 HG11 ' CD2' ' A' ' 143' ' ' HIS . 32.1 m -128.21 153.61 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.575 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -100.95 146.98 26.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 3.3 t80 -106.73 110.58 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.091 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 59.0 166.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.049 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 170.09 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.001 1.527 . . . . 0.0 110.278 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.9 51.93 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.398 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -156.56 -46.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.8 -67.65 2.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.589 HG22 ' OG ' ' A' ' 131' ' ' SER . 10.1 t -98.84 100.7 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -1.114 . . . . 0.0 110.116 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -174.87 88.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.24 130.33 7.58 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 -90.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.939 1.494 . . . . 0.0 110.487 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.04 21.16 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.182 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -65.47 117.02 7.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.7 t 52.18 -143.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.168 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.91 39.55 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -93.52 32.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -124.48 -49.2 0.21 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.871 ' CB ' HG21 ' A' ' 56' ' ' VAL . 5.6 m-85 -41.65 -48.95 10.06 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.249 -1.147 . . . . 0.0 110.305 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.9 Cg_endo -71.45 -56.97 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.597 1.314 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 16.7 m -59.76 -51.87 67.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 124' ' ' GLY . 12.1 ttp -41.29 -63.71 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.284 -0.885 . . . . 0.0 109.96 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.716 ' CE1' HD13 ' A' ' 24' ' ' ILE . 94.2 t80 -56.63 -42.1 78.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.617 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -46.12 -57.43 4.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.774 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.589 ' OG ' HG22 ' A' ' 115' ' ' VAL . 11.2 p -71.44 -43.97 65.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.523 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.916 HG13 ' HB3' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -42.1 -37.61 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.689 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.784 ' CB ' HD11 ' A' ' 24' ' ' ILE . 1.4 p -97.19 -42.36 7.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.3 OUTLIER -44.93 -46.54 11.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -102.72 41.71 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.202 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.63 ' HE2' ' HA ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -116.49 -2.35 12.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.264 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.608 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -104.88 -63.57 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 46.9 Cg_endo -73.58 1.14 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.75 1.395 . . . . 0.0 110.488 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.523 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 31.9 t80 -87.88 -68.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 140' ' ' LEU . 4.0 pp -74.03 -23.71 59.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.592 HG23 HG21 ' A' ' 146' ' ' ILE . 3.3 m -59.74 -43.04 94.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 144' ' ' GLY . 49.7 mt-10 -96.0 -37.33 10.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.9 ' CD2' HG11 ' A' ' 107' ' ' VAL . 1.2 m80 -44.01 -25.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 124.66 68.32 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -155.66 18.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.592 HG21 HG23 ' A' ' 141' ' ' THR . 23.6 pt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.192 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.24 0.543 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 46.51 -145.65 0.21 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.87 . . . . 0.0 110.189 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' OE1' ' CB ' ' A' ' 32' ' ' LYS . 14.7 tt0 -152.46 172.85 15.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 110.359 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.591 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -64.04 -69.53 0.27 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.512 -0.742 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 14.3 mttm -152.34 -155.59 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.981 . . . . 0.0 111.353 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.986 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.95 152.91 36.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.712 -0.618 . . . . 0.0 110.234 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.652 HG23 ' HB ' ' A' ' 34' ' ' ILE . 15.1 t -111.62 127.26 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 83' ' ' ILE . 10.2 tp -90.01 81.86 6.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 136' ' ' MET . 27.3 m-85 -68.82 117.49 10.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.943 . . . . 0.0 109.46 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 38' ' ' ALA . 52.7 t -130.9 161.04 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.601 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.876 ' HB3' HD22 ' A' ' 86' ' ' LEU . 28.6 p -159.38 39.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.102 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 90' ' ' ILE . 1.2 mt 59.38 60.49 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.267 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.882 ' H ' ' HB1' ' A' ' 39' ' ' ALA . . . 132.13 -24.72 3.97 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.922 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 13.5 t30 59.28 14.88 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -1.168 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' CA ' ' HB3' ' A' ' 19' ' ' PRO . 12.9 mt -123.17 -1.54 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 22.5 p -144.21 165.61 27.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.237 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.795 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.8 OUTLIER 71.05 -56.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 110.416 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.878 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.0 t -152.97 50.36 0.6 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.792 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.1 Cg_endo -78.17 -19.27 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.864 1.455 . . . . 0.0 110.066 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.671 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -86.76 6.73 30.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -0.79 . . . . 0.0 110.279 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.602 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 21.4 p -58.21 -28.96 65.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.337 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 26' ' ' ARG . 0.6 OUTLIER -67.66 -40.15 84.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.594 -0.691 . . . . 0.0 110.191 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -74.73 -49.69 10.28 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.807 HG21 HG23 ' A' ' 132' ' ' ILE . 1.1 tp -57.84 -44.35 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 0.0 110.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.742 ' SG ' HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -71.34 -43.37 67.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.314 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 2.7 mmm180 -58.97 -38.3 78.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.22 -39.67 47.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.117 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.525 ' C ' HG13 ' A' ' 29' ' ' VAL . 21.8 mtp -67.69 -51.09 53.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 28' ' ' MET . 14.0 m -151.3 44.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.319 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -63.54 -20.78 64.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -67.19 -7.37 23.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.412 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . 6.5 mttm -116.27 -137.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.05 -1.031 . . . . 0.0 110.272 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.814 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.2 mt -120.34 -122.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.986 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 49.46 3.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.621 -0.674 . . . . 0.0 111.644 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -104.09 95.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.832 -1.167 . . . . 0.0 110.547 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.875 ' OD1' ' HB1' ' A' ' 6' ' ' ALA . 3.1 m-20 -137.05 106.8 6.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.424 ' OG ' ' HG2' ' A' ' 22' ' ' GLU . 19.2 m -89.57 127.63 35.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.158 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.888 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -144.43 166.64 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.922 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -166.3 106.5 0.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' THR . 3.2 t -80.59 86.28 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 40' ' ' THR . 12.5 p 177.33 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 94.15 1.01 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -155.83 -40.54 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -1.136 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.27 92.91 4.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.88 . . . . 0.0 110.226 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 69' ' ' ALA . 38.5 t -148.19 160.73 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.257 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.46 24.99 7.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 48' ' ' SER . 13.1 pt20 -159.87 -148.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' GLN . 0.5 OUTLIER 61.39 90.78 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 110.21 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.36 80.53 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.957 1.503 . . . . 0.0 110.439 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -93.01 33.71 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.304 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.502 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 1.3 m -75.52 -31.52 60.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 108.908 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.613 ' O ' HG22 ' A' ' 56' ' ' VAL . 52.3 mtt180 -73.01 -48.96 31.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.313 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.585 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -61.81 -51.34 68.64 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.664 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.522 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -64.2 -33.86 76.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HE2' HG13 ' A' ' 56' ' ' VAL . 8.3 ttpt -60.04 -67.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 125' ' ' PHE . 27.5 m -53.51 -35.08 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.066 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.8 m -53.6 -50.79 64.89 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.425 -0.797 . . . . 0.0 109.261 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -31.8 71.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.492 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 1.2 t -77.05 -10.14 59.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.84 . . . . 0.0 110.034 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -112.89 -26.91 8.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.126 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 135.67 53.74 0.06 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.671 HG11 ' HB1' ' A' ' 20' ' ' ALA . 65.1 t -158.3 109.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -108.87 125.15 51.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.5 pt -106.22 174.63 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -131.3 -50.73 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 0.0 110.174 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -140.33 86.23 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.9 59.76 5.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -125.73 99.57 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' GLY . . . -44.45 159.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.222 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -160.38 40.45 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 110.235 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 70' ' ' ARG . 32.2 tt0 63.05 126.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.256 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -68.85 123.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.892 . . . . 0.0 110.14 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.61 ' N ' HD13 ' A' ' 72' ' ' ILE . 22.8 p -73.56 -175.82 2.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.895 . . . . 0.0 110.333 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 -15.93 25.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.21 -20.85 63.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.59 ' HB3' HD11 ' A' ' 72' ' ' ILE . 21.7 p-10 -52.03 -29.97 23.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE1' ' HD2' ' A' ' 98' ' ' LYS . 19.6 m-85 -86.19 49.05 1.71 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.268 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 1.3 t 171.66 -61.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.244 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.547 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -42.24 -27.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 110.228 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.832 ' CB ' ' HB3' ' A' ' 6' ' ' ALA . 8.1 m-85 -131.02 -135.13 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.079 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -177.95 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 0.0 110.644 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 16.3 t -104.5 84.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.015 -1.053 . . . . 0.0 110.463 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.849 HG21 ' CD1' ' A' ' 94' ' ' ILE . 2.9 mp -72.68 114.22 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.961 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -97.67 124.33 41.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -117.09 126.95 53.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.878 HD21 ' HB2' ' A' ' 18' ' ' SER . 1.1 mp -64.47 -54.42 32.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.352 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.46 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -103.29 -165.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 0.0 110.22 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 96.1 mt-30 -94.83 -36.84 11.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -42.84 -45.35 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.565 HD12 ' H ' ' A' ' 90' ' ' ILE . 2.2 mp -62.5 -47.2 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.205 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.11 -30.87 71.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.119 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.2 t -79.49 -30.8 42.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 96' ' ' SER . 3.3 m-20 -79.69 -55.27 5.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 83' ' ' ILE . 10.0 tt -47.58 -43.64 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 110.203 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.605 ' N ' HG23 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.08 -23.65 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -67.53 -10.35 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.183 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.561 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 6.4 mtm -116.64 -50.96 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.567 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 11.3 mtpt -40.78 129.75 1.89 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 110.432 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.445 ' HG2' ' OD1' ' A' ' 101' ' ' ASN . 46.3 Cg_endo -72.72 -163.54 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.025 1.539 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -101.16 28.72 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 22.9 p30 -150.79 94.2 2.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.06 179.04 8.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.82 6.73 4.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.267 -0.896 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -105.9 122.87 47.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.49 162.27 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.698 HG12 ' HB ' ' A' ' 83' ' ' ILE . 27.9 m -125.23 127.15 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.25 159.41 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 109' ' ' PHE . 3.5 tt -116.79 141.35 48.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.157 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.575 ' N ' HD23 ' A' ' 108' ' ' LEU . 7.5 m-85 -103.77 113.14 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 2.0 t30 58.66 144.77 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.533 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 46.3 Cg_endo -74.27 176.06 10.12 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.052 1.554 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.7 Cg_endo -71.74 53.83 1.92 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.892 1.47 . . . . 0.0 110.383 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -158.44 19.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.211 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 116' ' ' ASP . . . -135.91 -90.52 0.31 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 131' ' ' SER . 8.3 t -60.63 83.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -1.166 . . . . 0.0 110.19 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 114' ' ' GLY . 22.4 t70 -129.68 131.12 46.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.466 ' OD2' ' HA3' ' A' ' 124' ' ' GLY . 23.4 t0 -159.83 102.09 1.45 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.34 -89.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.994 1.523 . . . . 0.0 110.461 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.04 32.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.208 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 121' ' ' SER . 0.1 OUTLIER -93.03 102.25 14.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 58.94 173.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.35 65.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -115.94 129.42 56.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.159 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 112.31 -34.82 4.97 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.692 ' HB3' HG21 ' A' ' 56' ' ' VAL . 9.9 m-30 -41.31 -49.72 8.81 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.68 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.3 Cg_endo -70.87 -64.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.547 1.288 . . . . 0.0 110.436 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.571 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 21.4 p -53.33 -54.96 28.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.895 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.5 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 ttp -42.28 -69.72 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 110.024 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 24' ' ' ILE . 61.9 t80 -44.0 -49.66 8.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.757 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -47.92 -47.04 32.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.8 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -74.31 -33.68 63.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.882 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.807 HG23 HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -55.32 -45.5 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.615 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.555 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -83.71 -38.14 21.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.302 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 131' ' ' SER . 62.7 mm-40 -90.56 -30.33 17.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 9' ' ' PHE . 13.7 mtm -99.65 4.45 45.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -86.85 -51.04 0.45 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 0.0 110.017 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.88 -6.67 14.28 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.99 1.521 . . . . 0.0 110.435 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.513 ' CE1' ' CG ' ' A' ' 143' ' ' HIS . 85.2 t80 -108.16 -78.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.53 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 34' ' ' ILE . 15.9 tp -44.14 -24.62 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.481 ' HA ' ' HB ' ' A' ' 146' ' ' ILE . 4.6 m -89.11 -31.58 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.963 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 138' ' ' PRO . 3.3 mm-40 -105.09 -39.09 6.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 110.284 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.513 ' CG ' ' CE1' ' A' ' 139' ' ' PHE . 60.0 t60 -40.39 -29.39 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.0 60.87 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.53 HD22 HG21 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -154.87 -39.83 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -1.142 . . . . 0.0 110.183 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 146' ' ' ILE . 53.6 mt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.218 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.261 0.553 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.69 115.21 30.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 110.221 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.19 163.63 16.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.258 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.731 ' HG2' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.46 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.874 . . . . 0.0 108.758 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.687 ' HB2' HG22 ' A' ' 34' ' ' ILE . 9.3 mtpp -159.01 -164.42 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.977 -1.077 . . . . 0.0 110.493 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.763 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.91 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.566 -0.709 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.011 HG22 ' O ' ' A' ' 34' ' ' ILE . 2.1 m -90.55 138.66 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.976 . . . . 0.0 110.169 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.694 ' HG ' ' HB2' ' A' ' 38' ' ' ALA . 7.4 tp -89.89 88.15 7.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 110.129 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.645 ' CE2' HG21 ' A' ' 7' ' ' VAL . 5.5 m-85 -72.69 114.16 10.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.752 HG13 HD11 ' A' ' 90' ' ' ILE . 2.1 p -165.8 171.26 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.67 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.732 ' HA ' HD12 ' A' ' 90' ' ' ILE . 10.1 t 175.27 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 51.08 49.66 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 0.0 110.09 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.21 70.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.73 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -44.74 -45.35 9.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -1.14 . . . . 0.0 110.136 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 45' ' ' VAL . 25.9 mt -61.33 -12.35 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 19.8 m -99.67 153.4 19.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.966 ' HG2' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 61.5 11.07 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.387 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.626 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 0.4 OUTLIER -91.96 -64.26 0.16 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.976 . . . . 0.0 110.172 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.62 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 47.8 Cg_endo -74.27 -1.4 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.793 1.417 . . . . 0.0 110.299 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -103.15 -47.4 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.451 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.864 ' HA ' HD11 ' A' ' 132' ' ' ILE . 60.4 m -70.25 -38.51 75.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.978 . . . . 0.0 109.969 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.84 -44.28 96.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . -70.06 -48.5 39.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 ' CE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -53.0 -53.0 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -1.143 . . . . 0.0 110.038 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.937 ' HB3' HD11 ' A' ' 35' ' ' ILE . 63.9 m -69.4 -62.15 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 22.6 mmt180 -47.47 -22.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 23.8 t0 -85.81 -45.01 11.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 2.0 mtt -83.16 -1.72 53.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.0 110.425 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 25' ' ' CYS . 3.0 m -131.0 -28.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.947 . . . . 0.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 100.09 -58.75 0.76 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 17.5 p30 178.32 102.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -1.144 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.595 ' C ' HD12 ' A' ' 33' ' ' LEU . 13.3 ptpt -152.96 -136.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.009 ' O ' HD12 ' A' ' 35' ' ' ILE . 5.1 mp -112.78 -127.61 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.011 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.6 OUTLIER 51.62 4.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.598 -0.689 . . . . 0.0 111.157 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.009 HD12 ' O ' ' A' ' 33' ' ' LEU . 3.2 mt -127.48 113.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 0.0 110.717 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 8.2 m-20 -142.79 111.73 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.74 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.55 127.68 32.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.262 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' CG1' ' A' ' 10' ' ' VAL . . . -128.58 177.48 6.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -167.79 96.31 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.159 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.544 ' CG2' HG13 ' A' ' 90' ' ' ILE . 74.7 p -41.98 -35.19 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 m -116.97 -167.19 1.26 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.86 77.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -128.02 0.02 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 0.0 110.256 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 0.4 OUTLIER -122.42 -11.41 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.292 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.615 ' HA ' HD11 ' A' ' 15' ' ' ILE . 34.3 m -62.48 159.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.246 -0.909 . . . . 0.0 110.299 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.06 21.91 64.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.516 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 6.5 pt20 -173.7 -148.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -1.134 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 48' ' ' SER . 0.8 OUTLIER 64.43 112.41 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.35 87.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.928 1.488 . . . . 0.0 110.451 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -86.16 30.49 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.103 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -73.86 -27.46 61.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.23 -0.919 . . . . 0.0 109.005 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.605 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -71.61 -54.9 8.91 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.288 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.573 ' CB ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -59.7 -51.22 70.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 109.37 179.16 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 1.3 tt0 -60.86 -41.61 96.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.603 ' HE3' HG23 ' A' ' 56' ' ' VAL . 1.5 ttpt -52.83 -66.36 0.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' HE3' ' A' ' 55' ' ' LYS . 52.6 t -50.61 -37.34 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.895 . . . . 0.0 109.115 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -52.02 -52.65 49.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.488 -0.758 . . . . 0.0 109.409 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 -27.28 64.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.528 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 2.0 t -78.64 -11.48 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 109.896 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.36 -19.95 13.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.589 ' C ' HG13 ' A' ' 62' ' ' VAL . . . 106.16 97.07 2.48 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.731 HG12 ' CE2' ' A' ' 129' ' ' PHE . 16.1 m -154.76 -147.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.154 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.447 ' C ' HG23 ' A' ' 64' ' ' ILE . 5.7 t0 179.43 117.07 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.326 -0.859 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 65' ' ' SER . 15.0 pt -146.65 -37.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.334 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 64' ' ' ILE . 2.3 t 68.75 -67.0 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 64' ' ' ILE . 16.0 mmtt -136.05 -174.03 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.29 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.626 ' NE2' ' HB3' ' A' ' 18' ' ' SER . 30.1 mm100 -139.49 -77.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.17 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.87 84.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.73 ' HB1' ' CG ' ' A' ' 14' ' ' ASN . . . -76.95 179.05 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.221 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -153.11 29.92 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.263 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 50.7 tt0 55.93 162.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.961 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.476 HG13 ' OD2' ' A' ' 76' ' ' ASP . 5.3 tt -62.69 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.225 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.429 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -149.91 147.35 27.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 110.172 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -13.97 10.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -89.9 -9.65 48.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' OD2' HG13 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -44.55 -42.88 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.05 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 35.5 m-85 -59.31 -17.42 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 t -113.05 -44.15 3.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.057 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.605 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 18.0 tptt -45.89 -27.95 1.0 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.071 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 27.7 m-85 -144.78 179.25 7.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 110.196 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -114.87 -13.58 11.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 110.583 -179.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 76.9 t -128.74 143.67 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 0.0 110.465 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' VAL . 1.9 mp -116.71 119.92 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -100.41 110.92 23.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 110.654 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.932 ' HB1' HG21 ' A' ' 90' ' ' ILE . . . -104.74 133.21 49.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.023 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.966 HD22 ' HG2' ' A' ' 17' ' ' ARG . 2.6 tp -82.41 -31.15 29.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.279 -0.888 . . . . 0.0 110.49 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 90' ' ' ILE . 21.9 p-10 -118.65 178.81 4.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.977 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.52 -41.34 13.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.145 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.2 m -45.09 -48.0 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.035 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.932 HG21 ' HB1' ' A' ' 85' ' ' ALA . 6.5 tt -53.65 -39.46 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.032 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.509 ' N ' HG23 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -70.7 -42.16 71.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.917 . . . . 0.0 110.089 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.7 t -63.43 -30.93 71.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -88.54 -57.44 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.558 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.1 tt -46.04 -32.9 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 110.182 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.486 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 8.0 t-20 -78.67 -15.19 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -9.2 57.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.212 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.558 ' CE ' HG13 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -112.44 -21.51 11.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.145 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -49.48 151.73 2.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.192 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 100' ' ' SER . 44.3 Cg_endo -72.03 -52.19 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.966 1.508 . . . . 0.0 110.399 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 168.28 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.49 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 11.7 m120 -163.81 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.364 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.56 -150.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 109.951 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -133.47 63.24 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -156.36 156.05 33.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.8 139.67 53.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.164 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 61.6 t -94.22 139.2 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.673 HG11 ' NE2' ' A' ' 143' ' ' HIS . 16.1 m -136.53 142.63 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.02 132.56 38.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.16 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.493 ' HB3' HD12 ' A' ' 86' ' ' LEU . 10.1 t80 -87.05 -20.84 26.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 3.6 p-10 -177.48 164.66 1.37 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.0 Cg_endo -74.49 174.31 12.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.017 1.535 . . . . 0.0 110.348 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.77 51.57 2.34 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -111.63 -44.43 3.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.31 102.86 0.99 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.424 HG11 ' OD1' ' A' ' 110' ' ' ASN . 7.9 p -122.52 -9.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.687 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.2 t70 -117.02 -127.96 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.09 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -157.09 86.24 2.81 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.31 55.56 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.068 1.562 . . . . 0.0 110.45 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.468 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 1.1 m-85 46.45 -159.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.468 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 2.6 t80 67.06 9.15 6.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 2.2 t 171.75 165.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.115 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -111.14 -17.99 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 123' ' ' ASP . 2.9 p30 -67.02 68.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 122' ' ' SER . . . -176.77 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.67 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 15.5 m-85 -41.39 -51.37 8.52 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.341 -1.093 . . . . 0.0 110.471 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.67 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -72.42 -56.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.754 1.397 . . . . 0.0 110.334 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.8 m -52.74 -42.82 65.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.765 ' O ' HG22 ' A' ' 132' ' ' ILE . 24.8 ttp -49.69 -77.04 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 0.0 109.764 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 1.048 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.4 t80 -46.6 -54.55 9.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.114 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -50.84 -23.96 3.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.4 t -91.31 -57.29 2.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.338 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.864 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -54.71 -19.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.823 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.764 ' HB2' HD11 ' A' ' 24' ' ' ILE . 1.8 t -99.11 -50.19 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 109.77 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 12.0 tttt -59.31 -17.24 27.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.926 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HD2' ' A' ' 138' ' ' PRO . 1.4 tt0 -116.6 10.29 14.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.872 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.57 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 3.4 tpt -81.29 8.45 9.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 110.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.5 mtmt -88.6 -52.25 0.37 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.1 Cg_endo -76.66 6.79 3.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.97 1.511 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.57 ' CD2' ' CE ' ' A' ' 136' ' ' MET . 60.1 t80 -96.28 -60.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.153 -0.967 . . . . 0.0 110.366 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 140' ' ' LEU . 3.9 pp -84.6 -13.68 50.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.391 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 137' ' ' LYS . 3.4 m -69.31 -32.57 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.141 -0.974 . . . . 0.0 110.156 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 143' ' ' HIS . 16.5 mm-40 -102.45 -38.78 7.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.203 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.673 ' NE2' HG11 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -43.59 -32.7 1.0 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.307 -0.87 . . . . 0.0 110.236 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.97 73.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 145' ' ' LEU . 1.5 mt -163.05 -62.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 141' ' ' THR . 26.5 pt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.236 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.307 0.575 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.31 47.97 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.182 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.56 157.08 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.268 -0.895 . . . . 0.0 110.274 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.797 ' HG3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -84.19 150.74 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 179.263 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 34' ' ' ILE . 8.4 mtpt -134.48 -155.74 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 110.761 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.113 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.54 134.73 43.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 110.697 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.6 HG23 ' CG2' ' A' ' 34' ' ' ILE . 73.0 t -124.01 123.98 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.724 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.643 HD12 ' HB3' ' A' ' 36' ' ' ASP . 5.6 tp -80.79 103.41 10.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.67 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.64 102.86 13.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.033 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 57.4 t -129.45 169.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.394 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.54 ' N ' HG12 ' A' ' 10' ' ' VAL . 39.7 t -158.52 -65.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.583 HD11 ' CB ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 169.93 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 99.96 -26.91 22.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.641 ' ND2' ' HB2' ' A' ' 39' ' ' ALA . 2.6 t-20 70.53 3.28 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.334 -1.098 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.715 HD13 ' HB2' ' A' ' 48' ' ' SER . 97.7 mt -101.17 -39.81 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 59.7 m -121.89 153.37 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.989 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.973 ' CB ' HD23 ' A' ' 86' ' ' LEU . 11.0 mtm105 55.79 55.61 6.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.908 . . . . 0.0 110.1 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 176.1 -57.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.422 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.0 Cg_endo -72.08 -12.29 27.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.001 1.527 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.75 -11.48 28.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.065 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.662 ' HA ' HD11 ' A' ' 132' ' ' ILE . 28.3 m -64.75 -43.91 91.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 1.9 mt-10 -48.0 -52.85 18.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.499 -0.75 . . . . 0.0 109.717 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.966 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -64.27 -45.27 93.98 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.939 HD11 ' CD1' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -48.92 -52.27 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -1.097 . . . . 0.0 109.847 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.636 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -64.83 -43.89 91.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.064 179.868 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.474 ' HA ' ' N ' ' A' ' 31' ' ' ASP . 16.6 mtt85 -53.27 -44.54 68.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 -16.54 37.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.764 ' O ' HG13 ' A' ' 29' ' ' VAL . 2.9 mmt -83.32 -30.39 27.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.31 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 28' ' ' MET . 2.5 m -161.24 24.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 64.35 37.39 94.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.712 ' OD1' HD13 ' A' ' 35' ' ' ILE . 1.9 t70 68.7 85.31 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.14 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 29' ' ' VAL . 12.2 mmtt -88.9 36.17 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.974 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.916 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 71.91 -144.07 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 110.066 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.113 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 1.5 pp 35.65 22.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.492 -0.755 . . . . 0.0 112.032 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.2 mt -97.31 90.47 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.081 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' A' ' 8' ' ' LEU . 4.1 m-20 -122.95 79.43 1.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.312 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.16 130.94 44.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 110.039 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.033 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . . . -145.71 -176.33 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.665 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -148.06 150.14 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.192 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.826 ' CG2' HG23 ' A' ' 90' ' ' ILE . 69.3 p -83.1 -77.92 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.472 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.39 76.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 110.193 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.03 97.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.45 -10.24 11.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -1.162 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.692 ' O ' HD11 ' A' ' 15' ' ' ILE . 1.7 m-70 -117.68 98.51 6.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.174 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 69' ' ' ALA . 9.1 t -123.58 148.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.77 26.05 1.75 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 12.18 4.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -1.128 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.715 ' HB2' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -117.6 178.98 0.89 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 48' ' ' SER . 45.7 Cg_endo -69.21 -57.65 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 3.9 m-20 67.2 -54.86 0.46 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 m -71.84 -22.81 61.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.219 -0.925 . . . . 0.0 109.099 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HG2' ' CE2' ' A' ' 125' ' ' PHE . 19.6 tpp180 -73.58 -57.65 3.85 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.386 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.547 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -59.76 -48.76 80.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.163 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 20.0 tp60 -60.99 -40.3 92.97 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.14 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -55.32 -64.06 0.96 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.599 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 5.7 p -52.25 -34.72 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.041 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.847 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -55.73 -50.68 69.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.76 . . . . 0.0 109.388 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HG3' ' NE2' ' A' ' 54' ' ' GLN . 4.9 mmtt -68.06 -31.8 71.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 109.713 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.9 t -78.3 -11.27 59.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 0.0 109.987 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.566 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 5.4 m-20 -111.53 -34.75 5.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.313 -0.867 . . . . 0.0 109.11 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 138.32 73.55 0.05 OUTLIER Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.966 HG13 ' HA3' ' A' ' 23' ' ' GLY . 42.5 t -158.59 142.24 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -1.149 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 18.9 p30 -142.56 104.64 4.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 65' ' ' SER . 41.6 pt -108.39 -146.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.446 ' N ' HG13 ' A' ' 64' ' ' ILE . 11.0 p -145.78 -45.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.344 -0.848 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HD2' ' OG ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -150.54 150.07 30.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.27 116.89 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 1.8 ptm180 -151.93 123.6 7.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.639 ' HB3' HG22 ' A' ' 45' ' ' VAL . . . -70.63 121.91 18.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.154 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -132.44 15.25 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 72' ' ' ILE . 12.1 tt0 53.96 168.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 76' ' ' ASP . 16.6 tt -94.44 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -0.877 . . . . 0.0 110.277 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 7.3 m -109.75 15.68 22.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.5 mmtt 66.24 5.38 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.284 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -88.01 -24.07 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.286 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.826 ' HB3' HD11 ' A' ' 72' ' ' ILE . 5.2 p-10 -43.54 -29.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.1 m-85 -71.21 -27.2 63.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -123.18 9.23 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.153 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.467 ' C ' ' CD1' ' A' ' 80' ' ' PHE . 5.4 tptt -107.3 -36.83 6.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 5.9 m-30 -114.78 -142.59 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.78 -38.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 72.4 t -124.3 151.79 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.414 HG23 HD23 ' A' ' 8' ' ' LEU . 2.7 mt -129.78 114.92 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.482 ' HA ' HG23 ' A' ' 107' ' ' VAL . . . -98.14 138.36 35.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.98 141.53 49.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.199 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.973 HD23 ' CB ' ' A' ' 17' ' ' ARG . 5.0 tp -95.04 4.52 53.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.616 ' CB ' HD11 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -146.41 -156.08 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -117.77 -42.76 2.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.583 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -44.51 -28.69 0.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.826 HG23 ' CG2' ' A' ' 40' ' ' THR . 1.4 mp -70.9 -48.77 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.885 . . . . 0.0 110.126 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.425 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -68.61 -27.35 65.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.208 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 t -78.48 -40.51 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 96' ' ' SER . 40.1 m-20 -83.7 -50.54 8.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 95' ' ' ASN . 3.4 tt -45.43 -41.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.561 ' N ' HG23 ' A' ' 94' ' ' ILE . 3.5 t-20 -66.53 -7.84 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.229 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 57.2 m -86.79 -22.85 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.545 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.7 ptt? -104.98 -35.4 7.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 97' ' ' MET . 8.7 mtpt -42.24 122.8 2.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.155 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.97 -172.31 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.901 1.474 . . . . 0.0 110.455 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.21 13.4 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.887 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -137.41 91.47 2.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.0 p -149.65 177.07 10.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.39 27.03 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.2 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 138.17 52.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.7 156.63 17.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.445 ' C ' HG13 ' A' ' 107' ' ' VAL . 6.1 t -112.58 158.25 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.522 HG11 ' NE2' ' A' ' 143' ' ' HIS . 33.0 m -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.69 142.18 27.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.566 ' CE2' ' HE3' ' A' ' 136' ' ' MET . 0.1 OUTLIER -90.91 -64.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.44 ' OD1' HG22 ' A' ' 115' ' ' VAL . 10.5 p30 -141.78 164.17 36.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.484 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.4 Cg_endo -74.39 174.73 12.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.945 1.497 . . . . 0.0 110.281 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.09 52.45 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -152.65 -40.14 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.092 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.22 -67.89 1.98 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.568 HG23 ' HD3' ' A' ' 17' ' ' ARG . 21.8 m -103.51 86.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -1.196 . . . . 0.0 110.063 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.444 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 9.9 t70 -67.52 160.85 26.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.79 67.84 4.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.1 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 116' ' ' ASP . 46.0 Cg_endo -72.8 162.99 39.69 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.05 1.553 . . . . 0.0 110.539 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.71 163.77 27.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.163 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 50.83 26.82 2.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 122' ' ' SER . 26.0 t -155.53 -168.7 2.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.42 ' N ' ' OG ' ' A' ' 121' ' ' SER . 44.2 p -141.28 75.63 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -29.98 2.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 128' ' ' MET . . . -101.72 -34.7 4.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.676 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 12.3 m-85 -41.34 -55.38 5.33 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -1.128 . . . . 0.0 110.278 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.676 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -71.92 -60.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.835 1.439 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 131' ' ' SER . 9.8 m -49.83 -44.16 49.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.173 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.678 ' O ' HG22 ' A' ' 132' ' ' ILE . 25.1 ttp -50.95 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.21 -0.931 . . . . 0.0 109.788 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.939 ' CD1' HD11 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -45.81 -59.05 3.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.904 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -46.46 -26.45 0.86 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 110.037 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.555 ' CB ' ' CG1' ' A' ' 115' ' ' VAL . 1.1 m -87.92 -71.39 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -42.17 -25.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 179.072 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.516 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . 22.9 t -90.22 -60.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -51.61 -22.29 3.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.056 -1.028 . . . . 0.0 110.119 -179.918 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.528 ' HB3' ' CE1' ' A' ' 109' ' ' PHE . 0.8 OUTLIER -110.89 11.3 22.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.815 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.592 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -88.15 -3.84 58.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.8 mttt -90.55 -47.64 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.996 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.5 Cg_endo -75.37 1.84 7.47 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.631 1.332 . . . . 0.0 110.557 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.621 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 4.5 t80 -105.67 -47.25 3.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.037 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -78.3 -53.71 7.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.792 HG23 ' OXT' ' A' ' 146' ' ' ILE . 5.0 m -44.65 -26.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 143' ' ' HIS . 39.3 mt-10 -104.61 -40.3 6.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.621 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -43.05 -26.83 0.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.087 -1.008 . . . . 0.0 110.195 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 127.18 67.32 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.677 ' HB2' HD23 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -161.19 -70.72 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 110.114 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.792 ' OXT' HG23 ' A' ' 141' ' ' THR . 2.0 tt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.691 0.758 . . . . 4.21 110.46 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.752 ' HA ' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -119.4 143.19 47.59 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.092 -0.707 . . . . 4.04 109.092 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 15.3 mttt -115.19 -131.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.138 -0.976 . . . . 2.5800000000000001 110.708 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.822 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . -176.79 103.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.438 -0.789 . . . . 0.97999999999999998 109.672 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.807 ' CG1' ' HB2' ' A' ' 84' ' ' ALA . 41.4 t -90.32 138.65 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 1.24 110.495 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.777 HD12 ' HB2' ' A' ' 36' ' ' ASP . 5.7 tp -87.0 94.56 9.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 1.03 110.019 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.591 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 2.4 m-85 -78.44 104.33 8.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 2.3900000000000001 110.063 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.017 HG22 ' C ' ' A' ' 38' ' ' ALA . 30.5 t -123.46 163.11 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 1.4099999999999999 110.296 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 1.5 p -149.99 -53.53 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 2.0899999999999999 110.39 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 173.88 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.139 -0.975 . . . . 1.98 110.237 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.866 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . 136.21 -4.9 3.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.724 -1.35 . . . . 1.99 109.724 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.498 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 5.0 t30 69.43 38.13 1.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -1.148 . . . . 2.6299999999999999 110.262 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 44' ' ' HIS . 12.5 mt -136.49 -39.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 1.6200000000000001 110.235 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 88.3 m -90.39 107.79 19.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 3.4199999999999999 110.178 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.554 ' CG ' ' HG3' ' A' ' 128' ' ' MET . 0.9 OUTLIER 73.55 -4.19 2.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 3.54 110.392 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -84.42 -51.53 0.57 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 4.4500000000000002 110.66 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 18' ' ' SER . 47.3 Cg_endo -75.22 3.48 5.69 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.817 1.43 . . . . 2.3999999999999999 110.619 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.657 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -98.85 -19.01 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 1.21 110.209 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 132' ' ' ILE . 22.0 m -71.55 -36.98 71.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 1.5900000000000001 109.991 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.715 ' HA ' HG21 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -63.04 -38.38 90.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 2.2799999999999998 110.015 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.803 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -76.72 -56.01 4.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.636 -1.386 . . . . 0.81000000000000005 109.636 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 133' ' ' SER . 5.7 tp -50.11 -44.78 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -1.198 . . . . 1.1299999999999999 110.129 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.95 ' HB3' HD11 ' A' ' 35' ' ' ILE . 69.4 m -72.22 -53.31 12.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 1.3999999999999999 110.042 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -43.53 -41.03 4.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 2.4199999999999999 109.99 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -33.66 26.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 2.0600000000000001 110.243 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -59.12 -44.37 92.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 2.3900000000000001 110.468 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.584 HG11 ' HD2' ' A' ' 32' ' ' LYS . 5.6 t -108.3 -32.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.96 . . . . 2.2000000000000002 110.517 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 123.55 -54.1 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.546 -1.422 . . . . 2.29 109.546 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.6 t70 179.61 90.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 3.5899999999999999 110.254 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.584 ' HD2' HG11 ' A' ' 29' ' ' VAL . 15.0 mttt -141.61 -137.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 3.5 110.173 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.81 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.9 mt -116.39 -123.07 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 3.7200000000000002 110.07 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.028 HD13 HD13 ' A' ' 140' ' ' LEU . 0.5 OUTLIER 50.45 5.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.53 -0.731 . . . . 1.99 111.305 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.95 HD11 ' HB3' ' A' ' 25' ' ' CYS . 3.5 mt -121.2 109.27 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.95 -1.094 . . . . 2.21 110.724 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.777 ' HB2' HD12 ' A' ' 8' ' ' LEU . 6.7 m-20 -143.1 91.75 2.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.8799999999999999 109.986 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 2.8 m -69.4 137.97 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.6200000000000001 110.221 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.017 ' C ' HG22 ' A' ' 10' ' ' VAL . . . -151.61 177.18 10.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.94999999999999996 110.315 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -162.71 144.99 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 1.23 110.176 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -109.0 38.93 2.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 1.9399999999999999 110.193 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -160.72 87.04 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 1.8600000000000001 110.214 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.26 68.7 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.517 -1.433 . . . . 2.1600000000000001 109.517 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' SER . 2.1 m-85 -108.39 -61.05 1.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -1.164 . . . . 3.0299999999999998 110.172 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.421 ' O ' HD11 ' A' ' 15' ' ' ILE . 2.2 m170 -92.05 91.22 7.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 2.6200000000000001 110.191 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 64.5 t -136.06 162.77 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 1.98 110.229 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.418 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 53.61 37.12 55.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 1.6299999999999999 109.561 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 48' ' ' SER . 11.1 pt20 -172.11 -144.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -1.127 . . . . 1.77 110.196 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HG ' ' HH ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER 57.27 110.7 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 1.8600000000000001 110.167 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.8 Cg_endo -69.46 92.37 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.012 1.533 . . . . 1.78 110.45 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 1.2 m-20 -86.48 19.02 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 2.8399999999999999 110.207 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -75.43 -27.93 59.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.247 -0.908 . . . . 1.4299999999999999 109.077 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.603 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 45.0 mtt180 -72.6 -51.65 18.8 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.822 -0.751 . . . . 3.2200000000000002 109.369 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 t -63.55 -49.83 71.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -0.794 . . . . 1.51 109.615 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.511 ' CD ' HD11 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -60.42 -39.92 89.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.274 -0.891 . . . . 2.2000000000000002 109.305 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -59.42 -67.68 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 3.23 109.542 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.57 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 22.0 t -48.41 -34.21 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 1.8999999999999999 109.239 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.936 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.22 -54.93 41.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 1.25 109.605 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -68.54 -20.36 64.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 2.6400000000000001 109.706 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 2.4 t -87.65 -13.58 42.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.357 -0.839 . . . . 1.49 110.103 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -114.77 -30.7 6.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 1.6000000000000001 109.326 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.707 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 136.22 79.73 0.1 OUTLIER Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.922 -1.271 . . . . 1.25 109.922 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.936 HG11 ' SG ' ' A' ' 57' ' ' CYS . 40.6 t -159.61 123.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -1.079 . . . . 1.8 110.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.14 105.05 14.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 2.46 110.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.691 HD12 HE21 ' A' ' 67' ' ' GLN . 35.6 pt -120.73 -145.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 2.0299999999999998 110.237 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.488 ' N ' HG13 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -170.03 -64.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 3.6800000000000002 110.229 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' A' ' 65' ' ' SER . 15.7 mmtt -142.25 145.93 34.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 5.8300000000000001 110.126 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.691 HE21 HD12 ' A' ' 64' ' ' ILE . 32.3 mm-40 -122.11 56.65 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 2.77 110.258 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ALA . 1.5 ttp85 -69.18 71.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 4.2599999999999998 110.182 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB1' ' O ' ' A' ' 13' ' ' GLY . . . -42.51 136.28 2.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 1.3799999999999999 110.236 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 ptt-85 -140.34 158.44 44.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 2.1499999999999999 110.203 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.55 145.32 55.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 2.2400000000000002 110.197 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 72' ' ' ILE . 6.6 tt -89.96 128.76 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 1.49 110.213 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.2 p -86.22 -142.75 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 2.1099999999999999 110.213 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -109.43 -5.98 15.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 3.4100000000000001 110.222 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -75.19 -21.34 58.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.3300000000000001 110.247 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 4.2 p-10 -44.68 -28.81 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 2.46 110.194 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.578 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 25.1 m-85 -79.63 -46.49 17.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 1.55 110.248 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -95.06 8.42 43.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 1.9299999999999999 110.209 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.59 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 14.0 tptt -102.62 -2.76 27.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 2.7799999999999998 110.228 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.788 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 91.8 m-85 -151.62 -157.56 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 1.71 110.298 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.3 -26.28 2.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 2.3300000000000001 110.551 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' A' ' 143' ' ' HIS . 97.0 t -136.94 150.88 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.052 . . . . 1.26 110.576 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.676 HG21 ' CD1' ' A' ' 94' ' ' ILE . 1.7 mp -123.24 116.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.824 . . . . 0.83999999999999997 109.902 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.807 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -103.12 118.82 37.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.80000000000000004 110.483 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -109.61 112.72 24.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.78000000000000003 110.065 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 5.0 mp -59.48 -84.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 1.23 110.356 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.62 ' O ' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -62.77 159.81 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 2.02 110.273 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 2.0899999999999999 110.184 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -52.81 -40.16 63.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 1.6200000000000001 110.165 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 87' ' ' ASP . 2.8 mt -65.2 -51.73 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 1.7 110.189 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.539 HD12 ' HB3' ' A' ' 85' ' ' ALA . 0.5 OUTLIER -61.29 -43.55 98.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.92000000000000004 110.378 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 t -64.81 -48.62 73.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.917 . . . . 1.1899999999999999 110.264 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -64.65 -63.67 1.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 1.73 110.265 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.676 ' CD1' HG21 ' A' ' 83' ' ' ILE . 6.1 tt -42.76 -38.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 1.4299999999999999 110.248 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.496 ' N ' HG23 ' A' ' 94' ' ' ILE . 28.6 t-20 -71.9 -24.9 61.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 1.9399999999999999 110.214 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 93' ' ' ASP . 42.7 t -76.88 -2.02 31.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 1.3999999999999999 110.225 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.0 ptt? -123.97 -25.33 4.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 1.1200000000000001 110.219 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 1.4 mtpt -49.04 143.02 9.16 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 1.04 110.26 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.09 -159.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.991 1.522 . . . . 1.4399999999999999 110.438 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.84 2.62 15.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.86 . . . . 2.0800000000000001 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -149.16 108.11 3.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 3.3799999999999999 110.263 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.4 p -149.48 -173.79 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.887 . . . . 1.95 110.222 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 17.08 7.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 2.8399999999999999 110.218 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.46 157.93 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.88 110.208 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -115.43 157.23 24.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.281 -0.887 . . . . 2.5699999999999998 110.177 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.6 t -118.61 114.51 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 1.4299999999999999 110.185 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.569 HG11 ' CE1' ' A' ' 143' ' ' HIS . 27.6 m -121.58 148.19 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 1.4099999999999999 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 109' ' ' PHE . 1.3 tp -85.68 152.8 22.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 1.45 110.181 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.522 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 4.4 t80 -115.82 109.3 17.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 2.1699999999999999 110.268 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.494 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER 57.79 156.25 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 2.8399999999999999 110.28 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.494 ' HD2' ' ND2' ' A' ' 110' ' ' ASN . 47.0 Cg_endo -74.83 174.26 13.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.039 1.547 . . . . 2.6299999999999999 110.28 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.85 52.33 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 4.0899999999999999 110.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -145.9 -47.03 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 2.9500000000000002 110.251 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.39 -102.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 2.1499999999999999 109.552 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 115' ' ' VAL . 30.8 m -54.55 105.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 1.9199999999999999 110.225 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -148.22 29.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 4.1500000000000004 110.247 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.512 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 6.9 t0 -48.95 112.41 2.43 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 4.1399999999999997 110.199 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 46.8 Cg_endo -72.73 -93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.939 1.494 . . . . 3.5600000000000001 110.427 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 168.12 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 3.8700000000000001 110.178 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.19 -46.99 0.34 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 6.1500000000000004 110.254 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.59 167.07 10.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 2.27 110.227 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.548 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -88.24 32.68 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 2.6299999999999999 110.185 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.91 16.61 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 2.1600000000000001 110.221 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -118.91 -44.12 0.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.497 -1.441 . . . . 1.3200000000000001 109.497 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 5.2 m-85 -44.17 -48.15 23.76 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.169 . . . . 2.0899999999999999 110.396 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 46.7 Cg_endo -72.59 -54.53 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.625 1.329 . . . . 1.0800000000000001 110.349 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 23.1 m -62.13 -53.88 49.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 1.6000000000000001 110.142 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.657 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 10.7 ttp -41.85 -65.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 1.0900000000000001 110.108 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 50.2 t80 -56.25 -44.78 80.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 1.48 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -44.06 -59.73 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 1.1100000000000001 109.99 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 25.7 m -70.75 -42.31 70.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.6299999999999999 109.867 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.791 HD11 ' SG ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -41.58 -43.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 1.5 109.904 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.777 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.2 -40.49 7.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 1.5900000000000001 110.241 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 33.5 tttt -55.47 -16.64 3.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 3.5699999999999998 110.227 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.479 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 4.2 tp10 -117.9 16.13 14.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 3.0899999999999999 109.809 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.553 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -102.97 -21.2 13.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 2.8799999999999999 110.162 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 19.4 mttt -81.93 -47.04 1.01 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 3.1200000000000001 110.148 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -77.79 -2.52 12.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.982 1.517 . . . . 1.04 110.271 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 143' ' ' HIS . 48.8 t80 -111.03 -72.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 1.77 110.116 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.028 HD13 HD13 ' A' ' 34' ' ' ILE . 1.8 tp -47.83 -49.34 29.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 1.6100000000000001 110.052 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.742 HG23 ' OXT' ' A' ' 146' ' ' ILE . 6.7 m -58.3 -29.19 65.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.1699999999999999 110.349 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -106.84 5.93 28.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 2.2999999999999998 110.397 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.915 ' CD2' HG11 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -96.33 -6.16 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.129 -0.982 . . . . 2.21 110.348 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.469 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 124.77 28.47 1.15 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 2.1499999999999999 109.726 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -144.36 -103.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -1.182 . . . . 2.3799999999999999 110.191 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.953 HD13 ' OXT' ' A' ' 146' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.0 -1.0 . . . . 3.0600000000000001 110.148 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.558 0.694 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -119.42 145.07 46.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 34' ' ' ILE . 16.0 mtmt -125.7 -156.21 0.72 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.058 -1.026 . . . . 0.0 110.975 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.863 ' HB1' ' OD2' ' A' ' 36' ' ' ASP . . . -124.88 157.13 36.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.678 -0.639 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.689 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 13.6 t -138.75 121.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.692 HD13 ' CD2' ' A' ' 80' ' ' PHE . 7.7 tp -76.91 103.39 6.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 18.3 m-85 -83.16 86.28 7.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 38' ' ' ALA . 6.7 t -93.86 154.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.883 ' SG ' HD22 ' A' ' 86' ' ' LEU . 59.2 m -146.72 -71.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.136 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.447 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 175.96 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.262 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 80.47 -2.3 78.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.51 ' CB ' ' HB2' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 67.86 8.42 6.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.744 HG23 ' OD2' ' A' ' 50' ' ' ASP . 24.5 mt -118.61 -22.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.151 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 11' ' ' CYS . 14.5 m -86.09 111.64 20.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.267 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.61 ' HB2' HD22 ' A' ' 86' ' ' LEU . 1.1 mpt_? 60.9 12.28 3.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.535 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -78.85 -55.18 1.0 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.465 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 47.4 Cg_endo -74.23 1.34 7.39 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.844 1.444 . . . . 0.0 110.576 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -97.54 -28.34 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.347 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.826 ' HA ' HD11 ' A' ' 132' ' ' ILE . 63.8 m -74.1 -33.95 63.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.722 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -63.78 -45.66 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.462 -0.773 . . . . 0.0 110.304 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -76.77 -51.58 6.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.152 HD12 ' CD2' ' A' ' 129' ' ' PHE . 1.1 tt -52.01 -45.22 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 0.0 110.357 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.596 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 88.4 m -75.76 -51.85 11.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.179 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 3.6 mtp85 -44.12 -40.95 5.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.904 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -80.48 -43.01 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.721 ' SD ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -58.38 -52.6 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 0.0 110.437 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.504 HG13 HD22 ' A' ' 145' ' ' LEU . 2.8 t -87.8 -34.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.369 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.38 -82.84 0.33 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.446 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 16.4 t0 -156.39 85.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -1.09 . . . . 0.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 31' ' ' ASP . 18.0 mmtm -129.8 -139.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.125 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.5 mt -119.15 -33.02 4.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.987 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.706 ' CA ' ' HA ' ' A' ' 6' ' ' ALA . 2.4 pp -32.17 -31.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.647 -0.658 . . . . 0.0 111.145 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.722 HG23 ' HA ' ' A' ' 22' ' ' GLU . 1.7 mt -73.96 88.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.483 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.863 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 49.0 m-20 -127.33 68.75 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.117 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -54.77 139.41 39.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.766 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -153.73 -179.09 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 14' ' ' ASN . . . -150.07 -173.7 4.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 40' ' ' THR . 5.3 t -162.04 67.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.908 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 -68.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 110.206 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -22.6 39.63 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 45' ' ' VAL . 9.8 m-85 -62.69 -63.44 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.44 70.88 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.859 HG22 ' HB1' ' A' ' 69' ' ' ALA . 44.5 t -144.75 142.27 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.95 18.98 58.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -168.11 -142.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 110.255 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 15' ' ' ILE . 0.6 OUTLIER 62.1 108.36 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.208 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 103.06 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.072 1.564 . . . . 0.0 110.486 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' A' ' 15' ' ' ILE . 61.5 m-20 -95.99 20.51 9.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -74.39 -27.76 60.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.949 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.595 ' HB3' ' CG ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -74.01 -52.07 13.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.296 179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.512 ' O ' HG12 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -61.37 -51.67 67.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -61.37 -41.01 96.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 109.263 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -54.2 -66.16 0.45 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.416 -0.803 . . . . 0.0 109.467 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.575 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 10.0 p -53.41 -32.01 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.911 . . . . 0.0 109.216 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.959 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -56.3 -52.12 65.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.534 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -24.34 60.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.302 -0.874 . . . . 0.0 109.651 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -81.74 -12.42 58.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.3 m120 -114.59 -29.07 6.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.732 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 131.71 81.02 0.2 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.959 HG11 ' SG ' ' A' ' 57' ' ' CYS . 26.0 t -160.36 133.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -1.131 . . . . 0.0 110.14 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -122.15 93.15 3.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 0.0 110.2 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.485 HG12 ' NE2' ' A' ' 54' ' ' GLN . 26.0 pt -97.54 165.5 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.83 37.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.48 85.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 0.0 110.183 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.546 ' NE2' ' HB3' ' A' ' 19' ' ' PRO . 5.0 mp0 -105.18 -79.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.148 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' ALA . 7.3 ttp180 43.61 75.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 110.242 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.859 ' HB1' HG22 ' A' ' 45' ' ' VAL . . . -42.43 149.22 0.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.87 -170.44 3.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -107.66 155.43 20.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.68 155.78 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.02 168.99 9.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -16.31 23.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -22.57 62.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.182 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 28.4 p-10 -48.38 -37.88 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.241 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CE2' ' HD3' ' A' ' 99' ' ' PRO . 20.8 m-85 -65.85 -10.87 42.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 110.21 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.414 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 27.7 t -144.52 30.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.58 ' CG ' ' CE2' ' A' ' 80' ' ' PHE . 15.7 tptt -111.17 -5.33 14.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.692 ' CD2' HD13 ' A' ' 8' ' ' LEU . 87.0 m-85 -151.7 -139.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.235 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 -53.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.918 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 74.6 t -119.13 111.04 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.467 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.443 ' HB ' HG22 ' A' ' 106' ' ' VAL . 3.9 mt -84.29 110.39 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.053 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.73 135.78 38.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 110.386 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -117.43 121.75 41.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.883 HD22 ' SG ' ' A' ' 11' ' ' CYS . 2.2 mp -66.09 -80.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.451 ' C ' HD12 ' A' ' 90' ' ' ILE . 1.3 t0 -67.4 178.72 1.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.254 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -85.88 -35.07 20.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -51.46 -33.51 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 110.229 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.9 mt -71.02 -52.53 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.5 OUTLIER -64.12 -34.4 77.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.23 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 t -77.86 -46.97 19.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 89' ' ' SER . 5.4 m-20 -67.09 -57.41 6.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 90' ' ' ILE . 3.9 tt -46.37 -40.82 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.53 ' N ' HG23 ' A' ' 94' ' ' ILE . 8.3 t-20 -68.23 -24.93 64.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 93' ' ' ASP . 8.5 t -73.19 -17.08 61.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.537 ' HE1' HG13 ' A' ' 94' ' ' ILE . 9.3 ptt? -109.68 -27.14 9.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 2.3 mtpt -42.73 138.65 2.21 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.591 ' HD3' ' CE2' ' A' ' 77' ' ' PHE . 46.0 Cg_endo -73.26 -160.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.094 1.576 . . . . 0.0 110.422 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.497 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 26.3 t -113.36 15.78 19.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 110.153 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 100' ' ' SER . 4.8 m-80 -155.02 104.95 2.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.2 p -137.33 -179.91 6.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.89 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.414 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -127.05 -5.54 6.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.52 -168.06 1.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.253 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.64 150.45 41.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 83' ' ' ILE . 45.1 t -116.37 142.6 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.209 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 106' ' ' VAL . 13.1 m -151.64 155.36 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.523 ' CG ' ' OD1' ' A' ' 110' ' ' ASN . 1.6 tp -89.28 142.2 27.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 132' ' ' ILE . 36.1 t80 -129.11 76.14 1.7 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.523 ' OD1' ' CG ' ' A' ' 108' ' ' LEU . 6.8 p-10 -176.9 166.24 1.42 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.7 Cg_endo -75.53 175.89 10.69 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.043 1.549 . . . . 0.0 110.296 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.0 Cg_endo -73.72 4.72 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.932 1.491 . . . . 0.0 110.489 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -122.36 -14.86 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.217 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.04 141.56 8.91 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 4.0 m -80.06 4.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -1.138 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 14.5 t70 178.01 169.4 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.237 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.563 ' CB ' ' CD ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -179.8 -59.35 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 117' ' ' ASP . 46.9 Cg_endo -73.13 88.76 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.94 1.494 . . . . 0.0 110.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.525 ' CE1' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -65.78 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.942 . . . . 0.0 110.17 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.474 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 1.7 t80 66.66 -62.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 119' ' ' TYR . 52.4 p -70.47 144.73 51.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.465 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 5.5 p -80.89 48.59 1.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.72 42.45 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -159.65 -37.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.649 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 47.5 m-85 -52.15 -44.98 93.94 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -1.163 . . . . 0.0 110.572 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 46.8 Cg_endo -74.13 -59.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.685 1.36 . . . . 0.0 110.286 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -55.3 -43.12 74.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.722 ' O ' HG22 ' A' ' 132' ' ' ILE . 27.1 ttp -48.6 -80.55 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 1.152 ' CD2' HD12 ' A' ' 24' ' ' ILE . 6.1 t80 -49.01 -55.51 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.088 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -44.21 -28.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 110.513 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.8 m -88.85 -60.32 1.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.943 HG12 HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -50.46 -19.48 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.268 179.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 1.048 ' CB ' HD11 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -98.15 -48.68 5.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.894 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 1.9 mmmm -71.02 -2.71 16.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 110.131 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.15 5.22 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.839 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.673 ' HA ' ' HE3' ' A' ' 136' ' ' MET . 1.5 tpt -82.97 11.77 5.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.394 -0.816 . . . . 0.0 110.193 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.534 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 2.3 mmtt -90.51 -55.16 0.28 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.213 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 48.2 Cg_endo -76.26 -2.87 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CD1' ' CE ' ' A' ' 136' ' ' MET . 25.1 t80 -108.16 -51.92 2.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.259 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.721 HD22 ' SD ' ' A' ' 28' ' ' MET . 0.8 OUTLIER -71.67 -55.95 6.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.586 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 56.3 m -41.93 -36.71 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 110.468 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.22 -63.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.724 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -100.96 63.72 1.03 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.752 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -179.8 -32.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.015 ' HG ' HG22 ' A' ' 146' ' ' ILE . 0.6 OUTLIER 172.56 -91.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.472 -1.016 . . . . 0.0 109.864 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.015 HG22 ' HG ' ' A' ' 145' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.129 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.241 0.543 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.568 ' HE3' ' CA ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -76.58 -175.31 3.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.293 -0.879 . . . . 0.0 109.05 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.759 ' CD ' HD12 ' A' ' 145' ' ' LEU . 33.0 mtpt -145.9 177.37 8.98 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.901 -1.124 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.061 ' HB1' HD11 ' A' ' 34' ' ' ILE . . . -145.77 124.4 12.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.066 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 18.7 t -114.43 125.37 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.965 HD11 ' HB2' ' A' ' 38' ' ' ALA . 50.2 tp -79.24 98.94 6.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 1.116 ' CD1' HG23 ' A' ' 35' ' ' ILE . 96.7 m-85 -85.98 104.63 15.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.893 HG22 ' HB3' ' A' ' 38' ' ' ALA . 3.8 t -103.11 149.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.659 ' SG ' HD22 ' A' ' 86' ' ' LEU . 24.2 m -127.08 -151.33 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.92 . . . . 0.0 110.021 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -87.12 -30.46 21.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -144.18 9.99 2.0 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.99 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 43.5 t-20 59.26 49.68 8.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 0.0 110.29 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 69' ' ' ALA . 15.3 mt -136.75 -57.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.2 t -124.37 -138.42 0.29 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.288 -0.883 . . . . 0.0 110.133 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.85 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.38 -55.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.392 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.76 ' HB2' HD21 ' A' ' 86' ' ' LEU . 1.3 m -161.08 53.65 0.49 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.477 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.0 Cg_endo -75.31 -23.78 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.031 1.542 . . . . 0.0 110.308 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.999 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . . . -78.49 6.82 7.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.976 ' HB3' HG21 ' A' ' 35' ' ' ILE . 6.0 t -61.24 -32.04 71.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.819 ' HA ' HD13 ' A' ' 35' ' ' ILE . 2.1 tt0 -56.03 -54.05 49.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -76.48 -39.31 30.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.969 HD12 ' CD2' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -53.87 -47.21 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.243 . . . . 0.0 110.037 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.897 ' CB ' HD11 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.28 -49.97 11.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 9.0 mtt180 -54.23 -31.0 52.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.68 -40.83 12.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.496 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.55 -30.95 70.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.701 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.789 ' CB ' HD21 ' A' ' 33' ' ' LEU . 83.1 t -124.72 -22.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.92 -82.4 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.462 ' C ' ' CG ' ' A' ' 32' ' ' LYS . 2.7 m-20 -149.76 68.14 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.261 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.77 ' O ' HD23 ' A' ' 33' ' ' LEU . 2.0 mtpm? -148.9 37.86 0.81 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 29' ' ' VAL . 0.4 OUTLIER 166.6 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.437 -0.789 . . . . 0.0 109.591 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.061 HD11 ' HB1' ' A' ' 6' ' ' ALA . 2.7 pp -42.59 168.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.116 HG23 ' CD1' ' A' ' 9' ' ' PHE . 4.7 mp -121.06 102.32 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 80' ' ' PHE . 9.4 m-20 -88.31 114.21 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.062 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.7 m -75.17 116.3 15.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.032 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.965 ' HB2' HD11 ' A' ' 8' ' ' LEU . . . -120.85 175.18 6.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.99 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -161.16 149.3 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 t -116.75 -2.45 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.09 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.28 170.81 13.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 110.145 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.52 50.15 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -17.36 32.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -1.165 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.443 ' O ' HD11 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -141.97 80.47 1.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 69' ' ' ALA . 86.5 t -134.44 146.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.07 58.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 48' ' ' SER . 1.3 pt20 -158.94 -146.79 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -1.147 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 65.12 99.68 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 100.89 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.083 1.57 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 1.6 t0 -89.72 26.83 1.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.547 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -76.32 -31.92 58.42 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.225 -0.922 . . . . 0.0 109.051 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -70.31 -49.7 46.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.262 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.531 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.3 t -63.35 -53.49 51.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.573 -0.704 . . . . 0.0 109.683 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.682 ' HB2' HD13 ' A' ' 64' ' ' ILE . 4.1 pp0? -61.04 -31.2 70.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.257 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.4 -66.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.383 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.557 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 35.7 m -52.79 -33.36 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.203 -0.935 . . . . 0.0 109.115 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.999 ' SG ' ' HB2' ' A' ' 20' ' ' ALA . 32.0 m -57.47 -53.07 62.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 109.508 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -23.17 63.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.99 -11.9 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 110.061 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.6 m-80 -112.44 -23.77 10.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.212 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 124.17 75.79 0.29 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.659 HG11 ' CB ' ' A' ' 20' ' ' ALA . 55.0 t -158.09 102.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -1.145 . . . . 0.0 110.205 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -78.34 74.26 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.988 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 54' ' ' GLN . 3.4 pt -60.1 -173.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -160.22 70.07 0.41 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.22 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 90.3 mm-40 -56.52 -60.0 4.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.218 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.38 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.269 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.644 ' HB2' HG12 ' A' ' 15' ' ' ILE . . . -60.59 131.4 50.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -140.44 152.23 45.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.245 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.06 144.18 38.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.195 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.592 HD12 ' HB1' ' A' ' 38' ' ' ALA . 19.7 tt -75.8 145.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.281 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.778 HG22 ' OD1' ' A' ' 76' ' ' ASP . 9.1 t -89.72 -146.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.13 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -118.6 -5.29 10.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.31 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.63 ' H ' HG23 ' A' ' 73' ' ' THR . . . -96.67 -8.43 31.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.778 ' OD1' HG22 ' A' ' 73' ' ' THR . 1.1 m-20 -45.1 -47.63 12.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.587 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 53.5 m-85 -48.61 -36.71 16.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.9 t -102.07 -16.04 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.16 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -66.25 -25.56 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.194 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.878 ' CE2' HD13 ' A' ' 8' ' ' LEU . 7.4 m-85 -132.28 169.6 16.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.1 -33.78 20.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.377 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' CD2' ' A' ' 143' ' ' HIS . 47.6 t -134.23 153.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.31 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.521 HG23 ' HB3' ' A' ' 8' ' ' LEU . 4.8 mt -129.75 128.3 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 109' ' ' PHE . . . -126.12 143.37 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.464 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -113.67 156.49 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.85 HD23 ' HB3' ' A' ' 17' ' ' ARG . 1.2 tp -85.3 -52.88 5.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 3.7 m-20 -99.56 -174.87 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.905 . . . . 0.0 110.244 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.58 -35.74 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -46.13 -41.27 12.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 87' ' ' ASP . 1.4 mp -71.02 -54.15 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.152 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -60.49 -15.81 30.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 t -93.26 -41.26 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.18 -16.88 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.182 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.543 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.3 tt -74.14 -40.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.168 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.524 ' N ' HG23 ' A' ' 94' ' ' ILE . 29.6 p30 -68.12 -9.76 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.65 -38.71 23.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.883 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.543 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.1 ptt? -84.1 -34.3 24.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.239 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -52.62 126.55 40.09 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 100' ' ' SER . 45.2 Cg_endo -73.39 -87.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.053 1.554 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 169.74 -23.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.4 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.84 43.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.128 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.8 p -99.47 -145.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.267 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 27.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.03 32.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.45 146.05 45.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 9.8 m -108.41 132.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' ALA . 22.6 m -131.27 156.51 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.256 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.427 ' HB2' HD13 ' A' ' 91' ' ' LEU . 26.4 tp -92.46 102.4 14.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.123 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.58 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . 4.9 t80 -81.09 82.61 6.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.134 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 7.7 t30 -170.09 142.16 1.84 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.497 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.5 Cg_endo -74.35 175.01 11.56 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.94 1.495 . . . . 0.0 110.35 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.02 52.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.977 1.514 . . . . 0.0 110.434 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.59 -37.18 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.206 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 101.54 2.51 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.474 HG23 ' OD1' ' A' ' 110' ' ' ASN . 71.4 t -57.66 98.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -1.209 . . . . 0.0 110.118 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.23 148.03 26.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 110.197 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 87.73 6.52 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.89 173.47 13.48 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.005 1.529 . . . . 0.0 110.406 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -115.75 161.92 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.23 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 50.38 41.65 25.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.155 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -150.89 -174.76 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.3 p -143.79 40.17 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.892 . . . . 0.0 110.174 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.32 54.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.56 ' HA2' ' CG2' ' A' ' 127' ' ' THR . . . -179.08 -32.84 0.06 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.623 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 8.1 m-85 -41.76 -50.29 10.05 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 110.731 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 43.4 Cg_endo -71.38 -74.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.81 1.426 . . . . 0.0 110.975 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.56 ' CG2' ' HA2' ' A' ' 124' ' ' GLY . 15.1 t -39.95 -40.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.168 -0.958 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.797 ' O ' HG22 ' A' ' 132' ' ' ILE . 9.6 ttp -55.17 -78.95 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.188 -0.945 . . . . 0.0 109.823 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.969 ' CD2' HD12 ' A' ' 24' ' ' ILE . 2.7 t80 -42.6 -51.29 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.167 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.441 ' N ' ' HD1' ' A' ' 129' ' ' PHE . . . -58.81 -22.41 58.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.5 t -90.32 -51.28 5.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.04 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.886 HD11 ' CB ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -61.8 -16.96 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.786 ' HB2' HD11 ' A' ' 24' ' ' ILE . 2.3 t -96.0 -51.05 4.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.557 -0.714 . . . . 0.0 109.849 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.22 -20.84 65.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.974 . . . . 0.0 110.111 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 131' ' ' SER . 0.2 OUTLIER -76.93 -30.17 55.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.587 ' CE ' ' HA ' ' A' ' 133' ' ' SER . 0.6 OUTLIER -77.57 5.23 9.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.209 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.538 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 3.0 mmtt -89.24 -54.65 0.31 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.35 -10.73 17.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.041 1.548 . . . . 0.0 110.426 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 32.9 t80 -102.17 -77.23 0.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.616 HD21 HD22 ' A' ' 33' ' ' LEU . 14.6 tp -40.81 -62.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.382 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.845 HG23 HD12 ' A' ' 146' ' ' ILE . 30.6 m -41.66 -29.13 0.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LEU . 3.3 mm-40 -101.59 -25.82 13.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 1.5 t60 -66.32 -21.66 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.02 36.42 0.18 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.759 HD12 ' CD ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -173.38 93.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 110.14 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.845 HD12 HG23 ' A' ' 141' ' ' THR . 4.2 tp . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.246 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.51 ' O ' ' CD2' ' A' ' 145' ' ' LEU . 2.2 mm-40 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.249 0.547 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -80.47 171.2 15.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.309 -0.869 . . . . 0.0 108.762 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 9.4 mtpp -151.8 164.12 37.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.86 -1.15 . . . . 0.0 111.26 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.872 ' HA ' ' CG1' ' A' ' 34' ' ' ILE . . . -105.91 99.93 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.75 -0.593 . . . . 0.0 109.773 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 33' ' ' LEU . 12.6 t -104.01 108.35 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 38' ' ' ALA . 29.7 tp -92.56 111.04 22.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 1.071 ' CD1' HG23 ' A' ' 35' ' ' ILE . 12.5 m-85 -85.97 128.48 34.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.814 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.688 HG23 ' C ' ' A' ' 38' ' ' ALA . 10.9 p -143.37 172.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -0.981 . . . . 0.0 110.633 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.946 ' O ' HD12 ' A' ' 90' ' ' ILE . 16.8 t -153.6 -69.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 110.126 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 172.99 84.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.919 . . . . 0.0 110.285 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.67 ' H ' ' HB1' ' A' ' 39' ' ' ALA . . . 134.06 -31.67 2.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 6.4 t30 72.15 -0.15 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -1.183 . . . . 0.0 110.352 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.551 HG23 ' OG ' ' A' ' 48' ' ' SER . 23.4 mt -96.71 -85.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -85.27 44.17 1.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.613 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 9.7 mmt180 -115.73 69.14 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.849 ' OG ' HD21 ' A' ' 86' ' ' LEU . 16.5 m 44.18 57.29 13.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.9 . . . . 0.0 110.323 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HB3' ' OE1' ' A' ' 67' ' ' GLN . 43.7 Cg_endo -71.2 -13.18 30.88 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.971 1.511 . . . . 0.0 110.067 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.56 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -82.16 6.71 15.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.778 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.954 ' HB3' HG22 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -63.76 -38.78 92.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.647 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -66.57 -44.93 80.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.805 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.9 -54.65 13.44 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.634 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 4.8 tp -50.86 -44.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -1.174 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.707 ' HB2' HD12 ' A' ' 35' ' ' ILE . 5.8 t -71.31 -32.12 68.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -62.56 -55.42 27.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -34.11 66.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 110.492 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.56 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 6.1 ttm -73.05 -59.33 2.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG21 HD22 ' A' ' 140' ' ' LEU . 11.5 m -141.53 46.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 0.0 110.396 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . -59.59 78.14 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER 165.55 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -1.102 . . . . 0.0 110.123 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.914 ' HB3' HD11 ' A' ' 145' ' ' LEU . 11.6 mttp -139.42 112.93 8.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.737 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.989 HD22 ' HB3' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 77.54 65.02 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.043 0.925 . . . . 0.0 109.167 -179.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.872 ' CG1' ' HA ' ' A' ' 6' ' ' ALA . 2.6 pp -59.57 145.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.82 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.071 HG23 ' CD1' ' A' ' 9' ' ' PHE . 8.5 mt -119.31 89.87 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 69.1 m-20 -85.19 178.27 7.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 111.006 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 5.7 p -130.55 123.22 29.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.688 ' C ' HG23 ' A' ' 10' ' ' VAL . . . -133.06 -160.45 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.125 -0.985 . . . . 0.0 110.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.67 ' HB1' ' H ' ' A' ' 13' ' ' GLY . . . -171.55 144.43 1.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.524 ' OG1' HD22 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -81.3 -49.16 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.158 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.6 t -128.28 141.29 51.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.0 97.56 0.24 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.97 23.53 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.326 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.88 26.79 5.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 45' ' ' VAL . 16.0 m -64.96 125.27 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.258 -0.901 . . . . 0.0 110.304 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.68 34.0 0.62 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -101.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -1.114 . . . . 0.0 110.172 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 15' ' ' ILE . 2.9 t 61.26 71.69 0.76 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.206 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.51 66.42 1.62 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.0 1.526 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 21.5 m-20 -92.22 35.84 0.99 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 110.367 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -31.62 58.48 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mpt_? -73.94 -48.77 28.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.299 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -62.25 -48.21 80.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.459 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 0.0 OUTLIER -64.65 -36.37 84.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 109.262 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.3 ttpt -58.75 -64.74 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.258 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.579 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 9.0 p -54.81 -35.53 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.802 ' O ' HG22 ' A' ' 62' ' ' VAL . 4.3 m -53.51 -54.11 41.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.777 . . . . 0.0 109.411 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 54' ' ' GLN . 15.6 mtmt -69.03 -27.42 65.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 t -77.57 -14.08 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.89 -32.36 6.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.814 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 114.1 85.68 1.37 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.991 ' O ' HG23 ' A' ' 64' ' ' ILE . 2.5 m -162.65 87.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -1.084 . . . . 0.0 110.111 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -52.85 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.991 HG23 ' O ' ' A' ' 62' ' ' VAL . 1.2 pt -103.71 -158.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' HD12 ' A' ' 64' ' ' ILE . 68.7 m -144.75 -170.94 3.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.155 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 68' ' ' ARG . 21.2 mmtt -80.42 4.16 19.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 76.6 mm-40 59.75 -75.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 65.91 104.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 14' ' ' ASN . . . -61.43 113.13 2.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.433 ' CD ' ' O ' ' A' ' 71' ' ' GLN . 8.0 tmm_? -135.98 143.45 44.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.203 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.433 ' O ' ' CD ' ' A' ' 70' ' ' ARG . 1.6 tt0 -72.53 139.47 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.248 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.445 HD11 ' CB ' ' A' ' 76' ' ' ASP . 4.0 tt -95.46 136.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 178.79 6.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.47 4.05 33.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.88 -12.33 55.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 7.6 p-10 -49.97 -24.42 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.141 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.593 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.2 m-85 -75.83 -10.11 59.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 110.142 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.55 -45.48 4.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 80' ' ' PHE . 7.9 tptp -57.81 -51.2 70.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 11.8 m-85 -115.57 144.23 44.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.349 -0.845 . . . . 0.0 110.13 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.408 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 56.0 m-20 -91.32 -24.04 19.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 9.9 t -113.71 138.71 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.239 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.6 mt -137.54 115.38 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.066 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.497 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . . . -91.5 141.63 28.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.27 141.25 48.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.203 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.849 HD21 ' OG ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -73.33 -52.55 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -107.97 -178.92 3.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.03 -28.39 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.253 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.52 -59.8 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.182 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.946 HD12 ' O ' ' A' ' 11' ' ' CYS . 4.3 tt -51.39 -38.59 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.486 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -74.03 -27.52 60.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.479 ' O ' ' ND2' ' A' ' 95' ' ' ASN . 40.0 t -78.64 -29.38 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 0.0 110.2 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.98 -45.22 8.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.558 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.4 tt -48.45 -36.03 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 92' ' ' SER . 20.8 p30 -71.71 -8.99 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -77.72 -20.07 54.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.181 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.558 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.0 ptt? -102.78 -25.28 13.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.593 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -53.38 139.59 47.2 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.185 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.16 169.72 21.56 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.996 1.524 . . . . 0.0 110.415 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -71.58 -6.5 41.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.06 68.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.238 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 30.7 p -83.95 164.0 19.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.19 38.66 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 81' ' ' ASP . . . -157.61 161.42 38.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -122.73 132.41 54.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.9 . . . . 0.0 110.158 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.3 m -96.84 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.357 -0.839 . . . . 0.0 110.187 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 t -96.74 161.66 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.45 113.13 26.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 42.7 t80 -83.73 122.96 29.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.49 170.09 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.6 Cg_endo -75.8 175.62 11.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.026 1.54 . . . . 0.0 110.227 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.57 4.44 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.02 1.537 . . . . 0.0 110.514 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -54.3 -64.43 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 110.145 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.96 130.99 2.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 128' ' ' MET . 10.3 t -124.3 26.52 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 117' ' ' ASP . 1.0 OUTLIER -148.83 -40.91 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.243 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER 66.79 145.3 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.149 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 119' ' ' TYR . 45.9 Cg_endo -73.39 73.29 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 118' ' ' PRO . 26.0 m-85 51.22 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.271 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 121' ' ' SER . 1.7 t80 -152.13 94.53 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' TYR . 6.2 t 43.23 -145.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.465 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 15.1 m -70.25 -19.68 63.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.239 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 128' ' ' MET . . . 142.17 -71.5 0.4 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 3.2 m-85 -42.66 -48.6 13.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.149 . . . . 0.0 110.325 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -72.97 -55.0 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.671 1.353 . . . . 0.0 110.396 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 128' ' ' MET . 67.2 m -63.23 -53.26 55.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.186 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 124' ' ' GLY . 10.7 ttp -40.85 -70.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 66.7 t80 -58.31 -45.47 87.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -43.22 -67.32 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.869 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -65.12 -39.95 93.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.2 -0.938 . . . . 0.0 109.754 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -42.26 -42.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.819 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.554 ' CB ' HD11 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -98.26 -42.92 7.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.335 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 131' ' ' SER . 3.4 mmtt -47.5 -30.19 3.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.2 OUTLIER -105.65 -2.98 22.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.551 ' HB2' ' HA ' ' A' ' 133' ' ' SER . 0.8 OUTLIER -84.98 20.21 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.59 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -105.17 -65.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.153 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 48.3 Cg_endo -73.09 -1.54 10.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.753 1.396 . . . . 0.0 110.492 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.517 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 92.9 t80 -77.02 -76.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 110.339 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.989 ' HB3' HD22 ' A' ' 33' ' ' LEU . 3.1 pp -71.46 -33.51 69.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.297 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.513 HG23 HG22 ' A' ' 146' ' ' ILE . 85.8 m -57.13 -30.11 64.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 144' ' ' GLY . 5.0 mm-40 -104.81 -44.99 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.424 ' CD2' ' O ' ' A' ' 139' ' ' PHE . 14.9 m-70 -43.51 -25.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.068 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 126.96 66.8 0.15 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.914 HD11 ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -153.17 -45.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -1.106 . . . . 0.0 110.226 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.618 HD12 ' CD1' ' A' ' 140' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.441 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.354 0.597 . . . . 0.0 110.363 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.572 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -160.68 -42.86 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 110.446 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 2.0 ptpt 37.43 -155.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.699 -0.626 . . . . 0.0 110.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.836 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -159.91 138.43 10.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.497 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.8 m -103.16 112.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.403 -0.811 . . . . 0.0 109.56 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -59.44 95.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.98 . . . . 0.0 110.328 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.9 OUTLIER -85.79 108.97 18.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.301 -0.874 . . . . 0.0 109.303 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.075 HG13 ' CD1' ' A' ' 90' ' ' ILE . 6.8 p -137.86 171.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 111.088 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.795 ' HA ' HD12 ' A' ' 90' ' ' ILE . 23.9 t -162.74 55.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.895 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.655 HD23 ' HB ' ' A' ' 90' ' ' ILE . 3.8 mm? 59.54 -158.55 0.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.888 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.74 86.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.61 ' N ' ' O ' ' A' ' 12' ' ' LEU . 1.7 p-10 -134.46 5.8 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -1.209 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.853 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.9 mt 57.47 31.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 110.747 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.555 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 50.4 m 53.55 117.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.123 -0.986 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.734 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -83.21 66.66 8.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.646 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -68.24 -44.94 38.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.789 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.661 ' HA ' HG21 ' A' ' 64' ' ' ILE . 47.0 Cg_endo -74.51 -2.9 13.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.712 1.375 . . . . 0.0 110.781 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.864 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -102.77 -62.27 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.183 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.556 ' SG ' ' CG ' ' A' ' 9' ' ' PHE . 95.4 m -76.52 -48.29 19.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -65.79 -34.19 77.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.801 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.827 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -73.73 -57.16 5.07 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.848 HG12 HG22 ' A' ' 132' ' ' ILE . 8.7 tp -54.22 -40.43 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -1.174 . . . . 0.0 110.075 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 8.5 t -75.43 -67.08 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 ptm180 -41.82 -33.53 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' CG ' ' A' ' 26' ' ' ARG . 5.8 t70 -85.18 -36.32 21.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.452 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.489 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 4.9 ttt -84.29 -0.23 51.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.445 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' A' ' 32' ' ' LYS . 21.2 t -130.13 -43.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.321 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.16 65.54 0.16 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 72.7 m-20 47.81 77.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -1.196 . . . . 0.0 110.282 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.596 ' HG3' HG12 ' A' ' 29' ' ' VAL . 23.6 mmtm -128.54 -137.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.148 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.763 ' O ' HG13 ' A' ' 34' ' ' ILE . 96.4 mt -140.93 -95.12 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.028 HD13 HD13 ' A' ' 140' ' ' LEU . 0.7 OUTLIER 41.79 18.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.597 -0.69 . . . . 0.0 111.234 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -157.95 144.08 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.761 -1.212 . . . . 0.0 110.798 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.945 ' O ' HD13 ' A' ' 8' ' ' LEU . 6.7 m-20 -146.54 105.0 3.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.4 p -68.63 125.74 27.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 110.52 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.049 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -127.2 -169.4 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 110.192 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG23 ' A' ' 10' ' ' VAL . . . -174.79 88.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.878 ' OG1' HD12 ' A' ' 72' ' ' ILE . 18.4 m -71.3 87.96 0.84 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.4 p -159.6 -50.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.1 48.49 25.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.54 -47.06 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -1.132 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.429 ' O ' HG13 ' A' ' 15' ' ' ILE . 49.5 m-70 -94.01 44.0 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.79 156.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 28.09 72.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 48' ' ' SER . 4.3 pt20 -170.34 -147.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -1.124 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.441 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER 61.06 108.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.6 Cg_endo -69.59 99.62 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.513 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -90.5 27.76 1.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.153 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.4 m -74.95 -27.87 60.36 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.268 -0.895 . . . . 0.0 109.043 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.672 ' O ' HG22 ' A' ' 56' ' ' VAL . 11.0 mmt180 -73.48 -51.41 17.23 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.361 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 9.6 p -62.7 -50.85 69.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.781 . . . . 0.0 109.608 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HA ' ' CD1' ' A' ' 64' ' ' ILE . 1.1 tt0 -61.43 -39.39 90.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.256 -0.903 . . . . 0.0 109.31 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -59.23 -70.12 0.17 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 109.59 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 52' ' ' ARG . 35.8 m -48.82 -32.7 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.955 . . . . 0.0 109.19 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 62' ' ' VAL . 1.2 m -58.41 -52.48 65.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.845 . . . . 0.0 109.491 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -24.41 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.5 t -86.01 -10.78 54.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 8.8 m120 -114.93 -32.32 5.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.775 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 140.88 86.08 0.1 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.827 HG13 ' HA3' ' A' ' 23' ' ' GLY . 20.8 t -161.5 138.37 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -1.102 . . . . 0.0 110.058 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -103.11 95.94 6.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.284 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.661 HG21 ' HA ' ' A' ' 19' ' ' PRO . 6.3 pt -137.52 -171.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 p -176.91 -40.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.273 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 140.88 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.56 133.58 0.62 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -89.43 -141.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.106 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.23 153.2 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.51 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -141.18 -148.37 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.51 ' N ' ' HG3' ' A' ' 70' ' ' ARG . 7.6 tt0 -136.09 162.25 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.952 . . . . 0.0 110.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.878 HD12 ' OG1' ' A' ' 40' ' ' THR . 14.9 mt -77.1 -72.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.156 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER 65.78 -145.59 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -100.39 -14.44 18.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.42 74.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.883 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -53.53 -46.71 70.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.188 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.606 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 26.2 m-85 -67.23 60.57 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.032 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER 169.71 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.933 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 2.8 tptt -73.48 -1.31 17.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.825 ' CD1' ' HB3' ' A' ' 6' ' ' ALA . 79.8 m-85 -154.97 -153.1 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -130.25 -13.69 3.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 0.0 110.79 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.637 ' CB ' HG12 ' A' ' 7' ' ' VAL . 58.8 t -133.72 157.62 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.675 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 8' ' ' LEU . 1.7 mp -145.54 115.93 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.476 -0.765 . . . . 0.0 109.511 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.14 132.01 52.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 111.134 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 1.034 ' HB1' HG23 ' A' ' 90' ' ' ILE . . . -108.35 124.87 51.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.497 -0.752 . . . . 0.0 109.687 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.663 HD22 ' HB2' ' A' ' 11' ' ' CYS . 5.4 mp -58.14 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' ILE . 67.8 m-20 -67.8 -175.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.438 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' SER . 16.2 mt-30 -84.28 -43.36 14.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -43.12 -56.48 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.075 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.075 ' CD1' HG13 ' A' ' 10' ' ' VAL . 4.8 tt -49.81 -41.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.586 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -71.15 -41.13 70.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 t -62.75 -37.89 88.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -0.92 . . . . 0.0 110.216 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.4 OUTLIER -85.57 -55.72 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.586 ' CG2' ' HA ' ' A' ' 91' ' ' LEU . 12.9 tt -44.83 -42.79 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 110.184 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.567 ' N ' HG23 ' A' ' 94' ' ' ILE . 20.1 t-20 -75.55 -11.78 60.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' ASP . 11.0 t -95.69 6.54 48.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.592 ' HE2' ' CZ ' ' A' ' 77' ' ' PHE . 2.4 ptt? -128.83 -32.31 2.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.243 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.606 ' CE ' ' CD1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -42.63 150.78 0.41 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.291 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.03 1.542 . . . . 0.0 110.411 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.07 29.05 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 80.22 1.43 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.9 p -155.4 -174.28 4.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 110.196 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.458 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -139.65 48.91 1.81 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.46 178.61 4.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.87 137.56 48.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.69 130.39 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 108' ' ' LEU . 1.2 p -129.79 171.35 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.92 . . . . 0.0 110.279 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.561 ' N ' ' CG2' ' A' ' 107' ' ' VAL . 22.4 tp -105.69 156.1 18.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 110.167 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 43.0 t80 -149.4 106.81 3.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.962 . . . . 0.0 110.219 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' PHE . 0.7 OUTLIER -171.16 106.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 115' ' ' VAL . 47.6 Cg_endo -74.49 175.82 10.52 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.119 1.589 . . . . 0.0 110.266 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.8 Cg_endo -71.53 54.24 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.926 1.487 . . . . 0.0 110.484 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.62 -40.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.147 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.3 133.0 6.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.582 HG22 ' CB ' ' A' ' 131' ' ' SER . 5.5 t -121.34 -9.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -1.118 . . . . 0.0 110.177 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 1.5 p30 -55.93 133.12 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.92 109.98 31.7 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 116' ' ' ASP . 47.0 Cg_endo -73.68 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.978 1.515 . . . . 0.0 110.496 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.581 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 50.2 t80 -154.39 36.92 0.42 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -119.8 -11.47 9.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 123' ' ' ASP . 0.4 OUTLIER 174.95 166.55 0.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 74.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.241 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 121' ' ' SER . 1.0 OUTLIER -125.57 0.22 7.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 110.232 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -115.85 -44.09 0.65 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.657 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 8.6 m-85 -44.58 -47.96 27.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.186 -1.185 . . . . 0.0 110.358 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.657 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.7 Cg_endo -72.91 -51.72 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.72 1.379 . . . . 0.0 110.201 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.7 m -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.864 ' CE ' ' HB2' ' A' ' 20' ' ' ALA . 9.3 ttp -42.1 -65.9 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.106 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.668 ' CE1' HD13 ' A' ' 24' ' ' ILE . 44.9 t80 -56.12 -45.31 79.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -44.64 -62.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.582 ' CB ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -59.14 -47.61 84.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.848 HG22 HG12 ' A' ' 24' ' ' ILE . 4.3 mm -42.14 -65.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.868 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.715 ' CB ' HD11 ' A' ' 24' ' ' ILE . 1.7 p -71.35 -21.73 62.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -0.828 . . . . 0.0 110.43 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 2.7 tttp -63.5 -34.7 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.025 . . . . 0.0 110.109 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -132.22 66.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.328 -0.857 . . . . 0.0 110.442 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.53 ' CE ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -118.22 -5.29 10.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 110.08 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.0 mttt -87.48 -49.67 0.45 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 110.382 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -77.45 -8.08 17.11 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.888 1.467 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.698 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 10.7 t80 -88.08 -50.17 6.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.028 HD13 HD13 ' A' ' 34' ' ' ILE . 28.2 tp -82.12 -30.09 31.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.507 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 54.9 m -71.01 -24.06 62.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.966 . . . . 0.0 110.328 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -104.06 -44.16 5.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.913 . . . . 0.0 110.208 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.698 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -45.68 -39.11 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.273 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.573 ' C ' HD12 ' A' ' 145' ' ' LEU . . . 148.06 53.43 0.02 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.688 HD22 HD11 ' A' ' 140' ' ' LEU . 0.6 OUTLIER -160.6 -98.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.168 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.507 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 1.5 tp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.193 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.331 0.586 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.04 -159.47 0.06 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 108.725 178.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.757 ' H ' HG22 ' A' ' 34' ' ' ILE . 22.7 mttp -158.13 -164.29 1.47 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 110.62 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.021 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.93 119.43 8.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 110.803 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.957 ' HB ' HD12 ' A' ' 34' ' ' ILE . 5.8 t -114.14 121.55 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.543 -0.723 . . . . 0.0 109.79 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.861 HD21 ' CB ' ' A' ' 38' ' ' ALA . 3.6 tp -97.52 86.75 3.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.247 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 7.5 p90 -72.92 143.58 47.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.977 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.005 HG13 ' O ' ' A' ' 38' ' ' ALA . 46.9 t -142.83 155.68 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 110.28 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.938 ' HB2' HD22 ' A' ' 86' ' ' LEU . 8.1 t -139.56 -60.68 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 110.128 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 -55.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.176 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -131.79 21.44 4.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER 64.8 21.46 12.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -1.13 . . . . 0.0 110.265 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.458 HD11 ' HA ' ' A' ' 45' ' ' VAL . 10.2 mt -121.47 -27.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.179 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -106.1 123.8 48.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.127 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.843 ' HD2' HD23 ' A' ' 86' ' ' LEU . 40.4 mtt180 66.91 -53.97 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.617 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -42.1 -51.56 10.27 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.027 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.2 Cg_endo -72.35 -7.08 20.3 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.816 1.429 . . . . 0.0 110.563 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.62 ' C ' HD13 ' A' ' 132' ' ' ILE . . . -93.39 -21.17 19.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.598 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 16.8 t -70.05 -55.53 9.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.516 ' HG3' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -44.28 -37.04 3.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.437 -0.789 . . . . 0.0 109.43 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.94 -52.57 8.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.899 HD11 ' HB2' ' A' ' 133' ' ' SER . 2.8 tp -55.06 -34.29 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -1.23 . . . . 0.0 109.941 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 34' ' ' ILE . 1.4 m -73.14 -52.79 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 110.04 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -31.02 63.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -87.95 -58.61 2.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.087 -1.008 . . . . 0.0 110.088 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.7 OUTLIER -50.74 -27.05 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.701 HG12 ' HD3' ' A' ' 32' ' ' LYS . 6.7 t -105.82 -33.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 110.223 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.45 -68.39 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -174.65 38.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -1.157 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.701 ' HD3' HG12 ' A' ' 29' ' ' VAL . 4.1 mptp? -75.07 -113.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 35' ' ' ILE . 80.2 mt -152.92 -107.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.932 -1.105 . . . . 0.0 110.26 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.021 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 33.46 31.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 111.653 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -102.24 102.43 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 110.112 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.616 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 50.5 m-20 -135.84 140.67 44.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 110.02 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.576 ' CB ' ' CE1' ' A' ' 9' ' ' PHE . 10.2 t -124.17 143.4 50.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.482 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.005 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -146.21 167.53 23.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -154.98 154.53 32.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -134.76 80.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 t -170.02 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.17 32.57 4.28 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -114.72 -36.38 4.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.128 . . . . 0.0 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 48' ' ' SER . 2.0 t60 -122.61 84.3 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.231 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.101 HG13 ' HB3' ' A' ' 69' ' ' ALA . 46.1 t -146.15 135.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.86 76.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' NE2' ' HA ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -164.37 51.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.382 -1.069 . . . . 0.0 110.192 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.487 ' OG ' ' NE2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -154.79 129.53 4.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.53 106.67 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.971 1.511 . . . . 0.0 110.4 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.546 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.3 p-10 -90.82 22.49 3.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.8 m -71.98 -28.16 63.23 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.22 -0.925 . . . . 0.0 108.794 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.605 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 5.0 mmt180 -74.5 -45.23 47.26 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -63.57 -53.64 48.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 19.8 mt-30 -61.95 -41.44 97.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.323 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.7 ttpp -55.2 -69.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 109.485 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.56 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 37.4 t -48.28 -36.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.873 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.547 -0.721 . . . . 0.0 109.513 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -24.55 61.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.383 -0.823 . . . . 0.0 109.481 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -81.27 -13.06 58.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.503 ' ND2' HG13 ' A' ' 56' ' ' VAL . 16.9 m-80 -111.91 -31.04 7.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.291 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 119.5 94.56 1.54 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.873 HG11 ' SG ' ' A' ' 57' ' ' CYS . 9.8 p -178.71 151.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -1.114 . . . . 0.0 110.065 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -127.3 140.78 51.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.247 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.434 ' CD1' ' HG2' ' A' ' 54' ' ' GLN . 7.4 pt -124.73 163.58 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.139 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -112.27 -34.14 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 110.223 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' C ' ' CD ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -166.88 150.33 6.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.261 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 50' ' ' ASP . 1.6 mt-30 -132.16 74.85 1.6 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 110.28 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 68' ' ' ARG . 33.5 ttp85 -126.29 111.14 14.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.101 ' HB3' HG13 ' A' ' 45' ' ' VAL . . . -53.8 144.44 18.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.187 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.99 39.38 0.84 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' CA ' ' OE1' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 54.46 -164.15 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.267 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.564 HD12 ' HB1' ' A' ' 38' ' ' ALA . 15.4 tt -121.93 -39.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.504 ' N ' HG23 ' A' ' 72' ' ' ILE . 1.0 OUTLIER 63.72 157.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -67.37 -23.6 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.214 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -58.77 -26.69 64.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.269 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.554 ' HB2' HD22 ' A' ' 8' ' ' LEU . 24.6 p-10 -48.31 -34.75 11.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 44.7 m-85 -73.14 -39.09 65.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.242 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.52 -52.85 4.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -44.85 -26.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.214 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.58 ' CD1' ' OD2' ' A' ' 36' ' ' ASP . 9.3 m-85 -134.2 172.58 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.68 -20.26 9.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 58.4 t -125.56 139.15 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.9 . . . . 0.0 110.361 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 107' ' ' VAL . 1.4 mp -123.67 144.23 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 110.082 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.783 ' HB1' ' CD2' ' A' ' 109' ' ' PHE . . . -123.05 118.8 28.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.88 116.97 32.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.091 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.938 HD22 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mp -62.86 -85.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.426 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.409 ' N ' HD12 ' A' ' 90' ' ' ILE . 79.2 m-20 -73.53 -177.63 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 89' ' ' SER . 14.1 mt-30 -79.05 -40.85 30.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 110.183 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 4.3 m -42.02 -40.37 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.298 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.511 HD11 ' O ' ' A' ' 11' ' ' CYS . 3.8 mt -69.36 -48.14 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.56 -41.63 97.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 t -73.47 -40.41 64.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 96' ' ' SER . 82.9 m-20 -65.52 -61.97 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.594 HG23 ' N ' ' A' ' 95' ' ' ASN . 3.7 tt -42.71 -43.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.594 ' N ' HG23 ' A' ' 94' ' ' ILE . 3.0 t-20 -61.88 -33.03 73.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.973 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -67.47 -13.59 62.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.446 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 4.4 ptt? -122.34 -24.79 4.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 110.143 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 94' ' ' ILE . 0.3 OUTLIER -43.09 140.48 1.99 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -159.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.06 1.558 . . . . 0.0 110.397 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 m -129.37 3.99 5.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -152.38 88.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.4 p -144.32 -169.46 3.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.04 48.4 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 77' ' ' PHE . . . -131.61 164.77 25.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 33.8 tttt -123.58 160.51 26.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.163 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.84 106.94 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 83' ' ' ILE . 26.7 m -109.69 143.71 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.613 HD12 HD22 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -83.8 114.8 21.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.783 ' CD2' ' HB1' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -50.13 -69.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.953 . . . . 0.0 110.172 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.448 ' HB3' ' HD2' ' A' ' 111' ' ' PRO . 13.3 m-80 -147.19 166.91 14.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.495 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.6 Cg_endo -74.49 174.94 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.966 1.508 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.3 Cg_endo -72.86 52.81 2.23 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.921 1.485 . . . . 0.0 110.481 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -149.1 -36.86 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.07 -96.99 0.04 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.865 HG12 ' HB2' ' A' ' 131' ' ' SER . 4.7 m -62.67 136.65 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -1.139 . . . . 0.0 110.309 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.77 149.46 14.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -168.29 108.04 0.55 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 46.5 Cg_endo -73.15 -1.0 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 118' ' ' PRO . 1.2 m-85 61.31 24.83 14.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -126.88 -38.23 2.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.28 -176.01 3.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 122' ' ' SER . 1.8 t -87.6 22.67 2.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 0.0 110.166 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.32 62.34 5.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.73 -31.31 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.605 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 8.9 m-85 -56.4 -54.02 57.73 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.326 -1.103 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.6 Cg_endo -71.88 -43.39 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.867 1.456 . . . . 0.0 110.375 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.483 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 2.7 m -62.81 -35.73 80.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.58 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 25.6 ttp -52.51 -69.97 0.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.9 . . . . 0.0 109.92 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.632 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 30.7 t80 -62.93 -30.9 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.702 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -56.98 -35.91 69.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.977 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.865 ' HB2' HG12 ' A' ' 115' ' ' VAL . 5.6 m -87.29 -42.76 12.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.62 HD13 ' C ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -56.47 -27.25 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.805 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.899 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -102.06 -40.58 6.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.407 -0.808 . . . . 0.0 110.201 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -76.35 -4.91 44.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 131' ' ' SER . 6.0 mm-40 -126.19 18.82 7.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.503 ' HG3' ' O ' ' A' ' 136' ' ' MET . 1.8 tpt -96.17 7.97 45.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.349 -0.845 . . . . 0.0 110.245 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -86.59 -49.09 0.5 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.298 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.95 7.4 4.35 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.874 1.46 . . . . 0.0 110.591 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.603 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 5.6 t80 -107.96 -51.19 2.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.355 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 146' ' ' ILE . 4.2 tt -83.51 -15.04 50.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.339 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.942 HG23 ' OXT' ' A' ' 146' ' ' ILE . 24.7 m -82.8 -28.05 30.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -105.14 -25.48 12.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.286 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.603 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -52.74 -18.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 115.75 51.81 0.41 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 144' ' ' GLY . 11.9 mt -143.41 -52.78 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.942 ' OXT' HG23 ' A' ' 141' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.415 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.287 0.565 . . . . 0.0 110.113 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.582 ' C ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -80.9 -55.42 4.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.545 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' CG ' ' C ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER 35.21 -155.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.729 . . . . 0.0 110.541 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.88 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . . . -166.12 156.53 12.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 0.0 109.958 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG1' ' HB2' ' A' ' 84' ' ' ALA . 89.0 t -120.92 103.51 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.908 . . . . 0.0 109.903 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.729 ' HB3' HG23 ' A' ' 83' ' ' ILE . 16.6 tp -59.48 94.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 110.026 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.491 ' CE2' ' SD ' ' A' ' 136' ' ' MET . 0.4 OUTLIER -78.31 103.89 8.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.93 . . . . 0.0 109.818 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.828 HG13 ' O ' ' A' ' 38' ' ' ALA . 61.3 t -124.67 161.75 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.445 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.73 ' CB ' HD22 ' A' ' 86' ' ' LEU . 39.3 t -165.14 64.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 6.9 mt 57.09 33.59 23.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 147.0 -32.34 1.42 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 65.3 7.62 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -1.138 . . . . 0.0 110.102 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.7 HD13 ' OG ' ' A' ' 48' ' ' SER . 44.6 mt -96.51 -5.51 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 110.353 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 35.6 m -144.43 -173.25 3.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.456 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.674 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.9 mmt85 64.49 -78.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.556 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 86' ' ' LEU . 9.1 m -129.83 55.66 19.87 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 110.699 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.6 Cg_endo -79.79 0.57 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.987 1.519 . . . . 0.0 110.004 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -96.0 6.8 48.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.425 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 9.1 p -58.78 -35.54 72.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.803 ' HB3' HG23 ' A' ' 64' ' ' ILE . 1.4 tp10 -65.43 -48.54 72.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.67 -0.644 . . . . 0.0 109.866 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.583 ' CA ' ' CG1' ' A' ' 62' ' ' VAL . . . -69.83 -57.8 6.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 132' ' ' ILE . 5.3 tp -47.44 -43.47 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -1.163 . . . . 0.0 109.922 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.616 ' HB2' HD13 ' A' ' 35' ' ' ILE . 7.3 t -65.33 -51.53 59.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.412 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 15.3 mmt-85 -52.62 -40.62 62.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.145 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -76.0 -30.51 58.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.48 -57.96 3.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.485 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.745 HG11 ' HB2' ' A' ' 32' ' ' LYS . 61.9 t -87.09 -18.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.552 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 104.4 -66.91 0.29 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 53.8 t0 -176.25 57.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -1.13 . . . . 0.0 110.111 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.858 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.79 -100.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 32' ' ' LYS . 21.3 mt -143.95 -125.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.851 HG23 ' C ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER 70.81 -17.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.987 -0.446 . . . . 0.0 111.102 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -136.83 144.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.808 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.726 ' HB3' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -155.35 94.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -63.82 125.92 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 110.116 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.828 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -149.76 170.43 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.552 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.801 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -138.72 145.37 40.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.053 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.583 ' HA ' HG22 ' A' ' 72' ' ' ILE . 8.2 t -118.67 -9.65 10.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.31 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 t -112.36 109.48 19.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -55.97 101.58 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 2.5 m-85 -162.12 160.43 27.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -1.169 . . . . 0.0 110.264 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 63.19 25.21 14.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.6 t -85.25 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 37.68 6.37 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 48' ' ' SER . 4.3 pt20 179.59 -108.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -1.118 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.7 ' OG ' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 65.6 93.62 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.074 -1.016 . . . . 0.0 110.184 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 45.1 Cg_endo -69.11 -62.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.672 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 2.8 m-20 71.46 -5.95 1.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.241 -0.912 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -74.32 -27.54 60.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.177 -0.952 . . . . 0.0 108.975 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -52.85 12.52 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.336 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -61.57 -53.69 52.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -57.98 -42.46 85.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -51.85 -65.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.901 HG21 ' HA ' ' A' ' 125' ' ' PHE . 53.0 t -49.46 -35.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 109.113 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.526 ' SG ' ' CG1' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -57.27 -46.71 82.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.57 -0.706 . . . . 0.0 109.642 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -79.63 -17.86 52.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.509 ' HB2' ' CE ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -88.95 -12.25 42.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -116.37 -24.17 8.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.586 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.59 ' C ' HG23 ' A' ' 62' ' ' VAL . . . 117.21 62.34 0.31 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.59 HG23 ' C ' ' A' ' 61' ' ' GLY . 46.0 t -155.63 170.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.529 ' N ' HG12 ' A' ' 62' ' ' VAL . 58.6 t0 -157.02 121.21 4.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 110.267 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 22' ' ' GLU . 18.1 mt -108.82 170.62 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.147 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -106.39 -68.69 0.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -145.08 128.02 16.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 10.7 pt20 -142.26 98.43 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.217 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HA ' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -140.05 -162.69 1.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.174 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.87 123.65 50.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.229 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.78 33.02 1.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 60.02 158.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 76' ' ' ASP . 21.0 tt -138.87 152.5 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -112.57 -163.92 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 77' ' ' PHE . 4.1 mttp -69.7 -5.21 23.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.16 81.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.0 110.124 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.799 ' HB3' HD11 ' A' ' 72' ' ' ILE . 38.4 p-10 -47.84 -31.46 5.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 74' ' ' LYS . 13.1 m-85 -72.45 -25.74 61.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.0 p -127.29 41.86 3.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.202 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' CG ' ' CE2' ' A' ' 80' ' ' PHE . 37.8 tptt -123.19 -13.52 7.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.88 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 97.5 m-85 -151.74 -122.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 65.4 t0 -151.59 -40.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.045 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.76 HG11 ' HZ ' ' A' ' 139' ' ' PHE . 81.7 t -127.04 152.84 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.169 -0.957 . . . . 0.0 110.47 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 8' ' ' LEU . 1.7 mp -131.71 134.06 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 110.022 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -104.49 127.87 52.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.551 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.68 105.74 15.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.73 HD22 ' CB ' ' A' ' 11' ' ' CYS . 2.2 mp -50.36 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.505 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.422 ' C ' HD12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -81.5 -177.4 6.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.37 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -85.44 -40.8 16.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.37 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -41.67 -38.43 1.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.873 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.5 mp -69.62 -55.63 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.185 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.0 HD22 HD23 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -58.1 -28.74 64.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 t -78.39 -41.91 31.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 5.6 m-20 -80.92 -60.15 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.29 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 90' ' ' ILE . 4.7 tt -49.87 -25.3 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.301 -0.875 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 58.4 t-20 -90.37 -22.87 21.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.208 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -6.59 28.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.456 ' HE2' ' O ' ' A' ' 94' ' ' ILE . 6.2 mtm -108.81 -51.67 2.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.568 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -40.47 132.6 1.67 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.412 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 100' ' ' SER . 46.4 Cg_endo -73.51 0.66 7.79 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.06 1.558 . . . . 0.0 110.502 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER 68.02 19.22 9.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.131 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.12 67.76 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 95.4 m -132.21 -159.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.41 25.83 10.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.27 -175.46 3.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.89 . . . . 0.0 110.192 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.37 158.2 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.539 HG12 HD12 ' A' ' 91' ' ' LEU . 19.3 t -127.13 124.58 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.139 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -122.17 144.0 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.0 HD23 HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -77.11 133.81 38.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 110.173 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.605 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 1.9 m-85 -106.44 127.44 53.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.315 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 109' ' ' PHE . 0.9 OUTLIER 64.54 176.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -74.83 175.3 11.36 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 110.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.9 Cg_endo -72.26 53.86 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.051 1.553 . . . . 0.0 110.433 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.88 -38.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.03 145.12 11.19 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.557 HG11 ' CB ' ' A' ' 131' ' ' SER . 18.5 m -70.34 153.84 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -1.105 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.456 ' CB ' HG21 ' A' ' 127' ' ' THR . 42.9 t0 -42.09 134.58 2.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.369 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.8 p-10 -94.94 113.1 60.53 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.534 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 46.3 Cg_endo -73.7 58.31 3.91 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.936 1.492 . . . . 0.0 110.616 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 121' ' ' SER . 3.7 t80 -117.03 142.61 46.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.095 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.512 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 49.1 t80 61.0 -73.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.196 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 119' ' ' TYR . 2.2 m -89.89 118.33 29.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.84 89.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.77 9.64 1.55 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.258 -0.901 . . . . 0.0 110.183 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -118.88 -22.24 3.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.901 ' HA ' HG21 ' A' ' 56' ' ' VAL . 2.8 m-85 -34.1 -59.34 0.54 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.521 -0.988 . . . . 0.0 110.49 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.0 Cg_endo -72.12 -52.48 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.869 1.457 . . . . 0.0 110.318 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.456 HG21 ' CB ' ' A' ' 116' ' ' ASP . 8.8 m -58.18 -57.66 11.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.375 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.572 ' CE ' ' HB2' ' A' ' 20' ' ' ALA . 8.1 ttp -40.31 -48.85 2.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.612 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 48.7 t80 -70.17 -62.1 1.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 129' ' ' PHE . . . -43.05 -56.39 3.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.557 ' CB ' HG11 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -60.88 -45.07 96.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.926 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -46.76 -47.52 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.592 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 134' ' ' LYS . 0.4 OUTLIER -78.85 -59.26 2.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.297 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.498 ' N ' ' OG ' ' A' ' 133' ' ' SER . 3.2 mmtt -45.19 -29.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 131' ' ' SER . 27.0 mt-10 -74.97 -31.55 61.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.203 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.551 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 18.0 mtm -103.48 9.32 37.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 6.5 mtpt -82.28 -48.74 0.88 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 51.5 Cg_endo -81.11 -9.07 12.94 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.148 1.604 . . . . 0.0 110.402 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.76 ' HZ ' HG11 ' A' ' 82' ' ' VAL . 47.4 t80 -107.97 -77.96 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.061 ' CD1' HD22 ' A' ' 145' ' ' LEU . 13.8 tp -44.03 -24.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 11.8 m -87.07 -29.13 22.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 110.353 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 139' ' ' PHE . 4.7 mm-40 -105.2 -13.9 15.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.405 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.68 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 4.6 t60 -84.94 40.27 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.64 38.08 90.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.061 HD22 ' CD1' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.8 -31.08 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.106 . . . . 0.0 110.305 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 18.2 mm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.228 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.26 0.553 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.406 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -79.68 -162.54 0.43 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.534 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 34' ' ' ILE . 18.5 mttt -148.44 -164.5 2.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.783 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -130.74 148.92 52.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.183 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 34' ' ' ILE . 5.5 m -147.06 136.87 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.945 -1.097 . . . . 0.0 110.226 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.9 OUTLIER -89.65 118.31 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 0.0 110.945 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.497 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m-85 -93.85 96.06 9.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.555 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.534 ' CG2' HD23 ' A' ' 8' ' ' LEU . 16.0 t -100.65 156.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.444 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.491 ' CB ' ' OG ' ' A' ' 18' ' ' SER . 47.8 t -150.0 -65.9 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.015 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 177.05 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.174 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 85.92 -4.75 85.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.963 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 8.7 t30 59.7 29.87 19.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -1.158 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.925 HD13 ' HB2' ' A' ' 48' ' ' SER . 26.9 mt -113.0 -20.4 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 110.376 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 18' ' ' SER . 9.6 p -131.59 132.77 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.859 ' CB ' HD23 ' A' ' 86' ' ' LEU . 3.7 mtm180 65.46 -59.56 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.196 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.632 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -44.83 -50.7 24.6 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.428 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.6 Cg_endo -72.13 -19.97 25.57 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.848 1.446 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.569 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -69.78 -23.56 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.98 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.996 ' HA ' HD11 ' A' ' 132' ' ' ILE . 21.4 m -67.39 -32.88 74.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.863 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.738 ' HA ' HD11 ' A' ' 35' ' ' ILE . 1.6 tt0 -57.77 -54.89 41.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.912 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.697 ' HA3' HG22 ' A' ' 62' ' ' VAL . . . -67.09 -45.95 77.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.873 HD12 ' CE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -54.66 -54.36 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -1.202 . . . . 0.0 110.191 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.702 ' N ' HG22 ' A' ' 24' ' ' ILE . 79.4 m -60.29 -50.8 72.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.036 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.51 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 25.5 mtt-85 -45.82 -52.63 10.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -20.0 60.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.57 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.07 -45.82 32.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.831 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.554 ' CG1' ' HB3' ' A' ' 32' ' ' LYS . 63.1 t -137.05 -12.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.034 . . . . 0.0 111.258 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 29' ' ' VAL . . . 59.31 122.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' GLY . 11.8 t0 40.42 77.36 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.187 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.74 ' HG3' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -131.05 11.19 5.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.547 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.8 mt 65.01 -63.05 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.285 -0.884 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.963 HD12 ' N ' ' A' ' 35' ' ' ILE . 2.5 pp -27.39 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.454 -0.779 . . . . 0.0 111.047 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.963 ' N ' HD12 ' A' ' 34' ' ' ILE . 7.8 tt -64.03 87.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 121.368 -0.832 . . . . 0.0 111.079 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 18.6 m-20 -126.83 66.82 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 109.692 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.28 150.07 18.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 110.397 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -163.9 -171.62 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.963 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -150.17 120.9 7.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.578 ' HA ' HG21 ' A' ' 72' ' ' ILE . 10.8 t -67.06 -39.45 86.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.519 ' N ' HG23 ' A' ' 40' ' ' THR . 3.3 t -127.87 133.02 49.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . -67.76 -79.9 0.23 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 66.05 -73.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.526 ' HB3' HD12 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -90.15 91.06 8.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 46' ' ' GLY . 50.4 t -130.29 173.28 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 110.137 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.566 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 57.97 18.35 33.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.632 ' O ' ' CB ' ' A' ' 48' ' ' SER . 3.1 pt20 -177.68 152.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -1.124 . . . . 0.0 110.168 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.925 ' HB2' HD13 ' A' ' 15' ' ' ILE . 2.2 t 159.12 105.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.263 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 47.4 Cg_endo -69.78 70.78 1.57 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.104 1.581 . . . . 0.0 110.28 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.5 p30 -83.92 16.32 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.9 m -75.53 -32.58 60.52 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.185 -0.947 . . . . 0.0 109.007 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.638 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -74.1 -55.74 5.74 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.294 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -58.67 -53.43 58.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.454 -0.778 . . . . 0.0 109.501 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.93 ' HG3' HD11 ' A' ' 64' ' ' ILE . 12.1 tt0 -57.51 -45.56 84.82 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.25 -0.906 . . . . 0.0 109.508 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.2 ttpp -50.83 -65.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.422 -0.799 . . . . 0.0 109.793 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.573 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 11.3 p -56.55 -34.0 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.633 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.711 ' CB ' HG21 ' A' ' 62' ' ' VAL . 1.3 m -56.66 -47.47 79.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.696 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -73.8 -30.46 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.361 -0.837 . . . . 0.0 109.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 m -77.96 -12.05 59.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.003 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -116.08 -27.01 7.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.855 . . . . 0.0 109.38 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.81 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 139.25 98.78 0.42 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 61' ' ' GLY . 13.0 t -162.63 168.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -1.065 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.51 ' HB3' ' CD ' ' A' ' 26' ' ' ARG . 12.5 t0 -153.37 67.17 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.93 HD11 ' HG3' ' A' ' 54' ' ' GLN . 11.8 pt -116.55 -173.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.187 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -153.68 88.74 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' N ' ' HD3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 58.19 153.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.359 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.427 ' NE2' HD12 ' A' ' 64' ' ' ILE . 3.0 pt20 -171.93 126.99 0.59 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.358 -0.839 . . . . 0.0 110.194 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 1.2 mtm105 -99.87 -89.15 0.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 68' ' ' ARG . . . 176.94 79.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 ttp-105 -76.6 141.2 41.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.424 ' HG3' ' N ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.62 151.88 44.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.162 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.578 HG21 ' HA ' ' A' ' 40' ' ' THR . 19.4 tt -90.8 172.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t -124.4 172.2 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -78.33 2.85 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.112 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.02 -13.28 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' CG ' ' CG1' ' A' ' 72' ' ' ILE . 2.9 m-20 -52.92 -42.11 65.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -45.13 -55.77 5.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 26.82 3.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.622 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -104.64 -11.14 17.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 110.237 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.622 ' CE1' ' CG ' ' A' ' 79' ' ' LYS . 77.9 m-85 -143.07 -137.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -128.2 -53.42 1.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.471 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 48.9 t -133.26 123.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.195 -0.941 . . . . 0.0 110.451 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.898 HG21 HD11 ' A' ' 94' ' ' ILE . 5.7 mt -90.63 105.74 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.9 143.58 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.429 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -103.49 147.91 26.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.859 HD23 ' CB ' ' A' ' 17' ' ' ARG . 2.8 tp -98.64 31.77 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.934 ' O ' HD21 ' A' ' 108' ' ' LEU . 0.4 OUTLIER 174.31 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 110.178 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -59.93 -43.57 94.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.243 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.589 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 1.9 mp -57.67 -63.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.153 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.4 OUTLIER -53.09 -37.14 61.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.151 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -70.83 -26.89 63.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.236 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -92.06 -61.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.255 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.898 HD11 HG21 ' A' ' 83' ' ' ILE . 5.6 tt -45.63 -39.89 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.503 ' N ' HG23 ' A' ' 94' ' ' ILE . 4.6 t-20 -71.89 -15.18 62.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -76.37 -12.36 60.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.226 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.453 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 8.2 mtm -109.64 -52.04 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 5.6 mtpt -40.85 134.85 1.67 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 110.443 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.14 -169.59 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.069 1.562 . . . . 0.0 110.424 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.7 t -91.35 23.91 3.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 6.5 p-10 -176.79 123.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.4 p -143.59 -151.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -116.37 -18.63 10.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.104 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 -149.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -157.66 169.31 24.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.19 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.487 HG12 ' HB ' ' A' ' 83' ' ' ILE . 29.0 m -128.07 146.43 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 108' ' ' LEU . 78.6 t -144.01 170.19 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.94 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.934 HD21 ' O ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -109.52 121.91 46.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.181 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 132' ' ' ILE . 11.6 t80 -48.49 -51.52 26.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 111' ' ' PRO . 1.1 m-20 -176.52 -178.26 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 110' ' ' ASN . 46.7 Cg_endo -74.67 175.03 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.012 1.533 . . . . 0.0 110.302 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.2 52.94 2.41 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.959 1.505 . . . . 0.0 110.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -124.69 -27.3 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.75 -89.98 1.25 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 115' ' ' VAL . 19.5 m -75.9 103.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -1.156 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 15.6 p-10 -137.08 -156.63 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER 55.78 72.74 0.96 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 112.03 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.995 1.524 . . . . 0.0 110.508 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.499 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 12.4 m-85 50.48 -138.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 119' ' ' TYR . 27.5 p -168.79 -151.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 82.7 p -90.32 -138.56 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 122' ' ' SER . 2.3 t70 67.06 17.09 10.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.431 ' C ' ' HD2' ' A' ' 126' ' ' PRO . . . -144.29 -42.08 0.05 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.638 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 11.8 m-85 -42.08 -50.47 10.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.11 . . . . 0.0 110.473 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.6 Cg_endo -72.0 -56.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.619 1.326 . . . . 0.0 110.247 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -55.75 -43.66 76.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 110.006 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.724 ' O ' HG22 ' A' ' 132' ' ' ILE . 14.0 ttp -50.69 -75.71 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.873 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.6 t80 -46.67 -55.6 7.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.236 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -52.7 -22.56 5.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.4 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 128' ' ' MET . 3.2 m -90.12 -55.82 3.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.412 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.996 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -60.09 -15.33 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 0.0 109.028 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.731 ' HB2' HD11 ' A' ' 24' ' ' ILE . 2.0 t -101.93 -49.96 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 110.139 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -59.23 -30.85 68.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.108 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' OE2' ' ND2' ' A' ' 110' ' ' ASN . 6.1 mt-10 -102.75 22.37 13.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.647 ' HE1' ' HB3' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -89.61 1.36 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.25 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 77.0 mttt -91.88 -42.13 0.37 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 111.353 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.2 Cg_endo -76.41 4.79 5.16 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.403 1.212 . . . . 0.0 110.733 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.647 ' HB3' ' HE1' ' A' ' 136' ' ' MET . 39.2 t80 -108.08 -71.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -58.98 -55.0 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.116 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 137' ' ' LYS . 16.2 m -61.04 -12.87 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 144' ' ' GLY . 27.8 mt-10 -105.06 -55.33 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.542 ' NE2' HG21 ' A' ' 107' ' ' VAL . 3.1 t-80 -42.34 -26.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 130.84 46.62 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 15.0 mt -144.66 -98.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -1.186 . . . . 0.0 110.27 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.437 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 2.9 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.441 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 4.8 mm-40 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.272 0.558 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -82.38 156.02 24.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 178.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 34' ' ' ILE . 26.7 mttt -139.37 -165.79 1.93 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.989 -1.07 . . . . 0.0 110.867 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.855 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.19 156.79 29.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 110.516 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.802 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 40.0 t -141.95 113.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.668 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.951 HD13 ' CE2' ' A' ' 80' ' ' PHE . 26.2 tp -82.64 81.45 8.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 111.02 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.994 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 16.6 m-85 -55.84 126.39 25.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.086 -1.009 . . . . 0.0 109.367 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.948 HG22 ' O ' ' A' ' 38' ' ' ALA . 73.8 t -142.03 161.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 110.767 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.672 ' SG ' HD23 ' A' ' 86' ' ' LEU . 1.1 t -153.36 -58.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.413 -0.805 . . . . 0.0 110.191 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.584 ' CB ' ' NH1' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 169.84 150.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.463 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 64.48 10.14 41.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 72.8 -53.19 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.297 -1.119 . . . . 0.0 109.823 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' CYS . 8.9 mt -41.2 -33.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 3.3 t 68.25 105.44 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.584 ' NH1' ' CB ' ' A' ' 12' ' ' LEU . 18.3 mtt85 -52.67 -18.52 1.83 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.046 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.493 ' HB3' HD21 ' A' ' 86' ' ' LEU . 60.3 p -112.8 67.71 1.0 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 17' ' ' ARG . 45.6 Cg_endo -72.59 -12.33 26.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.902 1.475 . . . . 0.0 110.082 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.707 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -76.97 4.89 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 23.2 p -69.77 -37.62 76.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.785 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -68.98 -43.06 75.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.917 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -70.55 -51.78 19.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.821 HD12 ' CE1' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -55.62 -46.93 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -1.153 . . . . 0.0 110.274 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.657 ' O ' HG22 ' A' ' 29' ' ' VAL . 78.4 m -71.87 -48.59 44.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.115 -0.99 . . . . 0.0 110.053 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.529 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 10.1 mmt180 -49.35 -45.35 45.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.28 -24.09 32.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.259 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.558 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -73.88 -22.71 59.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.605 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 25' ' ' CYS . 4.7 m -142.14 -33.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.978 -1.076 . . . . 0.0 110.713 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 38.47 44.91 1.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 54.4 t0 -178.55 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.961 -1.317 . . . . 0.0 110.853 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' C ' ' HG ' ' A' ' 33' ' ' LEU . 12.3 mmtm -141.73 -143.34 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.4 mt -147.77 -34.53 0.24 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.416 -0.802 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.1 pp -30.05 -31.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.824 -0.548 . . . . 0.0 111.829 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.666 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.5 mp -62.47 87.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.998 -1.064 . . . . 0.0 110.939 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -130.39 162.47 29.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.96 . . . . 0.0 109.064 178.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.5 m -141.9 139.98 32.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.96 -1.088 . . . . 0.0 110.668 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.948 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -167.78 -176.24 3.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.354 -0.842 . . . . 0.0 110.33 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . . . 174.84 164.07 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 40' ' ' THR . 13.7 t -94.12 71.67 3.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.42 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.39 76.68 0.57 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.67 -57.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -1.141 . . . . 0.0 110.296 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -87.59 93.26 9.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 69' ' ' ALA . 34.9 t -125.95 -3.76 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.243 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.27 41.74 2.08 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 48' ' ' SER . 5.2 pt20 -161.78 -109.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 4.4 t 64.84 70.78 0.59 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.053 -1.03 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.38 66.05 1.56 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.459 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 4.2 p-10 -89.19 31.48 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.524 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -76.0 -34.19 59.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.898 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 6.9 mmt85 -70.76 -47.79 57.77 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -56.69 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.533 -0.729 . . . . 0.0 109.349 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.718 ' HB3' HD13 ' A' ' 64' ' ' ILE . 5.2 pp0? -56.97 -35.29 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.125 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.4 -65.92 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 109.13 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.604 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 41.4 t -49.69 -36.22 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.28 -0.887 . . . . 0.0 108.83 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -53.86 -52.76 59.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 62' ' ' VAL . 11.3 ttpt -71.13 -21.23 62.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.472 ' OG ' ' CE ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -86.6 -8.73 57.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.947 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.25 -17.74 12.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.865 . . . . 0.0 108.84 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 122.14 44.21 0.37 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 61' ' ' GLY . 54.3 t -158.37 144.87 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -1.087 . . . . 0.0 110.22 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.62 135.63 40.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.718 HD13 ' HB3' ' A' ' 54' ' ' GLN . 29.2 pt -92.76 -171.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 110.117 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -129.95 -51.46 1.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 110.194 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.52 149.03 3.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -111.91 99.48 8.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 111.9 24.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -93.91 102.5 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.199 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -122.79 158.14 30.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.92 143.81 57.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 72' ' ' ILE . 10.7 tt -84.61 87.94 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 74' ' ' LYS . 25.5 m -58.9 169.59 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 73' ' ' THR . 2.1 mtpp -65.73 -9.09 24.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.02 59.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 110.26 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' CG ' HG13 ' A' ' 72' ' ' ILE . 31.5 m-20 -49.69 -30.04 8.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -57.49 -41.27 80.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 110.17 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.98 -33.97 10.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER -44.35 -31.23 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.331 -0.856 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.951 ' CE2' HD13 ' A' ' 8' ' ' LEU . 11.9 m-85 -130.94 152.34 50.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.465 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.595 ' H ' ' HB3' ' A' ' 6' ' ' ALA . 3.9 m-20 -68.52 -47.07 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.442 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' A' ' 139' ' ' PHE . 53.9 t -130.85 156.68 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.937 HD13 HG12 ' A' ' 106' ' ' VAL . 1.6 mp -118.33 139.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.283 -0.886 . . . . 0.0 109.877 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.994 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -100.28 116.88 33.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.904 . . . . 0.0 110.385 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.68 ' O ' HD12 ' A' ' 108' ' ' LEU . . . -109.82 99.56 8.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 109.919 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.672 HD23 ' SG ' ' A' ' 11' ' ' CYS . 1.1 mp -60.78 -61.77 2.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.541 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.524 ' CB ' ' CD1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.54 171.79 11.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' SER . 21.0 mt-30 -83.59 -40.69 18.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -42.64 -37.86 1.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.557 HD11 ' O ' ' A' ' 11' ' ' CYS . 1.4 mp -71.97 -54.52 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.96 -19.58 62.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 0.0 110.349 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -86.61 -58.38 2.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.285 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.245 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.586 HG23 ' N ' ' A' ' 95' ' ' ASN . 2.5 tt -43.48 -43.28 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.586 ' N ' HG23 ' A' ' 94' ' ' ILE . 1.1 t-20 -60.89 -31.78 71.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' ASP . 19.5 t -64.36 -12.34 41.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.53 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.9 ptt? -123.17 -18.35 6.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.562 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -55.09 154.3 10.61 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.52 ' HD3' ' CD2' ' A' ' 77' ' ' PHE . 47.9 Cg_endo -73.36 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -125.42 101.13 6.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.53 ' N ' ' ND2' ' A' ' 101' ' ' ASN . 1.6 m120 64.06 110.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.257 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.0 m -150.23 -164.41 2.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.87 . . . . 0.0 110.209 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.83 32.55 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 77' ' ' PHE . . . -160.68 -177.09 5.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.231 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 16.4 pttm -176.53 158.23 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.937 HG12 HD13 ' A' ' 83' ' ' ILE . 3.6 m -111.59 151.33 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 m -138.87 147.43 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.197 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' O ' ' A' ' 85' ' ' ALA . 21.6 tp -81.6 126.05 31.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.223 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -93.46 89.76 6.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 0.0 110.211 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 56.52 162.77 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 45.8 Cg_endo -74.0 174.93 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.096 1.577 . . . . 0.0 110.275 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.7 Cg_endo -73.25 51.48 2.11 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.954 1.502 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 114' ' ' GLY . 19.2 m-20 -122.32 -63.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 127' ' ' THR . . . -44.25 -73.03 0.28 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.534 HG21 ' HG ' ' A' ' 86' ' ' LEU . 18.1 m -70.41 123.7 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.33 158.55 27.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.933 . . . . 0.0 110.256 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.574 ' HB2' ' CE2' ' A' ' 119' ' ' TYR . 8.2 p-10 -73.22 123.78 89.88 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -73.06 -89.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.008 1.53 . . . . 0.0 110.621 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 117' ' ' ASP . 12.3 m-30 58.21 -142.68 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.537 ' O ' ' CB ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -69.44 149.6 48.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.413 -0.805 . . . . 0.0 109.994 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER 71.56 3.89 4.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.38 -0.825 . . . . 0.0 110.166 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.537 ' HG ' ' HE2' ' A' ' 125' ' ' PHE . 73.7 m 42.19 -94.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.177 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' SER . 0.5 OUTLIER 44.98 49.06 9.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -175.39 -41.05 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.65 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 23.5 m-85 -41.58 -49.61 9.67 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.13 . . . . 0.0 110.527 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.33 -59.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.585 1.308 . . . . 0.0 110.194 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 114' ' ' GLY . 64.9 m -53.16 -48.17 68.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.646 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.707 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 7.9 ttp -50.02 -58.92 4.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.376 -0.827 . . . . 0.0 109.968 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.821 ' CE1' HD12 ' A' ' 24' ' ' ILE . 88.3 t80 -50.56 -50.54 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.0 -56.19 11.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 m -57.9 -46.5 84.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -45.38 -56.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.655 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -60.65 -45.88 92.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.54 ' O ' ' CD ' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -65.21 -13.04 57.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 14.8 mt-10 -90.0 -37.32 14.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.503 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -90.99 -3.69 57.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.931 . . . . 0.0 110.355 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 3.1 mttt -83.48 -50.2 0.68 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -0.961 . . . . 0.0 110.026 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 51.0 Cg_endo -80.08 -13.14 12.84 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.097 1.577 . . . . 0.0 110.414 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' A' ' 82' ' ' VAL . 5.3 t80 -103.72 -48.74 3.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -73.31 1.1 10.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.287 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 142' ' ' GLU . 21.0 m -104.22 -57.05 2.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 111.004 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' GLY . 7.3 mt-10 -105.2 -45.13 4.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.11 -0.994 . . . . 0.0 111.224 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -37.24 -29.65 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.211 -0.931 . . . . 0.0 110.434 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.863 ' O ' HD22 ' A' ' 145' ' ' LEU . . . 132.03 76.58 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -159.16 -38.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -1.218 . . . . 0.0 110.182 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.474 HD11 HD23 ' A' ' 140' ' ' LEU . 22.3 mt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.249 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.305 0.574 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.757 ' HG2' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -72.21 -161.35 0.08 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 108.701 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 1.027 ' C ' HG22 ' A' ' 34' ' ' ILE . 23.6 mtmt -157.32 -159.68 0.87 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.921 -1.112 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.0 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -142.41 123.23 14.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 111.251 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.963 HG11 ' CZ ' ' A' ' 9' ' ' PHE . 5.6 t -115.72 131.69 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.548 -0.72 . . . . 0.0 109.463 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 4.1 tp -90.66 92.1 8.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.916 . . . . 0.0 110.806 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.963 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 18.3 m-85 -82.99 106.85 15.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.014 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 14.0 p -125.47 173.87 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.528 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.751 ' O ' HD12 ' A' ' 90' ' ' ILE . 26.5 p -163.41 -38.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.616 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 168.76 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.123 -0.986 . . . . 0.0 110.295 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.742 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -91.03 -9.98 63.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 3.3 t-20 68.63 33.21 3.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -1.172 . . . . 0.0 110.224 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 16' ' ' CYS . 84.6 mt -108.74 -91.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.514 ' N ' HG22 ' A' ' 15' ' ' ILE . 5.8 t -95.74 64.53 2.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.882 . . . . 0.0 110.113 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.55 ' CB ' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER 171.6 52.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.064 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER 172.39 -55.37 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.3 Cg_endo -71.79 -13.65 29.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.9 1.474 . . . . 0.0 110.383 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -65.64 -12.6 54.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 17.4 m -72.39 -29.32 63.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.48 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HA ' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -70.34 -43.09 70.97 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.776 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -71.07 -45.57 49.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.744 HG21 HG23 ' A' ' 132' ' ' ILE . 6.1 tp -64.96 -43.19 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -1.167 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.606 ' N ' HG23 ' A' ' 24' ' ' ILE . 55.9 m -65.12 -49.86 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.319 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.516 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.9 ptm180 -68.15 -26.19 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.309 -0.87 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 1.3 m-20 -85.81 -25.56 26.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.042 -1.036 . . . . 0.0 110.277 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 3.0 tmm? -92.4 -21.91 19.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.564 HG11 ' HG2' ' A' ' 32' ' ' LYS . 57.6 t -127.72 -12.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.197 -0.939 . . . . 0.0 110.617 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.43 -22.13 36.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -149.48 -87.05 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.39 -1.065 . . . . 0.0 110.235 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HG2' HG11 ' A' ' 29' ' ' VAL . 0.1 OUTLIER 58.16 122.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.277 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.757 HD13 ' HG2' ' A' ' 4' ' ' LYS . 6.0 mp -98.12 -114.81 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.027 HG22 ' C ' ' A' ' 5' ' ' LYS . 0.8 OUTLIER 32.49 33.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 0.0 111.338 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.7 mt -104.49 95.12 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.963 -1.085 . . . . 0.0 110.602 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' OD2' ' CE2' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -126.37 99.96 6.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 9.7 p -79.12 130.58 35.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.213 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.014 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -122.33 -173.06 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.32 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 38' ' ' ALA . . . 171.16 109.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -69.41 -12.1 61.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -124.0 93.93 4.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.15 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.58 87.06 0.67 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -141.1 22.24 2.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -1.111 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.54 ' HA ' ' NE2' ' A' ' 47' ' ' GLN . 85.5 m-70 -141.16 40.4 1.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.94 . . . . 0.0 110.147 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.654 HG22 ' HB3' ' A' ' 69' ' ' ALA . 11.1 t -90.63 169.29 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.214 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.408 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 48.31 37.84 18.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 44' ' ' HIS . 12.2 pt20 -169.52 -148.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.471 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 60.88 131.98 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.189 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.42 70.6 1.39 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.63 13.18 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.26 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.04 -33.53 59.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.87 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -73.68 -44.73 55.82 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.388 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.548 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 3.4 t -63.57 -48.94 75.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.519 -0.738 . . . . 0.0 109.618 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 0.8 OUTLIER -62.74 -42.91 99.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.26 -69.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.571 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 52' ' ' ARG . 27.6 m -49.9 -32.97 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.141 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.811 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -55.51 -54.16 47.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.8 . . . . 0.0 109.487 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -29.95 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.6 t -77.78 -12.16 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.0 m-20 -113.68 -33.44 5.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 142.19 62.99 0.03 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.811 HG11 ' SG ' ' A' ' 57' ' ' CYS . 54.7 t -158.77 59.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -1.106 . . . . 0.0 110.107 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 0.2 OUTLIER -73.16 130.99 41.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.9 pt -145.38 -172.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.151 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -103.12 -61.96 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.062 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 65' ' ' SER . 12.3 mmmt -150.12 -178.4 6.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.079 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 67' ' ' GLN . 12.2 mm-40 -135.57 95.66 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.196 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -108.41 75.97 1.01 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 13' ' ' GLY . . . -44.17 106.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 110.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.491 ' HG2' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -101.94 159.23 15.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.122 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 60.8 tt0 -71.93 156.46 39.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.501 HG12 ' OD2' ' A' ' 76' ' ' ASP . 12.5 tt -79.92 159.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.446 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.8 p -119.68 176.13 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -19.7 61.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' A' ' 79' ' ' LYS . . . -64.7 -36.65 84.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.231 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.6 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 39.2 m-20 -47.53 -36.49 10.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.136 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.592 ' CD2' ' HG2' ' A' ' 98' ' ' LYS . 20.8 m-85 -94.55 16.34 15.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.137 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.18 11.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.619 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -137.11 -149.51 0.32 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.112 -0.992 . . . . 0.0 109.682 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER 36.67 -149.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.443 -0.786 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -140.06 -34.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.604 HG11 ' HZ ' ' A' ' 139' ' ' PHE . 15.8 t -139.75 149.59 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 110.714 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 8' ' ' LEU . 16.7 mt -121.76 126.61 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.828 . . . . 0.0 109.859 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 109' ' ' PHE . . . -120.26 135.09 55.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 90' ' ' ILE . . . -108.43 160.38 15.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.59 HD21 HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -105.06 2.7 29.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.965 . . . . 0.0 110.244 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 90' ' ' ILE . 22.9 t70 -137.85 174.14 10.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -89.66 -66.71 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.086 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -47.16 -40.69 16.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 11' ' ' CYS . 6.3 tt -52.35 -39.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.043 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.533 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.7 OUTLIER -81.58 -34.79 30.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.077 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -20.07 63.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -103.14 -44.64 5.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.537 HG13 ' CE ' ' A' ' 97' ' ' MET . 2.7 tt -48.15 -36.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.468 ' N ' HG23 ' A' ' 94' ' ' ILE . 38.4 p30 -69.98 -11.47 60.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 9.5 t -75.41 -26.86 58.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.537 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.3 ptt? -96.34 -34.99 11.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -45.22 145.58 1.78 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.26 -174.35 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.989 1.52 . . . . 0.0 110.34 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.63 -4.1 11.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.963 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.88 48.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.5 p -124.84 -161.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -132.52 -142.16 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.262 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 103' ' ' ARG . . . 56.86 -159.27 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 106' ' ' VAL . 7.9 tttt -173.41 148.11 1.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 0.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 106' ' ' VAL . 4.0 m -101.01 133.64 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.05 161.4 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.459 HD21 ' OD1' ' A' ' 110' ' ' ASN . 8.5 tp -83.51 149.21 26.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.727 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -136.3 85.71 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.236 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.459 ' OD1' HD21 ' A' ' 108' ' ' LEU . 2.0 p-10 -177.39 146.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.58 174.78 12.04 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.004 1.528 . . . . 0.0 110.373 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.1 Cg_endo -72.84 52.77 2.22 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.437 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.98 -50.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.96 91.86 1.41 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.844 HG13 ' HA ' ' A' ' 128' ' ' MET . 99.0 t -56.24 114.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.9 t70 57.63 168.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.948 . . . . 0.0 110.178 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.535 ' N ' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 171.61 -56.83 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.331 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 117' ' ' ASP . 46.1 Cg_endo -72.72 -37.69 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.995 1.524 . . . . 0.0 110.542 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 57.89 179.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.6 t80 60.32 25.75 15.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.234 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 t -163.89 -164.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.22 18.31 22.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.962 . . . . 0.0 110.21 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -90.53 34.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.189 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -147.23 -45.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.785 ' HB3' HG21 ' A' ' 56' ' ' VAL . 4.4 m-30 -50.42 -46.32 84.37 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.29 -1.124 . . . . 0.0 110.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 48.5 Cg_endo -74.65 -51.4 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.716 1.377 . . . . 0.0 110.171 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' MET . 3.3 m -58.99 -55.56 33.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.844 ' HA ' HG13 ' A' ' 115' ' ' VAL . 10.2 ttp -44.9 -40.58 6.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.367 -0.833 . . . . 0.0 110.084 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.528 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 37.1 t80 -70.35 -62.01 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.995 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.72 -47.27 15.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.92 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.792 ' CB ' HG22 ' A' ' 115' ' ' VAL . 71.6 m -70.88 -42.19 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.981 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.744 HG23 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -50.72 -43.11 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.941 . . . . 0.0 109.851 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.579 ' HA ' ' HE3' ' A' ' 136' ' ' MET . 1.1 t -85.29 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.516 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.95 -18.31 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.49 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 39.1 tp10 -98.28 -18.29 18.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.579 ' HE3' ' HA ' ' A' ' 133' ' ' SER . 3.9 ttp -101.45 -0.53 35.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 110.2 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -82.51 -48.29 0.87 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.933 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.3 -11.5 14.56 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.055 1.555 . . . . 0.0 110.326 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.604 ' HZ ' HG11 ' A' ' 82' ' ' VAL . 68.4 t80 -101.92 -61.98 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 146' ' ' ILE . 6.5 tp -52.73 -25.43 11.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.592 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 23.3 m -76.99 -40.91 45.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 110.373 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.3 -66.42 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.659 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.579 ' O ' ' CZ ' ' A' ' 139' ' ' PHE . 12.7 t-80 -96.89 60.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -0.933 . . . . 0.0 110.733 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 145' ' ' LEU . . . -176.16 -34.05 0.04 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER 172.06 -91.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.499 -1.001 . . . . 0.0 109.912 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.592 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.139 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.36 0.6 . . . . 0.0 110.339 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.917 ' HE2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -155.81 -48.1 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 110.684 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.952 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.2 mttt 68.83 -154.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 110.913 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.892 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -159.56 135.42 8.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.316 0.579 . . . . 0.0 109.977 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.887 HG12 HG11 ' A' ' 82' ' ' VAL . 3.5 m -104.07 115.43 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.503 -0.748 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.848 HD12 ' HB3' ' A' ' 36' ' ' ASP . 14.9 tp -66.37 89.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 110.089 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.585 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -78.64 101.45 7.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.045 HG22 ' HB3' ' A' ' 38' ' ' ALA . 15.2 t -116.9 157.05 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.759 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 11.9 t -145.85 -78.87 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -175.38 69.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.341 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 137.74 -21.85 3.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 4.8 t-20 71.15 1.45 3.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -1.132 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 69' ' ' ALA . 18.5 mm -89.59 -36.79 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.932 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 29.5 p -137.63 167.18 22.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.927 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.546 ' CG ' HD23 ' A' ' 86' ' ' LEU . 51.2 mtm180 56.22 43.04 27.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -0.968 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -173.31 -60.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 45.0 Cg_endo -71.78 -10.86 27.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.888 1.468 . . . . 0.0 110.33 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.751 ' HB3' HD12 ' A' ' 132' ' ' ILE . . . -75.72 -16.79 60.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.047 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 37.0 t -66.45 -55.42 15.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.799 ' HG3' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -43.37 -36.69 1.99 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 109.346 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -71.88 -50.26 19.5 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.987 HD11 ' OG ' ' A' ' 133' ' ' SER . 2.4 tp -55.86 -45.17 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.747 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.95 ' CB ' HD11 ' A' ' 35' ' ' ILE . 54.3 m -72.16 -30.47 65.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.562 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 0.1 OUTLIER -66.91 -37.1 83.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.895 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.402 ' HB2' ' HA ' ' A' ' 62' ' ' VAL . 22.1 t70 -82.81 -34.99 26.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 110.107 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.837 ' O ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -78.72 -28.16 45.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 110.406 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.837 HG13 ' O ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -163.7 41.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.79 94.51 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' VAL . 3.8 t0 170.5 -25.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 110.128 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.574 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.76 -138.94 0.31 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 110.022 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -152.88 -83.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.892 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 37.01 26.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.42 -0.8 . . . . 0.0 110.92 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.95 HD11 ' CB ' ' A' ' 25' ' ' CYS . 7.4 mt -131.55 132.64 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.158 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.848 ' HB3' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -145.03 90.05 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 179.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -67.19 124.68 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.045 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -141.45 176.03 9.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.701 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -159.61 -162.53 1.04 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.152 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -177.59 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -165.26 110.51 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 108.34 2.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.35 -41.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 44' ' ' HIS . 6.1 p80 -155.79 81.5 1.02 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 t -118.79 -20.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 110.303 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.15 31.7 8.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.502 ' HG3' ' N ' ' A' ' 48' ' ' SER . 17.7 pt20 -164.5 -140.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -1.116 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.502 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.61 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.174 -0.954 . . . . 0.0 110.15 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.9 Cg_endo -69.34 107.48 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.012 1.533 . . . . 0.0 110.538 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -94.26 21.31 7.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 3.7 m -71.08 -27.9 63.96 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.189 -0.944 . . . . 0.0 108.748 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -74.38 -43.45 56.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.214 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -54.92 28.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.483 -0.76 . . . . 0.0 109.6 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 20.0 mt-30 -61.58 -40.31 94.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.261 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.602 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.09 -71.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.832 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 52' ' ' ARG . 14.9 p -50.03 -34.28 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.494 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 64' ' ' ILE . 1.3 m -55.45 -53.71 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.507 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -69.43 -24.35 63.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.862 . . . . 0.0 109.566 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -82.58 -11.72 58.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.813 . . . . 0.0 109.993 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -111.45 -31.72 6.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 0.0 109.182 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 130.03 73.63 0.13 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 129' ' ' PHE . 2.2 p 173.34 137.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.289 -1.124 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -119.41 137.2 53.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.203 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.76 HD11 ' SG ' ' A' ' 57' ' ' CYS . 34.1 mt -120.58 -34.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.202 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER 53.66 97.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 65' ' ' SER . 3.6 mmmt 60.05 145.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.271 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.417 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 5.4 mm-40 -107.53 -52.58 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 67.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.94 . . . . 0.0 110.159 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -57.28 152.53 13.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 mtp-105 -137.1 -163.75 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 110.271 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -132.43 128.01 36.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 72' ' ' ILE . 11.9 tt -50.32 159.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.178 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 50.9 p -126.97 169.93 12.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -1.92 20.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.206 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.14 -8.64 21.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.543 ' HB2' HD22 ' A' ' 8' ' ' LEU . 20.5 p-10 -47.21 -37.25 10.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 39.5 m-85 -69.41 -17.04 63.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 m -123.06 13.44 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.203 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 3.5 tptt -94.82 -23.7 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.708 ' CD1' ' HB3' ' A' ' 6' ' ' ALA . 93.8 m-85 -147.35 -140.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.869 . . . . 0.0 109.983 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 4.0 m-20 -137.06 -23.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.054 -1.028 . . . . 0.0 111.029 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.887 HG11 HG12 ' A' ' 7' ' ' VAL . 39.1 t -113.42 138.76 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 0.0 110.509 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.652 HD12 ' CB ' ' A' ' 104' ' ' ALA . 47.4 mt -146.3 133.89 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.433 -0.792 . . . . 0.0 109.777 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -162.03 163.09 28.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.661 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.5 ' HB1' HD13 ' A' ' 90' ' ' ILE . . . -126.5 159.87 32.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.824 ' HG ' HG21 ' A' ' 115' ' ' VAL . 1.3 tp -85.64 -37.36 19.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -101.74 -176.26 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.194 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.8 mm-40 -92.45 -39.0 11.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 88' ' ' GLN . 15.6 m -42.75 -41.0 3.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.605 HD12 ' H ' ' A' ' 90' ' ' ILE . 2.1 mp -65.46 -40.08 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.91 . . . . 0.0 110.099 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.617 HD13 ' HB2' ' A' ' 108' ' ' LEU . 2.0 tp -67.64 -32.4 73.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.6 t -79.99 -30.62 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.246 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 96' ' ' SER . 1.8 m-20 -87.83 -54.58 4.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.256 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.633 HG13 ' HE1' ' A' ' 97' ' ' MET . 3.9 tt -46.69 -40.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.63 -8.81 56.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 2.7 m -96.78 -0.93 47.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.151 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.633 ' HE1' HG13 ' A' ' 94' ' ' ILE . 1.7 ptt? -122.56 -10.0 8.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 8.4 mtpt -63.59 143.75 97.88 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.411 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 45.9 Cg_endo -73.14 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.028 1.541 . . . . 0.0 110.419 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.4 m -105.61 28.38 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.416 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.1 p-10 -178.51 126.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 110.24 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 101' ' ' ASN . 83.5 m -149.56 -161.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.01 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.652 ' CB ' HD12 ' A' ' 83' ' ' ILE . . . -105.82 -152.07 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -148.75 111.15 4.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.167 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 71.1 t -87.39 125.46 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 110.088 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ALA . 3.6 t -135.11 159.07 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.617 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -119.19 108.17 14.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -55.27 -170.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.26 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.625 HD21 HG22 ' A' ' 115' ' ' VAL . 37.5 p-10 -42.57 166.04 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.503 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.9 Cg_endo -74.64 175.02 11.66 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.912 1.48 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.5 Cg_endo -71.74 54.45 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.996 1.524 . . . . 0.0 110.38 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.67 -29.95 4.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.876 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -107.45 -92.45 2.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.824 HG21 ' HG ' ' A' ' 86' ' ' LEU . 29.0 m -41.12 128.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 110.168 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -157.78 -65.7 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.42 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 0.5 OUTLIER 61.53 82.76 0.22 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.12 176.64 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.006 1.53 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 119' ' ' TYR . 67.7 m-85 -118.95 24.15 10.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -130.17 -34.68 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 110.335 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -145.62 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 110.246 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 p -153.97 54.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.137 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' A' ' 127' ' ' THR . 4.0 p30 -124.41 -6.14 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.265 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 117' ' ' ASP . . . -93.85 -22.37 25.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.619 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 13.5 m-85 -55.03 -49.81 90.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.331 -1.099 . . . . 0.0 110.365 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -73.34 -35.67 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.84 1.442 . . . . 0.0 110.385 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 123' ' ' ASP . 2.5 m -63.06 -51.96 64.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 20' ' ' ALA . 3.1 ttp -44.52 -55.42 5.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 11.1 t80 -68.23 -33.59 74.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.182 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.754 ' CB ' HG13 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -86.89 -43.45 12.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.057 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -57.85 -23.21 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -0.761 . . . . 0.0 109.472 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.987 ' OG ' HD11 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.32 -42.81 6.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.987 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 14.3 mttp -75.41 -5.69 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 131' ' ' SER . 70.3 mm-40 -129.2 34.34 4.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.15 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.55 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -116.21 -12.18 11.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.1 mttp -81.53 -47.4 1.06 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.44 0.33 10.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.99 1.521 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 62.8 t80 -108.06 -77.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.098 HD12 HD13 ' A' ' 145' ' ' LEU . 8.5 tp -51.16 -24.46 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.345 -0.847 . . . . 0.0 110.438 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.842 HG23 HD13 ' A' ' 146' ' ' ILE . 32.2 m -82.01 -30.61 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -105.22 -14.06 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.453 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.687 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 6.9 m80 -84.71 39.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.101 -0.999 . . . . 0.0 110.302 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.7 60.86 6.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.098 HD13 HD12 ' A' ' 140' ' ' LEU . 1.1 mt -163.67 34.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 110.021 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.842 HD13 HG23 ' A' ' 141' ' ' THR . 2.0 tp . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.227 0.537 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.514 ' HG3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.15 149.96 26.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.254 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.682 ' H ' HG22 ' A' ' 34' ' ' ILE . 23.1 mtpp -130.23 -155.62 0.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 110.982 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.077 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -147.23 117.2 7.22 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.546 0.689 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.893 ' HB ' HD12 ' A' ' 34' ' ' ILE . 21.9 t -108.2 126.62 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.578 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 38' ' ' ALA . 6.8 tp -98.13 80.95 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 0.0 110.752 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.949 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 69.5 m-85 -62.2 133.65 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.054 HG13 HD11 ' A' ' 90' ' ' ILE . 8.6 p -156.45 166.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.616 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.668 ' CA ' HD12 ' A' ' 90' ' ' ILE . 1.1 p -146.78 -98.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 109.904 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.58 86.7 2.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.101 -1.0 . . . . 0.0 110.185 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.581 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 85.37 -11.53 60.87 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 t30 74.75 -164.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -1.123 . . . . 0.0 109.782 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 15' ' ' ILE . 11.7 mm 58.12 13.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 2.0 t -174.89 175.33 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.955 . . . . 0.0 110.207 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.738 ' CB ' HD22 ' A' ' 86' ' ' LEU . 1.1 mtp180 70.72 -56.24 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.351 -0.843 . . . . 0.0 110.013 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.751 ' CB ' HD21 ' A' ' 86' ' ' LEU . 3.2 m -175.44 55.62 0.14 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.484 ' HD3' ' C ' ' A' ' 16' ' ' CYS . 50.0 Cg_endo -76.39 -1.14 11.15 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.971 1.511 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.926 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -100.12 7.01 44.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.348 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.677 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -59.73 -37.83 80.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.125 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -50.42 66.96 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.68 -0.638 . . . . 0.0 109.726 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.667 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -62.97 -58.27 12.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.983 HG21 HG23 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -55.13 -29.33 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -1.205 . . . . 0.0 109.91 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.3 m -69.09 -60.7 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.253 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 23' ' ' GLY . 11.6 ptm180 -61.1 -28.73 69.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.513 ' CB ' ' HA ' ' A' ' 62' ' ' VAL . 11.4 t70 -81.17 -53.06 6.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -55.58 -38.73 69.75 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.312 -0.867 . . . . 0.0 110.278 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 25' ' ' CYS . 4.4 m -84.54 -38.56 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.226 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.49 ' N ' HG23 ' A' ' 29' ' ' VAL . . . 106.0 -64.29 0.29 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.03 50.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -1.147 . . . . 0.0 110.251 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.778 ' C ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -95.48 -132.82 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 35' ' ' ILE . 4.9 mp -149.57 -120.63 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.383 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.077 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.0 29.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.812 . . . . 0.0 111.609 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.827 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -96.24 97.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.888 -1.133 . . . . 0.0 110.147 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.641 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 6.3 m-20 -135.76 144.27 45.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.5 p -137.56 151.34 48.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.432 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.786 ' O ' HG23 ' A' ' 10' ' ' VAL . . . -146.22 -172.9 4.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 110.361 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG23 ' A' ' 10' ' ' VAL . . . -169.4 100.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 41' ' ' SER . 25.8 p -54.48 -68.17 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 0.0 110.274 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.506 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.2 OUTLIER -64.71 -177.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.54 36.86 0.58 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -78.96 -31.64 45.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -1.147 . . . . 0.0 110.187 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.432 ' ND1' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -116.62 70.74 0.77 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -138.28 142.6 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 86.32 25.98 34.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 48' ' ' SER . 13.0 pt20 -176.96 -141.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -1.131 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 0.9 OUTLIER 59.03 108.31 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.62 100.37 0.8 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.012 1.532 . . . . 0.0 110.471 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.505 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 22.3 m-20 -87.33 27.12 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.231 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -75.02 -27.55 60.14 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.186 -0.946 . . . . 0.0 109.137 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.782 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -74.2 -51.77 14.47 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.442 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -63.01 -46.74 86.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 109.655 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 1.8 tt0 -62.76 -42.47 99.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.169 -0.957 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 3.5 ttpp -57.76 -67.13 0.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.704 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 52' ' ' ARG . 4.8 p -50.86 -33.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.237 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.679 ' CB ' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.37 -55.6 31.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.463 -0.773 . . . . 0.0 109.504 179.424 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -29.89 71.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 5.7 t -78.24 -14.46 59.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -111.7 -35.13 5.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.2 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.563 ' C ' HG12 ' A' ' 62' ' ' VAL . . . 127.58 84.81 0.48 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.926 HG23 ' N ' ' A' ' 24' ' ' ILE . 1.5 p 169.26 80.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.369 -1.077 . . . . 0.0 110.041 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -59.96 157.53 12.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.352 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.47 HG12 ' HA3' ' A' ' 23' ' ' GLY . 39.3 mt -148.81 -64.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.097 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER 66.54 96.78 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.47 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.56 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.286 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.422 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 21.4 mm100 -105.48 -145.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.7 70.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . . . -93.75 139.12 31.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -171.42 175.36 4.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -75.96 106.49 7.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.757 HD12 ' HB1' ' A' ' 38' ' ' ALA . 19.8 tt -46.23 157.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.41 159.9 37.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -55.38 -19.3 8.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.14 -12.89 44.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.98 -15.79 61.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.607 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 17.1 m-30 -81.73 -8.04 59.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.223 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.7 p -117.73 -48.98 2.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.582 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -51.37 -27.09 8.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.18 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.678 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 9.3 m-85 -134.1 157.09 47.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.252 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -104.25 -8.17 19.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.27 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.51 ' CG1' ' CE1' ' A' ' 143' ' ' HIS . 6.0 t -138.95 141.86 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.233 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.51 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 51.9 mt -123.84 143.36 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.949 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -114.64 120.51 40.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.851 ' HB1' HG23 ' A' ' 90' ' ' ILE . . . -111.22 113.62 26.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 18' ' ' SER . 2.2 mp -51.18 -83.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.492 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t0 -71.96 -179.43 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.241 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -84.41 -45.29 12.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 1.5 t -45.21 -51.14 11.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.956 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.054 HD11 HG13 ' A' ' 10' ' ' VAL . 6.8 tt -52.95 -47.16 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.363 -0.835 . . . . 0.0 110.086 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -58.16 -53.21 60.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -55.28 -54.87 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.845 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' SER . 29.1 m-20 -47.67 -60.32 2.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 110.147 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.667 HG23 ' CE ' ' A' ' 97' ' ' MET . 15.0 mt -58.74 -47.05 90.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -67.02 -16.13 64.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.557 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -80.82 -28.89 36.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.667 ' CE ' HG23 ' A' ' 94' ' ' ILE . 10.2 ptt? -97.07 -30.25 13.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.118 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -41.76 144.59 0.79 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 110.446 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.527 ' HD2' ' CE ' ' A' ' 98' ' ' LYS . 44.1 Cg_endo -71.37 177.39 6.74 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.13 1.595 . . . . 0.0 110.387 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.413 ' C ' ' OD1' ' A' ' 101' ' ' ASN . 0.9 OUTLIER -98.2 21.2 11.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 7.4 m120 -143.87 -137.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.102 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.31 -176.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 110.067 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.476 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -131.55 35.37 3.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.28 -171.52 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 146.04 11.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.483 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 37.8 t -112.17 127.0 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 108' ' ' LEU . 1.2 p -122.4 171.42 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.553 ' N ' HG22 ' A' ' 107' ' ' VAL . 6.0 tp -99.74 150.31 22.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.828 . . . . 0.0 110.138 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 135' ' ' GLU . 25.3 t80 -124.96 97.58 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 109' ' ' PHE . 18.8 t-20 60.14 144.9 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.561 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.3 Cg_endo -74.51 176.97 9.0 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.529 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.1 Cg_endo -72.18 3.05 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.027 1.54 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.47 -37.81 15.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 110.123 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 115' ' ' VAL . . . -78.49 -76.41 0.93 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 29.9 m -59.27 -150.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -1.1 . . . . 0.0 110.118 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 6.0 t0 63.77 135.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.442 ' OD1' ' SG ' ' A' ' 16' ' ' CYS . 1.2 p30 -170.23 157.63 5.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.963 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 -27.74 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.036 1.545 . . . . 0.0 110.448 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 56.3 34.92 24.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -110.41 -32.97 6.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 m -122.22 -86.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.5 ' O ' ' CD ' ' A' ' 126' ' ' PRO . 89.9 p -155.0 19.05 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.11 4.6 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 110.18 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -105.8 -45.99 1.24 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 12.8 m-85 -50.01 -45.69 81.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 110.566 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.736 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 45.9 Cg_endo -73.68 -51.02 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.573 1.302 . . . . 0.0 110.287 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 128' ' ' MET . 66.0 p -69.11 -56.59 7.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.23 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.63 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 8.8 ttp -41.33 -68.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 87.5 t80 -59.22 -44.04 92.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.119 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -44.56 -64.16 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.972 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -63.4 -45.3 91.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 109.953 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.983 HG23 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -40.7 -56.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.856 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.585 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -74.38 -47.36 34.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.225 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 3.8 tppt? -47.94 -22.79 0.64 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.578 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -125.57 31.34 5.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.986 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.533 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -115.21 -22.08 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.156 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 3.9 mttp -87.92 -52.36 0.39 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.72 5.64 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.521 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 41.3 t80 -93.82 -76.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.753 HD13 HD23 ' A' ' 145' ' ' LEU . 3.5 pp -65.66 -30.8 71.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.514 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.627 ' N ' HD12 ' A' ' 140' ' ' LEU . 22.3 m -56.06 -33.53 65.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 110.251 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.09 -34.87 7.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.16 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.534 ' NE2' HG11 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -44.33 -27.85 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 110.107 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.534 ' O ' ' HD2' ' A' ' 5' ' ' LYS . . . 127.08 67.8 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.753 HD23 HD13 ' A' ' 140' ' ' LEU . 26.5 tp -156.36 -54.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 0.0 110.227 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.764 ' C ' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.174 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.343 0.592 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.555 ' HG2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.84 -164.74 0.54 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.401 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.914 ' C ' HG22 ' A' ' 34' ' ' ILE . 24.7 mttm -156.02 -160.86 1.05 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 110.77 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.009 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -144.59 122.81 12.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.442 -0.787 . . . . 0.0 111.056 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.921 HG11 ' CZ ' ' A' ' 9' ' ' PHE . 43.5 t -113.21 128.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 109.669 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 80' ' ' PHE . 13.2 tp -86.93 85.87 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.485 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.921 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 34.0 m-85 -76.24 100.43 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.948 HG13 HD11 ' A' ' 90' ' ' ILE . 1.5 p -120.54 168.96 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.573 ' O ' HD12 ' A' ' 12' ' ' LEU . 19.4 t -154.14 -53.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.058 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER 176.58 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.501 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -104.31 -15.85 20.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.925 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 6.6 t-20 67.96 38.7 2.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -1.198 . . . . 0.0 110.205 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.653 HD13 ' CB ' ' A' ' 48' ' ' SER . 17.9 mt -114.76 -2.52 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 110.076 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 m -137.2 45.45 2.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 110.13 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HD3' HD22 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -146.7 -57.35 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 110.176 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.539 ' CB ' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -45.21 -56.57 9.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.139 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.83 ' HB3' HD12 ' A' ' 64' ' ' ILE . 46.9 Cg_endo -74.88 -0.96 10.55 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.928 1.488 . . . . 0.0 110.295 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.735 ' HB1' HG13 ' A' ' 132' ' ' ILE . . . -103.66 -44.98 4.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 110.213 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.562 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 60.9 m -74.21 -38.62 63.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.066 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.62 ' HG3' HG21 ' A' ' 35' ' ' ILE . 2.5 tt0 -69.68 -45.68 67.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 110.242 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.842 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -71.23 -46.65 41.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.628 HG12 HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -61.29 -43.8 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.14 . . . . 0.0 110.355 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.577 ' N ' HG23 ' A' ' 24' ' ' ILE . 58.3 m -69.71 -40.02 76.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 1.8 mmt-85 -67.5 -32.87 73.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.417 ' OD2' ' HA3' ' A' ' 61' ' ' GLY . 1.2 t70 -85.19 -48.69 8.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.039 . . . . 0.0 110.622 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -74.83 -21.58 59.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.745 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.784 HG11 ' HG3' ' A' ' 32' ' ' LYS . 2.3 t -119.98 -24.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.783 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 106.28 -60.97 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 13.7 t70 -178.27 94.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 110.215 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.796 ' C ' HD12 ' A' ' 33' ' ' LEU . 12.5 mmtm -119.86 -130.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.105 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.796 HD12 ' C ' ' A' ' 32' ' ' LYS . 5.2 mp -149.81 -118.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 110.643 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.009 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.17 29.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.459 -0.775 . . . . 0.0 111.496 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.784 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.1 mt -104.26 90.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.007 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 55.1 m-20 -121.79 97.49 5.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.68 134.72 36.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.832 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -137.04 168.35 19.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.487 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.925 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -140.38 142.83 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 110.08 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.911 HG21 HG13 ' A' ' 90' ' ' ILE . 11.8 p -103.7 41.57 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 40' ' ' THR . 2.4 p 170.16 103.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.86 58.05 0.99 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -88.59 -62.06 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -1.158 . . . . 0.0 110.189 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 102.4 9.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.288 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 69' ' ' ALA . 73.6 t -142.07 139.53 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.227 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.07 60.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 48' ' ' SER . 5.3 pt20 -123.52 -140.39 0.31 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 110.243 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.653 ' CB ' HD13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 66.21 126.36 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.36 90.36 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.349 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 2.5 t0 -99.26 24.03 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.259 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -76.47 -30.43 57.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.219 -0.925 . . . . 0.0 109.197 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.9 OUTLIER -74.16 -48.95 25.88 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.444 -0.785 . . . . 0.0 109.29 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.38 71.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 109.483 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -61.1 -42.13 97.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.267 179.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -54.74 -66.05 0.47 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.363 -0.836 . . . . 0.0 109.304 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.592 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.6 t -50.28 -35.06 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.939 . . . . 0.0 108.983 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.729 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -54.87 -51.11 66.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 109.427 179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -69.52 -28.55 66.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.719 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.3 -11.14 59.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -112.44 -26.49 8.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 131.17 80.18 0.2 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.842 HG13 ' HA3' ' A' ' 23' ' ' GLY . 66.5 t -158.89 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -1.108 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 32.1 p-10 -97.97 104.66 16.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 19' ' ' PRO . 13.6 pt -143.24 -171.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.36 125.97 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.061 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.458 ' OE1' ' HD3' ' A' ' 19' ' ' PRO . 33.9 mm-40 -84.38 96.07 8.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.345 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -89.66 74.41 7.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.118 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.868 ' HB3' HG13 ' A' ' 45' ' ' VAL . . . -41.9 126.63 3.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.9 tmm_? -106.06 151.45 24.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -90.62 144.14 26.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.903 . . . . 0.0 110.241 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 39' ' ' ALA . 16.5 tt -82.69 170.45 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 110.121 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.51 161.07 41.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -59.42 -14.84 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' O ' ' CE ' ' A' ' 79' ' ' LYS . . . -80.48 -12.02 59.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.165 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -47.96 -21.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.366 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.536 ' CD1' ' HE3' ' A' ' 98' ' ' LYS . 18.9 m-85 -76.92 52.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.113 -0.992 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.516 ' C ' ' CD ' ' A' ' 79' ' ' LYS . 1.1 p 175.02 31.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.344 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' CD ' ' C ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -135.74 -35.69 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.284 -0.885 . . . . 0.0 110.034 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.764 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 9.5 m-85 -123.32 156.46 35.27 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.549 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 1.3 m-20 -71.64 -36.63 70.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 50.4 t -140.8 156.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.039 . . . . 0.0 110.69 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 8' ' ' LEU . 9.5 mt -118.45 133.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.494 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -107.24 134.63 50.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 110.443 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.55 125.68 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.648 HD22 ' HD3' ' A' ' 17' ' ' ARG . 2.7 mp -78.99 -78.47 0.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 5.6 m-20 -56.91 178.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.517 ' NE2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -89.11 -55.15 3.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.2 m -45.62 -48.93 14.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.948 HD11 HG13 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -46.26 -49.69 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.71 HD13 ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -63.54 -49.62 72.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.835 179.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.0 t -60.88 -17.26 49.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.846 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -87.32 -67.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 90' ' ' ILE . 6.6 mt -44.75 -54.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.549 -0.72 . . . . 0.0 109.871 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -60.09 -14.9 19.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.697 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -81.7 -34.99 30.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 21.1 ptt? -96.53 -27.85 14.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE3' ' CD1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -40.71 139.32 1.17 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.66 -163.98 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.087 1.572 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -110.87 20.98 16.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.282 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -169.98 121.33 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.2 p -172.59 170.54 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 41.59 1.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -162.27 131.61 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.13 173.59 6.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 0.0 110.136 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.442 ' CG2' ' HD2' ' A' ' 98' ' ' LYS . 64.5 t -118.95 142.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -134.61 161.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.231 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.71 ' HG ' HD13 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -103.91 105.51 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.144 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.563 ' CZ ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -54.57 -57.18 12.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 18.7 p30 -162.11 164.11 17.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -73.96 175.21 11.14 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.133 1.596 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.0 Cg_endo -72.41 52.45 1.98 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.941 1.495 . . . . 0.0 110.422 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.41 -7.15 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.95 -91.18 1.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.949 HG22 ' HA ' ' A' ' 128' ' ' MET . 14.3 t -85.86 136.85 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.071 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.432 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 35.1 t70 -167.79 33.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.545 ' N ' ' CD ' ' A' ' 118' ' ' PRO . 55.8 m-20 43.76 49.39 5.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 117' ' ' ASP . 46.0 Cg_endo -72.72 139.9 31.52 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.02 1.537 . . . . 0.0 110.499 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.431 ' CE2' ' O ' ' A' ' 117' ' ' ASP . 49.5 m-85 -132.93 44.8 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.113 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -107.35 -35.98 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.139 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.7 m -159.16 -147.35 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.526 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 28.8 m -60.85 -25.74 66.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 123' ' ' ASP . 10.9 p30 -46.59 123.03 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.265 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 132.99 -27.0 3.51 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -98.42 -45.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.264 -1.139 . . . . 0.0 110.764 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 125' ' ' PHE . 48.4 Cg_endo -82.6 -73.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.586 1.308 . . . . 0.0 110.643 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 126' ' ' PRO . 1.1 t -42.95 -33.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.949 ' HA ' HG22 ' A' ' 115' ' ' VAL . 4.0 tmm? -62.05 -69.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 24' ' ' ILE . 5.8 t80 -49.22 -50.21 39.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.976 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -50.87 -47.56 60.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.427 ' CB ' HG23 ' A' ' 115' ' ' VAL . 38.5 t -64.78 -46.96 79.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.797 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.735 HG13 ' HB1' ' A' ' 20' ' ' ALA . 15.2 mm -47.51 -55.97 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 0.1 OUTLIER -63.89 -47.85 78.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.821 . . . . 0.0 110.146 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -52.99 -25.88 13.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.897 . . . . 0.0 110.145 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.563 ' O ' ' CZ ' ' A' ' 109' ' ' PHE . 80.6 mm-40 -116.88 14.94 15.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.564 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.79 -22.14 7.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.8 mtpm? -84.52 -47.9 0.67 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.1 Cg_endo -78.36 -4.59 14.36 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.013 1.533 . . . . 0.0 110.344 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 139' ' ' PHE . 4.6 t80 -108.03 -48.87 3.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.46 -9.58 19.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.228 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 4.3 m -73.8 -72.1 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.423 ' N ' HG22 ' A' ' 141' ' ' THR . 2.2 mt-10 -105.16 -5.66 20.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.68 22.86 15.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.163 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.835 ' C ' HD12 ' A' ' 145' ' ' LEU . . . -173.14 -54.64 0.05 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.835 HD12 ' C ' ' A' ' 144' ' ' GLY . 5.4 mp -149.77 -88.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -1.124 . . . . 0.0 110.126 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 1.7 tp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.149 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.283 0.563 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -85.63 156.72 20.58 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.734 ' H ' HG22 ' A' ' 34' ' ' ILE . 3.2 mtpt -133.53 -163.99 1.43 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.022 -1.049 . . . . 0.0 111.029 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.074 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -148.86 116.45 6.23 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.864 ' HB ' HD12 ' A' ' 34' ' ' ILE . 3.3 t -104.13 125.54 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.703 . . . . 0.0 109.159 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.739 HD13 ' CD2' ' A' ' 80' ' ' PHE . 13.5 tp -89.92 84.7 6.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 110.697 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.587 ' CG ' ' SG ' ' A' ' 21' ' ' CYS . 26.0 m-85 -67.27 108.72 2.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -0.95 . . . . 0.0 109.469 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.981 HG13 ' HA ' ' A' ' 39' ' ' ALA . 20.0 t -126.38 154.81 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.563 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 1.8 p -145.16 -108.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.854 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.617 HD23 ' OD2' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -118.51 82.24 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 0.0 110.104 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 77.37 0.39 71.83 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.5 t30 71.97 -158.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -1.087 . . . . 0.0 109.899 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 15' ' ' ILE . 8.4 mm 58.06 12.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.237 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 177.19 176.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.117 -0.99 . . . . 0.0 110.504 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.715 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER 71.72 -60.0 0.53 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.775 . . . . 0.0 110.237 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.606 ' OG ' HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -139.73 48.07 1.46 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.9 Cg_endo -77.82 -10.64 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.924 1.486 . . . . 0.0 110.054 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -97.5 6.99 47.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 110.43 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.803 ' SG ' HD12 ' A' ' 132' ' ' ILE . 1.4 m -62.78 -45.14 94.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.07 -1.019 . . . . 0.0 109.352 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.547 ' HG2' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.83 -47.4 85.88 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.55 -0.719 . . . . 0.0 109.88 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.841 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -68.49 -59.52 6.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.109 HD12 ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -43.0 -46.91 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -1.19 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.755 ' HB2' HD11 ' A' ' 35' ' ' ILE . 78.1 m -69.36 -37.44 77.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 13.6 mmt180 -62.04 -45.18 94.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.337 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 -45.79 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.69 ' O ' HG13 ' A' ' 29' ' ' VAL . 6.0 mmt -63.24 -41.32 99.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 28' ' ' MET . 3.5 m -158.77 36.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.405 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 25' ' ' CYS . . . -49.87 -22.67 4.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.82 -20.79 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.356 -1.085 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.658 ' HE2' HD11 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -104.77 -139.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.931 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.8 mt -147.77 -95.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.228 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.074 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 32.39 33.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 0.0 111.568 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 25' ' ' CYS . 3.5 mt -110.69 94.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.892 -1.13 . . . . 0.0 110.487 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.691 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 42.3 m-20 -126.05 104.48 8.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 m -95.15 130.94 41.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.772 ' C ' HG22 ' A' ' 10' ' ' VAL . . . -157.29 -172.79 4.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.482 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.981 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -164.06 146.55 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.125 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 40' ' ' THR . 14.0 t -93.87 64.74 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.177 -0.952 . . . . 0.0 110.256 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.508 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . 12.5 t -149.17 -75.66 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.242 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . 74.59 106.32 0.09 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 1.2 m-85 -170.04 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -1.146 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -123.98 23.88 8.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.229 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m -65.03 -9.19 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 110.403 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . -104.48 41.12 2.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' O ' ' CB ' ' A' ' 48' ' ' SER . 6.9 pt20 -177.92 -142.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.119 . . . . 0.0 110.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 67.45 98.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.56 83.53 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.004 1.529 . . . . 0.0 110.427 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -89.09 32.3 0.83 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -29.4 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 108.923 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' C ' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.72 -52.46 13.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.74 . . . . 0.0 109.306 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.625 ' N ' ' CZ ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -61.25 -48.22 82.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.622 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -61.27 -43.71 98.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.136 -0.978 . . . . 0.0 109.256 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 1.3 tptt -54.25 -65.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.393 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.859 HG11 ' HD2' ' A' ' 125' ' ' PHE . 24.3 m -53.75 -32.24 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.227 -0.921 . . . . 0.0 109.03 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.791 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -54.98 -55.63 28.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.429 -0.795 . . . . 0.0 109.29 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -33.31 75.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -11.21 60.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -0.836 . . . . 0.0 109.971 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.4 m-80 -113.32 -32.07 6.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 145.12 55.01 0.02 OUTLIER Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.841 HG13 ' HA3' ' A' ' 23' ' ' GLY . 53.8 t -158.66 89.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.135 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.29 103.55 16.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.436 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 41.2 pt -138.12 -161.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.29 133.89 0.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.237 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt 52.12 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' ARG . 6.0 mm-40 -44.72 -39.83 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 48.23 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . . . -102.18 155.63 18.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -152.73 158.39 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -79.77 124.63 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.2 tt -72.78 96.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.173 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -155.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.176 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.19 -7.24 59.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.79 -18.05 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.27 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 8.4 p-10 -61.01 -15.47 32.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.647 ' HE1' HD11 ' A' ' 94' ' ' ILE . 14.1 m-85 -82.81 2.04 36.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.152 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -47.88 -31.42 5.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.267 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.739 ' CD2' HD13 ' A' ' 8' ' ' LEU . 11.3 m-85 -134.94 156.07 49.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.33 -10.6 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.432 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.65 ' CG1' HG22 ' A' ' 7' ' ' VAL . 99.5 t -132.55 140.99 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.928 . . . . 0.0 110.387 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.447 ' HB ' HG12 ' A' ' 106' ' ' VAL . 53.1 mt -128.07 130.86 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -111.37 137.42 49.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.938 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.52 137.92 51.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.715 HD23 ' HB3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -96.69 -34.36 11.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.096 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.617 ' OD2' HD23 ' A' ' 12' ' ' LEU . 1.1 m-20 -111.57 -170.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 110.17 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -97.27 -36.9 10.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 p -43.96 -36.37 2.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.138 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.639 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.6 mp -73.12 -63.98 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.478 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -53.88 -17.61 2.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.252 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -95.61 -32.81 12.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.395 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -95.82 -56.9 2.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.712 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -47.29 -34.35 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.172 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 42.8 m-20 -78.48 -7.85 57.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.251 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -83.13 -18.54 39.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.913 . . . . 0.0 110.189 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.556 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 2.9 ptt? -102.16 -36.34 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -56.0 136.62 73.47 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.16 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.19 -90.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.981 1.516 . . . . 0.0 110.503 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 102' ' ' CYS . 26.3 m -153.12 -101.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 110.107 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.4 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 100' ' ' SER . 0.2 OUTLIER -90.57 -169.95 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.75 29.41 4.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.82 154.33 1.89 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -121.25 150.45 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.447 HG12 ' HB ' ' A' ' 83' ' ' ILE . 12.8 m -105.54 145.39 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.15 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.468 HG21 ' CE1' ' A' ' 139' ' ' PHE . 11.1 m -135.34 142.35 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.478 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -85.94 128.18 34.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.137 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -85.33 -36.04 21.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.161 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.474 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 6.8 p30 175.76 166.3 0.4 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.9 Cg_endo -74.5 174.86 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.013 1.533 . . . . 0.0 110.188 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.09 53.07 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.964 1.507 . . . . 0.0 110.437 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -143.04 -41.92 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.55 -74.06 0.68 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 115' ' ' VAL . 31.2 m -56.26 116.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.7 t70 -81.46 146.55 30.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.43 ' OD2' ' CZ ' ' A' ' 17' ' ' ARG . 19.4 m-20 -111.52 81.91 3.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -73.34 116.51 4.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.955 1.503 . . . . 0.0 110.459 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -111.96 -38.2 4.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.46 56.0 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.097 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.93 139.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.1 m -47.91 -29.1 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.257 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.27 121.94 11.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 114.73 -57.36 0.47 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.859 ' HD2' HG11 ' A' ' 56' ' ' VAL . 6.3 m-30 -34.49 -53.82 0.96 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.645 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.15 -59.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.651 1.343 . . . . 0.0 110.322 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 116' ' ' ASP . 97.1 m -53.37 -48.74 68.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.588 ' HE1' ' HG2' ' A' ' 19' ' ' PRO . 4.8 ttp -48.85 -69.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.817 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 1.109 ' CE1' HD12 ' A' ' 24' ' ' ILE . 9.0 t80 -43.81 -54.56 5.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.796 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 134' ' ' LYS . . . -51.85 -39.67 59.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.682 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.532 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 74.9 m -66.38 -57.75 6.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.803 HD12 ' SG ' ' A' ' 21' ' ' CYS . 12.0 mm -44.26 -47.97 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 2.5 t -71.22 -61.28 1.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 110.62 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -44.72 -23.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -112.43 14.92 20.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.973 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.541 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.7 -22.75 7.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -82.35 -47.06 0.94 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.111 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.5 Cg_endo -78.15 -8.77 16.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.862 1.454 . . . . 0.0 110.285 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.67 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 71.6 t80 -103.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.283 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.053 HD12 HD13 ' A' ' 145' ' ' LEU . 3.2 tp -52.74 -24.56 8.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 80.0 m -88.19 -27.89 21.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.445 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.22 -12.41 16.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.154 -0.966 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.67 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 3.5 t60 -84.59 39.69 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.21 45.69 87.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.053 HD13 HD12 ' A' ' 140' ' ' LEU . 1.4 mt -133.95 -58.53 0.85 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -1.133 . . . . 0.0 110.415 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.2 mp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.149 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.248 0.547 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.588 ' CG ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.8 156.89 24.68 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.685 ' H ' HG22 ' A' ' 34' ' ' ILE . 41.1 mtpt -127.03 -161.25 1.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.981 -1.075 . . . . 0.0 111.158 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.072 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.26 122.79 11.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.481 0.658 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' A' ' 34' ' ' ILE . 24.2 t -113.03 121.89 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.791 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.839 ' CG ' ' HB2' ' A' ' 38' ' ' ALA . 13.0 tp -94.85 81.45 3.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.405 -0.809 . . . . 0.0 110.398 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 7.5 p90 -74.36 140.41 44.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.151 -0.968 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.821 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 1.4 p -170.94 171.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 110.366 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.912 ' O ' HD12 ' A' ' 90' ' ' ILE . 46.9 t -140.74 -57.95 0.52 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.517 ' HA ' HD23 ' A' ' 12' ' ' LEU . 13.4 mt -155.56 -44.5 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.16 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -125.73 -3.95 6.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.997 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.6 t-20 64.67 30.21 12.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -1.148 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 70.8 mt -98.75 -35.8 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' SD ' ' A' ' 128' ' ' MET . 0.9 OUTLIER -104.57 18.68 21.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 1.023 ' HG2' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -135.86 -32.02 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -0.95 . . . . 0.0 110.311 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.542 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -62.15 -58.0 20.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 46.5 Cg_endo -73.08 -5.39 17.11 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.945 1.497 . . . . 0.0 110.456 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -107.03 -40.83 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.873 ' HA ' HD11 ' A' ' 132' ' ' ILE . 65.8 m -72.66 -36.88 68.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER -66.04 -45.15 82.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 110.075 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.546 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -70.78 -50.54 24.01 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.057 HD11 ' HB2' ' A' ' 133' ' ' SER . 0.3 OUTLIER -54.49 -44.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -1.213 . . . . 0.0 110.2 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.913 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.4 m -67.43 -52.55 38.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.21 -27.43 61.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.295 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -87.76 -30.08 20.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.379 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -78.81 -24.28 44.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.387 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.913 HG22 ' O ' ' A' ' 25' ' ' CYS . 19.5 m -119.32 -25.6 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 112.34 -63.16 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 18.9 p30 -179.76 70.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.809 ' O ' HD23 ' A' ' 33' ' ' LEU . 7.9 mmtt -102.76 -135.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 110.116 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 35' ' ' ILE . 32.7 mt -128.09 -119.31 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -0.974 . . . . 0.0 110.328 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.072 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 34.8 30.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 111.198 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -103.09 103.53 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.062 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.749 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 49.1 m-20 -136.71 132.63 35.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.147 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -108.48 144.89 35.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.839 ' HB2' ' CG ' ' A' ' 8' ' ' LEU . . . -134.07 179.06 6.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.36 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.997 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -172.53 89.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.195 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 40' ' ' THR . 3.5 m -85.72 83.08 7.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.231 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER 172.07 -53.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.236 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 56.97 104.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -145.91 -44.96 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.157 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.49 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 34.1 m-70 -124.23 27.44 7.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.454 ' H ' HG13 ' A' ' 45' ' ' VAL . 3.1 m -62.91 144.65 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.208 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 71.41 29.03 68.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 44' ' ' HIS . 13.3 pt20 -177.39 -139.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -1.122 . . . . 0.0 110.08 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 68.01 119.5 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.185 -0.947 . . . . 0.0 110.229 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.547 ' HD2' ' CE1' ' A' ' 119' ' ' TYR . 47.0 Cg_endo -69.37 73.56 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.056 1.556 . . . . 0.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.4 t0 -94.2 33.74 1.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.107 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -71.72 -24.21 61.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.226 -0.921 . . . . 0.0 108.977 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -72.05 -52.19 18.1 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.269 179.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.527 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -62.59 -50.17 72.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -0.772 . . . . 0.0 109.639 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.571 ' NE2' HD12 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -58.93 -43.97 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.553 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.5 ttpp -56.6 -68.65 0.2 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.658 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.553 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 19.5 m -48.35 -33.85 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.811 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.17 -52.13 66.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.17 -13.9 60.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.738 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -92.75 -12.29 31.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 110.117 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -117.15 -30.58 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.673 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 137.44 84.36 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.811 HG11 ' SG ' ' A' ' 57' ' ' CYS . 41.9 t -158.65 120.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -1.137 . . . . 0.0 110.126 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 64' ' ' ILE . 3.0 m-20 -90.17 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.954 . . . . 0.0 110.114 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 63' ' ' ASP . 12.0 pt -158.71 143.56 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 12.2 p -168.17 31.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 65' ' ' SER . 65.6 mmtt -149.2 -73.66 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.171 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 1.7 mp0 60.26 105.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 57.32 1.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -45.12 134.56 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.801 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 1.7 ptt-85 -166.22 156.97 12.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -79.15 135.07 36.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.245 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.459 HG13 ' OD2' ' A' ' 76' ' ' ASP . 19.7 tt -60.66 154.67 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -120.57 -65.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.164 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.63 -34.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.174 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.29 -15.49 16.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.459 ' OD2' HG13 ' A' ' 72' ' ' ILE . 5.4 m-20 -60.7 -23.19 64.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 22.3 m-85 -88.47 10.72 19.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -130.23 -62.44 0.94 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.551 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -45.52 -24.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 7.4 m-85 -131.3 154.28 48.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -104.14 -20.82 13.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 69.2 t -122.05 137.77 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.852 ' O ' HG22 ' A' ' 107' ' ' VAL . 3.3 mt -124.62 138.76 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.102 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' PHE . . . -121.6 126.09 48.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -108.66 152.29 25.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.023 HD22 ' HG2' ' A' ' 17' ' ' ARG . 1.4 tp -95.51 -43.58 7.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' HG22 ' A' ' 90' ' ' ILE . 27.0 t0 -103.94 168.72 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.298 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -81.0 -47.3 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.913 . . . . 0.0 110.215 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.2 t -43.29 -59.49 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.912 HD12 ' O ' ' A' ' 11' ' ' CYS . 8.9 tt -46.66 -35.49 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -72.07 -45.59 60.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.196 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 t -62.25 -30.5 71.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 97' ' ' MET . 72.1 m-20 -88.76 -53.68 4.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.485 ' O ' ' HG3' ' A' ' 97' ' ' MET . 3.8 tt -49.17 -37.25 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.497 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 1.9 t-20 -79.57 -16.2 56.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 47.8 t -87.43 -4.21 59.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.499 ' HE2' ' HZ ' ' A' ' 77' ' ' PHE . 1.5 ptt? -113.27 -11.63 13.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.571 ' HE3' ' CG ' ' A' ' 77' ' ' PHE . 13.4 mtpt -60.36 146.25 84.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.0 -171.78 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.055 1.555 . . . . 0.0 110.485 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.4 t -100.07 -5.64 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.162 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 6.4 p30 -128.34 59.18 1.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.18 176.03 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.38 16.51 2.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.66 -170.81 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.198 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -146.35 151.96 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.5 t -117.1 146.0 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 83' ' ' ILE . 35.5 m -144.94 161.13 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 142.6 27.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 0.1 OUTLIER -94.58 -45.78 7.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.979 ' HB3' HG21 ' A' ' 115' ' ' VAL . 48.7 m-80 -131.14 161.27 62.79 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.41 169.53 22.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.995 1.524 . . . . 0.0 110.317 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.37 50.09 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.955 1.503 . . . . 0.0 110.435 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -104.87 -37.98 6.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.99 84.24 0.13 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.979 HG21 ' HB3' ' A' ' 110' ' ' ASN . 59.0 t -119.12 -3.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.666 ' HB3' HD23 ' A' ' 86' ' ' LEU . 6.6 p-10 -131.05 156.45 45.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.183 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -175.95 150.22 1.08 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.56 -90.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.026 1.54 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.547 ' CE1' ' HD2' ' A' ' 49' ' ' PRO . 7.8 m-30 -95.97 -70.46 0.71 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER 58.93 149.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.404 ' HA ' ' CD2' ' A' ' 125' ' ' PHE . 53.8 p -160.0 21.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.3 26.47 6.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -134.05 -45.32 0.11 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.657 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 27.0 m-85 -47.31 -46.59 57.34 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.244 -1.151 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -72.23 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.641 1.337 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.458 ' OG1' ' HA2' ' A' ' 124' ' ' GLY . 3.0 p -52.14 -48.02 65.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.729 ' O ' HG22 ' A' ' 132' ' ' ILE . 17.1 ttp -42.86 -76.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 110.355 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 1.014 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.6 t80 -53.1 -55.14 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.407 ' N ' ' HD1' ' A' ' 129' ' ' PHE . . . -47.03 -24.22 0.59 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.404 ' HB3' HG13 ' A' ' 115' ' ' VAL . 2.7 t -89.35 -61.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.873 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -52.59 -20.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.818 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 1.057 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -91.41 -56.12 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.808 . . . . 0.0 109.603 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -51.36 -24.4 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.688 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.47 50.37 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 110.034 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.633 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -117.87 -24.13 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.651 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -83.32 -40.82 0.81 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.461 -0.774 . . . . 0.0 110.29 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.3 Cg_endo -79.76 -6.55 14.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.711 1.374 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.551 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 27.3 t80 -81.77 -69.0 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 136' ' ' MET . 0.9 OUTLIER -67.62 -22.85 65.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 146' ' ' ILE . 2.6 m -67.55 -31.93 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.016 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.86 -24.81 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 139' ' ' PHE . 14.7 m80 -66.39 -9.04 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . 114.79 58.98 0.36 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.581 ' H ' HD13 ' A' ' 146' ' ' ILE . 1.8 mt -162.65 61.14 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.058 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.294 0.569 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -72.55 -144.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 109.315 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.958 ' HB3' HG22 ' A' ' 34' ' ' ILE . 5.1 mtpt -143.2 150.24 39.08 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.663 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.793 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.93 113.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.478 -0.764 . . . . 0.0 109.917 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.697 HG22 ' CG1' ' A' ' 82' ' ' VAL . 28.5 t -102.99 134.13 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.745 HD13 ' CD2' ' A' ' 80' ' ' PHE . 7.8 tp -89.53 80.78 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.432 -0.792 . . . . 0.0 110.329 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.574 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 15.1 m-85 -68.48 110.43 4.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.039 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 49.0 t -135.1 153.54 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.897 . . . . 0.0 110.545 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.501 ' HB2' ' HD3' ' A' ' 17' ' ' ARG . 45.5 t -140.05 -56.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER 177.0 -60.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -0.908 . . . . 0.0 110.381 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -82.57 -8.29 86.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.807 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.3 OUTLIER 67.26 27.45 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.211 . . . . 0.0 110.076 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.641 HG21 ' OG ' ' A' ' 48' ' ' SER . 93.6 mt -133.64 -36.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.23 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 79.8 m -42.71 -49.63 5.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.178 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.772 ' HD3' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -98.46 128.63 44.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.117 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.579 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER 172.36 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.799 ' O ' HG22 ' A' ' 64' ' ' ILE . 46.4 Cg_endo -73.59 -26.33 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.872 1.459 . . . . 0.0 110.332 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB1' ' HB2' ' A' ' 129' ' ' PHE . . . -106.74 -27.22 10.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 4.2 t -79.02 -59.65 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.248 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 44.8 tt0 -56.41 -27.63 57.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.435 -0.791 . . . . 0.0 109.163 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -74.83 -55.59 5.29 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.788 HD11 ' CB ' ' A' ' 133' ' ' SER . 2.4 tp -52.71 -43.73 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.26 . . . . 0.0 109.835 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.827 ' SG ' HD11 ' A' ' 34' ' ' ILE . 73.2 m -74.7 -32.88 62.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 0.0 110.292 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.565 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 15.1 mmt180 -66.93 -39.75 87.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.949 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -79.59 -40.59 29.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.136 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.582 ' O ' HG13 ' A' ' 29' ' ' VAL . 18.7 mmt -71.41 -41.3 69.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 28' ' ' MET . 16.6 m -156.77 45.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -58.9 -19.12 42.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -84.12 27.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -1.089 . . . . 0.0 110.403 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.447 ' C ' HD12 ' A' ' 33' ' ' LEU . 52.6 mttt -150.75 -130.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.777 ' O ' HG13 ' A' ' 34' ' ' ILE . 4.7 mp -129.26 -112.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.958 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER 57.19 1.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.74 -0.6 . . . . 0.0 111.157 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.687 HD11 ' HB2' ' A' ' 25' ' ' CYS . 7.0 mt -114.07 103.71 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.88 -1.138 . . . . 0.0 110.95 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.597 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 10.3 m-20 -139.11 102.49 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.811 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.78 133.79 34.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.039 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . . . -147.7 166.58 27.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.337 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.807 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . . . 169.81 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 40' ' ' THR . 5.1 t -56.01 97.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 40' ' ' THR . 0.1 OUTLIER 174.68 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 110.199 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 44' ' ' HIS . . . 71.19 -106.32 1.86 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 52.86 -87.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.579 ' CD2' ' NE2' ' A' ' 47' ' ' GLN . 40.2 m170 -66.13 -7.81 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.757 HG23 ' HB3' ' A' ' 69' ' ' ALA . 2.1 p -49.44 129.85 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.261 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -27.04 20.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.579 ' NE2' ' CD2' ' A' ' 44' ' ' HIS . 3.0 pt20 -116.14 -134.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -1.144 . . . . 0.0 110.296 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.641 ' OG ' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 70.17 135.68 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.129 -0.982 . . . . 0.0 110.135 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.42 81.7 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.972 1.511 . . . . 0.0 110.422 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 31.8 p-10 -82.59 8.45 11.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -73.59 -26.96 61.05 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 108.981 179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.5 -48.66 31.59 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.31 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.536 ' HB2' ' CG ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -63.16 -49.85 72.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 0.0 109.65 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -60.33 -46.74 88.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.97 . . . . 0.0 109.411 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 7.5 ttpt -54.84 -69.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.82 . . . . 0.0 109.588 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.744 HG22 ' OD1' ' A' ' 60' ' ' ASN . 7.7 p -49.34 -34.92 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.265 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.952 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -54.89 -50.97 67.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 109.379 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -73.52 -22.18 60.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -12.94 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.0 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.744 ' OD1' HG22 ' A' ' 56' ' ' VAL . 11.2 m120 -111.23 -14.93 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.408 -0.808 . . . . 0.0 109.036 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.569 ' O ' ' CZ ' ' A' ' 129' ' ' PHE . . . 96.41 100.98 1.94 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.952 HG12 ' O ' ' A' ' 57' ' ' CYS . 13.9 p -172.11 145.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -86.03 118.05 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.799 HG22 ' O ' ' A' ' 19' ' ' PRO . 8.1 pt -130.23 173.07 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.152 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 51.6 p -165.96 29.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.54 149.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 110.228 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.431 ' OE1' ' CB ' ' A' ' 18' ' ' SER . 2.2 pt20 -165.43 -150.94 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.023 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.63 -178.65 7.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB3' HG23 ' A' ' 45' ' ' VAL . . . -106.51 122.82 47.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -110.47 25.6 11.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.108 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.548 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 3.4 pt20 38.24 -152.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 110.441 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.493 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 13.2 tt -133.22 164.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.0 p -125.46 -78.67 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 75' ' ' ALA . 2.3 pttp -164.88 -36.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -56.61 -20.4 20.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 110.226 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.6 p30 -42.59 -28.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 23.8 m-85 -70.69 -42.13 71.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.262 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.521 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -96.52 -48.55 5.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 4.2 tptt -44.49 -25.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 0.0 110.255 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.745 ' CD2' HD13 ' A' ' 8' ' ' LEU . 9.8 m-85 -133.07 -179.76 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.473 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.16 -29.37 4.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.844 . . . . 0.0 110.375 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.88 HG21 ' CD2' ' A' ' 143' ' ' HIS . 6.0 p -129.54 142.39 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.162 -0.961 . . . . 0.0 110.379 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.569 HG12 ' CD2' ' A' ' 8' ' ' LEU . 3.1 mt -113.78 134.22 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.1 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.0 122.37 47.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.12 137.12 42.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.772 HD22 ' HD3' ' A' ' 17' ' ' ARG . 5.1 tp -108.5 11.55 26.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -152.19 174.32 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.246 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.11 -57.92 3.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.148 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -51.44 42.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.985 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.918 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.7 tt -44.58 -51.13 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.607 ' H ' HG23 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -61.88 -55.79 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.7 t -54.49 -18.43 4.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.937 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 96' ' ' SER . 22.2 m-20 -85.28 -69.28 0.67 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 0.0 110.213 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 90' ' ' ILE . 3.2 mt -47.92 -53.14 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.432 -0.793 . . . . 0.0 109.982 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -59.11 -15.35 13.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.61 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -80.74 -40.69 24.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.995 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.747 ' CE ' HG23 ' A' ' 94' ' ' ILE . 6.9 ptt? -85.2 -26.9 26.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.567 ' CE ' ' CE1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -42.84 139.68 2.04 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.177 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.18 -161.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.052 1.554 . . . . 0.0 110.42 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 t -102.54 -4.56 25.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.213 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -155.8 111.01 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.216 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.411 ' SG ' ' NZ ' ' A' ' 98' ' ' LYS . 31.8 p -137.6 -159.31 0.94 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.521 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -132.31 31.82 4.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.112 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.86 37.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.124 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.85 162.18 18.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.527 HG22 HD13 ' A' ' 83' ' ' ILE . 90.3 t -116.09 130.04 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.54 164.04 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -108.24 131.13 55.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.088 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CD1' ' CE1' ' A' ' 139' ' ' PHE . 2.9 t80 -74.8 -61.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.503 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.7 OUTLIER -152.96 175.46 2.96 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.142 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.518 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 48.0 Cg_endo -75.15 175.9 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.042 1.548 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.37 4.86 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.937 1.493 . . . . 0.0 110.661 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.94 -1.48 16.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.256 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 116' ' ' ASP . . . -116.99 -107.24 2.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.614 HG13 ' HA ' ' A' ' 128' ' ' MET . 17.2 t -72.69 75.28 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -1.14 . . . . 0.0 110.214 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -155.1 138.83 16.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -112.74 110.83 51.9 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.463 ' HG2' ' OG ' ' A' ' 122' ' ' SER . 46.3 Cg_endo -73.04 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.95 1.5 . . . . 0.0 110.496 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.436 ' O ' ' C ' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -166.93 146.67 5.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.319 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.436 ' C ' ' O ' ' A' ' 119' ' ' TYR . 2.7 t80 42.26 -139.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -43.29 116.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' A' ' 118' ' ' PRO . 4.7 m -155.17 -177.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.331 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -136.94 20.85 3.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.106 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 116' ' ' ASP . . . -99.49 -23.63 10.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 9.9 m-85 -44.02 -57.26 6.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.085 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.4 Cg_endo -70.77 -44.11 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.905 1.476 . . . . 0.0 110.105 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 27.9 m -61.44 -27.45 68.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.614 ' HA ' HG13 ' A' ' 115' ' ' VAL . 30.7 ttp -60.1 -70.22 0.18 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.273 -0.892 . . . . 0.0 109.832 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.767 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 75.4 t80 -67.9 -21.87 65.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.79 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -65.95 -42.13 90.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 110.004 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.604 ' CB ' HG22 ' A' ' 115' ' ' VAL . 14.8 t -84.3 -31.69 24.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.274 -0.892 . . . . 0.0 108.787 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.769 HG23 HG12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -67.75 -27.83 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.682 -0.636 . . . . 0.0 109.395 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.788 ' CB ' HD11 ' A' ' 24' ' ' ILE . 24.9 p -103.18 -23.85 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.795 . . . . 0.0 110.272 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -88.6 -18.94 26.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.08 -1.013 . . . . 0.0 110.339 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.545 ' CG ' ' HG2' ' A' ' 138' ' ' PRO . 3.3 tt0 -124.31 40.01 3.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.381 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.576 ' HG2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -84.46 -20.41 31.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.968 . . . . 0.0 110.496 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -87.11 -44.48 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.865 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -76.48 2.98 6.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.609 1.321 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.587 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 71.7 t80 -108.05 -70.03 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.537 HD21 ' CE ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -62.54 -44.07 97.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.217 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.627 HG23 HD12 ' A' ' 146' ' ' ILE . 1.9 m -64.56 -10.33 25.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.36 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 138' ' ' PRO . 13.8 mm-40 -104.7 -46.95 4.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.302 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.88 ' CD2' HG21 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -44.46 -24.57 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.134 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.453 ' C ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.83 35.94 0.5 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.491 HD22 ' HG2' ' A' ' 5' ' ' LYS . 19.1 mt -137.45 -94.53 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.627 HD12 HG23 ' A' ' 141' ' ' THR . 2.4 tp . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.26 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.53 0.681 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -117.96 144.41 45.53 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 34' ' ' ILE . 4.4 mttt -119.1 -155.95 0.63 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.024 -1.048 . . . . 0.0 110.879 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.99 148.73 51.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.715 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 16.7 t -139.06 113.29 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.794 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.055 HD12 ' HB3' ' A' ' 36' ' ' ASP . 5.0 tp -78.7 101.34 7.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.453 -0.779 . . . . 0.0 110.784 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.516 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 36.8 m-85 -87.33 106.65 18.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.717 HG22 ' HB3' ' A' ' 38' ' ' ALA . 6.0 t -134.1 177.73 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 110.959 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 10' ' ' VAL . 1.7 p 169.6 53.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.786 . . . . 0.0 110.146 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 16.6 mt 54.77 -89.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' CYS . . . -89.91 80.22 1.47 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 38' ' ' ALA . 1.8 t-20 -58.44 -44.49 89.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -1.178 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.576 HG23 ' HE3' ' A' ' 66' ' ' LYS . 9.4 mt -38.78 -30.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 110.303 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 17' ' ' ARG . 26.8 p -125.38 34.99 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 109.811 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.644 ' HB3' HD23 ' A' ' 86' ' ' LEU . 43.8 mtt180 -157.27 80.81 0.91 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 110.175 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.614 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER 56.78 43.09 1.04 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 111.022 179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 18' ' ' SER . 45.3 Cg_endo -73.66 -21.44 19.12 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.743 1.391 . . . . 0.0 109.781 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.798 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -89.01 7.33 35.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.679 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.7 OUTLIER -56.41 -40.21 74.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.124 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.966 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -60.68 -44.22 96.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.281 0.562 . . . . 0.0 110.035 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' ILE . . . -74.14 -63.8 2.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.917 HG21 HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -42.36 -46.0 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 110.166 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.624 ' N ' HG23 ' A' ' 24' ' ' ILE . 69.0 m -72.98 -39.74 65.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 110.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 3.2 mmt180 -55.1 -34.88 64.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.736 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -88.95 -32.47 17.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 0.0 110.127 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.14 -27.01 60.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.411 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.651 HG12 ' HG3' ' A' ' 32' ' ' LYS . 10.1 t -123.79 -22.89 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.234 -0.916 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.04 -168.62 18.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.98 80.71 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -1.118 . . . . 0.0 110.133 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.651 ' HG3' HG12 ' A' ' 29' ' ' VAL . 7.5 mmtp -112.96 -137.77 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ILE . 18.1 mt -122.5 -40.13 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.22 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.839 HD11 ' CD1' ' A' ' 35' ' ' ILE . 2.6 pp -33.3 -32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.762 . . . . 0.0 110.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.966 HG23 ' HA ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -76.92 88.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 110.526 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 1.055 ' HB3' HD12 ' A' ' 8' ' ' LEU . 7.1 m-20 -124.35 71.4 1.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.907 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.6 t -73.04 131.2 41.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.717 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -144.05 -171.9 3.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.256 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -166.37 145.69 5.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 40' ' ' THR . 11.1 t -125.68 76.67 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 -59.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.46 36.77 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.99 -57.59 1.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -1.169 . . . . 0.0 110.212 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.423 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -85.78 63.61 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 68' ' ' ARG . 2.1 p -148.07 149.79 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.331 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.05 21.62 27.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 48' ' ' SER . 6.5 pt20 -173.82 -149.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.18 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.83 120.79 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.219 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.24 89.08 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.977 1.514 . . . . 0.0 110.455 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.7 p30 -88.43 14.47 9.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -74.1 -37.54 64.12 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.125 -0.984 . . . . 0.0 108.719 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.43 -37.96 68.45 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.345 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.53 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 6.3 m -65.63 -59.55 3.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.458 -0.776 . . . . 0.0 109.811 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 63.9 mt-30 -57.95 -44.15 86.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.165 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -53.34 -72.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.49 -0.756 . . . . 0.0 109.701 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' ' 125' ' ' PHE . 43.5 t -43.69 -38.17 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.362 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.578 ' CA ' HG13 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -55.28 -50.54 69.28 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.437 -0.79 . . . . 0.0 109.427 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -67.37 -28.08 67.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -83.29 -9.01 59.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.11 -31.4 7.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 135.18 60.39 0.06 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 129' ' ' PHE . 1.9 p 173.69 139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -1.163 . . . . 0.0 110.129 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -91.52 142.71 27.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.731 HG23 ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER 68.63 -175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.731 ' N ' HG23 ' A' ' 64' ' ' ILE . 5.6 t 179.66 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.073 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.576 ' HE3' HG23 ' A' ' 15' ' ' ILE . 4.9 mmmt -115.72 -168.69 1.45 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.936 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.3 pt20 177.67 144.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -61.95 79.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.089 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 45' ' ' VAL . . . -49.0 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.347 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 68' ' ' ARG . 2.6 ptt-85 -103.09 -149.04 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -103.28 146.54 28.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.216 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.526 HD11 ' HB3' ' A' ' 76' ' ' ASP . 19.9 tt -82.43 173.73 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.269 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.482 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 34.1 m -100.96 6.52 43.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 73' ' ' THR . 14.5 mtmt 68.19 5.23 4.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.3 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.59 -3.16 58.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.948 . . . . 0.0 110.331 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.596 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 11.9 p-10 -65.47 -24.61 67.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.608 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 21.3 m-85 -86.69 16.13 5.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 110.228 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.34 -15.23 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.576 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.641 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -127.25 -145.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.125 -0.985 . . . . 0.0 110.033 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.641 ' CD1' ' HB3' ' A' ' 79' ' ' LYS . 0.6 OUTLIER 37.87 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.448 -0.782 . . . . 0.0 110.676 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -135.53 -43.52 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 6' ' ' ALA . 11.8 p -137.24 159.6 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 110.626 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.694 ' HB ' HG12 ' A' ' 106' ' ' VAL . 1.7 mp -124.42 122.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . . . -108.54 131.12 55.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.58 161.65 19.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.644 HD23 ' HB3' ' A' ' 17' ' ' ARG . 7.1 tp -93.22 -43.37 8.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.414 ' C ' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -102.2 177.47 4.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.395 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.499 ' HG3' HD11 ' A' ' 108' ' ' LEU . 14.8 mt-30 -89.87 -38.25 13.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 88' ' ' GLN . 23.2 t -42.36 -39.87 2.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.5 mp -65.97 -53.59 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -63.77 -16.03 60.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.214 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 t -88.37 -39.22 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.373 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.41 -22.32 21.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.843 HD13 HG11 ' A' ' 106' ' ' VAL . 2.8 tt -68.41 -37.86 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' SER . 29.2 p30 -70.2 -18.59 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 48.0 t -78.0 -34.65 50.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.553 ' CE ' HG13 ' A' ' 94' ' ' ILE . 19.8 ptt? -93.29 -30.22 15.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.047 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.608 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 7.7 mmmt -38.98 141.52 0.6 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.478 -0.764 . . . . 0.0 110.704 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.489 ' HD2' ' HD2' ' A' ' 98' ' ' LYS . 46.4 Cg_endo -72.43 -179.79 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.18 1.621 . . . . 0.0 110.567 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -114.26 19.88 15.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.6 OUTLIER -153.14 78.92 1.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.281 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 6.4 p -143.56 -172.1 3.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.92 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.444 ' HD2' ' C ' ' A' ' 102' ' ' CYS . 1.1 mpt_? -135.34 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -163.76 165.43 23.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -141.61 170.11 16.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.843 HG11 HD13 ' A' ' 94' ' ' ILE . 33.0 m -111.52 167.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.52 HG13 ' C ' ' A' ' 106' ' ' VAL . 28.1 m -154.25 157.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 110.225 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.499 HD11 ' HG3' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -94.61 125.96 39.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -89.61 93.25 9.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 110.17 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.46 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER 65.62 159.31 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.472 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.56 174.44 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.04 1.547 . . . . 0.0 110.383 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.4 52.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.94 1.495 . . . . 0.0 110.403 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.24 -59.33 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.59 -46.87 65.61 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.774 HG12 ' HB2' ' A' ' 131' ' ' SER . 30.2 m -92.18 46.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -137.24 113.63 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -140.19 142.7 30.92 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 -13.65 26.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.069 1.563 . . . . 0.0 110.494 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.6 t80 50.14 38.89 18.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.64 -50.28 65.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -139.35 -69.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.02 44.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -103.7 -7.96 20.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.173 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -90.67 -40.03 5.74 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.641 ' HB3' HG11 ' A' ' 56' ' ' VAL . 5.4 m-30 -45.06 -47.5 31.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.148 -1.207 . . . . 0.0 110.472 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -72.42 -57.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.575 1.302 . . . . 0.0 110.382 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 15.5 m -64.57 -57.22 9.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.185 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.662 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 7.6 ttp -40.43 -69.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.755 ' CE1' HD12 ' A' ' 24' ' ' ILE . 75.3 t80 -55.93 -44.75 78.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.045 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -46.94 -59.77 2.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.94 . . . . 0.0 110.014 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.774 ' HB2' HG12 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -65.14 -45.2 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 110.024 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.917 HG23 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -43.27 -53.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.826 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.624 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -80.75 -37.77 29.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 5.2 tttt -50.08 -32.29 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 8.3 mm-40 -103.97 -5.59 22.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.189 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' A' ' 133' ' ' SER . 0.7 OUTLIER -82.78 14.24 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -104.71 -63.39 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.448 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 44.5 Cg_endo -72.26 -4.39 15.13 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.786 1.414 . . . . 0.0 110.471 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.657 ' CE2' HG11 ' A' ' 7' ' ' VAL . 34.1 t80 -93.1 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.997 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -45.52 -28.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 110.143 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 7.5 m -47.55 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.817 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 141' ' ' THR . 11.7 mt-10 -106.44 -0.27 24.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 110.792 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 33.77 5.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 111.16 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.697 ' HA3' HD13 ' A' ' 140' ' ' LEU . . . 173.42 -27.37 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.485 -1.341 . . . . 0.0 109.901 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.997 ' HB3' HD12 ' A' ' 140' ' ' LEU . 0.3 OUTLIER 175.02 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.234 -1.156 . . . . 0.0 110.363 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.774 HG22 ' CD2' ' A' ' 145' ' ' LEU . 7.3 tp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.116 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.223 0.535 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -82.99 -179.05 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.847 . . . . 0.0 109.237 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 1.019 ' C ' HG22 ' A' ' 34' ' ' ILE . 17.1 mttm -142.73 -161.34 1.23 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.065 -1.022 . . . . 0.0 110.676 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.031 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -141.18 121.92 14.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.996 ' HB ' HD12 ' A' ' 34' ' ' ILE . 2.7 t -111.22 123.0 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.765 . . . . 0.0 109.329 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 10' ' ' VAL . 6.5 tp -93.52 84.88 4.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.439 -0.788 . . . . 0.0 110.757 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.53 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 55.7 m-85 -60.79 123.73 18.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 8' ' ' LEU . 25.1 t -124.97 168.82 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.719 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.854 ' HB3' HD13 ' A' ' 86' ' ' LEU . 20.9 p -169.02 -141.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.911 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 76.07 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 14' ' ' ASN . . . 129.04 -6.89 6.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 13' ' ' GLY . 6.2 t-20 41.71 37.62 0.78 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -1.145 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.73 HD13 ' HB3' ' A' ' 48' ' ' SER . 3.2 mt -144.22 -59.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 15' ' ' ILE . 56.1 m -106.0 59.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.83 ' CB ' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -153.5 -50.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.468 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -152.13 47.76 0.43 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.038 -1.039 . . . . 0.0 110.743 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 18' ' ' SER . 47.7 Cg_endo -74.65 -16.0 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.843 1.444 . . . . 0.0 110.113 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.916 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -91.97 6.63 45.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.871 ' SG ' HD11 ' A' ' 132' ' ' ILE . 55.5 m -63.96 -35.01 79.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.642 ' HG2' HG23 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -68.83 -55.54 10.83 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.526 -0.734 . . . . 0.0 110.177 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' A' ' 63' ' ' ASP . . . -62.28 -51.81 53.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.784 HD11 ' CB ' ' A' ' 133' ' ' SER . 8.9 tp -56.3 -44.27 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 110.308 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.566 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 23.1 m -64.96 -35.52 81.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.238 -0.914 . . . . 0.0 110.054 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.4 mtt-85 -66.44 -45.12 80.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 110.124 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -34.9 58.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -74.96 -46.86 32.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 30' ' ' GLY . 13.6 m -150.93 45.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.22 -28.55 0.86 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.47 85.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -1.145 . . . . 0.0 110.061 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 34' ' ' ILE . 21.6 mttt -65.98 -23.25 66.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.138 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.941 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 67.66 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.031 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER 30.07 37.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.553 -0.717 . . . . 0.0 111.66 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.941 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -92.0 93.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.906 -1.121 . . . . 0.0 110.361 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.582 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 10.0 m-20 -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -168.86 163.15 11.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 110.372 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -169.26 -164.68 0.47 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' O ' HG22 ' A' ' 72' ' ' ILE . . . -174.92 -176.95 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -151.28 25.01 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -0.75 5.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . 49.88 -104.04 0.1 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 64.64 119.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.248 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.532 ' CD2' ' CD ' ' A' ' 47' ' ' GLN . 35.8 m170 55.66 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.309 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 69' ' ' ALA . 80.9 t 52.42 80.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.07 6.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.532 ' CD ' ' CD2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -148.75 13.86 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.247 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.73 ' HB3' HD13 ' A' ' 15' ' ' ILE . 2.7 t -106.97 111.64 63.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 47.1 Cg_endo -69.58 100.72 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.6 p30 -86.16 26.03 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.424 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -32.06 61.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.257 -0.902 . . . . 0.0 108.92 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.9 mtt180 -71.83 -52.23 18.49 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.213 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -52.59 65.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.43 -0.794 . . . . 0.0 109.359 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 6.8 tt0 -54.24 -56.42 18.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HE3' HG23 ' A' ' 56' ' ' VAL . 3.9 ttpp -44.85 -66.89 0.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.393 -0.817 . . . . 0.0 109.52 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.871 HG21 ' CB ' ' A' ' 125' ' ' PHE . 91.8 t -45.32 -36.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.639 ' CB ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.7 -42.15 92.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.439 -0.788 . . . . 0.0 109.042 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 1.6 mmtp -71.76 -27.74 63.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.416 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.42 -9.33 54.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -109.8 -26.61 9.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.195 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 115.43 81.26 0.92 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.639 HG13 ' CB ' ' A' ' 57' ' ' CYS . 2.1 p 174.66 170.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -1.1 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.567 ' N ' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -156.03 144.13 19.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.435 ' CG1' ' HG3' ' A' ' 54' ' ' GLN . 2.3 pt -133.51 164.89 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -115.58 76.05 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.947 . . . . 0.0 110.256 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 65' ' ' SER . 4.6 mttt 60.53 152.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.948 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -105.3 -64.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.09 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.767 ' HB3' HG22 ' A' ' 45' ' ' VAL . . . -49.12 157.59 0.43 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -0.891 . . . . 0.0 110.178 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -147.95 33.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 3.1 pt20 37.58 -153.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 72' ' ' ILE . 3.9 tt -153.73 129.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.211 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 174.24 6.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -72.94 -5.98 42.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -77.19 -34.2 56.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -42.65 -48.41 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.544 ' CE2' ' HG2' ' A' ' 98' ' ' LYS . 14.6 m-30 -47.3 -30.42 3.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.8 m -117.56 29.61 7.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.541 ' C ' ' CD1' ' A' ' 80' ' ' PHE . 9.6 tppt? -124.88 -9.36 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 79' ' ' LYS . 69.5 m-85 -140.3 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -124.34 -44.56 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 110.385 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 41.3 t -131.73 137.18 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.499 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' O ' HG22 ' A' ' 107' ' ' VAL . 54.4 mt -116.45 142.11 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.817 . . . . 0.0 110.044 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 107' ' ' VAL . . . -127.66 162.66 26.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -142.99 145.58 33.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -70.56 -79.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.539 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.427 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 7.3 m-20 -78.92 175.74 10.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 110.467 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.463 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.6 mm-40 -74.22 -41.46 61.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.8 t -40.13 -50.61 2.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.012 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.768 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.7 mt -61.37 -58.48 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 108' ' ' LEU . 3.1 tp -42.25 -60.97 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.119 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 96' ' ' SER . 46.6 t -55.33 -39.44 70.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.965 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 96' ' ' SER . 0.3 OUTLIER -54.3 -55.38 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.067 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.5 mp -57.89 -56.77 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -63.99 -19.23 65.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.844 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 92' ' ' SER . 1.0 OUTLIER -71.85 -8.86 56.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.5 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 7.6 mtm -125.88 -48.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.544 ' HG2' ' CE2' ' A' ' 77' ' ' PHE . 9.7 mtpt -41.82 138.14 1.82 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.96 -160.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.006 1.53 . . . . 0.0 110.581 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.1 m -106.56 5.32 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -134.97 104.95 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -174.01 4.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 28.8 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -148.59 176.38 10.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 110.182 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 104' ' ' ALA . 34.7 mtmt -143.23 166.12 25.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.13 -0.981 . . . . 0.0 110.282 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.4 t -117.27 132.64 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.9 HG11 ' CD2' ' A' ' 143' ' ' HIS . 32.1 m -128.21 153.61 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.575 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -100.95 146.98 26.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 3.3 t80 -106.73 110.58 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.091 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 59.0 166.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.049 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 170.09 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.001 1.527 . . . . 0.0 110.278 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.9 51.93 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.398 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -156.56 -46.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.8 -67.65 2.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.589 HG22 ' OG ' ' A' ' 131' ' ' SER . 10.1 t -98.84 100.7 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -1.114 . . . . 0.0 110.116 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -174.87 88.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.24 130.33 7.58 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 -90.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.939 1.494 . . . . 0.0 110.487 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.04 21.16 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.182 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -65.47 117.02 7.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.7 t 52.18 -143.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.168 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.91 39.55 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -93.52 32.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -124.48 -49.2 0.21 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.871 ' CB ' HG21 ' A' ' 56' ' ' VAL . 5.6 m-85 -41.65 -48.95 10.06 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.249 -1.147 . . . . 0.0 110.305 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.9 Cg_endo -71.45 -56.97 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.597 1.314 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 16.7 m -59.76 -51.87 67.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 124' ' ' GLY . 12.1 ttp -41.29 -63.71 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.284 -0.885 . . . . 0.0 109.96 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.716 ' CE1' HD13 ' A' ' 24' ' ' ILE . 94.2 t80 -56.63 -42.1 78.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.617 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -46.12 -57.43 4.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.774 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.589 ' OG ' HG22 ' A' ' 115' ' ' VAL . 11.2 p -71.44 -43.97 65.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.523 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.916 HG13 ' HB3' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -42.1 -37.61 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.689 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.784 ' CB ' HD11 ' A' ' 24' ' ' ILE . 1.4 p -97.19 -42.36 7.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.3 OUTLIER -44.93 -46.54 11.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -102.72 41.71 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.202 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.63 ' HE2' ' HA ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -116.49 -2.35 12.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.264 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.608 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -104.88 -63.57 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 46.9 Cg_endo -73.58 1.14 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.75 1.395 . . . . 0.0 110.488 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.523 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 31.9 t80 -87.88 -68.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 140' ' ' LEU . 4.0 pp -74.03 -23.71 59.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.592 HG23 HG21 ' A' ' 146' ' ' ILE . 3.3 m -59.74 -43.04 94.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 144' ' ' GLY . 49.7 mt-10 -96.0 -37.33 10.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.9 ' CD2' HG11 ' A' ' 107' ' ' VAL . 1.2 m80 -44.01 -25.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 124.66 68.32 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -155.66 18.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.592 HG21 HG23 ' A' ' 141' ' ' THR . 23.6 pt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.192 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' OE1' ' CB ' ' A' ' 32' ' ' LYS . 14.7 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.53 0.681 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.591 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -64.04 -69.53 0.27 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.512 -0.742 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 14.3 mttm -152.34 -155.59 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.981 . . . . 0.0 111.353 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.986 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.95 152.91 36.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.712 -0.618 . . . . 0.0 110.234 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.652 HG23 ' HB ' ' A' ' 34' ' ' ILE . 15.1 t -111.62 127.26 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 83' ' ' ILE . 10.2 tp -90.01 81.86 6.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 136' ' ' MET . 27.3 m-85 -68.82 117.49 10.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.943 . . . . 0.0 109.46 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 38' ' ' ALA . 52.7 t -130.9 161.04 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.601 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.876 ' HB3' HD22 ' A' ' 86' ' ' LEU . 28.6 p -159.38 39.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.102 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 90' ' ' ILE . 1.2 mt 59.38 60.49 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.267 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.882 ' H ' ' HB1' ' A' ' 39' ' ' ALA . . . 132.13 -24.72 3.97 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.922 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 13.5 t30 59.28 14.88 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -1.168 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.541 ' CA ' ' HB3' ' A' ' 19' ' ' PRO . 12.9 mt -123.17 -1.54 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 22.5 p -144.21 165.61 27.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.237 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.795 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.8 OUTLIER 71.05 -56.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 110.416 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.878 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.0 t -152.97 50.36 0.6 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.792 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.1 Cg_endo -78.17 -19.27 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.864 1.455 . . . . 0.0 110.066 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.671 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -86.76 6.73 30.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -0.79 . . . . 0.0 110.279 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.602 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 21.4 p -58.21 -28.96 65.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.337 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 26' ' ' ARG . 0.6 OUTLIER -67.66 -40.15 84.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.594 -0.691 . . . . 0.0 110.191 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -74.73 -49.69 10.28 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.807 HG21 HG23 ' A' ' 132' ' ' ILE . 1.1 tp -57.84 -44.35 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 0.0 110.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.742 ' SG ' HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -71.34 -43.37 67.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.314 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 2.7 mmm180 -58.97 -38.3 78.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.22 -39.67 47.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.117 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.525 ' C ' HG13 ' A' ' 29' ' ' VAL . 21.8 mtp -67.69 -51.09 53.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 28' ' ' MET . 14.0 m -151.3 44.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.319 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -63.54 -20.78 64.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -67.19 -7.37 23.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.412 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.534 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . 6.5 mttm -116.27 -137.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.05 -1.031 . . . . 0.0 110.272 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.814 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.2 mt -120.34 -122.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.986 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 49.46 3.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.621 -0.674 . . . . 0.0 111.644 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -104.09 95.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.832 -1.167 . . . . 0.0 110.547 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.875 ' OD1' ' HB1' ' A' ' 6' ' ' ALA . 3.1 m-20 -137.05 106.8 6.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.424 ' OG ' ' HG2' ' A' ' 22' ' ' GLU . 19.2 m -89.57 127.63 35.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.158 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.888 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -144.43 166.64 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.922 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -166.3 106.5 0.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' THR . 3.2 t -80.59 86.28 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 40' ' ' THR . 12.5 p 177.33 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 94.15 1.01 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -155.83 -40.54 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -1.136 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.27 92.91 4.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.88 . . . . 0.0 110.226 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 69' ' ' ALA . 38.5 t -148.19 160.73 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.257 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.46 24.99 7.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 48' ' ' SER . 13.1 pt20 -159.87 -148.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' GLN . 0.5 OUTLIER 61.39 90.78 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 110.21 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.36 80.53 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.957 1.503 . . . . 0.0 110.439 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -93.01 33.71 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.304 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.502 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 1.3 m -75.52 -31.52 60.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 108.908 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.613 ' O ' HG22 ' A' ' 56' ' ' VAL . 52.3 mtt180 -73.01 -48.96 31.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.313 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.585 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -61.81 -51.34 68.64 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.664 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.534 ' NE2' ' N ' ' A' ' 55' ' ' LYS . 4.6 pp0? -64.2 -33.86 76.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HE2' HG13 ' A' ' 56' ' ' VAL . 8.3 ttpt -60.04 -67.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 125' ' ' PHE . 27.5 m -53.51 -35.08 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.066 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.8 m -53.6 -50.79 64.89 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.425 -0.797 . . . . 0.0 109.261 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -31.8 71.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.492 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 1.2 t -77.05 -10.14 59.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.84 . . . . 0.0 110.034 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -112.89 -26.91 8.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.126 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 135.67 53.74 0.06 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.671 HG11 ' HB1' ' A' ' 20' ' ' ALA . 65.1 t -158.3 109.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -108.87 125.15 51.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.5 pt -106.22 174.63 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -131.3 -50.73 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 0.0 110.174 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -140.33 86.23 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.9 59.76 5.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -125.73 99.57 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' GLY . . . -44.45 159.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.222 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -160.38 40.45 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 110.235 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 70' ' ' ARG . 32.2 tt0 63.05 126.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.256 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -68.85 123.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.892 . . . . 0.0 110.14 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.61 ' N ' HD13 ' A' ' 72' ' ' ILE . 22.8 p -73.56 -175.82 2.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.895 . . . . 0.0 110.333 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 -15.93 25.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.21 -20.85 63.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.59 ' HB3' HD11 ' A' ' 72' ' ' ILE . 21.7 p-10 -52.03 -29.97 23.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE1' ' HD2' ' A' ' 98' ' ' LYS . 19.6 m-85 -86.19 49.05 1.71 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.268 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 1.3 t 171.66 -61.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.244 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.547 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -42.24 -27.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 110.228 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.832 ' CB ' ' HB3' ' A' ' 6' ' ' ALA . 8.1 m-85 -131.02 -135.13 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.079 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -177.95 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 0.0 110.644 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 16.3 t -104.5 84.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.015 -1.053 . . . . 0.0 110.463 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.849 HG21 ' CD1' ' A' ' 94' ' ' ILE . 2.9 mp -72.68 114.22 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.961 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -97.67 124.33 41.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -117.09 126.95 53.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.878 HD21 ' HB2' ' A' ' 18' ' ' SER . 1.1 mp -64.47 -54.42 32.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.352 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.46 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -103.29 -165.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 0.0 110.22 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 96.1 mt-30 -94.83 -36.84 11.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -42.84 -45.35 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.565 HD12 ' H ' ' A' ' 90' ' ' ILE . 2.2 mp -62.5 -47.2 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.205 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.11 -30.87 71.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.119 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.2 t -79.49 -30.8 42.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 96' ' ' SER . 3.3 m-20 -79.69 -55.27 5.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 83' ' ' ILE . 10.0 tt -47.58 -43.64 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 110.203 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.605 ' N ' HG23 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.08 -23.65 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -67.53 -10.35 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.183 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.561 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 6.4 mtm -116.64 -50.96 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.567 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 11.3 mtpt -40.78 129.75 1.89 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 110.432 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.445 ' HG2' ' OD1' ' A' ' 101' ' ' ASN . 46.3 Cg_endo -72.72 -163.54 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.025 1.539 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -101.16 28.72 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 22.9 p30 -150.79 94.2 2.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.06 179.04 8.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.82 6.73 4.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.267 -0.896 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -105.9 122.87 47.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.49 162.27 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.698 HG12 ' HB ' ' A' ' 83' ' ' ILE . 27.9 m -125.23 127.15 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.25 159.41 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 109' ' ' PHE . 3.5 tt -116.79 141.35 48.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.157 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.575 ' N ' HD23 ' A' ' 108' ' ' LEU . 7.5 m-85 -103.77 113.14 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 2.0 t30 58.66 144.77 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.533 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 46.3 Cg_endo -74.27 176.06 10.12 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.052 1.554 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.7 Cg_endo -71.74 53.83 1.92 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.892 1.47 . . . . 0.0 110.383 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -158.44 19.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.211 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 116' ' ' ASP . . . -135.91 -90.52 0.31 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 131' ' ' SER . 8.3 t -60.63 83.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -1.166 . . . . 0.0 110.19 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 114' ' ' GLY . 22.4 t70 -129.68 131.12 46.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.466 ' OD2' ' HA3' ' A' ' 124' ' ' GLY . 23.4 t0 -159.83 102.09 1.45 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.34 -89.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.994 1.523 . . . . 0.0 110.461 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.04 32.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.208 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 121' ' ' SER . 0.1 OUTLIER -93.03 102.25 14.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 58.94 173.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.35 65.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -115.94 129.42 56.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.159 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 112.31 -34.82 4.97 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.692 ' HB3' HG21 ' A' ' 56' ' ' VAL . 9.9 m-30 -41.31 -49.72 8.81 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.68 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.3 Cg_endo -70.87 -64.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.547 1.288 . . . . 0.0 110.436 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.571 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 21.4 p -53.33 -54.96 28.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.895 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.5 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 ttp -42.28 -69.72 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 110.024 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 24' ' ' ILE . 61.9 t80 -44.0 -49.66 8.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.757 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -47.92 -47.04 32.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.8 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -74.31 -33.68 63.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.882 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.807 HG23 HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -55.32 -45.5 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.615 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.555 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -83.71 -38.14 21.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.302 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 131' ' ' SER . 62.7 mm-40 -90.56 -30.33 17.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 9' ' ' PHE . 13.7 mtm -99.65 4.45 45.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -86.85 -51.04 0.45 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 0.0 110.017 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.88 -6.67 14.28 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.99 1.521 . . . . 0.0 110.435 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.639 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 85.2 t80 -108.16 -78.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.53 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 34' ' ' ILE . 15.9 tp -44.14 -24.62 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.481 ' HA ' ' HB ' ' A' ' 146' ' ' ILE . 4.6 m -89.11 -31.58 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.963 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 138' ' ' PRO . 3.3 mm-40 -105.09 -39.09 6.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 110.284 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.639 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 14.3 t-80 -40.39 -29.39 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.0 60.87 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.53 HD22 HG21 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -154.87 -39.83 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -1.142 . . . . 0.0 110.183 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 146' ' ' ILE . 53.6 mt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.218 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.333 0.587 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.731 ' HG2' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.46 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.874 . . . . 0.0 108.758 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.687 ' HB2' HG22 ' A' ' 34' ' ' ILE . 9.3 mtpp -159.01 -164.42 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.977 -1.077 . . . . 0.0 110.493 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.763 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.91 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.566 -0.709 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.011 HG22 ' O ' ' A' ' 34' ' ' ILE . 2.1 m -90.55 138.66 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.976 . . . . 0.0 110.169 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.694 ' HG ' ' HB2' ' A' ' 38' ' ' ALA . 7.4 tp -89.89 88.15 7.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 110.129 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.645 ' CE2' HG21 ' A' ' 7' ' ' VAL . 5.5 m-85 -72.69 114.16 10.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.752 HG13 HD11 ' A' ' 90' ' ' ILE . 2.1 p -165.8 171.26 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.67 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.732 ' HA ' HD12 ' A' ' 90' ' ' ILE . 10.1 t 175.27 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 51.08 49.66 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 0.0 110.09 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.21 70.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.73 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -44.74 -45.35 9.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -1.14 . . . . 0.0 110.136 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 45' ' ' VAL . 25.9 mt -61.33 -12.35 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 19.8 m -99.67 153.4 19.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.966 ' HG2' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 61.5 11.07 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.387 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.62 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -91.96 -64.26 0.16 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.976 . . . . 0.0 110.172 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.62 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 47.8 Cg_endo -74.27 -1.4 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.793 1.417 . . . . 0.0 110.299 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -103.15 -47.4 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.451 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.864 ' HA ' HD11 ' A' ' 132' ' ' ILE . 60.4 m -70.25 -38.51 75.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.978 . . . . 0.0 109.969 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.84 -44.28 96.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . -70.06 -48.5 39.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 ' CE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -53.0 -53.0 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -1.143 . . . . 0.0 110.038 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.937 ' HB3' HD11 ' A' ' 35' ' ' ILE . 63.9 m -69.4 -62.15 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 22.6 mmt180 -47.47 -22.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 23.8 t0 -85.81 -45.01 11.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 2.0 mtt -83.16 -1.72 53.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.0 110.425 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 25' ' ' CYS . 3.0 m -131.0 -28.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.947 . . . . 0.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 100.09 -58.75 0.76 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 17.5 p30 178.32 102.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -1.144 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.595 ' C ' HD12 ' A' ' 33' ' ' LEU . 13.3 ptpt -152.96 -136.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.009 ' O ' HD12 ' A' ' 35' ' ' ILE . 5.1 mp -112.78 -127.61 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.011 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.6 OUTLIER 51.62 4.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.598 -0.689 . . . . 0.0 111.157 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.009 HD12 ' O ' ' A' ' 33' ' ' LEU . 3.2 mt -127.48 113.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 0.0 110.717 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 8.2 m-20 -142.79 111.73 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.74 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.55 127.68 32.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.262 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' CG1' ' A' ' 10' ' ' VAL . . . -128.58 177.48 6.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -167.79 96.31 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.159 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.544 ' CG2' HG13 ' A' ' 90' ' ' ILE . 74.7 p -41.98 -35.19 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 m -116.97 -167.19 1.26 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.86 77.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -128.02 0.02 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 0.0 110.256 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 0.4 OUTLIER -122.42 -11.41 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.292 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.615 ' HA ' HD11 ' A' ' 15' ' ' ILE . 34.3 m -62.48 159.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.246 -0.909 . . . . 0.0 110.299 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.06 21.91 64.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.516 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 6.5 pt20 -173.7 -148.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -1.134 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 48' ' ' SER . 0.8 OUTLIER 64.43 112.41 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.35 87.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.928 1.488 . . . . 0.0 110.451 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -86.16 30.49 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.103 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -73.86 -27.46 61.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.23 -0.919 . . . . 0.0 109.005 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.605 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -71.61 -54.9 8.91 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.288 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.573 ' CB ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -59.7 -51.22 70.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 109.37 179.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -60.86 -41.61 96.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.603 ' HE3' HG23 ' A' ' 56' ' ' VAL . 1.5 ttpt -52.83 -66.36 0.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' HE3' ' A' ' 55' ' ' LYS . 52.6 t -50.61 -37.34 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.895 . . . . 0.0 109.115 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -52.02 -52.65 49.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.488 -0.758 . . . . 0.0 109.409 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 -27.28 64.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.528 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 2.0 t -78.64 -11.48 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 109.896 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.36 -19.95 13.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.589 ' C ' HG13 ' A' ' 62' ' ' VAL . . . 106.16 97.07 2.48 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.731 HG12 ' CE2' ' A' ' 129' ' ' PHE . 16.1 m -154.76 -147.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.154 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.447 ' C ' HG23 ' A' ' 64' ' ' ILE . 5.7 t0 179.43 117.07 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.326 -0.859 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.533 ' HB ' ' NE2' ' A' ' 67' ' ' GLN . 15.0 pt -146.65 -37.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.334 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 64' ' ' ILE . 2.3 t 68.75 -67.0 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 16.0 mmtt -136.05 -174.03 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.29 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.533 ' NE2' ' HB ' ' A' ' 64' ' ' ILE . 98.7 mm-40 -139.49 -77.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.17 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.87 84.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.73 ' HB1' ' CG ' ' A' ' 14' ' ' ASN . . . -76.95 179.05 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.221 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -153.11 29.92 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.263 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 50.7 tt0 55.93 162.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.961 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.476 HG13 ' OD2' ' A' ' 76' ' ' ASP . 5.3 tt -62.69 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.225 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.429 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -149.91 147.35 27.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 110.172 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -13.97 10.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -89.9 -9.65 48.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' OD2' HG13 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -44.55 -42.88 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.05 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 35.5 m-85 -59.31 -17.42 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 t -113.05 -44.15 3.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.057 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.605 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 18.0 tptt -45.89 -27.95 1.0 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.071 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 27.7 m-85 -144.78 179.25 7.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 110.196 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -114.87 -13.58 11.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 110.583 -179.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 76.9 t -128.74 143.67 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 0.0 110.465 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' VAL . 1.9 mp -116.71 119.92 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -100.41 110.92 23.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 110.654 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.932 ' HB1' HG21 ' A' ' 90' ' ' ILE . . . -104.74 133.21 49.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.023 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.966 HD22 ' HG2' ' A' ' 17' ' ' ARG . 2.6 tp -82.41 -31.15 29.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.279 -0.888 . . . . 0.0 110.49 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 90' ' ' ILE . 21.9 p-10 -118.65 178.81 4.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.977 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.52 -41.34 13.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.145 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.2 m -45.09 -48.0 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.035 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.932 HG21 ' HB1' ' A' ' 85' ' ' ALA . 6.5 tt -53.65 -39.46 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.032 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.509 ' N ' HG23 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -70.7 -42.16 71.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.917 . . . . 0.0 110.089 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.7 t -63.43 -30.93 71.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -88.54 -57.44 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.558 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.1 tt -46.04 -32.9 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 110.182 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.486 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 8.0 t-20 -78.67 -15.19 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -9.2 57.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.212 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.558 ' CE ' HG13 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -112.44 -21.51 11.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.145 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -49.48 151.73 2.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.192 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 100' ' ' SER . 44.3 Cg_endo -72.03 -52.19 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.966 1.508 . . . . 0.0 110.399 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 168.28 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.49 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 40.4 m-80 -163.81 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.364 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.56 -150.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 109.951 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -133.47 63.24 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -156.36 156.05 33.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.8 139.67 53.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.164 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 61.6 t -94.22 139.2 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.673 HG11 ' NE2' ' A' ' 143' ' ' HIS . 16.1 m -136.53 142.63 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.02 132.56 38.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.16 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.493 ' HB3' HD12 ' A' ' 86' ' ' LEU . 10.1 t80 -87.05 -20.84 26.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 3.6 p-10 -177.48 164.66 1.37 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.0 Cg_endo -74.49 174.31 12.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.017 1.535 . . . . 0.0 110.348 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.77 51.57 2.34 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -111.63 -44.43 3.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.31 102.86 0.99 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.424 HG11 ' OD1' ' A' ' 110' ' ' ASN . 7.9 p -122.52 -9.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.687 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.2 t70 -117.02 -127.96 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.09 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -157.09 86.24 2.81 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.31 55.56 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.068 1.562 . . . . 0.0 110.45 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.468 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 1.1 m-85 46.45 -159.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.468 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 2.6 t80 67.06 9.15 6.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 2.2 t 171.75 165.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.115 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -111.14 -17.99 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 123' ' ' ASP . 2.9 p30 -67.02 68.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 122' ' ' SER . . . -176.77 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.67 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 15.5 m-85 -41.39 -51.37 8.52 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.341 -1.093 . . . . 0.0 110.471 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.67 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -72.42 -56.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.754 1.397 . . . . 0.0 110.334 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.8 m -52.74 -42.82 65.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.765 ' O ' HG22 ' A' ' 132' ' ' ILE . 24.8 ttp -49.69 -77.04 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 0.0 109.764 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 1.048 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.4 t80 -46.6 -54.55 9.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.114 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -50.84 -23.96 3.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.4 t -91.31 -57.29 2.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.338 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.864 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -54.71 -19.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.823 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.764 ' HB2' HD11 ' A' ' 24' ' ' ILE . 1.8 t -99.11 -50.19 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 109.77 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 12.0 tttt -59.31 -17.24 27.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.926 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HD2' ' A' ' 138' ' ' PRO . 1.4 tt0 -116.6 10.29 14.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.872 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.57 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 3.4 tpt -81.29 8.45 9.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 110.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.5 mtmt -88.6 -52.25 0.37 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.1 Cg_endo -76.66 6.79 3.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.97 1.511 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.57 ' CD2' ' CE ' ' A' ' 136' ' ' MET . 60.1 t80 -96.28 -60.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.153 -0.967 . . . . 0.0 110.366 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 140' ' ' LEU . 3.9 pp -84.6 -13.68 50.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.391 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 137' ' ' LYS . 3.4 m -69.31 -32.57 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.141 -0.974 . . . . 0.0 110.156 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 143' ' ' HIS . 16.5 mm-40 -102.45 -38.78 7.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.203 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.673 ' NE2' HG11 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -43.59 -32.7 1.0 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.307 -0.87 . . . . 0.0 110.236 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.97 73.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 145' ' ' LEU . 1.5 mt -163.05 -62.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 141' ' ' THR . 26.5 pt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.236 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.244 0.545 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.797 ' HG3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -84.19 150.74 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 179.263 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 34' ' ' ILE . 8.4 mtpt -134.48 -155.74 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 110.761 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.113 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.54 134.73 43.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 110.697 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.6 HG23 ' CG2' ' A' ' 34' ' ' ILE . 73.0 t -124.01 123.98 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.724 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.643 HD12 ' HB3' ' A' ' 36' ' ' ASP . 5.6 tp -80.79 103.41 10.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.67 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.64 102.86 13.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.033 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 57.4 t -129.45 169.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.394 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.54 ' N ' HG12 ' A' ' 10' ' ' VAL . 39.7 t -158.52 -65.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.583 HD11 ' CB ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 169.93 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 99.96 -26.91 22.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.641 ' ND2' ' HB2' ' A' ' 39' ' ' ALA . 2.6 t-20 70.53 3.28 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.334 -1.098 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.715 HD13 ' HB2' ' A' ' 48' ' ' SER . 97.7 mt -101.17 -39.81 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 59.7 m -121.89 153.37 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.989 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.973 ' CB ' HD23 ' A' ' 86' ' ' LEU . 11.0 mtm105 55.79 55.61 6.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.908 . . . . 0.0 110.1 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 176.1 -57.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.422 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.0 Cg_endo -72.08 -12.29 27.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.001 1.527 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.75 -11.48 28.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.065 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.662 ' HA ' HD11 ' A' ' 132' ' ' ILE . 28.3 m -64.75 -43.91 91.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 1.9 mt-10 -48.0 -52.85 18.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.499 -0.75 . . . . 0.0 109.717 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.966 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -64.27 -45.27 93.98 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.939 HD11 ' CD1' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -48.92 -52.27 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -1.097 . . . . 0.0 109.847 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.636 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -64.83 -43.89 91.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.064 179.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.474 ' HA ' ' N ' ' A' ' 31' ' ' ASP . 16.6 mtt85 -53.27 -44.54 68.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 -16.54 37.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.764 ' O ' HG13 ' A' ' 29' ' ' VAL . 2.9 mmt -83.32 -30.39 27.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.31 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 28' ' ' MET . 2.5 m -161.24 24.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 64.35 37.39 94.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.712 ' OD1' HD13 ' A' ' 35' ' ' ILE . 1.9 t70 68.7 85.31 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.14 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 29' ' ' VAL . 12.2 mmtt -88.9 36.17 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.974 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.916 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 71.91 -144.07 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 110.066 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.113 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 1.5 pp 35.65 22.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.492 -0.755 . . . . 0.0 112.032 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.2 mt -97.31 90.47 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.081 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' A' ' 8' ' ' LEU . 4.1 m-20 -122.95 79.43 1.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.312 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.16 130.94 44.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 110.039 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.033 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . . . -145.71 -176.33 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.665 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -148.06 150.14 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.192 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.826 ' CG2' HG23 ' A' ' 90' ' ' ILE . 69.3 p -83.1 -77.92 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.472 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.39 76.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 110.193 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.03 97.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.45 -10.24 11.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -1.162 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.692 ' O ' HD11 ' A' ' 15' ' ' ILE . 32.2 m170 -117.68 98.51 6.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.174 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 69' ' ' ALA . 9.1 t -123.58 148.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.77 26.05 1.75 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 12.18 4.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -1.128 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.715 ' HB2' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -117.6 178.98 0.89 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 48' ' ' SER . 45.7 Cg_endo -69.21 -57.65 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 3.9 m-20 67.2 -54.86 0.46 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 m -71.84 -22.81 61.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.219 -0.925 . . . . 0.0 109.099 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HG2' ' CE2' ' A' ' 125' ' ' PHE . 19.6 tpp180 -73.58 -57.65 3.85 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.386 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.547 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -59.76 -48.76 80.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.163 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 1.0 OUTLIER -60.99 -40.3 92.97 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.14 179.205 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -55.32 -64.06 0.96 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.599 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 5.7 p -52.25 -34.72 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.041 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.847 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -55.73 -50.68 69.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.76 . . . . 0.0 109.388 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -68.06 -31.8 71.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 109.713 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.9 t -78.3 -11.27 59.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 0.0 109.987 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.566 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 5.4 m-20 -111.53 -34.75 5.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.313 -0.867 . . . . 0.0 109.11 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 138.32 73.55 0.05 OUTLIER Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.966 HG13 ' HA3' ' A' ' 23' ' ' GLY . 42.5 t -158.59 142.24 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -1.149 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 18.9 p30 -142.56 104.64 4.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.533 HD13 ' NE2' ' A' ' 67' ' ' GLN . 41.6 pt -108.39 -146.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.446 ' N ' HG13 ' A' ' 64' ' ' ILE . 11.0 p -145.78 -45.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.344 -0.848 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HD2' ' OG ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -150.54 150.07 30.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.533 ' NE2' HD13 ' A' ' 64' ' ' ILE . 2.3 mt-30 -130.27 116.89 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 1.8 ptm180 -151.93 123.6 7.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.639 ' HB3' HG22 ' A' ' 45' ' ' VAL . . . -70.63 121.91 18.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.154 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -132.44 15.25 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 72' ' ' ILE . 12.1 tt0 53.96 168.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 76' ' ' ASP . 16.6 tt -94.44 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -0.877 . . . . 0.0 110.277 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 7.3 m -109.75 15.68 22.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.5 mmtt 66.24 5.38 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.284 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -88.01 -24.07 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.286 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.826 ' HB3' HD11 ' A' ' 72' ' ' ILE . 5.2 p-10 -43.54 -29.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.1 m-85 -71.21 -27.2 63.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -123.18 9.23 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.153 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.467 ' C ' ' CD1' ' A' ' 80' ' ' PHE . 5.4 tptt -107.3 -36.83 6.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 5.9 m-30 -114.78 -142.59 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.78 -38.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 72.4 t -124.3 151.79 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.414 HG23 HD23 ' A' ' 8' ' ' LEU . 2.7 mt -129.78 114.92 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.482 ' HA ' HG23 ' A' ' 107' ' ' VAL . . . -98.14 138.36 35.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.98 141.53 49.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.199 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.973 HD23 ' CB ' ' A' ' 17' ' ' ARG . 5.0 tp -95.04 4.52 53.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.616 ' CB ' HD11 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -146.41 -156.08 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -117.77 -42.76 2.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.583 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -44.51 -28.69 0.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.826 HG23 ' CG2' ' A' ' 40' ' ' THR . 1.4 mp -70.9 -48.77 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.885 . . . . 0.0 110.126 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.425 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -68.61 -27.35 65.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.208 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 t -78.48 -40.51 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 96' ' ' SER . 40.1 m-20 -83.7 -50.54 8.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 95' ' ' ASN . 3.4 tt -45.43 -41.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.561 ' N ' HG23 ' A' ' 94' ' ' ILE . 3.5 t-20 -66.53 -7.84 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.229 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 57.2 m -86.79 -22.85 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.545 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.7 ptt? -104.98 -35.4 7.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 97' ' ' MET . 8.7 mtpt -42.24 122.8 2.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.155 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.97 -172.31 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.901 1.474 . . . . 0.0 110.455 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.21 13.4 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.887 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -137.41 91.47 2.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.0 p -149.65 177.07 10.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.39 27.03 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.2 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 138.17 52.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.7 156.63 17.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.445 ' C ' HG13 ' A' ' 107' ' ' VAL . 6.1 t -112.58 158.25 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.522 HG11 ' NE2' ' A' ' 143' ' ' HIS . 33.0 m -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.69 142.18 27.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.566 ' CE2' ' HE3' ' A' ' 136' ' ' MET . 0.1 OUTLIER -90.91 -64.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.44 ' OD1' HG22 ' A' ' 115' ' ' VAL . 10.5 p30 -141.78 164.17 36.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.484 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.4 Cg_endo -74.39 174.73 12.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.945 1.497 . . . . 0.0 110.281 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.09 52.45 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.65 -40.14 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.092 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.22 -67.89 1.98 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.568 HG23 ' HD3' ' A' ' 17' ' ' ARG . 21.8 m -103.51 86.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -1.196 . . . . 0.0 110.063 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.444 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 9.9 t70 -67.52 160.85 26.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.79 67.84 4.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.1 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 116' ' ' ASP . 46.0 Cg_endo -72.8 162.99 39.69 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.05 1.553 . . . . 0.0 110.539 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.71 163.77 27.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.163 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 50.83 26.82 2.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 122' ' ' SER . 26.0 t -155.53 -168.7 2.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.42 ' N ' ' OG ' ' A' ' 121' ' ' SER . 44.2 p -141.28 75.63 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -29.98 2.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 128' ' ' MET . . . -101.72 -34.7 4.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.676 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 12.3 m-85 -41.34 -55.38 5.33 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -1.128 . . . . 0.0 110.278 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.676 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -71.92 -60.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.835 1.439 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 131' ' ' SER . 9.8 m -49.83 -44.16 49.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.173 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.678 ' O ' HG22 ' A' ' 132' ' ' ILE . 25.1 ttp -50.95 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.21 -0.931 . . . . 0.0 109.788 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.939 ' CD1' HD11 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -45.81 -59.05 3.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.904 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -46.46 -26.45 0.86 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 110.037 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.555 ' CB ' ' CG1' ' A' ' 115' ' ' VAL . 1.1 m -87.92 -71.39 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -42.17 -25.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 179.072 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.516 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . 22.9 t -90.22 -60.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -51.61 -22.29 3.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.056 -1.028 . . . . 0.0 110.119 -179.918 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.528 ' HB3' ' CE1' ' A' ' 109' ' ' PHE . 0.8 OUTLIER -110.89 11.3 22.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.815 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.592 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -88.15 -3.84 58.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.8 mttt -90.55 -47.64 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.996 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.5 Cg_endo -75.37 1.84 7.47 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.631 1.332 . . . . 0.0 110.557 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.621 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 4.5 t80 -105.67 -47.25 3.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.037 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -78.3 -53.71 7.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.792 HG23 ' OXT' ' A' ' 146' ' ' ILE . 5.0 m -44.65 -26.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 143' ' ' HIS . 39.3 mt-10 -104.61 -40.3 6.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.621 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -43.05 -26.83 0.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.087 -1.008 . . . . 0.0 110.195 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 127.18 67.32 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.677 ' HB2' HD23 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -161.19 -70.72 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 110.114 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.792 ' OXT' HG23 ' A' ' 141' ' ' THR . 2.0 tt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.283 0.563 . . . . 5.2800000000000002 110.246 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.37 118.89 18.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 3.4900000000000002 110.158 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.11 -174.29 2.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 4.21 110.46 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.752 ' HA ' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -119.4 143.19 47.59 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.092 -0.707 . . . . 4.04 109.092 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 15.3 mttt -115.19 -131.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.138 -0.976 . . . . 2.5800000000000001 110.708 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.822 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . -176.79 103.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.438 -0.789 . . . . 0.97999999999999998 109.672 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.807 ' CG1' ' HB2' ' A' ' 84' ' ' ALA . 41.4 t -90.32 138.65 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 1.24 110.495 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.777 HD12 ' HB2' ' A' ' 36' ' ' ASP . 5.7 tp -87.0 94.56 9.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 1.03 110.019 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.591 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 2.4 m-85 -78.44 104.33 8.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 2.3900000000000001 110.063 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.017 HG22 ' C ' ' A' ' 38' ' ' ALA . 30.5 t -123.46 163.11 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 1.4099999999999999 110.296 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 1.5 p -149.99 -53.53 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 2.0899999999999999 110.39 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 173.88 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.139 -0.975 . . . . 1.98 110.237 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.866 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . 136.21 -4.9 3.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.724 -1.35 . . . . 1.99 109.724 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 5.0 t30 69.43 38.13 1.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -1.148 . . . . 2.6299999999999999 110.262 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 44' ' ' HIS . 12.5 mt -136.49 -39.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 1.6200000000000001 110.235 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 88.3 m -90.39 107.79 19.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 3.4199999999999999 110.178 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.554 ' CG ' ' HG3' ' A' ' 128' ' ' MET . 0.9 OUTLIER 73.55 -4.19 2.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 3.54 110.392 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -84.42 -51.53 0.57 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 4.4500000000000002 110.66 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 18' ' ' SER . 47.3 Cg_endo -75.22 3.48 5.69 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.817 1.43 . . . . 2.3999999999999999 110.619 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.657 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -98.85 -19.01 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 1.21 110.209 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 132' ' ' ILE . 22.0 m -71.55 -36.98 71.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 1.5900000000000001 109.991 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.715 ' HA ' HG21 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -63.04 -38.38 90.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 2.2799999999999998 110.015 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.803 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -76.72 -56.01 4.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.636 -1.386 . . . . 0.81000000000000005 109.636 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 133' ' ' SER . 5.7 tp -50.11 -44.78 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -1.198 . . . . 1.1299999999999999 110.129 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.95 ' HB3' HD11 ' A' ' 35' ' ' ILE . 69.4 m -72.22 -53.31 12.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 1.3999999999999999 110.042 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -43.53 -41.03 4.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 2.4199999999999999 109.99 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -33.66 26.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 2.0600000000000001 110.243 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -59.12 -44.37 92.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 2.3900000000000001 110.468 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.584 HG11 ' HD2' ' A' ' 32' ' ' LYS . 5.6 t -108.3 -32.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.96 . . . . 2.2000000000000002 110.517 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 123.55 -54.1 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.546 -1.422 . . . . 2.29 109.546 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.6 t70 179.61 90.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 3.5899999999999999 110.254 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.584 ' HD2' HG11 ' A' ' 29' ' ' VAL . 15.0 mttt -141.61 -137.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 3.5 110.173 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.81 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.9 mt -116.39 -123.07 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 3.7200000000000002 110.07 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.028 HD13 HD13 ' A' ' 140' ' ' LEU . 0.5 OUTLIER 50.45 5.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.53 -0.731 . . . . 1.99 111.305 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.95 HD11 ' HB3' ' A' ' 25' ' ' CYS . 3.5 mt -121.2 109.27 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.95 -1.094 . . . . 2.21 110.724 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.777 ' HB2' HD12 ' A' ' 8' ' ' LEU . 6.7 m-20 -143.1 91.75 2.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.8799999999999999 109.986 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 2.8 m -69.4 137.97 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.6200000000000001 110.221 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.017 ' C ' HG22 ' A' ' 10' ' ' VAL . . . -151.61 177.18 10.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.94999999999999996 110.315 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -162.71 144.99 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 1.23 110.176 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -109.0 38.93 2.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 1.9399999999999999 110.193 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -160.72 87.04 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 1.8600000000000001 110.214 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.26 68.7 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.517 -1.433 . . . . 2.1600000000000001 109.517 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' SER . 2.1 m-85 -108.39 -61.05 1.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -1.164 . . . . 3.0299999999999998 110.172 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.421 ' O ' HD11 ' A' ' 15' ' ' ILE . 2.2 m170 -92.05 91.22 7.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 2.6200000000000001 110.191 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 64.5 t -136.06 162.77 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 1.98 110.229 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.418 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 53.61 37.12 55.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 1.6299999999999999 109.561 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 48' ' ' SER . 11.1 pt20 -172.11 -144.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -1.127 . . . . 1.77 110.196 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HG ' ' HH ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER 57.27 110.7 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 1.8600000000000001 110.167 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.8 Cg_endo -69.46 92.37 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.012 1.533 . . . . 1.78 110.45 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 1.2 m-20 -86.48 19.02 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 2.8399999999999999 110.207 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -75.43 -27.93 59.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.247 -0.908 . . . . 1.4299999999999999 109.077 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.603 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 45.0 mtt180 -72.6 -51.65 18.8 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.822 -0.751 . . . . 3.2200000000000002 109.369 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 t -63.55 -49.83 71.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -0.794 . . . . 1.51 109.615 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' CD ' HD11 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -60.42 -39.92 89.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.274 -0.891 . . . . 2.2000000000000002 109.305 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -59.42 -67.68 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 3.23 109.542 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.57 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 22.0 t -48.41 -34.21 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 1.8999999999999999 109.239 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.936 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.22 -54.93 41.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 1.25 109.605 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -68.54 -20.36 64.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 2.6400000000000001 109.706 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 2.4 t -87.65 -13.58 42.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.357 -0.839 . . . . 1.49 110.103 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -114.77 -30.7 6.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 1.6000000000000001 109.326 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.707 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 136.22 79.73 0.1 OUTLIER Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.922 -1.271 . . . . 1.25 109.922 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.936 HG11 ' SG ' ' A' ' 57' ' ' CYS . 40.6 t -159.61 123.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -1.079 . . . . 1.8 110.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.14 105.05 14.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 2.46 110.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.691 HD12 HE21 ' A' ' 67' ' ' GLN . 35.6 pt -120.73 -145.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 2.0299999999999998 110.237 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.488 ' N ' HG13 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -170.03 -64.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 3.6800000000000002 110.229 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' A' ' 65' ' ' SER . 15.7 mmtt -142.25 145.93 34.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 5.8300000000000001 110.126 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.691 HE21 HD12 ' A' ' 64' ' ' ILE . 32.3 mm-40 -122.11 56.65 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 2.77 110.258 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ALA . 1.5 ttp85 -69.18 71.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 4.2599999999999998 110.182 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB1' ' O ' ' A' ' 13' ' ' GLY . . . -42.51 136.28 2.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 1.3799999999999999 110.236 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 ptt-85 -140.34 158.44 44.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 2.1499999999999999 110.203 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.55 145.32 55.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 2.2400000000000002 110.197 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 72' ' ' ILE . 6.6 tt -89.96 128.76 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 1.49 110.213 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.2 p -86.22 -142.75 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 2.1099999999999999 110.213 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -109.43 -5.98 15.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 3.4100000000000001 110.222 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -75.19 -21.34 58.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.3300000000000001 110.247 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 4.2 p-10 -44.68 -28.81 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 2.46 110.194 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.578 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 25.1 m-85 -79.63 -46.49 17.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 1.55 110.248 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -95.06 8.42 43.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 1.9299999999999999 110.209 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.59 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 14.0 tptt -102.62 -2.76 27.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 2.7799999999999998 110.228 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.788 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 91.8 m-85 -151.62 -157.56 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 1.71 110.298 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.3 -26.28 2.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 2.3300000000000001 110.551 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' A' ' 143' ' ' HIS . 97.0 t -136.94 150.88 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.052 . . . . 1.26 110.576 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.676 HG21 ' CD1' ' A' ' 94' ' ' ILE . 1.7 mp -123.24 116.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.824 . . . . 0.83999999999999997 109.902 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.807 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -103.12 118.82 37.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.80000000000000004 110.483 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -109.61 112.72 24.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.78000000000000003 110.065 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' CD2' ' HB2' ' A' ' 17' ' ' ARG . 5.0 mp -59.48 -84.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 1.23 110.356 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.62 ' O ' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -62.77 159.81 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 2.02 110.273 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 2.0899999999999999 110.184 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -52.81 -40.16 63.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 1.6200000000000001 110.165 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 87' ' ' ASP . 2.8 mt -65.2 -51.73 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 1.7 110.189 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.539 HD12 ' HB3' ' A' ' 85' ' ' ALA . 0.5 OUTLIER -61.29 -43.55 98.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.92000000000000004 110.378 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 t -64.81 -48.62 73.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.917 . . . . 1.1899999999999999 110.264 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -64.65 -63.67 1.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 1.73 110.265 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.676 ' CD1' HG21 ' A' ' 83' ' ' ILE . 6.1 tt -42.76 -38.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 1.4299999999999999 110.248 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.496 ' N ' HG23 ' A' ' 94' ' ' ILE . 28.6 t-20 -71.9 -24.9 61.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 1.9399999999999999 110.214 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 93' ' ' ASP . 42.7 t -76.88 -2.02 31.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 1.3999999999999999 110.225 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.0 ptt? -123.97 -25.33 4.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 1.1200000000000001 110.219 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 1.4 mtpt -49.04 143.02 9.16 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 1.04 110.26 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.09 -159.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.991 1.522 . . . . 1.4399999999999999 110.438 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.84 2.62 15.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.86 . . . . 2.0800000000000001 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -149.16 108.11 3.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 3.3799999999999999 110.263 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.4 p -149.48 -173.79 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.887 . . . . 1.95 110.222 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 17.08 7.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 2.8399999999999999 110.218 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.46 157.93 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.88 110.208 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -115.43 157.23 24.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.281 -0.887 . . . . 2.5699999999999998 110.177 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.6 t -118.61 114.51 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 1.4299999999999999 110.185 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.569 HG11 ' CE1' ' A' ' 143' ' ' HIS . 27.6 m -121.58 148.19 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 1.4099999999999999 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 109' ' ' PHE . 1.3 tp -85.68 152.8 22.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 1.45 110.181 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.522 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 4.4 t80 -115.82 109.3 17.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 2.1699999999999999 110.268 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.494 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER 57.79 156.25 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 2.8399999999999999 110.28 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.494 ' HD2' ' ND2' ' A' ' 110' ' ' ASN . 47.0 Cg_endo -74.83 174.26 13.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.039 1.547 . . . . 2.6299999999999999 110.28 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.85 52.33 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 4.0899999999999999 110.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -145.9 -47.03 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 2.9500000000000002 110.251 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.39 -102.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 2.1499999999999999 109.552 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 115' ' ' VAL . 30.8 m -54.55 105.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 1.9199999999999999 110.225 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -148.22 29.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 4.1500000000000004 110.247 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.512 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 6.9 t0 -48.95 112.41 2.43 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 4.1399999999999997 110.199 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 46.8 Cg_endo -72.73 -93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.939 1.494 . . . . 3.5600000000000001 110.427 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 168.12 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 3.8700000000000001 110.178 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.19 -46.99 0.34 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 6.1500000000000004 110.254 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.59 167.07 10.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 2.27 110.227 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.548 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -88.24 32.68 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 2.6299999999999999 110.185 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.91 16.61 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 2.1600000000000001 110.221 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -118.91 -44.12 0.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.497 -1.441 . . . . 1.3200000000000001 109.497 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 5.2 m-85 -44.17 -48.15 23.76 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.169 . . . . 2.0899999999999999 110.396 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 46.7 Cg_endo -72.59 -54.53 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.625 1.329 . . . . 1.0800000000000001 110.349 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 23.1 m -62.13 -53.88 49.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 1.6000000000000001 110.142 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.657 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 10.7 ttp -41.85 -65.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 1.0900000000000001 110.108 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 50.2 t80 -56.25 -44.78 80.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 1.48 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -44.06 -59.73 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 1.1100000000000001 109.99 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 25.7 m -70.75 -42.31 70.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.6299999999999999 109.867 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.791 HD11 ' SG ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -41.58 -43.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 1.5 109.904 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.777 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.2 -40.49 7.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 1.5900000000000001 110.241 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 33.5 tttt -55.47 -16.64 3.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 3.5699999999999998 110.227 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.479 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 4.2 tp10 -117.9 16.13 14.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 3.0899999999999999 109.809 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.553 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -102.97 -21.2 13.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 2.8799999999999999 110.162 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 19.4 mttt -81.93 -47.04 1.01 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 3.1200000000000001 110.148 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -77.79 -2.52 12.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.982 1.517 . . . . 1.04 110.271 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 143' ' ' HIS . 48.8 t80 -111.03 -72.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 1.77 110.116 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.028 HD13 HD13 ' A' ' 34' ' ' ILE . 1.8 tp -47.83 -49.34 29.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 1.6100000000000001 110.052 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.742 HG23 ' OXT' ' A' ' 146' ' ' ILE . 6.7 m -58.3 -29.19 65.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.1699999999999999 110.349 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -106.84 5.93 28.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 2.2999999999999998 110.397 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.915 ' CD2' HG11 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -96.33 -6.16 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.129 -0.982 . . . . 2.21 110.348 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.469 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 124.77 28.47 1.15 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 2.1499999999999999 109.726 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -144.36 -103.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -1.182 . . . . 2.3799999999999999 110.191 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.953 HD13 ' OXT' ' A' ' 146' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.0 -1.0 . . . . 3.0600000000000001 110.148 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.693 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.226 0.536 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 67.09 17.37 10.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 2' ' ' ALA . 0.7 OUTLIER -102.54 -161.06 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.26 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -119.42 145.07 46.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 34' ' ' ILE . 16.0 mtmt -125.7 -156.21 0.72 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.058 -1.026 . . . . 0.0 110.975 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.863 ' HB1' ' OD2' ' A' ' 36' ' ' ASP . . . -124.88 157.13 36.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.678 -0.639 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.689 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 13.6 t -138.75 121.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.692 HD13 ' CD2' ' A' ' 80' ' ' PHE . 7.7 tp -76.91 103.39 6.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 18.3 m-85 -83.16 86.28 7.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 38' ' ' ALA . 6.7 t -93.86 154.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.883 ' SG ' HD22 ' A' ' 86' ' ' LEU . 59.2 m -146.72 -71.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.136 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.447 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 175.96 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.262 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 80.47 -2.3 78.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.51 ' CB ' ' HB2' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 67.86 8.42 6.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.744 HG23 ' OD2' ' A' ' 50' ' ' ASP . 24.5 mt -118.61 -22.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.151 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 11' ' ' CYS . 14.5 m -86.09 111.64 20.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.267 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.61 ' HB2' HD22 ' A' ' 86' ' ' LEU . 1.1 mpt_? 60.9 12.28 3.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.535 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -78.85 -55.18 1.0 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.465 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 47.4 Cg_endo -74.23 1.34 7.39 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.844 1.444 . . . . 0.0 110.576 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -97.54 -28.34 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.347 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.826 ' HA ' HD11 ' A' ' 132' ' ' ILE . 63.8 m -74.1 -33.95 63.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.722 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -63.78 -45.66 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.462 -0.773 . . . . 0.0 110.304 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -76.77 -51.58 6.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.152 HD12 ' CD2' ' A' ' 129' ' ' PHE . 1.1 tt -52.01 -45.22 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 0.0 110.357 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.596 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 88.4 m -75.76 -51.85 11.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.179 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 3.6 mtp85 -44.12 -40.95 5.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.904 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -80.48 -43.01 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.721 ' SD ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -58.38 -52.6 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.915 . . . . 0.0 110.437 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.504 HG13 HD22 ' A' ' 145' ' ' LEU . 2.8 t -87.8 -34.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.369 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.38 -82.84 0.33 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 16.4 t0 -156.39 85.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -1.09 . . . . 0.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 31' ' ' ASP . 18.0 mmtm -129.8 -139.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.125 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.5 mt -119.15 -33.02 4.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.987 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.706 ' CA ' ' HA ' ' A' ' 6' ' ' ALA . 2.4 pp -32.17 -31.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.647 -0.658 . . . . 0.0 111.145 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.722 HG23 ' HA ' ' A' ' 22' ' ' GLU . 1.7 mt -73.96 88.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.483 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.863 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 49.0 m-20 -127.33 68.75 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.117 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -54.77 139.41 39.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.766 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -153.73 -179.09 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 14' ' ' ASN . . . -150.07 -173.7 4.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 40' ' ' THR . 5.3 t -162.04 67.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.908 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 -68.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 110.206 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -22.6 39.63 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 45' ' ' VAL . 9.8 m-85 -62.69 -63.44 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.44 70.88 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.859 HG22 ' HB1' ' A' ' 69' ' ' ALA . 44.5 t -144.75 142.27 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.95 18.98 58.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -168.11 -142.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 110.255 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 15' ' ' ILE . 0.6 OUTLIER 62.1 108.36 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.208 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 103.06 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.072 1.564 . . . . 0.0 110.486 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' A' ' 15' ' ' ILE . 61.5 m-20 -95.99 20.51 9.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -74.39 -27.76 60.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.949 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.595 ' HB3' ' CG ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -74.01 -52.07 13.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.296 179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.512 ' O ' HG12 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -61.37 -51.67 67.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -61.37 -41.01 96.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 109.263 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -54.2 -66.16 0.45 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.416 -0.803 . . . . 0.0 109.467 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.575 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 10.0 p -53.41 -32.01 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.911 . . . . 0.0 109.216 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.959 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -56.3 -52.12 65.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.534 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -24.34 60.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.302 -0.874 . . . . 0.0 109.651 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -81.74 -12.42 58.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.3 m120 -114.59 -29.07 6.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.732 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 131.71 81.02 0.2 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.959 HG11 ' SG ' ' A' ' 57' ' ' CYS . 26.0 t -160.36 133.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -1.131 . . . . 0.0 110.14 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -122.15 93.15 3.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 0.0 110.2 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.485 HG12 ' NE2' ' A' ' 54' ' ' GLN . 26.0 pt -97.54 165.5 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.83 37.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.48 85.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 0.0 110.183 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.546 ' NE2' ' HB3' ' A' ' 19' ' ' PRO . 5.0 mp0 -105.18 -79.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.148 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' ALA . 7.3 ttp180 43.61 75.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 110.242 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.859 ' HB1' HG22 ' A' ' 45' ' ' VAL . . . -42.43 149.22 0.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.87 -170.44 3.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -107.66 155.43 20.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.68 155.78 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.02 168.99 9.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -16.31 23.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -22.57 62.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.182 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 28.4 p-10 -48.38 -37.88 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.241 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CE2' ' HD3' ' A' ' 99' ' ' PRO . 20.8 m-85 -65.85 -10.87 42.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 110.21 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.414 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 27.7 t -144.52 30.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.58 ' CG ' ' CE2' ' A' ' 80' ' ' PHE . 15.7 tptt -111.17 -5.33 14.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.692 ' CD2' HD13 ' A' ' 8' ' ' LEU . 87.0 m-85 -151.7 -139.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.235 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 -53.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.918 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 74.6 t -119.13 111.04 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.467 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.443 ' HB ' HG22 ' A' ' 106' ' ' VAL . 3.9 mt -84.29 110.39 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.053 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.73 135.78 38.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 110.386 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -117.43 121.75 41.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.883 HD22 ' SG ' ' A' ' 11' ' ' CYS . 2.2 mp -66.09 -80.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.451 ' C ' HD12 ' A' ' 90' ' ' ILE . 1.3 t0 -67.4 178.72 1.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.254 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -85.88 -35.07 20.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -51.46 -33.51 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 110.229 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.9 mt -71.02 -52.53 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.5 OUTLIER -64.12 -34.4 77.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.23 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 t -77.86 -46.97 19.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 89' ' ' SER . 5.4 m-20 -67.09 -57.41 6.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 90' ' ' ILE . 3.9 tt -46.37 -40.82 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.53 ' N ' HG23 ' A' ' 94' ' ' ILE . 8.3 t-20 -68.23 -24.93 64.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 93' ' ' ASP . 8.5 t -73.19 -17.08 61.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.537 ' HE1' HG13 ' A' ' 94' ' ' ILE . 9.3 ptt? -109.68 -27.14 9.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 2.3 mtpt -42.73 138.65 2.21 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.591 ' HD3' ' CE2' ' A' ' 77' ' ' PHE . 46.0 Cg_endo -73.26 -160.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.094 1.576 . . . . 0.0 110.422 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.497 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 26.3 t -113.36 15.78 19.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 110.153 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 100' ' ' SER . 4.8 m-80 -155.02 104.95 2.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.2 p -137.33 -179.91 6.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.89 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.414 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -127.05 -5.54 6.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.52 -168.06 1.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.253 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.64 150.45 41.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 83' ' ' ILE . 45.1 t -116.37 142.6 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.209 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 106' ' ' VAL . 13.1 m -151.64 155.36 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.523 ' CG ' ' OD1' ' A' ' 110' ' ' ASN . 1.6 tp -89.28 142.2 27.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 132' ' ' ILE . 36.1 t80 -129.11 76.14 1.7 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.523 ' OD1' ' CG ' ' A' ' 108' ' ' LEU . 6.8 p-10 -176.9 166.24 1.42 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.7 Cg_endo -75.53 175.89 10.69 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.043 1.549 . . . . 0.0 110.296 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.0 Cg_endo -73.72 4.72 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.932 1.491 . . . . 0.0 110.489 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -122.36 -14.86 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.217 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.04 141.56 8.91 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 4.0 m -80.06 4.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -1.138 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 14.5 t70 178.01 169.4 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.237 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.563 ' CB ' ' CD ' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -179.8 -59.35 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 117' ' ' ASP . 46.9 Cg_endo -73.13 88.76 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.94 1.494 . . . . 0.0 110.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.525 ' CE1' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -65.78 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.942 . . . . 0.0 110.17 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.474 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 1.7 t80 66.66 -62.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 119' ' ' TYR . 52.4 p -70.47 144.73 51.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.465 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 5.5 p -80.89 48.59 1.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.72 42.45 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -159.65 -37.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.649 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 47.5 m-85 -52.15 -44.98 93.94 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -1.163 . . . . 0.0 110.572 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 46.8 Cg_endo -74.13 -59.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.685 1.36 . . . . 0.0 110.286 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -55.3 -43.12 74.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.722 ' O ' HG22 ' A' ' 132' ' ' ILE . 27.1 ttp -48.6 -80.55 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 1.152 ' CD2' HD12 ' A' ' 24' ' ' ILE . 6.1 t80 -49.01 -55.51 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.088 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -44.21 -28.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 110.513 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.8 m -88.85 -60.32 1.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.943 HG12 HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -50.46 -19.48 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.268 179.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 1.048 ' CB ' HD11 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -98.15 -48.68 5.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.894 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 1.9 mmmm -71.02 -2.71 16.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 110.131 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -122.15 5.22 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.839 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.673 ' HA ' ' HE3' ' A' ' 136' ' ' MET . 1.5 tpt -82.97 11.77 5.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.394 -0.816 . . . . 0.0 110.193 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.534 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 2.3 mmtt -90.51 -55.16 0.28 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.213 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 48.2 Cg_endo -76.26 -2.87 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CD1' ' CE ' ' A' ' 136' ' ' MET . 25.1 t80 -108.16 -51.92 2.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.259 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.721 HD22 ' SD ' ' A' ' 28' ' ' MET . 0.8 OUTLIER -71.67 -55.95 6.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.586 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 56.3 m -41.93 -36.71 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 110.468 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.22 -63.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.724 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -100.96 63.72 1.03 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.752 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -179.8 -32.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.015 ' HG ' HG22 ' A' ' 146' ' ' ILE . 0.6 OUTLIER 172.56 -91.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.472 -1.016 . . . . 0.0 109.864 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.015 HG22 ' HG ' ' A' ' 145' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.129 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.254 0.55 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 63.46 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.915 . . . . 0.0 110.265 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -120.94 157.12 30.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.349 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.568 ' HE3' ' CA ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -76.58 -175.31 3.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.293 -0.879 . . . . 0.0 109.05 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.759 ' CD ' HD12 ' A' ' 145' ' ' LEU . 33.0 mtpt -145.9 177.37 8.98 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.901 -1.124 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.061 ' HB1' HD11 ' A' ' 34' ' ' ILE . . . -145.77 124.4 12.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.066 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 18.7 t -114.43 125.37 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.965 HD11 ' HB2' ' A' ' 38' ' ' ALA . 50.2 tp -79.24 98.94 6.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 1.116 ' CD1' HG23 ' A' ' 35' ' ' ILE . 96.7 m-85 -85.98 104.63 15.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.893 HG22 ' HB3' ' A' ' 38' ' ' ALA . 3.8 t -103.11 149.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.659 ' SG ' HD22 ' A' ' 86' ' ' LEU . 24.2 m -127.08 -151.33 0.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.92 . . . . 0.0 110.021 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -87.12 -30.46 21.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -144.18 9.99 2.0 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.99 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 43.5 t-20 59.26 49.68 8.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 0.0 110.29 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 69' ' ' ALA . 15.3 mt -136.75 -57.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.2 t -124.37 -138.42 0.29 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.288 -0.883 . . . . 0.0 110.133 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.85 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.38 -55.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.392 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.76 ' HB2' HD21 ' A' ' 86' ' ' LEU . 1.3 m -161.08 53.65 0.49 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.477 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.0 Cg_endo -75.31 -23.78 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.031 1.542 . . . . 0.0 110.308 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.999 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . . . -78.49 6.82 7.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.976 ' HB3' HG21 ' A' ' 35' ' ' ILE . 6.0 t -61.24 -32.04 71.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.819 ' HA ' HD13 ' A' ' 35' ' ' ILE . 2.1 tt0 -56.03 -54.05 49.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -76.48 -39.31 30.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.969 HD12 ' CD2' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -53.87 -47.21 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.243 . . . . 0.0 110.037 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.897 ' CB ' HD11 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.28 -49.97 11.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 9.0 mtt180 -54.23 -31.0 52.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.68 -40.83 12.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.496 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.55 -30.95 70.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.701 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.789 ' CB ' HD21 ' A' ' 33' ' ' LEU . 83.1 t -124.72 -22.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.92 -82.4 0.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.462 ' C ' ' CG ' ' A' ' 32' ' ' LYS . 2.7 m-20 -149.76 68.14 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.261 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.77 ' O ' HD23 ' A' ' 33' ' ' LEU . 2.0 mtpm? -148.9 37.86 0.81 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 29' ' ' VAL . 0.4 OUTLIER 166.6 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.437 -0.789 . . . . 0.0 109.591 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.061 HD11 ' HB1' ' A' ' 6' ' ' ALA . 2.7 pp -42.59 168.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.116 HG23 ' CD1' ' A' ' 9' ' ' PHE . 4.7 mp -121.06 102.32 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 80' ' ' PHE . 9.4 m-20 -88.31 114.21 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.062 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.7 m -75.17 116.3 15.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.032 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.965 ' HB2' HD11 ' A' ' 8' ' ' LEU . . . -120.85 175.18 6.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.99 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -161.16 149.3 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 t -116.75 -2.45 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.09 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.28 170.81 13.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 110.145 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.52 50.15 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -17.36 32.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -1.165 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.443 ' O ' HD11 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -141.97 80.47 1.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 69' ' ' ALA . 86.5 t -134.44 146.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.07 58.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 48' ' ' SER . 1.3 pt20 -158.94 -146.79 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -1.147 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 65.12 99.68 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 100.89 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.083 1.57 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 1.6 t0 -89.72 26.83 1.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.547 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -76.32 -31.92 58.42 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.225 -0.922 . . . . 0.0 109.051 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -70.31 -49.7 46.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.262 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.531 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.3 t -63.35 -53.49 51.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.573 -0.704 . . . . 0.0 109.683 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.682 ' HB2' HD13 ' A' ' 64' ' ' ILE . 4.1 pp0? -61.04 -31.2 70.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.257 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -62.4 -66.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.383 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.557 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 35.7 m -52.79 -33.36 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.203 -0.935 . . . . 0.0 109.115 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.999 ' SG ' ' HB2' ' A' ' 20' ' ' ALA . 32.0 m -57.47 -53.07 62.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 109.508 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -23.17 63.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.99 -11.9 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 110.061 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.6 m-80 -112.44 -23.77 10.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.212 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 124.17 75.79 0.29 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.659 HG11 ' CB ' ' A' ' 20' ' ' ALA . 55.0 t -158.09 102.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -1.145 . . . . 0.0 110.205 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -78.34 74.26 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.988 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 54' ' ' GLN . 3.4 pt -60.1 -173.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -160.22 70.07 0.41 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.22 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 90.3 mm-40 -56.52 -60.0 4.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.218 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.38 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.269 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.644 ' HB2' HG12 ' A' ' 15' ' ' ILE . . . -60.59 131.4 50.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -140.44 152.23 45.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.245 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.06 144.18 38.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.195 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.592 HD12 ' HB1' ' A' ' 38' ' ' ALA . 19.7 tt -75.8 145.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.281 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.778 HG22 ' OD1' ' A' ' 76' ' ' ASP . 9.1 t -89.72 -146.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.13 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -118.6 -5.29 10.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.31 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.63 ' H ' HG23 ' A' ' 73' ' ' THR . . . -96.67 -8.43 31.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.778 ' OD1' HG22 ' A' ' 73' ' ' THR . 1.1 m-20 -45.1 -47.63 12.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.587 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 53.5 m-85 -48.61 -36.71 16.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.9 t -102.07 -16.04 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.16 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -66.25 -25.56 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.194 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.878 ' CE2' HD13 ' A' ' 8' ' ' LEU . 7.4 m-85 -132.28 169.6 16.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.1 -33.78 20.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.377 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' CD2' ' A' ' 143' ' ' HIS . 47.6 t -134.23 153.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.31 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.521 HG23 ' HB3' ' A' ' 8' ' ' LEU . 4.8 mt -129.75 128.3 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 109' ' ' PHE . . . -126.12 143.37 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.464 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -113.67 156.49 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.85 HD23 ' HB3' ' A' ' 17' ' ' ARG . 1.2 tp -85.3 -52.88 5.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 3.7 m-20 -99.56 -174.87 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.905 . . . . 0.0 110.244 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.58 -35.74 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -46.13 -41.27 12.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 87' ' ' ASP . 1.4 mp -71.02 -54.15 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.152 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -60.49 -15.81 30.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 t -93.26 -41.26 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.18 -16.88 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.182 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.543 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.3 tt -74.14 -40.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.168 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.524 ' N ' HG23 ' A' ' 94' ' ' ILE . 29.6 p30 -68.12 -9.76 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.65 -38.71 23.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.883 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.543 ' CE ' HG13 ' A' ' 94' ' ' ILE . 4.1 ptt? -84.1 -34.3 24.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.239 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -52.62 126.55 40.09 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 100' ' ' SER . 45.2 Cg_endo -73.39 -87.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.053 1.554 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 169.74 -23.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.4 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.84 43.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.128 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.8 p -99.47 -145.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.267 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 27.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.03 32.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.45 146.05 45.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 9.8 m -108.41 132.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' ALA . 22.6 m -131.27 156.51 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.256 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.427 ' HB2' HD13 ' A' ' 91' ' ' LEU . 26.4 tp -92.46 102.4 14.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.123 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.58 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . 4.9 t80 -81.09 82.61 6.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.134 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 7.7 t30 -170.09 142.16 1.84 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.497 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.5 Cg_endo -74.35 175.01 11.56 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.94 1.495 . . . . 0.0 110.35 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.02 52.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.977 1.514 . . . . 0.0 110.434 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.59 -37.18 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.206 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 101.54 2.51 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.474 HG23 ' OD1' ' A' ' 110' ' ' ASN . 71.4 t -57.66 98.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -1.209 . . . . 0.0 110.118 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.23 148.03 26.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 110.197 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 87.73 6.52 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.89 173.47 13.48 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.005 1.529 . . . . 0.0 110.406 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -115.75 161.92 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.23 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 50.38 41.65 25.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.155 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -150.89 -174.76 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.3 p -143.79 40.17 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.892 . . . . 0.0 110.174 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.32 54.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.56 ' HA2' ' CG2' ' A' ' 127' ' ' THR . . . -179.08 -32.84 0.06 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.623 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 8.1 m-85 -41.76 -50.29 10.05 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 110.731 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 43.4 Cg_endo -71.38 -74.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.81 1.426 . . . . 0.0 110.975 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.56 ' CG2' ' HA2' ' A' ' 124' ' ' GLY . 15.1 t -39.95 -40.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.168 -0.958 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.797 ' O ' HG22 ' A' ' 132' ' ' ILE . 9.6 ttp -55.17 -78.95 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.188 -0.945 . . . . 0.0 109.823 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.969 ' CD2' HD12 ' A' ' 24' ' ' ILE . 2.7 t80 -42.6 -51.29 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.167 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.441 ' N ' ' HD1' ' A' ' 129' ' ' PHE . . . -58.81 -22.41 58.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.5 t -90.32 -51.28 5.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.04 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.886 HD11 ' CB ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -61.8 -16.96 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.786 ' HB2' HD11 ' A' ' 24' ' ' ILE . 2.3 t -96.0 -51.05 4.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.557 -0.714 . . . . 0.0 109.849 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.22 -20.84 65.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.974 . . . . 0.0 110.111 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 131' ' ' SER . 0.2 OUTLIER -76.93 -30.17 55.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.587 ' CE ' ' HA ' ' A' ' 133' ' ' SER . 0.6 OUTLIER -77.57 5.23 9.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.209 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.538 ' CB ' ' HD3' ' A' ' 138' ' ' PRO . 3.0 mmtt -89.24 -54.65 0.31 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.35 -10.73 17.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.041 1.548 . . . . 0.0 110.426 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 32.9 t80 -102.17 -77.23 0.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.616 HD21 HD22 ' A' ' 33' ' ' LEU . 14.6 tp -40.81 -62.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.382 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.845 HG23 HD12 ' A' ' 146' ' ' ILE . 30.6 m -41.66 -29.13 0.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LEU . 3.3 mm-40 -101.59 -25.82 13.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 1.5 t60 -66.32 -21.66 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.02 36.42 0.18 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.759 HD12 ' CD ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -173.38 93.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 110.14 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.845 HD12 HG23 ' A' ' 141' ' ' THR . 4.2 tp . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.246 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.307 0.575 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 55.63 172.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.51 ' O ' ' CD2' ' A' ' 145' ' ' LEU . 2.2 mm-40 -99.97 168.04 10.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.04 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -80.47 171.2 15.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.309 -0.869 . . . . 0.0 108.762 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 9.4 mtpp -151.8 164.12 37.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.86 -1.15 . . . . 0.0 111.26 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.872 ' HA ' ' CG1' ' A' ' 34' ' ' ILE . . . -105.91 99.93 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.75 -0.593 . . . . 0.0 109.773 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 33' ' ' LEU . 12.6 t -104.01 108.35 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 38' ' ' ALA . 29.7 tp -92.56 111.04 22.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 1.071 ' CD1' HG23 ' A' ' 35' ' ' ILE . 12.5 m-85 -85.97 128.48 34.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.814 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.688 HG23 ' C ' ' A' ' 38' ' ' ALA . 10.9 p -143.37 172.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -0.981 . . . . 0.0 110.633 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.946 ' O ' HD12 ' A' ' 90' ' ' ILE . 16.8 t -153.6 -69.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 110.126 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 172.99 84.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.919 . . . . 0.0 110.285 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.67 ' H ' ' HB1' ' A' ' 39' ' ' ALA . . . 134.06 -31.67 2.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 6.4 t30 72.15 -0.15 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -1.183 . . . . 0.0 110.352 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.551 HG23 ' OG ' ' A' ' 48' ' ' SER . 23.4 mt -96.71 -85.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -85.27 44.17 1.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.613 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 9.7 mmt180 -115.73 69.14 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.849 ' OG ' HD21 ' A' ' 86' ' ' LEU . 16.5 m 44.18 57.29 13.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.9 . . . . 0.0 110.323 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HB3' ' OE1' ' A' ' 67' ' ' GLN . 43.7 Cg_endo -71.2 -13.18 30.88 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.971 1.511 . . . . 0.0 110.067 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.56 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -82.16 6.71 15.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.778 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.954 ' HB3' HG22 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -63.76 -38.78 92.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.647 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -66.57 -44.93 80.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.805 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.9 -54.65 13.44 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.634 ' CD1' ' CE1' ' A' ' 129' ' ' PHE . 4.8 tp -50.86 -44.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -1.174 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.707 ' HB2' HD12 ' A' ' 35' ' ' ILE . 5.8 t -71.31 -32.12 68.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -62.56 -55.42 27.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -34.11 66.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 110.492 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.56 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 6.1 ttm -73.05 -59.33 2.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG21 HD22 ' A' ' 140' ' ' LEU . 11.5 m -141.53 46.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 0.0 110.396 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . -59.59 78.14 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER 165.55 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -1.102 . . . . 0.0 110.123 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.914 ' HB3' HD11 ' A' ' 145' ' ' LEU . 11.6 mttp -139.42 112.93 8.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.737 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.989 HD22 ' HB3' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 77.54 65.02 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.043 0.925 . . . . 0.0 109.167 -179.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.872 ' CG1' ' HA ' ' A' ' 6' ' ' ALA . 2.6 pp -59.57 145.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.82 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.071 HG23 ' CD1' ' A' ' 9' ' ' PHE . 8.5 mt -119.31 89.87 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 69.1 m-20 -85.19 178.27 7.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 111.006 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 5.7 p -130.55 123.22 29.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.688 ' C ' HG23 ' A' ' 10' ' ' VAL . . . -133.06 -160.45 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.125 -0.985 . . . . 0.0 110.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.67 ' HB1' ' H ' ' A' ' 13' ' ' GLY . . . -171.55 144.43 1.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.524 ' OG1' HD22 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -81.3 -49.16 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.158 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.6 t -128.28 141.29 51.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.0 97.56 0.24 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.97 23.53 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.326 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.88 26.79 5.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 45' ' ' VAL . 16.0 m -64.96 125.27 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.258 -0.901 . . . . 0.0 110.304 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.68 34.0 0.62 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -101.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -1.114 . . . . 0.0 110.172 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 15' ' ' ILE . 2.9 t 61.26 71.69 0.76 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.206 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.51 66.42 1.62 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.0 1.526 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 21.5 m-20 -92.22 35.84 0.99 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 110.367 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -31.62 58.48 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mpt_? -73.94 -48.77 28.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.299 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -62.25 -48.21 80.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.459 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 0.0 OUTLIER -64.65 -36.37 84.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 109.262 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.3 ttpt -58.75 -64.74 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.258 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.579 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 9.0 p -54.81 -35.53 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.802 ' O ' HG22 ' A' ' 62' ' ' VAL . 4.3 m -53.51 -54.11 41.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.777 . . . . 0.0 109.411 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 54' ' ' GLN . 15.6 mtmt -69.03 -27.42 65.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 t -77.57 -14.08 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.89 -32.36 6.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.814 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 114.1 85.68 1.37 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.991 ' O ' HG23 ' A' ' 64' ' ' ILE . 2.5 m -162.65 87.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -1.084 . . . . 0.0 110.111 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -52.85 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.991 HG23 ' O ' ' A' ' 62' ' ' VAL . 1.2 pt -103.71 -158.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' HD12 ' A' ' 64' ' ' ILE . 68.7 m -144.75 -170.94 3.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.155 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 68' ' ' ARG . 21.2 mmtt -80.42 4.16 19.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 76.6 mm-40 59.75 -75.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 65.91 104.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 14' ' ' ASN . . . -61.43 113.13 2.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.433 ' CD ' ' O ' ' A' ' 71' ' ' GLN . 8.0 tmm_? -135.98 143.45 44.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.203 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.433 ' O ' ' CD ' ' A' ' 70' ' ' ARG . 1.6 tt0 -72.53 139.47 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.248 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.445 HD11 ' CB ' ' A' ' 76' ' ' ASP . 4.0 tt -95.46 136.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 178.79 6.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.47 4.05 33.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.88 -12.33 55.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 7.6 p-10 -49.97 -24.42 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.141 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.593 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.2 m-85 -75.83 -10.11 59.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 110.142 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.55 -45.48 4.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 80' ' ' PHE . 7.9 tptp -57.81 -51.2 70.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 11.8 m-85 -115.57 144.23 44.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.349 -0.845 . . . . 0.0 110.13 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.408 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 56.0 m-20 -91.32 -24.04 19.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 9.9 t -113.71 138.71 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.239 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.6 mt -137.54 115.38 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.066 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.497 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . . . -91.5 141.63 28.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.27 141.25 48.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.203 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.849 HD21 ' OG ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -73.33 -52.55 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -107.97 -178.92 3.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.03 -28.39 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.253 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.52 -59.8 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.182 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.946 HD12 ' O ' ' A' ' 11' ' ' CYS . 4.3 tt -51.39 -38.59 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.486 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -74.03 -27.52 60.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.479 ' O ' ' ND2' ' A' ' 95' ' ' ASN . 40.0 t -78.64 -29.38 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 0.0 110.2 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.98 -45.22 8.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.558 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.4 tt -48.45 -36.03 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 92' ' ' SER . 20.8 p30 -71.71 -8.99 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -77.72 -20.07 54.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.181 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.558 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.0 ptt? -102.78 -25.28 13.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.593 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -53.38 139.59 47.2 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.185 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.16 169.72 21.56 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.996 1.524 . . . . 0.0 110.415 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -71.58 -6.5 41.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.06 68.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.238 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 30.7 p -83.95 164.0 19.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.19 38.66 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 81' ' ' ASP . . . -157.61 161.42 38.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -122.73 132.41 54.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.9 . . . . 0.0 110.158 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.3 m -96.84 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.357 -0.839 . . . . 0.0 110.187 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 t -96.74 161.66 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.45 113.13 26.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 42.7 t80 -83.73 122.96 29.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.49 170.09 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.6 Cg_endo -75.8 175.62 11.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.026 1.54 . . . . 0.0 110.227 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.57 4.44 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.02 1.537 . . . . 0.0 110.514 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -54.3 -64.43 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 110.145 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.96 130.99 2.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 128' ' ' MET . 10.3 t -124.3 26.52 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 117' ' ' ASP . 1.0 OUTLIER -148.83 -40.91 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.243 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER 66.79 145.3 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.149 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 119' ' ' TYR . 45.9 Cg_endo -73.39 73.29 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 118' ' ' PRO . 26.0 m-85 51.22 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.271 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 121' ' ' SER . 1.7 t80 -152.13 94.53 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' TYR . 6.2 t 43.23 -145.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.465 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 15.1 m -70.25 -19.68 63.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.239 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 128' ' ' MET . . . 142.17 -71.5 0.4 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 3.2 m-85 -42.66 -48.6 13.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.149 . . . . 0.0 110.325 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -72.97 -55.0 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.671 1.353 . . . . 0.0 110.396 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 128' ' ' MET . 67.2 m -63.23 -53.26 55.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.186 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 124' ' ' GLY . 10.7 ttp -40.85 -70.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 66.7 t80 -58.31 -45.47 87.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -43.22 -67.32 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.869 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -65.12 -39.95 93.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.2 -0.938 . . . . 0.0 109.754 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -42.26 -42.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.819 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.554 ' CB ' HD11 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -98.26 -42.92 7.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.335 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 131' ' ' SER . 3.4 mmtt -47.5 -30.19 3.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.2 OUTLIER -105.65 -2.98 22.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.551 ' HB2' ' HA ' ' A' ' 133' ' ' SER . 0.8 OUTLIER -84.98 20.21 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.59 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -105.17 -65.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.153 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 48.3 Cg_endo -73.09 -1.54 10.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.753 1.396 . . . . 0.0 110.492 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.517 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 92.9 t80 -77.02 -76.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 110.339 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.989 ' HB3' HD22 ' A' ' 33' ' ' LEU . 3.1 pp -71.46 -33.51 69.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.297 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.513 HG23 HG22 ' A' ' 146' ' ' ILE . 85.8 m -57.13 -30.11 64.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 144' ' ' GLY . 5.0 mm-40 -104.81 -44.99 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.424 ' CD2' ' O ' ' A' ' 139' ' ' PHE . 14.9 m-70 -43.51 -25.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.068 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 126.96 66.8 0.15 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.914 HD11 ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -153.17 -45.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -1.106 . . . . 0.0 110.226 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.618 HD12 ' CD1' ' A' ' 140' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.254 0.55 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.01 85.71 6.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.898 . . . . 0.0 110.145 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.441 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -62.14 -147.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.266 -0.896 . . . . 0.0 110.363 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.572 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -160.68 -42.86 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 110.446 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 2.0 ptpt 37.43 -155.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.699 -0.626 . . . . 0.0 110.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.836 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -159.91 138.43 10.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.497 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.8 m -103.16 112.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.403 -0.811 . . . . 0.0 109.56 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -59.44 95.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.98 . . . . 0.0 110.328 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.9 OUTLIER -85.79 108.97 18.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.301 -0.874 . . . . 0.0 109.303 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.075 HG13 ' CD1' ' A' ' 90' ' ' ILE . 6.8 p -137.86 171.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 111.088 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.795 ' HA ' HD12 ' A' ' 90' ' ' ILE . 23.9 t -162.74 55.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.895 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.655 HD23 ' HB ' ' A' ' 90' ' ' ILE . 3.8 mm? 59.54 -158.55 0.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.888 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.74 86.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.61 ' N ' ' O ' ' A' ' 12' ' ' LEU . 1.7 p-10 -134.46 5.8 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -1.209 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.853 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.9 mt 57.47 31.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 110.747 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.555 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 50.4 m 53.55 117.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.123 -0.986 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.734 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -83.21 66.66 8.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.646 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -68.24 -44.94 38.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.789 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.661 ' HA ' HG21 ' A' ' 64' ' ' ILE . 47.0 Cg_endo -74.51 -2.9 13.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.712 1.375 . . . . 0.0 110.781 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.864 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -102.77 -62.27 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.183 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.556 ' SG ' ' CG ' ' A' ' 9' ' ' PHE . 95.4 m -76.52 -48.29 19.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -65.79 -34.19 77.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.801 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.827 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -73.73 -57.16 5.07 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.848 HG12 HG22 ' A' ' 132' ' ' ILE . 8.7 tp -54.22 -40.43 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -1.174 . . . . 0.0 110.075 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 8.5 t -75.43 -67.08 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 ptm180 -41.82 -33.53 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' CG ' ' A' ' 26' ' ' ARG . 5.8 t70 -85.18 -36.32 21.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.452 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.489 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 4.9 ttt -84.29 -0.23 51.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.445 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' A' ' 32' ' ' LYS . 21.2 t -130.13 -43.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.321 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.16 65.54 0.16 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 72.7 m-20 47.81 77.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -1.196 . . . . 0.0 110.282 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.596 ' HG3' HG12 ' A' ' 29' ' ' VAL . 23.6 mmtm -128.54 -137.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.148 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.763 ' O ' HG13 ' A' ' 34' ' ' ILE . 96.4 mt -140.93 -95.12 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.028 HD13 HD13 ' A' ' 140' ' ' LEU . 0.7 OUTLIER 41.79 18.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.597 -0.69 . . . . 0.0 111.234 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -157.95 144.08 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.761 -1.212 . . . . 0.0 110.798 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.945 ' O ' HD13 ' A' ' 8' ' ' LEU . 6.7 m-20 -146.54 105.0 3.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.4 p -68.63 125.74 27.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 110.52 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.049 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -127.2 -169.4 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 110.192 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG23 ' A' ' 10' ' ' VAL . . . -174.79 88.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.878 ' OG1' HD12 ' A' ' 72' ' ' ILE . 18.4 m -71.3 87.96 0.84 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.4 p -159.6 -50.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.1 48.49 25.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.54 -47.06 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -1.132 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.429 ' O ' HG13 ' A' ' 15' ' ' ILE . 49.5 m-70 -94.01 44.0 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.79 156.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 28.09 72.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 48' ' ' SER . 4.3 pt20 -170.34 -147.35 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -1.124 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.441 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER 61.06 108.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.6 Cg_endo -69.59 99.62 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.513 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -90.5 27.76 1.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.153 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.4 m -74.95 -27.87 60.36 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.268 -0.895 . . . . 0.0 109.043 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.672 ' O ' HG22 ' A' ' 56' ' ' VAL . 11.0 mmt180 -73.48 -51.41 17.23 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.361 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 9.6 p -62.7 -50.85 69.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.781 . . . . 0.0 109.608 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HA ' ' CD1' ' A' ' 64' ' ' ILE . 1.1 tt0 -61.43 -39.39 90.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.256 -0.903 . . . . 0.0 109.31 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -59.23 -70.12 0.17 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 109.59 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 52' ' ' ARG . 35.8 m -48.82 -32.7 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.955 . . . . 0.0 109.19 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 62' ' ' VAL . 1.2 m -58.41 -52.48 65.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.845 . . . . 0.0 109.491 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -24.41 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.5 t -86.01 -10.78 54.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 8.8 m120 -114.93 -32.32 5.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.775 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 140.88 86.08 0.1 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.827 HG13 ' HA3' ' A' ' 23' ' ' GLY . 20.8 t -161.5 138.37 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -1.102 . . . . 0.0 110.058 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -103.11 95.94 6.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.284 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.661 HG21 ' HA ' ' A' ' 19' ' ' PRO . 6.3 pt -137.52 -171.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 p -176.91 -40.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 110.273 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 140.88 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.56 133.58 0.62 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -89.43 -141.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.106 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.23 153.2 31.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.51 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -141.18 -148.37 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.51 ' N ' ' HG3' ' A' ' 70' ' ' ARG . 7.6 tt0 -136.09 162.25 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.952 . . . . 0.0 110.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.878 HD12 ' OG1' ' A' ' 40' ' ' THR . 14.9 mt -77.1 -72.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.156 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER 65.78 -145.59 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -100.39 -14.44 18.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.42 74.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.883 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -53.53 -46.71 70.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.188 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.606 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 26.2 m-85 -67.23 60.57 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.032 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER 169.71 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.933 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 2.8 tptt -73.48 -1.31 17.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.825 ' CD1' ' HB3' ' A' ' 6' ' ' ALA . 79.8 m-85 -154.97 -153.1 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -130.25 -13.69 3.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 0.0 110.79 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.637 ' CB ' HG12 ' A' ' 7' ' ' VAL . 58.8 t -133.72 157.62 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.675 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 8' ' ' LEU . 1.7 mp -145.54 115.93 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.476 -0.765 . . . . 0.0 109.511 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.14 132.01 52.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 111.134 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 1.034 ' HB1' HG23 ' A' ' 90' ' ' ILE . . . -108.35 124.87 51.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.497 -0.752 . . . . 0.0 109.687 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.663 HD22 ' HB2' ' A' ' 11' ' ' CYS . 5.4 mp -58.14 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' ILE . 67.8 m-20 -67.8 -175.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.438 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' SER . 16.2 mt-30 -84.28 -43.36 14.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -43.12 -56.48 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.075 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.075 ' CD1' HG13 ' A' ' 10' ' ' VAL . 4.8 tt -49.81 -41.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.586 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -71.15 -41.13 70.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 t -62.75 -37.89 88.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -0.92 . . . . 0.0 110.216 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.4 OUTLIER -85.57 -55.72 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.586 ' CG2' ' HA ' ' A' ' 91' ' ' LEU . 12.9 tt -44.83 -42.79 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 110.184 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.567 ' N ' HG23 ' A' ' 94' ' ' ILE . 20.1 t-20 -75.55 -11.78 60.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' ASP . 11.0 t -95.69 6.54 48.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.592 ' HE2' ' CZ ' ' A' ' 77' ' ' PHE . 2.4 ptt? -128.83 -32.31 2.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.243 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.606 ' CE ' ' CD1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -42.63 150.78 0.41 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.291 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.03 1.542 . . . . 0.0 110.411 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.07 29.05 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 80.22 1.43 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.9 p -155.4 -174.28 4.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 110.196 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.458 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -139.65 48.91 1.81 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.46 178.61 4.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.87 137.56 48.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.69 130.39 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 108' ' ' LEU . 1.2 p -129.79 171.35 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.92 . . . . 0.0 110.279 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.561 ' N ' ' CG2' ' A' ' 107' ' ' VAL . 22.4 tp -105.69 156.1 18.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 110.167 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 43.0 t80 -149.4 106.81 3.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.962 . . . . 0.0 110.219 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' PHE . 0.7 OUTLIER -171.16 106.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 115' ' ' VAL . 47.6 Cg_endo -74.49 175.82 10.52 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.119 1.589 . . . . 0.0 110.266 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.8 Cg_endo -71.53 54.24 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.926 1.487 . . . . 0.0 110.484 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.62 -40.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.147 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.3 133.0 6.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.582 HG22 ' CB ' ' A' ' 131' ' ' SER . 5.5 t -121.34 -9.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -1.118 . . . . 0.0 110.177 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 1.5 p30 -55.93 133.12 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.92 109.98 31.7 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 116' ' ' ASP . 47.0 Cg_endo -73.68 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.978 1.515 . . . . 0.0 110.496 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.581 ' O ' ' CG ' ' A' ' 119' ' ' TYR . 50.2 t80 -154.39 36.92 0.42 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -119.8 -11.47 9.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 123' ' ' ASP . 0.4 OUTLIER 174.95 166.55 0.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 74.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.241 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 121' ' ' SER . 1.0 OUTLIER -125.57 0.22 7.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 110.232 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -115.85 -44.09 0.65 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.657 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 8.6 m-85 -44.58 -47.96 27.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.186 -1.185 . . . . 0.0 110.358 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.657 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.7 Cg_endo -72.91 -51.72 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.72 1.379 . . . . 0.0 110.201 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.7 m -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.864 ' CE ' ' HB2' ' A' ' 20' ' ' ALA . 9.3 ttp -42.1 -65.9 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.106 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.668 ' CE1' HD13 ' A' ' 24' ' ' ILE . 44.9 t80 -56.12 -45.31 79.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -44.64 -62.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.582 ' CB ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -59.14 -47.61 84.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.848 HG22 HG12 ' A' ' 24' ' ' ILE . 4.3 mm -42.14 -65.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.868 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.715 ' CB ' HD11 ' A' ' 24' ' ' ILE . 1.7 p -71.35 -21.73 62.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -0.828 . . . . 0.0 110.43 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 2.7 tttp -63.5 -34.7 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.025 . . . . 0.0 110.109 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -132.22 66.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.328 -0.857 . . . . 0.0 110.442 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.53 ' CE ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -118.22 -5.29 10.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 110.08 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.0 mttt -87.48 -49.67 0.45 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 110.382 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -77.45 -8.08 17.11 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.888 1.467 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.698 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 10.7 t80 -88.08 -50.17 6.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.028 HD13 HD13 ' A' ' 34' ' ' ILE . 28.2 tp -82.12 -30.09 31.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.507 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 54.9 m -71.01 -24.06 62.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.966 . . . . 0.0 110.328 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -104.06 -44.16 5.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.913 . . . . 0.0 110.208 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.698 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 0.3 OUTLIER -45.68 -39.11 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.273 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.573 ' C ' HD12 ' A' ' 145' ' ' LEU . . . 148.06 53.43 0.02 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.688 HD22 HD11 ' A' ' 140' ' ' LEU . 0.6 OUTLIER -160.6 -98.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.168 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.507 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 1.5 tp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.193 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.201 0.524 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.69 175.76 5.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.252 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.05 160.73 14.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.33 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -73.04 -159.47 0.06 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 108.725 178.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.757 ' H ' HG22 ' A' ' 34' ' ' ILE . 22.7 mttp -158.13 -164.29 1.47 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 110.62 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.021 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.93 119.43 8.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 110.803 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.957 ' HB ' HD12 ' A' ' 34' ' ' ILE . 5.8 t -114.14 121.55 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.543 -0.723 . . . . 0.0 109.79 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.861 HD21 ' CB ' ' A' ' 38' ' ' ALA . 3.6 tp -97.52 86.75 3.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.247 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 7.5 p90 -72.92 143.58 47.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.977 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.005 HG13 ' O ' ' A' ' 38' ' ' ALA . 46.9 t -142.83 155.68 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 110.28 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.938 ' HB2' HD22 ' A' ' 86' ' ' LEU . 8.1 t -139.56 -60.68 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 110.128 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 -55.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.176 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -131.79 21.44 4.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER 64.8 21.46 12.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -1.13 . . . . 0.0 110.265 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.458 HD11 ' HA ' ' A' ' 45' ' ' VAL . 10.2 mt -121.47 -27.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.179 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -106.1 123.8 48.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.127 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.843 ' HD2' HD23 ' A' ' 86' ' ' LEU . 40.4 mtt180 66.91 -53.97 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.617 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -42.1 -51.56 10.27 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.027 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.2 Cg_endo -72.35 -7.08 20.3 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.816 1.429 . . . . 0.0 110.563 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.62 ' C ' HD13 ' A' ' 132' ' ' ILE . . . -93.39 -21.17 19.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.598 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 16.8 t -70.05 -55.53 9.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.516 ' HG3' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -44.28 -37.04 3.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.437 -0.789 . . . . 0.0 109.43 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.94 -52.57 8.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.899 HD11 ' HB2' ' A' ' 133' ' ' SER . 2.8 tp -55.06 -34.29 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -1.23 . . . . 0.0 109.941 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 34' ' ' ILE . 1.4 m -73.14 -52.79 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 110.04 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -31.02 63.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -87.95 -58.61 2.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.087 -1.008 . . . . 0.0 110.088 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.7 OUTLIER -50.74 -27.05 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.701 HG12 ' HD3' ' A' ' 32' ' ' LYS . 6.7 t -105.82 -33.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 110.223 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.45 -68.39 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -174.65 38.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -1.157 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.701 ' HD3' HG12 ' A' ' 29' ' ' VAL . 4.1 mptp? -75.07 -113.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 35' ' ' ILE . 80.2 mt -152.92 -107.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.932 -1.105 . . . . 0.0 110.26 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.021 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 33.46 31.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 111.653 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -102.24 102.43 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 110.112 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.616 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 50.5 m-20 -135.84 140.67 44.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 110.02 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.576 ' CB ' ' CE1' ' A' ' 9' ' ' PHE . 10.2 t -124.17 143.4 50.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.482 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.005 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -146.21 167.53 23.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -154.98 154.53 32.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -134.76 80.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 t -170.02 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.17 32.57 4.28 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -114.72 -36.38 4.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.128 . . . . 0.0 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 48' ' ' SER . 2.0 t60 -122.61 84.3 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.231 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.101 HG13 ' HB3' ' A' ' 69' ' ' ALA . 46.1 t -146.15 135.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.86 76.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' NE2' ' HA ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -164.37 51.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.382 -1.069 . . . . 0.0 110.192 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.487 ' OG ' ' NE2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -154.79 129.53 4.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.53 106.67 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.971 1.511 . . . . 0.0 110.4 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.546 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.3 p-10 -90.82 22.49 3.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 2.8 m -71.98 -28.16 63.23 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.22 -0.925 . . . . 0.0 108.794 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.605 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 5.0 mmt180 -74.5 -45.23 47.26 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -63.57 -53.64 48.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 19.8 mt-30 -61.95 -41.44 97.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.323 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.7 ttpp -55.2 -69.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 109.485 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.56 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 37.4 t -48.28 -36.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.873 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.547 -0.721 . . . . 0.0 109.513 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -24.55 61.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.383 -0.823 . . . . 0.0 109.481 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -81.27 -13.06 58.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.503 ' ND2' HG13 ' A' ' 56' ' ' VAL . 16.9 m-80 -111.91 -31.04 7.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.291 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 119.5 94.56 1.54 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.873 HG11 ' SG ' ' A' ' 57' ' ' CYS . 9.8 p -178.71 151.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -1.114 . . . . 0.0 110.065 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -127.3 140.78 51.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.247 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.434 ' CD1' ' HG2' ' A' ' 54' ' ' GLN . 7.4 pt -124.73 163.58 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.139 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -112.27 -34.14 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 110.223 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' C ' ' CD ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -166.88 150.33 6.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.261 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 50' ' ' ASP . 1.6 mt-30 -132.16 74.85 1.6 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 110.28 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 68' ' ' ARG . 33.5 ttp85 -126.29 111.14 14.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.101 ' HB3' HG13 ' A' ' 45' ' ' VAL . . . -53.8 144.44 18.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.187 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.99 39.38 0.84 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' CA ' ' OE1' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 54.46 -164.15 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.267 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.564 HD12 ' HB1' ' A' ' 38' ' ' ALA . 15.4 tt -121.93 -39.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.504 ' N ' HG23 ' A' ' 72' ' ' ILE . 1.0 OUTLIER 63.72 157.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -67.37 -23.6 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.214 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 79' ' ' LYS . . . -58.77 -26.69 64.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.269 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.554 ' HB2' HD22 ' A' ' 8' ' ' LEU . 24.6 p-10 -48.31 -34.75 11.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 44.7 m-85 -73.14 -39.09 65.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.242 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.52 -52.85 4.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -44.85 -26.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.214 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.58 ' CD1' ' OD2' ' A' ' 36' ' ' ASP . 9.3 m-85 -134.2 172.58 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.68 -20.26 9.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 58.4 t -125.56 139.15 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.9 . . . . 0.0 110.361 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 107' ' ' VAL . 1.4 mp -123.67 144.23 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 110.082 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.783 ' HB1' ' CD2' ' A' ' 109' ' ' PHE . . . -123.05 118.8 28.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.88 116.97 32.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.091 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.938 HD22 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mp -62.86 -85.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.426 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.409 ' N ' HD12 ' A' ' 90' ' ' ILE . 79.2 m-20 -73.53 -177.63 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 89' ' ' SER . 14.1 mt-30 -79.05 -40.85 30.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 110.183 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 4.3 m -42.02 -40.37 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.298 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.511 HD11 ' O ' ' A' ' 11' ' ' CYS . 3.8 mt -69.36 -48.14 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.56 -41.63 97.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 t -73.47 -40.41 64.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 96' ' ' SER . 82.9 m-20 -65.52 -61.97 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.594 HG23 ' N ' ' A' ' 95' ' ' ASN . 3.7 tt -42.71 -43.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.11 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.594 ' N ' HG23 ' A' ' 94' ' ' ILE . 3.0 t-20 -61.88 -33.03 73.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.973 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -67.47 -13.59 62.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.446 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 4.4 ptt? -122.34 -24.79 4.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 110.143 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 94' ' ' ILE . 0.3 OUTLIER -43.09 140.48 1.99 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -159.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.06 1.558 . . . . 0.0 110.397 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 m -129.37 3.99 5.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -152.38 88.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.4 p -144.32 -169.46 3.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.04 48.4 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 77' ' ' PHE . . . -131.61 164.77 25.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 33.8 tttt -123.58 160.51 26.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.163 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.84 106.94 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 83' ' ' ILE . 26.7 m -109.69 143.71 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.613 HD12 HD22 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -83.8 114.8 21.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.783 ' CD2' ' HB1' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -50.13 -69.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.953 . . . . 0.0 110.172 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.448 ' HB3' ' HD2' ' A' ' 111' ' ' PRO . 13.3 m-80 -147.19 166.91 14.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.495 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.6 Cg_endo -74.49 174.94 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.966 1.508 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.3 Cg_endo -72.86 52.81 2.23 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.921 1.485 . . . . 0.0 110.481 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -149.1 -36.86 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.07 -96.99 0.04 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.865 HG12 ' HB2' ' A' ' 131' ' ' SER . 4.7 m -62.67 136.65 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -1.139 . . . . 0.0 110.309 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.77 149.46 14.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -168.29 108.04 0.55 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 46.5 Cg_endo -73.15 -1.0 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 118' ' ' PRO . 1.2 m-85 61.31 24.83 14.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -126.88 -38.23 2.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.28 -176.01 3.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 122' ' ' SER . 1.8 t -87.6 22.67 2.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 0.0 110.166 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.32 62.34 5.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.73 -31.31 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.605 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 8.9 m-85 -56.4 -54.02 57.73 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.326 -1.103 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.6 Cg_endo -71.88 -43.39 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.867 1.456 . . . . 0.0 110.375 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.483 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 2.7 m -62.81 -35.73 80.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.58 ' HG2' ' N ' ' A' ' 129' ' ' PHE . 25.6 ttp -52.51 -69.97 0.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.9 . . . . 0.0 109.92 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.632 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 30.7 t80 -62.93 -30.9 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.702 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -56.98 -35.91 69.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.977 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.865 ' HB2' HG12 ' A' ' 115' ' ' VAL . 5.6 m -87.29 -42.76 12.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.62 HD13 ' C ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -56.47 -27.25 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.805 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.899 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -102.06 -40.58 6.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.407 -0.808 . . . . 0.0 110.201 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -76.35 -4.91 44.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 131' ' ' SER . 6.0 mm-40 -126.19 18.82 7.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.503 ' HG3' ' O ' ' A' ' 136' ' ' MET . 1.8 tpt -96.17 7.97 45.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.349 -0.845 . . . . 0.0 110.245 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -86.59 -49.09 0.5 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.298 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.95 7.4 4.35 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.874 1.46 . . . . 0.0 110.591 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.603 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 5.6 t80 -107.96 -51.19 2.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.355 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 146' ' ' ILE . 4.2 tt -83.51 -15.04 50.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.339 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.942 HG23 ' OXT' ' A' ' 146' ' ' ILE . 24.7 m -82.8 -28.05 30.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -105.14 -25.48 12.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.286 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.603 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -52.74 -18.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 115.75 51.81 0.41 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 144' ' ' GLY . 11.9 mt -143.41 -52.78 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.942 ' OXT' HG23 ' A' ' 141' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.229 0.538 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.07 113.88 25.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -87.95 154.28 20.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.113 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.582 ' C ' ' CG ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -80.9 -55.42 4.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.545 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' CG ' ' C ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER 35.21 -155.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.729 . . . . 0.0 110.541 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.88 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . . . -166.12 156.53 12.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 0.0 109.958 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG1' ' HB2' ' A' ' 84' ' ' ALA . 89.0 t -120.92 103.51 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.908 . . . . 0.0 109.903 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.729 ' HB3' HG23 ' A' ' 83' ' ' ILE . 16.6 tp -59.48 94.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 110.026 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.491 ' CE2' ' SD ' ' A' ' 136' ' ' MET . 0.4 OUTLIER -78.31 103.89 8.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.93 . . . . 0.0 109.818 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.828 HG13 ' O ' ' A' ' 38' ' ' ALA . 61.3 t -124.67 161.75 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.445 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.73 ' CB ' HD22 ' A' ' 86' ' ' LEU . 39.3 t -165.14 64.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 6.9 mt 57.09 33.59 23.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 147.0 -32.34 1.42 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 65.3 7.62 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -1.138 . . . . 0.0 110.102 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.7 HD13 ' OG ' ' A' ' 48' ' ' SER . 44.6 mt -96.51 -5.51 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 110.353 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 35.6 m -144.43 -173.25 3.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.456 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.674 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.9 mmt85 64.49 -78.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.556 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 86' ' ' LEU . 9.1 m -129.83 55.66 19.87 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 110.699 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 18' ' ' SER . 49.6 Cg_endo -79.79 0.57 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.987 1.519 . . . . 0.0 110.004 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -96.0 6.8 48.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.425 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 9.1 p -58.78 -35.54 72.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.803 ' HB3' HG23 ' A' ' 64' ' ' ILE . 1.4 tp10 -65.43 -48.54 72.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.67 -0.644 . . . . 0.0 109.866 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.583 ' CA ' ' CG1' ' A' ' 62' ' ' VAL . . . -69.83 -57.8 6.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 132' ' ' ILE . 5.3 tp -47.44 -43.47 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -1.163 . . . . 0.0 109.922 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.616 ' HB2' HD13 ' A' ' 35' ' ' ILE . 7.3 t -65.33 -51.53 59.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.412 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 15.3 mmt-85 -52.62 -40.62 62.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.145 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -76.0 -30.51 58.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.48 -57.96 3.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.485 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.745 HG11 ' HB2' ' A' ' 32' ' ' LYS . 61.9 t -87.09 -18.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.552 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 104.4 -66.91 0.29 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 53.8 t0 -176.25 57.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -1.13 . . . . 0.0 110.111 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.858 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.79 -100.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 32' ' ' LYS . 21.3 mt -143.95 -125.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.851 HG23 ' C ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER 70.81 -17.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.987 -0.446 . . . . 0.0 111.102 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -136.83 144.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.808 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.726 ' HB3' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -155.35 94.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -63.82 125.92 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 110.116 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.828 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -149.76 170.43 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.552 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.801 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -138.72 145.37 40.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.053 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.583 ' HA ' HG22 ' A' ' 72' ' ' ILE . 8.2 t -118.67 -9.65 10.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 110.31 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 t -112.36 109.48 19.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -55.97 101.58 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 2.5 m-85 -162.12 160.43 27.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -1.169 . . . . 0.0 110.264 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 63.19 25.21 14.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.6 t -85.25 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 37.68 6.37 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 48' ' ' SER . 4.3 pt20 179.59 -108.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -1.118 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.7 ' OG ' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 65.6 93.62 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.074 -1.016 . . . . 0.0 110.184 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 45.1 Cg_endo -69.11 -62.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.672 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 2.8 m-20 71.46 -5.95 1.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.241 -0.912 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -74.32 -27.54 60.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.177 -0.952 . . . . 0.0 108.975 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -52.85 12.52 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.336 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -61.57 -53.69 52.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -57.98 -42.46 85.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -51.85 -65.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.901 HG21 ' HA ' ' A' ' 125' ' ' PHE . 53.0 t -49.46 -35.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 109.113 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.526 ' SG ' ' CG1' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -57.27 -46.71 82.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.57 -0.706 . . . . 0.0 109.642 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -79.63 -17.86 52.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.509 ' HB2' ' CE ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -88.95 -12.25 42.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -116.37 -24.17 8.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.586 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.59 ' C ' HG23 ' A' ' 62' ' ' VAL . . . 117.21 62.34 0.31 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.59 HG23 ' C ' ' A' ' 61' ' ' GLY . 46.0 t -155.63 170.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' N ' HG12 ' A' ' 62' ' ' VAL . 58.6 t0 -157.02 121.21 4.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 110.267 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 22' ' ' GLU . 18.1 mt -108.82 170.62 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.147 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -106.39 -68.69 0.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -145.08 128.02 16.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 10.7 pt20 -142.26 98.43 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.217 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HA ' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -140.05 -162.69 1.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.174 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.87 123.65 50.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.229 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.78 33.02 1.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 60.02 158.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 76' ' ' ASP . 21.0 tt -138.87 152.5 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -112.57 -163.92 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 77' ' ' PHE . 4.1 mttp -69.7 -5.21 23.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.16 81.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.0 110.124 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.799 ' HB3' HD11 ' A' ' 72' ' ' ILE . 38.4 p-10 -47.84 -31.46 5.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 74' ' ' LYS . 13.1 m-85 -72.45 -25.74 61.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.0 p -127.29 41.86 3.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.202 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' CG ' ' CE2' ' A' ' 80' ' ' PHE . 37.8 tptt -123.19 -13.52 7.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.88 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 97.5 m-85 -151.74 -122.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 65.4 t0 -151.59 -40.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.045 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.76 HG11 ' HZ ' ' A' ' 139' ' ' PHE . 81.7 t -127.04 152.84 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.169 -0.957 . . . . 0.0 110.47 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 8' ' ' LEU . 1.7 mp -131.71 134.06 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 110.022 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -104.49 127.87 52.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.551 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.68 105.74 15.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.73 HD22 ' CB ' ' A' ' 11' ' ' CYS . 2.2 mp -50.36 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.505 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.422 ' C ' HD12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -81.5 -177.4 6.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.37 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -85.44 -40.8 16.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.37 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -41.67 -38.43 1.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.873 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.5 mp -69.62 -55.63 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.185 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.0 HD22 HD23 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -58.1 -28.74 64.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 t -78.39 -41.91 31.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 5.6 m-20 -80.92 -60.15 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.29 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 90' ' ' ILE . 4.7 tt -49.87 -25.3 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.301 -0.875 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 58.4 t-20 -90.37 -22.87 21.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.208 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -6.59 28.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.456 ' HE2' ' O ' ' A' ' 94' ' ' ILE . 6.2 mtm -108.81 -51.67 2.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.568 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -40.47 132.6 1.67 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.412 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 100' ' ' SER . 46.4 Cg_endo -73.51 0.66 7.79 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.06 1.558 . . . . 0.0 110.502 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER 68.02 19.22 9.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.131 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.12 67.76 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 95.4 m -132.21 -159.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.41 25.83 10.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.27 -175.46 3.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.89 . . . . 0.0 110.192 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.37 158.2 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 110.181 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.539 HG12 HD12 ' A' ' 91' ' ' LEU . 19.3 t -127.13 124.58 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.139 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -122.17 144.0 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.0 HD23 HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -77.11 133.81 38.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 110.173 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.605 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 1.9 m-85 -106.44 127.44 53.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.315 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 109' ' ' PHE . 0.9 OUTLIER 64.54 176.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.2 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -74.83 175.3 11.36 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 110.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.9 Cg_endo -72.26 53.86 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.051 1.553 . . . . 0.0 110.433 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.88 -38.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.03 145.12 11.19 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.557 HG11 ' CB ' ' A' ' 131' ' ' SER . 18.5 m -70.34 153.84 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -1.105 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.456 ' CB ' HG21 ' A' ' 127' ' ' THR . 42.9 t0 -42.09 134.58 2.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.369 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.8 p-10 -94.94 113.1 60.53 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.534 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 46.3 Cg_endo -73.7 58.31 3.91 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.936 1.492 . . . . 0.0 110.616 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 121' ' ' SER . 3.7 t80 -117.03 142.61 46.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.095 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.512 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 49.1 t80 61.0 -73.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.196 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 119' ' ' TYR . 2.2 m -89.89 118.33 29.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.84 89.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.77 9.64 1.55 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.258 -0.901 . . . . 0.0 110.183 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -118.88 -22.24 3.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.901 ' HA ' HG21 ' A' ' 56' ' ' VAL . 2.8 m-85 -34.1 -59.34 0.54 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.521 -0.988 . . . . 0.0 110.49 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 46.0 Cg_endo -72.12 -52.48 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.869 1.457 . . . . 0.0 110.318 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.456 HG21 ' CB ' ' A' ' 116' ' ' ASP . 8.8 m -58.18 -57.66 11.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.375 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.572 ' CE ' ' HB2' ' A' ' 20' ' ' ALA . 8.1 ttp -40.31 -48.85 2.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.612 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 48.7 t80 -70.17 -62.1 1.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 129' ' ' PHE . . . -43.05 -56.39 3.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.557 ' CB ' HG11 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -60.88 -45.07 96.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.926 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -46.76 -47.52 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.592 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 134' ' ' LYS . 0.4 OUTLIER -78.85 -59.26 2.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.297 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.498 ' N ' ' OG ' ' A' ' 133' ' ' SER . 3.2 mmtt -45.19 -29.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 131' ' ' SER . 27.0 mt-10 -74.97 -31.55 61.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.203 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.551 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 18.0 mtm -103.48 9.32 37.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 6.5 mtpt -82.28 -48.74 0.88 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 51.5 Cg_endo -81.11 -9.07 12.94 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.148 1.604 . . . . 0.0 110.402 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.76 ' HZ ' HG11 ' A' ' 82' ' ' VAL . 47.4 t80 -107.97 -77.96 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.061 ' CD1' HD22 ' A' ' 145' ' ' LEU . 13.8 tp -44.03 -24.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 11.8 m -87.07 -29.13 22.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 110.353 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 139' ' ' PHE . 4.7 mm-40 -105.2 -13.9 15.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.405 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.68 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 4.6 t60 -84.94 40.27 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.64 38.08 90.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.061 HD22 ' CD1' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.8 -31.08 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.106 . . . . 0.0 110.305 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 18.2 mm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.228 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.262 0.553 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.47 -54.19 46.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.174 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.2 158.22 29.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.078 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.406 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -79.68 -162.54 0.43 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.534 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 34' ' ' ILE . 18.5 mttt -148.44 -164.5 2.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.783 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -130.74 148.92 52.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.183 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 34' ' ' ILE . 5.5 m -147.06 136.87 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.945 -1.097 . . . . 0.0 110.226 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.9 OUTLIER -89.65 118.31 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 0.0 110.945 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.497 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m-85 -93.85 96.06 9.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.555 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.534 ' CG2' HD23 ' A' ' 8' ' ' LEU . 16.0 t -100.65 156.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.444 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.491 ' CB ' ' OG ' ' A' ' 18' ' ' SER . 47.8 t -150.0 -65.9 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.015 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER 177.05 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.174 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 85.92 -4.75 85.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.963 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 8.7 t30 59.7 29.87 19.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -1.158 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.925 HD13 ' HB2' ' A' ' 48' ' ' SER . 26.9 mt -113.0 -20.4 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 110.376 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 18' ' ' SER . 9.6 p -131.59 132.77 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.859 ' CB ' HD23 ' A' ' 86' ' ' LEU . 3.7 mtm180 65.46 -59.56 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.196 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.632 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -44.83 -50.7 24.6 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.428 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.6 Cg_endo -72.13 -19.97 25.57 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.848 1.446 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.569 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -69.78 -23.56 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.98 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.996 ' HA ' HD11 ' A' ' 132' ' ' ILE . 21.4 m -67.39 -32.88 74.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.863 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.738 ' HA ' HD11 ' A' ' 35' ' ' ILE . 1.6 tt0 -57.77 -54.89 41.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.912 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.697 ' HA3' HG22 ' A' ' 62' ' ' VAL . . . -67.09 -45.95 77.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.873 HD12 ' CE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -54.66 -54.36 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -1.202 . . . . 0.0 110.191 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.702 ' N ' HG22 ' A' ' 24' ' ' ILE . 79.4 m -60.29 -50.8 72.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.036 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.51 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 25.5 mtt-85 -45.82 -52.63 10.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.22 -20.0 60.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.57 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.07 -45.82 32.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.831 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.554 ' CG1' ' HB3' ' A' ' 32' ' ' LYS . 63.1 t -137.05 -12.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.034 . . . . 0.0 111.258 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 29' ' ' VAL . . . 59.31 122.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' GLY . 11.8 t0 40.42 77.36 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.187 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.74 ' HG3' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -131.05 11.19 5.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.547 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' ILE . 17.8 mt 65.01 -63.05 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.285 -0.884 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.963 HD12 ' N ' ' A' ' 35' ' ' ILE . 2.5 pp -27.39 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.454 -0.779 . . . . 0.0 111.047 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.963 ' N ' HD12 ' A' ' 34' ' ' ILE . 7.8 tt -64.03 87.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 121.368 -0.832 . . . . 0.0 111.079 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 18.6 m-20 -126.83 66.82 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 109.692 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.28 150.07 18.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 110.397 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -163.9 -171.62 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.963 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -150.17 120.9 7.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.578 ' HA ' HG21 ' A' ' 72' ' ' ILE . 10.8 t -67.06 -39.45 86.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.519 ' N ' HG23 ' A' ' 40' ' ' THR . 3.3 t -127.87 133.02 49.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . -67.76 -79.9 0.23 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 66.05 -73.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.526 ' HB3' HD12 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -90.15 91.06 8.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 46' ' ' GLY . 50.4 t -130.29 173.28 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 110.137 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.566 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 57.97 18.35 33.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.632 ' O ' ' CB ' ' A' ' 48' ' ' SER . 3.1 pt20 -177.68 152.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -1.124 . . . . 0.0 110.168 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.925 ' HB2' HD13 ' A' ' 15' ' ' ILE . 2.2 t 159.12 105.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.263 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 47.4 Cg_endo -69.78 70.78 1.57 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.104 1.581 . . . . 0.0 110.28 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.5 p30 -83.92 16.32 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.9 m -75.53 -32.58 60.52 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.185 -0.947 . . . . 0.0 109.007 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.638 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -74.1 -55.74 5.74 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.294 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -58.67 -53.43 58.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.454 -0.778 . . . . 0.0 109.501 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.93 ' HG3' HD11 ' A' ' 64' ' ' ILE . 12.1 tt0 -57.51 -45.56 84.82 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.25 -0.906 . . . . 0.0 109.508 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 1.2 ttpp -50.83 -65.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.422 -0.799 . . . . 0.0 109.793 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.573 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 11.3 p -56.55 -34.0 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.633 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.711 ' CB ' HG21 ' A' ' 62' ' ' VAL . 1.3 m -56.66 -47.47 79.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.696 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -73.8 -30.46 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.361 -0.837 . . . . 0.0 109.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 m -77.96 -12.05 59.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.003 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -116.08 -27.01 7.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.855 . . . . 0.0 109.38 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.81 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 139.25 98.78 0.42 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 61' ' ' GLY . 13.0 t -162.63 168.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -1.065 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.51 ' HB3' ' CD ' ' A' ' 26' ' ' ARG . 12.5 t0 -153.37 67.17 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.93 HD11 ' HG3' ' A' ' 54' ' ' GLN . 11.8 pt -116.55 -173.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.187 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -153.68 88.74 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' N ' ' HD3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 58.19 153.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.359 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.427 ' NE2' HD12 ' A' ' 64' ' ' ILE . 3.0 pt20 -171.93 126.99 0.59 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.358 -0.839 . . . . 0.0 110.194 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 1.2 mtm105 -99.87 -89.15 0.33 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 68' ' ' ARG . . . 176.94 79.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 ttp-105 -76.6 141.2 41.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' HG3' ' N ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.62 151.88 44.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.162 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.578 HG21 ' HA ' ' A' ' 40' ' ' THR . 19.4 tt -90.8 172.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t -124.4 172.2 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -78.33 2.85 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.112 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.02 -13.28 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' CG ' ' CG1' ' A' ' 72' ' ' ILE . 2.9 m-20 -52.92 -42.11 65.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -45.13 -55.77 5.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 26.82 3.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.622 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -104.64 -11.14 17.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 110.237 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.622 ' CE1' ' CG ' ' A' ' 79' ' ' LYS . 77.9 m-85 -143.07 -137.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -128.2 -53.42 1.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.471 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 48.9 t -133.26 123.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.195 -0.941 . . . . 0.0 110.451 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.898 HG21 HD11 ' A' ' 94' ' ' ILE . 5.7 mt -90.63 105.74 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.9 143.58 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.429 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -103.49 147.91 26.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.859 HD23 ' CB ' ' A' ' 17' ' ' ARG . 2.8 tp -98.64 31.77 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.934 ' O ' HD21 ' A' ' 108' ' ' LEU . 0.4 OUTLIER 174.31 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 110.178 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -59.93 -43.57 94.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.243 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.589 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 1.9 mp -57.67 -63.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.153 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.4 OUTLIER -53.09 -37.14 61.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.151 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -70.83 -26.89 63.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.236 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -92.06 -61.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.255 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.898 HD11 HG21 ' A' ' 83' ' ' ILE . 5.6 tt -45.63 -39.89 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.503 ' N ' HG23 ' A' ' 94' ' ' ILE . 4.6 t-20 -71.89 -15.18 62.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -76.37 -12.36 60.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.226 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.453 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 8.2 mtm -109.64 -52.04 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 5.6 mtpt -40.85 134.85 1.67 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 110.443 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.14 -169.59 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.069 1.562 . . . . 0.0 110.424 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.7 t -91.35 23.91 3.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 6.5 p-10 -176.79 123.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.4 p -143.59 -151.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -116.37 -18.63 10.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.104 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 -149.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -157.66 169.31 24.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.19 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.487 HG12 ' HB ' ' A' ' 83' ' ' ILE . 29.0 m -128.07 146.43 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 108' ' ' LEU . 78.6 t -144.01 170.19 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.94 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.934 HD21 ' O ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -109.52 121.91 46.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.181 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 132' ' ' ILE . 11.6 t80 -48.49 -51.52 26.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 111' ' ' PRO . 1.1 m-20 -176.52 -178.26 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 110' ' ' ASN . 46.7 Cg_endo -74.67 175.03 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.012 1.533 . . . . 0.0 110.302 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.2 52.94 2.41 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.959 1.505 . . . . 0.0 110.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -124.69 -27.3 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.75 -89.98 1.25 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 115' ' ' VAL . 19.5 m -75.9 103.24 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -1.156 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 15.6 p-10 -137.08 -156.63 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER 55.78 72.74 0.96 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 112.03 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.995 1.524 . . . . 0.0 110.508 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.499 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 12.4 m-85 50.48 -138.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 119' ' ' TYR . 27.5 p -168.79 -151.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 82.7 p -90.32 -138.56 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 122' ' ' SER . 2.3 t70 67.06 17.09 10.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.431 ' C ' ' HD2' ' A' ' 126' ' ' PRO . . . -144.29 -42.08 0.05 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.638 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 11.8 m-85 -42.08 -50.47 10.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.11 . . . . 0.0 110.473 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.6 Cg_endo -72.0 -56.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.619 1.326 . . . . 0.0 110.247 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -55.75 -43.66 76.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 110.006 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.724 ' O ' HG22 ' A' ' 132' ' ' ILE . 14.0 ttp -50.69 -75.71 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.873 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.6 t80 -46.67 -55.6 7.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.236 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -52.7 -22.56 5.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.4 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 128' ' ' MET . 3.2 m -90.12 -55.82 3.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.412 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.996 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -60.09 -15.33 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 0.0 109.028 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.731 ' HB2' HD11 ' A' ' 24' ' ' ILE . 2.0 t -101.93 -49.96 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 110.139 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -59.23 -30.85 68.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.108 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' OE2' ' ND2' ' A' ' 110' ' ' ASN . 6.1 mt-10 -102.75 22.37 13.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.647 ' HE1' ' HB3' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -89.61 1.36 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.25 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 77.0 mttt -91.88 -42.13 0.37 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 111.353 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.2 Cg_endo -76.41 4.79 5.16 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.403 1.212 . . . . 0.0 110.733 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.647 ' HB3' ' HE1' ' A' ' 136' ' ' MET . 39.2 t80 -108.08 -71.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -58.98 -55.0 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.116 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 137' ' ' LYS . 16.2 m -61.04 -12.87 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 144' ' ' GLY . 27.8 mt-10 -105.06 -55.33 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.542 ' NE2' HG21 ' A' ' 107' ' ' VAL . 3.1 t-80 -42.34 -26.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 130.84 46.62 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 15.0 mt -144.66 -98.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -1.186 . . . . 0.0 110.27 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.437 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 2.9 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.206 0.527 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 54.73 68.05 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.148 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.441 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 4.8 mm-40 -99.98 166.17 11.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.13 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -82.38 156.02 24.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 178.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 34' ' ' ILE . 26.7 mttt -139.37 -165.79 1.93 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.989 -1.07 . . . . 0.0 110.867 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.855 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.19 156.79 29.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 110.516 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.802 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 40.0 t -141.95 113.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.668 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.951 HD13 ' CE2' ' A' ' 80' ' ' PHE . 26.2 tp -82.64 81.45 8.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 111.02 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.994 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 16.6 m-85 -55.84 126.39 25.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.086 -1.009 . . . . 0.0 109.367 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.948 HG22 ' O ' ' A' ' 38' ' ' ALA . 73.8 t -142.03 161.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 110.767 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.672 ' SG ' HD23 ' A' ' 86' ' ' LEU . 1.1 t -153.36 -58.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.413 -0.805 . . . . 0.0 110.191 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.584 ' CB ' ' NH1' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 169.84 150.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.463 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 64.48 10.14 41.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 72.8 -53.19 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.297 -1.119 . . . . 0.0 109.823 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' CYS . 8.9 mt -41.2 -33.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 3.3 t 68.25 105.44 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.584 ' NH1' ' CB ' ' A' ' 12' ' ' LEU . 18.3 mtt85 -52.67 -18.52 1.83 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.046 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.493 ' HB3' HD21 ' A' ' 86' ' ' LEU . 60.3 p -112.8 67.71 1.0 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 17' ' ' ARG . 45.6 Cg_endo -72.59 -12.33 26.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.902 1.475 . . . . 0.0 110.082 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.707 ' HB2' ' HE1' ' A' ' 128' ' ' MET . . . -76.97 4.89 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 23.2 p -69.77 -37.62 76.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.785 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.9 OUTLIER -68.98 -43.06 75.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 109.917 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -70.55 -51.78 19.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.821 HD12 ' CE1' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -55.62 -46.93 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -1.153 . . . . 0.0 110.274 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.657 ' O ' HG22 ' A' ' 29' ' ' VAL . 78.4 m -71.87 -48.59 44.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.115 -0.99 . . . . 0.0 110.053 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.529 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 10.1 mmt180 -49.35 -45.35 45.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.28 -24.09 32.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.259 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.558 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -73.88 -22.71 59.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.605 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 25' ' ' CYS . 4.7 m -142.14 -33.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.978 -1.076 . . . . 0.0 110.713 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 38.47 44.91 1.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 54.4 t0 -178.55 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.961 -1.317 . . . . 0.0 110.853 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' C ' ' HG ' ' A' ' 33' ' ' LEU . 12.3 mmtm -141.73 -143.34 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.4 mt -147.77 -34.53 0.24 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.416 -0.802 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 2.1 pp -30.05 -31.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.824 -0.548 . . . . 0.0 111.829 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.666 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.5 mp -62.47 87.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.998 -1.064 . . . . 0.0 110.939 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -130.39 162.47 29.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.96 . . . . 0.0 109.064 178.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.5 m -141.9 139.98 32.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.96 -1.088 . . . . 0.0 110.668 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.948 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -167.78 -176.24 3.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.354 -0.842 . . . . 0.0 110.33 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . . . 174.84 164.07 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 40' ' ' THR . 13.7 t -94.12 71.67 3.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.42 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.39 76.68 0.57 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.67 -57.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -1.141 . . . . 0.0 110.296 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -87.59 93.26 9.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 69' ' ' ALA . 34.9 t -125.95 -3.76 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.243 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.27 41.74 2.08 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 48' ' ' SER . 5.2 pt20 -161.78 -109.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 4.4 t 64.84 70.78 0.59 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.053 -1.03 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.38 66.05 1.56 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.459 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 4.2 p-10 -89.19 31.48 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.524 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -76.0 -34.19 59.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.898 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 6.9 mmt85 -70.76 -47.79 57.77 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -56.69 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.533 -0.729 . . . . 0.0 109.349 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.718 ' HB3' HD13 ' A' ' 64' ' ' ILE . 5.2 pp0? -56.97 -35.29 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.125 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.4 -65.92 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 109.13 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.604 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 41.4 t -49.69 -36.22 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.28 -0.887 . . . . 0.0 108.83 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -53.86 -52.76 59.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 62' ' ' VAL . 11.3 ttpt -71.13 -21.23 62.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.472 ' OG ' ' CE ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -86.6 -8.73 57.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.947 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.25 -17.74 12.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.865 . . . . 0.0 108.84 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 122.14 44.21 0.37 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 61' ' ' GLY . 54.3 t -158.37 144.87 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -1.087 . . . . 0.0 110.22 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.62 135.63 40.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.718 HD13 ' HB3' ' A' ' 54' ' ' GLN . 29.2 pt -92.76 -171.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 110.117 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -129.95 -51.46 1.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 110.194 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.52 149.03 3.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -111.91 99.48 8.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 111.9 24.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -93.91 102.5 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.199 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -122.79 158.14 30.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.92 143.81 57.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 72' ' ' ILE . 10.7 tt -84.61 87.94 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 74' ' ' LYS . 25.5 m -58.9 169.59 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 73' ' ' THR . 2.1 mtpp -65.73 -9.09 24.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.02 59.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 110.26 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' CG ' HG13 ' A' ' 72' ' ' ILE . 31.5 m-20 -49.69 -30.04 8.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 23.7 m-85 -57.49 -41.27 80.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 110.17 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.98 -33.97 10.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER -44.35 -31.23 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.331 -0.856 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.951 ' CE2' HD13 ' A' ' 8' ' ' LEU . 11.9 m-85 -130.94 152.34 50.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.465 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.595 ' H ' ' HB3' ' A' ' 6' ' ' ALA . 3.9 m-20 -68.52 -47.07 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.442 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' A' ' 139' ' ' PHE . 53.9 t -130.85 156.68 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.937 HD13 HG12 ' A' ' 106' ' ' VAL . 1.6 mp -118.33 139.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.283 -0.886 . . . . 0.0 109.877 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.994 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -100.28 116.88 33.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.904 . . . . 0.0 110.385 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.68 ' O ' HD12 ' A' ' 108' ' ' LEU . . . -109.82 99.56 8.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 109.919 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.672 HD23 ' SG ' ' A' ' 11' ' ' CYS . 1.1 mp -60.78 -61.77 2.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.541 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.524 ' CB ' ' CD1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -85.54 171.79 11.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' SER . 21.0 mt-30 -83.59 -40.69 18.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -42.64 -37.86 1.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.557 HD11 ' O ' ' A' ' 11' ' ' CYS . 1.4 mp -71.97 -54.52 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.96 -19.58 62.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 0.0 110.349 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -86.61 -58.38 2.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.285 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.245 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.586 HG23 ' N ' ' A' ' 95' ' ' ASN . 2.5 tt -43.48 -43.28 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.586 ' N ' HG23 ' A' ' 94' ' ' ILE . 1.1 t-20 -60.89 -31.78 71.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' ASP . 19.5 t -64.36 -12.34 41.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.53 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.9 ptt? -123.17 -18.35 6.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.562 ' HG2' ' CE1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -55.09 154.3 10.61 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.52 ' HD3' ' CD2' ' A' ' 77' ' ' PHE . 47.9 Cg_endo -73.36 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -125.42 101.13 6.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.53 ' ND2' ' N ' ' A' ' 101' ' ' ASN . 1.6 m120 64.06 110.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.257 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.0 m -150.23 -164.41 2.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.87 . . . . 0.0 110.209 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.83 32.55 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 77' ' ' PHE . . . -160.68 -177.09 5.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.231 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 16.4 pttm -176.53 158.23 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.937 HG12 HD13 ' A' ' 83' ' ' ILE . 3.6 m -111.59 151.33 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 m -138.87 147.43 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.197 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' O ' ' A' ' 85' ' ' ALA . 21.6 tp -81.6 126.05 31.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.223 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -93.46 89.76 6.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 0.0 110.211 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 56.52 162.77 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 45.8 Cg_endo -74.0 174.93 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.096 1.577 . . . . 0.0 110.275 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.7 Cg_endo -73.25 51.48 2.11 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.954 1.502 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 114' ' ' GLY . 19.2 m-20 -122.32 -63.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 127' ' ' THR . . . -44.25 -73.03 0.28 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.534 HG21 ' HG ' ' A' ' 86' ' ' LEU . 18.1 m -70.41 123.7 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.33 158.55 27.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.933 . . . . 0.0 110.256 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.574 ' HB2' ' CE2' ' A' ' 119' ' ' TYR . 8.2 p-10 -73.22 123.78 89.88 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -73.06 -89.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.008 1.53 . . . . 0.0 110.621 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 117' ' ' ASP . 12.3 m-30 58.21 -142.68 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.537 ' O ' ' CB ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -69.44 149.6 48.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.413 -0.805 . . . . 0.0 109.994 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER 71.56 3.89 4.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.38 -0.825 . . . . 0.0 110.166 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.537 ' HG ' ' HE2' ' A' ' 125' ' ' PHE . 73.7 m 42.19 -94.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.177 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' SER . 0.5 OUTLIER 44.98 49.06 9.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -175.39 -41.05 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.65 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 23.5 m-85 -41.58 -49.61 9.67 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.13 . . . . 0.0 110.527 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.33 -59.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.585 1.308 . . . . 0.0 110.194 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 114' ' ' GLY . 64.9 m -53.16 -48.17 68.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.646 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.707 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 7.9 ttp -50.02 -58.92 4.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.376 -0.827 . . . . 0.0 109.968 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.821 ' CE1' HD12 ' A' ' 24' ' ' ILE . 88.3 t80 -50.56 -50.54 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.0 -56.19 11.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 m -57.9 -46.5 84.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -45.38 -56.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.655 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -60.65 -45.88 92.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.54 ' O ' ' CD ' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -65.21 -13.04 57.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 109' ' ' PHE . 14.8 mt-10 -90.0 -37.32 14.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.503 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -90.99 -3.69 57.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.931 . . . . 0.0 110.355 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 3.1 mttt -83.48 -50.2 0.68 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -0.961 . . . . 0.0 110.026 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 51.0 Cg_endo -80.08 -13.14 12.84 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.097 1.577 . . . . 0.0 110.414 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' A' ' 82' ' ' VAL . 5.3 t80 -103.72 -48.74 3.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -73.31 1.1 10.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.287 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 142' ' ' GLU . 21.0 m -104.22 -57.05 2.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 111.004 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' GLY . 7.3 mt-10 -105.2 -45.13 4.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.11 -0.994 . . . . 0.0 111.224 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -37.24 -29.65 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.211 -0.931 . . . . 0.0 110.434 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.863 ' O ' HD22 ' A' ' 145' ' ' LEU . . . 132.03 76.58 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -159.16 -38.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -1.218 . . . . 0.0 110.182 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.474 HD11 HD23 ' A' ' 140' ' ' LEU . 22.3 mt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.249 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.243 0.544 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 58.24 86.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -101.91 153.08 20.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 110.313 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.757 ' HG2' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -72.21 -161.35 0.08 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 108.701 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 1.027 ' C ' HG22 ' A' ' 34' ' ' ILE . 23.6 mtmt -157.32 -159.68 0.87 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.921 -1.112 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.0 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -142.41 123.23 14.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 111.251 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.963 HG11 ' CZ ' ' A' ' 9' ' ' PHE . 5.6 t -115.72 131.69 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.548 -0.72 . . . . 0.0 109.463 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 4.1 tp -90.66 92.1 8.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.916 . . . . 0.0 110.806 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.963 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 18.3 m-85 -82.99 106.85 15.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.014 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 14.0 p -125.47 173.87 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.528 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.751 ' O ' HD12 ' A' ' 90' ' ' ILE . 26.5 p -163.41 -38.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.616 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 0.2 OUTLIER 168.76 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.123 -0.986 . . . . 0.0 110.295 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.742 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -91.03 -9.98 63.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 3.3 t-20 68.63 33.21 3.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -1.172 . . . . 0.0 110.224 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 16' ' ' CYS . 84.6 mt -108.74 -91.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.514 ' N ' HG22 ' A' ' 15' ' ' ILE . 5.8 t -95.74 64.53 2.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.882 . . . . 0.0 110.113 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.55 ' CB ' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER 171.6 52.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.064 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER 172.39 -55.37 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.3 Cg_endo -71.79 -13.65 29.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.9 1.474 . . . . 0.0 110.383 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HB2' ' CE ' ' A' ' 128' ' ' MET . . . -65.64 -12.6 54.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 17.4 m -72.39 -29.32 63.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.48 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HA ' HG12 ' A' ' 35' ' ' ILE . 16.8 tt0 -70.34 -43.09 70.97 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.469 -0.769 . . . . 0.0 109.754 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.776 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -71.07 -45.57 49.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.744 HG21 HG23 ' A' ' 132' ' ' ILE . 6.1 tp -64.96 -43.19 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -1.167 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.606 ' N ' HG23 ' A' ' 24' ' ' ILE . 55.9 m -65.12 -49.86 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.319 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.516 ' CD ' ' HA2' ' A' ' 23' ' ' GLY . 8.9 ptm180 -68.15 -26.19 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.309 -0.87 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 1.3 m-20 -85.81 -25.56 26.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.042 -1.036 . . . . 0.0 110.277 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 3.0 tmm? -92.4 -21.91 19.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.564 HG11 ' HG2' ' A' ' 32' ' ' LYS . 57.6 t -127.72 -12.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.197 -0.939 . . . . 0.0 110.617 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.43 -22.13 36.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -149.48 -87.05 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.39 -1.065 . . . . 0.0 110.235 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HG2' HG11 ' A' ' 29' ' ' VAL . 0.1 OUTLIER 58.16 122.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.277 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.757 HD13 ' HG2' ' A' ' 4' ' ' LYS . 6.0 mp -98.12 -114.81 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.027 HG22 ' C ' ' A' ' 5' ' ' LYS . 0.8 OUTLIER 32.49 33.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 0.0 111.338 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.7 mt -104.49 95.12 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.963 -1.085 . . . . 0.0 110.602 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' OD2' ' CE2' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -126.37 99.96 6.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 9.7 p -79.12 130.58 35.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.213 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.014 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -122.33 -173.06 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.32 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 38' ' ' ALA . . . 171.16 109.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -69.41 -12.1 61.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -124.0 93.93 4.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.15 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.58 87.06 0.67 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -141.1 22.24 2.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -1.111 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.54 ' HA ' ' NE2' ' A' ' 47' ' ' GLN . 85.5 m-70 -141.16 40.4 1.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.94 . . . . 0.0 110.147 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.654 HG22 ' HB3' ' A' ' 69' ' ' ALA . 11.1 t -90.63 169.29 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.214 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.408 ' N ' HG12 ' A' ' 45' ' ' VAL . . . 48.31 37.84 18.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 44' ' ' HIS . 12.2 pt20 -169.52 -148.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.471 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 60.88 131.98 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.189 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.42 70.6 1.39 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.63 13.18 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.26 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.04 -33.53 59.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.87 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -73.68 -44.73 55.82 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.388 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.548 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 3.4 t -63.57 -48.94 75.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.519 -0.738 . . . . 0.0 109.618 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 0.8 OUTLIER -62.74 -42.91 99.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.26 -69.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.571 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 52' ' ' ARG . 27.6 m -49.9 -32.97 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.141 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.811 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -55.51 -54.16 47.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.8 . . . . 0.0 109.487 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -29.95 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.6 t -77.78 -12.16 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 5.0 m-20 -113.68 -33.44 5.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 142.19 62.99 0.03 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.811 HG11 ' SG ' ' A' ' 57' ' ' CYS . 54.7 t -158.77 59.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -1.106 . . . . 0.0 110.107 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 0.2 OUTLIER -73.16 130.99 41.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.9 pt -145.38 -172.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.151 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -103.12 -61.96 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.062 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 65' ' ' SER . 12.3 mmmt -150.12 -178.4 6.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.079 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 67' ' ' GLN . 12.2 mm-40 -135.57 95.66 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.196 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -108.41 75.97 1.01 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 13' ' ' GLY . . . -44.17 106.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 110.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.491 ' HG2' ' N ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -101.94 159.23 15.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.122 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 60.8 tt0 -71.93 156.46 39.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.501 HG12 ' OD2' ' A' ' 76' ' ' ASP . 12.5 tt -79.92 159.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.446 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.8 p -119.68 176.13 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -19.7 61.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' A' ' 79' ' ' LYS . . . -64.7 -36.65 84.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.231 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.6 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 39.2 m-20 -47.53 -36.49 10.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.136 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.592 ' CD2' ' HG2' ' A' ' 98' ' ' LYS . 20.8 m-85 -94.55 16.34 15.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.137 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.18 11.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.619 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -137.11 -149.51 0.32 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.112 -0.992 . . . . 0.0 109.682 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.9 OUTLIER 36.67 -149.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.443 -0.786 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -140.06 -34.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.604 HG11 ' HZ ' ' A' ' 139' ' ' PHE . 15.8 t -139.75 149.59 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 110.714 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 8' ' ' LEU . 16.7 mt -121.76 126.61 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.828 . . . . 0.0 109.859 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 109' ' ' PHE . . . -120.26 135.09 55.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 90' ' ' ILE . . . -108.43 160.38 15.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.59 HD21 HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -105.06 2.7 29.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.965 . . . . 0.0 110.244 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 90' ' ' ILE . 22.9 t70 -137.85 174.14 10.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -89.66 -66.71 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.086 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -47.16 -40.69 16.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 11' ' ' CYS . 6.3 tt -52.35 -39.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.043 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.533 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.7 OUTLIER -81.58 -34.79 30.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.077 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -20.07 63.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -103.14 -44.64 5.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.537 HG13 ' CE ' ' A' ' 97' ' ' MET . 2.7 tt -48.15 -36.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.468 ' N ' HG23 ' A' ' 94' ' ' ILE . 38.4 p30 -69.98 -11.47 60.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 9.5 t -75.41 -26.86 58.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.537 ' CE ' HG13 ' A' ' 94' ' ' ILE . 2.3 ptt? -96.34 -34.99 11.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -45.22 145.58 1.78 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.26 -174.35 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.989 1.52 . . . . 0.0 110.34 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.63 -4.1 11.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.963 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.88 48.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.5 p -124.84 -161.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -132.52 -142.16 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.262 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 103' ' ' ARG . . . 56.86 -159.27 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 106' ' ' VAL . 7.9 tttt -173.41 148.11 1.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 0.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 106' ' ' VAL . 4.0 m -101.01 133.64 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.05 161.4 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.459 HD21 ' OD1' ' A' ' 110' ' ' ASN . 8.5 tp -83.51 149.21 26.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.727 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -136.3 85.71 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.236 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.459 ' OD1' HD21 ' A' ' 108' ' ' LEU . 2.0 p-10 -177.39 146.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.58 174.78 12.04 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.004 1.528 . . . . 0.0 110.373 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.1 Cg_endo -72.84 52.77 2.22 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.437 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.98 -50.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.96 91.86 1.41 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.844 HG13 ' HA ' ' A' ' 128' ' ' MET . 99.0 t -56.24 114.1 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 10.9 t70 57.63 168.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.948 . . . . 0.0 110.178 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.535 ' N ' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER 171.61 -56.83 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.331 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 117' ' ' ASP . 46.1 Cg_endo -72.72 -37.69 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.995 1.524 . . . . 0.0 110.542 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 57.89 179.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.6 t80 60.32 25.75 15.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.234 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 t -163.89 -164.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.22 18.31 22.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.962 . . . . 0.0 110.21 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -90.53 34.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.189 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -147.23 -45.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.785 ' HB3' HG21 ' A' ' 56' ' ' VAL . 4.4 m-30 -50.42 -46.32 84.37 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.29 -1.124 . . . . 0.0 110.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 48.5 Cg_endo -74.65 -51.4 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.716 1.377 . . . . 0.0 110.171 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' MET . 3.3 m -58.99 -55.56 33.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.844 ' HA ' HG13 ' A' ' 115' ' ' VAL . 10.2 ttp -44.9 -40.58 6.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.367 -0.833 . . . . 0.0 110.084 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.528 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 37.1 t80 -70.35 -62.01 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.995 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.72 -47.27 15.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.92 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.792 ' CB ' HG22 ' A' ' 115' ' ' VAL . 71.6 m -70.88 -42.19 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.981 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.744 HG23 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -50.72 -43.11 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.941 . . . . 0.0 109.851 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.579 ' HA ' ' HE3' ' A' ' 136' ' ' MET . 1.1 t -85.29 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.516 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.95 -18.31 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.49 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 39.1 tp10 -98.28 -18.29 18.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.579 ' HE3' ' HA ' ' A' ' 133' ' ' SER . 3.9 ttp -101.45 -0.53 35.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 110.2 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -82.51 -48.29 0.87 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.933 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.3 -11.5 14.56 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.055 1.555 . . . . 0.0 110.326 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.604 ' HZ ' HG11 ' A' ' 82' ' ' VAL . 68.4 t80 -101.92 -61.98 1.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 146' ' ' ILE . 6.5 tp -52.73 -25.43 11.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.592 ' HA ' ' CA ' ' A' ' 146' ' ' ILE . 23.3 m -76.99 -40.91 45.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 110.373 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.3 -66.42 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.659 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.579 ' O ' ' CZ ' ' A' ' 139' ' ' PHE . 12.7 t-80 -96.89 60.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -0.933 . . . . 0.0 110.733 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 145' ' ' LEU . . . -176.16 -34.05 0.04 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER 172.06 -91.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.499 -1.001 . . . . 0.0 109.912 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.592 ' CA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.139 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.245 0.545 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.45 97.98 5.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.14 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -149.98 -154.06 0.53 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.248 -0.907 . . . . 0.0 110.339 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.917 ' HE2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -155.81 -48.1 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 110.684 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.952 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.2 mttt 68.83 -154.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 110.913 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.892 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -159.56 135.42 8.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.316 0.579 . . . . 0.0 109.977 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.887 HG12 HG11 ' A' ' 82' ' ' VAL . 3.5 m -104.07 115.43 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.503 -0.748 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.848 HD12 ' HB3' ' A' ' 36' ' ' ASP . 14.9 tp -66.37 89.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 110.089 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.585 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -78.64 101.45 7.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.045 HG22 ' HB3' ' A' ' 38' ' ' ALA . 15.2 t -116.9 157.05 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.759 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 11.9 t -145.85 -78.87 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -175.38 69.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.341 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 137.74 -21.85 3.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 4.8 t-20 71.15 1.45 3.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -1.132 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 69' ' ' ALA . 18.5 mm -89.59 -36.79 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.932 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 29.5 p -137.63 167.18 22.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.927 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.546 ' CG ' HD23 ' A' ' 86' ' ' LEU . 51.2 mtm180 56.22 43.04 27.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -0.968 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -173.31 -60.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 45.0 Cg_endo -71.78 -10.86 27.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.888 1.468 . . . . 0.0 110.33 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.751 ' HB3' HD12 ' A' ' 132' ' ' ILE . . . -75.72 -16.79 60.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.047 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 37.0 t -66.45 -55.42 15.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.799 ' HG3' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -43.37 -36.69 1.99 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 109.346 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -71.88 -50.26 19.5 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.987 HD11 ' OG ' ' A' ' 133' ' ' SER . 2.4 tp -55.86 -45.17 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.747 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.95 ' CB ' HD11 ' A' ' 35' ' ' ILE . 54.3 m -72.16 -30.47 65.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.562 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 0.1 OUTLIER -66.91 -37.1 83.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.895 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' HB2' ' HA ' ' A' ' 62' ' ' VAL . 22.1 t70 -82.81 -34.99 26.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 110.107 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.837 ' O ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -78.72 -28.16 45.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 110.406 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.837 HG13 ' O ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -163.7 41.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.79 94.51 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' VAL . 3.8 t0 170.5 -25.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 110.128 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.76 -138.94 0.31 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 110.022 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -152.88 -83.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.892 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 37.01 26.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.42 -0.8 . . . . 0.0 110.92 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.95 HD11 ' CB ' ' A' ' 25' ' ' CYS . 7.4 mt -131.55 132.64 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.844 -1.16 . . . . 0.0 111.158 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.848 ' HB3' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -145.03 90.05 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 179.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -67.19 124.68 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.045 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -141.45 176.03 9.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.701 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -159.61 -162.53 1.04 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.152 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -177.59 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -165.26 110.51 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 108.34 2.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.35 -41.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 44' ' ' HIS . 6.1 p80 -155.79 81.5 1.02 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 t -118.79 -20.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 110.303 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.15 31.7 8.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.502 ' HG3' ' N ' ' A' ' 48' ' ' SER . 17.7 pt20 -164.5 -140.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -1.116 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.502 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.61 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.174 -0.954 . . . . 0.0 110.15 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.9 Cg_endo -69.34 107.48 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.012 1.533 . . . . 0.0 110.538 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -94.26 21.31 7.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 3.7 m -71.08 -27.9 63.96 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.189 -0.944 . . . . 0.0 108.748 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -74.38 -43.45 56.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.214 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -54.92 28.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.483 -0.76 . . . . 0.0 109.6 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 20.0 mt-30 -61.58 -40.31 94.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.261 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.602 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -56.09 -71.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.832 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 52' ' ' ARG . 14.9 p -50.03 -34.28 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.494 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 64' ' ' ILE . 1.3 m -55.45 -53.71 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.507 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -69.43 -24.35 63.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.862 . . . . 0.0 109.566 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -82.58 -11.72 58.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.813 . . . . 0.0 109.993 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -111.45 -31.72 6.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 0.0 109.182 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 130.03 73.63 0.13 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 129' ' ' PHE . 2.2 p 173.34 137.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.289 -1.124 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -119.41 137.2 53.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.203 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.76 HD11 ' SG ' ' A' ' 57' ' ' CYS . 34.1 mt -120.58 -34.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.202 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER 53.66 97.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 65' ' ' SER . 3.6 mmmt 60.05 145.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.271 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.417 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 5.4 mm-40 -107.53 -52.58 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 67.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.94 . . . . 0.0 110.159 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 14' ' ' ASN . . . -57.28 152.53 13.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 mtp-105 -137.1 -163.75 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 110.271 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -132.43 128.01 36.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 72' ' ' ILE . 11.9 tt -50.32 159.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.178 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 50.9 p -126.97 169.93 12.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -1.92 20.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.206 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.14 -8.64 21.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.543 ' HB2' HD22 ' A' ' 8' ' ' LEU . 20.5 p-10 -47.21 -37.25 10.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 39.5 m-85 -69.41 -17.04 63.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 m -123.06 13.44 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.203 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 3.5 tptt -94.82 -23.7 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.708 ' CD1' ' HB3' ' A' ' 6' ' ' ALA . 93.8 m-85 -147.35 -140.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.869 . . . . 0.0 109.983 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 4.0 m-20 -137.06 -23.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.054 -1.028 . . . . 0.0 111.029 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.887 HG11 HG12 ' A' ' 7' ' ' VAL . 39.1 t -113.42 138.76 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 0.0 110.509 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.652 HD12 ' CB ' ' A' ' 104' ' ' ALA . 47.4 mt -146.3 133.89 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.433 -0.792 . . . . 0.0 109.777 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -162.03 163.09 28.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.661 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.5 ' HB1' HD13 ' A' ' 90' ' ' ILE . . . -126.5 159.87 32.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.824 ' HG ' HG21 ' A' ' 115' ' ' VAL . 1.3 tp -85.64 -37.36 19.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -101.74 -176.26 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.194 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.8 mm-40 -92.45 -39.0 11.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 88' ' ' GLN . 15.6 m -42.75 -41.0 3.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.605 HD12 ' H ' ' A' ' 90' ' ' ILE . 2.1 mp -65.46 -40.08 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.91 . . . . 0.0 110.099 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.617 HD13 ' HB2' ' A' ' 108' ' ' LEU . 2.0 tp -67.64 -32.4 73.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.6 t -79.99 -30.62 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.246 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 96' ' ' SER . 1.8 m-20 -87.83 -54.58 4.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.256 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.633 HG13 ' HE1' ' A' ' 97' ' ' MET . 3.9 tt -46.69 -40.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.63 -8.81 56.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 2.7 m -96.78 -0.93 47.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.151 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.633 ' HE1' HG13 ' A' ' 94' ' ' ILE . 1.7 ptt? -122.56 -10.0 8.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.185 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 8.4 mtpt -63.59 143.75 97.88 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.411 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 45.9 Cg_endo -73.14 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.028 1.541 . . . . 0.0 110.419 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.4 m -105.61 28.38 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.416 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.1 p-10 -178.51 126.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 110.24 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 101' ' ' ASN . 83.5 m -149.56 -161.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.01 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.652 ' CB ' HD12 ' A' ' 83' ' ' ILE . . . -105.82 -152.07 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -148.75 111.15 4.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.167 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 71.1 t -87.39 125.46 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 110.088 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ALA . 3.6 t -135.11 159.07 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.617 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -119.19 108.17 14.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -55.27 -170.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.26 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.625 HD21 HG22 ' A' ' 115' ' ' VAL . 37.5 p-10 -42.57 166.04 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.503 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.9 Cg_endo -74.64 175.02 11.66 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.912 1.48 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.5 Cg_endo -71.74 54.45 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.996 1.524 . . . . 0.0 110.38 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.67 -29.95 4.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.876 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -107.45 -92.45 2.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.824 HG21 ' HG ' ' A' ' 86' ' ' LEU . 29.0 m -41.12 128.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 110.168 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -157.78 -65.7 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.42 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 0.5 OUTLIER 61.53 82.76 0.22 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.12 176.64 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.006 1.53 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 119' ' ' TYR . 67.7 m-85 -118.95 24.15 10.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -130.17 -34.68 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 110.335 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -145.62 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 110.246 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 p -153.97 54.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.137 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' A' ' 127' ' ' THR . 4.0 p30 -124.41 -6.14 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.265 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 117' ' ' ASP . . . -93.85 -22.37 25.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.619 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 13.5 m-85 -55.03 -49.81 90.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.331 -1.099 . . . . 0.0 110.365 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -73.34 -35.67 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.84 1.442 . . . . 0.0 110.385 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 123' ' ' ASP . 2.5 m -63.06 -51.96 64.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 20' ' ' ALA . 3.1 ttp -44.52 -55.42 5.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 24' ' ' ILE . 11.1 t80 -68.23 -33.59 74.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.182 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.754 ' CB ' HG13 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -86.89 -43.45 12.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.057 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -57.85 -23.21 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -0.761 . . . . 0.0 109.472 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.987 ' OG ' HD11 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -99.32 -42.81 6.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.987 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 14.3 mttp -75.41 -5.69 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 131' ' ' SER . 70.3 mm-40 -129.2 34.34 4.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.15 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.55 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -116.21 -12.18 11.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.1 mttp -81.53 -47.4 1.06 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.4 Cg_endo -78.44 0.33 10.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.99 1.521 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 62.8 t80 -108.06 -77.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -0.892 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.098 HD12 HD13 ' A' ' 145' ' ' LEU . 8.5 tp -51.16 -24.46 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.345 -0.847 . . . . 0.0 110.438 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.842 HG23 HD13 ' A' ' 146' ' ' ILE . 32.2 m -82.01 -30.61 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -105.22 -14.06 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.453 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.687 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 6.9 m80 -84.71 39.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.101 -0.999 . . . . 0.0 110.302 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.7 60.86 6.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.098 HD13 HD12 ' A' ' 140' ' ' LEU . 1.1 mt -163.67 34.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 110.021 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.842 HD13 HG23 ' A' ' 141' ' ' THR . 2.0 tp . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.229 0.538 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.79 138.35 32.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.69 149.46 28.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.271 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.514 ' HG3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.15 149.96 26.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.254 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.682 ' H ' HG22 ' A' ' 34' ' ' ILE . 23.1 mtpp -130.23 -155.62 0.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 110.982 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.077 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -147.23 117.2 7.22 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.546 0.689 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.893 ' HB ' HD12 ' A' ' 34' ' ' ILE . 21.9 t -108.2 126.62 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.578 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 38' ' ' ALA . 6.8 tp -98.13 80.95 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 0.0 110.752 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.949 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 69.5 m-85 -62.2 133.65 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.054 HG13 HD11 ' A' ' 90' ' ' ILE . 8.6 p -156.45 166.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.616 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.668 ' CA ' HD12 ' A' ' 90' ' ' ILE . 1.1 p -146.78 -98.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 109.904 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.58 86.7 2.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.101 -1.0 . . . . 0.0 110.185 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.581 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 85.37 -11.53 60.87 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 t30 74.75 -164.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -1.123 . . . . 0.0 109.782 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 15' ' ' ILE . 11.7 mm 58.12 13.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 2.0 t -174.89 175.33 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.955 . . . . 0.0 110.207 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.738 ' CB ' HD22 ' A' ' 86' ' ' LEU . 1.1 mtp180 70.72 -56.24 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.351 -0.843 . . . . 0.0 110.013 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.751 ' CB ' HD21 ' A' ' 86' ' ' LEU . 3.2 m -175.44 55.62 0.14 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.484 ' HD3' ' C ' ' A' ' 16' ' ' CYS . 50.0 Cg_endo -76.39 -1.14 11.15 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.971 1.511 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.926 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -100.12 7.01 44.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.348 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.677 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -59.73 -37.83 80.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.125 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -50.42 66.96 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.68 -0.638 . . . . 0.0 109.726 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.667 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -62.97 -58.27 12.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.983 HG21 HG23 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -55.13 -29.33 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -1.205 . . . . 0.0 109.91 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.3 m -69.09 -60.7 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.253 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 23' ' ' GLY . 11.6 ptm180 -61.1 -28.73 69.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.513 ' CB ' ' HA ' ' A' ' 62' ' ' VAL . 11.4 t70 -81.17 -53.06 6.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -55.58 -38.73 69.75 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.312 -0.867 . . . . 0.0 110.278 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 25' ' ' CYS . 4.4 m -84.54 -38.56 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.226 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.49 ' N ' HG23 ' A' ' 29' ' ' VAL . . . 106.0 -64.29 0.29 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.03 50.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -1.147 . . . . 0.0 110.251 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.778 ' C ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -95.48 -132.82 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 35' ' ' ILE . 4.9 mp -149.57 -120.63 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.383 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.077 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.0 29.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.812 . . . . 0.0 111.609 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.827 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -96.24 97.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.888 -1.133 . . . . 0.0 110.147 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.641 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 6.3 m-20 -135.76 144.27 45.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.5 p -137.56 151.34 48.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.432 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.786 ' O ' HG23 ' A' ' 10' ' ' VAL . . . -146.22 -172.9 4.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 110.361 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HA ' HG23 ' A' ' 10' ' ' VAL . . . -169.4 100.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 41' ' ' SER . 25.8 p -54.48 -68.17 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 0.0 110.274 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.506 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.2 OUTLIER -64.71 -177.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.54 36.86 0.58 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -78.96 -31.64 45.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -1.147 . . . . 0.0 110.187 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.432 ' ND1' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -116.62 70.74 0.77 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -138.28 142.6 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 86.32 25.98 34.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 48' ' ' SER . 13.0 pt20 -176.96 -141.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -1.131 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 47' ' ' GLN . 0.9 OUTLIER 59.03 108.31 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.62 100.37 0.8 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.012 1.532 . . . . 0.0 110.471 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.505 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 22.3 m-20 -87.33 27.12 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.231 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -75.02 -27.55 60.14 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.186 -0.946 . . . . 0.0 109.137 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.782 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -74.2 -51.77 14.47 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.442 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.404 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -63.01 -46.74 86.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 109.655 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 1.8 tt0 -62.76 -42.47 99.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.169 -0.957 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 3.5 ttpp -57.76 -67.13 0.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.704 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 52' ' ' ARG . 4.8 p -50.86 -33.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.237 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.679 ' CB ' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.37 -55.6 31.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.463 -0.773 . . . . 0.0 109.504 179.424 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -29.89 71.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 5.7 t -78.24 -14.46 59.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -111.7 -35.13 5.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.2 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.563 ' C ' HG12 ' A' ' 62' ' ' VAL . . . 127.58 84.81 0.48 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.926 HG23 ' N ' ' A' ' 24' ' ' ILE . 1.5 p 169.26 80.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.369 -1.077 . . . . 0.0 110.041 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -59.96 157.53 12.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.352 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.47 HG12 ' HA3' ' A' ' 23' ' ' GLY . 39.3 mt -148.81 -64.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.097 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER 66.54 96.78 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.47 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.56 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.286 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.422 ' HG3' ' OD2' ' A' ' 50' ' ' ASP . 21.4 mm100 -105.48 -145.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.7 70.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . . . -93.75 139.12 31.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -171.42 175.36 4.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -75.96 106.49 7.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.757 HD12 ' HB1' ' A' ' 38' ' ' ALA . 19.8 tt -46.23 157.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.41 159.9 37.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -55.38 -19.3 8.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.14 -12.89 44.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.98 -15.79 61.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.607 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 17.1 m-30 -81.73 -8.04 59.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.223 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.7 p -117.73 -48.98 2.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.582 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -51.37 -27.09 8.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.18 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.678 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 9.3 m-85 -134.1 157.09 47.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.252 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -104.25 -8.17 19.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.27 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.51 ' CG1' ' CE1' ' A' ' 143' ' ' HIS . 6.0 t -138.95 141.86 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.233 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.51 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 51.9 mt -123.84 143.36 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.039 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.949 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -114.64 120.51 40.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.851 ' HB1' HG23 ' A' ' 90' ' ' ILE . . . -111.22 113.62 26.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 18' ' ' SER . 2.2 mp -51.18 -83.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.492 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t0 -71.96 -179.43 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.241 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -84.41 -45.29 12.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 1.5 t -45.21 -51.14 11.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.956 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.054 HD11 HG13 ' A' ' 10' ' ' VAL . 6.8 tt -52.95 -47.16 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.363 -0.835 . . . . 0.0 110.086 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -58.16 -53.21 60.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -55.28 -54.87 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.845 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' SER . 29.1 m-20 -47.67 -60.32 2.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 110.147 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.667 HG23 ' CE ' ' A' ' 97' ' ' MET . 15.0 mt -58.74 -47.05 90.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -67.02 -16.13 64.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.557 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -80.82 -28.89 36.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.667 ' CE ' HG23 ' A' ' 94' ' ' ILE . 10.2 ptt? -97.07 -30.25 13.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.118 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -41.76 144.59 0.79 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 110.446 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.527 ' HD2' ' CE ' ' A' ' 98' ' ' LYS . 44.1 Cg_endo -71.37 177.39 6.74 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.13 1.595 . . . . 0.0 110.387 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.413 ' C ' ' OD1' ' A' ' 101' ' ' ASN . 0.9 OUTLIER -98.2 21.2 11.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 7.4 m120 -143.87 -137.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.102 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.31 -176.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 110.067 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.476 ' CD ' ' N ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -131.55 35.37 3.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.28 -171.52 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 146.04 11.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.483 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 37.8 t -112.17 127.0 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 108' ' ' LEU . 1.2 p -122.4 171.42 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.553 ' N ' HG22 ' A' ' 107' ' ' VAL . 6.0 tp -99.74 150.31 22.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.828 . . . . 0.0 110.138 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 135' ' ' GLU . 25.3 t80 -124.96 97.58 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.22 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 109' ' ' PHE . 18.8 t-20 60.14 144.9 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.561 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.3 Cg_endo -74.51 176.97 9.0 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.529 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.1 Cg_endo -72.18 3.05 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.027 1.54 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.47 -37.81 15.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -0.952 . . . . 0.0 110.123 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 115' ' ' VAL . . . -78.49 -76.41 0.93 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 29.9 m -59.27 -150.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -1.1 . . . . 0.0 110.118 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 6.0 t0 63.77 135.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.442 ' OD1' ' SG ' ' A' ' 16' ' ' CYS . 1.2 p30 -170.23 157.63 5.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.963 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 -27.74 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.036 1.545 . . . . 0.0 110.448 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 56.3 34.92 24.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -110.41 -32.97 6.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 m -122.22 -86.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.5 ' O ' ' CD ' ' A' ' 126' ' ' PRO . 89.9 p -155.0 19.05 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.11 4.6 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 110.18 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . -105.8 -45.99 1.24 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 12.8 m-85 -50.01 -45.69 81.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 110.566 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.736 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 45.9 Cg_endo -73.68 -51.02 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.573 1.302 . . . . 0.0 110.287 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 128' ' ' MET . 66.0 p -69.11 -56.59 7.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.23 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.63 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 8.8 ttp -41.33 -68.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 24' ' ' ILE . 87.5 t80 -59.22 -44.04 92.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.119 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -44.56 -64.16 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.972 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -63.4 -45.3 91.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 109.953 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.983 HG23 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -40.7 -56.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.856 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.585 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -74.38 -47.36 34.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.225 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 3.8 tppt? -47.94 -22.79 0.64 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.578 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -125.57 31.34 5.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.986 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.533 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -115.21 -22.08 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.156 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 3.9 mttp -87.92 -52.36 0.39 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.7 Cg_endo -77.72 5.64 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.521 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 41.3 t80 -93.82 -76.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.753 HD13 HD23 ' A' ' 145' ' ' LEU . 3.5 pp -65.66 -30.8 71.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.514 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.627 ' N ' HD12 ' A' ' 140' ' ' LEU . 22.3 m -56.06 -33.53 65.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 110.251 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.09 -34.87 7.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.16 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.534 ' NE2' HG11 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -44.33 -27.85 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 110.107 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.534 ' O ' ' HD2' ' A' ' 5' ' ' LYS . . . 127.08 67.8 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.753 HD23 HD13 ' A' ' 140' ' ' LEU . 26.5 tp -156.36 -54.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 0.0 110.227 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.764 ' C ' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.174 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.261 0.553 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.35 -40.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 110.215 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.59 158.27 30.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.22 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.555 ' HG2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -77.84 -164.74 0.54 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.401 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.914 ' C ' HG22 ' A' ' 34' ' ' ILE . 24.7 mttm -156.02 -160.86 1.05 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 110.77 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.009 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -144.59 122.81 12.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.442 -0.787 . . . . 0.0 111.056 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.921 HG11 ' CZ ' ' A' ' 9' ' ' PHE . 43.5 t -113.21 128.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 109.669 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 80' ' ' PHE . 13.2 tp -86.93 85.87 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.485 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.921 ' CZ ' HG11 ' A' ' 7' ' ' VAL . 34.0 m-85 -76.24 100.43 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.948 HG13 HD11 ' A' ' 90' ' ' ILE . 1.5 p -120.54 168.96 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.573 ' O ' HD12 ' A' ' 12' ' ' LEU . 19.4 t -154.14 -53.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.058 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER 176.58 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.501 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -104.31 -15.85 20.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.925 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 6.6 t-20 67.96 38.7 2.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -1.198 . . . . 0.0 110.205 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.653 HD13 ' CB ' ' A' ' 48' ' ' SER . 17.9 mt -114.76 -2.52 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 110.076 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 m -137.2 45.45 2.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 110.13 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HD3' HD22 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -146.7 -57.35 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 110.176 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.539 ' CB ' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -45.21 -56.57 9.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.139 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.83 ' HB3' HD12 ' A' ' 64' ' ' ILE . 46.9 Cg_endo -74.88 -0.96 10.55 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.928 1.488 . . . . 0.0 110.295 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.735 ' HB1' HG13 ' A' ' 132' ' ' ILE . . . -103.66 -44.98 4.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 110.213 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.562 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 60.9 m -74.21 -38.62 63.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.066 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.62 ' HG3' HG21 ' A' ' 35' ' ' ILE . 2.5 tt0 -69.68 -45.68 67.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 110.242 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.842 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -71.23 -46.65 41.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.628 HG12 HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -61.29 -43.8 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.14 . . . . 0.0 110.355 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.577 ' N ' HG23 ' A' ' 24' ' ' ILE . 58.3 m -69.71 -40.02 76.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 1.8 mmt-85 -67.5 -32.87 73.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.417 ' OD2' ' HA3' ' A' ' 61' ' ' GLY . 1.2 t70 -85.19 -48.69 8.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.039 . . . . 0.0 110.622 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -74.83 -21.58 59.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.745 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.784 HG11 ' HG3' ' A' ' 32' ' ' LYS . 2.3 t -119.98 -24.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.783 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . 106.28 -60.97 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 13.7 t70 -178.27 94.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 110.215 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.796 ' C ' HD12 ' A' ' 33' ' ' LEU . 12.5 mmtm -119.86 -130.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.105 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.796 HD12 ' C ' ' A' ' 32' ' ' LYS . 5.2 mp -149.81 -118.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 110.643 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.009 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 35.17 29.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.459 -0.775 . . . . 0.0 111.496 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.784 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.1 mt -104.26 90.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.007 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 55.1 m-20 -121.79 97.49 5.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.68 134.72 36.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.832 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . . . -137.04 168.35 19.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.487 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.925 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -140.38 142.83 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 110.08 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.911 HG21 HG13 ' A' ' 90' ' ' ILE . 11.8 p -103.7 41.57 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 40' ' ' THR . 2.4 p 170.16 103.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.86 58.05 0.99 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -88.59 -62.06 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -1.158 . . . . 0.0 110.189 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 102.4 9.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.288 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 69' ' ' ALA . 73.6 t -142.07 139.53 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.227 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.07 60.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 48' ' ' SER . 5.3 pt20 -123.52 -140.39 0.31 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 110.243 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.653 ' CB ' HD13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 66.21 126.36 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.36 90.36 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.349 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 2.5 t0 -99.26 24.03 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.259 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -76.47 -30.43 57.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.219 -0.925 . . . . 0.0 109.197 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.9 OUTLIER -74.16 -48.95 25.88 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.444 -0.785 . . . . 0.0 109.29 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.38 71.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 109.483 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -61.1 -42.13 97.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.267 179.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -54.74 -66.05 0.47 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.363 -0.836 . . . . 0.0 109.304 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.592 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.6 t -50.28 -35.06 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.939 . . . . 0.0 108.983 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.729 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -54.87 -51.11 66.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 109.427 179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -69.52 -28.55 66.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.719 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.3 -11.14 59.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -112.44 -26.49 8.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 131.17 80.18 0.2 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.842 HG13 ' HA3' ' A' ' 23' ' ' GLY . 66.5 t -158.89 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -1.108 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 32.1 p-10 -97.97 104.66 16.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 19' ' ' PRO . 13.6 pt -143.24 -171.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.36 125.97 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.061 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' OE1' ' HD3' ' A' ' 19' ' ' PRO . 33.9 mm-40 -84.38 96.07 8.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.345 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -89.66 74.41 7.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.118 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.868 ' HB3' HG13 ' A' ' 45' ' ' VAL . . . -41.9 126.63 3.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.9 tmm_? -106.06 151.45 24.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -90.62 144.14 26.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.903 . . . . 0.0 110.241 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 39' ' ' ALA . 16.5 tt -82.69 170.45 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 110.121 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.51 161.07 41.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -59.42 -14.84 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' O ' ' CE ' ' A' ' 79' ' ' LYS . . . -80.48 -12.02 59.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.165 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -47.96 -21.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.366 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.536 ' CD1' ' HE3' ' A' ' 98' ' ' LYS . 18.9 m-85 -76.92 52.71 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.113 -0.992 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.516 ' C ' ' CD ' ' A' ' 79' ' ' LYS . 1.1 p 175.02 31.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.344 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' CD ' ' C ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -135.74 -35.69 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.284 -0.885 . . . . 0.0 110.034 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.764 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 9.5 m-85 -123.32 156.46 35.27 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.549 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 1.3 m-20 -71.64 -36.63 70.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 50.4 t -140.8 156.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.039 . . . . 0.0 110.69 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 8' ' ' LEU . 9.5 mt -118.45 133.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.494 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -107.24 134.63 50.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 110.443 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.55 125.68 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.648 HD22 ' HD3' ' A' ' 17' ' ' ARG . 2.7 mp -78.99 -78.47 0.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 5.6 m-20 -56.91 178.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' NE2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -89.11 -55.15 3.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.2 m -45.62 -48.93 14.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.948 HD11 HG13 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -46.26 -49.69 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.71 HD13 ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -63.54 -49.62 72.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.835 179.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.0 t -60.88 -17.26 49.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.846 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -87.32 -67.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 90' ' ' ILE . 6.6 mt -44.75 -54.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.549 -0.72 . . . . 0.0 109.871 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -60.09 -14.9 19.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.697 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -81.7 -34.99 30.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 21.1 ptt? -96.53 -27.85 14.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE3' ' CD1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -40.71 139.32 1.17 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.66 -163.98 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.087 1.572 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -110.87 20.98 16.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.282 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -169.98 121.33 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.2 p -172.59 170.54 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 41.59 1.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -162.27 131.61 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.13 173.59 6.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 0.0 110.136 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.442 ' CG2' ' HD2' ' A' ' 98' ' ' LYS . 64.5 t -118.95 142.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -134.61 161.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.231 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.71 ' HG ' HD13 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -103.91 105.51 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.144 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.563 ' CZ ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -54.57 -57.18 12.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 18.7 p30 -162.11 164.11 17.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.2 Cg_endo -73.96 175.21 11.14 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.133 1.596 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 45.0 Cg_endo -72.41 52.45 1.98 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.941 1.495 . . . . 0.0 110.422 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.41 -7.15 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.95 -91.18 1.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.949 HG22 ' HA ' ' A' ' 128' ' ' MET . 14.3 t -85.86 136.85 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.071 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.432 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 35.1 t70 -167.79 33.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.545 ' N ' ' CD ' ' A' ' 118' ' ' PRO . 55.8 m-20 43.76 49.39 5.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 117' ' ' ASP . 46.0 Cg_endo -72.72 139.9 31.52 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.02 1.537 . . . . 0.0 110.499 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.431 ' CE2' ' O ' ' A' ' 117' ' ' ASP . 49.5 m-85 -132.93 44.8 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.113 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -107.35 -35.98 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.139 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.7 m -159.16 -147.35 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.526 ' HA ' ' CE2' ' A' ' 125' ' ' PHE . 28.8 m -60.85 -25.74 66.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 123' ' ' ASP . 10.9 p30 -46.59 123.03 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.265 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 132.99 -27.0 3.51 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -98.42 -45.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.264 -1.139 . . . . 0.0 110.764 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 125' ' ' PHE . 48.4 Cg_endo -82.6 -73.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.586 1.308 . . . . 0.0 110.643 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 126' ' ' PRO . 1.1 t -42.95 -33.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.949 ' HA ' HG22 ' A' ' 115' ' ' VAL . 4.0 tmm? -62.05 -69.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 24' ' ' ILE . 5.8 t80 -49.22 -50.21 39.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.976 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -50.87 -47.56 60.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.427 ' CB ' HG23 ' A' ' 115' ' ' VAL . 38.5 t -64.78 -46.96 79.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.797 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.735 HG13 ' HB1' ' A' ' 20' ' ' ALA . 15.2 mm -47.51 -55.97 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 0.1 OUTLIER -63.89 -47.85 78.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.821 . . . . 0.0 110.146 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -52.99 -25.88 13.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.897 . . . . 0.0 110.145 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.563 ' O ' ' CZ ' ' A' ' 109' ' ' PHE . 80.6 mm-40 -116.88 14.94 15.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.564 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.79 -22.14 7.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.8 mtpm? -84.52 -47.9 0.67 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.1 Cg_endo -78.36 -4.59 14.36 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.013 1.533 . . . . 0.0 110.344 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 139' ' ' PHE . 4.6 t80 -108.03 -48.87 3.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.46 -9.58 19.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.228 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 4.3 m -73.8 -72.1 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 110.227 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.423 ' N ' HG22 ' A' ' 141' ' ' THR . 2.2 mt-10 -105.16 -5.66 20.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.68 22.86 15.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.163 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.835 ' C ' HD12 ' A' ' 145' ' ' LEU . . . -173.14 -54.64 0.05 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.835 HD12 ' C ' ' A' ' 144' ' ' GLY . 5.4 mp -149.77 -88.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -1.124 . . . . 0.0 110.126 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 1.7 tp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.149 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.287 0.565 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 56.2 165.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -99.88 171.52 7.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.254 -0.904 . . . . 0.0 110.085 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -85.63 156.72 20.58 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.734 ' H ' HG22 ' A' ' 34' ' ' ILE . 3.2 mtpt -133.53 -163.99 1.43 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.022 -1.049 . . . . 0.0 111.029 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.074 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -148.86 116.45 6.23 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.864 ' HB ' HD12 ' A' ' 34' ' ' ILE . 3.3 t -104.13 125.54 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.703 . . . . 0.0 109.159 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.739 HD13 ' CD2' ' A' ' 80' ' ' PHE . 13.5 tp -89.92 84.7 6.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 110.697 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.587 ' CG ' ' SG ' ' A' ' 21' ' ' CYS . 26.0 m-85 -67.27 108.72 2.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -0.95 . . . . 0.0 109.469 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.981 HG13 ' HA ' ' A' ' 39' ' ' ALA . 20.0 t -126.38 154.81 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.563 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 1.8 p -145.16 -108.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.854 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.617 HD23 ' OD2' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -118.51 82.24 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 0.0 110.104 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 77.37 0.39 71.83 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 1.5 t30 71.97 -158.16 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -1.087 . . . . 0.0 109.899 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 15' ' ' ILE . 8.4 mm 58.06 12.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.237 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 177.19 176.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.117 -0.99 . . . . 0.0 110.504 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.715 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER 71.72 -60.0 0.53 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.775 . . . . 0.0 110.237 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.606 ' OG ' HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -139.73 48.07 1.46 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.9 Cg_endo -77.82 -10.64 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.924 1.486 . . . . 0.0 110.054 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -97.5 6.99 47.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 110.43 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.803 ' SG ' HD12 ' A' ' 132' ' ' ILE . 1.4 m -62.78 -45.14 94.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.07 -1.019 . . . . 0.0 109.352 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.547 ' HG2' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.83 -47.4 85.88 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.55 -0.719 . . . . 0.0 109.88 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.841 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -68.49 -59.52 6.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.109 HD12 ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -43.0 -46.91 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -1.19 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.755 ' HB2' HD11 ' A' ' 35' ' ' ILE . 78.1 m -69.36 -37.44 77.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 13.6 mmt180 -62.04 -45.18 94.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.337 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 -45.79 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.69 ' O ' HG13 ' A' ' 29' ' ' VAL . 6.0 mmt -63.24 -41.32 99.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 28' ' ' MET . 3.5 m -158.77 36.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.405 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 25' ' ' CYS . . . -49.87 -22.67 4.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.82 -20.79 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.356 -1.085 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.658 ' HE2' HD11 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -104.77 -139.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.931 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 35' ' ' ILE . 95.8 mt -147.77 -95.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.228 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.074 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 32.39 33.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 0.0 111.568 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 25' ' ' CYS . 3.5 mt -110.69 94.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.892 -1.13 . . . . 0.0 110.487 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.691 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 42.3 m-20 -126.05 104.48 8.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 m -95.15 130.94 41.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.772 ' C ' HG22 ' A' ' 10' ' ' VAL . . . -157.29 -172.79 4.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.482 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.981 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -164.06 146.55 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.125 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 40' ' ' THR . 14.0 t -93.87 64.74 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.177 -0.952 . . . . 0.0 110.256 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.508 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . 12.5 t -149.17 -75.66 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.242 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . 74.59 106.32 0.09 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 42' ' ' GLY . 1.2 m-85 -170.04 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -1.146 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -123.98 23.88 8.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.229 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m -65.03 -9.19 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 110.403 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . -104.48 41.12 2.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' O ' ' CB ' ' A' ' 48' ' ' SER . 6.9 pt20 -177.92 -142.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.119 . . . . 0.0 110.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 67.45 98.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.56 83.53 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.004 1.529 . . . . 0.0 110.427 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -89.09 32.3 0.83 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -29.4 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 108.923 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' C ' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.72 -52.46 13.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.74 . . . . 0.0 109.306 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.625 ' N ' ' CZ ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -61.25 -48.22 82.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.622 179.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -61.27 -43.71 98.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.136 -0.978 . . . . 0.0 109.256 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 1.3 tptt -54.25 -65.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.393 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.859 HG11 ' HD2' ' A' ' 125' ' ' PHE . 24.3 m -53.75 -32.24 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.227 -0.921 . . . . 0.0 109.03 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.791 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -54.98 -55.63 28.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.429 -0.795 . . . . 0.0 109.29 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -33.31 75.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -11.21 60.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -0.836 . . . . 0.0 109.971 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 1.4 m-80 -113.32 -32.07 6.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 145.12 55.01 0.02 OUTLIER Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.841 HG13 ' HA3' ' A' ' 23' ' ' GLY . 53.8 t -158.66 89.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.135 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.29 103.55 16.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.436 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 41.2 pt -138.12 -161.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.29 133.89 0.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.237 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt 52.12 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' ARG . 6.0 mm-40 -44.72 -39.83 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 48.23 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . . . -102.18 155.63 18.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -152.73 158.39 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -79.77 124.63 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.2 tt -72.78 96.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.173 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -155.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.176 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.19 -7.24 59.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.79 -18.05 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.27 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 77' ' ' PHE . 8.4 p-10 -61.01 -15.47 32.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.647 ' HE1' HD11 ' A' ' 94' ' ' ILE . 14.1 m-85 -82.81 2.04 36.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.152 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -47.88 -31.42 5.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.267 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.739 ' CD2' HD13 ' A' ' 8' ' ' LEU . 11.3 m-85 -134.94 156.07 49.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.33 -10.6 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.432 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.65 ' CG1' HG22 ' A' ' 7' ' ' VAL . 99.5 t -132.55 140.99 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.928 . . . . 0.0 110.387 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.447 ' HB ' HG12 ' A' ' 106' ' ' VAL . 53.1 mt -128.07 130.86 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -111.37 137.42 49.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.938 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.52 137.92 51.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.715 HD23 ' HB3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -96.69 -34.36 11.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.096 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.617 ' OD2' HD23 ' A' ' 12' ' ' LEU . 1.1 m-20 -111.57 -170.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 110.17 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -97.27 -36.9 10.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 p -43.96 -36.37 2.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.138 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.639 ' O ' HG22 ' A' ' 94' ' ' ILE . 1.6 mp -73.12 -63.98 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.478 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -53.88 -17.61 2.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.252 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -95.61 -32.81 12.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.395 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -95.82 -56.9 2.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.712 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -47.29 -34.35 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.172 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 94' ' ' ILE . 42.8 m-20 -78.48 -7.85 57.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.251 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -83.13 -18.54 39.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.913 . . . . 0.0 110.189 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.556 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 2.9 ptt? -102.16 -36.34 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 10.1 mtpt -56.0 136.62 73.47 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.16 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.19 -90.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.981 1.516 . . . . 0.0 110.503 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 102' ' ' CYS . 26.3 m -153.12 -101.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 110.107 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.4 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 100' ' ' SER . 0.2 OUTLIER -90.57 -169.95 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.75 29.41 4.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.82 154.33 1.89 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -121.25 150.45 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.447 HG12 ' HB ' ' A' ' 83' ' ' ILE . 12.8 m -105.54 145.39 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.15 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.468 HG21 ' CE1' ' A' ' 139' ' ' PHE . 11.1 m -135.34 142.35 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.478 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -85.94 128.18 34.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.137 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -85.33 -36.04 21.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.161 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.474 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 6.8 p30 175.76 166.3 0.4 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.9 Cg_endo -74.5 174.86 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.013 1.533 . . . . 0.0 110.188 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.2 Cg_endo -73.09 53.07 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.964 1.507 . . . . 0.0 110.437 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -143.04 -41.92 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.55 -74.06 0.68 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 115' ' ' VAL . 31.2 m -56.26 116.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.7 t70 -81.46 146.55 30.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.43 ' OD2' ' CZ ' ' A' ' 17' ' ' ARG . 19.4 m-20 -111.52 81.91 3.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 46.6 Cg_endo -73.34 116.51 4.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.955 1.503 . . . . 0.0 110.459 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -111.96 -38.2 4.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.46 56.0 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.097 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.93 139.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.1 m -47.91 -29.1 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.257 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.27 121.94 11.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 114.73 -57.36 0.47 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.859 ' HD2' HG11 ' A' ' 56' ' ' VAL . 6.3 m-30 -34.49 -53.82 0.96 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.645 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.8 Cg_endo -71.15 -59.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.651 1.343 . . . . 0.0 110.322 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 116' ' ' ASP . 97.1 m -53.37 -48.74 68.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.588 ' HE1' ' HG2' ' A' ' 19' ' ' PRO . 4.8 ttp -48.85 -69.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 109.817 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 1.109 ' CE1' HD12 ' A' ' 24' ' ' ILE . 9.0 t80 -43.81 -54.56 5.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.796 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 134' ' ' LYS . . . -51.85 -39.67 59.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.682 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.532 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 74.9 m -66.38 -57.75 6.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.803 HD12 ' SG ' ' A' ' 21' ' ' CYS . 12.0 mm -44.26 -47.97 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 136' ' ' MET . 2.5 t -71.22 -61.28 1.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 110.62 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -44.72 -23.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -112.43 14.92 20.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.973 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.541 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -118.7 -22.75 7.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -82.35 -47.06 0.94 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.111 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 49.5 Cg_endo -78.15 -8.77 16.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.862 1.454 . . . . 0.0 110.285 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.67 ' CZ ' ' CD2' ' A' ' 143' ' ' HIS . 71.6 t80 -103.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.283 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.053 HD12 HD13 ' A' ' 145' ' ' LEU . 3.2 tp -52.74 -24.56 8.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 80.0 m -88.19 -27.89 21.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.445 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.22 -12.41 16.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.154 -0.966 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.67 ' CD2' ' CZ ' ' A' ' 139' ' ' PHE . 3.5 t60 -84.59 39.69 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.21 45.69 87.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.053 HD13 HD12 ' A' ' 140' ' ' LEU . 1.4 mt -133.95 -58.53 0.85 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -1.133 . . . . 0.0 110.415 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.2 mp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.149 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.261 0.553 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.96 152.94 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 110.211 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.62 143.84 45.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.392 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.588 ' CG ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.8 156.89 24.68 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.685 ' H ' HG22 ' A' ' 34' ' ' ILE . 41.1 mtpt -127.03 -161.25 1.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.981 -1.075 . . . . 0.0 111.158 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.072 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -146.26 122.79 11.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.481 0.658 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' A' ' 34' ' ' ILE . 24.2 t -113.03 121.89 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.791 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.839 ' CG ' ' HB2' ' A' ' 38' ' ' ALA . 13.0 tp -94.85 81.45 3.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.405 -0.809 . . . . 0.0 110.398 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 7.5 p90 -74.36 140.41 44.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.151 -0.968 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.821 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 1.4 p -170.94 171.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 110.366 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.912 ' O ' HD12 ' A' ' 90' ' ' ILE . 46.9 t -140.74 -57.95 0.52 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.517 ' HA ' HD23 ' A' ' 12' ' ' LEU . 13.4 mt -155.56 -44.5 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.16 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -125.73 -3.95 6.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.997 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.6 t-20 64.67 30.21 12.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -1.148 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 70.8 mt -98.75 -35.8 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' SD ' ' A' ' 128' ' ' MET . 0.9 OUTLIER -104.57 18.68 21.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 1.023 ' HG2' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -135.86 -32.02 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -0.95 . . . . 0.0 110.311 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.542 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -62.15 -58.0 20.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 46.5 Cg_endo -73.08 -5.39 17.11 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.945 1.497 . . . . 0.0 110.456 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -107.03 -40.83 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.873 ' HA ' HD11 ' A' ' 132' ' ' ILE . 65.8 m -72.66 -36.88 68.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER -66.04 -45.15 82.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 110.075 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.546 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -70.78 -50.54 24.01 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.057 HD11 ' HB2' ' A' ' 133' ' ' SER . 0.3 OUTLIER -54.49 -44.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -1.213 . . . . 0.0 110.2 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.913 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.4 m -67.43 -52.55 38.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.21 -27.43 61.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.295 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -87.76 -30.08 20.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.379 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -78.81 -24.28 44.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.387 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.913 HG22 ' O ' ' A' ' 25' ' ' CYS . 19.5 m -119.32 -25.6 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 112.34 -63.16 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 18.9 p30 -179.76 70.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.809 ' O ' HD23 ' A' ' 33' ' ' LEU . 7.9 mmtt -102.76 -135.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 110.116 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 35' ' ' ILE . 32.7 mt -128.09 -119.31 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -0.974 . . . . 0.0 110.328 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.072 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 34.8 30.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 111.198 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -103.09 103.53 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.062 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.749 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 49.1 m-20 -136.71 132.63 35.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.147 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -108.48 144.89 35.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.839 ' HB2' ' CG ' ' A' ' 8' ' ' LEU . . . -134.07 179.06 6.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.36 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.997 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -172.53 89.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.195 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 40' ' ' THR . 3.5 m -85.72 83.08 7.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.231 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER 172.07 -53.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.236 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 56.97 104.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -145.91 -44.96 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.157 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.49 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 34.1 m-70 -124.23 27.44 7.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.454 ' H ' HG13 ' A' ' 45' ' ' VAL . 3.1 m -62.91 144.65 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.208 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' GLN . . . 71.41 29.03 68.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 44' ' ' HIS . 13.3 pt20 -177.39 -139.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -1.122 . . . . 0.0 110.08 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.2 OUTLIER 68.01 119.5 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.185 -0.947 . . . . 0.0 110.229 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.547 ' HD2' ' CE1' ' A' ' 119' ' ' TYR . 47.0 Cg_endo -69.37 73.56 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.056 1.556 . . . . 0.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.4 t0 -94.2 33.74 1.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.107 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -71.72 -24.21 61.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.226 -0.921 . . . . 0.0 108.977 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -72.05 -52.19 18.1 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.269 179.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.527 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -62.59 -50.17 72.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -0.772 . . . . 0.0 109.639 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.571 ' NE2' HD12 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -58.93 -43.97 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.553 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 4.5 ttpp -56.6 -68.65 0.2 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.658 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.553 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 19.5 m -48.35 -33.85 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.811 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.17 -52.13 66.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.17 -13.9 60.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.738 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -92.75 -12.29 31.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 110.117 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -117.15 -30.58 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.673 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 137.44 84.36 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.811 HG11 ' SG ' ' A' ' 57' ' ' CYS . 41.9 t -158.65 120.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -1.137 . . . . 0.0 110.126 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 64' ' ' ILE . 3.0 m-20 -90.17 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.954 . . . . 0.0 110.114 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 63' ' ' ASP . 12.0 pt -158.71 143.56 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 12.2 p -168.17 31.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 65' ' ' SER . 65.6 mmtt -149.2 -73.66 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.171 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 1.7 mp0 60.26 105.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 57.32 1.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -45.12 134.56 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.801 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 1.7 ptt-85 -166.22 156.97 12.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -79.15 135.07 36.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.245 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.459 HG13 ' OD2' ' A' ' 76' ' ' ASP . 19.7 tt -60.66 154.67 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -120.57 -65.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.164 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.63 -34.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.174 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.29 -15.49 16.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.459 ' OD2' HG13 ' A' ' 72' ' ' ILE . 5.4 m-20 -60.7 -23.19 64.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 22.3 m-85 -88.47 10.72 19.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -130.23 -62.44 0.94 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.551 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -45.52 -24.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 7.4 m-85 -131.3 154.28 48.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -104.14 -20.82 13.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 69.2 t -122.05 137.77 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.852 ' O ' HG22 ' A' ' 107' ' ' VAL . 3.3 mt -124.62 138.76 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.102 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' PHE . . . -121.6 126.09 48.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -108.66 152.29 25.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.023 HD22 ' HG2' ' A' ' 17' ' ' ARG . 1.4 tp -95.51 -43.58 7.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' HG22 ' A' ' 90' ' ' ILE . 27.0 t0 -103.94 168.72 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.298 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -81.0 -47.3 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.913 . . . . 0.0 110.215 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.2 t -43.29 -59.49 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.912 HD12 ' O ' ' A' ' 11' ' ' CYS . 8.9 tt -46.66 -35.49 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -72.07 -45.59 60.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.196 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 t -62.25 -30.5 71.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 97' ' ' MET . 72.1 m-20 -88.76 -53.68 4.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.485 ' O ' ' HG3' ' A' ' 97' ' ' MET . 3.8 tt -49.17 -37.25 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.497 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 1.9 t-20 -79.57 -16.2 56.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 47.8 t -87.43 -4.21 59.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.499 ' HE2' ' HZ ' ' A' ' 77' ' ' PHE . 1.5 ptt? -113.27 -11.63 13.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.571 ' HE3' ' CG ' ' A' ' 77' ' ' PHE . 13.4 mtpt -60.36 146.25 84.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.0 -171.78 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.055 1.555 . . . . 0.0 110.485 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.4 t -100.07 -5.64 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.162 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 6.4 p30 -128.34 59.18 1.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.18 176.03 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.38 16.51 2.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.66 -170.81 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.198 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -146.35 151.96 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.5 t -117.1 146.0 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 83' ' ' ILE . 35.5 m -144.94 161.13 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 142.6 27.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 0.1 OUTLIER -94.58 -45.78 7.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.979 ' HB3' HG21 ' A' ' 115' ' ' VAL . 48.7 m-80 -131.14 161.27 62.79 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.41 169.53 22.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.995 1.524 . . . . 0.0 110.317 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.37 50.09 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.955 1.503 . . . . 0.0 110.435 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -104.87 -37.98 6.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.99 84.24 0.13 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.979 HG21 ' HB3' ' A' ' 110' ' ' ASN . 59.0 t -119.12 -3.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.666 ' HB3' HD23 ' A' ' 86' ' ' LEU . 6.6 p-10 -131.05 156.45 45.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.183 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -175.95 150.22 1.08 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.56 -90.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.026 1.54 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.547 ' CE1' ' HD2' ' A' ' 49' ' ' PRO . 7.8 m-30 -95.97 -70.46 0.71 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER 58.93 149.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.404 ' HA ' ' CD2' ' A' ' 125' ' ' PHE . 53.8 p -160.0 21.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.3 26.47 6.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . -134.05 -45.32 0.11 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.657 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 27.0 m-85 -47.31 -46.59 57.34 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.244 -1.151 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -72.23 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.641 1.337 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.458 ' OG1' ' HA2' ' A' ' 124' ' ' GLY . 3.0 p -52.14 -48.02 65.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.729 ' O ' HG22 ' A' ' 132' ' ' ILE . 17.1 ttp -42.86 -76.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 110.355 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 1.014 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.6 t80 -53.1 -55.14 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.407 ' N ' ' HD1' ' A' ' 129' ' ' PHE . . . -47.03 -24.22 0.59 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.404 ' HB3' HG13 ' A' ' 115' ' ' VAL . 2.7 t -89.35 -61.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.873 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -52.59 -20.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.818 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 1.057 ' HB2' HD11 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -91.41 -56.12 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.808 . . . . 0.0 109.603 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -51.36 -24.4 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.688 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.47 50.37 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 110.034 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.633 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -117.87 -24.13 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.651 ' N ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -83.32 -40.82 0.81 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.461 -0.774 . . . . 0.0 110.29 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 137' ' ' LYS . 49.3 Cg_endo -79.76 -6.55 14.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.711 1.374 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.551 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 27.3 t80 -81.77 -69.0 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 136' ' ' MET . 0.9 OUTLIER -67.62 -22.85 65.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 146' ' ' ILE . 2.6 m -67.55 -31.93 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.016 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.86 -24.81 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 139' ' ' PHE . 14.7 m80 -66.39 -9.04 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . 114.79 58.98 0.36 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.581 ' H ' HD13 ' A' ' 146' ' ' ILE . 1.8 mt -162.65 61.14 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.058 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.272 0.558 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 55.31 67.09 1.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.09 137.68 56.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 110.524 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -72.55 -144.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 109.315 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.958 ' HB3' HG22 ' A' ' 34' ' ' ILE . 5.1 mtpt -143.2 150.24 39.08 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.663 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.793 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.93 113.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.478 -0.764 . . . . 0.0 109.917 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.697 HG22 ' CG1' ' A' ' 82' ' ' VAL . 28.5 t -102.99 134.13 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.745 HD13 ' CD2' ' A' ' 80' ' ' PHE . 7.8 tp -89.53 80.78 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.432 -0.792 . . . . 0.0 110.329 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.574 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 15.1 m-85 -68.48 110.43 4.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.039 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 49.0 t -135.1 153.54 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.897 . . . . 0.0 110.545 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.501 ' HB2' ' HD3' ' A' ' 17' ' ' ARG . 45.5 t -140.05 -56.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER 177.0 -60.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -0.908 . . . . 0.0 110.381 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . -82.57 -8.29 86.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.807 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.3 OUTLIER 67.26 27.45 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.211 . . . . 0.0 110.076 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.641 HG21 ' OG ' ' A' ' 48' ' ' SER . 93.6 mt -133.64 -36.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.23 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 79.8 m -42.71 -49.63 5.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.178 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.772 ' HD3' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -98.46 128.63 44.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.117 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.579 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER 172.36 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.799 ' O ' HG22 ' A' ' 64' ' ' ILE . 46.4 Cg_endo -73.59 -26.33 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.872 1.459 . . . . 0.0 110.332 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB1' ' HB2' ' A' ' 129' ' ' PHE . . . -106.74 -27.22 10.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 9' ' ' PHE . 4.2 t -79.02 -59.65 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.248 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 44.8 tt0 -56.41 -27.63 57.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.435 -0.791 . . . . 0.0 109.163 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -74.83 -55.59 5.29 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.788 HD11 ' CB ' ' A' ' 133' ' ' SER . 2.4 tp -52.71 -43.73 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.26 . . . . 0.0 109.835 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.827 ' SG ' HD11 ' A' ' 34' ' ' ILE . 73.2 m -74.7 -32.88 62.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 0.0 110.292 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.565 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 15.1 mmt180 -66.93 -39.75 87.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.949 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -79.59 -40.59 29.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.136 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.582 ' O ' HG13 ' A' ' 29' ' ' VAL . 18.7 mmt -71.41 -41.3 69.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 28' ' ' MET . 16.6 m -156.77 45.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -58.9 -19.12 42.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -84.12 27.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -1.089 . . . . 0.0 110.403 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' C ' HD12 ' A' ' 33' ' ' LEU . 52.6 mttt -150.75 -130.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.777 ' O ' HG13 ' A' ' 34' ' ' ILE . 4.7 mp -129.26 -112.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.958 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.6 OUTLIER 57.19 1.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.74 -0.6 . . . . 0.0 111.157 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.687 HD11 ' HB2' ' A' ' 25' ' ' CYS . 7.0 mt -114.07 103.71 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.88 -1.138 . . . . 0.0 110.95 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.597 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 10.3 m-20 -139.11 102.49 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.811 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.78 133.79 34.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.039 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . . . -147.7 166.58 27.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.337 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.807 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . . . 169.81 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 40' ' ' THR . 5.1 t -56.01 97.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 40' ' ' THR . 0.1 OUTLIER 174.68 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 110.199 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 44' ' ' HIS . . . 71.19 -106.32 1.86 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 52.86 -87.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.579 ' CD2' ' NE2' ' A' ' 47' ' ' GLN . 40.2 m170 -66.13 -7.81 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.757 HG23 ' HB3' ' A' ' 69' ' ' ALA . 2.1 p -49.44 129.85 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.261 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -27.04 20.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.579 ' NE2' ' CD2' ' A' ' 44' ' ' HIS . 3.0 pt20 -116.14 -134.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -1.144 . . . . 0.0 110.296 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.641 ' OG ' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 70.17 135.68 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.129 -0.982 . . . . 0.0 110.135 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.42 81.7 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.972 1.511 . . . . 0.0 110.422 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 31.8 p-10 -82.59 8.45 11.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -73.59 -26.96 61.05 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 108.981 179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -73.5 -48.66 31.59 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.31 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.536 ' HB2' ' CG ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -63.16 -49.85 72.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 0.0 109.65 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -60.33 -46.74 88.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.97 . . . . 0.0 109.411 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' N ' ' A' ' 56' ' ' VAL . 7.5 ttpt -54.84 -69.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.82 . . . . 0.0 109.588 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.744 HG22 ' OD1' ' A' ' 60' ' ' ASN . 7.7 p -49.34 -34.92 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.265 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.952 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -54.89 -50.97 67.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 109.379 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -73.52 -22.18 60.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -12.94 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.0 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.744 ' OD1' HG22 ' A' ' 56' ' ' VAL . 11.2 m120 -111.23 -14.93 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.408 -0.808 . . . . 0.0 109.036 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.569 ' O ' ' CZ ' ' A' ' 129' ' ' PHE . . . 96.41 100.98 1.94 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.952 HG12 ' O ' ' A' ' 57' ' ' CYS . 13.9 p -172.11 145.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -86.03 118.05 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.799 HG22 ' O ' ' A' ' 19' ' ' PRO . 8.1 pt -130.23 173.07 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.152 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 51.6 p -165.96 29.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 65' ' ' SER . 0.0 OUTLIER 58.54 149.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 110.228 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.431 ' OE1' ' CB ' ' A' ' 18' ' ' SER . 2.2 pt20 -165.43 -150.94 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.023 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.63 -178.65 7.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB3' HG23 ' A' ' 45' ' ' VAL . . . -106.51 122.82 47.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -110.47 25.6 11.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.108 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.548 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 3.4 pt20 38.24 -152.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 110.441 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.493 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 13.2 tt -133.22 164.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.0 p -125.46 -78.67 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 75' ' ' ALA . 2.3 pttp -164.88 -36.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -56.61 -20.4 20.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 0.0 110.226 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.6 p30 -42.59 -28.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 23.8 m-85 -70.69 -42.13 71.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.262 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.521 ' OG ' ' NH2' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -96.52 -48.55 5.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 4.2 tptt -44.49 -25.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 0.0 110.255 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.745 ' CD2' HD13 ' A' ' 8' ' ' LEU . 9.8 m-85 -133.07 -179.76 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.473 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.16 -29.37 4.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.844 . . . . 0.0 110.375 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.88 HG21 ' CD2' ' A' ' 143' ' ' HIS . 6.0 p -129.54 142.39 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.162 -0.961 . . . . 0.0 110.379 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.569 HG12 ' CD2' ' A' ' 8' ' ' LEU . 3.1 mt -113.78 134.22 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.1 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.0 122.37 47.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.12 137.12 42.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.772 HD22 ' HD3' ' A' ' 17' ' ' ARG . 5.1 tp -108.5 11.55 26.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -152.19 174.32 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.246 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.11 -57.92 3.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.148 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -51.44 42.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.985 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.918 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.7 tt -44.58 -51.13 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.607 ' H ' HG23 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -61.88 -55.79 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 96' ' ' SER . 2.7 t -54.49 -18.43 4.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.937 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 96' ' ' SER . 22.2 m-20 -85.28 -69.28 0.67 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 0.0 110.213 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 90' ' ' ILE . 3.2 mt -47.92 -53.14 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.432 -0.793 . . . . 0.0 109.982 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -59.11 -15.35 13.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.61 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -80.74 -40.69 24.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.995 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.747 ' CE ' HG23 ' A' ' 94' ' ' ILE . 6.9 ptt? -85.2 -26.9 26.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.567 ' CE ' ' CE1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -42.84 139.68 2.04 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.177 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.18 -161.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.052 1.554 . . . . 0.0 110.42 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 t -102.54 -4.56 25.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.213 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -155.8 111.01 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.216 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.411 ' SG ' ' NZ ' ' A' ' 98' ' ' LYS . 31.8 p -137.6 -159.31 0.94 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.521 ' NH2' ' OG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -132.31 31.82 4.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.112 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.86 37.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.124 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.85 162.18 18.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.527 HG22 HD13 ' A' ' 83' ' ' ILE . 90.3 t -116.09 130.04 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.54 164.04 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.141 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -108.24 131.13 55.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.088 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CD1' ' CE1' ' A' ' 139' ' ' PHE . 2.9 t80 -74.8 -61.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.503 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.7 OUTLIER -152.96 175.46 2.96 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.142 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.518 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 48.0 Cg_endo -75.15 175.9 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.042 1.548 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.37 4.86 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.937 1.493 . . . . 0.0 110.661 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.94 -1.48 16.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.256 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 116' ' ' ASP . . . -116.99 -107.24 2.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.614 HG13 ' HA ' ' A' ' 128' ' ' MET . 17.2 t -72.69 75.28 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -1.14 . . . . 0.0 110.214 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -155.1 138.83 16.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -112.74 110.83 51.9 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.463 ' HG2' ' OG ' ' A' ' 122' ' ' SER . 46.3 Cg_endo -73.04 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.95 1.5 . . . . 0.0 110.496 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.436 ' O ' ' C ' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -166.93 146.67 5.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.319 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.436 ' C ' ' O ' ' A' ' 119' ' ' TYR . 2.7 t80 42.26 -139.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -43.29 116.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' A' ' 118' ' ' PRO . 4.7 m -155.17 -177.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.331 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -136.94 20.85 3.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.106 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 116' ' ' ASP . . . -99.49 -23.63 10.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 52' ' ' ARG . 9.9 m-85 -44.02 -57.26 6.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.085 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.4 Cg_endo -70.77 -44.11 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.905 1.476 . . . . 0.0 110.105 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 27.9 m -61.44 -27.45 68.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.614 ' HA ' HG13 ' A' ' 115' ' ' VAL . 30.7 ttp -60.1 -70.22 0.18 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.273 -0.892 . . . . 0.0 109.832 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.767 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 75.4 t80 -67.9 -21.87 65.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.79 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -65.95 -42.13 90.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 110.004 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.604 ' CB ' HG22 ' A' ' 115' ' ' VAL . 14.8 t -84.3 -31.69 24.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.274 -0.892 . . . . 0.0 108.787 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.769 HG23 HG12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -67.75 -27.83 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.682 -0.636 . . . . 0.0 109.395 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.788 ' CB ' HD11 ' A' ' 24' ' ' ILE . 24.9 p -103.18 -23.85 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.795 . . . . 0.0 110.272 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -88.6 -18.94 26.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.08 -1.013 . . . . 0.0 110.339 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.545 ' CG ' ' HG2' ' A' ' 138' ' ' PRO . 3.3 tt0 -124.31 40.01 3.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.381 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.576 ' HG2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -84.46 -20.41 31.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.968 . . . . 0.0 110.496 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -87.11 -44.48 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.865 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.9 Cg_endo -76.48 2.98 6.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.609 1.321 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.587 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 71.7 t80 -108.05 -70.03 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.537 HD21 ' CE ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -62.54 -44.07 97.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.217 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.627 HG23 HD12 ' A' ' 146' ' ' ILE . 1.9 m -64.56 -10.33 25.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.36 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 138' ' ' PRO . 13.8 mm-40 -104.7 -46.95 4.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.302 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.88 ' CD2' HG21 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -44.46 -24.57 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.134 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.453 ' C ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.83 35.94 0.5 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.491 HD22 ' HG2' ' A' ' 5' ' ' LYS . 19.1 mt -137.45 -94.53 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.627 HD12 HG23 ' A' ' 141' ' ' THR . 2.4 tp . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.26 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.301 0.572 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.39 45.38 0.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -178.03 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.491 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -117.96 144.41 45.53 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 34' ' ' ILE . 4.4 mttt -119.1 -155.95 0.63 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.024 -1.048 . . . . 0.0 110.879 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.99 148.73 51.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.715 ' N ' ' HA ' ' A' ' 34' ' ' ILE . 16.7 t -139.06 113.29 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.794 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.055 HD12 ' HB3' ' A' ' 36' ' ' ASP . 5.0 tp -78.7 101.34 7.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.453 -0.779 . . . . 0.0 110.784 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.516 ' CD2' ' SG ' ' A' ' 21' ' ' CYS . 36.8 m-85 -87.33 106.65 18.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.717 HG22 ' HB3' ' A' ' 38' ' ' ALA . 6.0 t -134.1 177.73 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 110.959 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 10' ' ' VAL . 1.7 p 169.6 53.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.786 . . . . 0.0 110.146 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 16.6 mt 54.77 -89.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' CYS . . . -89.91 80.22 1.47 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 38' ' ' ALA . 1.8 t-20 -58.44 -44.49 89.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -1.178 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.576 HG23 ' HE3' ' A' ' 66' ' ' LYS . 9.4 mt -38.78 -30.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 110.303 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 17' ' ' ARG . 26.8 p -125.38 34.99 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 109.811 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.644 ' HB3' HD23 ' A' ' 86' ' ' LEU . 43.8 mtt180 -157.27 80.81 0.91 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 110.175 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.614 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER 56.78 43.09 1.04 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 111.022 179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 18' ' ' SER . 45.3 Cg_endo -73.66 -21.44 19.12 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.743 1.391 . . . . 0.0 109.781 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.798 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -89.01 7.33 35.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.679 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.7 OUTLIER -56.41 -40.21 74.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.124 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.966 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -60.68 -44.22 96.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.281 0.562 . . . . 0.0 110.035 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' ILE . . . -74.14 -63.8 2.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.917 HG21 HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -42.36 -46.0 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 110.166 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.624 ' N ' HG23 ' A' ' 24' ' ' ILE . 69.0 m -72.98 -39.74 65.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 110.103 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 3.2 mmt180 -55.1 -34.88 64.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.736 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -88.95 -32.47 17.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 0.0 110.127 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.14 -27.01 60.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.411 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.651 HG12 ' HG3' ' A' ' 32' ' ' LYS . 10.1 t -123.79 -22.89 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.234 -0.916 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' ARG . . . 103.04 -168.62 18.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.98 80.71 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -1.118 . . . . 0.0 110.133 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.651 ' HG3' HG12 ' A' ' 29' ' ' VAL . 7.5 mmtp -112.96 -137.77 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ILE . 18.1 mt -122.5 -40.13 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.22 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.839 HD11 ' CD1' ' A' ' 35' ' ' ILE . 2.6 pp -33.3 -32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.762 . . . . 0.0 110.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.966 HG23 ' HA ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -76.92 88.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 110.526 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 1.055 ' HB3' HD12 ' A' ' 8' ' ' LEU . 7.1 m-20 -124.35 71.4 1.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.907 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 1.6 t -73.04 131.2 41.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.717 ' HB3' HG22 ' A' ' 10' ' ' VAL . . . -144.05 -171.9 3.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.256 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . . . -166.37 145.69 5.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 40' ' ' THR . 11.1 t -125.68 76.67 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 -59.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.46 36.77 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.99 -57.59 1.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -1.169 . . . . 0.0 110.212 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.423 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -85.78 63.61 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 68' ' ' ARG . 2.1 p -148.07 149.79 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.331 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.05 21.62 27.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 48' ' ' SER . 6.5 pt20 -173.82 -149.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.18 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER 67.83 120.79 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.219 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.24 89.08 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.977 1.514 . . . . 0.0 110.455 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.7 p30 -88.43 14.47 9.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -74.1 -37.54 64.12 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.125 -0.984 . . . . 0.0 108.719 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.43 -37.96 68.45 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.345 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.53 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 6.3 m -65.63 -59.55 3.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.458 -0.776 . . . . 0.0 109.811 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 63.9 mt-30 -57.95 -44.15 86.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.165 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -53.34 -72.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.49 -0.756 . . . . 0.0 109.701 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' ' 125' ' ' PHE . 43.5 t -43.69 -38.17 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.362 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.578 ' CA ' HG13 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -55.28 -50.54 69.28 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.437 -0.79 . . . . 0.0 109.427 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -67.37 -28.08 67.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.505 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -83.29 -9.01 59.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.11 -31.4 7.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 135.18 60.39 0.06 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 129' ' ' PHE . 1.9 p 173.69 139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -1.163 . . . . 0.0 110.129 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -91.52 142.71 27.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.731 HG23 ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER 68.63 -175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.731 ' N ' HG23 ' A' ' 64' ' ' ILE . 5.6 t 179.66 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.073 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.576 ' HE3' HG23 ' A' ' 15' ' ' ILE . 4.9 mmmt -115.72 -168.69 1.45 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.936 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.3 pt20 177.67 144.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -61.95 79.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.089 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 45' ' ' VAL . . . -49.0 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.347 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 68' ' ' ARG . 2.6 ptt-85 -103.09 -149.04 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -103.28 146.54 28.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.216 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.526 HD11 ' HB3' ' A' ' 76' ' ' ASP . 19.9 tt -82.43 173.73 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.269 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.482 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 34.1 m -100.96 6.52 43.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 73' ' ' THR . 14.5 mtmt 68.19 5.23 4.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.3 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.59 -3.16 58.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.948 . . . . 0.0 110.331 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.596 ' HA ' ' CE1' ' A' ' 80' ' ' PHE . 11.9 p-10 -65.47 -24.61 67.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.608 ' CD1' ' HD3' ' A' ' 98' ' ' LYS . 21.3 m-85 -86.69 16.13 5.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 110.228 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.34 -15.23 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.576 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.641 ' HB3' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -127.25 -145.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.125 -0.985 . . . . 0.0 110.033 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.641 ' CD1' ' HB3' ' A' ' 79' ' ' LYS . 0.6 OUTLIER 37.87 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.448 -0.782 . . . . 0.0 110.676 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -135.53 -43.52 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 6' ' ' ALA . 11.8 p -137.24 159.6 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 110.626 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.694 ' HB ' HG12 ' A' ' 106' ' ' VAL . 1.7 mp -124.42 122.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . . . -108.54 131.12 55.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.58 161.65 19.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.644 HD23 ' HB3' ' A' ' 17' ' ' ARG . 7.1 tp -93.22 -43.37 8.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.414 ' C ' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -102.2 177.47 4.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.395 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.499 ' HG3' HD11 ' A' ' 108' ' ' LEU . 14.8 mt-30 -89.87 -38.25 13.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 88' ' ' GLN . 23.2 t -42.36 -39.87 2.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.5 mp -65.97 -53.59 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -63.77 -16.03 60.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.214 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 t -88.37 -39.22 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.373 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.41 -22.32 21.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.843 HD13 HG11 ' A' ' 106' ' ' VAL . 2.8 tt -68.41 -37.86 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' SER . 29.2 p30 -70.2 -18.59 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASN . 48.0 t -78.0 -34.65 50.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.553 ' CE ' HG13 ' A' ' 94' ' ' ILE . 19.8 ptt? -93.29 -30.22 15.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.047 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.608 ' HD3' ' CD1' ' A' ' 77' ' ' PHE . 7.7 mmmt -38.98 141.52 0.6 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.478 -0.764 . . . . 0.0 110.704 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.489 ' HD2' ' HD2' ' A' ' 98' ' ' LYS . 46.4 Cg_endo -72.43 -179.79 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.18 1.621 . . . . 0.0 110.567 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -114.26 19.88 15.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.6 OUTLIER -153.14 78.92 1.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.281 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 6.4 p -143.56 -172.1 3.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.92 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.444 ' HD2' ' C ' ' A' ' 102' ' ' CYS . 1.1 mpt_? -135.34 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -163.76 165.43 23.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -141.61 170.11 16.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.843 HG11 HD13 ' A' ' 94' ' ' ILE . 33.0 m -111.52 167.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.52 HG13 ' C ' ' A' ' 106' ' ' VAL . 28.1 m -154.25 157.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 110.225 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.499 HD11 ' HG3' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -94.61 125.96 39.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -89.61 93.25 9.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -0.878 . . . . 0.0 110.17 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.46 ' ND2' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER 65.62 159.31 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.472 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.1 Cg_endo -74.56 174.44 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.04 1.547 . . . . 0.0 110.383 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 47.0 Cg_endo -73.4 52.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.94 1.495 . . . . 0.0 110.403 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.24 -59.33 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.59 -46.87 65.61 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.774 HG12 ' HB2' ' A' ' 131' ' ' SER . 30.2 m -92.18 46.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -137.24 113.63 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -140.19 142.7 30.92 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 -13.65 26.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.069 1.563 . . . . 0.0 110.494 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.6 t80 50.14 38.89 18.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.64 -50.28 65.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -139.35 -69.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.02 44.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -103.7 -7.96 20.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.173 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -90.67 -40.03 5.74 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.641 ' HB3' HG11 ' A' ' 56' ' ' VAL . 5.4 m-30 -45.06 -47.5 31.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.148 -1.207 . . . . 0.0 110.472 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 125' ' ' PHE . 45.8 Cg_endo -72.42 -57.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.575 1.302 . . . . 0.0 110.382 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 15.5 m -64.57 -57.22 9.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.185 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.662 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 7.6 ttp -40.43 -69.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.755 ' CE1' HD12 ' A' ' 24' ' ' ILE . 75.3 t80 -55.93 -44.75 78.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.045 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 126' ' ' PRO . . . -46.94 -59.77 2.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.94 . . . . 0.0 110.014 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.774 ' HB2' HG12 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -65.14 -45.2 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 110.024 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.917 HG23 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -43.27 -53.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.826 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.624 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -80.75 -37.77 29.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 131' ' ' SER . 5.2 tttt -50.08 -32.29 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 8.3 mm-40 -103.97 -5.59 22.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.189 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' A' ' 133' ' ' SER . 0.7 OUTLIER -82.78 14.24 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -104.71 -63.39 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.448 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 44.5 Cg_endo -72.26 -4.39 15.13 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.786 1.414 . . . . 0.0 110.471 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.657 ' CE2' HG11 ' A' ' 7' ' ' VAL . 34.1 t80 -93.1 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.997 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -45.52 -28.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 110.143 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 146' ' ' ILE . 7.5 m -47.55 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.817 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 141' ' ' THR . 11.7 mt-10 -106.44 -0.27 24.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 110.792 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 33.77 5.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 111.16 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.697 ' HA3' HD13 ' A' ' 140' ' ' LEU . . . 173.42 -27.37 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.485 -1.341 . . . . 0.0 109.901 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.997 ' HB3' HD12 ' A' ' 140' ' ' LEU . 0.3 OUTLIER 175.02 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.234 -1.156 . . . . 0.0 110.363 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.774 HG22 ' CD2' ' A' ' 145' ' ' LEU . 7.3 tp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.116 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.265 0.555 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 1' ' ' ALA . . . 175.39 112.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.227 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 158.21 30.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.266 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -82.99 -179.05 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.847 . . . . 0.0 109.237 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 1.019 ' C ' HG22 ' A' ' 34' ' ' ILE . 17.1 mttm -142.73 -161.34 1.23 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.065 -1.022 . . . . 0.0 110.676 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.031 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -141.18 121.92 14.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.244 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.996 ' HB ' HD12 ' A' ' 34' ' ' ILE . 2.7 t -111.22 123.0 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.765 . . . . 0.0 109.329 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 10' ' ' VAL . 6.5 tp -93.52 84.88 4.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.439 -0.788 . . . . 0.0 110.757 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.53 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 55.7 m-85 -60.79 123.73 18.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 8' ' ' LEU . 25.1 t -124.97 168.82 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.719 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.854 ' HB3' HD13 ' A' ' 86' ' ' LEU . 20.9 p -169.02 -141.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.911 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 76.07 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 14' ' ' ASN . . . 129.04 -6.89 6.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 13' ' ' GLY . 6.2 t-20 41.71 37.62 0.78 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -1.145 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.73 HD13 ' HB3' ' A' ' 48' ' ' SER . 3.2 mt -144.22 -59.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 15' ' ' ILE . 56.1 m -106.0 59.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.83 ' CB ' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -153.5 -50.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.468 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -152.13 47.76 0.43 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.038 -1.039 . . . . 0.0 110.743 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 18' ' ' SER . 47.7 Cg_endo -74.65 -16.0 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.843 1.444 . . . . 0.0 110.113 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.916 ' HB3' HG13 ' A' ' 132' ' ' ILE . . . -91.97 6.63 45.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.871 ' SG ' HD11 ' A' ' 132' ' ' ILE . 55.5 m -63.96 -35.01 79.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.642 ' HG2' HG23 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -68.83 -55.54 10.83 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.526 -0.734 . . . . 0.0 110.177 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' A' ' 63' ' ' ASP . . . -62.28 -51.81 53.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.784 HD11 ' CB ' ' A' ' 133' ' ' SER . 8.9 tp -56.3 -44.27 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 110.308 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.566 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 23.1 m -64.96 -35.52 81.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.238 -0.914 . . . . 0.0 110.054 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.4 mtt-85 -66.44 -45.12 80.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 110.124 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -34.9 58.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -74.96 -46.86 32.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 30' ' ' GLY . 13.6 m -150.93 45.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 26' ' ' ARG . . . -43.22 -28.55 0.86 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -47.47 85.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -1.145 . . . . 0.0 110.061 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 34' ' ' ILE . 21.6 mttt -65.98 -23.25 66.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.138 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.941 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 67.66 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.031 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER 30.07 37.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.553 -0.717 . . . . 0.0 111.66 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.941 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -92.0 93.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.906 -1.121 . . . . 0.0 110.361 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.582 ' OD2' ' HB1' ' A' ' 6' ' ' ALA . 10.0 m-20 -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -168.86 163.15 11.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 110.372 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -169.26 -164.68 0.47 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' O ' HG22 ' A' ' 72' ' ' ILE . . . -174.92 -176.95 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -151.28 25.01 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -0.75 5.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 43' ' ' PHE . . . 49.88 -104.04 0.1 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 64.64 119.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.248 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.532 ' CD2' ' CD ' ' A' ' 47' ' ' GLN . 35.8 m170 55.66 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.309 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 69' ' ' ALA . 80.9 t 52.42 80.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.07 6.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.532 ' CD ' ' CD2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -148.75 13.86 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.247 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.73 ' HB3' HD13 ' A' ' 15' ' ' ILE . 2.7 t -106.97 111.64 63.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 47.1 Cg_endo -69.58 100.72 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 3.6 p30 -86.16 26.03 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.424 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -32.06 61.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.257 -0.902 . . . . 0.0 108.92 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.9 mtt180 -71.83 -52.23 18.49 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.213 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -52.59 65.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.43 -0.794 . . . . 0.0 109.359 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 6.8 tt0 -54.24 -56.42 18.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HE3' HG23 ' A' ' 56' ' ' VAL . 3.9 ttpp -44.85 -66.89 0.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.393 -0.817 . . . . 0.0 109.52 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.871 HG21 ' CB ' ' A' ' 125' ' ' PHE . 91.8 t -45.32 -36.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.639 ' CB ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.7 -42.15 92.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.439 -0.788 . . . . 0.0 109.042 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 1.6 mmtp -71.76 -27.74 63.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.416 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.42 -9.33 54.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -109.8 -26.61 9.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.195 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 115.43 81.26 0.92 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.639 HG13 ' CB ' ' A' ' 57' ' ' CYS . 2.1 p 174.66 170.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -1.1 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.567 ' N ' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -156.03 144.13 19.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.435 ' CG1' ' HG3' ' A' ' 54' ' ' GLN . 2.3 pt -133.51 164.89 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -115.58 76.05 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.947 . . . . 0.0 110.256 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 65' ' ' SER . 4.6 mttt 60.53 152.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.948 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -105.3 -64.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.09 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.767 ' HB3' HG22 ' A' ' 45' ' ' VAL . . . -49.12 157.59 0.43 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -0.891 . . . . 0.0 110.178 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -147.95 33.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 3.1 pt20 37.58 -153.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 72' ' ' ILE . 3.9 tt -153.73 129.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.211 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 174.24 6.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -72.94 -5.98 42.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -77.19 -34.2 56.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -42.65 -48.41 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.544 ' CE2' ' HG2' ' A' ' 98' ' ' LYS . 14.6 m-30 -47.3 -30.42 3.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.8 m -117.56 29.61 7.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.541 ' C ' ' CD1' ' A' ' 80' ' ' PHE . 9.6 tppt? -124.88 -9.36 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 79' ' ' LYS . 69.5 m-85 -140.3 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -124.34 -44.56 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 110.385 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 41.3 t -131.73 137.18 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.499 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' O ' HG22 ' A' ' 107' ' ' VAL . 54.4 mt -116.45 142.11 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.817 . . . . 0.0 110.044 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 107' ' ' VAL . . . -127.66 162.66 26.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -142.99 145.58 33.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -70.56 -79.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.539 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.427 ' HB2' ' CD1' ' A' ' 90' ' ' ILE . 7.3 m-20 -78.92 175.74 10.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 110.467 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.463 ' O ' ' C ' ' A' ' 89' ' ' SER . 2.6 mm-40 -74.22 -41.46 61.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 88' ' ' GLN . 2.8 t -40.13 -50.61 2.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.012 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.768 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.7 mt -61.37 -58.48 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 108' ' ' LEU . 3.1 tp -42.25 -60.97 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.119 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 96' ' ' SER . 46.6 t -55.33 -39.44 70.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.965 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 96' ' ' SER . 0.3 OUTLIER -54.3 -55.38 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.067 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.5 mp -57.89 -56.77 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -63.99 -19.23 65.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.844 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 92' ' ' SER . 1.0 OUTLIER -71.85 -8.86 56.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.5 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 7.6 mtm -125.88 -48.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.544 ' HG2' ' CE2' ' A' ' 77' ' ' PHE . 9.7 mtpt -41.82 138.14 1.82 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.96 -160.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.006 1.53 . . . . 0.0 110.581 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.1 m -106.56 5.32 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -134.97 104.95 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -174.01 4.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 28.8 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -148.59 176.38 10.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 110.182 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 104' ' ' ALA . 34.7 mtmt -143.23 166.12 25.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.13 -0.981 . . . . 0.0 110.282 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.4 t -117.27 132.64 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.9 HG11 ' CD2' ' A' ' 143' ' ' HIS . 32.1 m -128.21 153.61 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.575 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -100.95 146.98 26.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 135' ' ' GLU . 3.3 t80 -106.73 110.58 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.091 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' PHE . 2.1 m120 59.0 166.75 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.049 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 170.09 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.001 1.527 . . . . 0.0 110.278 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.9 51.93 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.398 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -156.56 -46.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.8 -67.65 2.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.589 HG22 ' OG ' ' A' ' 131' ' ' SER . 10.1 t -98.84 100.7 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -1.114 . . . . 0.0 110.116 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -174.87 88.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.24 130.33 7.58 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 -90.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.939 1.494 . . . . 0.0 110.487 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.04 21.16 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.182 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -65.47 117.02 7.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.7 t 52.18 -143.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.168 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.91 39.55 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -93.52 32.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 128' ' ' MET . . . -124.48 -49.2 0.21 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.871 ' CB ' HG21 ' A' ' 56' ' ' VAL . 5.6 m-85 -41.65 -48.95 10.06 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.249 -1.147 . . . . 0.0 110.305 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.9 Cg_endo -71.45 -56.97 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.597 1.314 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 16.7 m -59.76 -51.87 67.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 124' ' ' GLY . 12.1 ttp -41.29 -63.71 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.284 -0.885 . . . . 0.0 109.96 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.716 ' CE1' HD13 ' A' ' 24' ' ' ILE . 94.2 t80 -56.63 -42.1 78.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.617 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -46.12 -57.43 4.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.774 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.589 ' OG ' HG22 ' A' ' 115' ' ' VAL . 11.2 p -71.44 -43.97 65.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.523 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.916 HG13 ' HB3' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -42.1 -37.61 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.689 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.784 ' CB ' HD11 ' A' ' 24' ' ' ILE . 1.4 p -97.19 -42.36 7.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.3 OUTLIER -44.93 -46.54 11.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -102.72 41.71 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.202 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.63 ' HE2' ' HA ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -116.49 -2.35 12.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.264 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.608 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -104.88 -63.57 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 137' ' ' LYS . 46.9 Cg_endo -73.58 1.14 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.75 1.395 . . . . 0.0 110.488 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.523 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 31.9 t80 -87.88 -68.56 0.75 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 140' ' ' LEU . 4.0 pp -74.03 -23.71 59.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.592 HG23 HG21 ' A' ' 146' ' ' ILE . 3.3 m -59.74 -43.04 94.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 144' ' ' GLY . 49.7 mt-10 -96.0 -37.33 10.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.9 ' CD2' HG11 ' A' ' 107' ' ' VAL . 1.2 m80 -44.01 -25.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 124.66 68.32 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -155.66 18.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.592 HG21 HG23 ' A' ' 141' ' ' THR . 23.6 pt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.192 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.24 0.543 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 46.51 -145.65 0.21 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.87 . . . . 0.0 110.189 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' OE1' ' CB ' ' A' ' 32' ' ' LYS . 14.7 tt0 -152.46 172.85 15.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 110.359 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.591 ' C ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -64.04 -69.53 0.27 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.512 -0.742 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 14.3 mttm -152.34 -155.59 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.981 . . . . 0.0 111.353 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.986 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -119.95 152.91 36.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.712 -0.618 . . . . 0.0 110.234 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.652 HG23 ' HB ' ' A' ' 34' ' ' ILE . 15.1 t -111.62 127.26 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 83' ' ' ILE . 10.2 tp -90.01 81.86 6.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 136' ' ' MET . 27.3 m-85 -68.82 117.49 10.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.943 . . . . 0.0 109.46 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 38' ' ' ALA . 52.7 t -130.9 161.04 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.601 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.876 ' HB3' HD22 ' A' ' 86' ' ' LEU . 28.6 p -159.38 39.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.102 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 90' ' ' ILE . 1.2 mt 59.38 60.49 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.267 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.882 ' H ' ' HB1' ' A' ' 39' ' ' ALA . . . 132.13 -24.72 3.97 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.922 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 13.5 t30 59.28 14.88 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -1.168 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' CA ' ' HB3' ' A' ' 19' ' ' PRO . 12.9 mt -123.17 -1.54 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 22.5 p -144.21 165.61 27.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.237 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.795 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.8 OUTLIER 71.05 -56.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 110.416 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.878 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.0 t -152.97 50.36 0.6 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.792 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 18' ' ' SER . 50.1 Cg_endo -78.17 -19.27 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.864 1.455 . . . . 0.0 110.066 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.671 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -86.76 6.73 30.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -0.79 . . . . 0.0 110.279 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.602 ' HA ' ' CG2' ' A' ' 24' ' ' ILE . 21.4 p -58.21 -28.96 65.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.337 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 26' ' ' ARG . 0.6 OUTLIER -67.66 -40.15 84.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.594 -0.691 . . . . 0.0 110.191 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -74.73 -49.69 10.28 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.807 HG21 HG23 ' A' ' 132' ' ' ILE . 1.1 tp -57.84 -44.35 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 0.0 110.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.742 ' SG ' HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -71.34 -43.37 67.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.314 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 2.7 mmm180 -58.97 -38.3 78.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.22 -39.67 47.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.117 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.525 ' C ' HG13 ' A' ' 29' ' ' VAL . 21.8 mtp -67.69 -51.09 53.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 28' ' ' MET . 14.0 m -151.3 44.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.319 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 26' ' ' ARG . . . -63.54 -20.78 64.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -67.19 -7.37 23.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.412 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . 6.5 mttm -116.27 -137.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.05 -1.031 . . . . 0.0 110.272 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.814 ' O ' HG13 ' A' ' 34' ' ' ILE . 23.2 mt -120.34 -122.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.986 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 0.6 OUTLIER 49.46 3.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.621 -0.674 . . . . 0.0 111.644 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -104.09 95.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.832 -1.167 . . . . 0.0 110.547 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.875 ' OD1' ' HB1' ' A' ' 6' ' ' ALA . 3.1 m-20 -137.05 106.8 6.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.424 ' OG ' ' HG2' ' A' ' 22' ' ' GLU . 19.2 m -89.57 127.63 35.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.158 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.888 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -144.43 166.64 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.922 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . . . -166.3 106.5 0.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' THR . 3.2 t -80.59 86.28 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 40' ' ' THR . 12.5 p 177.33 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 94.15 1.01 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -155.83 -40.54 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -1.136 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.27 92.91 4.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.88 . . . . 0.0 110.226 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 69' ' ' ALA . 38.5 t -148.19 160.73 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.257 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.46 24.99 7.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 48' ' ' SER . 13.1 pt20 -159.87 -148.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' GLN . 0.5 OUTLIER 61.39 90.78 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 110.21 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 48' ' ' SER . 46.2 Cg_endo -69.36 80.53 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.957 1.503 . . . . 0.0 110.439 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -93.01 33.71 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.304 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.502 ' HA ' ' CG ' ' A' ' 54' ' ' GLN . 1.3 m -75.52 -31.52 60.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 108.908 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.613 ' O ' HG22 ' A' ' 56' ' ' VAL . 52.3 mtt180 -73.01 -48.96 31.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.313 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.585 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -61.81 -51.34 68.64 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.664 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' NE2' ' N ' ' A' ' 55' ' ' LYS . 4.6 pp0? -64.2 -33.86 76.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HE2' HG13 ' A' ' 56' ' ' VAL . 8.3 ttpt -60.04 -67.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 125' ' ' PHE . 27.5 m -53.51 -35.08 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.066 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.8 m -53.6 -50.79 64.89 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.425 -0.797 . . . . 0.0 109.261 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -31.8 71.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.492 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 1.2 t -77.05 -10.14 59.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.84 . . . . 0.0 110.034 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -112.89 -26.91 8.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.126 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 135.67 53.74 0.06 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.671 HG11 ' HB1' ' A' ' 20' ' ' ALA . 65.1 t -158.3 109.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -108.87 125.15 51.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.5 pt -106.22 174.63 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -131.3 -50.73 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 0.0 110.174 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -140.33 86.23 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.23 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.9 59.76 5.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -125.73 99.57 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' GLY . . . -44.45 159.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.222 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -160.38 40.45 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 110.235 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 70' ' ' ARG . 32.2 tt0 63.05 126.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.256 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -68.85 123.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.892 . . . . 0.0 110.14 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.61 ' N ' HD13 ' A' ' 72' ' ' ILE . 22.8 p -73.56 -175.82 2.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.895 . . . . 0.0 110.333 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 -15.93 25.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.21 -20.85 63.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.59 ' HB3' HD11 ' A' ' 72' ' ' ILE . 21.7 p-10 -52.03 -29.97 23.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE1' ' HD2' ' A' ' 98' ' ' LYS . 19.6 m-85 -86.19 49.05 1.71 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.268 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 1.3 t 171.66 -61.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.244 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.547 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -42.24 -27.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 110.228 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.832 ' CB ' ' HB3' ' A' ' 6' ' ' ALA . 8.1 m-85 -131.02 -135.13 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.079 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB3' ' HD2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -177.95 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 0.0 110.644 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 16.3 t -104.5 84.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.015 -1.053 . . . . 0.0 110.463 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.849 HG21 ' CD1' ' A' ' 94' ' ' ILE . 2.9 mp -72.68 114.22 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.961 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 9' ' ' PHE . . . -97.67 124.33 41.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -117.09 126.95 53.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.878 HD21 ' HB2' ' A' ' 18' ' ' SER . 1.1 mp -64.47 -54.42 32.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.352 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.46 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -103.29 -165.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 0.0 110.22 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 96.1 mt-30 -94.83 -36.84 11.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -42.84 -45.35 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.565 HD12 ' H ' ' A' ' 90' ' ' ILE . 2.2 mp -62.5 -47.2 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.205 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.11 -30.87 71.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.119 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.2 t -79.49 -30.8 42.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 96' ' ' SER . 3.3 m-20 -79.69 -55.27 5.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 83' ' ' ILE . 10.0 tt -47.58 -43.64 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 110.203 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.605 ' N ' HG23 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -71.08 -23.65 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -67.53 -10.35 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.183 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.561 ' CE ' ' HA ' ' A' ' 94' ' ' ILE . 6.4 mtm -116.64 -50.96 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.567 ' HD2' ' CE1' ' A' ' 77' ' ' PHE . 11.3 mtpt -40.78 129.75 1.89 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 110.432 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.445 ' HG2' ' OD1' ' A' ' 101' ' ' ASN . 46.3 Cg_endo -72.72 -163.54 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.025 1.539 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -101.16 28.72 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.269 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 22.9 p30 -150.79 94.2 2.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.06 179.04 8.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.82 6.73 4.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.267 -0.896 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -105.9 122.87 47.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.49 162.27 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.698 HG12 ' HB ' ' A' ' 83' ' ' ILE . 27.9 m -125.23 127.15 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.25 159.41 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 109' ' ' PHE . 3.5 tt -116.79 141.35 48.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.157 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.575 ' N ' HD23 ' A' ' 108' ' ' LEU . 7.5 m-85 -103.77 113.14 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 111' ' ' PRO . 2.0 t30 58.66 144.77 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.533 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 46.3 Cg_endo -74.27 176.06 10.12 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.052 1.554 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 44.7 Cg_endo -71.74 53.83 1.92 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.892 1.47 . . . . 0.0 110.383 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -158.44 19.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.211 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 116' ' ' ASP . . . -135.91 -90.52 0.31 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 131' ' ' SER . 8.3 t -60.63 83.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -1.166 . . . . 0.0 110.19 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 114' ' ' GLY . 22.4 t70 -129.68 131.12 46.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.466 ' OD2' ' HA3' ' A' ' 124' ' ' GLY . 23.4 t0 -159.83 102.09 1.45 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.34 -89.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.994 1.523 . . . . 0.0 110.461 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.04 32.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.208 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 121' ' ' SER . 0.1 OUTLIER -93.03 102.25 14.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 58.94 173.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.35 65.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -115.94 129.42 56.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.159 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 128' ' ' MET . . . 112.31 -34.82 4.97 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.692 ' HB3' HG21 ' A' ' 56' ' ' VAL . 9.9 m-30 -41.31 -49.72 8.81 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.68 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 43.3 Cg_endo -70.87 -64.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.547 1.288 . . . . 0.0 110.436 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.571 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 21.4 p -53.33 -54.96 28.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.895 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.5 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 ttp -42.28 -69.72 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 110.024 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 24' ' ' ILE . 61.9 t80 -44.0 -49.66 8.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.757 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 127' ' ' THR . . . -47.92 -47.04 32.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.8 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -74.31 -33.68 63.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.882 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.807 HG23 HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -55.32 -45.5 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.615 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.555 ' N ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -83.71 -38.14 21.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.302 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 131' ' ' SER . 62.7 mm-40 -90.56 -30.33 17.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 9' ' ' PHE . 13.7 mtm -99.65 4.45 45.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.2 OUTLIER -86.85 -51.04 0.45 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 0.0 110.017 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 50.2 Cg_endo -79.88 -6.67 14.28 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.99 1.521 . . . . 0.0 110.435 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.639 ' CE1' ' CD2' ' A' ' 143' ' ' HIS . 85.2 t80 -108.16 -78.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.53 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 34' ' ' ILE . 15.9 tp -44.14 -24.62 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.481 ' HA ' ' HB ' ' A' ' 146' ' ' ILE . 4.6 m -89.11 -31.58 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.963 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 138' ' ' PRO . 3.3 mm-40 -105.09 -39.09 6.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 110.284 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.639 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 14.3 t-80 -40.39 -29.39 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 145' ' ' LEU . . . 127.0 60.87 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.53 HD22 HG21 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -154.87 -39.83 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -1.142 . . . . 0.0 110.183 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 146' ' ' ILE . 53.6 mt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.218 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.261 0.553 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.69 115.21 30.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 110.221 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.19 163.63 16.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.258 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.731 ' HG2' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.46 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.874 . . . . 0.0 108.758 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.687 ' HB2' HG22 ' A' ' 34' ' ' ILE . 9.3 mtpp -159.01 -164.42 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.977 -1.077 . . . . 0.0 110.493 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.763 ' HA ' ' CA ' ' A' ' 34' ' ' ILE . . . 178.91 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.566 -0.709 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.011 HG22 ' O ' ' A' ' 34' ' ' ILE . 2.1 m -90.55 138.66 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.976 . . . . 0.0 110.169 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.694 ' HG ' ' HB2' ' A' ' 38' ' ' ALA . 7.4 tp -89.89 88.15 7.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 110.129 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.645 ' CE2' HG21 ' A' ' 7' ' ' VAL . 5.5 m-85 -72.69 114.16 10.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.752 HG13 HD11 ' A' ' 90' ' ' ILE . 2.1 p -165.8 171.26 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.67 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.732 ' HA ' HD12 ' A' ' 90' ' ' ILE . 10.1 t 175.27 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 51.08 49.66 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 0.0 110.09 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.21 70.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.73 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -44.74 -45.35 9.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -1.14 . . . . 0.0 110.136 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 45' ' ' VAL . 25.9 mt -61.33 -12.35 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 19.8 m -99.67 153.4 19.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.966 ' HG2' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 61.5 11.07 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.387 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.62 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -91.96 -64.26 0.16 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.976 . . . . 0.0 110.172 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.62 ' CD ' ' CB ' ' A' ' 18' ' ' SER . 47.8 Cg_endo -74.27 -1.4 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.793 1.417 . . . . 0.0 110.299 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -103.15 -47.4 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.451 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.864 ' HA ' HD11 ' A' ' 132' ' ' ILE . 60.4 m -70.25 -38.51 75.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.978 . . . . 0.0 109.969 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.84 -44.28 96.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . -70.06 -48.5 39.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 ' CE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -53.0 -53.0 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -1.143 . . . . 0.0 110.038 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.937 ' HB3' HD11 ' A' ' 35' ' ' ILE . 63.9 m -69.4 -62.15 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 22.6 mmt180 -47.47 -22.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 23.8 t0 -85.81 -45.01 11.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 2.0 mtt -83.16 -1.72 53.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.0 110.425 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 25' ' ' CYS . 3.0 m -131.0 -28.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.947 . . . . 0.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 31' ' ' ASP . . . 100.09 -58.75 0.76 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 17.5 p30 178.32 102.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -1.144 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.595 ' C ' HD12 ' A' ' 33' ' ' LEU . 13.3 ptpt -152.96 -136.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.009 ' O ' HD12 ' A' ' 35' ' ' ILE . 5.1 mp -112.78 -127.61 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.011 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.6 OUTLIER 51.62 4.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.598 -0.689 . . . . 0.0 111.157 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.009 HD12 ' O ' ' A' ' 33' ' ' LEU . 3.2 mt -127.48 113.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 0.0 110.717 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 8.2 m-20 -142.79 111.73 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.74 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.55 127.68 32.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.262 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' CG1' ' A' ' 10' ' ' VAL . . . -128.58 177.48 6.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -167.79 96.31 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.159 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.544 ' CG2' HG13 ' A' ' 90' ' ' ILE . 74.7 p -41.98 -35.19 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 m -116.97 -167.19 1.26 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.86 77.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -128.02 0.02 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 0.0 110.256 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 0.4 OUTLIER -122.42 -11.41 8.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.292 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.615 ' HA ' HD11 ' A' ' 15' ' ' ILE . 34.3 m -62.48 159.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.246 -0.909 . . . . 0.0 110.299 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.06 21.91 64.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.516 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 6.5 pt20 -173.7 -148.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -1.134 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 48' ' ' SER . 0.8 OUTLIER 64.43 112.41 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.35 87.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.928 1.488 . . . . 0.0 110.451 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -86.16 30.49 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.103 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -73.86 -27.46 61.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.23 -0.919 . . . . 0.0 109.005 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.605 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -71.61 -54.9 8.91 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.288 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.573 ' CB ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -59.7 -51.22 70.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 109.37 179.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -60.86 -41.61 96.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.603 ' HE3' HG23 ' A' ' 56' ' ' VAL . 1.5 ttpt -52.83 -66.36 0.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' HE3' ' A' ' 55' ' ' LYS . 52.6 t -50.61 -37.34 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.895 . . . . 0.0 109.115 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -52.02 -52.65 49.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.488 -0.758 . . . . 0.0 109.409 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 -27.28 64.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.528 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 2.0 t -78.64 -11.48 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 109.896 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.36 -19.95 13.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.589 ' C ' HG13 ' A' ' 62' ' ' VAL . . . 106.16 97.07 2.48 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.731 HG12 ' CE2' ' A' ' 129' ' ' PHE . 16.1 m -154.76 -147.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.154 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.447 ' C ' HG23 ' A' ' 64' ' ' ILE . 5.7 t0 179.43 117.07 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.326 -0.859 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.533 ' HB ' ' NE2' ' A' ' 67' ' ' GLN . 15.0 pt -146.65 -37.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.334 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 64' ' ' ILE . 2.3 t 68.75 -67.0 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 16.0 mmtt -136.05 -174.03 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.29 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.533 ' NE2' ' HB ' ' A' ' 64' ' ' ILE . 98.7 mm-40 -139.49 -77.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.17 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.87 84.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.73 ' HB1' ' CG ' ' A' ' 14' ' ' ASN . . . -76.95 179.05 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.221 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -153.11 29.92 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.263 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 50.7 tt0 55.93 162.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.961 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.476 HG13 ' OD2' ' A' ' 76' ' ' ASP . 5.3 tt -62.69 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.225 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.429 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -149.91 147.35 27.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 110.172 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -13.97 10.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . -89.9 -9.65 48.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' OD2' HG13 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -44.55 -42.88 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.05 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 35.5 m-85 -59.31 -17.42 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 t -113.05 -44.15 3.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 110.057 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.605 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 18.0 tptt -45.89 -27.95 1.0 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.071 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 27.7 m-85 -144.78 179.25 7.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 110.196 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -114.87 -13.58 11.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 110.583 -179.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 76.9 t -128.74 143.67 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 0.0 110.465 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' VAL . 1.9 mp -116.71 119.92 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -100.41 110.92 23.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 110.654 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.932 ' HB1' HG21 ' A' ' 90' ' ' ILE . . . -104.74 133.21 49.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.023 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.966 HD22 ' HG2' ' A' ' 17' ' ' ARG . 2.6 tp -82.41 -31.15 29.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.279 -0.888 . . . . 0.0 110.49 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 90' ' ' ILE . 21.9 p-10 -118.65 178.81 4.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.977 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.52 -41.34 13.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.145 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.2 m -45.09 -48.0 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.035 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.932 HG21 ' HB1' ' A' ' 85' ' ' ALA . 6.5 tt -53.65 -39.46 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.032 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.509 ' N ' HG23 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -70.7 -42.16 71.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.917 . . . . 0.0 110.089 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.7 t -63.43 -30.93 71.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -88.54 -57.44 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.558 HG13 ' CE ' ' A' ' 97' ' ' MET . 3.1 tt -46.04 -32.9 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 110.182 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.486 ' HA ' ' HG3' ' A' ' 98' ' ' LYS . 8.0 t-20 -78.67 -15.19 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -9.2 57.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.212 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.558 ' CE ' HG13 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -112.44 -21.51 11.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.145 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -49.48 151.73 2.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.192 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 100' ' ' SER . 44.3 Cg_endo -72.03 -52.19 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.966 1.508 . . . . 0.0 110.399 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 168.28 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.49 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 40.4 m-80 -163.81 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.364 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER 71.56 -150.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 109.951 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -133.47 63.24 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 81' ' ' ASP . . . -156.36 156.05 33.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.8 139.67 53.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.164 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 61.6 t -94.22 139.2 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.673 HG11 ' NE2' ' A' ' 143' ' ' HIS . 16.1 m -136.53 142.63 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.02 132.56 38.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.16 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.493 ' HB3' HD12 ' A' ' 86' ' ' LEU . 10.1 t80 -87.05 -20.84 26.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 3.6 p-10 -177.48 164.66 1.37 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 47.0 Cg_endo -74.49 174.31 12.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.017 1.535 . . . . 0.0 110.348 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.77 51.57 2.34 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -111.63 -44.43 3.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.31 102.86 0.99 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.424 HG11 ' OD1' ' A' ' 110' ' ' ASN . 7.9 p -122.52 -9.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.687 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.2 t70 -117.02 -127.96 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.09 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -157.09 86.24 2.81 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.31 55.56 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.068 1.562 . . . . 0.0 110.45 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.468 ' O ' ' CB ' ' A' ' 120' ' ' TYR . 1.1 m-85 46.45 -159.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.468 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 2.6 t80 67.06 9.15 6.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 120' ' ' TYR . 2.2 t 171.75 165.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.115 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -111.14 -17.99 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 123' ' ' ASP . 2.9 p30 -67.02 68.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 122' ' ' SER . . . -176.77 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.67 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 15.5 m-85 -41.39 -51.37 8.52 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.341 -1.093 . . . . 0.0 110.471 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.67 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 45.5 Cg_endo -72.42 -56.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.754 1.397 . . . . 0.0 110.334 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.8 m -52.74 -42.82 65.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.765 ' O ' HG22 ' A' ' 132' ' ' ILE . 24.8 ttp -49.69 -77.04 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 0.0 109.764 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 1.048 ' CE2' HD12 ' A' ' 24' ' ' ILE . 4.4 t80 -46.6 -54.55 9.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.114 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 134' ' ' LYS . . . -50.84 -23.96 3.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.4 t -91.31 -57.29 2.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.338 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.864 HD11 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -54.71 -19.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.823 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.764 ' HB2' HD11 ' A' ' 24' ' ' ILE . 1.8 t -99.11 -50.19 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 109.77 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 130' ' ' ALA . 12.0 tttt -59.31 -17.24 27.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.926 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HD2' ' A' ' 138' ' ' PRO . 1.4 tt0 -116.6 10.29 14.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.872 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.57 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 3.4 tpt -81.29 8.45 9.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 110.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.5 mtmt -88.6 -52.25 0.37 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 48.1 Cg_endo -76.66 6.79 3.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.97 1.511 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.57 ' CD2' ' CE ' ' A' ' 136' ' ' MET . 60.1 t80 -96.28 -60.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.153 -0.967 . . . . 0.0 110.366 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 140' ' ' LEU . 3.9 pp -84.6 -13.68 50.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.391 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 137' ' ' LYS . 3.4 m -69.31 -32.57 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.141 -0.974 . . . . 0.0 110.156 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 143' ' ' HIS . 16.5 mm-40 -102.45 -38.78 7.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.203 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.673 ' NE2' HG11 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -43.59 -32.7 1.0 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.307 -0.87 . . . . 0.0 110.236 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.97 73.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 145' ' ' LEU . 1.5 mt -163.05 -62.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 141' ' ' THR . 26.5 pt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.236 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.307 0.575 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.31 47.97 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.182 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.56 157.08 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.268 -0.895 . . . . 0.0 110.274 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.797 ' HG3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -84.19 150.74 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 179.263 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 34' ' ' ILE . 8.4 mtpt -134.48 -155.74 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 110.761 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.113 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . . . -133.54 134.73 43.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 110.697 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.6 HG23 ' CG2' ' A' ' 34' ' ' ILE . 73.0 t -124.01 123.98 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.724 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.643 HD12 ' HB3' ' A' ' 36' ' ' ASP . 5.6 tp -80.79 103.41 10.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.67 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.64 102.86 13.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.033 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 57.4 t -129.45 169.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.394 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.54 ' N ' HG12 ' A' ' 10' ' ' VAL . 39.7 t -158.52 -65.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.583 HD11 ' CB ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 169.93 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.265 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 99.96 -26.91 22.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.641 ' ND2' ' HB2' ' A' ' 39' ' ' ALA . 2.6 t-20 70.53 3.28 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.334 -1.098 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.715 HD13 ' HB2' ' A' ' 48' ' ' SER . 97.7 mt -101.17 -39.81 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 59.7 m -121.89 153.37 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.989 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.973 ' CB ' HD23 ' A' ' 86' ' ' LEU . 11.0 mtm105 55.79 55.61 6.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.908 . . . . 0.0 110.1 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 176.1 -57.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.422 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 18' ' ' SER . 44.0 Cg_endo -72.08 -12.29 27.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.001 1.527 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.75 -11.48 28.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.065 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.662 ' HA ' HD11 ' A' ' 132' ' ' ILE . 28.3 m -64.75 -43.91 91.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 1.9 mt-10 -48.0 -52.85 18.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.499 -0.75 . . . . 0.0 109.717 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.966 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -64.27 -45.27 93.98 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.939 HD11 ' CD1' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -48.92 -52.27 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -1.097 . . . . 0.0 109.847 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.636 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -64.83 -43.89 91.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.064 179.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.474 ' HA ' ' N ' ' A' ' 31' ' ' ASP . 16.6 mtt85 -53.27 -44.54 68.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.17 -16.54 37.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.764 ' O ' HG13 ' A' ' 29' ' ' VAL . 2.9 mmt -83.32 -30.39 27.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.31 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 28' ' ' MET . 2.5 m -161.24 24.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 64.35 37.39 94.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.712 ' OD1' HD13 ' A' ' 35' ' ' ILE . 1.9 t70 68.7 85.31 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.14 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 29' ' ' VAL . 12.2 mmtt -88.9 36.17 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.974 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.916 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 71.91 -144.07 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 110.066 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.113 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 1.5 pp 35.65 22.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.492 -0.755 . . . . 0.0 112.032 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.2 mt -97.31 90.47 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.081 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' A' ' 8' ' ' LEU . 4.1 m-20 -122.95 79.43 1.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.312 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.16 130.94 44.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 110.039 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.033 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . . . -145.71 -176.33 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.665 ' HA ' HG13 ' A' ' 10' ' ' VAL . . . -148.06 150.14 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.192 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.826 ' CG2' HG23 ' A' ' 90' ' ' ILE . 69.3 p -83.1 -77.92 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.472 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.39 76.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 110.193 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.03 97.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.45 -10.24 11.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -1.162 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.692 ' O ' HD11 ' A' ' 15' ' ' ILE . 32.2 m170 -117.68 98.51 6.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.174 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 69' ' ' ALA . 9.1 t -123.58 148.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.77 26.05 1.75 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 12.18 4.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -1.128 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.715 ' HB2' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -117.6 178.98 0.89 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 48' ' ' SER . 45.7 Cg_endo -69.21 -57.65 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 3.9 m-20 67.2 -54.86 0.46 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 m -71.84 -22.81 61.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.219 -0.925 . . . . 0.0 109.099 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HG2' ' CE2' ' A' ' 125' ' ' PHE . 19.6 tpp180 -73.58 -57.65 3.85 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.386 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.547 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -59.76 -48.76 80.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.163 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 57' ' ' CYS . 1.0 OUTLIER -60.99 -40.3 92.97 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.14 179.205 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HG3' ' N ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -55.32 -64.06 0.96 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.599 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 5.7 p -52.25 -34.72 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.041 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.847 ' SG ' HG11 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -55.73 -50.68 69.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.76 . . . . 0.0 109.388 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -68.06 -31.8 71.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 109.713 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.9 t -78.3 -11.27 59.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 0.0 109.987 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.566 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 5.4 m-20 -111.53 -34.75 5.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.313 -0.867 . . . . 0.0 109.11 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 138.32 73.55 0.05 OUTLIER Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.966 HG13 ' HA3' ' A' ' 23' ' ' GLY . 42.5 t -158.59 142.24 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -1.149 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 18.9 p30 -142.56 104.64 4.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.533 HD13 ' NE2' ' A' ' 67' ' ' GLN . 41.6 pt -108.39 -146.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.446 ' N ' HG13 ' A' ' 64' ' ' ILE . 11.0 p -145.78 -45.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.344 -0.848 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HD2' ' OG ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -150.54 150.07 30.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.533 ' NE2' HD13 ' A' ' 64' ' ' ILE . 2.3 mt-30 -130.27 116.89 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 1.8 ptm180 -151.93 123.6 7.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.639 ' HB3' HG22 ' A' ' 45' ' ' VAL . . . -70.63 121.91 18.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.154 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -132.44 15.25 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 72' ' ' ILE . 12.1 tt0 53.96 168.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 76' ' ' ASP . 16.6 tt -94.44 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -0.877 . . . . 0.0 110.277 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 7.3 m -109.75 15.68 22.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.5 mmtt 66.24 5.38 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.284 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -88.01 -24.07 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.286 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.826 ' HB3' HD11 ' A' ' 72' ' ' ILE . 5.2 p-10 -43.54 -29.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CZ ' ' HG2' ' A' ' 98' ' ' LYS . 29.1 m-85 -71.21 -27.2 63.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -123.18 9.23 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.153 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.467 ' C ' ' CD1' ' A' ' 80' ' ' PHE . 5.4 tptt -107.3 -36.83 6.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 5.9 m-30 -114.78 -142.59 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.78 -38.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 72.4 t -124.3 151.79 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.414 HG23 HD23 ' A' ' 8' ' ' LEU . 2.7 mt -129.78 114.92 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.482 ' HA ' HG23 ' A' ' 107' ' ' VAL . . . -98.14 138.36 35.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.98 141.53 49.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.199 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.973 HD23 ' CB ' ' A' ' 17' ' ' ARG . 5.0 tp -95.04 4.52 53.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.616 ' CB ' HD11 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -146.41 -156.08 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -117.77 -42.76 2.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.583 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -44.51 -28.69 0.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.826 HG23 ' CG2' ' A' ' 40' ' ' THR . 1.4 mp -70.9 -48.77 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.885 . . . . 0.0 110.126 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.425 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -68.61 -27.35 65.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.208 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 t -78.48 -40.51 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 96' ' ' SER . 40.1 m-20 -83.7 -50.54 8.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 95' ' ' ASN . 3.4 tt -45.43 -41.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.561 ' N ' HG23 ' A' ' 94' ' ' ILE . 3.5 t-20 -66.53 -7.84 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.229 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 57.2 m -86.79 -22.85 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.545 ' CE ' HG13 ' A' ' 94' ' ' ILE . 10.7 ptt? -104.98 -35.4 7.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 97' ' ' MET . 8.7 mtpt -42.24 122.8 2.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.155 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.97 -172.31 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.901 1.474 . . . . 0.0 110.455 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.21 13.4 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.887 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -137.41 91.47 2.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.0 p -149.65 177.07 10.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.39 27.03 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.2 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -118.07 138.17 52.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.7 156.63 17.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.445 ' C ' HG13 ' A' ' 107' ' ' VAL . 6.1 t -112.58 158.25 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.522 HG11 ' NE2' ' A' ' 143' ' ' HIS . 33.0 m -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.69 142.18 27.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.566 ' CE2' ' HE3' ' A' ' 136' ' ' MET . 0.1 OUTLIER -90.91 -64.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.44 ' OD1' HG22 ' A' ' 115' ' ' VAL . 10.5 p30 -141.78 164.17 36.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.484 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 46.4 Cg_endo -74.39 174.73 12.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.945 1.497 . . . . 0.0 110.281 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 111' ' ' PRO . 46.5 Cg_endo -73.09 52.45 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.65 -40.14 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.092 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.22 -67.89 1.98 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.568 HG23 ' HD3' ' A' ' 17' ' ' ARG . 21.8 m -103.51 86.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -1.196 . . . . 0.0 110.063 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.444 ' C ' ' HD3' ' A' ' 118' ' ' PRO . 9.9 t70 -67.52 160.85 26.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.79 67.84 4.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.1 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 116' ' ' ASP . 46.0 Cg_endo -72.8 162.99 39.69 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.05 1.553 . . . . 0.0 110.539 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.71 163.77 27.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.163 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 50.83 26.82 2.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 122' ' ' SER . 26.0 t -155.53 -168.7 2.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.42 ' N ' ' OG ' ' A' ' 121' ' ' SER . 44.2 p -141.28 75.63 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -29.98 2.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 128' ' ' MET . . . -101.72 -34.7 4.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.676 ' HB2' ' HD3' ' A' ' 126' ' ' PRO . 12.3 m-85 -41.34 -55.38 5.33 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -1.128 . . . . 0.0 110.278 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.676 ' HD3' ' HB2' ' A' ' 125' ' ' PHE . 44.8 Cg_endo -71.92 -60.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.835 1.439 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 131' ' ' SER . 9.8 m -49.83 -44.16 49.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.173 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.678 ' O ' HG22 ' A' ' 132' ' ' ILE . 25.1 ttp -50.95 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.21 -0.931 . . . . 0.0 109.788 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.939 ' CD1' HD11 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -45.81 -59.05 3.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.904 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' CG ' ' A' ' 134' ' ' LYS . . . -46.46 -26.45 0.86 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 110.037 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.555 ' CB ' ' CG1' ' A' ' 115' ' ' VAL . 1.1 m -87.92 -71.39 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -42.17 -25.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 179.072 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.516 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . 22.9 t -90.22 -60.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -51.61 -22.29 3.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.056 -1.028 . . . . 0.0 110.119 -179.918 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.528 ' HB3' ' CE1' ' A' ' 109' ' ' PHE . 0.8 OUTLIER -110.89 11.3 22.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.815 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.592 ' HA ' ' CE ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -88.15 -3.84 58.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 1.8 mttt -90.55 -47.64 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.996 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 47.5 Cg_endo -75.37 1.84 7.47 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.631 1.332 . . . . 0.0 110.557 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.621 ' CZ ' ' NE2' ' A' ' 143' ' ' HIS . 4.5 t80 -105.67 -47.25 3.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 110.037 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -78.3 -53.71 7.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.792 HG23 ' OXT' ' A' ' 146' ' ' ILE . 5.0 m -44.65 -26.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 143' ' ' HIS . 39.3 mt-10 -104.61 -40.3 6.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.621 ' NE2' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -43.05 -26.83 0.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.087 -1.008 . . . . 0.0 110.195 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 142' ' ' GLU . . . 127.18 67.32 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.677 ' HB2' HD23 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -161.19 -70.72 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 110.114 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.792 ' OXT' HG23 ' A' ' 141' ' ' THR . 2.0 tt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.208 179.933 . . . . . . . . 1 1 . 1 stop_ save_